{"reaction_id": "31-117-CAS-22288687", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 35.0, "time_h": 0.75, "yield_pct": 80.0}, "smiles": {"reactants": "COc1ccc(C(=CC(=O)O)Cc2ccccc2)cc1.CCCN", "products": "CCCNC(=O)CC(=Cc1ccccc1)c1ccc(OC)cc1"}, "reference": {"title": "Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents", "authors": "Imran Ahamad, Mohd.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(11), 127138.", "doi": "10.1016/j.bmcl.2020.127138", "raw": "Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents | Imran Ahamad, Mohd.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(11), 127138. | 10.1016/j.bmcl.2020.127138"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-117-CAS-22288687", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 30 min, 0 °C", "1.2|15 min, 0 °C; 35 °C", "Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis", "By: Yu, Wei-Chieh; et al", "Journal of Medicinal Chemistry (2023), 66(15), 10528-10557.", "10.1021/acs.jmedchem.3c00644"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "ac220dd2", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 75-64-9 + 402-13-1 | PRO: 142641-24-5 | RGT: 1892-57-5 + 2592-95-2 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents\", \"authors\": \"Imran Ahamad, Mohd.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(11), 127138.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-117-CAS-22288687\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 30 min, 0 °C\", \"1.2\", \"15 min, 0 °C; 35 °C\", \"56. Scheme 56 (1 Reaction)\", \"Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis\", \"By: Yu, Wei-Chieh; et al\", \"Journal of Medicinal Chemistry (2023), 66(15), 10528-10557.\", \"10.1021/acs.jmedchem.3c00644\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-64-9\", \"402-13-1\"], \"pro_cas\": [\"142641-24-5\"], \"rgt_cas\": [\"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-64-9", "402-13-1"], "products": ["142641-24-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-170-CAS-23304717", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "KOH", "cas": "1310-58-3", "role": "BASE"}, {"name": "Potassium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethyl Sulfoxide", "cas": "67-68-5"}], "conditions": {"temperature_c": 125.0, "time_h": 21.0, "yield_pct": 83.0}, "smiles": {"reactants": "Nc1cc(F)ccc1C(=O)O.CC(=O)O.N=CN.CN(C)CCCO", "products": "CN(C)CCCOc1ccc2c(=O)nc[nH]c2c1"}, "reference": {"title": "Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors", "authors": "Reddy, Julakanti Satyanarayana; et al", "citation": "Organic Process Research & Development (2021), 25(4), 817-830.", "doi": "10.1021/acs.oprd.0c00515", "raw": "Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors | Reddy, Julakanti Satyanarayana; et al | Organic Process Research & Development (2021), 25(4), 817-830. | 10.1021/acs.oprd.0c00515"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-170-CAS-23304717", "1.1|Solvents: Dimethyl sulfoxide; rt; 4 h, rt → 120 °C", "1.2|1 h, 120 °C", "1.3|Reagents: Potassium hydroxide; 16 h, 125 °C", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/KOH|1310-58-3+Potassium hydroxide|/Dimethyl Sulfoxide|67-68-5", "cond_sig": "7ca62e4d", "fam_sig": "1bfe3eaa"}, "raw_data": {"raw_cas": "RCT: 3075104-43-4 + 62965-35-9 | PRO: 3075104-54-7 | RGT: 1310-58-3 | SOL: 67-68-5", "raw_data_json": "{\"txt\": {\"title\": \"Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors\", \"authors\": \"Reddy, Julakanti Satyanarayana; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(4), 817-830.\", \"reagents\": [\"Potassium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Dimethyl sulfoxide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-170-CAS-23304717\", \"1.1\", \"Solvents: Dimethyl sulfoxide; rt; 4 h, rt → 120 °C\", \"1.2\", \"1 h, 120 °C\", \"1.3\", \"Reagents: Potassium hydroxide; 16 h, 125 °C\", \"103. Scheme 103 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-43-4\", \"62965-35-9\"], \"pro_cas\": [\"3075104-54-7\"], \"rgt_cas\": [\"1310-58-3\"], \"cat_cas\": [], \"sol_cas\": [\"67-68-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3075104-43-4", "62965-35-9"], "products": ["3075104-54-7"], "reagents": ["KOH"], "catalysts": [], "solvents": ["Dimethyl Sulfoxide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-356-CAS-22071800", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 40.0, "time_h": 30.0, "yield_pct": 82.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CO.Cl.C(=NC1CCCCC1)=NC1CCCCC1.O=C(O)/C=C/c1ccc(F)cc1", "products": "COC(=O)[C@H](CO)NC(=O)/C=C/c1ccc(F)cc1.COC(=O)[C@H](COC(=O)/C=C/c1ccc(F)cc1)NC(=O)/C=C/c1ccc(F)cc1.O=C(/C=C/c1ccc(F)cc1)OC(=NC1CCCCC1)NC1CCCCC1"}, "reference": {"title": "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine", "authors": "Aguirre-Renteria, Saul A.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.", "doi": "10.1016/j.bmcl.2020.127074", "raw": "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine | Aguirre-Renteria, Saul A.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074. | 10.1016/j.bmcl.2020.127074"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-356-CAS-22071800", "1.1|Reagents: Triethylamine", "Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C", "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease", "By: Kilpelainen, Tommi P.; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.", "10.1021/acs.jmedchem.3c00235"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 154740-93-9 + 13515-97-4 | PRO: 3007690-41-4 | RGT: 121-44-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine\", \"authors\": \"Aguirre-Renteria, Saul A.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-356-CAS-22071800\", \"1.1\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C\", \"88. Scheme 88 (1 Reaction)\", \"Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease\", \"By: Kilpelainen, Tommi P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.\", \"10.1021/acs.jmedchem.3c00235\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"154740-93-9\", \"13515-97-4\"], \"pro_cas\": [\"3007690-41-4\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["154740-93-9", "13515-97-4"], "products": ["3007690-41-4"], "reagents": ["Triethylamine"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-356-CAS-22071801", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 40.0, "time_h": 30.0, "yield_pct": 82.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CO.Cl.COc1ccc(/C=C/C(=O)O)cc1", "products": "COC(=O)[C@H](CO)NC(=O)/C=C/c1ccc(OC)cc1.COC(=O)[C@H](COC(=O)/C=C/c1ccc(OC)cc1)NC(=O)/C=C/c1ccc(OC)cc1"}, "reference": {"title": "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine", "authors": "Aguirre-Renteria, Saul A.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.", "doi": "10.1016/j.bmcl.2020.127074", "raw": "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine | Aguirre-Renteria, Saul A.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074. | 10.1016/j.bmcl.2020.127074"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-356-CAS-22071801", "1.1|Reagents: Triethylamine", "Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C", "1.2|Reagents: Dicyclohexylcarbodiimide", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "eb31588e", "fam_sig": "a163b931"}, "raw_data": {"raw_cas": "RCT: 51293-47-1 + 34017-27-1 | PRO: 2387522-85-0 | RGT: 121-44-8 + 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine\", \"authors\": \"Aguirre-Renteria, Saul A.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.\", \"reagents\": [\"Triethylamine\", \"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-356-CAS-22071801\", \"1.1\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C\", \"1.2\", \"Reagents: Dicyclohexylcarbodiimide\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C\", \"90. Scheme 90 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"51293-47-1\", \"34017-27-1\"], \"pro_cas\": [\"2387522-85-0\"], \"rgt_cas\": [\"121-44-8\", \"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["51293-47-1", "34017-27-1"], "products": ["2387522-85-0"], "reagents": ["Triethylamine", "N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-356-CAS-22071802", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 40.0, "time_h": 30.0, "yield_pct": 85.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CO.Cl.C(=NC1CCCCC1)=NC1CCCCC1.Cc1ccc(/C=C/C(=O)O)cc1", "products": "Cc1ccc(/C=C/C(=O)OC(=NC2CCCCC2)NC2CCCCC2)cc1.COC(=O)[C@H](CO)NC(=O)/C=C/c1ccc(C)cc1.COC(=O)[C@H](COC(=O)/C=C/c1ccc(C)cc1)NC(=O)/C=C/c1ccc(C)cc1"}, "reference": {"title": "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine", "authors": "Aguirre-Renteria, Saul A.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.", "doi": "10.1016/j.bmcl.2020.127074", "raw": "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine | Aguirre-Renteria, Saul A.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074. | 10.1016/j.bmcl.2020.127074"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-356-CAS-22071802", "1.1|Reagents: Triethylamine", "Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of Nanomolar DCAF1 Small Molecule Ligands", "By: Li, Alice Shi Ming; et al", "Journal of Medicinal Chemistry (2023), 66(7), 5041-5060.", "10.1021/acs.jmedchem.2c02132"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 103365-47-5 + 74-89-5 | PRO: 2734274-03-2 | RGT: 121-44-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine\", \"authors\": \"Aguirre-Renteria, Saul A.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-356-CAS-22071802\", \"1.1\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 2 h, 40 °C; 0.5 h, 40 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 30 min, 40 °C; 2 h, 40 °C; 24 h, rt; 1 h, 5 °C\", \"54. Scheme 54 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of Nanomolar DCAF1 Small Molecule Ligands\", \"By: Li, Alice Shi Ming; et al\", \"Journal of Medicinal Chemistry (2023), 66(7), 5041-5060.\", \"10.1021/acs.jmedchem.2c02132\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"103365-47-5\", \"74-89-5\"], \"pro_cas\": [\"2734274-03-2\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["103365-47-5", "74-89-5"], "products": ["2734274-03-2"], "reagents": ["Triethylamine"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-363-CAS-23416807", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Methanol", "cas": "67-56-1"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 88.0}, "smiles": {"reactants": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)cc1.CC(C)(C)OC(=O)NCCCCCC(=O)O", "products": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCNC(=O)OC(C)(C)C)C(C)(C)C)cc1"}, "reference": {"title": "Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers", "authors": "Cao, Chaoguo; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.", "doi": "10.1021/acs.jmedchem.0c00821", "raw": "Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers | Cao, Chaoguo; et al | Journal of Medicinal Chemistry (2020), 63(19), 11012-11033. | 10.1021/acs.jmedchem.0c00821"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-363-CAS-23416807", "1.1|Reagents: Hydrochloric acid", "Solvents: Methanol, Dichloromethane, 1,4-Dioxane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; rt → 0 °C; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease", "By: Liu, Longbin; et al", "Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.", "10.1021/acs.jmedchem.3c01173"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Methanol|67-56-1", "cond_sig": "d8e2405a", "fam_sig": "0118baf3"}, "raw_data": {"raw_cas": "RCT: 1643412-36-5 + 2743342-83-6 | PRO: 2743340-78-3 | RGT: 7647-01-0 + 7087-68-5 + 148893-10-1 | SOL: 67-56-1 + 75-09-2 + 123-91-1 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers\", \"authors\": \"Cao, Chaoguo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Methanol\", \"Dichloromethane\", \"1,4-Dioxane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-363-CAS-23416807\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Methanol, Dichloromethane, 1,4-Dioxane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; rt → 0 °C; 2 h, rt\", \"342. Scheme 342 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease\", \"By: Liu, Longbin; et al\", \"Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.\", \"10.1021/acs.jmedchem.3c01173\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1643412-36-5\", \"2743342-83-6\"], \"pro_cas\": [\"2743340-78-3\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"67-56-1\", \"75-09-2\", \"123-91-1\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1643412-36-5", "2743342-83-6"], "products": ["2743340-78-3"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Methanol", "Dichloromethane", "1,4-Dioxane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21533229", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC(=O)CCC(=O)O.CC(C)c1cc(C(=O)N2Cc3ccc(N)cc3C2)c(OCc2ccccc2)cc1OCc1ccccc1", "products": "COC(=O)CCC(=O)Nc1ccc2c(c1)CN(C(=O)c1cc(C(C)C)c(OCc3ccccc3)cc1OCc1ccccc1)C2"}, "reference": {"title": "Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo", "authors": "Ojha, Ritu; et al", "citation": "European Journal of Medicinal Chemistry (2020), 190, 112086pp..", "doi": "10.1016/j.ejmech.2020.112086", "raw": "Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo | Ojha, Ritu; et al | European Journal of Medicinal Chemistry (2020), 190, 112086pp.. | 10.1016/j.ejmech.2020.112086"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-21533229", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 5 h, rt; 5 h, rt", "1.2|Reagents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1", "By: Zhou, Qilong; et al", "European Journal of Medicinal Chemistry (2022), 244, 114830.", "10.1016/j.ejmech.2022.114830"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "604db6ad", "fam_sig": "9a5591be"}, "raw_data": {"raw_cas": "RCT: 32667-98-4 + 3033295-77-8 | PRO: 3033295-78-9 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo\", \"authors\": \"Ojha, Ritu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 190, 112086pp..\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21533229\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 5 h, rt; 5 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"358. Scheme 358 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1\", \"By: Zhou, Qilong; et al\", \"European Journal of Medicinal Chemistry (2022), 244, 114830.\", \"10.1016/j.ejmech.2022.114830\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"32667-98-4\", \"3033295-77-8\"], \"pro_cas\": [\"3033295-78-9\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["32667-98-4", "3033295-77-8"], "products": ["3033295-78-9"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21607012", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 6.5, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.Cn1cc(Nc2cc(-c3cccc(N)c3)ncn2)cn1", "products": "Cn1cc(Nc2cc(-c3cccc(NC(=O)CNC(=O)OC(C)(C)C)c3)ncn2)cn1"}, "reference": {"title": "Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors", "authors": "Shu, Lei; et al", "citation": "European Journal of Medicinal Chemistry (2020), 191, 112148pp..", "doi": "10.1016/j.ejmech.2020.112148", "raw": "Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors | Shu, Lei; et al | European Journal of Medicinal Chemistry (2020), 191, 112148pp.. | 10.1016/j.ejmech.2020.112148"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-21607012", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|6 h, 0 °C → rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272", "By: Kempson, James; et al", "Organic Process Research & Development (2022), 26(4), 1327-1335.", "10.1021/acs.oprd.2c00036"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 21743-75-9 + 1441057-79-9 | PRO: 2765826-08-0 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors\", \"authors\": \"Shu, Lei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 191, 112148pp..\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21607012\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"6 h, 0 °C → rt\", \"129. Scheme 129 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272\", \"By: Kempson, James; et al\", \"Organic Process Research & Development (2022), 26(4), 1327-1335.\", \"10.1021/acs.oprd.2c00036\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"21743-75-9\", \"1441057-79-9\"], \"pro_cas\": [\"2765826-08-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["21743-75-9", "1441057-79-9"], "products": ["2765826-08-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21607035", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "N#CCC(=O)O.Cn1cc(Nc2cc(-c3cccc(N)c3)ncn2)cn1", "products": "Cn1cc(Nc2cc(-c3cccc(NC(=O)CC#N)c3)ncn2)cn1"}, "reference": {"title": "Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors", "authors": "Shu, Lei; et al", "citation": "European Journal of Medicinal Chemistry (2020), 191, 112148pp..", "doi": "10.1016/j.ejmech.2020.112148", "raw": "Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors | Shu, Lei; et al | European Journal of Medicinal Chemistry (2020), 191, 112148pp.. | 10.1016/j.ejmech.2020.112148"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-367-CAS-21607035", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 0 °C; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "004c71d2", "fam_sig": "6a8d59c1"}, "raw_data": {"raw_cas": "RCT: 2387522-91-8 + 247068-85-5 | PRO: 2387523-05-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors\", \"authors\": \"Shu, Lei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 191, 112148pp..\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21607035\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 0 °C; 16 h, rt\", \"482. Scheme 482 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-91-8\", \"247068-85-5\"], \"pro_cas\": [\"2387523-05-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387522-91-8", "247068-85-5"], "products": ["2387523-05-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21717118", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.167, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1ccc2oc(=O)ccc2c1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2ccc3oc(=O)ccc3c2)cc1"}, "reference": {"title": "Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2020), 186, 111900.", "doi": "10.1016/j.ejmech.2019.111900", "raw": "Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2020), 186, 111900. | 10.1016/j.ejmech.2019.111900"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-367-CAS-21717118", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 10 min, 0 °C; 1 h, rt", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, rt", "Double bond geometry shown", "Relative stereochemistry shown", "Relative stereochemistry shown", "Double bond geometry shown", "Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors", "By: Kong, Deyu; et al", "Journal of Medicinal Chemistry (2024), 67(7), 5866-5882.", "10.1021/acs.jmedchem.4c00148"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 62456-15-9 + 3036049-14-3 | PRO: 3036049-15-4 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 186, 111900.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21717118\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 10 min, 0 °C; 1 h, rt\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, rt\", \"230. Scheme 230 (1 Reaction)\", \"Double bond geometry shown\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Double bond geometry shown\", \"Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors\", \"By: Kong, Deyu; et al\", \"Journal of Medicinal Chemistry (2024), 67(7), 5866-5882.\", \"10.1021/acs.jmedchem.4c00148\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"62456-15-9\", \"3036049-14-3\"], \"pro_cas\": [\"3036049-15-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["62456-15-9", "3036049-14-3"], "products": ["3036049-15-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21782635", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": -10.0, "time_h": 16.0, "yield_pct": 97.0}, "smiles": {"reactants": "C=C[C@@H](C)C(=O)O.C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2ccc(NC(=O)OC)cc2N)ccn1", "products": "C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2ccc(NC(=O)OC)cc2NC(=O)[C@H](C)C=C)ccn1"}, "reference": {"title": "Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups", "authors": "Corte, James R.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(2), 784-803.", "doi": "10.1021/acs.jmedchem.9b01768", "raw": "Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups | Corte, James R.; et al | Journal of Medicinal Chemistry (2020), 63(2), 784-803. | 10.1021/acs.jmedchem.9b01768"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-367-CAS-21782635", "1.1|Reagents: Pyridine, Propylphosphonic anhydride", "Solvents: Ethyl acetate; -10 °C; -10 °C → rt; overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs", "By: Shah, Rishi R.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4641-4654.", "10.1021/acs.jmedchem.3c02123"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Pyridine|110-86-1/Ethyl Acetate|141-78-6", "cond_sig": "8c6e1da2", "fam_sig": "2425fcc8"}, "raw_data": {"raw_cas": "RCT: 87691-27-8 + 1448189-30-7 | PRO: 1797406-73-5 | RGT: 110-86-1 + 68957-94-8 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups\", \"authors\": \"Corte, James R.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(2), 784-803.\", \"reagents\": [\"Pyridine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21782635\", \"1.1\", \"Reagents: Pyridine, Propylphosphonic anhydride\", \"Solvents: Ethyl acetate; -10 °C; -10 °C → rt; overnight, rt\", \"133. Scheme 133 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs\", \"By: Shah, Rishi R.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4641-4654.\", \"10.1021/acs.jmedchem.3c02123\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"87691-27-8\", \"1448189-30-7\"], \"pro_cas\": [\"1797406-73-5\"], \"rgt_cas\": [\"110-86-1\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["87691-27-8", "1448189-30-7"], "products": ["1797406-73-5"], "reagents": ["Pyridine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.023882", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822005", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 80.0}, "smiles": {"reactants": "Cc1ccccc1NC(=O)C=CC(=O)O.NC1Cc2ccccc2NC1=O", "products": "Cc1ccccc1NC(=O)C=CC(=O)NC1Cc2ccccc2NC1=O"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-21822005", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties", "By: Yamaguchi-Sasaki, Toru; et al", "Bioorganic & Medicinal Chemistry (2020), 28(24), 115818.", "10.1016/j.bmc.2020.115818"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 13734-36-6 + 2561412-98-2 | PRO: 2755959-76-1 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822005\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"380. Scheme 380 (1 Reaction)\", \"Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties\", \"By: Yamaguchi-Sasaki, Toru; et al\", \"Bioorganic & Medicinal Chemistry (2020), 28(24), 115818.\", \"10.1016/j.bmc.2020.115818\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-36-6\", \"2561412-98-2\"], \"pro_cas\": [\"2755959-76-1\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13734-36-6", "2561412-98-2"], "products": ["2755959-76-1"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822006", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 82.0}, "smiles": {"reactants": "Cc1cccc(NC(=O)C=CC(=O)O)c1.NC1Cc2ccccc2NC1=O", "products": "Cc1cccc(NC(=O)C=CC(=O)NC2Cc3ccccc3NC2=O)c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-21822006", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 37904-03-3 + 40615-17-6 | PRO: 2416338-25-3 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822006\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"383. Scheme 383 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"37904-03-3\", \"40615-17-6\"], \"pro_cas\": [\"2416338-25-3\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["37904-03-3", "40615-17-6"], "products": ["2416338-25-3"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822007", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 80.0}, "smiles": {"reactants": "Cc1ccc(NC(=O)C=CC(=O)O)cc1.NC1Cc2ccccc2NC1=O", "products": "Cc1ccc(NC(=O)C=CC(=O)NC2Cc3ccccc3NC2=O)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-21822007", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis", "By: Hopkins, Brian T.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1206-1224.", "10.1021/acs.jmedchem.1c00926"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 1798794-71-4 + 2247616-84-6 | PRO: 2763636-79-7 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822007\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"384. Scheme 384 (1 Reaction)\", \"Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis\", \"By: Hopkins, Brian T.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1206-1224.\", \"10.1021/acs.jmedchem.1c00926\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1798794-71-4\", \"2247616-84-6\"], \"pro_cas\": [\"2763636-79-7\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1798794-71-4", "2247616-84-6"], "products": ["2763636-79-7"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822008", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 81.0}, "smiles": {"reactants": "COc1ccccc1NC(=O)C=CC(=O)O.NC1Cc2ccccc2NC1=O", "products": "COc1ccccc1NC(=O)C=CC(=O)NC1Cc2ccccc2NC1=O"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-21822008", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 3471-31-6 + 36377-59-0 | PRO: 2020043-88-1 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822008\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"21. Scheme 21 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3471-31-6\", \"36377-59-0\"], \"pro_cas\": [\"2020043-88-1\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3471-31-6", "36377-59-0"], "products": ["2020043-88-1"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822009", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 81.0}, "smiles": {"reactants": "COc1ccc(NC(=O)C=CC(=O)O)cc1.NC1Cc2ccccc2NC1=O", "products": "COc1ccc(NC(=O)C=CC(=O)NC2Cc3ccccc3NC2=O)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-21822009", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 326914-22-1 + 40615-17-6 | PRO: 2416338-34-4 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822009\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"465. Scheme 465 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"326914-22-1\", \"40615-17-6\"], \"pro_cas\": [\"2416338-34-4\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["326914-22-1", "40615-17-6"], "products": ["2416338-34-4"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822010", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccccc1[N+](=O)[O-].NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1[N+](=O)[O-]"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-21822010", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 36847-94-6 + 40615-17-6 | PRO: 2416338-26-4 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822010\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"20. Scheme 20 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36847-94-6\", \"40615-17-6\"], \"pro_cas\": [\"2416338-26-4\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36847-94-6", "40615-17-6"], "products": ["2416338-26-4"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822011", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -3.0, "time_h": 0.25, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1cccc([N+](=O)[O-])c1.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1cccc([N+](=O)[O-])c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-21822011", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation", "By: Namballa, Hari K.; et al", "Journal of Medicinal Chemistry (2023), 66(14), 10060-10079.", "10.1021/acs.jmedchem.3c00976"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 2983777-44-0 + 94026-91-2 | PRO: 2983777-45-1 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822011\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"26. Scheme 26 (1 Reaction)\", \"Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation\", \"By: Namballa, Hari K.; et al\", \"Journal of Medicinal Chemistry (2023), 66(14), 10060-10079.\", \"10.1021/acs.jmedchem.3c00976\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2983777-44-0\", \"94026-91-2\"], \"pro_cas\": [\"2983777-45-1\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2983777-44-0", "94026-91-2"], "products": ["2983777-45-1"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822012", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccc([N+](=O)[O-])cc1.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-21822012", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors", "By: Wiedemeyer, Simon J. A.; et al", "ChemMedChem (2023), 18(6), e202200632.", "10.1002/cmdc.202200632"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 33305-77-0 + 1515293-47-6 | PRO: 2938349-12-1 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822012\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"459. Scheme 459 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors\", \"By: Wiedemeyer, Simon J. A.; et al\", \"ChemMedChem (2023), 18(6), e202200632.\", \"10.1002/cmdc.202200632\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"33305-77-0\", \"1515293-47-6\"], \"pro_cas\": [\"2938349-12-1\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["33305-77-0", "1515293-47-6"], "products": ["2938349-12-1"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822013", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccccc1Cl.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1Cl"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-21822013", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 383135-47-5 + 3032933-04-0 | PRO: 2983540-54-9 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822013\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"489. Scheme 489 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"383135-47-5\", \"3032933-04-0\"], \"pro_cas\": [\"2983540-54-9\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["383135-47-5", "3032933-04-0"], "products": ["2983540-54-9"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822014", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccc(Cl)cc1.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc(Cl)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-21822014", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 60252-79-1 + 40615-17-6 | PRO: 2416338-37-7 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822014\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"451. Scheme 451 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"60252-79-1\", \"40615-17-6\"], \"pro_cas\": [\"2416338-37-7\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["60252-79-1", "40615-17-6"], "products": ["2416338-37-7"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822015", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccccc1Br.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1Br"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-21822015", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 36847-87-7 + 40615-17-6 | PRO: 2416338-31-1 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822015\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"488. Scheme 488 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36847-87-7\", \"40615-17-6\"], \"pro_cas\": [\"2416338-31-1\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36847-87-7", "40615-17-6"], "products": ["2416338-31-1"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822016", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1cccc(Br)c1.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1cccc(Br)c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-21822016", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale", "By: McCoy, Michael A.; et al", "Journal of Medicinal Chemistry (2022), 65(10), 7246-7261.", "10.1021/acs.jmedchem.2c00228"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 144-62-7 + 367-31-7 | PRO: 61875-34-1 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822016\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"466. Scheme 466 (1 Reaction)\", \"Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale\", \"By: McCoy, Michael A.; et al\", \"Journal of Medicinal Chemistry (2022), 65(10), 7246-7261.\", \"10.1021/acs.jmedchem.2c00228\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"144-62-7\", \"367-31-7\"], \"pro_cas\": [\"61875-34-1\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["144-62-7", "367-31-7"], "products": ["61875-34-1"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822017", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccc(Br)cc1.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc(Br)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-21822017", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 1417404-28-4 + 4726-85-6 | PRO: 2614241-78-8 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822017\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"449. Scheme 449 (1 Reaction)\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1417404-28-4\", \"4726-85-6\"], \"pro_cas\": [\"2614241-78-8\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1417404-28-4", "4726-85-6"], "products": ["2614241-78-8"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822018", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccccc1F.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1F"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-21822018", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 99-10-5 + 772318-79-3 | PRO: 2892016-32-7 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822018\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"491. Scheme 491 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"99-10-5\", \"772318-79-3\"], \"pro_cas\": [\"2892016-32-7\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["99-10-5", "772318-79-3"], "products": ["2892016-32-7"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822019", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccc(F)cc1.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccc(F)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-21822019", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors", "By: Zhang, Hao; et al", "Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.", "10.1021/acs.jmedchem.2c00611"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 100564-78-1 + 1138018-69-5 | PRO: 2307267-76-9 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822019\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"452. Scheme 452 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors\", \"By: Zhang, Hao; et al\", \"Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.\", \"10.1021/acs.jmedchem.2c00611\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"100564-78-1\", \"1138018-69-5\"], \"pro_cas\": [\"2307267-76-9\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["100564-78-1", "1138018-69-5"], "products": ["2307267-76-9"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.025885", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822021", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1ccccc1.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1ccccc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-21822021", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease", "By: Zhou, Jianhui; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.", "10.1021/acs.jmedchem.4c00159"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 830-96-6 | PRO: 929809-53-0 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822021\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"352. Scheme 352 (1 Reaction)\", \"Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease\", \"By: Zhou, Jianhui; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.\", \"10.1021/acs.jmedchem.4c00159\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"830-96-6\"], \"pro_cas\": [\"929809-53-0\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "830-96-6"], "products": ["929809-53-0"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21822022", "reaction_type": "Other", "catalyst": {"core": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}], "generic": [], "ligands": [], "full_system": [{"name": "Iodine", "cas": "7553-56-2"}, {"name": "Triethyl phosphite", "cas": "122-52-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)C=CC(=O)Nc1cccc2ccccc12.NC1Cc2ccccc2NC1=O", "products": "O=C(C=CC(=O)NC1Cc2ccccc2NC1=O)Nc1cccc2ccccc12"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "authors": "Li, Baihui; et al", "citation": "European Journal of Medicinal Chemistry (2020), 195, 112278.", "doi": "10.1016/j.ejmech.2020.112278", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents | Li, Baihui; et al | European Journal of Medicinal Chemistry (2020), 195, 112278. | 10.1016/j.ejmech.2020.112278"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-21822022", "1.1|Reagents: Triethylamine", "Catalysts: Triethyl phosphite, Iodine", "Solvents: Dichloromethane; 15 min, cooled", "1.2|cooled; rt", "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease", "By: Zhou, Jianhui; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.", "10.1021/acs.jmedchem.4c00159"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 830-96-6 + 1484-85-1 | PRO: 1036111-16-6 | RGT: 121-44-8 | CAT: 122-52-1 + 7553-56-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"authors\": \"Li, Baihui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"Triethyl phosphite\", \"Iodine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21822022\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: Triethyl phosphite, Iodine\", \"Solvents: Dichloromethane; 15 min, cooled\", \"1.2\", \"cooled; rt\", \"434. Scheme 434 (1 Reaction)\", \"Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease\", \"By: Zhou, Jianhui; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.\", \"10.1021/acs.jmedchem.4c00159\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"830-96-6\", \"1484-85-1\"], \"pro_cas\": [\"1036111-16-6\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"122-52-1\", \"7553-56-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["830-96-6", "1484-85-1"], "products": ["1036111-16-6"], "reagents": ["Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21894967", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 10.0, "time_h": 1.0, "yield_pct": 96.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)Nc1nc(/C(=N/OC2(C(=O)OC(c3ccccc3)c3ccccc3)CC2)C(=O)O)cs1.COc1nc(Cl)nc(OC)n1.N[C@@H]1C(=O)N[C@@H]1CN1CCOC1=O", "products": "COc1nc(OC)nc(Oc2nc(OC)nc(OC)n2)n1.CC(C)(C)OC(=O)Nc1nc(/C(=N/OC2(C(=O)OC(c3ccccc3)c3ccccc3)CC2)C(=O)N[C@@H]2C(=O)N[C@@H]2CN2CCOC2=O)cs1.CC(C)(C)OC(=O)Nc1nc(/C(=N/OC2(C(=O)OC(c3ccccc3)c3ccccc3)CC2)C(=O)N[C@@H]2C(=O)N[C@@H]2CN2C(=O)OCC2O)cs1"}, "reference": {"title": "Process Development for the Synthesis of a Monobactam Antibiotic-LYS228", "authors": "Fei, Zhongbo; et al", "citation": "Organic Process Research & Development (2020), 24(3), 363-370.", "doi": "10.1021/acs.oprd.9b00330", "raw": "Process Development for the Synthesis of a Monobactam Antibiotic-LYS228 | Fei, Zhongbo; et al | Organic Process Research & Development (2020), 24(3), 363-370. | 10.1021/acs.oprd.9b00330"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-367-CAS-21894967", "1.1|Reagents: 4-Methylmorpholine", "Solvents: Dimethylformamide; rt; rt → 0 °C", "1.2|< 10 °C; 1 h, 0 - 5 °C", "1.3|Solvents: Dimethylformamide, Water", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities", "By: Sun, Lin; et al", "Journal of Medicinal Chemistry (2020), 63(9), 4790-4810.", "10.1021/acs.jmedchem.0c00015"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+N-Methylmorpholine|109-02-4/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "6c385b3a", "fam_sig": "1a47ce78"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 1562441-91-1 | PRO: 2354397-14-9 | RGT: 109-02-4 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Process Development for the Synthesis of a Monobactam Antibiotic-LYS228\", \"authors\": \"Fei, Zhongbo; et al\", \"citation\": \"Organic Process Research & Development (2020), 24(3), 363-370.\", \"reagents\": [\"4-Methylmorpholine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21894967\", \"1.1\", \"Reagents: 4-Methylmorpholine\", \"Solvents: Dimethylformamide; rt; rt → 0 °C\", \"1.2\", \"< 10 °C; 1 h, 0 - 5 °C\", \"1.3\", \"Solvents: Dimethylformamide, Water\", \"403. Scheme 403 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities\", \"By: Sun, Lin; et al\", \"Journal of Medicinal Chemistry (2020), 63(9), 4790-4810.\", \"10.1021/acs.jmedchem.0c00015\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"1562441-91-1\"], \"pro_cas\": [\"2354397-14-9\"], \"rgt_cas\": [\"109-02-4\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "1562441-91-1"], "products": ["2354397-14-9"], "reagents": ["N-Methylmorpholine"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21911742", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.COc1ccc(N(C)C(=O)[C@@H](N)Cc2ccccc2)cc1", "products": "COc1ccc(N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities", "authors": "Sun, Lin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(9), 4790-4810.", "doi": "10.1021/acs.jmedchem.0c00015", "raw": "Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities | Sun, Lin; et al | Journal of Medicinal Chemistry (2020), 63(9), 4790-4810. | 10.1021/acs.jmedchem.0c00015"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-21911742", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, 0 °C", "1.2|Reagents: Diisopropylethylamine; 0 °C; 6 h, rt", "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands", "By: Andreasson, Maans; et al", "Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.", "10.1021/acs.jmedchem.3c02127"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 113-24-6 + 3171-45-7 | PRO: 28082-86-2 | RGT: 148893-10-1 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities\", \"authors\": \"Sun, Lin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(9), 4790-4810.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21911742\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 0 °C; 6 h, rt\", \"404. Scheme 404 (1 Reaction)\", \"Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands\", \"By: Andreasson, Maans; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.\", \"10.1021/acs.jmedchem.3c02127\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"113-24-6\", \"3171-45-7\"], \"pro_cas\": [\"28082-86-2\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["113-24-6", "3171-45-7"], "products": ["28082-86-2"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21945245", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)c1cc(Br)c(Br)s1.CC(C)(C)OC(=O)N1CCC(CN)CC1", "products": "CC(C)(C)OC(=O)N1CCC(CNC(=O)c2cc(Br)c(Br)s2)CC1"}, "reference": {"title": "Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP", "authors": "Wu, Fangrui; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(9), 4716-4731.", "doi": "10.1021/acs.jmedchem.9b02164", "raw": "Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP | Wu, Fangrui; et al | Journal of Medicinal Chemistry (2020), 63(9), 4716-4731. | 10.1021/acs.jmedchem.9b02164"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-367-CAS-21945245", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 0 °C; 1 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase", "By: Russ, Nadine; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.", "10.1021/acs.jmedchem.1c00845"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+NaHCO3|144-55-8+Sodium bicarbonate|+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "6a7197d1", "fam_sig": "5a33deee"}, "raw_data": {"raw_cas": "RCT: 1065075-68-4 + 7663-77-6 | PRO: 1421367-69-2 | RGT: 121-44-8 + 1892-57-5 + 2592-95-2 + 144-55-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP\", \"authors\": \"Wu, Fangrui; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(9), 4716-4731.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21945245\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"317. Scheme 317 (1 Reaction)\", \"Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase\", \"By: Russ, Nadine; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.\", \"10.1021/acs.jmedchem.1c00845\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1065075-68-4\", \"7663-77-6\"], \"pro_cas\": [\"1421367-69-2\"], \"rgt_cas\": [\"121-44-8\", \"1892-57-5\", \"2592-95-2\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1065075-68-4", "7663-77-6"], "products": ["1421367-69-2"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21974278", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)Cc1ccc([N+](=O)[O-])cc1Br.NCCc1ccccc1", "products": "O=C(Cc1ccc([N+](=O)[O-])cc1Br)NCCc1ccccc1"}, "reference": {"title": "Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity", "authors": "Karki, Anupam; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.", "doi": "10.1016/j.bmcl.2020.127053", "raw": "Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity | Karki, Anupam; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053. | 10.1016/j.bmcl.2020.127053"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-367-CAS-21974278", "1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Tetrahydrofuran; 30 min, rt", "1.2|Solvents: Tetrahydrofuran; 30 min, rt; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1/Tetrahydrofuran|109-99-9", "cond_sig": "a62e10b0", "fam_sig": "1338a6ec"}, "raw_data": {"raw_cas": "RCT: 114873-06-2 + 5466-22-8 | PRO: 2380970-89-6 | RGT: 94790-37-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity\", \"authors\": \"Karki, Anupam; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21974278\", \"1.1\", \"Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Tetrahydrofuran; 30 min, rt\", \"1.2\", \"Solvents: Tetrahydrofuran; 30 min, rt; 12 h, rt\", \"115. Scheme 115 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"114873-06-2\", \"5466-22-8\"], \"pro_cas\": [\"2380970-89-6\"], \"rgt_cas\": [\"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["114873-06-2", "5466-22-8"], "products": ["2380970-89-6"], "reagents": ["HBTU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21974286", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)Cc1ccc([N+](=O)[O-])cc1Br.COc1cc(CCN)ccc1OCc1ccccc1", "products": "COc1cc(CCNC(=O)Cc2ccc([N+](=O)[O-])cc2Br)ccc1OCc1ccccc1"}, "reference": {"title": "Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity", "authors": "Karki, Anupam; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.", "doi": "10.1016/j.bmcl.2020.127053", "raw": "Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity | Karki, Anupam; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053. | 10.1016/j.bmcl.2020.127053"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-367-CAS-21974286", "1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Tetrahydrofuran; 30 min, rt", "1.2|Solvents: Tetrahydrofuran; 30 min, rt; 12 h, rt", "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety", "By: Pandrala, Mallesh; et al", "Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.", "10.1021/acs.jmedchem.1c01853"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1/Tetrahydrofuran|109-99-9", "cond_sig": "a62e10b0", "fam_sig": "1338a6ec"}, "raw_data": {"raw_cas": "RCT: 68507-19-7 + 694499-26-8 | PRO: 1701486-06-7 | RGT: 94790-37-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity\", \"authors\": \"Karki, Anupam; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21974286\", \"1.1\", \"Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Tetrahydrofuran; 30 min, rt\", \"1.2\", \"Solvents: Tetrahydrofuran; 30 min, rt; 12 h, rt\", \"456. Scheme 456 (1 Reaction)\", \"Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety\", \"By: Pandrala, Mallesh; et al\", \"Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.\", \"10.1021/acs.jmedchem.1c01853\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"68507-19-7\", \"694499-26-8\"], \"pro_cas\": [\"1701486-06-7\"], \"rgt_cas\": [\"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["68507-19-7", "694499-26-8"], "products": ["1701486-06-7"], "reagents": ["HBTU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21978534", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.NCC1(CC(=O)OCc2ccccc2)CCCCC1.O=C(O)C(F)(F)F", "products": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NCC1(CC(=O)OCc2ccccc2)CCCCC1"}, "reference": {"title": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "authors": "Meena, Chhuttan L.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "doi": "10.1016/j.bmcl.2020.127039", "raw": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors | Meena, Chhuttan L.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039. | 10.1016/j.bmcl.2020.127039"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-21978534", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "By: Yamada, Yousuke; et al", "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "10.1021/acs.jmedchem.0c01215"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 1535-73-5 + 62234-36-0 | PRO: 2682842-35-7 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"authors\": \"Meena, Chhuttan L.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21978534\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 16 h, rt\", \"30. Scheme 30 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"By: Yamada, Yousuke; et al\", \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"10.1021/acs.jmedchem.0c01215\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1535-73-5\", \"62234-36-0\"], \"pro_cas\": [\"2682842-35-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["1535-73-5", "62234-36-0"], "products": ["2682842-35-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21978535", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.CC(C)(N)C(=O)OCc1ccccc1.O=C(O)C(F)(F)F", "products": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NC(C)(C)C(=O)OCc1ccccc1"}, "reference": {"title": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "authors": "Meena, Chhuttan L.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "doi": "10.1016/j.bmcl.2020.127039", "raw": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors | Meena, Chhuttan L.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039. | 10.1016/j.bmcl.2020.127039"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-367-CAS-21978535", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "By: Guryanov, Ivan; et al", "Organic Process Research & Development (2021), 25(7), 1598-1611.", "10.1021/acs.oprd.1c00021"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 166108-71-0 + 1188328-39-3 | PRO: 1118767-16-0 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"authors\": \"Meena, Chhuttan L.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21978535\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 16 h, rt\", \"399. Scheme 399 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"By: Guryanov, Ivan; et al\", \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"10.1021/acs.oprd.1c00021\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"166108-71-0\", \"1188328-39-3\"], \"pro_cas\": [\"1118767-16-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["166108-71-0", "1188328-39-3"], "products": ["1118767-16-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21978536", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.NC1(C(=O)OCc2ccccc2)CCCCC1.O=C(O)C(F)(F)F", "products": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NC1(C(=O)OCc2ccccc2)CCCCC1"}, "reference": {"title": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "authors": "Meena, Chhuttan L.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "doi": "10.1016/j.bmcl.2020.127039", "raw": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors | Meena, Chhuttan L.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039. | 10.1016/j.bmcl.2020.127039"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-367-CAS-21978536", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 2237-36-7 + 251105-80-3 | PRO: 2892016-17-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"authors\": \"Meena, Chhuttan L.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21978536\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 16 h, rt\", \"125. Scheme 125 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2237-36-7\", \"251105-80-3\"], \"pro_cas\": [\"2892016-17-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["2237-36-7", "251105-80-3"], "products": ["2892016-17-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-21978537", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.COc1c(N)cccc1C(=O)OCc1ccccc1.O=C(O)C(F)(F)F", "products": "COc1c(NC(=O)[C@@H](Cc2ccccc2)NC(=O)OC(C)(C)C)cccc1C(=O)OCc1ccccc1"}, "reference": {"title": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "authors": "Meena, Chhuttan L.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "doi": "10.1016/j.bmcl.2020.127039", "raw": "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors | Meena, Chhuttan L.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039. | 10.1016/j.bmcl.2020.127039"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-367-CAS-21978537", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 884512-77-0 + 2765293-23-8 | PRO: 2765293-62-5 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"authors\": \"Meena, Chhuttan L.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-21978537\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 16 h, rt\", \"233. Scheme 233 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"884512-77-0\", \"2765293-23-8\"], \"pro_cas\": [\"2765293-62-5\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["884512-77-0", "2765293-23-8"], "products": ["2765293-62-5"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22020035", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Na2CO3", "cas": "497-19-8", "role": "UNK"}, {"name": "Sodium carbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Xylene", "cas": "1330-20-7"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 100.0, "time_h": 7.5, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)c1cccc([N+](=O)[O-])c1F.Nc1ccc(C(F)(C(F)(F)F)C(F)(F)F)cc1C(F)(F)F", "products": "O=C(Nc1ccc(C(F)(C(F)(F)F)C(F)(F)F)cc1C(F)(F)F)c1cccc([N+](=O)[O-])c1F"}, "reference": {"title": "Development of an efficient synthetic process for broflanilide", "authors": "Luo, Chunyan; et al", "citation": "Organic Process Research & Development (2020), 24(6), 1024-1031.", "doi": "10.1021/acs.oprd.0c00028", "raw": "Development of an efficient synthetic process for broflanilide | Luo, Chunyan; et al | Organic Process Research & Development (2020), 24(6), 1024-1031. | 10.1021/acs.oprd.0c00028"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-367-CAS-22020035", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Xylene; 25 °C; 2 h, reflux", "1.2|Solvents: Xylene; 5 h, 100 °C", "1.3|Reagents: Sodium carbonate", "Solvents: Water; 100 °C; 30 min, 80 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors", "By: Zhang, Hao; et al", "Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.", "10.1021/acs.jmedchem.2c00611"], "signatures": {"cond_key": "none/none/Na2CO3|497-19-8+Sodium carbonate|+Thionyl chloride|7719-09-7/Water|7732-18-5+Xylene|1330-20-7", "cond_sig": "a3200d4c", "fam_sig": "80823691"}, "raw_data": {"raw_cas": "RCT: 2307266-42-6 + 2623-87-2 | PRO: 2307267-73-6 | RGT: 7719-09-7 + 497-19-8 | CAT: 68-12-2 | SOL: 1330-20-7 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Development of an efficient synthetic process for broflanilide\", \"authors\": \"Luo, Chunyan; et al\", \"citation\": \"Organic Process Research & Development (2020), 24(6), 1024-1031.\", \"reagents\": [\"Thionyl chloride\", \"Sodium carbonate\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Xylene\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22020035\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Xylene; 25 °C; 2 h, reflux\", \"1.2\", \"Solvents: Xylene; 5 h, 100 °C\", \"1.3\", \"Reagents: Sodium carbonate\", \"Solvents: Water; 100 °C; 30 min, 80 °C\", \"420. Scheme 420 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors\", \"By: Zhang, Hao; et al\", \"Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.\", \"10.1021/acs.jmedchem.2c00611\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2307266-42-6\", \"2623-87-2\"], \"pro_cas\": [\"2307267-73-6\"], \"rgt_cas\": [\"7719-09-7\", \"497-19-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"1330-20-7\", \"7732-18-5\"], \"notes\": [\"optimization study, optimized on solvent, temperature and time\"]}}", "enriched_names": {"reactants": ["2307266-42-6", "2623-87-2"], "products": ["2307267-73-6"], "reagents": ["7719-09-7", "Na2CO3"], "catalysts": ["Dimethylformamide"], "solvents": ["Xylene", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22020083", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "N-Methylmorpholine", "cas": "109-02-4"}, {"name": "4-Methylmorpholine", "cas": ""}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F", "products": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C"}, "reference": {"title": "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma", "authors": "Zhou, Yi; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.", "doi": "10.1021/acs.jmedchem.9b02161", "raw": "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma | Zhou, Yi; et al | Journal of Medicinal Chemistry (2020), 63(9), 4701-4715. | 10.1021/acs.jmedchem.9b02161"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-367-CAS-22020083", "1.1|Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt", "Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance", "By: He, Siyu; et al", "ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294.", "10.1021/acsmedchemlett.2c00175"], "signatures": {"cond_key": "none/none/O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/4-Methylmorpholine|+Dimethylformamide|68-12-2+N-Methylmorpholine|109-02-4", "cond_sig": "8df0d8a0", "fam_sig": "8997954d"}, "raw_data": {"raw_cas": "RCT: 742120-03-2 + 35303-76-5 | PRO: 1090816-80-0 | RGT: 125700-67-6 | SOL: 68-12-2 + 109-02-4", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma\", \"authors\": \"Zhou, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.\", \"reagents\": [\"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"4-Methylmorpholine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22020083\", \"1.1\", \"Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt\", \"57. Scheme 57 (1 Reaction)\", \"Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance\", \"By: He, Siyu; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294.\", \"10.1021/acsmedchemlett.2c00175\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"742120-03-2\", \"35303-76-5\"], \"pro_cas\": [\"1090816-80-0\"], \"rgt_cas\": [\"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-02-4\"], \"notes\": []}}", "enriched_names": {"reactants": ["742120-03-2", "35303-76-5"], "products": ["1090816-80-0"], "reagents": ["125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "N-Methylmorpholine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22020084", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "N-Methylmorpholine", "cas": "109-02-4"}, {"name": "4-Methylmorpholine", "cas": ""}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F", "products": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C"}, "reference": {"title": "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma", "authors": "Zhou, Yi; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.", "doi": "10.1021/acs.jmedchem.9b02161", "raw": "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma | Zhou, Yi; et al | Journal of Medicinal Chemistry (2020), 63(9), 4701-4715. | 10.1021/acs.jmedchem.9b02161"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-22020084", "1.1|Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/4-Methylmorpholine|+Dimethylformamide|68-12-2+N-Methylmorpholine|109-02-4", "cond_sig": "8df0d8a0", "fam_sig": "8997954d"}, "raw_data": {"raw_cas": "RCT: 118-41-2 + 2919713-61-2 | PRO: 2919713-82-7 | RGT: 125700-67-6 | SOL: 68-12-2 + 109-02-4", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma\", \"authors\": \"Zhou, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.\", \"reagents\": [\"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"4-Methylmorpholine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22020084\", \"1.1\", \"Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt\", \"306. Scheme 306 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"118-41-2\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-82-7\"], \"rgt_cas\": [\"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-02-4\"], \"notes\": []}}", "enriched_names": {"reactants": ["118-41-2", "2919713-61-2"], "products": ["2919713-82-7"], "reagents": ["125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "N-Methylmorpholine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.027888", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22020120", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "N-Methylmorpholine", "cas": "109-02-4"}, {"name": "4-Methylmorpholine", "cas": ""}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 99.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F", "products": "CC(C)C[C@H](NC(=O)CNC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C"}, "reference": {"title": "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma", "authors": "Zhou, Yi; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.", "doi": "10.1021/acs.jmedchem.9b02161", "raw": "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma | Zhou, Yi; et al | Journal of Medicinal Chemistry (2020), 63(9), 4701-4715. | 10.1021/acs.jmedchem.9b02161"}, "original_text": ["Steps: 1, Yield: 89-99%", "CAS Reaction Number: 31-367-CAS-22020120", "1.1|Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt", "Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma", "By: Wang, Xueyuan; et al", "European Journal of Medicinal Chemistry (2023), 250, 115187.", "10.1016/j.ejmech.2023.115187"], "signatures": {"cond_key": "none/none/O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/4-Methylmorpholine|+Dimethylformamide|68-12-2+N-Methylmorpholine|109-02-4", "cond_sig": "8df0d8a0", "fam_sig": "8997954d"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 2415205-36-4 | PRO: 2415205-25-1 | RGT: 125700-67-6 | SOL: 68-12-2 + 109-02-4", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma\", \"authors\": \"Zhou, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.\", \"reagents\": [\"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"4-Methylmorpholine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22020120\", \"1.1\", \"Reagents: O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, 4-Methylmorpholine; 0 °C; 16 h, rt\", \"Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma\", \"By: Wang, Xueyuan; et al\", \"European Journal of Medicinal Chemistry (2023), 250, 115187.\", \"10.1016/j.ejmech.2023.115187\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"2415205-36-4\"], \"pro_cas\": [\"2415205-25-1\"], \"rgt_cas\": [\"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-02-4\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "2415205-36-4"], "products": ["2415205-25-1"], "reagents": ["125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "N-Methylmorpholine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22303119", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 20.25, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)CCCc1cccs1.Nc1ccc(C(F)(F)F)cc1", "products": "O=C(CCCc1cccs1)Nc1ccc(C(F)(F)F)cc1"}, "reference": {"title": "Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase", "authors": "Devine, R.; et al", "citation": "European Journal of Medicinal Chemistry (2020), 202, 112416.", "doi": "10.1016/j.ejmech.2020.112416", "raw": "Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase | Devine, R.; et al | European Journal of Medicinal Chemistry (2020), 202, 112416. | 10.1016/j.ejmech.2020.112416"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-367-CAS-22303119", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 15 min, rt", "1.2|Solvents: Dichloromethane; 20 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Double bond geometry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine", "By: Aguirre-Renteria, Saul A.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.", "10.1016/j.bmcl.2020.127074"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "dd0dd51f", "fam_sig": "792b55e2"}, "raw_data": {"raw_cas": "RCT: 5680-80-8 + 538-75-0 + 14290-86-9 | PRO: 2414059-77-9 + 2414059-84-8 + 2414146-71-5 | RGT: 121-44-8 + 2592-95-2 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase\", \"authors\": \"Devine, R.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 202, 112416.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22303119\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"Solvents: Dichloromethane; 20 h, rt\", \"87. Scheme 87 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine\", \"By: Aguirre-Renteria, Saul A.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.\", \"10.1016/j.bmcl.2020.127074\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5680-80-8\", \"538-75-0\", \"14290-86-9\"], \"pro_cas\": [\"2414059-77-9\", \"2414059-84-8\", \"2414146-71-5\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5680-80-8", "N,N-Dicyclohexylcarbodiimide", "14290-86-9"], "products": ["2414059-77-9", "2414059-84-8", "2414146-71-5"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22370048", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 19.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1ccccc1F.Nc1ccc([N+](=O)[O-])cc1O", "products": "O=C(Nc1ccc([N+](=O)[O-])cc1O)c1ccccc1F"}, "reference": {"title": "Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors", "authors": "Martinez-Gonzalez, Sonia; et al", "citation": "European Journal of Medicinal Chemistry (2020), 201, 112443.", "doi": "10.1016/j.ejmech.2020.112443", "raw": "Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors | Martinez-Gonzalez, Sonia; et al | European Journal of Medicinal Chemistry (2020), 201, 112443. | 10.1016/j.ejmech.2020.112443"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-367-CAS-22370048", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 3 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 0 °C; overnight, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 7, rt", "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "By: Hiesinger, Kerstin; et al", "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "10.1021/acs.jmedchem.0c00561"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "f2777e4f", "fam_sig": "aeb73fb0"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 2709014-53-7 | PRO: 2709014-29-7 | RGT: 79-37-8 + 7087-68-5 + 7647-01-0 | CAT: 68-12-2 | SOL: 75-09-2 + 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors\", \"authors\": \"Martinez-Gonzalez, Sonia; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 201, 112443.\", \"reagents\": [\"Oxalyl chloride\", \"Diisopropylethylamine\", \"Hydrochloric acid\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22370048\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 3 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 0 °C; overnight, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 7, rt\", \"166. Scheme 166 (1 Reaction)\", \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"By: Hiesinger, Kerstin; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"10.1021/acs.jmedchem.0c00561\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"2709014-53-7\"], \"pro_cas\": [\"2709014-29-7\"], \"rgt_cas\": [\"79-37-8\", \"7087-68-5\", \"7647-01-0\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "2709014-53-7"], "products": ["2709014-29-7"], "reagents": ["79-37-8", "N,N-Diisopropylethylamine", "Hydrochloric acid"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22401841", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.5, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1.COC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "COC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1"}, "reference": {"title": "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2", "authors": "Roussel, Emile; et al", "citation": "European Journal of Medicinal Chemistry (2020), 202, 112503.", "doi": "10.1016/j.ejmech.2020.112503", "raw": "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2 | Roussel, Emile; et al | European Journal of Medicinal Chemistry (2020), 202, 112503. | 10.1016/j.ejmech.2020.112503"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-367-CAS-22401841", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 30 min, rt", "1.2|Solvents: Dimethylformamide; 12 - 24 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; acidified, rt", "Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization", "By: Zirimwabagabo, Jean-Olivier; et al", "Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.", "10.1021/acs.jmedchem.0c02191"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "5571caf8", "fam_sig": "0be6ca32"}, "raw_data": {"raw_cas": "RCT: 938460-60-7 + 2252342-91-7 | PRO: 2252343-35-2 | RGT: 7087-68-5 + 125700-67-6 + 7647-01-0 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2\", \"authors\": \"Roussel, Emile; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 202, 112503.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22401841\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"Solvents: Dimethylformamide; 12 - 24 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; acidified, rt\", \"353. Scheme 353 (1 Reaction)\", \"Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization\", \"By: Zirimwabagabo, Jean-Olivier; et al\", \"Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.\", \"10.1021/acs.jmedchem.0c02191\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"938460-60-7\", \"2252342-91-7\"], \"pro_cas\": [\"2252343-35-2\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["938460-60-7", "2252342-91-7"], "products": ["2252343-35-2"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22401842", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.5, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1.COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.Cl", "products": "COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1"}, "reference": {"title": "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2", "authors": "Roussel, Emile; et al", "citation": "European Journal of Medicinal Chemistry (2020), 202, 112503.", "doi": "10.1016/j.ejmech.2020.112503", "raw": "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2 | Roussel, Emile; et al | European Journal of Medicinal Chemistry (2020), 202, 112503. | 10.1016/j.ejmech.2020.112503"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-22401842", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 30 min, rt", "1.2|Solvents: Dimethylformamide; 12 - 24 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; acidified, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2", "By: Roussel, Emile; et al", "European Journal of Medicinal Chemistry (2020), 202, 112503.", "10.1016/j.ejmech.2020.112503"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "5571caf8", "fam_sig": "0be6ca32"}, "raw_data": {"raw_cas": "RCT: 1353747-19-9 + 14907-27-8 | PRO: 2454588-24-8 | RGT: 7087-68-5 + 125700-67-6 + 7647-01-0 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2\", \"authors\": \"Roussel, Emile; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 202, 112503.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22401842\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"Solvents: Dimethylformamide; 12 - 24 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; acidified, rt\", \"433. Scheme 433 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2\", \"By: Roussel, Emile; et al\", \"European Journal of Medicinal Chemistry (2020), 202, 112503.\", \"10.1016/j.ejmech.2020.112503\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1353747-19-9\", \"14907-27-8\"], \"pro_cas\": [\"2454588-24-8\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1353747-19-9", "14907-27-8"], "products": ["2454588-24-8"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22401843", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.5, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1.COC(=O)[C@H](N)Cc1c[nH]c2ccccc12.Cl", "products": "COC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)c2c(OCc3ccc(Br)cc3)cccc2o1"}, "reference": {"title": "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2", "authors": "Roussel, Emile; et al", "citation": "European Journal of Medicinal Chemistry (2020), 202, 112503.", "doi": "10.1016/j.ejmech.2020.112503", "raw": "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2 | Roussel, Emile; et al | European Journal of Medicinal Chemistry (2020), 202, 112503. | 10.1016/j.ejmech.2020.112503"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-22401843", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 30 min, rt", "1.2|Solvents: Dimethylformamide; 12 - 24 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; acidified, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "By: Guryanov, Ivan; et al", "Organic Process Research & Development (2021), 25(7), 1598-1611.", "10.1021/acs.oprd.1c00021"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "5571caf8", "fam_sig": "0be6ca32"}, "raw_data": {"raw_cas": "RCT: 29022-11-5 + 71989-18-9 + 35661-60-0 + 71989-38-3 + 71989-33-8 + 68858-20-8 + 71989-14-5 | PRO: 1787252-17-8 | RGT: 7087-68-5 + 125700-67-6 + 7647-01-0 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2\", \"authors\": \"Roussel, Emile; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 202, 112503.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22401843\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"Solvents: Dimethylformamide; 12 - 24 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; acidified, rt\", \"434. Scheme 434 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"By: Guryanov, Ivan; et al\", \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"10.1021/acs.oprd.1c00021\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"29022-11-5\", \"71989-18-9\", \"35661-60-0\", \"71989-38-3\", \"71989-33-8\", \"68858-20-8\", \"71989-14-5\"], \"pro_cas\": [\"1787252-17-8\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["29022-11-5", "71989-18-9", "35661-60-0", "71989-38-3", "71989-33-8", "68858-20-8", "71989-14-5"], "products": ["1787252-17-8"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22470947", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.0, "yield_pct": 100.0}, "smiles": {"reactants": "C[C@@H](C(=O)N[C@H](C(=O)N1C[C@@H](N)C[C@H]1C(=O)Nc1c(F)cccc1F)C(C)(C)C)N(C)C(=O)OC(C)(C)C.CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CC(=O)NCCOCCOCCOCCC(=O)O)CC4)cn3)nc2n(C2CCCC2)c1=O", "products": "CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CC(=O)NCCOCCOCCOCCC(=O)N[C@H]5C[C@@H](C(=O)Nc6c(F)cccc6F)N(C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)OC(C)(C)C)C(C)(C)C)C5)CC4)cn3)nc2n(C2CCCC2)c1=O"}, "reference": {"title": "Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs", "authors": "Anderson, Niall A.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106.", "doi": "10.1016/j.bmcl.2020.127106", "raw": "Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs | Anderson, Niall A.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106. | 10.1016/j.bmcl.2020.127106"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-367-CAS-22470947", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 0 °C; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2249975-11-7 + 1626337-85-6 | PRO: 2896197-72-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs\", \"authors\": \"Anderson, Niall A.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22470947\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 0 °C; 2 h, rt\", \"486. Scheme 486 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2249975-11-7\", \"1626337-85-6\"], \"pro_cas\": [\"2896197-72-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2249975-11-7", "1626337-85-6"], "products": ["2896197-72-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22486109", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 20.0, "yield_pct": 85.0}, "smiles": {"reactants": "NS(=O)(=O)c1ccc(-n2nc(C(=O)O)cc2-c2ccccc2)cc1.NC1CCCCC1", "products": "NS(=O)(=O)c1ccc(-n2nc(C(=O)NC3CCCCC3)cc2-c2ccccc2)cc1"}, "reference": {"title": "Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks", "authors": "Abdelazeem, Ahmed H.; et al", "citation": "European Journal of Medicinal Chemistry (2020), 205, 112662.", "doi": "10.1016/j.ejmech.2020.112662", "raw": "Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks | Abdelazeem, Ahmed H.; et al | European Journal of Medicinal Chemistry (2020), 205, 112662. | 10.1016/j.ejmech.2020.112662"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-22486109", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 3 h, reflux", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; overnight, rt", "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "By: Sheppard, George S.; et al", "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "10.1021/acs.jmedchem.0c00628"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "7e24dde3", "fam_sig": "465abb34"}, "raw_data": {"raw_cas": "RCT: 1622303-52-9 + 765-30-0 | PRO: 2138864-24-9 | RGT: 7719-09-7 + 121-44-8 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks\", \"authors\": \"Abdelazeem, Ahmed H.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 205, 112662.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22486109\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 3 h, reflux\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; overnight, rt\", \"437. Scheme 437 (1 Reaction)\", \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"By: Sheppard, George S.; et al\", \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"10.1021/acs.jmedchem.0c00628\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1622303-52-9\", \"765-30-0\"], \"pro_cas\": [\"2138864-24-9\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1622303-52-9", "765-30-0"], "products": ["2138864-24-9"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22493175", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.083, "yield_pct": 82.0}, "smiles": {"reactants": "CC(C)Cc1nc(Br)sc1C(=O)O.NCc1ccc(F)cc1", "products": "CC(C)Cc1nc(Br)sc1C(=O)NCc1ccc(F)cc1"}, "reference": {"title": "Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors", "authors": "Jia, Haiyong; et al", "citation": "European Journal of Medicinal Chemistry (2020), 202, 112495.", "doi": "10.1016/j.ejmech.2020.112495", "raw": "Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors | Jia, Haiyong; et al | European Journal of Medicinal Chemistry (2020), 202, 112495. | 10.1016/j.ejmech.2020.112495"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-22493175", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 5 min, rt", "1.2|Reagents: Diisopropylethylamine; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity", "By: Ikeda, Zenichi; et al", "Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.", "10.1021/acs.jmedchem.2c00463"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 156-38-7 + 1791-13-5 | PRO: 3031537-44-4 | RGT: 148893-10-1 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors\", \"authors\": \"Jia, Haiyong; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 202, 112495.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22493175\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 5 min, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; 2 h, rt\", \"232. Scheme 232 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity\", \"By: Ikeda, Zenichi; et al\", \"Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.\", \"10.1021/acs.jmedchem.2c00463\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"156-38-7\", \"1791-13-5\"], \"pro_cas\": [\"3031537-44-4\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["156-38-7", "1791-13-5"], "products": ["3031537-44-4"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22513054", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 45.0, "time_h": 3.5, "yield_pct": 83.0}, "smiles": {"reactants": "CN.COc1ccc(Br)c(F)c1CC(=O)O", "products": "CNC(=O)Cc1c(OC)ccc(Br)c1F"}, "reference": {"title": "Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process", "authors": "Smith, Daniel; et al", "citation": "Organic Process Research & Development (2020), 24(6), 1157-1163.", "doi": "10.1021/acs.oprd.0c00198", "raw": "Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process | Smith, Daniel; et al | Organic Process Research & Development (2020), 24(6), 1157-1163. | 10.1021/acs.oprd.0c00198"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-22513054", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Tetrahydrofuran; rt; rt → 45 °C; 2 h, rt", "1.2|Reagents: Water; 30 min, rt; 1 h, rt", "Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site", "By: Lin, Songwen; et al", "Journal of Medicinal Chemistry (2022), 65(24), 16372-16391.", "10.1021/acs.jmedchem.2c01208"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9", "cond_sig": "21a87c2a", "fam_sig": "469a1196"}, "raw_data": {"raw_cas": "RCT: 2458-12-0 + 3731-52-0 | PRO: 85366-81-0 | RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 68-12-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process\", \"authors\": \"Smith, Daniel; et al\", \"citation\": \"Organic Process Research & Development (2020), 24(6), 1157-1163.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22513054\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Tetrahydrofuran; rt; rt → 45 °C; 2 h, rt\", \"1.2\", \"Reagents: Water; 30 min, rt; 1 h, rt\", \"99. Scheme 99 (1 Reaction)\", \"Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site\", \"By: Lin, Songwen; et al\", \"Journal of Medicinal Chemistry (2022), 65(24), 16372-16391.\", \"10.1021/acs.jmedchem.2c01208\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2458-12-0\", \"3731-52-0\"], \"pro_cas\": [\"85366-81-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["2458-12-0", "3731-52-0"], "products": ["85366-81-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22513060", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "N-Methyl-2-pyrrolidone", "cas": "872-50-4"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 80.0}, "smiles": {"reactants": "Cl.NC1(c2ncccn2)CC1.CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)O)ccc3C)c(F)c12", "products": "CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)c(F)c12"}, "reference": {"title": "Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process", "authors": "Smith, Daniel; et al", "citation": "Organic Process Research & Development (2020), 24(6), 1157-1163.", "doi": "10.1021/acs.oprd.0c00198", "raw": "Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process | Smith, Daniel; et al | Organic Process Research & Development (2020), 24(6), 1157-1163. | 10.1021/acs.oprd.0c00198"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-22513060", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: N-Methyl-2-pyrrolidone; rt; 3 h, rt", "1.2|Reagents: Water; 10 min, rt", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/N-Methyl-2-pyrrolidone|872-50-4", "cond_sig": "2835350c", "fam_sig": "f16784b8"}, "raw_data": {"raw_cas": "RCT: 2892557-05-8 + 104-94-9 | PRO: 2892557-13-8 | RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 872-50-4", "raw_data_json": "{\"txt\": {\"title\": \"Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process\", \"authors\": \"Smith, Daniel; et al\", \"citation\": \"Organic Process Research & Development (2020), 24(6), 1157-1163.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"N-Methyl-2-pyrrolidone\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22513060\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: N-Methyl-2-pyrrolidone; rt; 3 h, rt\", \"1.2\", \"Reagents: Water; 10 min, rt\", \"380. Scheme 380 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-05-8\", \"104-94-9\"], \"pro_cas\": [\"2892557-13-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"872-50-4\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-05-8", "104-94-9"], "products": ["2892557-13-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["N-Methyl-2-pyrrolidone"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.029890", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22568847", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(Nc1ccccc1C(=O)O)OCc1ccccc1.CC(C)(C)OC(=O)NC1CC1c1ccc(N)cc1", "products": "CC(C)(C)OC(=O)NC1CC1c1ccc(NC(=O)c2ccccc2NC(=O)OCc2ccccc2)cc1"}, "reference": {"title": "Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation", "authors": "Fioravanti, Rossella; et al", "citation": "ChemMedChem (2020), 15(7), 643-658.", "doi": "10.1002/cmdc.201900730", "raw": "Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation | Fioravanti, Rossella; et al | ChemMedChem (2020), 15(7), 643-658. | 10.1002/cmdc.201900730"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-22568847", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 1 h, rt", "1.2|Reagents: Water; rt", "Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects", "By: Nepali, Kunal; et al", "European Journal of Medicinal Chemistry (2023), 248, 115054.", "10.1016/j.ejmech.2022.115054"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Triethylamine|121-44-8+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "4c97c8d9", "fam_sig": "3dd20a59"}, "raw_data": {"raw_cas": "RCT: 3946-32-5 + 1001848-81-2 | PRO: 3041972-50-0 | RGT: 121-44-8 + 25952-53-8 + 7732-18-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation\", \"authors\": \"Fioravanti, Rossella; et al\", \"citation\": \"ChemMedChem (2020), 15(7), 643-658.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22568847\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"39. Scheme 39 (1 Reaction)\", \"Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects\", \"By: Nepali, Kunal; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115054.\", \"10.1016/j.ejmech.2022.115054\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3946-32-5\", \"1001848-81-2\"], \"pro_cas\": [\"3041972-50-0\"], \"rgt_cas\": [\"121-44-8\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3946-32-5", "1001848-81-2"], "products": ["3041972-50-0"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.031633", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22568850", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 82.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NC1CC1c1ccc(N)cc1.O=C(Nc1cc(-c2ccccc2)ccc1C(=O)O)OCc1ccccc1", "products": "CC(C)(C)OC(=O)NC1CC1c1ccc(NC(=O)c2ccc(-c3ccccc3)cc2NC(=O)OCc2ccccc2)cc1"}, "reference": {"title": "Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation", "authors": "Fioravanti, Rossella; et al", "citation": "ChemMedChem (2020), 15(7), 643-658.", "doi": "10.1002/cmdc.201900730", "raw": "Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation | Fioravanti, Rossella; et al | ChemMedChem (2020), 15(7), 643-658. | 10.1002/cmdc.201900730"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-22568850", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 1 h, rt", "1.2|Reagents: Water; rt", "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "By: Shan, Bin; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "10.1021/acs.jmedchem.2c01714"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Triethylamine|121-44-8+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "4c97c8d9", "fam_sig": "3dd20a59"}, "raw_data": {"raw_cas": "RCT: 26759-46-6 + 2913152-05-1 | PRO: 2913152-10-8 | RGT: 121-44-8 + 25952-53-8 + 7732-18-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation\", \"authors\": \"Fioravanti, Rossella; et al\", \"citation\": \"ChemMedChem (2020), 15(7), 643-658.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22568850\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"111. Scheme 111 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"By: Shan, Bin; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"10.1021/acs.jmedchem.2c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"26759-46-6\", \"2913152-05-1\"], \"pro_cas\": [\"2913152-10-8\"], \"rgt_cas\": [\"121-44-8\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["26759-46-6", "2913152-05-1"], "products": ["2913152-10-8"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.031633", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22615131", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)Cc1ccccc1.CC(C)(C)OC(=O)CCSc1nnc(N)s1", "products": "CC(C)(C)OC(=O)CCSc1nnc(NC(=O)Cc2ccccc2)s1"}, "reference": {"title": "Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker", "authors": "Duvall, Bridget; et al", "citation": "Bioorganic & Medicinal Chemistry (2020), 28(20), 115698.", "doi": "10.1016/j.bmc.2020.115698", "raw": "Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker | Duvall, Bridget; et al | Bioorganic & Medicinal Chemistry (2020), 28(20), 115698. | 10.1016/j.bmc.2020.115698"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-367-CAS-22615131", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; overnight, 0 °C → rt", "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer", "By: Sharma, Horrick; et al", "European Journal of Medicinal Chemistry (2024), 275, 116598.", "10.1016/j.ejmech.2024.116598"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 501-52-0 + 498581-88-7 | PRO: 3048689-42-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker\", \"authors\": \"Duvall, Bridget; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2020), 28(20), 115698.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22615131\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; overnight, 0 °C → rt\", \"207. Scheme 207 (1 Reaction)\", \"Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer\", \"By: Sharma, Horrick; et al\", \"European Journal of Medicinal Chemistry (2024), 275, 116598.\", \"10.1016/j.ejmech.2024.116598\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"501-52-0\", \"498581-88-7\"], \"pro_cas\": [\"3048689-42-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["501-52-0", "498581-88-7"], "products": ["3048689-42-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.031633", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22629929", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.5, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1cccnc1.Nc1nc(-c2ccncc2)cs1", "products": "O=C(Nc1nc(-c2ccncc2)cs1)c1cccnc1"}, "reference": {"title": "Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors", "authors": "Ma, Shuchao; et al", "citation": "Bioorganic & Medicinal Chemistry (2020), 28(19), 115683.", "doi": "10.1016/j.bmc.2020.115683", "raw": "Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors | Ma, Shuchao; et al | Bioorganic & Medicinal Chemistry (2020), 28(19), 115683. | 10.1016/j.bmc.2020.115683"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-22629929", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 30 min, rt", "1.2|Solvents: Dichloromethane; 8 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers", "By: Braconi, Laura; et al", "European Journal of Medicinal Chemistry (2023), 259, 115716.", "10.1016/j.ejmech.2023.115716"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 20329-98-0 + 39552-81-3 | PRO: 3052839-58-1 | RGT: 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors\", \"authors\": \"Ma, Shuchao; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2020), 28(19), 115683.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22629929\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"Solvents: Dichloromethane; 8 h, rt\", \"275. Scheme 275 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers\", \"By: Braconi, Laura; et al\", \"European Journal of Medicinal Chemistry (2023), 259, 115716.\", \"10.1016/j.ejmech.2023.115716\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"20329-98-0\", \"39552-81-3\"], \"pro_cas\": [\"3052839-58-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["20329-98-0", "39552-81-3"], "products": ["3052839-58-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22631808", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Tetramethylchloroformamidinium hexafluorophosphate", "cas": "330645-87-9", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 99.0}, "smiles": {"reactants": "CC(C)CN.CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N(NC(=O)OC(C)(C)C)[C@H](Cc1ccccc1)C(=O)O", "products": "CC(C)CNC(=O)[C@@H](Cc1ccccc1)N(NC(=O)OC(C)(C)C)C(=O)[C@H](CC(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S", "authors": "Rathman, Benjamin M.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.", "doi": "10.1016/j.bmcl.2020.127283", "raw": "Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S | Rathman, Benjamin M.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283. | 10.1016/j.bmcl.2020.127283"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-367-CAS-22631808", "1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-5-chloro-1H-benzotriazolium 3-oxide hexafluorophosphate(1-) (1:1)", "Solvents: Dimethylformamide; 1 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2023), 246, 114981.", "10.1016/j.ejmech.2022.114981"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+N-Methylmorpholine|109-02-4+Tetramethylchloroformamidinium hexafluorophosphate|330645-87-9/Dimethylformamide|68-12-2", "cond_sig": "d22d16de", "fam_sig": "745e4010"}, "raw_data": {"raw_cas": "RCT: 496-41-3 + 159005-71-7 | PRO: 2883496-03-3 | RGT: 109-02-4 + 330645-87-9 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S\", \"authors\": \"Rathman, Benjamin M.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.\", \"reagents\": [\"4-Methylmorpholine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22631808\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-5-chloro-1H-benzotriazolium 3-oxide hexafluorophosphate(1-) (1:1)\", \"Solvents: Dimethylformamide; 1 h, rt\", \"205. Scheme 205 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2023), 246, 114981.\", \"10.1016/j.ejmech.2022.114981\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"496-41-3\", \"159005-71-7\"], \"pro_cas\": [\"2883496-03-3\"], \"rgt_cas\": [\"109-02-4\", \"330645-87-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["496-41-3", "159005-71-7"], "products": ["2883496-03-3"], "reagents": ["N-Methylmorpholine", "Tetramethylchloroformamidinium hexafluorophosphate"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22631809", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Tetramethylchloroformamidinium hexafluorophosphate", "cas": "330645-87-9", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)CN.CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N(NC(=O)OC(C)(C)C)[C@H](Cc1ccccc1)C(=O)O", "products": "CC(C)CNC(=O)[C@H](Cc1ccccc1)N(NC(=O)OC(C)(C)C)C(=O)[C@H](CC(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S", "authors": "Rathman, Benjamin M.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.", "doi": "10.1016/j.bmcl.2020.127283", "raw": "Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S | Rathman, Benjamin M.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283. | 10.1016/j.bmcl.2020.127283"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-22631809", "1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-5-chloro-1H-benzotriazolium 3-oxide hexafluorophosphate(1-) (1:1)", "Solvents: Dimethylformamide; 1 h, rt", "Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor", "By: Wang, Le; et al", "ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836.", "10.1021/acsmedchemlett.9b00568"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+N-Methylmorpholine|109-02-4+Tetramethylchloroformamidinium hexafluorophosphate|330645-87-9/Dimethylformamide|68-12-2", "cond_sig": "d22d16de", "fam_sig": "745e4010"}, "raw_data": {"raw_cas": "RCT: 878798-87-9 + 136-95-8 | PRO: 1235034-71-5 | RGT: 109-02-4 + 330645-87-9 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S\", \"authors\": \"Rathman, Benjamin M.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.\", \"reagents\": [\"4-Methylmorpholine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22631809\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-5-chloro-1H-benzotriazolium 3-oxide hexafluorophosphate(1-) (1:1)\", \"Solvents: Dimethylformamide; 1 h, rt\", \"210. Scheme 210 (1 Reaction)\", \"Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor\", \"By: Wang, Le; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836.\", \"10.1021/acsmedchemlett.9b00568\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"878798-87-9\", \"136-95-8\"], \"pro_cas\": [\"1235034-71-5\"], \"rgt_cas\": [\"109-02-4\", \"330645-87-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["878798-87-9", "136-95-8"], "products": ["1235034-71-5"], "reagents": ["N-Methylmorpholine", "Tetramethylchloroformamidinium hexafluorophosphate"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22706647", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 0.167, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1cnccn1.C#CCN", "products": "C#CCNC(=O)c1cnccn1"}, "reference": {"title": "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles", "authors": "Reddyrajula, Rajkumar; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.", "doi": "10.1016/j.bmcl.2019.126846", "raw": "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles | Reddyrajula, Rajkumar; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846. | 10.1016/j.bmcl.2019.126846"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-367-CAS-22706647", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C; 10 min, rt", "1.2|Reagents: Triethylamine", "Solvents: Dimethylformamide; rt", "1.3|Reagents: Water; 0 °C", "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "By: Li, Bing-yan; et al", "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "10.1021/acs.jmedchem.3c02407"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8+Water|7732-18-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "4d6cc8f4", "fam_sig": "d67cb962"}, "raw_data": {"raw_cas": "RCT: 6232-88-8 + 107-10-8 | PRO: 1225777-88-7 | RGT: 7719-09-7 + 121-44-8 + 7732-18-5 | CAT: 68-12-2 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles\", \"authors\": \"Reddyrajula, Rajkumar; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\", \"Water\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22706647\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C; 10 min, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dimethylformamide; rt\", \"1.3\", \"Reagents: Water; 0 °C\", \"7. Scheme 7 (1 Reaction)\", \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"By: Li, Bing-yan; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"10.1021/acs.jmedchem.3c02407\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6232-88-8\", \"107-10-8\"], \"pro_cas\": [\"1225777-88-7\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\", \"7732-18-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["6232-88-8", "107-10-8"], "products": ["1225777-88-7"], "reagents": ["7719-09-7", "Triethylamine", "Water"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22706648", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 0.167, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1cccnc1.C#CCN", "products": "C#CCNC(=O)c1cccnc1"}, "reference": {"title": "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles", "authors": "Reddyrajula, Rajkumar; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.", "doi": "10.1016/j.bmcl.2019.126846", "raw": "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles | Reddyrajula, Rajkumar; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846. | 10.1016/j.bmcl.2019.126846"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-22706648", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C; 10 min, rt", "1.2|Reagents: Triethylamine", "Solvents: Dimethylformamide; rt", "1.3|Reagents: Water; 0 °C", "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles", "By: Reddyrajula, Rajkumar; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.", "10.1016/j.bmcl.2019.126846"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8+Water|7732-18-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "4d6cc8f4", "fam_sig": "d67cb962"}, "raw_data": {"raw_cas": "RCT: 98-97-5 + 2450-71-7 | PRO: 1090998-64-3 | RGT: 7719-09-7 + 121-44-8 + 7732-18-5 | CAT: 68-12-2 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles\", \"authors\": \"Reddyrajula, Rajkumar; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\", \"Water\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22706648\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C; 10 min, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dimethylformamide; rt\", \"1.3\", \"Reagents: Water; 0 °C\", \"6. Scheme 6 (1 Reaction)\", \"The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles\", \"By: Reddyrajula, Rajkumar; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.\", \"10.1016/j.bmcl.2019.126846\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"98-97-5\", \"2450-71-7\"], \"pro_cas\": [\"1090998-64-3\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\", \"7732-18-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["98-97-5", "2450-71-7"], "products": ["1090998-64-3"], "reagents": ["7719-09-7", "Triethylamine", "Water"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22706649", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 0.167, "yield_pct": 94.0}, "smiles": {"reactants": "O=C(O)c1ccccc1.C#CCN", "products": "C#CCNC(=O)c1ccccc1"}, "reference": {"title": "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles", "authors": "Reddyrajula, Rajkumar; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.", "doi": "10.1016/j.bmcl.2019.126846", "raw": "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles | Reddyrajula, Rajkumar; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846. | 10.1016/j.bmcl.2019.126846"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-367-CAS-22706649", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C; 10 min, rt", "1.2|Reagents: Triethylamine", "Solvents: Dimethylformamide; rt", "1.3|Reagents: Water; 0 °C", "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "By: Bayrak, Alp; et al", "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "10.1021/acs.jmedchem.2c01198"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8+Water|7732-18-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "4d6cc8f4", "fam_sig": "d67cb962"}, "raw_data": {"raw_cas": "RCT: 118-92-3 + 74-89-5 | PRO: 4141-08-6 | RGT: 7719-09-7 + 121-44-8 + 7732-18-5 | CAT: 68-12-2 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles\", \"authors\": \"Reddyrajula, Rajkumar; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\", \"Water\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22706649\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C; 10 min, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dimethylformamide; rt\", \"1.3\", \"Reagents: Water; 0 °C\", \"2. Scheme 2 (1 Reaction)\", \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"By: Bayrak, Alp; et al\", \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"10.1021/acs.jmedchem.2c01198\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"118-92-3\", \"74-89-5\"], \"pro_cas\": [\"4141-08-6\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\", \"7732-18-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["118-92-3", "74-89-5"], "products": ["4141-08-6"], "reagents": ["7719-09-7", "Triethylamine", "Water"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22721830", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 4.083, "yield_pct": 85.0}, "smiles": {"reactants": "Cc1cc(=O)oc2cc(NC(=O)[C@@H](N)CCCCNC(=O)OCC3c4ccccc4-c4ccccc43)ccc12.O=C(O)C(F)(F)F.CC(=O)N[C@@H](CCC(=O)NC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)O", "products": "CC(=O)N[C@@H](CCC(=O)NC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)Nc1ccc2c(C)cc(=O)oc2c1.O=C(O)C(F)(F)F"}, "reference": {"title": "Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition", "authors": "Rajabi, Nima; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892.", "doi": "10.1021/acsmedchemlett.9b00580", "raw": "Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition | Rajabi, Nima; et al | ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892. | 10.1021/acsmedchemlett.9b00580"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-22721830", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Solvents: Dimethylformamide, Dichloromethane; 5 min, 0 °C; 3 h, rt", "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "By: Wang, Yuan-Yuan; et al", "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "10.1021/acs.jmedchem.2c02044"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "e75a8cfa", "fam_sig": "1a2ac61a"}, "raw_data": {"raw_cas": "RCT: 812653-97-7 + 3035080-41-9 | PRO: 3035080-47-5 | RGT: 1892-57-5 + 2592-95-2 + 7087-68-5 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition\", \"authors\": \"Rajabi, Nima; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22721830\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Solvents: Dimethylformamide, Dichloromethane; 5 min, 0 °C; 3 h, rt\", \"480. Scheme 480 (1 Reaction)\", \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"By: Wang, Yuan-Yuan; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"10.1021/acs.jmedchem.2c02044\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"812653-97-7\", \"3035080-41-9\"], \"pro_cas\": [\"3035080-47-5\"], \"rgt_cas\": [\"1892-57-5\", \"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["812653-97-7", "3035080-41-9"], "products": ["3035080-47-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22759240", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 80.0, "time_h": 18.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1ccc2ncccc2c1.COc1cccc2nc(Nc3cccc(N)c3)ccc12", "products": "COc1cccc2nc(Nc3cccc(NC(=O)c4ccc5ncccc5c4)c3)ccc12"}, "reference": {"title": "2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in-vitro cell-based and oncogenic kinase assessments", "authors": "El-Damasy, Ashraf K.; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112756.", "doi": "10.1016/j.ejmech.2020.112756", "raw": "2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in-vitro cell-based and oncogenic kinase assessments | El-Damasy, Ashraf K.; et al | European Journal of Medicinal Chemistry (2020), 208, 112756. | 10.1016/j.ejmech.2020.112756"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-22759240", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2.5 - 18 h, 70 - 80 °C", "1.2|Reagents: Water", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "By: Yamada, Yousuke; et al", "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "10.1021/acs.jmedchem.0c01215"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "e0675df9", "fam_sig": "b547340e"}, "raw_data": {"raw_cas": "RCT: 1535-73-5 + 51186-58-4 | PRO: 2682842-44-8 | RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in-vitro cell-based and oncogenic kinase assessments\", \"authors\": \"El-Damasy, Ashraf K.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112756.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22759240\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2.5 - 18 h, 70 - 80 °C\", \"1.2\", \"Reagents: Water\", \"117. Scheme 117 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"By: Yamada, Yousuke; et al\", \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"10.1021/acs.jmedchem.0c01215\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1535-73-5\", \"51186-58-4\"], \"pro_cas\": [\"2682842-44-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1535-73-5", "51186-58-4"], "products": ["2682842-44-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22782720", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 82.0}, "smiles": {"reactants": "CCCCCCOC(C)c1c(C)c2cc3nc(c(CC(=O)O)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C.CC(C)(C)OC(=O)C[C@H](N)C(=O)OC(C)(C)C.Cl", "products": "CCCCCCOC(C)c1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy", "authors": "Zhang, Xing-Jie; et al", "citation": "European Journal of Medicinal Chemistry (2020), 207, 112715.", "doi": "10.1016/j.ejmech.2020.112715", "raw": "Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy | Zhang, Xing-Jie; et al | European Journal of Medicinal Chemistry (2020), 207, 112715. | 10.1016/j.ejmech.2020.112715"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-22782720", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 4 h, rt", "1.2|Reagents: Diisopropylethylamine; 8 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy", "By: Murphy, Sean T.; et al", "ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550.", "10.1021/acsmedchemlett.3c00351"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "104c360d", "fam_sig": "df34aecc"}, "raw_data": {"raw_cas": "RCT: 38041-19-9 + 2415441-73-3 | PRO: 3054124-45-4 | RGT: 25952-53-8 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy\", \"authors\": \"Zhang, Xing-Jie; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 207, 112715.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22782720\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 4 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; 8 h, rt\", \"440. Scheme 440 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy\", \"By: Murphy, Sean T.; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550.\", \"10.1021/acsmedchemlett.3c00351\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"38041-19-9\", \"2415441-73-3\"], \"pro_cas\": [\"3054124-45-4\"], \"rgt_cas\": [\"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["38041-19-9", "2415441-73-3"], "products": ["3054124-45-4"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22827989", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 17.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)C(CO)c1ccccc1.NCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1.O=C(O)C(F)(F)F", "products": "O=C(NCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)C(CO)c1ccccc1"}, "reference": {"title": "Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans", "authors": "Binjubair, Faizah A.; et al", "citation": "ChemMedChem (2020), 15(14), 1294-1309.", "doi": "10.1002/cmdc.202000250", "raw": "Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans | Binjubair, Faizah A.; et al | ChemMedChem (2020), 15(14), 1294-1309. | 10.1002/cmdc.202000250"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-22827989", "1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Ethyl acetate; 30 min, 0 °C", "1.2|Reagents: Triethylamine", "Solvents: Ethyl acetate; 30 min, rt; overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity", "By: Ikeda, Zenichi; et al", "Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.", "10.1021/acs.jmedchem.2c00463"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+Triethylamine|121-44-8/Ethyl Acetate|141-78-6", "cond_sig": "fbb736df", "fam_sig": "88192398"}, "raw_data": {"raw_cas": "RCT: 156-38-7 + 172793-31-6 | PRO: 3031537-46-6 | RGT: 538-75-0 + 2592-95-2 + 121-44-8 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans\", \"authors\": \"Binjubair, Faizah A.; et al\", \"citation\": \"ChemMedChem (2020), 15(14), 1294-1309.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22827989\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Ethyl acetate; 30 min, 0 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Ethyl acetate; 30 min, rt; overnight, rt\", \"243. Scheme 243 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity\", \"By: Ikeda, Zenichi; et al\", \"Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.\", \"10.1021/acs.jmedchem.2c00463\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"156-38-7\", \"172793-31-6\"], \"pro_cas\": [\"3031537-46-6\"], \"rgt_cas\": [\"538-75-0\", \"2592-95-2\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": [\"stages 1 and 2 combined after 30 minutes (stage 2)\"]}}", "enriched_names": {"reactants": ["156-38-7", "172793-31-6"], "products": ["3031537-46-6"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole", "Triethylamine"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22829000", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 17.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)C(CO)c1ccccc1.COc1ccc(S(=O)(=O)Nc2ccc(CN)cc2)cc1.O=C(O)C(F)(F)F", "products": "COc1ccc(S(=O)(=O)Nc2ccc(CNC(=O)C(CO)c3ccccc3)cc2)cc1"}, "reference": {"title": "Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans", "authors": "Binjubair, Faizah A.; et al", "citation": "ChemMedChem (2020), 15(14), 1294-1309.", "doi": "10.1002/cmdc.202000250", "raw": "Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans | Binjubair, Faizah A.; et al | ChemMedChem (2020), 15(14), 1294-1309. | 10.1002/cmdc.202000250"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-367-CAS-22829000", "1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Ethyl acetate; 30 min, 0 °C", "1.2|Reagents: Triethylamine", "Solvents: Ethyl acetate; 30 min, rt; overnight, rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+Triethylamine|121-44-8/Ethyl Acetate|141-78-6", "cond_sig": "fbb736df", "fam_sig": "88192398"}, "raw_data": {"raw_cas": "RCT: 383135-47-5 + 3032933-03-9 | PRO: 2983540-53-8 | RGT: 538-75-0 + 2592-95-2 + 121-44-8 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans\", \"authors\": \"Binjubair, Faizah A.; et al\", \"citation\": \"ChemMedChem (2020), 15(14), 1294-1309.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22829000\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Ethyl acetate; 30 min, 0 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Ethyl acetate; 30 min, rt; overnight, rt\", \"234. Scheme 234 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"383135-47-5\", \"3032933-03-9\"], \"pro_cas\": [\"2983540-53-8\"], \"rgt_cas\": [\"538-75-0\", \"2592-95-2\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": [\"stages 1 and 2 combined after 30 minutes (stage 2)\"]}}", "enriched_names": {"reactants": ["383135-47-5", "3032933-03-9"], "products": ["2983540-53-8"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole", "Triethylamine"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22856831", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 23.0, "time_h": 2.0, "yield_pct": 84.0}, "smiles": {"reactants": "CC(=O)O[C@H]1C[C@]2(C)[C@H]3CC[C@@H]4[C@H]5[C@H](C(C)=O)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C(C)(C)[C@H]1OC(C)=O.NCc1ccccc1", "products": "CC(=O)O[C@H]1C[C@]2(C)[C@H]3CC[C@@H]4[C@H]5[C@H](C(C)=O)CC[C@]5(C(=O)NCc5ccccc5)CC[C@@]4(C)[C@]3(C)CC[C@H]2C(C)(C)[C@H]1OC(C)=O"}, "reference": {"title": "Betulinic acid derived amides are highly cytotoxic, apoptotic and selective", "authors": "Hoenke, Sophie; et al", "citation": "European Journal of Medicinal Chemistry (2020), 207, 112815.", "doi": "10.1016/j.ejmech.2020.112815", "raw": "Betulinic acid derived amides are highly cytotoxic, apoptotic and selective | Hoenke, Sophie; et al | European Journal of Medicinal Chemistry (2020), 207, 112815. | 10.1016/j.ejmech.2020.112815"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-22856831", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 1 h, 23 °C", "1.2|Solvents: Dichloromethane; 1 h, 23 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei", "By: Scheuplein, Nicolas J.; et al", "Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.", "10.1021/acs.jmedchem.3c00458"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Dichloromethane|75-09-2", "cond_sig": "af81cf42", "fam_sig": "feb01660"}, "raw_data": {"raw_cas": "RCT: 26250-84-0 + 2411459-88-4 | PRO: 2984600-23-7 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Betulinic acid derived amides are highly cytotoxic, apoptotic and selective\", \"authors\": \"Hoenke, Sophie; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 207, 112815.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22856831\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 1 h, 23 °C\", \"1.2\", \"Solvents: Dichloromethane; 1 h, 23 °C\", \"187. Scheme 187 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei\", \"By: Scheuplein, Nicolas J.; et al\", \"Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.\", \"10.1021/acs.jmedchem.3c00458\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"26250-84-0\", \"2411459-88-4\"], \"pro_cas\": [\"2984600-23-7\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["26250-84-0", "2411459-88-4"], "products": ["2984600-23-7"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22861646", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.167, "yield_pct": 82.0}, "smiles": {"reactants": "CCC1(CC)O[C@H]2[C@H](OC[C@@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)O[C@H](CN=[N+]=[N-])[C@H]2O1.CC1(C)O[C@@H]2[C@H](O1)[C@@H](CN)O[C@H]2n1ccc(=O)[nH]c1=O", "products": "CCC1(CC)O[C@H]2[C@H](OC[C@@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)NC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(C)(C)O[C@@H]43)O[C@H](CN=[N+]=[N-])[C@H]2O1"}, "reference": {"title": "Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores", "authors": "Patel, Bhautikkumar; et al", "citation": "ChemMedChem (2020), 15(15), 1429-1438.", "doi": "10.1002/cmdc.202000033", "raw": "Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores | Patel, Bhautikkumar; et al | ChemMedChem (2020), 15(15), 1429-1438. | 10.1002/cmdc.202000033"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-22861646", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 10 min, rt", "1.2|overnight, rt", "Absolute stereochemistry shown", "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen", "By: Hekking, Koen F. W.; et al", "Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.", "10.1021/acs.jmedchem.3c02206"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 3076055-82-5 | PRO: 3076781-10-4 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores\", \"authors\": \"Patel, Bhautikkumar; et al\", \"citation\": \"ChemMedChem (2020), 15(15), 1429-1438.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22861646\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 10 min, rt\", \"1.2\", \"overnight, rt\", \"496. Scheme 496 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen\", \"By: Hekking, Koen F. W.; et al\", \"Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.\", \"10.1021/acs.jmedchem.3c02206\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3076055-82-5\"], \"pro_cas\": [\"3076781-10-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3076055-82-5"], "products": ["3076781-10-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22862660", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.167, "yield_pct": 84.0}, "smiles": {"reactants": "CCC1(CC)O[C@H]2[C@H](OC[C@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)O)O[C@H](CN=[N+]=[N-])[C@H]2O1.CC1(C)O[C@@H]2[C@H](O1)[C@@H](CN)O[C@H]2n1ccc(=O)[nH]c1=O", "products": "CCC1(CC)O[C@H]2[C@H](OC[C@H](NC(=O)OCC3c4ccccc4-c4ccccc43)C(=O)NC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(C)(C)O[C@@H]43)O[C@H](CN=[N+]=[N-])[C@H]2O1"}, "reference": {"title": "Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores", "authors": "Patel, Bhautikkumar; et al", "citation": "ChemMedChem (2020), 15(15), 1429-1438.", "doi": "10.1002/cmdc.202000033", "raw": "Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores | Patel, Bhautikkumar; et al | ChemMedChem (2020), 15(15), 1429-1438. | 10.1002/cmdc.202000033"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-22862660", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 10 min, rt", "1.2|overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores", "By: Patel, Bhautikkumar; et al", "ChemMedChem (2020), 15(15), 1429-1438.", "10.1002/cmdc.202000033"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 2493230-06-9 + 68691-77-0 | PRO: 2493230-10-5 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores\", \"authors\": \"Patel, Bhautikkumar; et al\", \"citation\": \"ChemMedChem (2020), 15(15), 1429-1438.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22862660\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 10 min, rt\", \"1.2\", \"overnight, rt\", \"495. Scheme 495 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores\", \"By: Patel, Bhautikkumar; et al\", \"ChemMedChem (2020), 15(15), 1429-1438.\", \"10.1002/cmdc.202000033\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2493230-06-9\", \"68691-77-0\"], \"pro_cas\": [\"2493230-10-5\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2493230-06-9", "68691-77-0"], "products": ["2493230-10-5"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22866626", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 5.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1cccnc1.CN(C)c1ccc([N+](=O)[O-])cc1N", "products": "CN(C)c1ccc([N+](=O)[O-])cc1NC(=O)c1cccnc1"}, "reference": {"title": "Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury", "authors": "Pang, Haiying; et al", "citation": "European Journal of Medicinal Chemistry (2020), 197, 112314.", "doi": "10.1016/j.ejmech.2020.112314", "raw": "Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury | Pang, Haiying; et al | European Journal of Medicinal Chemistry (2020), 197, 112314. | 10.1016/j.ejmech.2020.112314"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-367-CAS-22866626", "1.1|Reagents: Thionyl chloride; rt; 4 h, reflux", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 1 h, rt", "Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis", "By: Mohamed, Abdelrahman; et al", "Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.", "10.1021/acs.jmedchem.2c00589"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "7e24dde3", "fam_sig": "465abb34"}, "raw_data": {"raw_cas": "RCT: 585-70-6 + 3430-10-2 | PRO: 1519619-65-8 | RGT: 7719-09-7 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury\", \"authors\": \"Pang, Haiying; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 197, 112314.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22866626\", \"1.1\", \"Reagents: Thionyl chloride; rt; 4 h, reflux\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"239. Scheme 239 (1 Reaction)\", \"Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis\", \"By: Mohamed, Abdelrahman; et al\", \"Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.\", \"10.1021/acs.jmedchem.2c00589\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"585-70-6\", \"3430-10-2\"], \"pro_cas\": [\"1519619-65-8\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["585-70-6", "3430-10-2"], "products": ["1519619-65-8"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-22988979", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.533, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CC[C@H](N(Cc2ccccc2)Cc2ccccc2)[C@@H](C(=O)O)C1.NC1CCCCC1", "products": "CC(C)(C)OC(=O)N1CC[C@H](N(Cc2ccccc2)Cc2ccccc2)[C@@H](C(=O)NC2CCCCC2)C1"}, "reference": {"title": "GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins", "authors": "Watson, Robert J.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(17), 9045-9069.", "doi": "10.1021/acs.jmedchem.0c00614", "raw": "GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins | Watson, Robert J.; et al | Journal of Medicinal Chemistry (2020), 63(17), 9045-9069. | 10.1021/acs.jmedchem.0c00614"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-367-CAS-22988979", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 min, rt", "1.2|0.5 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors", "By: Jelisejevs, Daniels; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 96, 129530.", "10.1016/j.bmcl.2023.129530"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1477-50-5 + 15100-75-1 | PRO: 3054277-59-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins\", \"authors\": \"Watson, Robert J.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(17), 9045-9069.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-22988979\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 min, rt\", \"1.2\", \"0.5 h, rt\", \"427. Scheme 427 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors\", \"By: Jelisejevs, Daniels; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 96, 129530.\", \"10.1016/j.bmcl.2023.129530\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1477-50-5\", \"15100-75-1\"], \"pro_cas\": [\"3054277-59-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1477-50-5", "15100-75-1"], "products": ["3054277-59-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23040320", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)Cc1c[nH]c2ccccc12.COc1ccc(CCN)cc1OC", "products": "COc1ccc(CCNC(=O)Cc2c[nH]c3ccccc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-367-CAS-23040320", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "1.2|3 h, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "By: Chen, Yuanguang; et al", "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "10.1021/acs.jmedchem.3c02006"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 4138-35-6 + 2847839-81-8 | PRO: 2847839-83-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23040320\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"1.2\", \"3 h, rt\", \"372. Scheme 372 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"By: Chen, Yuanguang; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"10.1021/acs.jmedchem.3c02006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4138-35-6\", \"2847839-81-8\"], \"pro_cas\": [\"2847839-83-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["4138-35-6", "2847839-81-8"], "products": ["2847839-83-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23040326", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.Cn1cc(CC(=O)O)c2ccccc21", "products": "COc1ccc(CCNC(=O)Cc2cn(C)c3ccccc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23040326", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Relative stereochemistry shown", "Relative stereochemistry shown", "Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma", "By: Weiss, Matthew M.; et al", "Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.", "10.1021/acs.jmedchem.3c01823"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 2092601-78-8 + 2304449-48-5 | PRO: 2654056-19-4 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23040326\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"425. Scheme 425 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma\", \"By: Weiss, Matthew M.; et al\", \"Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.\", \"10.1021/acs.jmedchem.3c01823\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2092601-78-8\", \"2304449-48-5\"], \"pro_cas\": [\"2654056-19-4\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2092601-78-8", "2304449-48-5"], "products": ["2654056-19-4"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23040400", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2ccc(Br)cc12", "products": "COc1ccc(CCNC(=O)Cc2c[nH]c3ccc(Br)cc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23040400", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 2882-15-7 | PRO: 1985862-30-3 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23040400\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"24. Scheme 24 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"2882-15-7\"], \"pro_cas\": [\"1985862-30-3\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "2882-15-7"], "products": ["1985862-30-3"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23040590", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": 1.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.COc1ccc2[nH]cc(CC(=O)O)c2c1", "products": "COc1ccc2[nH]cc(CC(=O)NCCc3ccc(OC)c(OC)c3)c2c1"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23040590", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 36847-91-3 + 40615-17-6 | PRO: 2416338-30-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23040590\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"458. Scheme 458 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36847-91-3\", \"40615-17-6\"], \"pro_cas\": [\"2416338-30-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36847-91-3", "40615-17-6"], "products": ["2416338-30-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23040801", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.Cc1ccc2[nH]cc(CC(=O)O)c2c1", "products": "COc1ccc(CCNC(=O)Cc2c[nH]c3ccc(C)cc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23040801", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease", "By: Zhou, Jianhui; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.", "10.1021/acs.jmedchem.4c00159"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 830-96-6 + 36377-59-0 | PRO: 2358754-53-5 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23040801\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"394. Scheme 394 (1 Reaction)\", \"Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease\", \"By: Zhou, Jianhui; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.\", \"10.1021/acs.jmedchem.4c00159\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"830-96-6\", \"36377-59-0\"], \"pro_cas\": [\"2358754-53-5\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["830-96-6", "36377-59-0"], "products": ["2358754-53-5"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23040945", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2cc(Cl)ccc12", "products": "COc1ccc(CCNC(=O)Cc2c[nH]c3cc(Cl)ccc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23040945", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics", "By: Garsi, Jean-Baptiste; et al", "ACS Medicinal Chemistry Letters (2022), 13(6), 949-954.", "10.1021/acsmedchemlett.2c00094"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 109425-55-0 + 62893-54-3 | PRO: 2768147-21-1 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23040945\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"16. Scheme 16 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics\", \"By: Garsi, Jean-Baptiste; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(6), 949-954.\", \"10.1021/acsmedchemlett.2c00094\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"109425-55-0\", \"62893-54-3\"], \"pro_cas\": [\"2768147-21-1\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["109425-55-0", "62893-54-3"], "products": ["2768147-21-1"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23040954", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)Cc1c[nH]c2cccc(Cl)c12.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)Cc2c[nH]c3cccc(Cl)c23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23040954", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 1912-41-0 + 36377-59-0 | PRO: 2565618-10-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23040954\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"86. Scheme 86 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1912-41-0\", \"36377-59-0\"], \"pro_cas\": [\"2565618-10-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1912-41-0", "36377-59-0"], "products": ["2565618-10-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23041098", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2c(Cl)cccc12", "products": "COc1ccc(CCNC(=O)Cc2c[nH]c3c(Cl)cccc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23041098", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "By: Novotna, Katerina; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "10.1021/acs.jmedchem.3c01681"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 29022-11-5 + 2851863-10-8 | PRO: 2861234-17-3 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23041098\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"45. Scheme 45 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"By: Novotna, Katerina; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"10.1021/acs.jmedchem.3c01681\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"29022-11-5\", \"2851863-10-8\"], \"pro_cas\": [\"2861234-17-3\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["29022-11-5", "2851863-10-8"], "products": ["2861234-17-3"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23041868", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)Cc1c[nH]c2cc(Cl)ccc12.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)Cc2c[nH]c3cc(Cl)ccc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23041868", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 155480-08-3 + 251105-80-3 | PRO: 2765293-73-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23041868\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"54. Scheme 54 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"155480-08-3\", \"251105-80-3\"], \"pro_cas\": [\"2765293-73-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["155480-08-3", "251105-80-3"], "products": ["2765293-73-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23042059", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)Cc1ccccc1.COc1ccc(CCN)cc1OC", "products": "COc1ccc(CCNC(=O)Cc2ccccc2)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23042059", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process", "By: Smith, Daniel; et al", "Organic Process Research & Development (2020), 24(6), 1157-1163.", "10.1021/acs.oprd.0c00198"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 74-89-5 + 1784193-80-1 | PRO: 2420449-19-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23042059\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"98. Scheme 98 (1 Reaction)\", \"Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process\", \"By: Smith, Daniel; et al\", \"Organic Process Research & Development (2020), 24(6), 1157-1163.\", \"10.1021/acs.oprd.0c00198\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"74-89-5\", \"1784193-80-1\"], \"pro_cas\": [\"2420449-19-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["74-89-5", "1784193-80-1"], "products": ["2420449-19-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23042848", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": 6.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.O=C(O)Cc1ccsc1", "products": "COc1ccc(CCNC(=O)Cc2ccsc2)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23042848", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors", "By: Martinez-Gonzalez, Sonia; et al", "European Journal of Medicinal Chemistry (2020), 201, 112443.", "10.1016/j.ejmech.2020.112443"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 445-29-4 + 121-88-0 | PRO: 1007681-02-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23042848\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"165. Scheme 165 (1 Reaction)\", \"Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors\", \"By: Martinez-Gonzalez, Sonia; et al\", \"European Journal of Medicinal Chemistry (2020), 201, 112443.\", \"10.1016/j.ejmech.2020.112443\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"445-29-4\", \"121-88-0\"], \"pro_cas\": [\"1007681-02-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["445-29-4", "121-88-0"], "products": ["1007681-02-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23043310", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "Cn1cc(CC(=O)O)c2ccccc21.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)Cc2cn(C)c3ccccc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23043310", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "By: Shan, Bin; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "10.1021/acs.jmedchem.2c01714"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 2475-80-1 + 2913152-05-1 | PRO: 2913152-08-4 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23043310\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"486. Scheme 486 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"By: Shan, Bin; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"10.1021/acs.jmedchem.2c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2475-80-1\", \"2913152-05-1\"], \"pro_cas\": [\"2913152-08-4\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2475-80-1", "2913152-05-1"], "products": ["2913152-08-4"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23044787", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)Cc1c[nH]c2c(Cl)cccc12.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)Cc2c[nH]c3c(Cl)cccc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23044787", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles", "By: Osawa, Hinata; et al", "Bioorganic & Medicinal Chemistry (2023), 84, 117259.", "10.1016/j.bmc.2023.117259"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 927877-48-3 + 2924897-08-3 | PRO: 927878-42-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23044787\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"87. Scheme 87 (1 Reaction)\", \"CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles\", \"By: Osawa, Hinata; et al\", \"Bioorganic & Medicinal Chemistry (2023), 84, 117259.\", \"10.1016/j.bmc.2023.117259\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"927877-48-3\", \"2924897-08-3\"], \"pro_cas\": [\"927878-42-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["927877-48-3", "2924897-08-3"], "products": ["927878-42-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23044991", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.O=C(O)Cc1cc2ccccc2[nH]1", "products": "COc1ccc(CCNC(=O)Cc2cc3ccccc3[nH]2)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23044991", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice", "By: Zareba, Paula; et al", "European Journal of Medicinal Chemistry (2020), 188, 111920.", "10.1016/j.ejmech.2019.111920"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 35197-64-9 + 140-75-0 | PRO: 1621341-92-1 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23044991\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"365. Scheme 365 (1 Reaction)\", \"Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice\", \"By: Zareba, Paula; et al\", \"European Journal of Medicinal Chemistry (2020), 188, 111920.\", \"10.1016/j.ejmech.2019.111920\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"35197-64-9\", \"140-75-0\"], \"pro_cas\": [\"1621341-92-1\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["35197-64-9", "140-75-0"], "products": ["1621341-92-1"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23045015", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "Cc1ccc2[nH]cc(CC(=O)O)c2c1.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)Cc2c[nH]c3ccc(C)cc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23045015", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks", "By: Abdelazeem, Ahmed H.; et al", "European Journal of Medicinal Chemistry (2020), 205, 112662.", "10.1016/j.ejmech.2020.112662"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 586333-65-5 + 108-91-8 | PRO: 2474977-42-7 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23045015\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"436. Scheme 436 (1 Reaction)\", \"Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks\", \"By: Abdelazeem, Ahmed H.; et al\", \"European Journal of Medicinal Chemistry (2020), 205, 112662.\", \"10.1016/j.ejmech.2020.112662\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"586333-65-5\", \"108-91-8\"], \"pro_cas\": [\"2474977-42-7\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["586333-65-5", "108-91-8"], "products": ["2474977-42-7"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23045625", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc2[nH]cc(CC(=O)O)c2c1.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)Cc2c[nH]c3ccc(OC)cc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23045625", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 98874-04-5 + 2761157-71-3 | PRO: 2761157-30-4 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23045625\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"22. Scheme 22 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"98874-04-5\", \"2761157-71-3\"], \"pro_cas\": [\"2761157-30-4\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["98874-04-5", "2761157-71-3"], "products": ["2761157-30-4"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23045691", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": 1.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.COc1ccc2[nH]c(C)c(CC(=O)O)c2c1", "products": "COc1ccc2[nH]c(C)c(CC(=O)NCCc3ccc(OC)c(OC)c3)c2c1"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23045691", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 36847-90-2 + 40615-17-6 | PRO: 2416338-29-7 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23045691\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"25. Scheme 25 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36847-90-2\", \"40615-17-6\"], \"pro_cas\": [\"2416338-29-7\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36847-90-2", "40615-17-6"], "products": ["2416338-29-7"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23045819", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "CCOc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2ccc(Br)cc12", "products": "CCOc1ccc(CCNC(=O)Cc2c[nH]c3ccc(Br)cc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23045819", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 455-40-3 + 2761158-08-9 | PRO: 2761157-35-9 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23045819\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"63. Scheme 63 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-40-3\", \"2761158-08-9\"], \"pro_cas\": [\"2761157-35-9\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-40-3", "2761158-08-9"], "products": ["2761157-35-9"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23046042", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.O=C(O)Cc1c[nH]c2cccc(Cl)c12", "products": "COc1ccc(CCNC(=O)Cc2c[nH]c3cccc(Cl)c23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23046042", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 1912-41-0 | PRO: 2309063-82-7 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23046042\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"44. Scheme 44 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"1912-41-0\"], \"pro_cas\": [\"2309063-82-7\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "1912-41-0"], "products": ["2309063-82-7"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23046121", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc2[nH]c(C)c(CC(=O)O)c2c1.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)Cc2c(C)[nH]c3ccc(OC)cc23)cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "authors": "Zhang, Rui; et al", "citation": "European Journal of Medicinal Chemistry (2021), 211, 113004.", "doi": "10.1016/j.ejmech.2020.113004", "raw": "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment | Zhang, Rui; et al | European Journal of Medicinal Chemistry (2021), 211, 113004. | 10.1016/j.ejmech.2020.113004"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23046121", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 455-40-3 + 2761158-04-5 | PRO: 2761157-24-6 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"authors\": \"Zhang, Rui; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23046121\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"60. Scheme 60 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-40-3\", \"2761158-04-5\"], \"pro_cas\": [\"2761157-24-6\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-40-3", "2761158-04-5"], "products": ["2761157-24-6"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23182426", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 23.5, "yield_pct": 80.0}, "smiles": {"reactants": "Nc1ccc(Cl)c(F)c1.CC(C)(C)OC(=O)N1CCC[C@H](C(=O)O)C1", "products": "CC(C)(C)OC(=O)N1CCC[C@H](C(=O)Nc2ccc(Cl)c(F)c2)C1"}, "reference": {"title": "Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity", "authors": "Grenier, Melissa C.; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(3), 371-378.", "doi": "10.1021/acsmedchemlett.9b00445", "raw": "Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity | Grenier, Melissa C.; et al | ACS Medicinal Chemistry Letters (2020), 11(3), 371-378. | 10.1021/acsmedchemlett.9b00445"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-23182426", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 22 h, rt", "1.2|Reagents: Water; 30 min, rt", "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "By: Sheppard, George S.; et al", "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "10.1021/acs.jmedchem.0c00628"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "18f8fedd", "fam_sig": "cf00684a"}, "raw_data": {"raw_cas": "RCT: 1622303-52-9 + 75-64-9 | PRO: 2138863-24-6 | RGT: 25952-53-8 + 7732-18-5 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity\", \"authors\": \"Grenier, Melissa C.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(3), 371-378.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23182426\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 22 h, rt\", \"1.2\", \"Reagents: Water; 30 min, rt\", \"408. Scheme 408 (1 Reaction)\", \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"By: Sheppard, George S.; et al\", \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"10.1021/acs.jmedchem.0c00628\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1622303-52-9\", \"75-64-9\"], \"pro_cas\": [\"2138863-24-6\"], \"rgt_cas\": [\"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1622303-52-9", "75-64-9"], "products": ["2138863-24-6"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23230949", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 6.5, "yield_pct": 85.0}, "smiles": {"reactants": "C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)C(=O)O)[C@@H]1/C=C/C1=CCOC1=O.NCc1ccccc1", "products": "C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)C(=O)NCc2ccccc2)[C@@H]1/C=C/C1=CCOC1=O"}, "reference": {"title": "Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo", "authors": "Zhang, Songxuan; et al", "citation": "European Journal of Medicinal Chemistry (2021), 213, 113185.", "doi": "10.1016/j.ejmech.2021.113185", "raw": "Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo | Zhang, Songxuan; et al | European Journal of Medicinal Chemistry (2021), 213, 113185. | 10.1016/j.ejmech.2021.113185"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-23230949", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 15 min, rt", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt", "1.3|6 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2", "By: Grifagni, Deborah; et al", "ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.", "10.1021/acsmedchemlett.3c00498"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2018-66-8 + 1027601-37-1 | PRO: 1429218-44-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo\", \"authors\": \"Zhang, Songxuan; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 213, 113185.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23230949\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt\", \"1.3\", \"6 h, rt\", \"83. Scheme 83 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2\", \"By: Grifagni, Deborah; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.\", \"10.1021/acsmedchemlett.3c00498\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2018-66-8\", \"1027601-37-1\"], \"pro_cas\": [\"1429218-44-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2018-66-8", "1027601-37-1"], "products": ["1429218-44-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23231473", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)CCCC[C@@H]1CCSS1.COC(=O)/C(O)=C/C(=O)c1ccc(N)cc1", "products": "COC(=O)/C(O)=C/C(=O)c1ccc(NC(=O)CCCC[C@H]2CCSS2)cc1"}, "reference": {"title": "Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles", "authors": "Sanna, Vanna; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(5), 857-861.", "doi": "10.1021/acsmedchemlett.9b00648", "raw": "Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles | Sanna, Vanna; et al | ACS Medicinal Chemistry Letters (2020), 11(5), 857-861. | 10.1021/acsmedchemlett.9b00648"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-367-CAS-23231473", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylacetamide; 1 h, rt", "1.2|3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors", "By: Zhang, Hao; et al", "Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.", "10.1021/acs.jmedchem.2c00611"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dimethylacetamide|127-19-5", "cond_sig": "5d4ee19e", "fam_sig": "8acdc753"}, "raw_data": {"raw_cas": "RCT: 1003-03-8 + 102922-72-5 | PRO: 2307268-42-2 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 127-19-5", "raw_data_json": "{\"txt\": {\"title\": \"Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles\", \"authors\": \"Sanna, Vanna; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(5), 857-861.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylacetamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23231473\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylacetamide; 1 h, rt\", \"1.2\", \"3 h, rt\", \"241. Scheme 241 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors\", \"By: Zhang, Hao; et al\", \"Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.\", \"10.1021/acs.jmedchem.2c00611\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1003-03-8\", \"102922-72-5\"], \"pro_cas\": [\"2307268-42-2\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"127-19-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1003-03-8", "102922-72-5"], "products": ["2307268-42-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylacetamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23309934", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 6.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CC1CCCCC1.Cl", "products": "COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C"}, "reference": {"title": "A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors", "authors": "Yang, Kai S.; et al", "citation": "ChemMedChem (2021), 16(6), 942-948.", "doi": "10.1002/cmdc.202000924", "raw": "A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors | Yang, Kai S.; et al | ChemMedChem (2021), 16(6), 942-948. | 10.1002/cmdc.202000924"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-23309934", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors", "By: Zhu, Junjie; et al", "European Journal of Medicinal Chemistry (2023), 259, 115666.", "10.1016/j.ejmech.2023.115666"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 75-64-9 + 3705-42-8 | PRO: 39538-24-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors\", \"authors\": \"Yang, Kai S.; et al\", \"citation\": \"ChemMedChem (2021), 16(6), 942-948.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23309934\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 6 h, rt\", \"346. Scheme 346 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors\", \"By: Zhu, Junjie; et al\", \"European Journal of Medicinal Chemistry (2023), 259, 115666.\", \"10.1016/j.ejmech.2023.115666\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-64-9\", \"3705-42-8\"], \"pro_cas\": [\"39538-24-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-64-9", "3705-42-8"], "products": ["39538-24-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23310372", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 6.0, "yield_pct": 83.0}, "smiles": {"reactants": "C[C@@H](OC(C)(C)C)[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CC1CCCCC1.Cl", "products": "COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)[C@@H](C)OC(C)(C)C"}, "reference": {"title": "A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors", "authors": "Yang, Kai S.; et al", "citation": "ChemMedChem (2021), 16(6), 942-948.", "doi": "10.1002/cmdc.202000924", "raw": "A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors | Yang, Kai S.; et al | ChemMedChem (2021), 16(6), 942-948. | 10.1002/cmdc.202000924"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-23310372", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 6 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1912-44-3 + 36377-59-0 | PRO: 2565618-09-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors\", \"authors\": \"Yang, Kai S.; et al\", \"citation\": \"ChemMedChem (2021), 16(6), 942-948.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23310372\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 6 h, rt\", \"53. Scheme 53 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1912-44-3\", \"36377-59-0\"], \"pro_cas\": [\"2565618-09-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1912-44-3", "36377-59-0"], "products": ["2565618-09-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.032355", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23337821", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 96.0}, "smiles": {"reactants": "Nc1cccnc1.O=C(O)c1ccc(CNC(=O)c2ccc(F)cc2)cc1", "products": "O=C(NCc1ccc(C(=O)Nc2cccnc2)cc1)c1ccc(F)cc1"}, "reference": {"title": "A new chemotype with promise against Trypanosoma cruzi", "authors": "Wang, Xiaofang; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "doi": "10.1016/j.bmcl.2019.126778", "raw": "A new chemotype with promise against Trypanosoma cruzi | Wang, Xiaofang; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778. | 10.1016/j.bmcl.2019.126778"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-367-CAS-23337821", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylacetamide; 24 h, rt", "1.2|Reagents: Water; rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8+Water|7732-18-5/Dimethylacetamide|127-19-5", "cond_sig": "b3f5ce70", "fam_sig": "43586c5e"}, "raw_data": {"raw_cas": "RCT: 1878-71-3 + 2983540-42-5 | PRO: 2983540-50-5 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 + 7732-18-5 | SOL: 127-19-5", "raw_data_json": "{\"txt\": {\"title\": \"A new chemotype with promise against Trypanosoma cruzi\", \"authors\": \"Wang, Xiaofang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23337821\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylacetamide; 24 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"194. Scheme 194 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1878-71-3\", \"2983540-42-5\"], \"pro_cas\": [\"2983540-50-5\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1878-71-3", "2983540-42-5"], "products": ["2983540-50-5"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Dimethylacetamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23338306", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 91.0}, "smiles": {"reactants": "Cc1ccc(N)c(C)n1.O=C(O)c1ccc(CNS(=O)(=O)c2ccc(F)cc2)cc1", "products": "Cc1ccc(NC(=O)c2ccc(CNS(=O)(=O)c3ccc(F)cc3)cc2)c(C)n1"}, "reference": {"title": "A new chemotype with promise against Trypanosoma cruzi", "authors": "Wang, Xiaofang; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "doi": "10.1016/j.bmcl.2019.126778", "raw": "A new chemotype with promise against Trypanosoma cruzi | Wang, Xiaofang; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778. | 10.1016/j.bmcl.2019.126778"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-367-CAS-23338306", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylacetamide; 24 h, rt", "1.2|Reagents: Water; rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders", "By: Li, Huajie; et al", "ACS Medicinal Chemistry Letters (2024), 15(5), 631-639.", "10.1021/acsmedchemlett.4c00029"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8+Water|7732-18-5/Dimethylacetamide|127-19-5", "cond_sig": "b3f5ce70", "fam_sig": "43586c5e"}, "raw_data": {"raw_cas": "RCT: 1415303-42-2 + 2417720-65-9 | PRO: 2971850-47-0 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 + 7732-18-5 | SOL: 127-19-5", "raw_data_json": "{\"txt\": {\"title\": \"A new chemotype with promise against Trypanosoma cruzi\", \"authors\": \"Wang, Xiaofang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23338306\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylacetamide; 24 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"328. Scheme 328 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders\", \"By: Li, Huajie; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(5), 631-639.\", \"10.1021/acsmedchemlett.4c00029\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1415303-42-2\", \"2417720-65-9\"], \"pro_cas\": [\"2971850-47-0\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1415303-42-2", "2417720-65-9"], "products": ["2971850-47-0"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Dimethylacetamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23338374", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 97.0}, "smiles": {"reactants": "Nc1cccnc1.O=C(O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(F)cc2)CC1", "products": "O=C(Nc1cccnc1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(F)cc2)CC1"}, "reference": {"title": "A new chemotype with promise against Trypanosoma cruzi", "authors": "Wang, Xiaofang; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "doi": "10.1016/j.bmcl.2019.126778", "raw": "A new chemotype with promise against Trypanosoma cruzi | Wang, Xiaofang; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778. | 10.1016/j.bmcl.2019.126778"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-367-CAS-23338374", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylacetamide; 24 h, rt", "1.2|Reagents: Water; rt", "A new chemotype with promise against Trypanosoma cruzi", "By: Wang, Xiaofang; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "10.1016/j.bmcl.2019.126778"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8+Water|7732-18-5/Dimethylacetamide|127-19-5", "cond_sig": "b3f5ce70", "fam_sig": "43586c5e"}, "raw_data": {"raw_cas": "RCT: 3430-14-6 + 438575-58-7 | PRO: 2581111-05-7 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 + 7732-18-5 | SOL: 127-19-5", "raw_data_json": "{\"txt\": {\"title\": \"A new chemotype with promise against Trypanosoma cruzi\", \"authors\": \"Wang, Xiaofang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23338374\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylacetamide; 24 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"290. Scheme 290 (1 Reaction)\", \"A new chemotype with promise against Trypanosoma cruzi\", \"By: Wang, Xiaofang; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"10.1016/j.bmcl.2019.126778\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3430-14-6\", \"438575-58-7\"], \"pro_cas\": [\"2581111-05-7\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3430-14-6", "438575-58-7"], "products": ["2581111-05-7"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Dimethylacetamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23338923", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 90.0}, "smiles": {"reactants": "Cc1ccc(N)cn1.O=C(O)c1ccc(CNS(=O)(=O)c2ccc(F)cc2)cc1", "products": "Cc1ccc(NC(=O)c2ccc(CNS(=O)(=O)c3ccc(F)cc3)cc2)cn1"}, "reference": {"title": "A new chemotype with promise against Trypanosoma cruzi", "authors": "Wang, Xiaofang; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "doi": "10.1016/j.bmcl.2019.126778", "raw": "A new chemotype with promise against Trypanosoma cruzi | Wang, Xiaofang; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778. | 10.1016/j.bmcl.2019.126778"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-367-CAS-23338923", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylacetamide; 24 h, rt", "1.2|Reagents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "By: Yamada, Yousuke; et al", "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "10.1021/acs.jmedchem.0c01215"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8+Water|7732-18-5/Dimethylacetamide|127-19-5", "cond_sig": "b3f5ce70", "fam_sig": "43586c5e"}, "raw_data": {"raw_cas": "RCT: 92-92-2 + 3350-15-0 | PRO: 2682842-26-6 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 + 7732-18-5 | SOL: 127-19-5", "raw_data_json": "{\"txt\": {\"title\": \"A new chemotype with promise against Trypanosoma cruzi\", \"authors\": \"Wang, Xiaofang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23338923\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylacetamide; 24 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"291. Scheme 291 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"By: Yamada, Yousuke; et al\", \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"10.1021/acs.jmedchem.0c01215\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"92-92-2\", \"3350-15-0\"], \"pro_cas\": [\"2682842-26-6\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["92-92-2", "3350-15-0"], "products": ["2682842-26-6"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Dimethylacetamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23349010", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 92.0}, "smiles": {"reactants": "Nc1ccc(F)cc1.CC(C(=O)O)C12CC(NC(=O)OC(C)(C)C)(C1)C2", "products": "CC(C(=O)Nc1ccc(F)cc1)C12CC(NC(=O)OC(C)(C)C)(C1)C2"}, "reference": {"title": "Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors", "authors": "Pu, Qinglin; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(8), 1548-1554.", "doi": "10.1021/acsmedchemlett.0c00195", "raw": "Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors | Pu, Qinglin; et al | ACS Medicinal Chemistry Letters (2020), 11(8), 1548-1554. | 10.1021/acsmedchemlett.0c00195"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-367-CAS-23349010", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "By: Bayrak, Alp; et al", "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "10.1021/acs.jmedchem.2c01198"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 4141-08-6 + 13734-36-6 | PRO: 2998587-29-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors\", \"authors\": \"Pu, Qinglin; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(8), 1548-1554.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23349010\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"249. Scheme 249 (1 Reaction)\", \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"By: Bayrak, Alp; et al\", \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"10.1021/acs.jmedchem.2c01198\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4141-08-6\", \"13734-36-6\"], \"pro_cas\": [\"2998587-29-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4141-08-6", "13734-36-6"], "products": ["2998587-29-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23361600", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "4-(Dimethylamino)pyridine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}], "conditions": {"temperature_c": 50.0, "time_h": 12.0, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)(C)c1ccc(C(=O)O)cc1.COC(=O)c1ccc(Cn2ccc3ccc(N)cc32)cc1", "products": "COC(=O)c1ccc(Cn2ccc3ccc(NC(=O)c4ccc(C(C)(C)C)cc4)cc32)cc1"}, "reference": {"title": "Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast", "authors": "Schierle, Simone; et al", "citation": "ChemMedChem (2020), 15(1), 50-67.", "doi": "10.1002/cmdc.201900576", "raw": "Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast | Schierle, Simone; et al | ChemMedChem (2020), 15(1), 50-67. | 10.1002/cmdc.201900576"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-367-CAS-23361600", "1.1|Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Chloroform; 12 h, 50 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (+)", "Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity", "By: Grenier, Melissa C.; et al", "ACS Medicinal Chemistry Letters (2020), 11(3), 371-378.", "10.1021/acsmedchemlett.9b00445"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+4-(Dimethylamino)pyridine|+4-Dimethylaminopyridine|1122-58-3/Chloroform|67-66-3", "cond_sig": "3a158ca9", "fam_sig": "ef3caf69"}, "raw_data": {"raw_cas": "RCT: 367-22-6 + 88495-54-9 | PRO: 2410447-06-0 | RGT: 1122-58-3 + 25952-53-8 | SOL: 67-66-3", "raw_data_json": "{\"txt\": {\"title\": \"Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast\", \"authors\": \"Schierle, Simone; et al\", \"citation\": \"ChemMedChem (2020), 15(1), 50-67.\", \"reagents\": [\"4-(Dimethylamino)pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23361600\", \"1.1\", \"Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Chloroform; 12 h, 50 °C\", \"407. Scheme 407 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity\", \"By: Grenier, Melissa C.; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(3), 371-378.\", \"10.1021/acsmedchemlett.9b00445\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"367-22-6\", \"88495-54-9\"], \"pro_cas\": [\"2410447-06-0\"], \"rgt_cas\": [\"1122-58-3\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\"], \"notes\": []}}", "enriched_names": {"reactants": ["367-22-6", "88495-54-9"], "products": ["2410447-06-0"], "reagents": ["4-Dimethylaminopyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Chloroform"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23413494", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1C[C@H](O)C[C@H]1C(=O)O.Cc1ncsc1-c1ccc(CN)cc1", "products": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers", "authors": "Cao, Chaoguo; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.", "doi": "10.1021/acs.jmedchem.0c00821", "raw": "Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers | Cao, Chaoguo; et al | Journal of Medicinal Chemistry (2020), 63(19), 11012-11033. | 10.1021/acs.jmedchem.0c00821"}, "original_text": ["Steps: 1, Yield: 83-90%", "CAS Reaction Number: 31-367-CAS-23413494", "1.1|Solvents: Dimethylformamide; rt → 0 °C", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 2 h, rt", "Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma", "By: Tu, Yalin; et al", "Journal of Medicinal Chemistry (2021), 64(14), 10167-10184.", "10.1021/acs.jmedchem.1c00460"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 13726-69-7 + 1448189-30-7 | PRO: 1448191-54-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers\", \"authors\": \"Cao, Chaoguo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23413494\", \"1.1\", \"Solvents: Dimethylformamide; rt → 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 2 h, rt\", \"Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma\", \"By: Tu, Yalin; et al\", \"Journal of Medicinal Chemistry (2021), 64(14), 10167-10184.\", \"10.1021/acs.jmedchem.1c00460\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13726-69-7\", \"1448189-30-7\"], \"pro_cas\": [\"1448191-54-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13726-69-7", "1448189-30-7"], "products": ["1448191-54-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23439616", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Methanol", "cas": "67-56-1"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 22.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)CCCCCN1C(=O)C=CC1=O.COc1cc2c(cc1OCCCOc1cc3c(cc1OC)C(=O)N1C=C(c4ccc(N5CCN(C)CC5)cc4)C[C@H]1C=N3)N=C[C@@H]1CC(c3ccc(NC(=O)[C@@H](C)NC(=O)[C@@H](N)C(C)C)cc3)=CN1C2=O", "products": "COc1cc2c(cc1OCCCOc1cc3c(cc1OC)C(=O)N1C=C(c4ccc(N5CCN(C)CC5)cc4)C[C@H]1C=N3)N=C[C@@H]1CC(c3ccc(NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)CCCCCN4C(=O)C=CC4=O)C(C)C)cc3)=CN1C2=O"}, "reference": {"title": "Early Development, Scale-Up, and Reverse-Phase Purification of a Highly Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug Conjugates", "authors": "Holte, Dane; et al", "citation": "Organic Process Research & Development (2021), 25(4), 799-809.", "doi": "10.1021/acs.oprd.0c00497", "raw": "Early Development, Scale-Up, and Reverse-Phase Purification of a Highly Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug Conjugates | Holte, Dane; et al | Organic Process Research & Development (2021), 25(4), 799-809. | 10.1021/acs.oprd.0c00497"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-23439616", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Methanol, Dichloromethane; 22 h, rt", "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension", "By: Vakalopoulos, Alexandros; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.", "10.1021/acs.jmedchem.2c02082"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2+Methanol|67-56-1", "cond_sig": "1b521cd9", "fam_sig": "53ceaa76"}, "raw_data": {"raw_cas": "RCT: 1270494-14-8 + 1415501-19-7 | PRO: 1609344-74-2 | RGT: 25952-53-8 | SOL: 67-56-1 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Early Development, Scale-Up, and Reverse-Phase Purification of a Highly Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug Conjugates\", \"authors\": \"Holte, Dane; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(4), 799-809.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Methanol\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23439616\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Methanol, Dichloromethane; 22 h, rt\", \"470. Scheme 470 (1 Reaction)\", \"New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension\", \"By: Vakalopoulos, Alexandros; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.\", \"10.1021/acs.jmedchem.2c02082\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1270494-14-8\", \"1415501-19-7\"], \"pro_cas\": [\"1609344-74-2\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"67-56-1\", \"75-09-2\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["1270494-14-8", "1415501-19-7"], "products": ["1609344-74-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Methanol", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23500779", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Megestrol acetate", "cas": "595-33-5", "role": "UNK"}, {"name": "(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate", "cas": "56602-33-6", "role": "UNK"}, {"name": "BOP reagent", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 84.0}, "smiles": {"reactants": "Cc1ccc(C(=O)O)cc1.COC(=O)c1cc(N)cc(Br)c1", "products": "COC(=O)c1cc(Br)cc(NC(=O)c2ccc(C)cc2)c1"}, "reference": {"title": "Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis", "authors": "Lu, Ran; et al", "citation": "European Journal of Medicinal Chemistry (2021), 216, 113313.", "doi": "10.1016/j.ejmech.2021.113313", "raw": "Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis | Lu, Ran; et al | European Journal of Medicinal Chemistry (2021), 216, 113313. | 10.1016/j.ejmech.2021.113313"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-23500779", "1.1|Reagents: Megestrol acetate, BOP reagent", "Solvents: Dichloromethane; 15 min, rt", "1.2|overnight, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate|56602-33-6+BOP reagent|+Megestrol acetate|595-33-5/Dichloromethane|75-09-2", "cond_sig": "25a227d8", "fam_sig": "08f051d6"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 121492-06-6 | PRO: 3031471-32-3 | RGT: 595-33-5 + 56602-33-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis\", \"authors\": \"Lu, Ran; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 216, 113313.\", \"reagents\": [\"Megestrol acetate\", \"BOP reagent\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23500779\", \"1.1\", \"Reagents: Megestrol acetate, BOP reagent\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"overnight, rt\", \"135. Scheme 135 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"121492-06-6\"], \"pro_cas\": [\"3031471-32-3\"], \"rgt_cas\": [\"595-33-5\", \"56602-33-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "121492-06-6"], "products": ["3031471-32-3"], "reagents": ["595-33-5", "(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23513655", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)c1ccc(Br)cn1.CC(C)(C)OC(=O)NC1=N[C@](C)(c2cccc(N)c2)CO[C@@]1(C)C(F)(F)F", "products": "CC(C)(C)OC(=O)NC1=N[C@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@]1(C)C(F)(F)F"}, "reference": {"title": "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360", "authors": "Rueeger, Heinrich; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.", "doi": "10.1021/acs.jmedchem.0c02143", "raw": "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360 | Rueeger, Heinrich; et al | Journal of Medicinal Chemistry (2021), 64(8), 4677-4696. | 10.1021/acs.jmedchem.0c02143"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-367-CAS-23513655", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 2 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy", "By: Zhang, Xing-Jie; et al", "European Journal of Medicinal Chemistry (2020), 207, 112715.", "10.1016/j.ejmech.2020.112715"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 128146-81-6 + 1791-13-5 | PRO: 2222800-20-4 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360\", \"authors\": \"Rueeger, Heinrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23513655\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 2 h, 25 °C\", \"439. Scheme 439 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of novel 131-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy\", \"By: Zhang, Xing-Jie; et al\", \"European Journal of Medicinal Chemistry (2020), 207, 112715.\", \"10.1016/j.ejmech.2020.112715\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"128146-81-6\", \"1791-13-5\"], \"pro_cas\": [\"2222800-20-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["128146-81-6", "1791-13-5"], "products": ["2222800-20-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23514679", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1ccc(Br)cn1.CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(N)ccc2F)CO[C@@]1(C)C(F)(F)F", "products": "CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@]1(C)C(F)(F)F"}, "reference": {"title": "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360", "authors": "Rueeger, Heinrich; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.", "doi": "10.1021/acs.jmedchem.0c02143", "raw": "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360 | Rueeger, Heinrich; et al | Journal of Medicinal Chemistry (2021), 64(8), 4677-4696. | 10.1021/acs.jmedchem.0c02143"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-367-CAS-23514679", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 2 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension", "By: Vakalopoulos, Alexandros; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.", "10.1021/acs.jmedchem.2c02082"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 1609082-37-2 + 1609346-13-5 | PRO: 1609346-15-7 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360\", \"authors\": \"Rueeger, Heinrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23514679\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 2 h, 25 °C\", \"454. Scheme 454 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension\", \"By: Vakalopoulos, Alexandros; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.\", \"10.1021/acs.jmedchem.2c02082\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1609082-37-2\", \"1609346-13-5\"], \"pro_cas\": [\"1609346-15-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1609082-37-2", "1609346-13-5"], "products": ["1609346-15-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23515650", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 44.0, "yield_pct": 83.0}, "smiles": {"reactants": "COc1cccc(C(=O)O)c1OC.CCOC(CN)OCC", "products": "CCOC(CNC(=O)c1cccc(OC)c1OC)OCC"}, "reference": {"title": "The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors", "authors": "Tajiri, Misato; et al", "citation": "European Journal of Medicinal Chemistry (2021), 215, 113289.", "doi": "10.1016/j.ejmech.2021.113289", "raw": "The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors | Tajiri, Misato; et al | European Journal of Medicinal Chemistry (2021), 215, 113289. | 10.1016/j.ejmech.2021.113289"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-23515650", "1.1|Reagents: Thionyl chloride", "Solvents: Dichloromethane; -80 °C; 20 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 24 h, 0 °C", "Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes", "By: Saint-Dizier, Francois; et al", "Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.", "10.1021/acs.jmedchem.2c01591"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9", "cond_sig": "188a8c70", "fam_sig": "82e8854b"}, "raw_data": {"raw_cas": "RCT: 3196-73-4 + 264264-32-6 | PRO: 2902671-83-2 | RGT: 7719-09-7 + 7087-68-5 | SOL: 75-09-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors\", \"authors\": \"Tajiri, Misato; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 215, 113289.\", \"reagents\": [\"Thionyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23515650\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Dichloromethane; -80 °C; 20 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 24 h, 0 °C\", \"223. Scheme 223 (1 Reaction)\", \"Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes\", \"By: Saint-Dizier, Francois; et al\", \"Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.\", \"10.1021/acs.jmedchem.2c01591\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3196-73-4\", \"264264-32-6\"], \"pro_cas\": [\"2902671-83-2\"], \"rgt_cas\": [\"7719-09-7\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3196-73-4", "264264-32-6"], "products": ["2902671-83-2"], "reagents": ["7719-09-7", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23517437", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 20.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(N)ccc2F)CO[C@@]1(C)C(F)(F)F.Cc1cc(C#N)cnc1C(=O)O", "products": "Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(NC(=O)OC(C)(C)C)=N2)c1"}, "reference": {"title": "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360", "authors": "Rueeger, Heinrich; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.", "doi": "10.1021/acs.jmedchem.0c02143", "raw": "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360 | Rueeger, Heinrich; et al | Journal of Medicinal Chemistry (2021), 64(8), 4677-4696. | 10.1021/acs.jmedchem.0c02143"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-23517437", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; 0 - 5 °C; overnight, 20 °C", "Double bond geometry shown", "Double bond geometry shown", "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "By: Tang, Sheng; et al", "European Journal of Medicinal Chemistry (2024), 263, 115939.", "10.1016/j.ejmech.2023.115939"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7/Dimethylformamide|68-12-2", "cond_sig": "5ac08243", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 33763-20-1 + 2761180-24-7 + 625-35-4 | PRO: 3020728-65-5 | RGT: 25952-53-8 + 39968-33-7 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360\", \"authors\": \"Rueeger, Heinrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23517437\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; 0 - 5 °C; overnight, 20 °C\", \"457. Scheme 457 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"By: Tang, Sheng; et al\", \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"10.1016/j.ejmech.2023.115939\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"33763-20-1\", \"2761180-24-7\", \"625-35-4\"], \"pro_cas\": [\"3020728-65-5\"], \"rgt_cas\": [\"25952-53-8\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["33763-20-1", "2761180-24-7", "625-35-4"], "products": ["3020728-65-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23575722", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 87.0}, "smiles": {"reactants": "Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)O)n[nH]1.NC1CCCCC1", "products": "Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)NC2CCCCC2)n[nH]1"}, "reference": {"title": "Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity", "authors": "Patel, Bhautikkumar; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.", "doi": "10.1016/j.bmcl.2021.127853", "raw": "Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity | Patel, Bhautikkumar; et al | Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853. | 10.1016/j.bmcl.2021.127853"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-367-CAS-23575722", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|8 - 16 h, rt", "Development of an efficient synthetic process for broflanilide", "By: Luo, Chunyan; et al", "Organic Process Research & Development (2020), 24(6), 1024-1031.", "10.1021/acs.oprd.0c00028"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 317-46-4 + 1207314-85-9 | PRO: 2416320-48-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity\", \"authors\": \"Patel, Bhautikkumar; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23575722\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"8 - 16 h, rt\", \"419. Scheme 419 (1 Reaction)\", \"Development of an efficient synthetic process for broflanilide\", \"By: Luo, Chunyan; et al\", \"Organic Process Research & Development (2020), 24(6), 1024-1031.\", \"10.1021/acs.oprd.0c00028\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"317-46-4\", \"1207314-85-9\"], \"pro_cas\": [\"2416320-48-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["317-46-4", "1207314-85-9"], "products": ["2416320-48-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.041159", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23580267", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 83.0}, "smiles": {"reactants": "Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)O)n[nH]1.Nc1ccccc1", "products": "Cc1nc(-c2ccc(I)cc2)sc1-c1cc(C(=O)Nc2ccccc2)n[nH]1"}, "reference": {"title": "Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity", "authors": "Patel, Bhautikkumar; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.", "doi": "10.1016/j.bmcl.2021.127853", "raw": "Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity | Patel, Bhautikkumar; et al | Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853. | 10.1016/j.bmcl.2021.127853"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-23580267", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|8 - 16 h, rt", "Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast", "By: Schierle, Simone; et al", "ChemMedChem (2020), 15(1), 50-67.", "10.1002/cmdc.201900576"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 98-73-7 + 1096264-03-7 | PRO: 2581825-97-8 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity\", \"authors\": \"Patel, Bhautikkumar; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23580267\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"8 - 16 h, rt\", \"406. Scheme 406 (1 Reaction)\", \"Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast\", \"By: Schierle, Simone; et al\", \"ChemMedChem (2020), 15(1), 50-67.\", \"10.1002/cmdc.201900576\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"98-73-7\", \"1096264-03-7\"], \"pro_cas\": [\"2581825-97-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["98-73-7", "1096264-03-7"], "products": ["2581825-97-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23620855", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Isopropanol", "cas": "67-63-0"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 21.0, "yield_pct": 93.0}, "smiles": {"reactants": "O=C(O)c1ccc(OC(F)F)cn1.C[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2nc(N)cs2)CO1", "products": "C[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)cs2)CO1"}, "reference": {"title": "Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors", "authors": "Li, Bryan; et al", "citation": "Organic Process Research & Development (2021), 25(6), 1440-1453.", "doi": "10.1021/acs.oprd.1c00126", "raw": "Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors | Li, Bryan; et al | Organic Process Research & Development (2021), 25(6), 1440-1453. | 10.1021/acs.oprd.1c00126"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-367-CAS-23620855", "1.1|Reagents: Triethylamine, Propylphosphonic anhydride", "Solvents: Ethyl acetate; < 5 °C; 5 °C → 25 °C; 12 h, 25 °C; 25 °C → 15 °C", "1.2|Reagents: Hydrochloric acid", "Solvents: Isopropanol, Water; 3 h, 0 - 10 °C; 6 h, 0 - 10 °C", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Propylphosphonic anhydride|68957-94-8+Triethylamine|121-44-8/Ethyl Acetate|141-78-6+Isopropanol|67-63-0+Water|7732-18-5", "cond_sig": "10e9ce41", "fam_sig": "c545875e"}, "raw_data": {"raw_cas": "RCT: 10517-21-2 + 2632874-83-8 | PRO: 2892485-72-0 | RGT: 121-44-8 + 68957-94-8 + 7647-01-0 | SOL: 141-78-6 + 67-63-0 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors\", \"authors\": \"Li, Bryan; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(6), 1440-1453.\", \"reagents\": [\"Triethylamine\", \"Propylphosphonic anhydride\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Isopropanol\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23620855\", \"1.1\", \"Reagents: Triethylamine, Propylphosphonic anhydride\", \"Solvents: Ethyl acetate; < 5 °C; 5 °C → 25 °C; 12 h, 25 °C; 25 °C → 15 °C\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: Isopropanol, Water; 3 h, 0 - 10 °C; 6 h, 0 - 10 °C\", \"410. Scheme 410 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"10517-21-2\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-72-0\"], \"rgt_cas\": [\"121-44-8\", \"68957-94-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"67-63-0\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["10517-21-2", "2632874-83-8"], "products": ["2892485-72-0"], "reagents": ["Triethylamine", "Propylphosphonic anhydride", "Hydrochloric acid"], "catalysts": [], "solvents": ["Ethyl Acetate", "Isopropanol", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23643185", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 3.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccc(C(F)(F)F)cc1.Nc1cccc(Br)c1", "products": "O=C(Nc1cccc(Br)c1)c1ccc(C(F)(F)F)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors", "authors": "Hou, Shaohua; et al", "citation": "European Journal of Medicinal Chemistry (2021), 220, 113482.", "doi": "10.1016/j.ejmech.2021.113482", "raw": "Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors | Hou, Shaohua; et al | European Journal of Medicinal Chemistry (2021), 220, 113482. | 10.1016/j.ejmech.2021.113482"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-367-CAS-23643185", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Tetrahydrofuran; 0 °C; 1 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "By: Fuchs, Natalie; et al", "ChemMedChem (2023), 18(15), e202300160.", "10.1002/cmdc.202300160"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Oxalyl chloride|79-37-8/Tetrahydrofuran|109-99-9", "cond_sig": "88d941cc", "fam_sig": "6b84e4d8"}, "raw_data": {"raw_cas": "RCT: 55-22-1 + 2743-40-0 | PRO: 3054992-10-5 | RGT: 79-37-8 + 7087-68-5 | CAT: 68-12-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors\", \"authors\": \"Hou, Shaohua; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 220, 113482.\", \"reagents\": [\"Oxalyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23643185\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Tetrahydrofuran; 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 2 h, rt\", \"64. Scheme 64 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"By: Fuchs, Natalie; et al\", \"ChemMedChem (2023), 18(15), e202300160.\", \"10.1002/cmdc.202300160\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55-22-1\", \"2743-40-0\"], \"pro_cas\": [\"3054992-10-5\"], \"rgt_cas\": [\"79-37-8\", \"7087-68-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["55-22-1", "2743-40-0"], "products": ["3054992-10-5"], "reagents": ["79-37-8", "N,N-Diisopropylethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23663323", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 100.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CCOC(=O)c1csc([C@@H](N)C(C)C)n1.O=C(O)C(F)(F)F", "products": "CCOC(=O)c1csc([C@@H](NC(=O)[C@@H](CCCCNC(=O)OCC2c3ccccc3-c3ccccc32)NC(=O)OC(C)(C)C)C(C)C)n1"}, "reference": {"title": "Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins", "authors": "Sindhikara, Dan; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.", "doi": "10.1021/acs.jmedchem.0c01500", "raw": "Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins | Sindhikara, Dan; et al | Journal of Medicinal Chemistry (2020), 63(20), 12100-12115. | 10.1021/acs.jmedchem.0c01500"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-367-CAS-23663323", "1.1|Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, rt", "Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs", "By: Maucort, Chloe; et al", "Journal of Medicinal Chemistry (2023), 66(15), 10639-10657.", "10.1021/acs.jmedchem.3c00797"], "signatures": {"cond_key": "none/none/1-Hydroxy-7-azabenzotriazole|39968-33-7+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "76d1c3bb", "fam_sig": "d52f289d"}, "raw_data": {"raw_cas": "RCT: 308849-82-3 + 68076-39-1 | PRO: 2636656-78-3 | RGT: 7087-68-5 + 39968-33-7 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins\", \"authors\": \"Sindhikara, Dan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.\", \"reagents\": [\"Diisopropylethylamine\", \"HOAt\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23663323\", \"1.1\", \"Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, rt\", \"319. Scheme 319 (1 Reaction)\", \"Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs\", \"By: Maucort, Chloe; et al\", \"Journal of Medicinal Chemistry (2023), 66(15), 10639-10657.\", \"10.1021/acs.jmedchem.3c00797\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"308849-82-3\", \"68076-39-1\"], \"pro_cas\": [\"2636656-78-3\"], \"rgt_cas\": [\"7087-68-5\", \"39968-33-7\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["308849-82-3", "68076-39-1"], "products": ["2636656-78-3"], "reagents": ["N,N-Diisopropylethylamine", "1-Hydroxy-7-azabenzotriazole", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23663728", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)OC(C)(C)C)c1nc(C(=O)O)cs1", "products": "CC(C)[C@@H]1NC(=O)[C@H](NC(=O)OC(C)(C)C)CCCCNC(=O)c2csc1n2"}, "reference": {"title": "Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins", "authors": "Sindhikara, Dan; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.", "doi": "10.1021/acs.jmedchem.0c01500", "raw": "Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins | Sindhikara, Dan; et al | Journal of Medicinal Chemistry (2020), 63(20), 12100-12115. | 10.1021/acs.jmedchem.0c01500"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-367-CAS-23663728", "1.1|Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Dichloromethane; overnight, rt", "Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis", "By: Betzemeier, Bodo; et al", "European Journal of Medicinal Chemistry (2024), 265, 116038.", "10.1016/j.ejmech.2023.116038"], "signatures": {"cond_key": "none/none/1-Hydroxy-7-azabenzotriazole|39968-33-7+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "3888029c", "fam_sig": "cf58d48b"}, "raw_data": {"raw_cas": "RCT: 3042822-32-9 + 3042822-36-3 | PRO: 3042822-38-5 | RGT: 7087-68-5 + 39968-33-7 + 148893-10-1 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins\", \"authors\": \"Sindhikara, Dan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.\", \"reagents\": [\"Diisopropylethylamine\", \"HOAt\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23663728\", \"1.1\", \"Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Dichloromethane; overnight, rt\", \"198. Scheme 198 (1 Reaction)\", \"Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis\", \"By: Betzemeier, Bodo; et al\", \"European Journal of Medicinal Chemistry (2024), 265, 116038.\", \"10.1016/j.ejmech.2023.116038\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3042822-32-9\", \"3042822-36-3\"], \"pro_cas\": [\"3042822-38-5\"], \"rgt_cas\": [\"7087-68-5\", \"39968-33-7\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3042822-32-9", "3042822-36-3"], "products": ["3042822-38-5"], "reagents": ["N,N-Diisopropylethylamine", "1-Hydroxy-7-azabenzotriazole", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23696722", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 5.0, "time_h": 5.5, "yield_pct": 87.0}, "smiles": {"reactants": "Cl.NCc1csc(-c2ccc(Cl)cc2)n1.CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2", "products": "CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)NCc1csc(-c3ccc(Cl)cc3)n1)C2"}, "reference": {"title": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "authors": "Huang, Danling; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "doi": "10.1016/j.bmcl.2021.128006", "raw": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold | Huang, Danling; et al | Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006. | 10.1016/j.bmcl.2021.128006"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-367-CAS-23696722", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt", "New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria", "By: Picconi, Pietro; et al", "Journal of Medicinal Chemistry (2020), 63(13), 6941-6958.", "10.1021/acs.jmedchem.0c00328"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 2101433-29-6 + 77716-11-1 | PRO: 2101433-31-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"authors\": \"Huang, Danling; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23696722\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt\", \"227. Scheme 227 (1 Reaction)\", \"New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria\", \"By: Picconi, Pietro; et al\", \"Journal of Medicinal Chemistry (2020), 63(13), 6941-6958.\", \"10.1021/acs.jmedchem.0c00328\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2101433-29-6\", \"77716-11-1\"], \"pro_cas\": [\"2101433-31-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2101433-29-6", "77716-11-1"], "products": ["2101433-31-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23698808", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 5.0, "time_h": 5.5, "yield_pct": 82.0}, "smiles": {"reactants": "CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2.Cc1ccc(-c2nc(CN)cs2)cc1.Cl", "products": "Cc1ccc(-c2nc(CNC(=O)CCC(=O)O[C@@H]3C[C@@H]4CC[C@@]3(C)C4(C)C)cs2)cc1"}, "reference": {"title": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "authors": "Huang, Danling; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "doi": "10.1016/j.bmcl.2021.128006", "raw": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold | Huang, Danling; et al | Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006. | 10.1016/j.bmcl.2021.128006"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-23698808", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer", "By: Yang, Yifei; et al", "European Journal of Medicinal Chemistry (2024), 271, 116400.", "10.1016/j.ejmech.2024.116400"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 1335049-54-1 + 2964558-71-0 | PRO: 2964558-72-1 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"authors\": \"Huang, Danling; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23698808\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt\", \"182. Scheme 182 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer\", \"By: Yang, Yifei; et al\", \"European Journal of Medicinal Chemistry (2024), 271, 116400.\", \"10.1016/j.ejmech.2024.116400\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1335049-54-1\", \"2964558-71-0\"], \"pro_cas\": [\"2964558-72-1\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1335049-54-1", "2964558-71-0"], "products": ["2964558-72-1"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23701150", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 5.0, "time_h": 5.5, "yield_pct": 91.0}, "smiles": {"reactants": "CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2.Cl.NCc1csc(-c2ccc(F)cc2)n1", "products": "CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)NCc1csc(-c3ccc(F)cc3)n1)C2"}, "reference": {"title": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "authors": "Huang, Danling; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "doi": "10.1016/j.bmcl.2021.128006", "raw": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold | Huang, Danling; et al | Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006. | 10.1016/j.bmcl.2021.128006"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-367-CAS-23701150", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "By: Huang, Danling; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "10.1016/j.bmcl.2021.128006"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 690632-35-0 + 1092569-57-7 | PRO: 2656367-53-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"authors\": \"Huang, Danling; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23701150\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt\", \"226. Scheme 226 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"By: Huang, Danling; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"10.1016/j.bmcl.2021.128006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"690632-35-0\", \"1092569-57-7\"], \"pro_cas\": [\"2656367-53-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["690632-35-0", "1092569-57-7"], "products": ["2656367-53-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23701514", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 5.0, "time_h": 5.5, "yield_pct": 90.0}, "smiles": {"reactants": "Cl.NCc1csc(-c2ccccc2)n1.CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)O)C2", "products": "CC1(C)[C@H]2CC[C@]1(C)[C@H](OC(=O)CCC(=O)NCc1csc(-c3ccccc3)n1)C2"}, "reference": {"title": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "authors": "Huang, Danling; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "doi": "10.1016/j.bmcl.2021.128006", "raw": "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold | Huang, Danling; et al | Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006. | 10.1016/j.bmcl.2021.128006"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-367-CAS-23701514", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt", "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "By: Zhang, Yi; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "10.1021/acs.jmedchem.3c00504"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 2691174-96-4 + 771579-27-2 | PRO: 2691174-97-5 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"authors\": \"Huang, Danling; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23701514\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, 0 - 5 °C; 5 h, rt\", \"172. Scheme 172 (1 Reaction)\", \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"By: Zhang, Yi; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"10.1021/acs.jmedchem.3c00504\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2691174-96-4\", \"771579-27-2\"], \"pro_cas\": [\"2691174-97-5\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2691174-96-4", "771579-27-2"], "products": ["2691174-97-5"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23747861", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 20.167, "yield_pct": 81.0}, "smiles": {"reactants": "CC(=O)O.Cc1ccc(CNC(=O)C(CCN)N(C)CCC=C2c3ccccc3CCc3ccccc32)cc1", "products": "CC(=O)NCCC(C(=O)NCc1ccc(C)cc1)N(C)CCC=C1c2ccccc2CCc2ccccc21"}, "reference": {"title": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "authors": "Zareba, Paula; et al", "citation": "European Journal of Medicinal Chemistry (2021), 221, 113512.", "doi": "10.1016/j.ejmech.2021.113512", "raw": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity | Zareba, Paula; et al | European Journal of Medicinal Chemistry (2021), 221, 113512. | 10.1016/j.ejmech.2021.113512"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-23747861", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 10 min, 0 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors", "By: Yang, Kai S.; et al", "ChemMedChem (2021), 16(6), 942-948.", "10.1002/cmdc.202000924"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 1149-26-4 + 17193-39-4 | PRO: 2481133-92-8 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"authors\": \"Zareba, Paula; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23747861\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 10 min, 0 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt\", \"345. Scheme 345 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors\", \"By: Yang, Kai S.; et al\", \"ChemMedChem (2021), 16(6), 942-948.\", \"10.1002/cmdc.202000924\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1149-26-4\", \"17193-39-4\"], \"pro_cas\": [\"2481133-92-8\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1149-26-4", "17193-39-4"], "products": ["2481133-92-8"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23747921", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 20.167, "yield_pct": 89.0}, "smiles": {"reactants": "CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccc(Cl)cc1", "products": "CC(=O)NCCC(C(=O)NCc1ccc(Cl)cc1)N(C)CCC=C1c2ccccc2CCc2ccccc21"}, "reference": {"title": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "authors": "Zareba, Paula; et al", "citation": "European Journal of Medicinal Chemistry (2021), 221, 113512.", "doi": "10.1016/j.ejmech.2021.113512", "raw": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity | Zareba, Paula; et al | European Journal of Medicinal Chemistry (2021), 221, 113512. | 10.1016/j.ejmech.2021.113512"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-367-CAS-23747921", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 10 min, 0 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt", "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "By: Zareba, Paula; et al", "European Journal of Medicinal Chemistry (2021), 221, 113512.", "10.1016/j.ejmech.2021.113512"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 64-19-7 + 2648234-36-8 | PRO: 2648234-41-5 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"authors\": \"Zareba, Paula; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23747921\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 10 min, 0 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt\", \"417. Scheme 417 (1 Reaction)\", \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"By: Zareba, Paula; et al\", \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"10.1016/j.ejmech.2021.113512\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-19-7\", \"2648234-36-8\"], \"pro_cas\": [\"2648234-41-5\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["Acetic Acid", "2648234-36-8"], "products": ["2648234-41-5"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23748721", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 20.167, "yield_pct": 95.0}, "smiles": {"reactants": "CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccccc1", "products": "CC(=O)NCCC(C(=O)NCc1ccccc1)N(C)CCC=C1c2ccccc2CCc2ccccc21"}, "reference": {"title": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "authors": "Zareba, Paula; et al", "citation": "European Journal of Medicinal Chemistry (2021), 221, 113512.", "doi": "10.1016/j.ejmech.2021.113512", "raw": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity | Zareba, Paula; et al | European Journal of Medicinal Chemistry (2021), 221, 113512. | 10.1016/j.ejmech.2021.113512"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-367-CAS-23748721", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 10 min, 0 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt", "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "By: Huang, Daowei; et al", "European Journal of Medicinal Chemistry (2021), 223, 113648.", "10.1016/j.ejmech.2021.113648"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 83-10-3 + 123-30-8 | PRO: 1552280-87-1 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"authors\": \"Zareba, Paula; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23748721\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 10 min, 0 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt\", \"319. Scheme 319 (1 Reaction)\", \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"By: Huang, Daowei; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"10.1016/j.ejmech.2021.113648\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"83-10-3\", \"123-30-8\"], \"pro_cas\": [\"1552280-87-1\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["83-10-3", "123-30-8"], "products": ["1552280-87-1"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23749117", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 20.167, "yield_pct": 84.0}, "smiles": {"reactants": "CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccc(F)cc1", "products": "CC(=O)NCCC(C(=O)NCc1ccc(F)cc1)N(C)CCC=C1c2ccccc2CCc2ccccc21"}, "reference": {"title": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "authors": "Zareba, Paula; et al", "citation": "European Journal of Medicinal Chemistry (2021), 221, 113512.", "doi": "10.1016/j.ejmech.2021.113512", "raw": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity | Zareba, Paula; et al | European Journal of Medicinal Chemistry (2021), 221, 113512. | 10.1016/j.ejmech.2021.113512"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-23749117", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 10 min, 0 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt", "Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity", "By: Patel, Bhautikkumar; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.", "10.1016/j.bmcl.2021.127853"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 2627559-46-8 + 108-91-8 | PRO: 2627559-48-0 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"authors\": \"Zareba, Paula; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23749117\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 10 min, 0 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt\", \"418. Scheme 418 (1 Reaction)\", \"Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity\", \"By: Patel, Bhautikkumar; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.\", \"10.1016/j.bmcl.2021.127853\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2627559-46-8\", \"108-91-8\"], \"pro_cas\": [\"2627559-48-0\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2627559-46-8", "108-91-8"], "products": ["2627559-48-0"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.043163", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23749889", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 23.167, "yield_pct": 97.0}, "smiles": {"reactants": "CC(=O)O.CN(CCC=C1c2ccccc2CCc2ccccc21)C(CCN)C(=O)NCc1ccccc1Cl", "products": "CC(=O)NCCC(C(=O)NCc1ccccc1Cl)N(C)CCC=C1c2ccccc2CCc2ccccc21"}, "reference": {"title": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "authors": "Zareba, Paula; et al", "citation": "European Journal of Medicinal Chemistry (2021), 221, 113512.", "doi": "10.1016/j.ejmech.2021.113512", "raw": "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity | Zareba, Paula; et al | European Journal of Medicinal Chemistry (2021), 221, 113512. | 10.1016/j.ejmech.2021.113512"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-367-CAS-23749889", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 10 min, 0 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt", "Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors", "By: Li, Peng; et al", "European Journal of Medicinal Chemistry (2021), 216, 113291.", "10.1016/j.ejmech.2021.113291"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 20776-50-5 | PRO: 194851-16-6 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"authors\": \"Zareba, Paula; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23749889\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 10 min, 0 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 20 h, rt\", \"430. Scheme 430 (2 Reactions)\", \"Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors\", \"By: Li, Peng; et al\", \"European Journal of Medicinal Chemistry (2021), 216, 113291.\", \"10.1016/j.ejmech.2021.113291\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"20776-50-5\"], \"pro_cas\": [\"194851-16-6\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "20776-50-5"], "products": ["194851-16-6"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23753109", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Pyridine", "cas": "110-86-1"}], "conditions": {"temperature_c": 25.0, "time_h": 20.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)c1[nH]ccc(=O)c1OCc1ccccc1.C[C@@H](N)C(F)(F)F", "products": "C[C@@H](NC(=O)c1[nH]ccc(=O)c1OCc1ccccc1)C(F)(F)F"}, "reference": {"title": "Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor", "authors": "Taoda, Yoshiyuki; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547.", "doi": "10.1016/j.bmcl.2020.127547", "raw": "Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor | Taoda, Yoshiyuki; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547. | 10.1016/j.bmcl.2020.127547"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-367-CAS-23753109", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Pyridine; 20 h, rt", "Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity", "By: Zhang, Sicheng; et al", "ACS Medicinal Chemistry Letters (2021), 12(4), 572-578.", "10.1021/acsmedchemlett.0c00571"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Pyridine|110-86-1", "cond_sig": "4da3c8cb", "fam_sig": "2756a92f"}, "raw_data": {"raw_cas": "RCT: 2257-35-4 + 2763378-74-9 | PRO: 2763378-75-0 | RGT: 2592-95-2 + 25952-53-8 | SOL: 110-86-1", "raw_data_json": "{\"txt\": {\"title\": \"Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor\", \"authors\": \"Taoda, Yoshiyuki; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Pyridine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23753109\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Pyridine; 20 h, rt\", \"36. Scheme 36 (1 Reaction)\", \"Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity\", \"By: Zhang, Sicheng; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(4), 572-578.\", \"10.1021/acsmedchemlett.0c00571\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2257-35-4\", \"2763378-74-9\"], \"pro_cas\": [\"2763378-75-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"110-86-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["2257-35-4", "2763378-74-9"], "products": ["2763378-75-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Pyridine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23761770", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 92.0}, "smiles": {"reactants": "CCOC(CN)OCC.CC(C)(C)OC(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)O", "products": "CCOC(CNC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C)OCC"}, "reference": {"title": "Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis", "authors": "Koralewski, Robert; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.", "doi": "10.1021/acs.jmedchem.0c01179", "raw": "Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis | Koralewski, Robert; et al | Journal of Medicinal Chemistry (2020), 63(24), 15527-15540. | 10.1021/acs.jmedchem.0c01179"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-367-CAS-23761770", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 3 h, rt", "DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry", "By: Xia, Bing; et al", "ACS Medicinal Chemistry Letters (2021), 12(7), 1166-1172.", "10.1021/acsmedchemlett.1c00156"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 109-85-3 + 2867540-40-5 | PRO: 2867540-41-6 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis\", \"authors\": \"Koralewski, Robert; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23761770\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 3 h, rt\", \"293. Scheme 293 (1 Reaction)\", \"DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry\", \"By: Xia, Bing; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(7), 1166-1172.\", \"10.1021/acsmedchemlett.1c00156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"109-85-3\", \"2867540-40-5\"], \"pro_cas\": [\"2867540-41-6\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["109-85-3", "2867540-40-5"], "products": ["2867540-41-6"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23762561", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "CC(C)(C)OC[C@H](Br)C(=O)O.N[C@H](CO)Cc1ccc(Cl)cc1", "products": "CC(C)(C)OC[C@@H](Br)C(=O)N[C@H](CO)Cc1ccc(Cl)cc1"}, "reference": {"title": "Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis", "authors": "Koralewski, Robert; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.", "doi": "10.1021/acs.jmedchem.0c01179", "raw": "Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis | Koralewski, Robert; et al | Journal of Medicinal Chemistry (2020), 63(24), 15527-15540. | 10.1021/acs.jmedchem.0c01179"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-367-CAS-23762561", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; overnight, rt", "A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region", "By: Wang, Chao; et al", "Journal of Medicinal Chemistry (2021), 64(15), 11460-11471.", "10.1021/acs.jmedchem.1c00781"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 25503-90-6 + 95-74-9 | PRO: 898130-92-2 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis\", \"authors\": \"Koralewski, Robert; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23762561\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; overnight, rt\", \"154. Scheme 154 (1 Reaction)\", \"A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region\", \"By: Wang, Chao; et al\", \"Journal of Medicinal Chemistry (2021), 64(15), 11460-11471.\", \"10.1021/acs.jmedchem.1c00781\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"25503-90-6\", \"95-74-9\"], \"pro_cas\": [\"898130-92-2\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["25503-90-6", "95-74-9"], "products": ["898130-92-2"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23762826", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "N-Methyl-2-pyrrolidone", "cas": "872-50-4"}], "conditions": {"temperature_c": 25.0, "time_h": null, "yield_pct": 80.0}, "smiles": {"reactants": "Cl.NCC(O)C(F)(F)F.Nc1cc(Br)cnc1C(=O)O", "products": "Nc1cc(Br)cnc1C(=O)NCC(O)C(F)(F)F"}, "reference": {"title": "Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis", "authors": "Van der Plas, Steven E.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(1), 343-353.", "doi": "10.1021/acs.jmedchem.0c01796", "raw": "Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis | Van der Plas, Steven E.; et al | Journal of Medicinal Chemistry (2021), 64(1), 343-353. | 10.1021/acs.jmedchem.0c01796"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-23762826", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: N-Methyl-2-pyrrolidone; rt", "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer", "By: Sharma, Horrick; et al", "European Journal of Medicinal Chemistry (2024), 275, 116598.", "10.1016/j.ejmech.2024.116598"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/N-Methyl-2-pyrrolidone|872-50-4", "cond_sig": "48b47183", "fam_sig": "a0e88171"}, "raw_data": {"raw_cas": "RCT: 103-82-2 + 498581-88-7 | PRO: 3048689-43-3 | RGT: 121-44-8 + 148893-10-1 | SOL: 872-50-4", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis\", \"authors\": \"Van der Plas, Steven E.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(1), 343-353.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"N-Methyl-2-pyrrolidone\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23762826\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: N-Methyl-2-pyrrolidone; rt\", \"198. Scheme 198 (1 Reaction)\", \"Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer\", \"By: Sharma, Horrick; et al\", \"European Journal of Medicinal Chemistry (2024), 275, 116598.\", \"10.1016/j.ejmech.2024.116598\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"103-82-2\", \"498581-88-7\"], \"pro_cas\": [\"3048689-43-3\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"872-50-4\"], \"notes\": []}}", "enriched_names": {"reactants": ["103-82-2", "498581-88-7"], "products": ["3048689-43-3"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["N-Methyl-2-pyrrolidone"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23860462", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)CNC(=O)OCc1ccccc1.COC(=O)CN.Cl", "products": "COC(=O)CNC(=O)CNC(=O)OCc1ccccc1"}, "reference": {"title": "Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6", "authors": "Osko, Jeremy D.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(1), 295-308.", "doi": "10.1021/acs.jmedchem.9b01540", "raw": "Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6 | Osko, Jeremy D.; et al | Journal of Medicinal Chemistry (2020), 63(1), 295-308. | 10.1021/acs.jmedchem.9b01540"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-367-CAS-23860462", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Dichloromethane; 0 °C; 1 h, 0 °C", "1.2|Reagents: Water; cooled", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria", "By: de Lera Ruiz, Manuel; et al", "ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.", "10.1021/acsmedchemlett.2c00355"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "977d99b1", "fam_sig": "7f1c9fc3"}, "raw_data": {"raw_cas": "RCT: 327056-74-6 + 2627-86-3 | PRO: 2852783-58-3 | RGT: 7087-68-5 + 68957-94-8 + 7732-18-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6\", \"authors\": \"Osko, Jeremy D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(1), 295-308.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23860462\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Dichloromethane; 0 °C; 1 h, 0 °C\", \"1.2\", \"Reagents: Water; cooled\", \"60. Scheme 60 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria\", \"By: de Lera Ruiz, Manuel; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.\", \"10.1021/acsmedchemlett.2c00355\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"327056-74-6\", \"2627-86-3\"], \"pro_cas\": [\"2852783-58-3\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["327056-74-6", "2627-86-3"], "products": ["2852783-58-3"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride", "Water"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23881400", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 80.0}, "smiles": {"reactants": "NCc1ccco1.CC1(C)C(=O)N(Cc2ccccc2F)c2cc(C(=O)O)ccc21", "products": "CC1(C)C(=O)N(Cc2ccccc2F)c2cc(C(=O)NCc3ccco3)ccc21"}, "reference": {"title": "The discovery of potent small molecule activators of human STING", "authors": "Pryde, David C.; et al", "citation": "European Journal of Medicinal Chemistry (2021), 209, 112869.", "doi": "10.1016/j.ejmech.2020.112869", "raw": "The discovery of potent small molecule activators of human STING | Pryde, David C.; et al | European Journal of Medicinal Chemistry (2021), 209, 112869. | 10.1016/j.ejmech.2020.112869"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-23881400", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; rt; 2 h, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2020), 186, 111900.", "10.1016/j.ejmech.2019.111900"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 7734-80-7 + 2396534-97-5 | PRO: 2396534-39-5 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"The discovery of potent small molecule activators of human STING\", \"authors\": \"Pryde, David C.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 209, 112869.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23881400\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; rt; 2 h, rt\", \"229. Scheme 229 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2020), 186, 111900.\", \"10.1016/j.ejmech.2019.111900\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7734-80-7\", \"2396534-97-5\"], \"pro_cas\": [\"2396534-39-5\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["7734-80-7", "2396534-97-5"], "products": ["2396534-39-5"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23896427", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.333, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)/C=C/c1ccc(Cl)cc1.Cc1nccc2c1[nH]c1ccc(OCCN)cc12", "products": "Cc1nccc2c1[nH]c1ccc(OCCNC(=O)/C=C/c3ccc(Cl)cc3)cc12"}, "reference": {"title": "Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action", "authors": "Marinovic, Marina; et al", "citation": "European Journal of Medicinal Chemistry (2021), 224, 113687.", "doi": "10.1016/j.ejmech.2021.113687", "raw": "Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action | Marinovic, Marina; et al | European Journal of Medicinal Chemistry (2021), 224, 113687. | 10.1016/j.ejmech.2021.113687"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-367-CAS-23896427", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 20 min, rt", "1.2|1 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action", "By: Marinovic, Marina; et al", "European Journal of Medicinal Chemistry (2021), 224, 113687.", "10.1016/j.ejmech.2021.113687"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 14290-86-9 + 2685741-31-3 | PRO: 2685741-68-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action\", \"authors\": \"Marinovic, Marina; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 224, 113687.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23896427\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 20 min, rt\", \"1.2\", \"1 h, rt\", \"242. Scheme 242 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action\", \"By: Marinovic, Marina; et al\", \"European Journal of Medicinal Chemistry (2021), 224, 113687.\", \"10.1016/j.ejmech.2021.113687\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"14290-86-9\", \"2685741-31-3\"], \"pro_cas\": [\"2685741-68-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["14290-86-9", "2685741-31-3"], "products": ["2685741-68-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23896526", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 14.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)C(Br)CCN1C(=O)c2ccccc2C1=O.NCc1ccc(F)cc1", "products": "O=C(NCc1ccc(F)cc1)C(Br)CCN1C(=O)c2ccccc2C1=O"}, "reference": {"title": "Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice", "authors": "Zareba, Paula; et al", "citation": "European Journal of Medicinal Chemistry (2020), 188, 111920.", "doi": "10.1016/j.ejmech.2019.111920", "raw": "Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice | Zareba, Paula; et al | European Journal of Medicinal Chemistry (2020), 188, 111920. | 10.1016/j.ejmech.2019.111920"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-23896526", "1.1|Reagents: Propylphosphonic anhydride", "Solvents: Dichloromethane, Ethyl acetate; 2 h, 0 °C", "1.2|Reagents: Triethylamine; 12 h, rt", "Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice", "By: Zareba, Paula; et al", "European Journal of Medicinal Chemistry (2020), 188, 111920.", "10.1016/j.ejmech.2019.111920"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "2f991eb3", "fam_sig": "a8325c36"}, "raw_data": {"raw_cas": "RCT: 35197-64-9 + 104-86-9 | PRO: 1621341-90-9 | RGT: 68957-94-8 + 121-44-8 | SOL: 75-09-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice\", \"authors\": \"Zareba, Paula; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 188, 111920.\", \"reagents\": [\"Propylphosphonic anhydride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23896526\", \"1.1\", \"Reagents: Propylphosphonic anhydride\", \"Solvents: Dichloromethane, Ethyl acetate; 2 h, 0 °C\", \"1.2\", \"Reagents: Triethylamine; 12 h, rt\", \"366. Scheme 366 (1 Reaction)\", \"Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice\", \"By: Zareba, Paula; et al\", \"European Journal of Medicinal Chemistry (2020), 188, 111920.\", \"10.1016/j.ejmech.2019.111920\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"35197-64-9\", \"104-86-9\"], \"pro_cas\": [\"1621341-90-9\"], \"rgt_cas\": [\"68957-94-8\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["35197-64-9", "104-86-9"], "products": ["1621341-90-9"], "reagents": ["Propylphosphonic anhydride", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23896755", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.333, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)/C=C/c1ccc(F)cc1.Cc1nccc2c1[nH]c1ccc(OCCN)cc12", "products": "Cc1nccc2c1[nH]c1ccc(OCCNC(=O)/C=C/c3ccc(F)cc3)cc12"}, "reference": {"title": "Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action", "authors": "Marinovic, Marina; et al", "citation": "European Journal of Medicinal Chemistry (2021), 224, 113687.", "doi": "10.1016/j.ejmech.2021.113687", "raw": "Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action | Marinovic, Marina; et al | European Journal of Medicinal Chemistry (2021), 224, 113687. | 10.1016/j.ejmech.2021.113687"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-367-CAS-23896755", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 20 min, rt", "1.2|1 h, rt", "Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors", "By: Deng, Wuqing; et al", "ACS Medicinal Chemistry Letters (2021), 12(4), 647-652.", "10.1021/acsmedchemlett.1c00052"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 372-09-8 + 2093305-95-2 | PRO: 2745203-62-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action\", \"authors\": \"Marinovic, Marina; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 224, 113687.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23896755\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 20 min, rt\", \"1.2\", \"1 h, rt\", \"243. Scheme 243 (1 Reaction)\", \"Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors\", \"By: Deng, Wuqing; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(4), 647-652.\", \"10.1021/acsmedchemlett.1c00052\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"372-09-8\", \"2093305-95-2\"], \"pro_cas\": [\"2745203-62-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["372-09-8", "2093305-95-2"], "products": ["2745203-62-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23897128", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 14.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)C(Br)CCN1C(=O)c2ccccc2C1=O.NCc1ccc(Cl)cc1", "products": "O=C(NCc1ccc(Cl)cc1)C(Br)CCN1C(=O)c2ccccc2C1=O"}, "reference": {"title": "Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice", "authors": "Zareba, Paula; et al", "citation": "European Journal of Medicinal Chemistry (2020), 188, 111920.", "doi": "10.1016/j.ejmech.2019.111920", "raw": "Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice | Zareba, Paula; et al | European Journal of Medicinal Chemistry (2020), 188, 111920. | 10.1016/j.ejmech.2019.111920"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-367-CAS-23897128", "1.1|Reagents: Propylphosphonic anhydride", "Solvents: Dichloromethane, Ethyl acetate; 2 h, 0 °C", "1.2|Reagents: Triethylamine; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer", "By: Zhu, Di; et al", "Journal of Medicinal Chemistry (2024), 67(10), 7973-7994.", "10.1021/acs.jmedchem.4c00030"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "2f991eb3", "fam_sig": "a8325c36"}, "raw_data": {"raw_cas": "RCT: 100-46-9 + 7733-29-1 | PRO: 2524375-70-8 | RGT: 68957-94-8 + 121-44-8 | SOL: 75-09-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice\", \"authors\": \"Zareba, Paula; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 188, 111920.\", \"reagents\": [\"Propylphosphonic anhydride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23897128\", \"1.1\", \"Reagents: Propylphosphonic anhydride\", \"Solvents: Dichloromethane, Ethyl acetate; 2 h, 0 °C\", \"1.2\", \"Reagents: Triethylamine; 12 h, rt\", \"367. Scheme 367 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer\", \"By: Zhu, Di; et al\", \"Journal of Medicinal Chemistry (2024), 67(10), 7973-7994.\", \"10.1021/acs.jmedchem.4c00030\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"100-46-9\", \"7733-29-1\"], \"pro_cas\": [\"2524375-70-8\"], \"rgt_cas\": [\"68957-94-8\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["100-46-9", "7733-29-1"], "products": ["2524375-70-8"], "reagents": ["Propylphosphonic anhydride", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23899050", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1cnc(Cl)cn1.COC[C@]12C[C@H]1[C@@](C)(c1cc(N)cc(F)c1F)N=C(N)S2", "products": "COC[C@]12C[C@H]1[C@@](C)(c1cc(NC(=O)c3cnc(Cl)cn3)cc(F)c1F)N=C(N)S2"}, "reference": {"title": "Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2", "authors": "Pettus, Liping H.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.", "doi": "10.1021/acs.jmedchem.9b01034", "raw": "Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2 | Pettus, Liping H.; et al | Journal of Medicinal Chemistry (2020), 63(5), 2263-2281. | 10.1021/acs.jmedchem.9b01034"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-23899050", "1.1|Reagents: Propylphosphonic anhydride", "Solvents: Dichloromethane, Ethyl acetate; rt; overnight, rt", "Double bond geometry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Double bond geometry shown", "Economical and Practical Process Development for a Novel Multitarget Tyrosine Kinase Inhibitor Vorolanib", "By: Xiu, Xiaomeng; et al", "Organic Process Research & Development (2024), 28(2), 492-499.", "10.1021/acs.oprd.3c00311"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "182d9b4d", "fam_sig": "1d131160"}, "raw_data": {"raw_cas": "RCT: 356068-93-4 + 147081-44-5 | PRO: 3023042-26-1 | RGT: 68957-94-8 | SOL: 75-09-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2\", \"authors\": \"Pettus, Liping H.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.\", \"reagents\": [\"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23899050\", \"1.1\", \"Reagents: Propylphosphonic anhydride\", \"Solvents: Dichloromethane, Ethyl acetate; rt; overnight, rt\", \"404. Scheme 404 (1 Reaction)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Economical and Practical Process Development for a Novel Multitarget Tyrosine Kinase Inhibitor Vorolanib\", \"By: Xiu, Xiaomeng; et al\", \"Organic Process Research & Development (2024), 28(2), 492-499.\", \"10.1021/acs.oprd.3c00311\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"356068-93-4\", \"147081-44-5\"], \"pro_cas\": [\"3023042-26-1\"], \"rgt_cas\": [\"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["356068-93-4", "147081-44-5"], "products": ["3023042-26-1"], "reagents": ["Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dichloromethane", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23901334", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}, {"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N(COCC[Si](C)(C)C)C1=N[C@](C)(c2cccc(F)c2F)[C@@H]2C[C@]2(C(=O)O)S1.CN", "products": "CNC(=O)[C@]12C[C@H]1[C@@](C)(c1cccc(F)c1F)N=C(N(COCC[Si](C)(C)C)C(=O)OC(C)(C)C)S2"}, "reference": {"title": "Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2", "authors": "Pettus, Liping H.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.", "doi": "10.1021/acs.jmedchem.9b01034", "raw": "Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2 | Pettus, Liping H.; et al | Journal of Medicinal Chemistry (2020), 63(5), 2263-2281. | 10.1021/acs.jmedchem.9b01034"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-23901334", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Chloroform, Acetonitrile; 45 min, rt", "1.2|Solvents: Tetrahydrofuran; 30 min, rt", "Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy", "By: Wang, Jin; et al", "European Journal of Medicinal Chemistry (2022), 230, 114120.", "10.1016/j.ejmech.2022.114120"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Acetonitrile|75-05-8+Chloroform|67-66-3+Tetrahydrofuran|109-99-9", "cond_sig": "c85fd686", "fam_sig": "d80cf722"}, "raw_data": {"raw_cas": "RCT: 505-73-7 + 2899263-61-5 | PRO: 2899263-57-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 67-66-3 + 75-05-8 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2\", \"authors\": \"Pettus, Liping H.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Chloroform\", \"Acetonitrile\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23901334\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Chloroform, Acetonitrile; 45 min, rt\", \"1.2\", \"Solvents: Tetrahydrofuran; 30 min, rt\", \"290. Scheme 290 (1 Reaction)\", \"Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy\", \"By: Wang, Jin; et al\", \"European Journal of Medicinal Chemistry (2022), 230, 114120.\", \"10.1016/j.ejmech.2022.114120\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"505-73-7\", \"2899263-61-5\"], \"pro_cas\": [\"2899263-57-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\", \"75-05-8\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["505-73-7", "2899263-61-5"], "products": ["2899263-57-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Chloroform", "Acetonitrile", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23922679", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 48.0, "yield_pct": 97.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.O=C(O)CCC(CCC(=O)O)(CCC(=O)O)[N+](=O)[O-]", "products": "COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCC(CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)(CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)[N+](=O)[O-]"}, "reference": {"title": "Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors", "authors": "Martinez-Gualda, Belen; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(1), 349-368.", "doi": "10.1021/acs.jmedchem.9b01737", "raw": "Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors | Martinez-Gualda, Belen; et al | Journal of Medicinal Chemistry (2020), 63(1), 349-368. | 10.1021/acs.jmedchem.9b01737"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-367-CAS-23922679", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 48 h, 30 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 157567-13-0 + 884512-77-0 | PRO: 2765293-59-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors\", \"authors\": \"Martinez-Gualda, Belen; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(1), 349-368.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23922679\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 48 h, 30 °C\", \"217. Scheme 217 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"157567-13-0\", \"884512-77-0\"], \"pro_cas\": [\"2765293-59-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["157567-13-0", "884512-77-0"], "products": ["2765293-59-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.045166", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23923283", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 48.0, "yield_pct": 82.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.O=C(O)CCOCC(COCCC(=O)O)(COCCC(=O)O)COCCC(=O)O", "products": "COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCOCC(COCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)(COCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC)COCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC"}, "reference": {"title": "Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors", "authors": "Martinez-Gualda, Belen; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(1), 349-368.", "doi": "10.1021/acs.jmedchem.9b01737", "raw": "Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors | Martinez-Gualda, Belen; et al | Journal of Medicinal Chemistry (2020), 63(1), 349-368. | 10.1021/acs.jmedchem.9b01737"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-367-CAS-23923283", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 48 h, 30 °C", "Relative stereochemistry shown", "Relative stereochemistry shown", "Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development", "By: Maeba, Takaki; et al", "Journal of Medicinal Chemistry (2024), 67(2), 952-970.", "10.1021/acs.jmedchem.3c01933"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 3032485-30-3 + 615-65-6 | PRO: 3032485-31-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors\", \"authors\": \"Martinez-Gualda, Belen; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(1), 349-368.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23923283\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 48 h, 30 °C\", \"253. Scheme 253 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development\", \"By: Maeba, Takaki; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 952-970.\", \"10.1021/acs.jmedchem.3c01933\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3032485-30-3\", \"615-65-6\"], \"pro_cas\": [\"3032485-31-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3032485-30-3", "615-65-6"], "products": ["3032485-31-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.047169", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-23963694", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.083, "yield_pct": 99.0}, "smiles": {"reactants": "O=C(O)c1ccc2nc(-c3cccc(F)c3)cn2c1.CC(C)(O)[C@@H]1CC[C@@H](N)CO1", "products": "CC(C)(O)[C@H]1CC[C@H](NC(=O)c2ccc3nc(-c4cccc(F)c4)cn3c2)CO1"}, "reference": {"title": "A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors", "authors": "Schulte, Christie A.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 47, 128113.", "doi": "10.1016/j.bmcl.2021.128113", "raw": "A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors | Schulte, Christie A.; et al | Bioorganic & Medicinal Chemistry Letters (2021), 47, 128113. | 10.1016/j.bmcl.2021.128113"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-367-CAS-23963694", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 5 min, rt; overnight, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 6314-28-9 + 2632874-83-8 | PRO: 2892485-63-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors\", \"authors\": \"Schulte, Christie A.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 47, 128113.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-23963694\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 5 min, rt; overnight, rt\", \"360. Scheme 360 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6314-28-9\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-63-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["6314-28-9", "2632874-83-8"], "products": ["2892485-63-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.047169", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-24091261", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Dimethyl carbonate", "cas": "616-38-6", "role": "UNK"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": 80.0, "time_h": 22.067, "yield_pct": 94.0}, "smiles": {"reactants": "C[C@@H]1CCO[C@H]2Cn3cc(C(=O)O)c(=O)c(O)c3C(=O)N12.NCc1ccc(F)cc1F", "products": "C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12.[Na]"}, "reference": {"title": "Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus Integrase Inhibitor Dolutegravir Sodium", "authors": "Dietz, Jule-Philipp; et al", "citation": "Organic Process Research & Development (2021), 25(8), 1898-1910.", "doi": "10.1021/acs.oprd.1c00139", "raw": "Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus Integrase Inhibitor Dolutegravir Sodium | Dietz, Jule-Philipp; et al | Organic Process Research & Development (2021), 25(8), 1898-1910. | 10.1021/acs.oprd.1c00139"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-367-CAS-24091261", "1.1|Reagents: 1,1′-Carbonyldiimidazole, Dimethyl carbonate; 2 h, rt → 80 °C; 80 °C → rt", "1.2|< 2 min, rt; 2 h, rt", "1.3|Reagents: Sodium hydroxide", "Solvents: Dichloromethane, Water; 18 h, rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 1 - 2, 0 °C", "1.5|Reagents: Sodium hydroxide", "Solvents: Ethanol; 2 min, rt → reflux", "Relative stereochemistry shown", "Relative stereochemistry shown", "Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy", "By: Bumpers, Quinn A.; et al", "Journal of Medicinal Chemistry (2024), 67(16), 14466-14477.", "10.1021/acs.jmedchem.4c01232"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Dimethyl carbonate|616-38-6+Hydrochloric acid|7647-01-0+N,N'-Carbonyldiimidazole|530-62-1+NaOH|1310-73-2+Sodium hydroxide|/Dichloromethane|75-09-2+Ethanol|64-17-5+Water|7732-18-5", "cond_sig": "419b1b86", "fam_sig": "f7b42d0a"}, "raw_data": {"raw_cas": "RCT: 3054862-82-4 + 3054862-83-5 | PRO: 3054862-74-4 | RGT: 530-62-1 + 616-38-6 + 1310-73-2 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5 + 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus Integrase Inhibitor Dolutegravir Sodium\", \"authors\": \"Dietz, Jule-Philipp; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(8), 1898-1910.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Dimethyl carbonate\", \"Sodium hydroxide\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\", \"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-24091261\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole, Dimethyl carbonate; 2 h, rt → 80 °C; 80 °C → rt\", \"1.2\", \"< 2 min, rt; 2 h, rt\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Dichloromethane, Water; 18 h, rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 1 - 2, 0 °C\", \"1.5\", \"Reagents: Sodium hydroxide\", \"Solvents: Ethanol; 2 min, rt → reflux\", \"452. Scheme 452 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy\", \"By: Bumpers, Quinn A.; et al\", \"Journal of Medicinal Chemistry (2024), 67(16), 14466-14477.\", \"10.1021/acs.jmedchem.4c01232\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3054862-82-4\", \"3054862-83-5\"], \"pro_cas\": [\"3054862-74-4\"], \"rgt_cas\": [\"530-62-1\", \"616-38-6\", \"1310-73-2\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\", \"64-17-5\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["3054862-82-4", "3054862-83-5"], "products": ["3054862-74-4"], "reagents": ["N,N'-Carbonyldiimidazole", "616-38-6", "NaOH", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water", "Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.047169", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-24132213", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "BASE"}, {"name": "N-Hydroxysuccinimide", "cas": "6066-82-6", "role": "NUC"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Copper sulfate", "cas": "7758-98-7", "role": "UNK"}, {"name": "Ethylenediaminetetraacetic acid", "cas": "60-00-4", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetone", "cas": "67-64-1"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 82.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C.Cl.NCCCC[C@H](N)C(=O)O", "products": "CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](N)C(=O)O)C(=O)OC(C)(C)C"}, "reference": {"title": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "authors": "Guryanov, Ivan; et al", "citation": "Organic Process Research & Development (2021), 25(7), 1598-1611.", "doi": "10.1021/acs.oprd.1c00021", "raw": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide | Guryanov, Ivan; et al | Organic Process Research & Development (2021), 25(7), 1598-1611. | 10.1021/acs.oprd.1c00021"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-367-CAS-24132213", "1.1|Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide", "Solvents: Acetone; 1 h, rt", "1.2|Reagents: Sodium bicarbonate, Copper sulfate", "Solvents: Water; 1 h, rt; overnight, rt; 2 d, rt", "1.3|Reagents: Ethylenediaminetetraacetic acid", "Solvents: Water; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Copper sulfate|7758-98-7+Diisopropylcarbodiimide|+Ethylenediaminetetraacetic acid|60-00-4+N,N-Diisopropylcarbodiimide|693-13-0+N-Hydroxysuccinimide|6066-82-6+NaHCO3|144-55-8+Sodium bicarbonate|/Acetone|67-64-1+Water|7732-18-5", "cond_sig": "2e71284f", "fam_sig": "ca7e2d8a"}, "raw_data": {"raw_cas": "RCT: 2387523-01-3 + 247068-85-5 | PRO: 2387523-26-2 | RGT: 693-13-0 + 6066-82-6 + 144-55-8 + 7758-98-7 + 60-00-4 | SOL: 67-64-1 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"authors\": \"Guryanov, Ivan; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"reagents\": [\"Diisopropylcarbodiimide\", \"N-Hydroxysuccinimide\", \"Sodium bicarbonate\", \"Copper sulfate\", \"Ethylenediaminetetraacetic acid\"], \"catalysts\": [], \"solvents\": [\"Acetone\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-24132213\", \"1.1\", \"Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide\", \"Solvents: Acetone; 1 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate, Copper sulfate\", \"Solvents: Water; 1 h, rt; overnight, rt; 2 d, rt\", \"1.3\", \"Reagents: Ethylenediaminetetraacetic acid\", \"Solvents: Water; overnight, rt\", \"476. Scheme 476 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387523-01-3\", \"247068-85-5\"], \"pro_cas\": [\"2387523-26-2\"], \"rgt_cas\": [\"693-13-0\", \"6066-82-6\", \"144-55-8\", \"7758-98-7\", \"60-00-4\"], \"cat_cas\": [], \"sol_cas\": [\"67-64-1\", \"7732-18-5\"], \"notes\": [\"inverse addition after overnight (stage 2)\"]}}", "enriched_names": {"reactants": ["2387523-01-3", "247068-85-5"], "products": ["2387523-26-2"], "reagents": ["N,N-Diisopropylcarbodiimide", "N-Hydroxysuccinimide", "NaHCO3", "7758-98-7", "60-00-4"], "catalysts": [], "solvents": ["Acetone", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.047169", "export_version": "1.0"}}
{"reaction_id": "31-367-CAS-24133668", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "BASE"}, {"name": "N-Hydroxysuccinimide", "cas": "6066-82-6", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 32.0, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)O", "products": "CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C"}, "reference": {"title": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "authors": "Guryanov, Ivan; et al", "citation": "Organic Process Research & Development (2021), 25(7), 1598-1611.", "doi": "10.1021/acs.oprd.1c00021", "raw": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide | Guryanov, Ivan; et al | Organic Process Research & Development (2021), 25(7), 1598-1611. | 10.1021/acs.oprd.1c00021"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-367-CAS-24133668", "1.1|Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide", "Solvents: Acetonitrile, Dichloromethane; overnight, rt", "1.2|Reagents: Diisopropylethylamine; overnight, rt", "Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT", "By: Wannowius, Marie; et al", "Journal of Medicinal Chemistry (2024), 67(21), 19342-19364.", "10.1021/acs.jmedchem.4c01743"], "signatures": {"cond_key": "none/none/Diisopropylcarbodiimide|+Diisopropylethylamine|+N,N-Diisopropylcarbodiimide|693-13-0+N,N-Diisopropylethylamine|7087-68-5+N-Hydroxysuccinimide|6066-82-6/Acetonitrile|75-05-8+Dichloromethane|75-09-2", "cond_sig": "5946d2fa", "fam_sig": "fb916c4f"}, "raw_data": {"raw_cas": "RCT: 3303-84-2 + 95-76-1 | PRO: 1036620-02-6 | RGT: 693-13-0 + 6066-82-6 + 7087-68-5 | SOL: 75-05-8 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"authors\": \"Guryanov, Ivan; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"reagents\": [\"Diisopropylcarbodiimide\", \"N-Hydroxysuccinimide\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-367-CAS-24133668\", \"1.1\", \"Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide\", \"Solvents: Acetonitrile, Dichloromethane; overnight, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; overnight, rt\", \"152. Scheme 152 (1 Reaction)\", \"Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT\", \"By: Wannowius, Marie; et al\", \"Journal of Medicinal Chemistry (2024), 67(21), 19342-19364.\", \"10.1021/acs.jmedchem.4c01743\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3303-84-2\", \"95-76-1\"], \"pro_cas\": [\"1036620-02-6\"], \"rgt_cas\": [\"693-13-0\", \"6066-82-6\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3303-84-2", "95-76-1"], "products": ["1036620-02-6"], "reagents": ["N,N-Diisopropylcarbodiimide", "N-Hydroxysuccinimide", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Acetonitrile", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.047169", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-23925515", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 89.0}, "smiles": {"reactants": "Cc1c(N)cccc1Br.O=C(O)Cc1cc(Cl)ccn1", "products": "Cc1c(Br)cccc1NC(=O)Cc1cc(Cl)ccn1"}, "reference": {"title": "Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK", "authors": "Srivastava, Anurag S.; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(11), 2195-2203.", "doi": "10.1021/acsmedchemlett.0c00335", "raw": "Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK | Srivastava, Anurag S.; et al | ACS Medicinal Chemistry Letters (2020), 11(11), 2195-2203. | 10.1021/acsmedchemlett.0c00335"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-23925515", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 90 min, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties", "By: Tsuji, Kohei; et al", "Journal of Medicinal Chemistry (2023), 66(19), 13516-13529.", "10.1021/acs.jmedchem.3c00777"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 21691-53-2 + 124655-17-0 | PRO: 3033747-56-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK\", \"authors\": \"Srivastava, Anurag S.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(11), 2195-2203.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-23925515\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 90 min, rt\", \"147. Scheme 147 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties\", \"By: Tsuji, Kohei; et al\", \"Journal of Medicinal Chemistry (2023), 66(19), 13516-13529.\", \"10.1021/acs.jmedchem.3c00777\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"21691-53-2\", \"124655-17-0\"], \"pro_cas\": [\"3033747-56-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["21691-53-2", "124655-17-0"], "products": ["3033747-56-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.047169", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-23938496", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 5.0, "time_h": 15.083, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)CCCCCNC(=O)OCc1ccccc1.CC(C)[C@H]1CC[C@@H](N2CCC(n3cc(CN)c4ccccc43)CC2)CC1.Cl", "products": "CC(C)[C@H]1CC[C@@H](N2CCC(n3cc(CNC(=O)CCCCCNC(=O)OCc4ccccc4)c4ccccc43)CC2)CC1"}, "reference": {"title": "Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models", "authors": "Kamakolanu, Uma Gayathri; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(5), 2688-2704.", "doi": "10.1021/acs.jmedchem.9b02134", "raw": "Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models | Kamakolanu, Uma Gayathri; et al | Journal of Medicinal Chemistry (2020), 63(5), 2688-2704. | 10.1021/acs.jmedchem.9b02134"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-23938496", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 2 h, 5 °C", "1.2|Solvents: Dichloromethane; 1 h, 5 °C; 5 °C → rt; 12 h, rt", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water; 5 min, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer", "By: Xiang, Weiguo; et al", "Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.", "10.1021/acs.jmedchem.1c00900"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+NaHCO3|144-55-8+Sodium bicarbonate|+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "62e96c25", "fam_sig": "5a33deee"}, "raw_data": {"raw_cas": "RCT: 162046-66-4 + 1335195-90-8 | PRO: 2222119-02-8 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 + 144-55-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models\", \"authors\": \"Kamakolanu, Uma Gayathri; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(5), 2688-2704.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-23938496\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 2 h, 5 °C\", \"1.2\", \"Solvents: Dichloromethane; 1 h, 5 °C; 5 °C → rt; 12 h, rt\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; 5 min, rt\", \"189. Scheme 189 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer\", \"By: Xiang, Weiguo; et al\", \"Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.\", \"10.1021/acs.jmedchem.1c00900\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"162046-66-4\", \"1335195-90-8\"], \"pro_cas\": [\"2222119-02-8\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["162046-66-4", "1335195-90-8"], "products": ["2222119-02-8"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.048175", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-23938870", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate", "cas": "56602-33-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "BOP reagent", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 20.0, "time_h": 25.0, "yield_pct": 85.0}, "smiles": {"reactants": "CCCCCCOc1ccc(C(=O)O)cc1.COC(=O)[C@@H](N)C(C)C.Cl", "products": "CCCCCCOc1ccc(C(=O)N[C@H](C(=O)OC)C(C)C)cc1"}, "reference": {"title": "A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities", "authors": "Peiretti, Franck; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(21), 13124-13139.", "doi": "10.1021/acs.jmedchem.0c01555", "raw": "A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities | Peiretti, Franck; et al | Journal of Medicinal Chemistry (2020), 63(21), 13124-13139. | 10.1021/acs.jmedchem.0c01555"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-23938870", "1.1|Reagents: Diisopropylethylamine, BOP reagent", "Solvents: Dichloromethane; 24 h, 20 °C", "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors", "By: Rullo, Mariagrazia; et al", "European Journal of Medicinal Chemistry (2023), 255, 115352.", "10.1016/j.ejmech.2023.115352"], "signatures": {"cond_key": "none/none/(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate|56602-33-6+BOP reagent|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "9d7fe2a4", "fam_sig": "3cee77f2"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 19335-11-6 | PRO: 1303926-40-0 | RGT: 7087-68-5 + 56602-33-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities\", \"authors\": \"Peiretti, Franck; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(21), 13124-13139.\", \"reagents\": [\"Diisopropylethylamine\", \"BOP reagent\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-23938870\", \"1.1\", \"Reagents: Diisopropylethylamine, BOP reagent\", \"Solvents: Dichloromethane; 24 h, 20 °C\", \"163. Scheme 163 (1 Reaction)\", \"Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors\", \"By: Rullo, Mariagrazia; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115352.\", \"10.1016/j.ejmech.2023.115352\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"19335-11-6\"], \"pro_cas\": [\"1303926-40-0\"], \"rgt_cas\": [\"7087-68-5\", \"56602-33-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "19335-11-6"], "products": ["1303926-40-0"], "reagents": ["N,N-Diisopropylethylamine", "(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.048175", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-23939232", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.083, "yield_pct": 97.0}, "smiles": {"reactants": "O=C(O)c1ccc(-c2ccccc2)cc1.COC(=O)[C@@H](N)CCNC(=O)OC(C)(C)C.Cl", "products": "COC(=O)[C@H](CCNC(=O)OC(C)(C)C)NC(=O)c1ccc(-c2ccccc2)cc1"}, "reference": {"title": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "authors": "Yamada, Yousuke; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "doi": "10.1021/acs.jmedchem.0c01215", "raw": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity | Yamada, Yousuke; et al | Journal of Medicinal Chemistry (2020), 63(23), 14805-14820. | 10.1021/acs.jmedchem.0c01215"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-23939232", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 5 min, rt; 16 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis", "By: Koralewski, Robert; et al", "Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.", "10.1021/acs.jmedchem.0c01179"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 645-36-3 + 68090-88-0 | PRO: 2088455-53-0 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"authors\": \"Yamada, Yousuke; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-23939232\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 5 min, rt; 16 h, rt\", \"292. Scheme 292 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis\", \"By: Koralewski, Robert; et al\", \"Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.\", \"10.1021/acs.jmedchem.0c01179\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"645-36-3\", \"68090-88-0\"], \"pro_cas\": [\"2088455-53-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["645-36-3", "68090-88-0"], "products": ["2088455-53-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-23939242", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 96.0}, "smiles": {"reactants": "Nc1cccc(OC(F)(F)F)c1.CSCC[C@@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "CSCC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1cccc(OC(F)(F)F)c1"}, "reference": {"title": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "authors": "Yamada, Yousuke; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "doi": "10.1021/acs.jmedchem.0c01215", "raw": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity | Yamada, Yousuke; et al | Journal of Medicinal Chemistry (2020), 63(23), 14805-14820. | 10.1021/acs.jmedchem.0c01215"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-23939242", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates", "By: Saini, Varsha; et al", "Journal of Medicinal Chemistry (2022), 65(22), 15312-15326.", "10.1021/acs.jmedchem.2c01293"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "104c360d", "fam_sig": "df34aecc"}, "raw_data": {"raw_cas": "RCT: 81-25-4 + 2450-71-7 | PRO: 1021182-35-3 | RGT: 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"authors\": \"Yamada, Yousuke; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-23939242\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 h, rt\", \"315. Scheme 315 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates\", \"By: Saini, Varsha; et al\", \"Journal of Medicinal Chemistry (2022), 65(22), 15312-15326.\", \"10.1021/acs.jmedchem.2c01293\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"81-25-4\", \"2450-71-7\"], \"pro_cas\": [\"1021182-35-3\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["81-25-4", "2450-71-7"], "products": ["1021182-35-3"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-23939243", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 91.0}, "smiles": {"reactants": "Nc1cccc(OC(F)(F)F)c1.CC(C)(C)OC(=O)NC[C@@H](NC(=O)OCc1ccccc1)C(=O)O", "products": "CC(C)(C)OC(=O)NC[C@@H](NC(=O)OCc1ccccc1)C(=O)Nc1cccc(OC(F)(F)F)c1"}, "reference": {"title": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "authors": "Yamada, Yousuke; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "doi": "10.1021/acs.jmedchem.0c01215", "raw": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity | Yamada, Yousuke; et al | Journal of Medicinal Chemistry (2020), 63(23), 14805-14820. | 10.1021/acs.jmedchem.0c01215"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-23939243", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 h, rt", "Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model", "By: He, Feng; et al", "Journal of Medicinal Chemistry (2021), 64(7), 3794-3812.", "10.1021/acs.jmedchem.0c01940"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "104c360d", "fam_sig": "df34aecc"}, "raw_data": {"raw_cas": "RCT: 608-07-1 + 4530-20-5 | PRO: 150184-21-7 | RGT: 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"authors\": \"Yamada, Yousuke; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-23939243\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 h, rt\", \"31. Scheme 31 (1 Reaction)\", \"Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model\", \"By: He, Feng; et al\", \"Journal of Medicinal Chemistry (2021), 64(7), 3794-3812.\", \"10.1021/acs.jmedchem.0c01940\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"608-07-1\", \"4530-20-5\"], \"pro_cas\": [\"150184-21-7\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["608-07-1", "4530-20-5"], "products": ["150184-21-7"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-23939255", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 94.0}, "smiles": {"reactants": "Nc1cccc(OC(F)(F)F)c1.CC(C)(C)OC(=O)N[C@H](CC(=O)OCc1ccccc1)C(=O)O", "products": "CC(C)(C)OC(=O)N[C@H](CC(=O)OCc1ccccc1)C(=O)Nc1cccc(OC(F)(F)F)c1"}, "reference": {"title": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "authors": "Yamada, Yousuke; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "doi": "10.1021/acs.jmedchem.0c01215", "raw": "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity | Yamada, Yousuke; et al | Journal of Medicinal Chemistry (2020), 63(23), 14805-14820. | 10.1021/acs.jmedchem.0c01215"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-23939255", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced Dynamic Resolution", "By: Takiguchi, Hiromu; et al", "Organic Process Research & Development (2023), 27(12), 2355-2364.", "10.1021/acs.oprd.3c00320"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "104c360d", "fam_sig": "df34aecc"}, "raw_data": {"raw_cas": "RCT: 3008246-52-1 + 615-65-6 | PRO: 1404380-58-0 | RGT: 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"authors\": \"Yamada, Yousuke; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-23939255\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 h, rt\", \"118. Scheme 118 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced Dynamic Resolution\", \"By: Takiguchi, Hiromu; et al\", \"Organic Process Research & Development (2023), 27(12), 2355-2364.\", \"10.1021/acs.oprd.3c00320\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3008246-52-1\", \"615-65-6\"], \"pro_cas\": [\"1404380-58-0\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3008246-52-1", "615-65-6"], "products": ["1404380-58-0"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24003995", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 15.0, "yield_pct": 100.0}, "smiles": {"reactants": "CN(CC(=O)O)C(=O)OC(C)(C)C.COC(=O)c1cc(F)ccc1OCCN", "products": "COC(=O)c1cc(F)ccc1OCCNC(=O)CN(C)C(=O)OC(C)(C)C"}, "reference": {"title": "Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties", "authors": "Yamaguchi-Sasaki, Toru; et al", "citation": "Bioorganic & Medicinal Chemistry (2020), 28(24), 115818.", "doi": "10.1016/j.bmc.2020.115818", "raw": "Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties | Yamaguchi-Sasaki, Toru; et al | Bioorganic & Medicinal Chemistry (2020), 28(24), 115818. | 10.1016/j.bmc.2020.115818"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-24003995", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors", "By: Gade, Narendar Reddy; et al", "ACS Medicinal Chemistry Letters (2023), 14(7), 943-948.", "10.1021/acsmedchemlett.3c00087"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 1138-80-3 + 16874-12-7 | PRO: 2104077-53-2 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties\", \"authors\": \"Yamaguchi-Sasaki, Toru; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2020), 28(24), 115818.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24003995\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 h, rt\", \"381. Scheme 381 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors\", \"By: Gade, Narendar Reddy; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(7), 943-948.\", \"10.1021/acsmedchemlett.3c00087\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1138-80-3\", \"16874-12-7\"], \"pro_cas\": [\"2104077-53-2\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1138-80-3", "16874-12-7"], "products": ["2104077-53-2"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24031232", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 9.0, "yield_pct": 92.0}, "smiles": {"reactants": "Nc1ccccc1.O=C(O)CCC(=O)c1ccc(F)cc1", "products": "O=C(CCC(=O)c1ccc(F)cc1)Nc1ccccc1"}, "reference": {"title": "Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections", "authors": "Chen, Wei-Chia; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(3), 1313-1327.", "doi": "10.1021/acs.jmedchem.9b01779", "raw": "Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections | Chen, Wei-Chia; et al | Journal of Medicinal Chemistry (2020), 63(3), 1313-1327. | 10.1021/acs.jmedchem.9b01779"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-24031232", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Tetrahydrofuran; 8 h, rt", "On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System", "By: Fang, Zhengqi; et al", "Organic Process Research & Development (2024), 28(8), 3143-3151.", "10.1021/acs.oprd.4c00043"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "7013d991", "fam_sig": "ebaccb75"}, "raw_data": {"raw_cas": "RCT: 7305-71-7 + 18212-21-0 | PRO: 908298-37-3 | RGT: 7087-68-5 + 94790-37-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections\", \"authors\": \"Chen, Wei-Chia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(3), 1313-1327.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24031232\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Tetrahydrofuran; 8 h, rt\", \"82. Scheme 82 (1 Reaction)\", \"On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System\", \"By: Fang, Zhengqi; et al\", \"Organic Process Research & Development (2024), 28(8), 3143-3151.\", \"10.1021/acs.oprd.4c00043\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7305-71-7\", \"18212-21-0\"], \"pro_cas\": [\"908298-37-3\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["7305-71-7", "18212-21-0"], "products": ["908298-37-3"], "reagents": ["N,N-Diisopropylethylamine", "HBTU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24100902", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1N.O=C(O)c1cc(-c2ccc(F)cc2F)on1", "products": "COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1NC(=O)c1cc(-c2ccc(F)cc2F)on1"}, "reference": {"title": "Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239", "authors": "Richard-Bildstein, Sylvia; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.", "doi": "10.1021/acs.jmedchem.0c01588", "raw": "Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239 | Richard-Bildstein, Sylvia; et al | Journal of Medicinal Chemistry (2020), 63(24), 15864-15882. | 10.1021/acs.jmedchem.0c01588"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-24100902", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 496-41-3 + 2632874-83-8 | PRO: 2892485-62-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239\", \"authors\": \"Richard-Bildstein, Sylvia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24100902\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"334. Scheme 334 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"496-41-3\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-62-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["496-41-3", "2632874-83-8"], "products": ["2892485-62-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24100916", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 87.0}, "smiles": {"reactants": "Cl.NC1(c2ncccn2)CC1.CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)O)C1", "products": "CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)NC2(c3ncccn3)CC2)C1"}, "reference": {"title": "Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239", "authors": "Richard-Bildstein, Sylvia; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.", "doi": "10.1021/acs.jmedchem.0c01588", "raw": "Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239 | Richard-Bildstein, Sylvia; et al | Journal of Medicinal Chemistry (2020), 63(24), 15864-15882. | 10.1021/acs.jmedchem.0c01588"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-24100916", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 4 h, rt", "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "By: Tang, Sheng; et al", "European Journal of Medicinal Chemistry (2024), 263, 115939.", "10.1016/j.ejmech.2023.115939"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 4521-28-2 + 2761180-24-7 + 141-75-3 | PRO: 3020728-48-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239\", \"authors\": \"Richard-Bildstein, Sylvia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24100916\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 4 h, rt\", \"412. Scheme 412 (1 Reaction)\", \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"By: Tang, Sheng; et al\", \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"10.1016/j.ejmech.2023.115939\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4521-28-2\", \"2761180-24-7\", \"141-75-3\"], \"pro_cas\": [\"3020728-48-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4521-28-2", "2761180-24-7", "141-75-3"], "products": ["3020728-48-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24120096", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "Ammonia", "cas": "7664-41-7", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 92.0}, "smiles": {"reactants": "CCOC(=O)C[C@@H](Cc1ccc(Br)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)CCC(=O)O", "products": "CCOC(=O)C[C@@H](Cc1ccc(Br)cc1)NC(=O)CCC(=O)OC(C)(C)C"}, "reference": {"title": "Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors", "authors": "Kawanami, Toshio; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(2), 188-194.", "doi": "10.1021/acsmedchemlett.9b00578", "raw": "Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors | Kawanami, Toshio; et al | ACS Medicinal Chemistry Letters (2020), 11(2), 188-194. | 10.1021/acsmedchemlett.9b00578"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-24120096", "1.1|Reagents: Hydrochloric acid", "Solvents: 1,4-Dioxane; 1 h, rt", "1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; 2 h, rt", "1.3|Reagents: Ammonia", "Solvents: Water", "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "By: Amblard, Franck; et al", "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "10.1016/j.bmc.2020.115952"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7+Ammonia|7664-41-7+Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5/1,4-Dioxane|123-91-1+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "82e07335", "fam_sig": "9756f41b"}, "raw_data": {"raw_cas": "RCT: 2450-71-7 + 1644485-94-8 | PRO: 2133017-35-1 | RGT: 7647-01-0 + 7087-68-5 + 25952-53-8 + 39968-33-7 + 7664-41-7 | SOL: 123-91-1 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors\", \"authors\": \"Kawanami, Toshio; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(2), 188-194.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\", \"Ammonia\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24120096\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: 1,4-Dioxane; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; 2 h, rt\", \"1.3\", \"Reagents: Ammonia\", \"Solvents: Water\", \"264. Scheme 264 (1 Reaction)\", \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"By: Amblard, Franck; et al\", \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"10.1016/j.bmc.2020.115952\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2450-71-7\", \"1644485-94-8\"], \"pro_cas\": [\"2133017-35-1\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"25952-53-8\", \"39968-33-7\", \"7664-41-7\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\", \"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2450-71-7", "1644485-94-8"], "products": ["2133017-35-1"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole", "7664-41-7"], "catalysts": [], "solvents": ["1,4-Dioxane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24126939", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Acetic anhydride", "cas": "108-24-7", "role": "UNK"}, {"name": "Piperidine", "cas": "110-89-4", "role": "UNK"}, {"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "UNK"}, {"name": "Ethyl 2-cyano-2-(hydroxyimino)acetate", "cas": "3849-21-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Methanol", "cas": "67-56-1"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 10.0, "time_h": 14.333, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)Oc1ccc(C[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)cc1.CC(C)(C)OC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O", "products": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(OC(C)(C)C)cc1)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21)C(C)C)C(=O)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)NCC(=O)O"}, "reference": {"title": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "authors": "Guryanov, Ivan; et al", "citation": "Organic Process Research & Development (2021), 25(7), 1598-1611.", "doi": "10.1021/acs.oprd.1c00021", "raw": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide | Guryanov, Ivan; et al | Organic Process Research & Development (2021), 25(7), 1598-1611. | 10.1021/acs.oprd.1c00021"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-24126939", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dichloromethane; 1 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Methanol, Dichloromethane; 15 min, rt", "1.3|Reagents: Acetic anhydride, Diisopropylethylamine", "Solvents: Dichloromethane; 15 min, rt", "1.4|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "1.5|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt", "1.6|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "1.7|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt", "1.8|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "1.9|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt", "1.10|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "1.11|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt", "1.12|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "1.13|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt", "1.14|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "1.15|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt", "1.16|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)", "By: Shi, Yan; et al", "Journal of Medicinal Chemistry (2022), 65(5), 4291-4317.", "10.1021/acs.jmedchem.1c02110"], "signatures": {"cond_key": "none/none/Acetic anhydride|108-24-7+Diisopropylcarbodiimide|+Diisopropylethylamine|+Ethyl 2-cyano-2-(hydroxyimino)acetate|3849-21-6+N,N-Diisopropylcarbodiimide|693-13-0+N,N-Diisopropylethylamine|7087-68-5+Piperidine|110-89-4/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Methanol|67-56-1", "cond_sig": "9feba688", "fam_sig": "05ca12ff"}, "raw_data": {"raw_cas": "RCT: 919784-65-9 + 1001419-61-9 | PRO: 1001419-18-6 | RGT: 7087-68-5 + 108-24-7 + 110-89-4 + 693-13-0 + 3849-21-6 | SOL: 75-09-2 + 67-56-1 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"authors\": \"Guryanov, Ivan; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"reagents\": [\"Diisopropylethylamine\", \"Acetic anhydride\", \"Piperidine\", \"Diisopropylcarbodiimide\", \"Ethyl 2-cyano-2-(hydroxyimino)acetate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Methanol\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24126939\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Methanol, Dichloromethane; 15 min, rt\", \"1.3\", \"Reagents: Acetic anhydride, Diisopropylethylamine\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.4\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.5\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt\", \"1.6\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.7\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt\", \"1.8\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.9\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt\", \"1.10\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.11\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt\", \"1.12\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.13\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt\", \"1.14\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.15\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 5 min, 10 °C; 90 min, rt\", \"1.16\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"435. Scheme 435 (1 Reaction)\", \"Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)\", \"By: Shi, Yan; et al\", \"Journal of Medicinal Chemistry (2022), 65(5), 4291-4317.\", \"10.1021/acs.jmedchem.1c02110\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"919784-65-9\", \"1001419-61-9\"], \"pro_cas\": [\"1001419-18-6\"], \"rgt_cas\": [\"7087-68-5\", \"108-24-7\", \"110-89-4\", \"693-13-0\", \"3849-21-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"67-56-1\", \"68-12-2\"], \"notes\": [\"solid-supported reaction, Fmoc chemistry used, MBH-Br resin use (stage 1)\"]}}", "enriched_names": {"reactants": ["919784-65-9", "1001419-61-9"], "products": ["1001419-18-6"], "reagents": ["N,N-Diisopropylethylamine", "Acetic anhydride", "Piperidine", "N,N-Diisopropylcarbodiimide", "3849-21-6"], "catalysts": [], "solvents": ["Dichloromethane", "Methanol", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24126943", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Acetic anhydride", "cas": "108-24-7", "role": "UNK"}, {"name": "Piperidine", "cas": "110-89-4", "role": "UNK"}, {"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "UNK"}, {"name": "Ethyl 2-cyano-2-(hydroxyimino)acetate", "cas": "3849-21-6", "role": "UNK"}, {"name": "1,1,1,3,3,3-Hexafluoro-2-propanol", "cas": "920-66-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Methanol", "cas": "67-56-1"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 20.883, "yield_pct": 92.0}, "smiles": {"reactants": "O=C(O)COCCOCCNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C", "products": "CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C"}, "reference": {"title": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "authors": "Guryanov, Ivan; et al", "citation": "Organic Process Research & Development (2021), 25(7), 1598-1611.", "doi": "10.1021/acs.oprd.1c00021", "raw": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide | Guryanov, Ivan; et al | Organic Process Research & Development (2021), 25(7), 1598-1611. | 10.1021/acs.oprd.1c00021"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-24126943", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Acetic anhydride, Diisopropylethylamine", "Solvents: Methanol, Dichloromethane; rt", "1.3|Reagents: Piperidine", "Solvents: Dimethylformamide; rt", "1.4|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 3 min, rt; 90 min, rt", "1.5|Reagents: Piperidine", "Solvents: Dimethylformamide; 20 min, rt", "1.6|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; overnight, rt", "1.7|Reagents: Acetic anhydride", "Solvents: Dimethylformamide; rt", "1.8|Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol", "Solvents: Dichloromethane; 60 min, rt", "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "By: Chen, Yuanguang; et al", "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "10.1021/acs.jmedchem.3c02006"], "signatures": {"cond_key": "none/none/1,1,1,3,3,3-Hexafluoro-2-propanol|920-66-1+Acetic anhydride|108-24-7+Diisopropylcarbodiimide|+Diisopropylethylamine|+Ethyl 2-cyano-2-(hydroxyimino)acetate|3849-21-6+N,N-Diisopropylcarbodiimide|693-13-0+N,N-Diisopropylethylamine|7087-68-5+Piperidine|110-89-4/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Methanol|67-56-1", "cond_sig": "fe8e27ea", "fam_sig": "01bda81a"}, "raw_data": {"raw_cas": "RCT: 2780-89-4 + 3032415-34-9 | PRO: 3032415-36-1 | RGT: 7087-68-5 + 108-24-7 + 110-89-4 + 693-13-0 + 3849-21-6 + 920-66-1 | SOL: 75-09-2 + 67-56-1 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"authors\": \"Guryanov, Ivan; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"reagents\": [\"Diisopropylethylamine\", \"Acetic anhydride\", \"Piperidine\", \"Diisopropylcarbodiimide\", \"Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"1,1,1,3,3,3-Hexafluoro-2-propanol\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Methanol\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24126943\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Acetic anhydride, Diisopropylethylamine\", \"Solvents: Methanol, Dichloromethane; rt\", \"1.3\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; rt\", \"1.4\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate; 3 min, rt; 90 min, rt\", \"1.5\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.6\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; overnight, rt\", \"1.7\", \"Reagents: Acetic anhydride\", \"Solvents: Dimethylformamide; rt\", \"1.8\", \"Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol\", \"Solvents: Dichloromethane; 60 min, rt\", \"400. Scheme 400 (1 Reaction)\", \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"By: Chen, Yuanguang; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"10.1021/acs.jmedchem.3c02006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2780-89-4\", \"3032415-34-9\"], \"pro_cas\": [\"3032415-36-1\"], \"rgt_cas\": [\"7087-68-5\", \"108-24-7\", \"110-89-4\", \"693-13-0\", \"3849-21-6\", \"920-66-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"67-56-1\", \"68-12-2\"], \"notes\": [\"solid-supported reaction, CTC resin used (stage 1)\"]}}", "enriched_names": {"reactants": ["2780-89-4", "3032415-34-9"], "products": ["3032415-36-1"], "reagents": ["N,N-Diisopropylethylamine", "Acetic anhydride", "Piperidine", "N,N-Diisopropylcarbodiimide", "3849-21-6", "1,1,1,3,3,3-Hexafluoro-2-propanol"], "catalysts": [], "solvents": ["Dichloromethane", "Methanol", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.049010", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24128601", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 6.0, "yield_pct": 83.0}, "smiles": {"reactants": "C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.NCCN", "products": "C=C(C)[C@@H]1CC[C@]2(C(=O)NCCN)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12"}, "reference": {"title": "Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum", "authors": "Kraft, Oliver; et al", "citation": "European Journal of Medicinal Chemistry (2021), 209, 112920.", "doi": "10.1016/j.ejmech.2020.112920", "raw": "Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum | Kraft, Oliver; et al | European Journal of Medicinal Chemistry (2021), 209, 112920. | 10.1016/j.ejmech.2020.112920"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-24128601", "1.1|Reagents: Oxalyl chloride", "Solvents: Dimethylformamide, Dichloromethane; 4 h, 0 °C → 25 °C", "1.2|Solvents: Dichloromethane; 2 h, 0 °C → rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19", "By: Allais, Christophe; et al", "Organic Process Research & Development (2023), 27(12), 2223-2239.", "10.1021/acs.oprd.2c00375"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "79f3ec06", "fam_sig": "7782e8c3"}, "raw_data": {"raw_cas": "RCT: 7517-19-3 + 103260-65-7 | PRO: 2640981-14-0 | RGT: 79-37-8 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum\", \"authors\": \"Kraft, Oliver; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 209, 112920.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24128601\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dimethylformamide, Dichloromethane; 4 h, 0 °C → 25 °C\", \"1.2\", \"Solvents: Dichloromethane; 2 h, 0 °C → rt\", \"33. Scheme 33 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19\", \"By: Allais, Christophe; et al\", \"Organic Process Research & Development (2023), 27(12), 2223-2239.\", \"10.1021/acs.oprd.2c00375\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7517-19-3\", \"103260-65-7\"], \"pro_cas\": [\"2640981-14-0\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["7517-19-3", "103260-65-7"], "products": ["2640981-14-0"], "reagents": ["79-37-8"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24132347", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "BASE"}, {"name": "N-Hydroxysuccinimide", "cas": "6066-82-6", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 32.0, "yield_pct": 90.0}, "smiles": {"reactants": "CCCCCCCCCCCCCCCC(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)O", "products": "CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C"}, "reference": {"title": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "authors": "Guryanov, Ivan; et al", "citation": "Organic Process Research & Development (2021), 25(7), 1598-1611.", "doi": "10.1021/acs.oprd.1c00021", "raw": "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide | Guryanov, Ivan; et al | Organic Process Research & Development (2021), 25(7), 1598-1611. | 10.1021/acs.oprd.1c00021"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-24132347", "1.1|Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide", "Solvents: Acetonitrile, Dichloromethane; overnight, rt", "1.2|Reagents: Diisopropylethylamine; overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "By: Wang, Xu; et al", "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "10.1021/acs.jmedchem.4c02009"], "signatures": {"cond_key": "none/none/Diisopropylcarbodiimide|+Diisopropylethylamine|+N,N-Diisopropylcarbodiimide|693-13-0+N,N-Diisopropylethylamine|7087-68-5+N-Hydroxysuccinimide|6066-82-6/Acetonitrile|75-05-8+Dichloromethane|75-09-2", "cond_sig": "5946d2fa", "fam_sig": "fb916c4f"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 57292-44-1 | PRO: 3061154-80-8 | RGT: 693-13-0 + 6066-82-6 + 7087-68-5 | SOL: 75-05-8 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"authors\": \"Guryanov, Ivan; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"reagents\": [\"Diisopropylcarbodiimide\", \"N-Hydroxysuccinimide\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24132347\", \"1.1\", \"Reagents: Diisopropylcarbodiimide, N-Hydroxysuccinimide\", \"Solvents: Acetonitrile, Dichloromethane; overnight, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; overnight, rt\", \"104. Scheme 104 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"By: Wang, Xu; et al\", \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"10.1021/acs.jmedchem.4c02009\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"57292-44-1\"], \"pro_cas\": [\"3061154-80-8\"], \"rgt_cas\": [\"693-13-0\", \"6066-82-6\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "57292-44-1"], "products": ["3061154-80-8"], "reagents": ["N,N-Diisopropylcarbodiimide", "N-Hydroxysuccinimide", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Acetonitrile", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24176908", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC(=O)c1ccccc1CSC[C@@H](NC(=O)OC(C)(C)C)C(=O)N(C)C.CC(C)(C)OC(=O)NCC(=O)O", "products": "COC(=O)c1ccccc1CSC[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(=O)N(C)C"}, "reference": {"title": "Mining Natural Products for Macrocycles to Drug Difficult Targets", "authors": "Begnini, Fabio; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(2), 1054-1072.", "doi": "10.1021/acs.jmedchem.0c01569", "raw": "Mining Natural Products for Macrocycles to Drug Difficult Targets | Begnini, Fabio; et al | Journal of Medicinal Chemistry (2021), 64(2), 1054-1072. | 10.1021/acs.jmedchem.0c01569"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-24176908", "1.1|Reagents: Hydrochloric acid", "Solvents: 1,4-Dioxane; 1 h, rt", "1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 2 h, rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5/1,4-Dioxane|123-91-1", "cond_sig": "e475ab36", "fam_sig": "440f6629"}, "raw_data": {"raw_cas": "RCT: 5194-32-1 + 2983540-42-5 | PRO: 2983540-45-8 | RGT: 7647-01-0 + 7087-68-5 + 25952-53-8 | SOL: 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Mining Natural Products for Macrocycles to Drug Difficult Targets\", \"authors\": \"Begnini, Fabio; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(2), 1054-1072.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24176908\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: 1,4-Dioxane; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 2 h, rt\", \"284. Scheme 284 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5194-32-1\", \"2983540-42-5\"], \"pro_cas\": [\"2983540-45-8\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["5194-32-1", "2983540-42-5"], "products": ["2983540-45-8"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24250402", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 80.0}, "smiles": {"reactants": "Cl.N[C@@H]1[C@H]2COC[C@@H]12.CNC(=O)c1cc(C(=O)O)cc2c1O[C@H](CF)[C@H]2c1ccccc1", "products": "CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1"}, "reference": {"title": "GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family", "authors": "Preston, Alex; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587.", "doi": "10.1021/acsmedchemlett.0c00247", "raw": "GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | Preston, Alex; et al | ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587. | 10.1021/acsmedchemlett.0c00247"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-24250402", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 16 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins", "By: Sindhikara, Dan; et al", "Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.", "10.1021/acs.jmedchem.0c01500"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 115186-31-7 + 1017321-07-1 | PRO: 2452190-19-9 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family\", \"authors\": \"Preston, Alex; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24250402\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 16 h, rt\", \"318. Scheme 318 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins\", \"By: Sindhikara, Dan; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.\", \"10.1021/acs.jmedchem.0c01500\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"115186-31-7\", \"1017321-07-1\"], \"pro_cas\": [\"2452190-19-9\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["115186-31-7", "1017321-07-1"], "products": ["2452190-19-9"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24281822", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 17.0, "yield_pct": 83.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CO.CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O", "products": "COC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Synthesis and Biological Evaluation of CF3Se-Substituted α-Amino Acid Derivatives", "authors": "Han, Zhou-Zhou; et al", "citation": "ChemMedChem (2021), 16(20), 3177-3180.", "doi": "10.1002/cmdc.202100451", "raw": "Synthesis and Biological Evaluation of CF3Se-Substituted α-Amino Acid Derivatives | Han, Zhou-Zhou; et al | ChemMedChem (2021), 16(20), 3177-3180. | 10.1002/cmdc.202100451"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-24281822", "1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 1 h, 0 °C; 12 h, 0 °C → rt", "1.2|Reagents: Hydrochloric acid", "Solvents: Water; pH 2 - 3, rt", "Development and in-vitro Profiling of Dual FXR/LTA4H Modulators", "By: Schierle, Simone; et al", "ChemMedChem (2021), 16(15), 2366-2374.", "10.1002/cmdc.202100118"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+Hydrochloric acid|7647-01-0+N,N-Dicyclohexylcarbodiimide|538-75-0+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "af1d88cd", "fam_sig": "6be07587"}, "raw_data": {"raw_cas": "RCT: 94-09-7 + 30762-07-3 | PRO: 2762795-95-7 | RGT: 121-44-8 + 538-75-0 + 2592-95-2 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Biological Evaluation of CF3Se-Substituted α-Amino Acid Derivatives\", \"authors\": \"Han, Zhou-Zhou; et al\", \"citation\": \"ChemMedChem (2021), 16(20), 3177-3180.\", \"reagents\": [\"Triethylamine\", \"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24281822\", \"1.1\", \"Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 1 h, 0 °C; 12 h, 0 °C → rt\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 2 - 3, rt\", \"204. Scheme 204 (1 Reaction)\", \"Development and in-vitro Profiling of Dual FXR/LTA4H Modulators\", \"By: Schierle, Simone; et al\", \"ChemMedChem (2021), 16(15), 2366-2374.\", \"10.1002/cmdc.202100118\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"94-09-7\", \"30762-07-3\"], \"pro_cas\": [\"2762795-95-7\"], \"rgt_cas\": [\"121-44-8\", \"538-75-0\", \"2592-95-2\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": [\"aerobic\"]}}", "enriched_names": {"reactants": ["94-09-7", "30762-07-3"], "products": ["2762795-95-7"], "reagents": ["Triethylamine", "N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24304120", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "DBU", "cas": "6674-22-2", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}, {"name": "1,8-Diazabicyclo[5.4.0]undec-7-ene", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 60.0, "time_h": 13.0, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCc2cccc(C(=O)O)c2C1.Nc1nc2ccccc2s1", "products": "CC(C)(C)OC(=O)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1"}, "reference": {"title": "Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor", "authors": "Wang, Le; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836.", "doi": "10.1021/acsmedchemlett.9b00568", "raw": "Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor | Wang, Le; et al | ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836. | 10.1021/acsmedchemlett.9b00568"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-24304120", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Acetonitrile; 30 min, 25 °C", "1.2|Reagents: 1,8-Diazabicyclo[5.4.0]undec-7-ene; 30 min, 25 °C", "1.3|12 h, 60 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities", "By: Wang, Juan; et al", "European Journal of Medicinal Chemistry (2021), 215, 113267.", "10.1016/j.ejmech.2021.113267"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+1,8-Diazabicyclo[5.4.0]undec-7-ene|+DBU|6674-22-2+N,N'-Carbonyldiimidazole|530-62-1/Acetonitrile|75-05-8", "cond_sig": "34e3d6e1", "fam_sig": "1a5eca27"}, "raw_data": {"raw_cas": "RCT: 2018-66-8 + 7524-52-9 | PRO: 14437-50-4 | RGT: 530-62-1 + 6674-22-2 | SOL: 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor\", \"authors\": \"Wang, Le; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(10), 1829-1836.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"1,8-Diazabicyclo[5.4.0]undec-7-ene\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24304120\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Acetonitrile; 30 min, 25 °C\", \"1.2\", \"Reagents: 1,8-Diazabicyclo[5.4.0]undec-7-ene; 30 min, 25 °C\", \"1.3\", \"12 h, 60 °C\", \"211. Scheme 211 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities\", \"By: Wang, Juan; et al\", \"European Journal of Medicinal Chemistry (2021), 215, 113267.\", \"10.1016/j.ejmech.2021.113267\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2018-66-8\", \"7524-52-9\"], \"pro_cas\": [\"14437-50-4\"], \"rgt_cas\": [\"530-62-1\", \"6674-22-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["2018-66-8", "7524-52-9"], "products": ["14437-50-4"], "reagents": ["N,N'-Carbonyldiimidazole", "DBU"], "catalysts": [], "solvents": ["Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24357848", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 99.0}, "smiles": {"reactants": "Cl.NCCCl.Cc1cc[nH]c1C(=O)O", "products": "Cc1cc[nH]c1C(=O)NCCCl"}, "reference": {"title": "Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors", "authors": "Li, Zizhou; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(8), 3956-3975.", "doi": "10.1021/acs.jmedchem.9b01784", "raw": "Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors | Li, Zizhou; et al | Journal of Medicinal Chemistry (2020), 63(8), 3956-3975. | 10.1021/acs.jmedchem.9b01784"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-24357848", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 2 h, rt", "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "By: Sharma, Sudripet; et al", "Organic Process Research & Development (2021), 25(8), 1960-1965.", "10.1021/acs.oprd.1c00203"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 108-69-0 + 156-38-7 | PRO: 131179-77-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors\", \"authors\": \"Li, Zizhou; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(8), 3956-3975.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24357848\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 2 h, rt\", \"31. Scheme 31 (1 Reaction)\", \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"By: Sharma, Sudripet; et al\", \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"10.1021/acs.oprd.1c00203\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"108-69-0\", \"156-38-7\"], \"pro_cas\": [\"131179-77-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["108-69-0", "156-38-7"], "products": ["131179-77-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24358051", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 93.0}, "smiles": {"reactants": "Cn1cc(Br)c2cc(C(=O)O)[nH]c2c1=O.CC(C)(C)N", "products": "Cn1cc(Br)c2cc(C(=O)NC(C)(C)C)[nH]c2c1=O"}, "reference": {"title": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "authors": "Sheppard, George S.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "doi": "10.1021/acs.jmedchem.0c00628", "raw": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain | Sheppard, George S.; et al | Journal of Medicinal Chemistry (2020), 63(10), 5585-5623. | 10.1021/acs.jmedchem.0c00628"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-24358051", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 3 h, rt", "1.2|Solvents: Tetrahydrofuran; 1 h, rt", "Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors", "By: Li, Chuchu; et al", "European Journal of Medicinal Chemistry (2023), 247, 115030.", "10.1016/j.ejmech.2022.115030"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9", "cond_sig": "d75aac85", "fam_sig": "e8060687"}, "raw_data": {"raw_cas": "RCT: 1208084-53-0 + 64-04-0 | PRO: 2891692-74-1 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 75-09-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"authors\": \"Sheppard, George S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24358051\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 3 h, rt\", \"1.2\", \"Solvents: Tetrahydrofuran; 1 h, rt\", \"409. Scheme 409 (1 Reaction)\", \"Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors\", \"By: Li, Chuchu; et al\", \"European Journal of Medicinal Chemistry (2023), 247, 115030.\", \"10.1016/j.ejmech.2022.115030\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1208084-53-0\", \"64-04-0\"], \"pro_cas\": [\"2891692-74-1\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["1208084-53-0", "64-04-0"], "products": ["2891692-74-1"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24358052", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 84.0}, "smiles": {"reactants": "Cn1cc(Br)c2cc(C(=O)O)[nH]c2c1=O.CN", "products": "CNC(=O)c1cc2c(Br)cn(C)c(=O)c2[nH]1"}, "reference": {"title": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "authors": "Sheppard, George S.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "doi": "10.1021/acs.jmedchem.0c00628", "raw": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain | Sheppard, George S.; et al | Journal of Medicinal Chemistry (2020), 63(10), 5585-5623. | 10.1021/acs.jmedchem.0c00628"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-24358052", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 2 h, rt", "1.2|Solvents: Dimethylformamide, Tetrahydrofuran; 2 h, rt", "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "By: Narayanan, Dilip; et al", "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "10.1021/acs.jmedchem.2c00830"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9", "cond_sig": "c2b0ffd0", "fam_sig": "26e21dfd"}, "raw_data": {"raw_cas": "RCT: 6223-83-2 + 15028-40-7 | PRO: 3031559-89-1 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 75-09-2 + 68-12-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"authors\": \"Sheppard, George S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24358052\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Solvents: Dimethylformamide, Tetrahydrofuran; 2 h, rt\", \"335. Scheme 335 (1 Reaction)\", \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"By: Narayanan, Dilip; et al\", \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"10.1021/acs.jmedchem.2c00830\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6223-83-2\", \"15028-40-7\"], \"pro_cas\": [\"3031559-89-1\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["6223-83-2", "15028-40-7"], "products": ["3031559-89-1"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Dimethylformamide", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24358057", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethyl Sulfoxide", "cas": "67-68-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.083, "yield_pct": 84.0}, "smiles": {"reactants": "Cn1cc(Br)c2cc(C(=O)O)[nH]c2c1=O.NC1CC1", "products": "Cn1cc(Br)c2cc(C(=O)NC3CC3)[nH]c2c1=O"}, "reference": {"title": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "authors": "Sheppard, George S.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "doi": "10.1021/acs.jmedchem.0c00628", "raw": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain | Sheppard, George S.; et al | Journal of Medicinal Chemistry (2020), 63(10), 5585-5623. | 10.1021/acs.jmedchem.0c00628"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-24358057", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethyl sulfoxide; 5 min, rt", "1.2|overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethyl Sulfoxide|67-68-5", "cond_sig": "9df36921", "fam_sig": "81c4862b"}, "raw_data": {"raw_cas": "RCT: 2387522-99-6 + 247068-85-5 | PRO: 935888-33-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 67-68-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"authors\": \"Sheppard, George S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethyl sulfoxide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24358057\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethyl sulfoxide; 5 min, rt\", \"1.2\", \"overnight, rt\", \"438. Scheme 438 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-99-6\", \"247068-85-5\"], \"pro_cas\": [\"935888-33-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"67-68-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387522-99-6", "247068-85-5"], "products": ["935888-33-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethyl Sulfoxide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24358105", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 89.0}, "smiles": {"reactants": "CCS(=O)(=O)c1ccc(F)c(-c2cn(C)c(=O)c3[nH]c(C(=O)O)cc23)c1.CCN", "products": "CCNC(=O)c1cc2c(-c3cc(S(=O)(=O)CC)ccc3F)cn(C)c(=O)c2[nH]1"}, "reference": {"title": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "authors": "Sheppard, George S.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "doi": "10.1021/acs.jmedchem.0c00628", "raw": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain | Sheppard, George S.; et al | Journal of Medicinal Chemistry (2020), 63(10), 5585-5623. | 10.1021/acs.jmedchem.0c00628"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-24358105", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 2 h, rt", "1.2|Solvents: Dimethylformamide, Tetrahydrofuran; 2 h, rt", "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "By: Chen, Bei; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "10.1021/acs.jmedchem.3c01326"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9", "cond_sig": "c2b0ffd0", "fam_sig": "26e21dfd"}, "raw_data": {"raw_cas": "RCT: 942217-34-7 + 1307702-36-8 | PRO: 3002420-78-9 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 75-09-2 + 68-12-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"authors\": \"Sheppard, George S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24358105\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Solvents: Dimethylformamide, Tetrahydrofuran; 2 h, rt\", \"281. Scheme 281 (1 Reaction)\", \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"By: Chen, Bei; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"10.1021/acs.jmedchem.3c01326\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"942217-34-7\", \"1307702-36-8\"], \"pro_cas\": [\"3002420-78-9\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["942217-34-7", "1307702-36-8"], "products": ["3002420-78-9"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Dimethylformamide", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24358150", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Hexane", "cas": "110-54-3"}], "conditions": {"temperature_c": 25.0, "time_h": 25.0, "yield_pct": 97.0}, "smiles": {"reactants": "Cc1cccc(C)c1Oc1ccc(C(=O)O)cc1Br.CCN.Cl", "products": "CCNC(=O)c1ccc(Oc2c(C)cccc2C)c(Br)c1"}, "reference": {"title": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "authors": "Sheppard, George S.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "doi": "10.1021/acs.jmedchem.0c00628", "raw": "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain | Sheppard, George S.; et al | Journal of Medicinal Chemistry (2020), 63(10), 5585-5623. | 10.1021/acs.jmedchem.0c00628"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-24358150", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane, Hexane; rt; 1 h, rt", "1.2|24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "By: Fuchs, Natalie; et al", "ChemMedChem (2023), 18(15), e202300160.", "10.1002/cmdc.202300160"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Hexane|110-54-3", "cond_sig": "3bdaa9fd", "fam_sig": "aa2c5c60"}, "raw_data": {"raw_cas": "RCT: 55-22-1 + 169961-66-4 | PRO: 3054992-08-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2 + 110-54-3", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"authors\": \"Sheppard, George S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Hexane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24358150\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane, Hexane; rt; 1 h, rt\", \"1.2\", \"24 h, rt\", \"187. Scheme 187 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"By: Fuchs, Natalie; et al\", \"ChemMedChem (2023), 18(15), e202300160.\", \"10.1002/cmdc.202300160\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55-22-1\", \"169961-66-4\"], \"pro_cas\": [\"3054992-08-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"110-54-3\"], \"notes\": []}}", "enriched_names": {"reactants": ["55-22-1", "169961-66-4"], "products": ["3054992-08-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane", "Hexane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24359763", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cc(Br)c(Br)o1.C#CCN", "products": "C#CCNC(=O)c1cc(Br)c(Br)o1"}, "reference": {"title": "From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase", "authors": "Juillet, Charlotte; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.", "doi": "10.1021/acs.jmedchem.0c02064", "raw": "From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase | Juillet, Charlotte; et al | Journal of Medicinal Chemistry (2021), 64(2), 1197-1219. | 10.1021/acs.jmedchem.0c02064"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-24359763", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Ethyl acetate; rt; 1 d, rt", "1.2|Reagents: Water; rt", "Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3", "By: Deng, Lin; et al", "Journal of Medicinal Chemistry (2022), 65(19), 13094-13111.", "10.1021/acs.jmedchem.2c00940"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8+Water|7732-18-5/Ethyl Acetate|141-78-6", "cond_sig": "f6120e9e", "fam_sig": "0bb267c4"}, "raw_data": {"raw_cas": "RCT: 65-85-0 + 214360-73-3 | PRO: 935660-75-6 | RGT: 7087-68-5 + 68957-94-8 + 7732-18-5 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase\", \"authors\": \"Juillet, Charlotte; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24359763\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Ethyl acetate; rt; 1 d, rt\", \"1.2\", \"Reagents: Water; rt\", \"73. Scheme 73 (1 Reaction)\", \"Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3\", \"By: Deng, Lin; et al\", \"Journal of Medicinal Chemistry (2022), 65(19), 13094-13111.\", \"10.1021/acs.jmedchem.2c00940\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"65-85-0\", \"214360-73-3\"], \"pro_cas\": [\"935660-75-6\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["65-85-0", "214360-73-3"], "products": ["935660-75-6"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride", "Water"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.051781", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24359775", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 28.0, "yield_pct": 90.0}, "smiles": {"reactants": "C#CCN.O=C(O)c1cc(Br)c(Br)s1", "products": "C#CCNC(=O)c1cc(Br)c(Br)s1"}, "reference": {"title": "From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase", "authors": "Juillet, Charlotte; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.", "doi": "10.1021/acs.jmedchem.0c02064", "raw": "From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase | Juillet, Charlotte; et al | Journal of Medicinal Chemistry (2021), 64(2), 1197-1219. | 10.1021/acs.jmedchem.0c02064"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-24359775", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Ethyl acetate; rt; 1 d, rt", "1.2|Reagents: Water; rt", "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease", "By: Li, Feng; et al", "Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.", "10.1021/acs.jmedchem.0c01544"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8+Water|7732-18-5/Ethyl Acetate|141-78-6", "cond_sig": "f6120e9e", "fam_sig": "0bb267c4"}, "raw_data": {"raw_cas": "RCT: 75-31-0 + 434-76-4 | PRO: 1042434-88-7 | RGT: 7087-68-5 + 68957-94-8 + 7732-18-5 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase\", \"authors\": \"Juillet, Charlotte; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24359775\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Ethyl acetate; rt; 1 d, rt\", \"1.2\", \"Reagents: Water; rt\", \"40. Scheme 40 (1 Reaction)\", \"Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease\", \"By: Li, Feng; et al\", \"Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.\", \"10.1021/acs.jmedchem.0c01544\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-31-0\", \"434-76-4\"], \"pro_cas\": [\"1042434-88-7\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-31-0", "434-76-4"], "products": ["1042434-88-7"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride", "Water"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24398148", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 16.167, "yield_pct": 85.0}, "smiles": {"reactants": "Nc1ccc(Br)cc1C(=O)O.CCN", "products": "CCNC(=O)c1cc(Br)ccc1N"}, "reference": {"title": "Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels", "authors": "Fernandez, Ariadna; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.", "doi": "10.1021/acsmedchemlett.1c00416", "raw": "Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels | Fernandez, Ariadna; et al | ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809. | 10.1021/acsmedchemlett.1c00416"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-24398148", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 10 min, 0 °C", "1.2|Solvents: Tetrahydrofuran; 0 °C; overnight, rt", "Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors", "By: Zhao, Zhixiang; et al", "Bioorganic & Medicinal Chemistry (2023), 80, 117172.", "10.1016/j.bmc.2023.117172"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9", "cond_sig": "0e0b1c61", "fam_sig": "c2197079"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 62-53-3 | PRO: 27904-92-3 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels\", \"authors\": \"Fernandez, Ariadna; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24398148\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 10 min, 0 °C\", \"1.2\", \"Solvents: Tetrahydrofuran; 0 °C; overnight, rt\", \"37. Scheme 37 (1 Reaction)\", \"Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors\", \"By: Zhao, Zhixiang; et al\", \"Bioorganic & Medicinal Chemistry (2023), 80, 117172.\", \"10.1016/j.bmc.2023.117172\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"62-53-3\"], \"pro_cas\": [\"27904-92-3\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "62-53-3"], "products": ["27904-92-3"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24398168", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 100.0}, "smiles": {"reactants": "CCC[C@H](O)C(=O)O.CCNC(=O)c1cc(Br)ccc1N", "products": "CCC[C@H](O)C(=O)Nc1ccc(Br)cc1C(=O)NCC"}, "reference": {"title": "Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels", "authors": "Fernandez, Ariadna; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.", "doi": "10.1021/acsmedchemlett.1c00416", "raw": "Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels | Fernandez, Ariadna; et al | ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809. | 10.1021/acsmedchemlett.1c00416"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-24398168", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors", "By: Pu, Qinglin; et al", "ACS Medicinal Chemistry Letters (2020), 11(8), 1548-1554.", "10.1021/acsmedchemlett.0c00195"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 371-40-4 + 2379569-54-5 | PRO: 2379569-61-4 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels\", \"authors\": \"Fernandez, Ariadna; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24398168\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"248. Scheme 248 (1 Reaction)\", \"Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors\", \"By: Pu, Qinglin; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(8), 1548-1554.\", \"10.1021/acsmedchemlett.0c00195\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"371-40-4\", \"2379569-54-5\"], \"pro_cas\": [\"2379569-61-4\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"incremental addition (HATU)\"]}}", "enriched_names": {"reactants": ["371-40-4", "2379569-54-5"], "products": ["2379569-61-4"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414244", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Diisopropylamine", "cas": "108-18-9", "role": "NUC"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 20.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.NCCC(c1ccccc1)c1ccc(OC(F)(F)F)cc1", "products": "O=C(NCCC(c1ccccc1)c1ccc(OC(F)(F)F)cc1)c1cccc(I)c1"}, "reference": {"title": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "authors": "Hiesinger, Kerstin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "doi": "10.1021/acs.jmedchem.0c00561", "raw": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase | Hiesinger, Kerstin; et al | Journal of Medicinal Chemistry (2020), 63(20), 11498-11521. | 10.1021/acs.jmedchem.0c00561"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-24414244", "1.1|Reagents: Diisopropylamine, PyBOP", "Solvents: Tetrahydrofuran; 16 - 20 h, rt", "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "By: Ryan, Michael C.; et al", "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "10.1021/acsmedchemlett.1c00539"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylamine|108-18-9/Tetrahydrofuran|109-99-9", "cond_sig": "25bde2e7", "fam_sig": "7b4b2b34"}, "raw_data": {"raw_cas": "RCT: 104-94-9 + 99767-45-0 | PRO: 2765056-71-9 | RGT: 108-18-9 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"authors\": \"Hiesinger, Kerstin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"reagents\": [\"Diisopropylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414244\", \"1.1\", \"Reagents: Diisopropylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 16 - 20 h, rt\", \"221. Scheme 221 (1 Reaction)\", \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"By: Ryan, Michael C.; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"10.1021/acsmedchemlett.1c00539\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"104-94-9\", \"99767-45-0\"], \"pro_cas\": [\"2765056-71-9\"], \"rgt_cas\": [\"108-18-9\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["104-94-9", "99767-45-0"], "products": ["2765056-71-9"], "reagents": ["Diisopropylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414246", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Diisopropylamine", "cas": "108-18-9", "role": "NUC"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 60.0, "time_h": 1.0, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.NCCC(c1ccccc1)c1ccc(Cl)c(Cl)c1", "products": "O=C(NCCC(c1ccccc1)c1ccc(Cl)c(Cl)c1)c1cccc(I)c1"}, "reference": {"title": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "authors": "Hiesinger, Kerstin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "doi": "10.1021/acs.jmedchem.0c00561", "raw": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase | Hiesinger, Kerstin; et al | Journal of Medicinal Chemistry (2020), 63(20), 11498-11521. | 10.1021/acs.jmedchem.0c00561"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-24414246", "1.1|Reagents: Diisopropylamine, PyBOP", "Solvents: Tetrahydrofuran; 1 h, 60 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis", "By: Houstecka, Radka; et al", "Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.", "10.1021/acs.jmedchem.9b01351"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylamine|108-18-9/Tetrahydrofuran|109-99-9", "cond_sig": "25bde2e7", "fam_sig": "7b4b2b34"}, "raw_data": {"raw_cas": "RCT: 13734-41-3 + 53005-24-6 | PRO: 195147-01-4 | RGT: 108-18-9 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"authors\": \"Hiesinger, Kerstin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"reagents\": [\"Diisopropylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414246\", \"1.1\", \"Reagents: Diisopropylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 1 h, 60 °C\", \"160. Scheme 160 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis\", \"By: Houstecka, Radka; et al\", \"Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.\", \"10.1021/acs.jmedchem.9b01351\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-41-3\", \"53005-24-6\"], \"pro_cas\": [\"195147-01-4\"], \"rgt_cas\": [\"108-18-9\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"microwave irradiation\"]}}", "enriched_names": {"reactants": ["13734-41-3", "53005-24-6"], "products": ["195147-01-4"], "reagents": ["Diisopropylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414253", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 60.0, "time_h": 1.0, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.NCCC(c1ccccc1)c1ccc(S(N)(=O)=O)cc1", "products": "NS(=O)(=O)c1ccc(C(CCNC(=O)c2cccc(I)c2)c2ccccc2)cc1"}, "reference": {"title": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "authors": "Hiesinger, Kerstin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "doi": "10.1021/acs.jmedchem.0c00561", "raw": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase | Hiesinger, Kerstin; et al | Journal of Medicinal Chemistry (2020), 63(20), 11498-11521. | 10.1021/acs.jmedchem.0c00561"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-24414253", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; rt; 1 h, 60 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic", "By: Shurtleff, Valerie W.; et al", "Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.", "10.1021/acs.jmedchem.3c02248"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "a35b2b39", "fam_sig": "579e0556"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 2952552-89-3 | PRO: 2952552-91-7 | RGT: 2592-95-2 + 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"authors\": \"Hiesinger, Kerstin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414253\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; rt; 1 h, 60 °C\", \"167. Scheme 167 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic\", \"By: Shurtleff, Valerie W.; et al\", \"Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.\", \"10.1021/acs.jmedchem.3c02248\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"2952552-89-3\"], \"pro_cas\": [\"2952552-91-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"microwave irradiation\"]}}", "enriched_names": {"reactants": ["593-51-1", "2952552-89-3"], "products": ["2952552-91-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414256", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 60.0, "time_h": 1.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.NCCC(c1ccc(F)cc1)c1ccc(OC(F)(F)F)cc1", "products": "O=C(NCCC(c1ccc(F)cc1)c1ccc(OC(F)(F)F)cc1)c1cccc(I)c1"}, "reference": {"title": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "authors": "Hiesinger, Kerstin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "doi": "10.1021/acs.jmedchem.0c00561", "raw": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase | Hiesinger, Kerstin; et al | Journal of Medicinal Chemistry (2020), 63(20), 11498-11521. | 10.1021/acs.jmedchem.0c00561"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-24414256", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; rt; 1 h, 60 °C", "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "By: Sarkar, Dipayan; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "10.1021/acs.jmedchem.3c01431"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "a35b2b39", "fam_sig": "579e0556"}, "raw_data": {"raw_cas": "RCT: 616-79-5 + 123-00-2 | PRO: 1442107-58-5 | RGT: 2592-95-2 + 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"authors\": \"Hiesinger, Kerstin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414256\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; rt; 1 h, 60 °C\", \"271. Scheme 271 (1 Reaction)\", \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"By: Sarkar, Dipayan; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"10.1021/acs.jmedchem.3c01431\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"616-79-5\", \"123-00-2\"], \"pro_cas\": [\"1442107-58-5\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"microwave irradiation\"]}}", "enriched_names": {"reactants": ["616-79-5", "123-00-2"], "products": ["1442107-58-5"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414263", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.NCCC(c1ccc(F)cc1)c1ccc(F)cc1", "products": "O=C(NCCC(c1ccc(F)cc1)c1ccc(F)cc1)c1cccc(I)c1"}, "reference": {"title": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "authors": "Hiesinger, Kerstin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "doi": "10.1021/acs.jmedchem.0c00561", "raw": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase | Hiesinger, Kerstin; et al | Journal of Medicinal Chemistry (2020), 63(20), 11498-11521. | 10.1021/acs.jmedchem.0c00561"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-24414263", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; rt; 18 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors", "By: Gao, Dingding; et al", "European Journal of Medicinal Chemistry (2021), 216, 113333.", "10.1016/j.ejmech.2021.113333"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "a35b2b39", "fam_sig": "579e0556"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 41851-59-6 | PRO: 2768892-13-1 | RGT: 2592-95-2 + 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"authors\": \"Hiesinger, Kerstin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414263\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; rt; 18 h, rt\", \"120. Scheme 120 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors\", \"By: Gao, Dingding; et al\", \"European Journal of Medicinal Chemistry (2021), 216, 113333.\", \"10.1016/j.ejmech.2021.113333\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"41851-59-6\"], \"pro_cas\": [\"2768892-13-1\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "41851-59-6"], "products": ["2768892-13-1"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414274", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 100.0}, "smiles": {"reactants": "Cc1ccc2[nH]c(C(=O)O)cc2c1.COC(=O)[C@H]1CN(S(=O)(=O)c2ccccc2)CC[C@@H]1N.Cl", "products": "COC(=O)[C@H]1CN(S(=O)(=O)c2ccccc2)CC[C@@H]1NC(=O)c1cc2cc(C)ccc2[nH]1"}, "reference": {"title": "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists", "authors": "Cooper, Martin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.", "doi": "10.1021/acs.jmedchem.0c00828", "raw": "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists | Cooper, Martin; et al | Journal of Medicinal Chemistry (2020), 63(17), 9705-9730. | 10.1021/acs.jmedchem.0c00828"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-24414274", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach", "By: Iannelli, Giulia; et al", "Journal of Medicinal Chemistry (2022), 65(17), 11574-11606.", "10.1021/acs.jmedchem.2c00252"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 27219-07-4 + 3031795-19-1 | PRO: 3031795-20-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists\", \"authors\": \"Cooper, Martin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414274\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"180. Scheme 180 (1 Reaction)\", \"Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach\", \"By: Iannelli, Giulia; et al\", \"Journal of Medicinal Chemistry (2022), 65(17), 11574-11606.\", \"10.1021/acs.jmedchem.2c00252\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"27219-07-4\", \"3031795-19-1\"], \"pro_cas\": [\"3031795-20-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["27219-07-4", "3031795-19-1"], "products": ["3031795-20-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414277", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.NCCN(c1ccccc1)c1ccccc1", "products": "O=C(NCCN(c1ccccc1)c1ccccc1)c1cccc(I)c1"}, "reference": {"title": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "authors": "Hiesinger, Kerstin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "doi": "10.1021/acs.jmedchem.0c00561", "raw": "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase | Hiesinger, Kerstin; et al | Journal of Medicinal Chemistry (2020), 63(20), 11498-11521. | 10.1021/acs.jmedchem.0c00561"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-24414277", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; rt; 24 h, rt", "Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer", "By: He, Pei; et al", "European Journal of Medicinal Chemistry (2024), 268, 116236.", "10.1016/j.ejmech.2024.116236"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "a35b2b39", "fam_sig": "579e0556"}, "raw_data": {"raw_cas": "RCT: 3946-32-5 + 163036-58-6 | PRO: 3057270-77-3 | RGT: 2592-95-2 + 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"authors\": \"Hiesinger, Kerstin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414277\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; rt; 24 h, rt\", \"129. Scheme 129 (1 Reaction)\", \"Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer\", \"By: He, Pei; et al\", \"European Journal of Medicinal Chemistry (2024), 268, 116236.\", \"10.1016/j.ejmech.2024.116236\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3946-32-5\", \"163036-58-6\"], \"pro_cas\": [\"3057270-77-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3946-32-5", "163036-58-6"], "products": ["3057270-77-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414281", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 90.0}, "smiles": {"reactants": "Cc1ccc2[nH]c(C(=O)O)cc2c1.CCOC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1N", "products": "CCOC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1NC(=O)c1cc2cc(C)ccc2[nH]1"}, "reference": {"title": "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists", "authors": "Cooper, Martin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.", "doi": "10.1021/acs.jmedchem.0c00828", "raw": "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists | Cooper, Martin; et al | Journal of Medicinal Chemistry (2020), 63(17), 9705-9730. | 10.1021/acs.jmedchem.0c00828"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-24414281", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Acetonitrile; 30 min, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Acetonitrile|75-05-8", "cond_sig": "c5516f0f", "fam_sig": "3c11f3e0"}, "raw_data": {"raw_cas": "RCT: 79-09-4 + 2632874-83-8 | PRO: 2892485-49-1 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists\", \"authors\": \"Cooper, Martin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414281\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Acetonitrile; 30 min, rt\", \"261. Scheme 261 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"79-09-4\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-49-1\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["Propionic Acid", "2632874-83-8"], "products": ["2892485-49-1"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24414310", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "Cc1ccc2[nH]c(C(=O)O)cc2c1.COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)C[C@@H]1N.Cl", "products": "COC(=O)[C@H]1CN(C(=O)OC(C)(C)C)C[C@@H]1NC(=O)c1cc2cc(C)ccc2[nH]1"}, "reference": {"title": "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists", "authors": "Cooper, Martin; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.", "doi": "10.1021/acs.jmedchem.0c00828", "raw": "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists | Cooper, Martin; et al | Journal of Medicinal Chemistry (2020), 63(17), 9705-9730. | 10.1021/acs.jmedchem.0c00828"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-24414310", "1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization", "By: Zirimwabagabo, Jean-Olivier; et al", "Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.", "10.1021/acs.jmedchem.0c02191"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+HATU|148893-10-1+N-Methylmorpholine|109-02-4+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "0249269f", "fam_sig": "33326d02"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 938460-60-7 | PRO: 2252343-64-7 | RGT: 109-02-4 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists\", \"authors\": \"Cooper, Martin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.\", \"reagents\": [\"4-Methylmorpholine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24414310\", \"1.1\", \"Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"248. Scheme 248 (1 Reaction)\", \"Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization\", \"By: Zirimwabagabo, Jean-Olivier; et al\", \"Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.\", \"10.1021/acs.jmedchem.0c02191\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"938460-60-7\"], \"pro_cas\": [\"2252343-64-7\"], \"rgt_cas\": [\"109-02-4\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "938460-60-7"], "products": ["2252343-64-7"], "reagents": ["N-Methylmorpholine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24494512", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 23.0, "time_h": 22.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1cccc(-c2ccc(Cl)cc2)c1.COC(=O)c1ccccc1N", "products": "COC(=O)c1ccccc1NC(=O)c1cccc(-c2ccc(Cl)cc2)c1"}, "reference": {"title": "Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure", "authors": "Velcicky, Juraj; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(17), 9856-9875.", "doi": "10.1021/acs.jmedchem.0c01020", "raw": "Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure | Velcicky, Juraj; et al | Journal of Medicinal Chemistry (2020), 63(17), 9856-9875. | 10.1021/acs.jmedchem.0c01020"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-24494512", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 2 h, 23 °C", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 20 h, 23 °C", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water", "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "By: Sarkar, Dipayan; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "10.1021/acs.jmedchem.3c01431"], "signatures": {"cond_key": "none/none/NaHCO3|144-55-8+Oxalyl chloride|79-37-8+Sodium bicarbonate|+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "0f0f5a4e", "fam_sig": "4e44700d"}, "raw_data": {"raw_cas": "RCT: 616-79-5 + 2038-03-1 | PRO: 1442094-57-6 | RGT: 79-37-8 + 121-44-8 + 144-55-8 | CAT: 68-12-2 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure\", \"authors\": \"Velcicky, Juraj; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(17), 9856-9875.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Sodium bicarbonate\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24494512\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 2 h, 23 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 20 h, 23 °C\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water\", \"259. Scheme 259 (1 Reaction)\", \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"By: Sarkar, Dipayan; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"10.1021/acs.jmedchem.3c01431\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"616-79-5\", \"2038-03-1\"], \"pro_cas\": [\"1442094-57-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"144-55-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["616-79-5", "2038-03-1"], "products": ["1442094-57-6"], "reagents": ["79-37-8", "Triethylamine", "NaHCO3"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24495739", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)C(F)(F)c1ccc(Cl)cc1.NCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O", "products": "O=C1CCC(N2Cc3cc(CNC(=O)C(F)(F)c4ccc(Cl)cc4)ccc3C2=O)C(=O)N1"}, "reference": {"title": "CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia", "authors": "Hansen, Joshua D.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(4), 1835-1843.", "doi": "10.1021/acs.jmedchem.0c01489", "raw": "CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia | Hansen, Joshua D.; et al | Journal of Medicinal Chemistry (2021), 64(4), 1835-1843. | 10.1021/acs.jmedchem.0c01489"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-24495739", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 24 h, 25 °C", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 118-91-2 + 2919713-61-2 | PRO: 2919713-68-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia\", \"authors\": \"Hansen, Joshua D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(4), 1835-1843.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24495739\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 24 h, 25 °C\", \"301. Scheme 301 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"118-91-2\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-68-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["118-91-2", "2919713-61-2"], "products": ["2919713-68-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.053784", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24533574", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 99.0}, "smiles": {"reactants": "O=C(O)c1ccoc1.COC(=O)[C@@H](N)CC(C)C.Cl", "products": "COC(=O)[C@H](CC(C)C)NC(=O)c1ccoc1"}, "reference": {"title": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "authors": "Sampaio-Dias, Ivo E.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "doi": "10.1021/acs.jmedchem.1c00252", "raw": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide | Sampaio-Dias, Ivo E.; et al | Journal of Medicinal Chemistry (2021), 64(9), 6209-6220. | 10.1021/acs.jmedchem.1c00252"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-24533574", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 30 min, rt", "1.2|1 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "By: Sharma, Sudripet; et al", "Organic Process Research & Development (2021), 25(8), 1960-1965.", "10.1021/acs.oprd.1c00203"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 65-85-0 + 7524-50-7 | PRO: 3005-61-6 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"authors\": \"Sampaio-Dias, Ivo E.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24533574\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"1 h, rt\", \"75. Scheme 75 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"By: Sharma, Sudripet; et al\", \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"10.1021/acs.oprd.1c00203\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"65-85-0\", \"7524-50-7\"], \"pro_cas\": [\"3005-61-6\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["65-85-0", "7524-50-7"], "products": ["3005-61-6"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24554462", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.5, "yield_pct": 96.0}, "smiles": {"reactants": "CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C(=O)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C.Br.NCCBr", "products": "CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5[C@@H](C)[C@H](C)CC[C@]5(C(=O)NCCBr)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C"}, "reference": {"title": "Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors", "authors": "Wei, Huiqiang; et al", "citation": "European Journal of Medicinal Chemistry (2022), 227, 113918.", "doi": "10.1016/j.ejmech.2021.113918", "raw": "Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors | Wei, Huiqiang; et al | European Journal of Medicinal Chemistry (2022), 227, 113918. | 10.1016/j.ejmech.2021.113918"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-24554462", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0.5 h, 0 °C; 0 °C; overnight, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency", "By: Guzelj, Samo; et al", "ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.", "10.1021/acsmedchemlett.2c00121"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4cfa4784", "fam_sig": "1c23a12a"}, "raw_data": {"raw_cas": "RCT: 3032888-52-8 + 4530-20-5 | PRO: 3032888-66-4 | RGT: 79-37-8 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors\", \"authors\": \"Wei, Huiqiang; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 227, 113918.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24554462\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0.5 h, 0 °C; 0 °C; overnight, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; rt\", \"6. Scheme 6 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency\", \"By: Guzelj, Samo; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.\", \"10.1021/acsmedchemlett.2c00121\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3032888-52-8\", \"4530-20-5\"], \"pro_cas\": [\"3032888-66-4\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3032888-52-8", "4530-20-5"], "products": ["3032888-66-4"], "reagents": ["79-37-8", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24558277", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 85.0}, "smiles": {"reactants": "CC(=O)c1ccc(C(=O)O)cc1.COC(=O)CCCCN.Cl", "products": "COC(=O)CCCCNC(=O)c1ccc(C(C)=O)cc1"}, "reference": {"title": "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells", "authors": "Liang, Tao; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.", "doi": "10.1021/acs.jmedchem.0c01454", "raw": "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells | Liang, Tao; et al | Journal of Medicinal Chemistry (2020), 63(20), 12083-12099. | 10.1021/acs.jmedchem.0c01454"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-24558277", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt", "1.2|overnight, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors", "By: Massaro, Chelsea; et al", "Journal of Medicinal Chemistry (2020), 63(6), 2814-2832.", "10.1021/acs.jmedchem.9b00568"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/none", "cond_sig": "07a7db6b", "fam_sig": "c57016f3"}, "raw_data": {"raw_cas": "RCT: 1070-83-3 + 7524-50-7 | PRO: 1887235-21-3 | RGT: 7087-68-5 + 148893-10-1", "raw_data_json": "{\"txt\": {\"title\": \"HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells\", \"authors\": \"Liang, Tao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24558277\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt\", \"1.2\", \"overnight, rt\", \"50. Scheme 50 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors\", \"By: Massaro, Chelsea; et al\", \"Journal of Medicinal Chemistry (2020), 63(6), 2814-2832.\", \"10.1021/acs.jmedchem.9b00568\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1070-83-3\", \"7524-50-7\"], \"pro_cas\": [\"1887235-21-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["1070-83-3", "7524-50-7"], "products": ["1887235-21-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24558288", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 96.0}, "smiles": {"reactants": "CC(=O)c1ccc(C(=O)O)cc1.COC(=O)CCCCCCN.Cl", "products": "COC(=O)CCCCCCNC(=O)c1ccc(C(C)=O)cc1"}, "reference": {"title": "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells", "authors": "Liang, Tao; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.", "doi": "10.1021/acs.jmedchem.0c01454", "raw": "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells | Liang, Tao; et al | Journal of Medicinal Chemistry (2020), 63(20), 12083-12099. | 10.1021/acs.jmedchem.0c01454"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-24558288", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt", "1.2|overnight, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Double bond geometry shown", "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine", "By: Aguirre-Renteria, Saul A.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.", "10.1016/j.bmcl.2020.127074"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/none", "cond_sig": "07a7db6b", "fam_sig": "c57016f3"}, "raw_data": {"raw_cas": "RCT: 5680-80-8 + 538-75-0 + 940-61-4 | PRO: 1240512-89-3 + 2414059-79-1 + 2414059-88-2 | RGT: 7087-68-5 + 148893-10-1", "raw_data_json": "{\"txt\": {\"title\": \"HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells\", \"authors\": \"Liang, Tao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24558288\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt\", \"1.2\", \"overnight, rt\", \"53. Scheme 53 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine\", \"By: Aguirre-Renteria, Saul A.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.\", \"10.1016/j.bmcl.2020.127074\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5680-80-8\", \"538-75-0\", \"940-61-4\"], \"pro_cas\": [\"1240512-89-3\", \"2414059-79-1\", \"2414059-88-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["5680-80-8", "N,N-Dicyclohexylcarbodiimide", "940-61-4"], "products": ["1240512-89-3", "2414059-79-1", "2414059-88-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24558300", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 99.0}, "smiles": {"reactants": "CC(=O)c1ccc(C(=O)O)cc1.COC(=O)c1ccc(CN)cc1.Cl", "products": "COC(=O)c1ccc(CNC(=O)c2ccc(C(C)=O)cc2)cc1"}, "reference": {"title": "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells", "authors": "Liang, Tao; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.", "doi": "10.1021/acs.jmedchem.0c01454", "raw": "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells | Liang, Tao; et al | Journal of Medicinal Chemistry (2020), 63(20), 12083-12099. | 10.1021/acs.jmedchem.0c01454"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-24558300", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt", "1.2|overnight, rt", "Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors", "By: Balestri, Lorenzo Jacopo Ilic; et al", "ACS Medicinal Chemistry Letters (2023), 14(4), 417-424.", "10.1021/acsmedchemlett.2c00472"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/none", "cond_sig": "07a7db6b", "fam_sig": "c57016f3"}, "raw_data": {"raw_cas": "RCT: 107-11-9 + 5105-78-2 | PRO: 2676166-04-2 | RGT: 7087-68-5 + 148893-10-1", "raw_data_json": "{\"txt\": {\"title\": \"HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells\", \"authors\": \"Liang, Tao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24558300\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 30 min, rt\", \"1.2\", \"overnight, rt\", \"48. Scheme 48 (1 Reaction)\", \"Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors\", \"By: Balestri, Lorenzo Jacopo Ilic; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(4), 417-424.\", \"10.1021/acsmedchemlett.2c00472\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"107-11-9\", \"5105-78-2\"], \"pro_cas\": [\"2676166-04-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["107-11-9", "5105-78-2"], "products": ["2676166-04-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24719960", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 80.0}, "smiles": {"reactants": "Cc1cc(F)c(C(=O)O)cc1Br.CC(C)(C)CCCN.Cl", "products": "Cc1cc(F)c(C(=O)NCCCC(C)(C)C)cc1Br"}, "reference": {"title": "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor", "authors": "Huestis, Malcolm P.; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.", "doi": "10.1021/acsmedchemlett.1c00063", "raw": "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor | Huestis, Malcolm P.; et al | ACS Medicinal Chemistry Letters (2021), 12(5), 791-797. | 10.1021/acsmedchemlett.1c00063"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-24719960", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 68076-36-8 | PRO: 2361527-93-5 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor\", \"authors\": \"Huestis, Malcolm P.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24719960\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"107. Scheme 107 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"68076-36-8\"], \"pro_cas\": [\"2361527-93-5\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "68076-36-8"], "products": ["2361527-93-5"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24719966", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 17.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)(C#N)c1cccc(C(=O)O)c1.Cc1cc(F)c(N)cc1Br", "products": "Cc1cc(F)c(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Br"}, "reference": {"title": "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor", "authors": "Huestis, Malcolm P.; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.", "doi": "10.1021/acsmedchemlett.1c00063", "raw": "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor | Huestis, Malcolm P.; et al | ACS Medicinal Chemistry Letters (2021), 12(5), 791-797. | 10.1021/acsmedchemlett.1c00063"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-24719966", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C → rt; 17 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels", "By: Fernandez, Ariadna; et al", "ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.", "10.1021/acsmedchemlett.1c00416"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 41014-93-1 + 1263377-68-9 | PRO: 2730115-19-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor\", \"authors\": \"Huestis, Malcolm P.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24719966\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C → rt; 17 h, rt\", \"247. Scheme 247 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels\", \"By: Fernandez, Ariadna; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.\", \"10.1021/acsmedchemlett.1c00416\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"41014-93-1\", \"1263377-68-9\"], \"pro_cas\": [\"2730115-19-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["41014-93-1", "1263377-68-9"], "products": ["2730115-19-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24775907", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 94.0}, "smiles": {"reactants": "O=C(O)c1ccoc1.COC(=O)[C@@H](N)C(C)C.Cl", "products": "COC(=O)[C@@H](NC(=O)c1ccoc1)C(C)C"}, "reference": {"title": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "authors": "Sampaio-Dias, Ivo E.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "doi": "10.1021/acs.jmedchem.1c00252", "raw": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide | Sampaio-Dias, Ivo E.; et al | Journal of Medicinal Chemistry (2021), 64(9), 6209-6220. | 10.1021/acs.jmedchem.1c00252"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-24775907", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 30 min, rt", "1.2|1 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "By: Xu, Zhongren; et al", "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "10.1021/acs.jmedchem.3c00063"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 22204-53-1 + 2450-71-7 | PRO: 1060964-03-5 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"authors\": \"Sampaio-Dias, Ivo E.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24775907\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"1 h, rt\", \"62. Scheme 62 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"By: Xu, Zhongren; et al\", \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"10.1021/acs.jmedchem.3c00063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"22204-53-1\", \"2450-71-7\"], \"pro_cas\": [\"1060964-03-5\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["22204-53-1", "2450-71-7"], "products": ["1060964-03-5"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24775908", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)[C@H](NC(=O)c1ccoc1)C(=O)O.COC(=O)[C@H](C)N.Cl", "products": "COC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1ccoc1)C(C)C"}, "reference": {"title": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "authors": "Sampaio-Dias, Ivo E.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "doi": "10.1021/acs.jmedchem.1c00252", "raw": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide | Sampaio-Dias, Ivo E.; et al | Journal of Medicinal Chemistry (2021), 64(9), 6209-6220. | 10.1021/acs.jmedchem.1c00252"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-24775908", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 30 min, rt", "1.2|1 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 108468-00-4 | PRO: 3031471-27-6 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"authors\": \"Sampaio-Dias, Ivo E.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24775908\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"1 h, rt\", \"156. Scheme 156 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"108468-00-4\"], \"pro_cas\": [\"3031471-27-6\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "108468-00-4"], "products": ["3031471-27-6"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24775917", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 82.0}, "smiles": {"reactants": "CC(C)[C@H](NC(=O)c1ccoc1)C(=O)O.COC(=O)CN.Cl", "products": "COC(=O)CNC(=O)[C@@H](NC(=O)c1ccoc1)C(C)C"}, "reference": {"title": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "authors": "Sampaio-Dias, Ivo E.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "doi": "10.1021/acs.jmedchem.1c00252", "raw": "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide | Sampaio-Dias, Ivo E.; et al | Journal of Medicinal Chemistry (2021), 64(9), 6209-6220. | 10.1021/acs.jmedchem.1c00252"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-24775917", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 30 min, rt", "1.2|1 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability", "By: Meta, Mergim; et al", "ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.", "10.1021/acsmedchemlett.4c00050"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 5337-03-1 + 17193-39-4 | PRO: 3085792-07-7 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"authors\": \"Sampaio-Dias, Ivo E.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24775917\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"1 h, rt\", \"138. Scheme 138 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability\", \"By: Meta, Mergim; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.\", \"10.1021/acsmedchemlett.4c00050\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5337-03-1\", \"17193-39-4\"], \"pro_cas\": [\"3085792-07-7\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5337-03-1", "17193-39-4"], "products": ["3085792-07-7"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24782806", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 65.0, "time_h": 16.0, "yield_pct": 82.0}, "smiles": {"reactants": "Nc1ccc(F)c(F)c1.Cn1cccc1C(=O)O", "products": "Cn1cccc1C(=O)Nc1ccc(F)c(F)c1"}, "reference": {"title": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "authors": "Amblard, Franck; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "doi": "10.1016/j.bmc.2020.115952", "raw": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents | Amblard, Franck; et al | Bioorganic & Medicinal Chemistry (2021), 31, 115952. | 10.1016/j.bmc.2020.115952"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-24782806", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; rt; overnight, 65 °C", "1.2|Reagents: Ammonium chloride", "Solvents: Water", "Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker", "By: Duvall, Bridget; et al", "Bioorganic & Medicinal Chemistry (2020), 28(20), 115698.", "10.1016/j.bmc.2020.115698"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "eb9a32e6", "fam_sig": "5f51edc3"}, "raw_data": {"raw_cas": "RCT: 103-82-2 + 1599822-92-0 | PRO: 2484994-88-7 | RGT: 7087-68-5 + 148893-10-1 + 12125-02-9 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"authors\": \"Amblard, Franck; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24782806\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; rt; overnight, 65 °C\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water\", \"206. Scheme 206 (1 Reaction)\", \"Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker\", \"By: Duvall, Bridget; et al\", \"Bioorganic & Medicinal Chemistry (2020), 28(20), 115698.\", \"10.1016/j.bmc.2020.115698\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"103-82-2\", \"1599822-92-0\"], \"pro_cas\": [\"2484994-88-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["103-82-2", "1599822-92-0"], "products": ["2484994-88-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24782811", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 98.0}, "smiles": {"reactants": "C#CCN.Cn1cc(C(=O)C(=O)O)cc1C(=O)Nc1ccc(F)c(F)c1", "products": "C#CCNC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(F)c2)n(C)c1"}, "reference": {"title": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "authors": "Amblard, Franck; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "doi": "10.1016/j.bmc.2020.115952", "raw": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents | Amblard, Franck; et al | Bioorganic & Medicinal Chemistry (2021), 31, 115952. | 10.1016/j.bmc.2020.115952"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-24782811", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "By: Amblard, Franck; et al", "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "10.1016/j.bmc.2020.115952"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Ammonium chloride|12125-02-9+N,N'-Carbonyldiimidazole|530-62-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "849b22be", "fam_sig": "6edde9c6"}, "raw_data": {"raw_cas": "RCT: 107-11-9 + 1644485-79-9 | PRO: 2133017-44-2 | RGT: 530-62-1 + 12125-02-9 | SOL: 68-12-2 + 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"authors\": \"Amblard, Franck; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24782811\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"105. Scheme 105 (1 Reaction)\", \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"By: Amblard, Franck; et al\", \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"10.1016/j.bmc.2020.115952\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"107-11-9\", \"1644485-79-9\"], \"pro_cas\": [\"2133017-44-2\"], \"rgt_cas\": [\"530-62-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["107-11-9", "1644485-79-9"], "products": ["2133017-44-2"], "reagents": ["N,N'-Carbonyldiimidazole", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24782812", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 81.0}, "smiles": {"reactants": "C=CCN.Cn1cc(C(=O)C(=O)O)cc1C(=O)Nc1ccc(F)c(F)c1", "products": "C=CCNC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(F)c2)n(C)c1"}, "reference": {"title": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "authors": "Amblard, Franck; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "doi": "10.1016/j.bmc.2020.115952", "raw": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents | Amblard, Franck; et al | Bioorganic & Medicinal Chemistry (2021), 31, 115952. | 10.1016/j.bmc.2020.115952"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-24782812", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "By: Christie, Louisa A.; et al", "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "10.1021/acs.jmedchem.3c00630"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Ammonium chloride|12125-02-9+N,N'-Carbonyldiimidazole|530-62-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "849b22be", "fam_sig": "6edde9c6"}, "raw_data": {"raw_cas": "RCT: 1898075-33-6 + 42389-57-1 | PRO: 2919850-96-5 | RGT: 530-62-1 + 12125-02-9 | SOL: 68-12-2 + 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"authors\": \"Amblard, Franck; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24782812\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"106. Scheme 106 (1 Reaction)\", \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"By: Christie, Louisa A.; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"10.1021/acs.jmedchem.3c00630\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1898075-33-6\", \"42389-57-1\"], \"pro_cas\": [\"2919850-96-5\"], \"rgt_cas\": [\"530-62-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1898075-33-6", "42389-57-1"], "products": ["2919850-96-5"], "reagents": ["N,N'-Carbonyldiimidazole", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24782813", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 99.0}, "smiles": {"reactants": "NCc1ccccc1.Cn1cc(C(=O)C(=O)O)cc1C(=O)Nc1ccc(F)c(F)c1", "products": "Cn1cc(C(=O)C(=O)NCc2ccccc2)cc1C(=O)Nc1ccc(F)c(F)c1"}, "reference": {"title": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "authors": "Amblard, Franck; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "doi": "10.1016/j.bmc.2020.115952", "raw": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents | Amblard, Franck; et al | Bioorganic & Medicinal Chemistry (2021), 31, 115952. | 10.1016/j.bmc.2020.115952"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-24782813", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Ammonium chloride|12125-02-9+N,N'-Carbonyldiimidazole|530-62-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "849b22be", "fam_sig": "6edde9c6"}, "raw_data": {"raw_cas": "RCT: 159005-71-7 + 1315051-74-1 | PRO: 2765293-26-1 | RGT: 530-62-1 + 12125-02-9 | SOL: 68-12-2 + 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"authors\": \"Amblard, Franck; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24782813\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide, Dichloromethane; 1 - 2 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"165. Scheme 165 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"159005-71-7\", \"1315051-74-1\"], \"pro_cas\": [\"2765293-26-1\"], \"rgt_cas\": [\"530-62-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["159005-71-7", "1315051-74-1"], "products": ["2765293-26-1"], "reagents": ["N,N'-Carbonyldiimidazole", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.055787", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24782838", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "WORKUP"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Methanol", "cas": "67-56-1"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 87.0}, "smiles": {"reactants": "C#CCN.CCOC(=O)c1c(C)c(C(=O)C(=O)O)c(C)n1C", "products": "C#CCNC(=O)C(=O)c1c(C)c(C(=O)O)n(C)c1C"}, "reference": {"title": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "authors": "Amblard, Franck; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "doi": "10.1016/j.bmc.2020.115952", "raw": "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents | Amblard, Franck; et al | Bioorganic & Medicinal Chemistry (2021), 31, 115952. | 10.1016/j.bmc.2020.115952"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-24782838", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide, Dichloromethane; 2 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "1.3|Reagents: Sodium hydroxide", "Solvents: Methanol, Tetrahydrofuran, Water; overnight, rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 1, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies", "By: Rahman, Toufiqur Md; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.", "10.1021/acs.jmedchem.1c01075"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Ammonium chloride|12125-02-9+Hydrochloric acid|7647-01-0+N,N'-Carbonyldiimidazole|530-62-1+NaOH|1310-73-2+Sodium hydroxide|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Methanol|67-56-1+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "9362bff5", "fam_sig": "97b9195a"}, "raw_data": {"raw_cas": "RCT: 7782-24-3 + 2821859-77-0 | PRO: 2821859-80-5 | RGT: 530-62-1 + 12125-02-9 + 1310-73-2 + 7647-01-0 | SOL: 68-12-2 + 75-09-2 + 7732-18-5 + 67-56-1 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"authors\": \"Amblard, Franck; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Ammonium chloride\", \"Sodium hydroxide\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\", \"Water\", \"Methanol\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24782838\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide, Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Methanol, Tetrahydrofuran, Water; overnight, rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 1, rt\", \"265. Scheme 265 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies\", \"By: Rahman, Toufiqur Md; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.\", \"10.1021/acs.jmedchem.1c01075\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7782-24-3\", \"2821859-77-0\"], \"pro_cas\": [\"2821859-80-5\"], \"rgt_cas\": [\"530-62-1\", \"12125-02-9\", \"1310-73-2\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\", \"7732-18-5\", \"67-56-1\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["7782-24-3", "2821859-77-0"], "products": ["2821859-80-5"], "reagents": ["N,N'-Carbonyldiimidazole", "12125-02-9", "NaOH", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane", "Water", "Methanol", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24840905", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 12.0, "yield_pct": 98.0}, "smiles": {"reactants": "CC1(C)O[C@@H]2[C@H](O1)[C@@H](CSCCN)O[C@H]2n1cnc2c(N)ncnc21.CC(C)(C)OC(=O)N1Cc2ccccc2CC1C(=O)O", "products": "CC(C)(C)OC(=O)N1Cc2ccccc2CC1C(=O)NCCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@@H]2OC(C)(C)O[C@@H]21"}, "reference": {"title": "Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1", "authors": "Lu, Jian; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(22), 13878-13898.", "doi": "10.1021/acs.jmedchem.0c01475", "raw": "Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1 | Lu, Jian; et al | Journal of Medicinal Chemistry (2020), 63(22), 13878-13898. | 10.1021/acs.jmedchem.0c01475"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-24840905", "1.1|Reagents: 4-Methylmorpholine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide, Water; 0 °C → rt; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease", "By: Machauer, Rainer; et al", "Journal of Medicinal Chemistry (2021), 64(20), 15262-15279.", "10.1021/acs.jmedchem.1c01300"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+4-Methylmorpholine|+N-Methylmorpholine|109-02-4/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "8f8e877a", "fam_sig": "732510e4"}, "raw_data": {"raw_cas": "RCT: 80194-68-9 + 1387561-59-2 | PRO: 2173393-97-8 | RGT: 109-02-4 + 2592-95-2 + 25952-53-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1\", \"authors\": \"Lu, Jian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(22), 13878-13898.\", \"reagents\": [\"4-Methylmorpholine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24840905\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide, Water; 0 °C → rt; 12 h, rt\", \"472. Scheme 472 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease\", \"By: Machauer, Rainer; et al\", \"Journal of Medicinal Chemistry (2021), 64(20), 15262-15279.\", \"10.1021/acs.jmedchem.1c01300\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"80194-68-9\", \"1387561-59-2\"], \"pro_cas\": [\"2173393-97-8\"], \"rgt_cas\": [\"109-02-4\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["80194-68-9", "1387561-59-2"], "products": ["2173393-97-8"], "reagents": ["N-Methylmorpholine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24891371", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 0.167, "yield_pct": 96.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(c2c(N)cnc3cc(Br)c(Cl)cc23)C(C(=O)O)C1", "products": "CC(C)(C)OC(=O)N1CCN2c3c(cnc4cc(Br)c(Cl)cc34)NC(=O)C2C1"}, "reference": {"title": "Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C", "authors": "Kettle, Jason G.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(9), 4468-4483.", "doi": "10.1021/acs.jmedchem.9b01720", "raw": "Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C | Kettle, Jason G.; et al | Journal of Medicinal Chemistry (2020), 63(9), 4468-4483. | 10.1021/acs.jmedchem.9b01720"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-24891371", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 10 min, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites", "By: Belouin, Audrey; et al", "Bioorganic & Medicinal Chemistry (2024), 98, 117553.", "10.1016/j.bmc.2023.117553"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "004c71d2", "fam_sig": "6a8d59c1"}, "raw_data": {"raw_cas": "RCT: 901-79-1 + 3036050-17-3 | PRO: 3036050-20-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C\", \"authors\": \"Kettle, Jason G.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(9), 4468-4483.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24891371\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 10 min, rt\", \"478. Scheme 478 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites\", \"By: Belouin, Audrey; et al\", \"Bioorganic & Medicinal Chemistry (2024), 98, 117553.\", \"10.1016/j.bmc.2023.117553\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"901-79-1\", \"3036050-17-3\"], \"pro_cas\": [\"3036050-20-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["901-79-1", "3036050-17-3"], "products": ["3036050-20-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24900179", "reaction_type": "Other", "catalyst": {"core": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}]}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 60.0, "time_h": 0.583, "yield_pct": 90.0}, "smiles": {"reactants": "Cc1cc(C)cc(N)c1.O=C(O)Cc1ccc(O)cc1", "products": "Cc1cc(C)cc(NC(=O)Cc2ccc(O)cc2)c1"}, "reference": {"title": "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "authors": "Sharma, Sudripet; et al", "citation": "Organic Process Research & Development (2021), 25(8), 1960-1965.", "doi": "10.1021/acs.oprd.1c00203", "raw": "Insights into Fast Amide Couplings in Aqueous Nanomicelles | Sharma, Sudripet; et al | Organic Process Research & Development (2021), 25(8), 1960-1965. | 10.1021/acs.oprd.1c00203"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-24900179", "1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-", "Solvents: Water; 35 min, 60 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+Pyridine|110-86-1/Water|7732-18-5", "cond_sig": "179b850c", "fam_sig": "5956c1c2"}, "raw_data": {"raw_cas": "RCT: 13139-15-6 + 2450-71-7 | PRO: 1268671-03-9 | RGT: 110-86-1 + 1892-57-5 | CAT: 2135447-74-2 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"authors\": \"Sharma, Sudripet; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"reagents\": [\"Pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\"], \"catalysts\": [\"Poly(oxy-1,2-ethanediyl)\", \"α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\"], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24900179\", \"1.1\", \"Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\", \"Solvents: Water; 35 min, 60 °C\", \"32. Scheme 32 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13139-15-6\", \"2450-71-7\"], \"pro_cas\": [\"1268671-03-9\"], \"rgt_cas\": [\"110-86-1\", \"1892-57-5\"], \"cat_cas\": [\"2135447-74-2\"], \"sol_cas\": [\"7732-18-5\"], \"notes\": [\"Multi-gram scale, sealed flask used\"]}}", "enriched_names": {"reactants": ["13139-15-6", "2450-71-7"], "products": ["1268671-03-9"], "reagents": ["Pyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide"], "catalysts": ["2135447-74-2"], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24942483", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Methanol", "cas": "67-56-1"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.5, "yield_pct": 95.0}, "smiles": {"reactants": "CN(C)C(=O)c1cc(-c2ccc(NC(=O)OC(C)(C)C)cc2)cn1C.Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)O", "products": "CN(C)C(=O)c1cc(-c2ccc(NC(=O)c3cc(NC(=O)OC(C)(C)C)cn3C)cc2)cn1C"}, "reference": {"title": "New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria", "authors": "Picconi, Pietro; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(13), 6941-6958.", "doi": "10.1021/acs.jmedchem.0c00328", "raw": "New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria | Picconi, Pietro; et al | Journal of Medicinal Chemistry (2020), 63(13), 6941-6958. | 10.1021/acs.jmedchem.0c00328"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-24942483", "1.1|Reagents: Hydrochloric acid", "Solvents: Methanol, 1,4-Dioxane; 2 h, rt", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 30 min, rt; overnight, rt", "1.3|Reagents: Water; rt", "The discovery of potent small molecule activators of human STING", "By: Pryde, David C.; et al", "European Journal of Medicinal Chemistry (2021), 209, 112869.", "10.1016/j.ejmech.2020.112869"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Hydrochloric acid|7647-01-0+Water|7732-18-5/1,4-Dioxane|123-91-1+Dimethylformamide|68-12-2+Methanol|67-56-1", "cond_sig": "b7e697a6", "fam_sig": "a29b95cb"}, "raw_data": {"raw_cas": "RCT: 617-89-0 + 2259626-67-8 | PRO: 2259624-70-7 | RGT: 7647-01-0 + 25952-53-8 + 7732-18-5 | CAT: 1122-58-3 | SOL: 67-56-1 + 123-91-1 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria\", \"authors\": \"Picconi, Pietro; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(13), 6941-6958.\", \"reagents\": [\"Hydrochloric acid\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Methanol\", \"1,4-Dioxane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24942483\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Methanol, 1,4-Dioxane; 2 h, rt\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 30 min, rt; overnight, rt\", \"1.3\", \"Reagents: Water; rt\", \"228. Scheme 228 (1 Reaction)\", \"The discovery of potent small molecule activators of human STING\", \"By: Pryde, David C.; et al\", \"European Journal of Medicinal Chemistry (2021), 209, 112869.\", \"10.1016/j.ejmech.2020.112869\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"617-89-0\", \"2259626-67-8\"], \"pro_cas\": [\"2259624-70-7\"], \"rgt_cas\": [\"7647-01-0\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"67-56-1\", \"123-91-1\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["617-89-0", "2259626-67-8"], "products": ["2259624-70-7"], "reagents": ["Hydrochloric acid", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Methanol", "1,4-Dioxane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-24985530", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "cas": "1075198-30-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 82.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.CNc1ccccc1N", "products": "CNc1ccccc1NC(=O)CNC(=O)OC(C)(C)C"}, "reference": {"title": "Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors", "authors": "Leiris, Simon; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(2), 217-227.", "doi": "10.1021/acsmedchemlett.0c00554", "raw": "Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors | Leiris, Simon; et al | ACS Medicinal Chemistry Letters (2021), 12(2), 217-227. | 10.1021/acsmedchemlett.0c00554"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-24985530", "1.1|Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "Solvents: Dichloromethane; 2 h, rt", "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "By: Ryan, Michael C.; et al", "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "10.1021/acsmedchemlett.1c00539"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate|1075198-30-9/Dichloromethane|75-09-2", "cond_sig": "70b43dbe", "fam_sig": "0e481db2"}, "raw_data": {"raw_cas": "RCT: 62-53-3 + 616-79-5 | PRO: 30481-54-0 | RGT: 7087-68-5 + 1075198-30-9 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors\", \"authors\": \"Leiris, Simon; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(2), 217-227.\", \"reagents\": [\"Diisopropylethylamine\", \"N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-24985530\", \"1.1\", \"Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\", \"Solvents: Dichloromethane; 2 h, rt\", \"85. Scheme 85 (1 Reaction)\", \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"By: Ryan, Michael C.; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"10.1021/acsmedchemlett.1c00539\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"62-53-3\", \"616-79-5\"], \"pro_cas\": [\"30481-54-0\"], \"rgt_cas\": [\"7087-68-5\", \"1075198-30-9\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["62-53-3", "616-79-5"], "products": ["30481-54-0"], "reagents": ["N,N-Diisopropylethylamine", "1075198-30-9"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25082100", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 89.0}, "smiles": {"reactants": "N#CCC(=O)O.COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3N)nc2)c1Cl", "products": "COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CC#N)nc2)c1Cl"}, "reference": {"title": "Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors", "authors": "Deng, Wuqing; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(4), 647-652.", "doi": "10.1021/acsmedchemlett.1c00052", "raw": "Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors | Deng, Wuqing; et al | ACS Medicinal Chemistry Letters (2021), 12(4), 647-652. | 10.1021/acsmedchemlett.1c00052"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-25082100", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Demonstrating Ligandability of the LC3A and LC3B Adapter Interface", "By: Hartmann, Markus; et al", "Journal of Medicinal Chemistry (2021), 64(7), 3720-3746.", "10.1021/acs.jmedchem.0c01564"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 105337-81-3 + 2083629-05-2 | PRO: 2756363-68-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors\", \"authors\": \"Deng, Wuqing; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(4), 647-652.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25082100\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"244. Scheme 244 (1 Reaction)\", \"Demonstrating Ligandability of the LC3A and LC3B Adapter Interface\", \"By: Hartmann, Markus; et al\", \"Journal of Medicinal Chemistry (2021), 64(7), 3720-3746.\", \"10.1021/acs.jmedchem.0c01564\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"105337-81-3\", \"2083629-05-2\"], \"pro_cas\": [\"2756363-68-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["105337-81-3", "2083629-05-2"], "products": ["2756363-68-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25082446", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 8.25, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.COc1ccc([C@H](C)N)cc1", "products": "COc1ccc([C@H](C)NC(=O)CNC(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors", "authors": "Gao, Dingding; et al", "citation": "European Journal of Medicinal Chemistry (2021), 216, 113333.", "doi": "10.1016/j.ejmech.2021.113333", "raw": "Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors | Gao, Dingding; et al | European Journal of Medicinal Chemistry (2021), 216, 113333. | 10.1016/j.ejmech.2021.113333"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-25082446", "1.1|Reagents: HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 15 min, 0 °C", "1.2|Reagents: Diisopropylethylamine; 8 h, rt", "Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy", "By: Gu, Yun-Qiong; et al", "Journal of Medicinal Chemistry (2023), 66(14), 9592-9606.", "10.1021/acs.jmedchem.3c00318"], "signatures": {"cond_key": "none/none/1-Hydroxy-7-azabenzotriazole|39968-33-7+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "e60798e9", "fam_sig": "967b17ec"}, "raw_data": {"raw_cas": "RCT: 1702-17-6 + 62-53-3 | PRO: 1021043-37-7 | RGT: 39968-33-7 + 148893-10-1 + 7087-68-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors\", \"authors\": \"Gao, Dingding; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 216, 113333.\", \"reagents\": [\"HOAt\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25082446\", \"1.1\", \"Reagents: HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 15 min, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 8 h, rt\", \"121. Scheme 121 (1 Reaction)\", \"Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy\", \"By: Gu, Yun-Qiong; et al\", \"Journal of Medicinal Chemistry (2023), 66(14), 9592-9606.\", \"10.1021/acs.jmedchem.3c00318\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1702-17-6\", \"62-53-3\"], \"pro_cas\": [\"1021043-37-7\"], \"rgt_cas\": [\"39968-33-7\", \"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["1702-17-6", "62-53-3"], "products": ["1021043-37-7"], "reagents": ["1-Hydroxy-7-azabenzotriazole", "HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25109422", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dimethylaniline", "cas": "121-69-7", "role": "NUC"}, {"name": "Phosphorus oxychloride", "cas": "10025-87-3", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Toluene", "cas": "108-88-3"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 95.0, "time_h": 2.0, "yield_pct": 84.0}, "smiles": {"reactants": "Nc1cc(Cl)ccc1Nc1ccc(F)cc1C(=O)O", "products": "O=C1Nc2cc(Cl)ccc2Nc2ccc(F)cc21"}, "reference": {"title": "Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors", "authors": "Watanabe, Hitoshi; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 40, 127911.", "doi": "10.1016/j.bmcl.2021.127911", "raw": "Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors | Watanabe, Hitoshi; et al | Bioorganic & Medicinal Chemistry Letters (2021), 40, 127911. | 10.1016/j.bmcl.2021.127911"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-25109422", "1.1|Reagents: N,N-Dimethylaniline, Phosphorus oxychloride", "Solvents: Toluene; 2 h, 95 °C", "1.2|Solvents: Water; 0 °C", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water; neutralized, 0 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations", "By: Thomson, Clare; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.", "10.1021/acs.jmedchem.4c00227"], "signatures": {"cond_key": "none/none/N,N-Dimethylaniline|121-69-7+NaHCO3|144-55-8+Phosphorus oxychloride|10025-87-3+Sodium bicarbonate|/Toluene|108-88-3+Water|7732-18-5", "cond_sig": "6ecb1853", "fam_sig": "9bad4e86"}, "raw_data": {"raw_cas": "RCT: 1368466-66-3 + 3055872-81-3 | PRO: 3055872-93-7 | RGT: 121-69-7 + 10025-87-3 + 144-55-8 | SOL: 108-88-3 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors\", \"authors\": \"Watanabe, Hitoshi; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 40, 127911.\", \"reagents\": [\"N,N-Dimethylaniline\", \"Phosphorus oxychloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Toluene\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25109422\", \"1.1\", \"Reagents: N,N-Dimethylaniline, Phosphorus oxychloride\", \"Solvents: Toluene; 2 h, 95 °C\", \"1.2\", \"Solvents: Water; 0 °C\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; neutralized, 0 °C\", \"376. Scheme 376 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations\", \"By: Thomson, Clare; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.\", \"10.1021/acs.jmedchem.4c00227\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1368466-66-3\", \"3055872-81-3\"], \"pro_cas\": [\"3055872-93-7\"], \"rgt_cas\": [\"121-69-7\", \"10025-87-3\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"108-88-3\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1368466-66-3", "3055872-81-3"], "products": ["3055872-93-7"], "reagents": ["121-69-7", "10025-87-3", "NaHCO3"], "catalysts": [], "solvents": ["Toluene", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25136532", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 21.0, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)CCc1cccc(C(=O)O)c1.Cl.Nc1c(O)c2ccc([N+](=O)[O-])cc2oc1=O", "products": "CC(C)CCc1cccc(C(=O)Nc2c(O)c3ccc([N+](=O)[O-])cc3oc2=O)c1"}, "reference": {"title": "Demonstrating Ligandability of the LC3A and LC3B Adapter Interface", "authors": "Hartmann, Markus; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(7), 3720-3746.", "doi": "10.1021/acs.jmedchem.0c01564", "raw": "Demonstrating Ligandability of the LC3A and LC3B Adapter Interface | Hartmann, Markus; et al | Journal of Medicinal Chemistry (2021), 64(7), 3720-3746. | 10.1021/acs.jmedchem.0c01564"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-25136532", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 16 h, rt", "1.2|Reagents: Sodium hydroxide", "Solvents: Water; 5 h, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+NaOH|1310-73-2+Sodium hydroxide|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "13e08c59", "fam_sig": "14ef8ed6"}, "raw_data": {"raw_cas": "RCT: 64-19-7 + 2632874-83-8 | PRO: 2632874-41-8 | RGT: 2592-95-2 + 25952-53-8 + 1310-73-2 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Demonstrating Ligandability of the LC3A and LC3B Adapter Interface\", \"authors\": \"Hartmann, Markus; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(7), 3720-3746.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Sodium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25136532\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 16 h, rt\", \"1.2\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 5 h, rt\", \"245. Scheme 245 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-19-7\", \"2632874-83-8\"], \"pro_cas\": [\"2632874-41-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"1310-73-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["Acetic Acid", "2632874-83-8"], "products": ["2632874-41-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "NaOH"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25838983", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 180.0, "time_h": 14.0, "yield_pct": 82.0}, "smiles": {"reactants": "NC=O.Nc1cc(F)ccc1C(=O)O", "products": "O=c1nc[nH]c2cc(F)ccc12"}, "reference": {"title": "Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists", "authors": "Bae, Inhwan; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 34, 127676.", "doi": "10.1016/j.bmcl.2020.127676", "raw": "Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists | Bae, Inhwan; et al | Bioorganic & Medicinal Chemistry Letters (2021), 34, 127676. | 10.1016/j.bmcl.2020.127676"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-25838983", "1.1|Catalysts: Dimethylformamide; rt → 180 °C; 14 h, 180 °C", "Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR", "By: Grossman, Scott; et al", "European Journal of Medicinal Chemistry (2020), 208, 112778.", "10.1016/j.ejmech.2020.112778"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 89-77-0 | PRO: 31374-18-2 | CAT: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists\", \"authors\": \"Bae, Inhwan; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 34, 127676.\", \"reagents\": [], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25838983\", \"1.1\", \"Catalysts: Dimethylformamide; rt → 180 °C; 14 h, 180 °C\", \"432. Scheme 432 (1 Reaction)\", \"Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR\", \"By: Grossman, Scott; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112778.\", \"10.1016/j.ejmech.2020.112778\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"89-77-0\"], \"pro_cas\": [\"31374-18-2\"], \"rgt_cas\": [], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "89-77-0"], "products": ["31374-18-2"], "reagents": [], "catalysts": ["Dimethylformamide"], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25849249", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 83.0}, "smiles": {"reactants": "Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21.CC(C)(C)C(=O)N(CC(=O)O)Cc1ccccc1Br", "products": "CC(C)(C)C(=O)N(CC(=O)Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21)Cc1ccccc1Br"}, "reference": {"title": "Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization", "authors": "Zirimwabagabo, Jean-Olivier; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.", "doi": "10.1021/acs.jmedchem.0c02191", "raw": "Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization | Zirimwabagabo, Jean-Olivier; et al | Journal of Medicinal Chemistry (2021), 64(6), 3299-3319. | 10.1021/acs.jmedchem.0c02191"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-25849249", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; 18 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "By: Ryu, SeongShick; et al", "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "10.1021/acs.jmedchem.1c01359"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "196bb350", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 2761691-53-4 + 13726-85-7 | PRO: 2761691-54-5 | RGT: 7087-68-5 + 25952-53-8 + 39968-33-7 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization\", \"authors\": \"Zirimwabagabo, Jean-Olivier; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25849249\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; 18 h, rt\", \"354. Scheme 354 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"By: Ryu, SeongShick; et al\", \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"10.1021/acs.jmedchem.1c01359\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2761691-53-4\", \"13726-85-7\"], \"pro_cas\": [\"2761691-54-5\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2761691-53-4", "13726-85-7"], "products": ["2761691-54-5"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25849341", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 99.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21", "products": "CC(C)(C)OC(=O)NCC(=O)Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21"}, "reference": {"title": "Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization", "authors": "Zirimwabagabo, Jean-Olivier; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.", "doi": "10.1021/acs.jmedchem.0c02191", "raw": "Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization | Zirimwabagabo, Jean-Olivier; et al | Journal of Medicinal Chemistry (2021), 64(6), 3299-3319. | 10.1021/acs.jmedchem.0c02191"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-25849341", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; 18 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases", "By: Andrews, Mark D.; et al", "Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.", "10.1021/acs.jmedchem.2c00422"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+Sodium bicarbonate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "8bfa7906", "fam_sig": "655a495c"}, "raw_data": {"raw_cas": "RCT: 920006-32-2 + 2446808-54-2 | PRO: 2446806-89-7 | RGT: 7087-68-5 + 25952-53-8 + 39968-33-7 + 144-55-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization\", \"authors\": \"Zirimwabagabo, Jean-Olivier; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(6), 3299-3319.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25849341\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; 18 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"249. Scheme 249 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases\", \"By: Andrews, Mark D.; et al\", \"Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.\", \"10.1021/acs.jmedchem.2c00422\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"920006-32-2\", \"2446808-54-2\"], \"pro_cas\": [\"2446806-89-7\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\", \"39968-33-7\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["920006-32-2", "2446808-54-2"], "products": ["2446806-89-7"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole", "NaHCO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.057790", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-25849885", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 2.017, "yield_pct": 99.0}, "smiles": {"reactants": "Cn1cc(-c2cc(C(=O)O)ccc2OCc2ccccc2)nn1.CCN", "products": "CCNC(=O)c1ccc(OCc2ccccc2)c(-c2cn(C)nn2)c1"}, "reference": {"title": "Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors", "authors": "Aylott, Helen E.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(6), 3249-3281.", "doi": "10.1021/acs.jmedchem.0c02156", "raw": "Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors | Aylott, Helen E.; et al | Journal of Medicinal Chemistry (2021), 64(6), 3249-3281. | 10.1021/acs.jmedchem.0c02156"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-25849885", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 10 s", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 1 min", "1.3|Solvents: Tetrahydrofuran; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9", "cond_sig": "ec1a0320", "fam_sig": "1abbcdec"}, "raw_data": {"raw_cas": "RCT: 50-79-3 + 2760538-75-6 | PRO: 2760538-82-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors\", \"authors\": \"Aylott, Helen E.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(6), 3249-3281.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-25849885\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 10 s\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 1 min\", \"1.3\", \"Solvents: Tetrahydrofuran; 2 h, rt\", \"362. Scheme 362 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"50-79-3\", \"2760538-75-6\"], \"pro_cas\": [\"2760538-82-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["50-79-3", "2760538-75-6"], "products": ["2760538-82-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-26205271", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 135.0, "time_h": 7.0, "yield_pct": 95.0}, "smiles": {"reactants": "NC=O.Nc1ccc(Br)cc1C(=O)O", "products": "O=c1nc[nH]c2ccc(Br)cc12"}, "reference": {"title": "Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition", "authors": "Fan, Chengcheng; et al", "citation": "European Journal of Medicinal Chemistry (2020), 190, 112108pp..", "doi": "10.1016/j.ejmech.2020.112108", "raw": "Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition | Fan, Chengcheng; et al | European Journal of Medicinal Chemistry (2020), 190, 112108pp.. | 10.1016/j.ejmech.2020.112108"}, "original_text": ["Steps: 1, Yield: 88-95%", "CAS Reaction Number: 31-614-CAS-26205271", "1.1|4 h, 130 - 135 °C", "Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition", "By: Yang, Huarong; et al", "Bioorganic & Medicinal Chemistry (2021), 46, 116346.", "10.1016/j.bmc.2021.116346"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 5794-88-7 | PRO: 32084-59-6", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition\", \"authors\": \"Fan, Chengcheng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 190, 112108pp..\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-26205271\", \"1.1\", \"4 h, 130 - 135 °C\", \"Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition\", \"By: Yang, Huarong; et al\", \"Bioorganic & Medicinal Chemistry (2021), 46, 116346.\", \"10.1016/j.bmc.2021.116346\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"5794-88-7\"], \"pro_cas\": [\"32084-59-6\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "5794-88-7"], "products": ["32084-59-6"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-26768391", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Acetic Acid", "cas": "64-19-7"}], "conditions": {"temperature_c": 120.0, "time_h": 4.0, "yield_pct": 94.0}, "smiles": {"reactants": "CC(=O)O.N=CN.Nc1ccc(Br)cc1C(=O)O", "products": "O=c1nc[nH]c2ccc(Br)cc12"}, "reference": {"title": "Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity", "authors": "Teng, Yu; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112865.", "doi": "10.1016/j.ejmech.2020.112865", "raw": "Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity | Teng, Yu; et al | European Journal of Medicinal Chemistry (2020), 208, 112865. | 10.1016/j.ejmech.2020.112865"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-26768391", "1.1|Solvents: Acetic acid; 4 h, 120 °C", "Double bond geometry shown", "Double bond geometry shown", "In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole", "By: Zhao, Ya-Dong; et al", "Bioorganic & Medicinal Chemistry Letters (2024), 105, 129752.", "10.1016/j.bmcl.2024.129752"], "signatures": {"cond_key": "none/none/none/Acetic Acid|64-19-7", "cond_sig": "b1357eba", "fam_sig": "b1357eba"}, "raw_data": {"raw_cas": "RCT: 38489-74-6 + 136-95-8 | PRO: 1162684-18-5 | SOL: 64-19-7", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity\", \"authors\": \"Teng, Yu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112865.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Acetic acid\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-26768391\", \"1.1\", \"Solvents: Acetic acid; 4 h, 120 °C\", \"442. Scheme 442 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole\", \"By: Zhao, Ya-Dong; et al\", \"Bioorganic & Medicinal Chemistry Letters (2024), 105, 129752.\", \"10.1016/j.bmcl.2024.129752\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"38489-74-6\", \"136-95-8\"], \"pro_cas\": [\"1162684-18-5\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"64-19-7\"], \"notes\": []}}", "enriched_names": {"reactants": ["38489-74-6", "136-95-8"], "products": ["1162684-18-5"], "reagents": [], "catalysts": [], "solvents": ["Acetic Acid"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-27641723", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1C[C@H](O)C[C@H]1C(=O)O.Cc1ncsc1-c1ccc(CN)cc1", "products": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma", "authors": "Tu, Yalin; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(14), 10167-10184.", "doi": "10.1021/acs.jmedchem.1c00460", "raw": "Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma | Tu, Yalin; et al | Journal of Medicinal Chemistry (2021), 64(14), 10167-10184. | 10.1021/acs.jmedchem.1c00460"}, "original_text": ["Steps: 1, Yield: 83-90%", "CAS Reaction Number: 31-614-CAS-27641723", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; 2 h, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "004c71d2", "fam_sig": "6a8d59c1"}, "raw_data": {"raw_cas": "RCT: 3075104-38-7 + 62965-35-9 | PRO: 3075104-49-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma\", \"authors\": \"Tu, Yalin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(14), 10167-10184.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-27641723\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; 2 h, rt\", \"137. Scheme 137 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-38-7\", \"62965-35-9\"], \"pro_cas\": [\"3075104-49-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3075104-38-7", "62965-35-9"], "products": ["3075104-49-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-28202897", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 150.0, "time_h": 12.0, "yield_pct": 89.0}, "smiles": {"reactants": "NC=O.Nc1cc(Br)ccc1C(=O)O", "products": "O=c1nc[nH]c2cc(Br)ccc12"}, "reference": {"title": "Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors", "authors": "Li, Peng; et al", "citation": "European Journal of Medicinal Chemistry (2021), 216, 113291.", "doi": "10.1016/j.ejmech.2021.113291", "raw": "Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors | Li, Peng; et al | European Journal of Medicinal Chemistry (2021), 216, 113291. | 10.1016/j.ejmech.2021.113291"}, "original_text": ["Steps: 1, Yield: 87-89%", "CAS Reaction Number: 31-614-CAS-28202897", "1.1|12 h, 150 °C", "Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy", "By: Meng, Yangyang; et al", "Journal of Medicinal Chemistry (2023), 66(17), 11815-11830.", "10.1021/acs.jmedchem.3c00264"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 20776-50-5 | PRO: 194851-16-6", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors\", \"authors\": \"Li, Peng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 216, 113291.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-28202897\", \"1.1\", \"12 h, 150 °C\", \"Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy\", \"By: Meng, Yangyang; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 11815-11830.\", \"10.1021/acs.jmedchem.3c00264\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"20776-50-5\"], \"pro_cas\": [\"194851-16-6\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "20776-50-5"], "products": ["194851-16-6"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-29435452", "reaction_type": "Other", "catalyst": {"core": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}]}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 60.0, "time_h": 0.25, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)c1ccccc1.COC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1"}, "reference": {"title": "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "authors": "Sharma, Sudripet; et al", "citation": "Organic Process Research & Development (2021), 25(8), 1960-1965.", "doi": "10.1021/acs.oprd.1c00203", "raw": "Insights into Fast Amide Couplings in Aqueous Nanomicelles | Sharma, Sudripet; et al | Organic Process Research & Development (2021), 25(8), 1960-1965. | 10.1021/acs.oprd.1c00203"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-29435452", "1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-", "Solvents: Water; 15 min, 60 °C", "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "By: Sarkar, Dipayan; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "10.1021/acs.jmedchem.3c01431"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+Pyridine|110-86-1/Water|7732-18-5", "cond_sig": "179b850c", "fam_sig": "5956c1c2"}, "raw_data": {"raw_cas": "RCT: 616-79-5 + 109-73-9 | PRO: 502144-21-0 | RGT: 110-86-1 + 1892-57-5 | CAT: 2135447-74-2 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"authors\": \"Sharma, Sudripet; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"reagents\": [\"Pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\"], \"catalysts\": [\"Poly(oxy-1,2-ethanediyl)\", \"α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\"], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-29435452\", \"1.1\", \"Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\", \"Solvents: Water; 15 min, 60 °C\", \"76. Scheme 76 (1 Reaction)\", \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"By: Sarkar, Dipayan; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"10.1021/acs.jmedchem.3c01431\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"616-79-5\", \"109-73-9\"], \"pro_cas\": [\"502144-21-0\"], \"rgt_cas\": [\"110-86-1\", \"1892-57-5\"], \"cat_cas\": [\"2135447-74-2\"], \"sol_cas\": [\"7732-18-5\"], \"notes\": [\"sealed flask used, Multi-gram scale, optimization study, optimized on reagent and catalyst\"]}}", "enriched_names": {"reactants": ["616-79-5", "109-73-9"], "products": ["502144-21-0"], "reagents": ["Pyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide"], "catalysts": ["2135447-74-2"], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-29435453", "reaction_type": "Other", "catalyst": {"core": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}]}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 60.0, "time_h": 0.417, "yield_pct": 93.0}, "smiles": {"reactants": "Nc1ccccc1.CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)O", "products": "CC(C)[C@@H](NC(=O)OCc1ccccc1)C(=O)Nc1ccccc1"}, "reference": {"title": "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "authors": "Sharma, Sudripet; et al", "citation": "Organic Process Research & Development (2021), 25(8), 1960-1965.", "doi": "10.1021/acs.oprd.1c00203", "raw": "Insights into Fast Amide Couplings in Aqueous Nanomicelles | Sharma, Sudripet; et al | Organic Process Research & Development (2021), 25(8), 1960-1965. | 10.1021/acs.oprd.1c00203"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-29435453", "1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-", "Solvents: Water; 25 min, 60 °C", "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "By: Huang, Daowei; et al", "European Journal of Medicinal Chemistry (2021), 223, 113648.", "10.1016/j.ejmech.2021.113648"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+Pyridine|110-86-1/Water|7732-18-5", "cond_sig": "179b850c", "fam_sig": "5956c1c2"}, "raw_data": {"raw_cas": "RCT: 54-60-4 + 123-30-8 | PRO: 1207981-11-0 | RGT: 110-86-1 + 1892-57-5 | CAT: 2135447-74-2 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"authors\": \"Sharma, Sudripet; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"reagents\": [\"Pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\"], \"catalysts\": [\"Poly(oxy-1,2-ethanediyl)\", \"α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\"], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-29435453\", \"1.1\", \"Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\", \"Solvents: Water; 25 min, 60 °C\", \"178. Scheme 178 (1 Reaction)\", \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"By: Huang, Daowei; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"10.1016/j.ejmech.2021.113648\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"54-60-4\", \"123-30-8\"], \"pro_cas\": [\"1207981-11-0\"], \"rgt_cas\": [\"110-86-1\", \"1892-57-5\"], \"cat_cas\": [\"2135447-74-2\"], \"sol_cas\": [\"7732-18-5\"], \"notes\": [\"sealed flask used, Multi-gram scale\"]}}", "enriched_names": {"reactants": ["54-60-4", "123-30-8"], "products": ["1207981-11-0"], "reagents": ["Pyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide"], "catalysts": ["2135447-74-2"], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-29435454", "reaction_type": "Other", "catalyst": {"core": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Poly(oxy-1,2-ethanediyl)", "cas": "2135447-74-2"}]}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 60.0, "time_h": 0.583, "yield_pct": 91.0}, "smiles": {"reactants": "Cc1cc(C)cc(N)c1.CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O", "products": "Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2C(=O)OC(C)(C)C)c1"}, "reference": {"title": "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "authors": "Sharma, Sudripet; et al", "citation": "Organic Process Research & Development (2021), 25(8), 1960-1965.", "doi": "10.1021/acs.oprd.1c00203", "raw": "Insights into Fast Amide Couplings in Aqueous Nanomicelles | Sharma, Sudripet; et al | Organic Process Research & Development (2021), 25(8), 1960-1965. | 10.1021/acs.oprd.1c00203"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-29435454", "1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-", "Solvents: Water; 35 min, 60 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21", "By: Goericke, Fabian; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.", "10.1021/acs.jmedchem.2c01933"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+Pyridine|110-86-1/Water|7732-18-5", "cond_sig": "179b850c", "fam_sig": "5956c1c2"}, "raw_data": {"raw_cas": "RCT: 86123-95-7 + 2159560-75-3 | PRO: 3042818-59-4 | RGT: 110-86-1 + 1892-57-5 | CAT: 2135447-74-2 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"authors\": \"Sharma, Sudripet; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"reagents\": [\"Pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\"], \"catalysts\": [\"Poly(oxy-1,2-ethanediyl)\", \"α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\"], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-29435454\", \"1.1\", \"Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Catalysts: Poly(oxy-1,2-ethanediyl), α-[[(2S)-1-(1-oxododecyl)-2-pyrrolidinyl]carbonyl]-ω-methoxy-\", \"Solvents: Water; 35 min, 60 °C\", \"300. Scheme 300 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21\", \"By: Goericke, Fabian; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.\", \"10.1021/acs.jmedchem.2c01933\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"86123-95-7\", \"2159560-75-3\"], \"pro_cas\": [\"3042818-59-4\"], \"rgt_cas\": [\"110-86-1\", \"1892-57-5\"], \"cat_cas\": [\"2135447-74-2\"], \"sol_cas\": [\"7732-18-5\"], \"notes\": [\"sealed flask used, multi-gram scale\"]}}", "enriched_names": {"reactants": ["86123-95-7", "2159560-75-3"], "products": ["3042818-59-4"], "reagents": ["Pyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide"], "catalysts": ["2135447-74-2"], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31159913", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": null, "time_h": null, "yield_pct": 96.0}, "smiles": {"reactants": "Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1.COCCS(=O)(=O)c1ccc2c(c1)CN(C(=O)OC(C)(C)C)C2C(=O)O", "products": "COCCS(=O)(=O)c1ccc2c(c1)CN(C(=O)OC(C)(C)C)C2C(=O)Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1"}, "reference": {"title": "AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2", "authors": "Narjes, Frank; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.", "doi": "10.1021/acs.jmedchem.1c01197", "raw": "AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2 | Narjes, Frank; et al | Journal of Medicinal Chemistry (2021), 64(18), 13807-13829. | 10.1021/acs.jmedchem.1c01197"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-31159913", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 5381-25-9 + 2632874-83-8 | PRO: 2892485-64-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2\", \"authors\": \"Narjes, Frank; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31159913\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane\", \"364. Scheme 364 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5381-25-9\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-64-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5381-25-9", "2632874-83-8"], "products": ["2892485-64-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31159925", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 82.0}, "smiles": {"reactants": "Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1.N#CC1(CS(=O)(=O)c2ccc3c(c2)CN(C(=O)OCC2c4ccccc4-c4ccccc42)C3C(=O)O)CC1", "products": "N#CC1(CS(=O)(=O)c2ccc3c(c2)CN(C(=O)OCC2c4ccccc4-c4ccccc42)C3C(=O)Nc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)CC1"}, "reference": {"title": "AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2", "authors": "Narjes, Frank; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.", "doi": "10.1021/acs.jmedchem.1c01197", "raw": "AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2 | Narjes, Frank; et al | Journal of Medicinal Chemistry (2021), 64(18), 13807-13829. | 10.1021/acs.jmedchem.1c01197"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-31159925", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors", "By: Ma, Chunhua; et al", "Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.", "10.1021/acs.jmedchem.1c01559"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 33252-32-3 + 2557171-64-7 | PRO: 2557173-60-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2\", \"authors\": \"Narjes, Frank; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31159925\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 2 h, rt\", \"437. Scheme 437 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors\", \"By: Ma, Chunhua; et al\", \"Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.\", \"10.1021/acs.jmedchem.1c01559\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"33252-32-3\", \"2557171-64-7\"], \"pro_cas\": [\"2557173-60-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["33252-32-3", "2557171-64-7"], "products": ["2557173-60-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31168962", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 4.5, "yield_pct": 100.0}, "smiles": {"reactants": "Cc1cc2cc(Br)cc(C(=O)O)c2o1.CN", "products": "CNC(=O)c1cc(Br)cc2cc(C)oc12"}, "reference": {"title": "Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow", "authors": "Alder, Catherine M.; et al", "citation": "Organic Process Research & Development (2022), 26(2), 365-379.", "doi": "10.1021/acs.oprd.1c00422", "raw": "Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow | Alder, Catherine M.; et al | Organic Process Research & Development (2022), 26(2), 365-379. | 10.1021/acs.oprd.1c00422"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-31168962", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C; 2 h, 0 °C; 2 h, 0 °C", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dichloromethane, Tetrahydrofuran; 30 min, 0 °C", "Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways", "By: Kandasamy, Pachamuthu; et al", "Journal of Medicinal Chemistry (2023), 66(4), 2506-2523.", "10.1021/acs.jmedchem.2c01337"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9", "cond_sig": "d17ab3c9", "fam_sig": "a7f7dfc8"}, "raw_data": {"raw_cas": "RCT: 3903-40-0 + 175724-30-8 | PRO: 1551527-33-3 | RGT: 79-37-8 + 7087-68-5 | CAT: 68-12-2 | SOL: 75-09-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow\", \"authors\": \"Alder, Catherine M.; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(2), 365-379.\", \"reagents\": [\"Oxalyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31168962\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C; 2 h, 0 °C; 2 h, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dichloromethane, Tetrahydrofuran; 30 min, 0 °C\", \"216. Scheme 216 (1 Reaction)\", \"Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways\", \"By: Kandasamy, Pachamuthu; et al\", \"Journal of Medicinal Chemistry (2023), 66(4), 2506-2523.\", \"10.1021/acs.jmedchem.2c01337\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3903-40-0\", \"175724-30-8\"], \"pro_cas\": [\"1551527-33-3\"], \"rgt_cas\": [\"79-37-8\", \"7087-68-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"109-99-9\"], \"notes\": [\"incremental addition of agent and catalyst in stage 1\"]}}", "enriched_names": {"reactants": ["3903-40-0", "175724-30-8"], "products": ["1551527-33-3"], "reagents": ["79-37-8", "N,N-Diisopropylethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31168985", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 80.0}, "smiles": {"reactants": "Cl.N[C@@H]1[C@H]2COC[C@@H]12.CNC(=O)c1cc(C(=O)O)cc2c1O[C@H](CF)[C@H]2c1ccccc1", "products": "CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1"}, "reference": {"title": "Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow", "authors": "Alder, Catherine M.; et al", "citation": "Organic Process Research & Development (2022), 26(2), 365-379.", "doi": "10.1021/acs.oprd.1c00422", "raw": "Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow | Alder, Catherine M.; et al | Organic Process Research & Development (2022), 26(2), 365-379. | 10.1021/acs.oprd.1c00422"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31168985", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 16 h, rt", "Absolute stereochemistry shown", "Relative stereochemistry shown", "Absolute stereochemistry shown", "GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family", "By: Preston, Alex; et al", "ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587.", "10.1021/acsmedchemlett.0c00247"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 1048962-49-7 + 2138475-04-2 | PRO: 2138473-38-6 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow\", \"authors\": \"Alder, Catherine M.; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(2), 365-379.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31168985\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 16 h, rt\", \"317. Scheme 317 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Relative stereochemistry shown\", \"Absolute stereochemistry shown\", \"GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family\", \"By: Preston, Alex; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(8), 1581-1587.\", \"10.1021/acsmedchemlett.0c00247\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1048962-49-7\", \"2138475-04-2\"], \"pro_cas\": [\"2138473-38-6\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["1048962-49-7", "2138475-04-2"], "products": ["2138473-38-6"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31186582", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 93.0}, "smiles": {"reactants": "COc1cc(F)cc([C@H](N)CO)c1.Cl.COc1cc(Nc2ncc(Cl)c(-c3ccc4c(c3)C(=O)N([C@H](C)C(=O)O)C4)n2)ccn1", "products": "COc1cc(F)cc([C@@H](CO)NC(=O)[C@@H](C)N2Cc3ccc(-c4nc(Nc5ccnc(OC)c5)ncc4Cl)cc3C2=O)c1"}, "reference": {"title": "Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2", "authors": "Heightman, Tom D.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12286-12303.", "doi": "10.1021/acs.jmedchem.1c00905", "raw": "Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 | Heightman, Tom D.; et al | Journal of Medicinal Chemistry (2021), 64(16), 12286-12303. | 10.1021/acs.jmedchem.1c00905"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-31186582", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 1 h, rt", "Absolute stereochemistry shown", "Relative stereochemistry shown", "Absolute stereochemistry shown", "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.", "10.1021/acs.jmedchem.3c02183"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2", "cond_sig": "7dec0139", "fam_sig": "3e568a1e"}, "raw_data": {"raw_cas": "RCT: 2787516-56-5 + 2787517-22-8 | PRO: 2787520-36-7 | RGT: 7087-68-5 + 125700-67-6 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2\", \"authors\": \"Heightman, Tom D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12286-12303.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31186582\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"444. Scheme 444 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Relative stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.\", \"10.1021/acs.jmedchem.3c02183\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2787516-56-5\", \"2787517-22-8\"], \"pro_cas\": [\"2787520-36-7\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"regioselective\"]}}", "enriched_names": {"reactants": ["2787516-56-5", "2787517-22-8"], "products": ["2787520-36-7"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31186652", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.083, "yield_pct": 81.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)cn(C)c1=O.NCC(c1ccccc1)c1ccccc1", "products": "Cc1cc(C(=O)NCC(c2ccccc2)c2ccccc2)cn(C)c1=O"}, "reference": {"title": "Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit", "authors": "Rianjongdee, Francesco; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(15), 10806-10833.", "doi": "10.1021/acs.jmedchem.1c00412", "raw": "Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit | Rianjongdee, Francesco; et al | Journal of Medicinal Chemistry (2021), 64(15), 10806-10833. | 10.1021/acs.jmedchem.1c00412"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31186652", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 5 min, rt", "1.2|1 h, rt", "Development and in-vitro Profiling of Dual FXR/LTA4H Modulators", "By: Schierle, Simone; et al", "ChemMedChem (2021), 16(15), 2366-2374.", "10.1002/cmdc.202100118"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 99-09-2 + 30762-07-3 | PRO: 2762795-92-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit\", \"authors\": \"Rianjongdee, Francesco; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(15), 10806-10833.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31186652\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 5 min, rt\", \"1.2\", \"1 h, rt\", \"252. Scheme 252 (1 Reaction)\", \"Development and in-vitro Profiling of Dual FXR/LTA4H Modulators\", \"By: Schierle, Simone; et al\", \"ChemMedChem (2021), 16(15), 2366-2374.\", \"10.1002/cmdc.202100118\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"99-09-2\", \"30762-07-3\"], \"pro_cas\": [\"2762795-92-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["99-09-2", "30762-07-3"], "products": ["2762795-92-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.059792", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31187992", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 3.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.Cl.NCCc1c[nH]c2ccccc12", "products": "O=C(NCCc1c[nH]c2ccccc12)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31187992", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders", "By: Turdi, Huji; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14773-14792.", "10.1021/acs.jmedchem.1c01356"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 21743-75-9 + 1441058-04-3 | PRO: 3035755-54-2 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31187992\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"142. Scheme 142 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders\", \"By: Turdi, Huji; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14773-14792.\", \"10.1021/acs.jmedchem.1c01356\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"21743-75-9\", \"1441058-04-3\"], \"pro_cas\": [\"3035755-54-2\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["21743-75-9", "1441058-04-3"], "products": ["3035755-54-2"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31187995", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 4.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.NCCC(N)=O", "products": "NC(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-31187995", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 306935-74-0 + 40615-17-6 | PRO: 2416338-32-2 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31187995\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"450. Scheme 450 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"306935-74-0\", \"40615-17-6\"], \"pro_cas\": [\"2416338-32-2\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["306935-74-0", "40615-17-6"], "products": ["2416338-32-2"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188001", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 3.0, "yield_pct": 97.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.Nc1ccccc1", "products": "O=C(Nc1ccccc1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-31188001", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma", "By: Morelli, Maria Beatrice; et al", "Journal of Medicinal Chemistry (2024), 67(11), 9662-9685.", "10.1021/acs.jmedchem.4c00821"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 768-94-5 + 331943-38-5 | PRO: 2820409-56-9 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188001\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"354. Scheme 354 (1 Reaction)\", \"Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma\", \"By: Morelli, Maria Beatrice; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 9662-9685.\", \"10.1021/acs.jmedchem.4c00821\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"768-94-5\", \"331943-38-5\"], \"pro_cas\": [\"2820409-56-9\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["768-94-5", "331943-38-5"], "products": ["2820409-56-9"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188010", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 3.0, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)CCN.Cl", "products": "COC(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-31188010", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors", "By: Wiedemeyer, Simon J. A.; et al", "ChemMedChem (2023), 18(6), e202200632.", "10.1002/cmdc.202200632"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 33305-77-0 + 1417694-17-7 | PRO: 3055540-36-5 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188010\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"12. Scheme 12 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors\", \"By: Wiedemeyer, Simon J. A.; et al\", \"ChemMedChem (2023), 18(6), e202200632.\", \"10.1002/cmdc.202200632\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"33305-77-0\", \"1417694-17-7\"], \"pro_cas\": [\"3055540-36-5\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["33305-77-0", "1417694-17-7"], "products": ["3055540-36-5"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188011", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 4.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)CCCN.Cl", "products": "COC(=O)CCCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-31188011", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 36847-89-9 + 40615-17-6 | PRO: 2416338-28-6 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188011\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"19. Scheme 19 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36847-89-9\", \"40615-17-6\"], \"pro_cas\": [\"2416338-28-6\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36847-89-9", "40615-17-6"], "products": ["2416338-28-6"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188013", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 3.0, "yield_pct": 97.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)CC[C@H](N)C(=O)OC.Cl", "products": "COC(=O)CC[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)OC"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-31188013", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups", "By: Corte, James R.; et al", "Journal of Medicinal Chemistry (2020), 63(2), 784-803.", "10.1021/acs.jmedchem.9b01768"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 20626-49-7 + 1329171-26-7 | PRO: 1422387-17-4 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188013\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"132. Scheme 132 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups\", \"By: Corte, James R.; et al\", \"Journal of Medicinal Chemistry (2020), 63(2), 784-803.\", \"10.1021/acs.jmedchem.9b01768\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"20626-49-7\", \"1329171-26-7\"], \"pro_cas\": [\"1422387-17-4\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["20626-49-7", "1329171-26-7"], "products": ["1422387-17-4"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188014", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 3.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2.COC(=O)C(N)Cc1ccccc1.Cl", "products": "COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31188014", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation", "By: Fioravanti, Rossella; et al", "ChemMedChem (2020), 15(7), 643-658.", "10.1002/cmdc.201900730"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 1642574-87-5 + 2414144-46-8 | PRO: 2414142-57-5 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188014\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"110. Scheme 110 (1 Reaction)\", \"Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation\", \"By: Fioravanti, Rossella; et al\", \"ChemMedChem (2020), 15(7), 643-658.\", \"10.1002/cmdc.201900730\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1642574-87-5\", \"2414144-46-8\"], \"pro_cas\": [\"2414142-57-5\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1642574-87-5", "2414144-46-8"], "products": ["2414142-57-5"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188036", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 3.0, "yield_pct": 99.0}, "smiles": {"reactants": "Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(C(=O)O)cc1C2=O.COC(=O)CCN", "products": "COC(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3N)cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-31188036", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|1 h, 50 °C", "1.3|Reagents: Water", "Design and synthesis of novel cereblon binders for use in targeted protein degradation", "By: Norris, Stephen; et al", "Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.", "10.1021/acs.jmedchem.3c01848"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "49f62d62", "fam_sig": "83aa71fe"}, "raw_data": {"raw_cas": "RCT: 2353-44-8 + 33233-67-9 | PRO: 2946672-64-4 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188036\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"387. Scheme 387 (1 Reaction)\", \"Design and synthesis of novel cereblon binders for use in targeted protein degradation\", \"By: Norris, Stephen; et al\", \"Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.\", \"10.1021/acs.jmedchem.3c01848\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2353-44-8\", \"33233-67-9\"], \"pro_cas\": [\"2946672-64-4\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2353-44-8", "33233-67-9"], "products": ["2946672-64-4"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188048", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 50.0, "time_h": 3.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3[N+](=O)[O-])cc1CC2.CN", "products": "CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3[N+](=O)[O-])cc1CC2"}, "reference": {"title": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "authors": "Tormaehlen, Niklas M.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.0c01773", "raw": "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors | Tormaehlen, Niklas M.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1225-1242. | 10.1021/acs.jmedchem.0c01773"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-31188048", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 2 h, 50 °C", "1.2|Solvents: Tetrahydrofuran; 1 h, 50 °C", "1.3|Reagents: Water", "Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis", "By: Zhou, Zi-ying; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1742-1760.", "10.1021/acs.jmedchem.2c01377"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Water|7732-18-5/Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9", "cond_sig": "350d891c", "fam_sig": "48590d0d"}, "raw_data": {"raw_cas": "RCT: 50551-61-6 + 56-40-6 | PRO: 2339980-44-6 | RGT: 530-62-1 + 7732-18-5 | SOL: 68-12-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"authors\": \"Tormaehlen, Niklas M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188048\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 2 h, 50 °C\", \"1.2\", \"Solvents: Tetrahydrofuran; 1 h, 50 °C\", \"1.3\", \"Reagents: Water\", \"305. Scheme 305 (1 Reaction)\", \"Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis\", \"By: Zhou, Zi-ying; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1742-1760.\", \"10.1021/acs.jmedchem.2c01377\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"50551-61-6\", \"56-40-6\"], \"pro_cas\": [\"2339980-44-6\"], \"rgt_cas\": [\"530-62-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["50551-61-6", "56-40-6"], "products": ["2339980-44-6"], "reagents": ["N,N'-Carbonyldiimidazole", "Water"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188278", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Chloro-N,N-2-trimethylpropenylamine", "cas": "26189-59-3", "role": "NUC"}, {"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 73.5, "yield_pct": 100.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)O)C1.Nc1cc(Br)ccn1", "products": "CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(Br)ccn2)C1"}, "reference": {"title": "Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies", "authors": "Barlaam, Bernard; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.", "doi": "10.1021/acs.jmedchem.0c01754", "raw": "Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies | Barlaam, Bernard; et al | Journal of Medicinal Chemistry (2020), 63(24), 15564-15590. | 10.1021/acs.jmedchem.0c01754"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-31188278", "1.1|Reagents: 1-Chloro-N,N-2-trimethylpropenylamine", "Solvents: Dichloromethane; 1.5 h, 0 °C", "1.2|Reagents: Pyridine", "Solvents: Dichloromethane; 0 °C → rt; 72 h, rt", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/1-Chloro-N,N-2-trimethylpropenylamine|26189-59-3+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "037fdb92", "fam_sig": "898b2243"}, "raw_data": {"raw_cas": "RCT: 2614241-22-2 + 4138-35-6 | PRO: 2614243-00-2 | RGT: 26189-59-3 + 110-86-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies\", \"authors\": \"Barlaam, Bernard; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.\", \"reagents\": [\"1-Chloro-N,N-2-trimethylpropenylamine\", \"Pyridine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188278\", \"1.1\", \"Reagents: 1-Chloro-N,N-2-trimethylpropenylamine\", \"Solvents: Dichloromethane; 1.5 h, 0 °C\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Dichloromethane; 0 °C → rt; 72 h, rt\", \"386. Scheme 386 (1 Reaction)\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2614241-22-2\", \"4138-35-6\"], \"pro_cas\": [\"2614243-00-2\"], \"rgt_cas\": [\"26189-59-3\", \"110-86-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2614241-22-2", "4138-35-6"], "products": ["2614243-00-2"], "reagents": ["26189-59-3", "Pyridine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31188286", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Chloro-N,N-2-trimethylpropenylamine", "cas": "26189-59-3", "role": "NUC"}, {"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 17.5, "yield_pct": 100.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)O)C1.Nc1cc(Br)c(Cl)cn1", "products": "CC(C)(C)OC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(Br)c(Cl)cn2)C1"}, "reference": {"title": "Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies", "authors": "Barlaam, Bernard; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.", "doi": "10.1021/acs.jmedchem.0c01754", "raw": "Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies | Barlaam, Bernard; et al | Journal of Medicinal Chemistry (2020), 63(24), 15564-15590. | 10.1021/acs.jmedchem.0c01754"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-31188286", "1.1|Reagents: 1-Chloro-N,N-2-trimethylpropenylamine", "Solvents: Dichloromethane; 0 °C; 1.5 h, rt", "1.2|Reagents: Pyridine; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells", "By: Obara, Takahiro; et al", "Bioorganic & Medicinal Chemistry (2024), 108, 117773.", "10.1016/j.bmc.2024.117773"], "signatures": {"cond_key": "none/none/1-Chloro-N,N-2-trimethylpropenylamine|26189-59-3+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "037fdb92", "fam_sig": "898b2243"}, "raw_data": {"raw_cas": "RCT: 3084084-40-9 + 1227203-83-9 | PRO: 3084084-42-1 | RGT: 26189-59-3 + 110-86-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies\", \"authors\": \"Barlaam, Bernard; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.\", \"reagents\": [\"1-Chloro-N,N-2-trimethylpropenylamine\", \"Pyridine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31188286\", \"1.1\", \"Reagents: 1-Chloro-N,N-2-trimethylpropenylamine\", \"Solvents: Dichloromethane; 0 °C; 1.5 h, rt\", \"1.2\", \"Reagents: Pyridine; 16 h, rt\", \"14. Scheme 14 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells\", \"By: Obara, Takahiro; et al\", \"Bioorganic & Medicinal Chemistry (2024), 108, 117773.\", \"10.1016/j.bmc.2024.117773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3084084-40-9\", \"1227203-83-9\"], \"pro_cas\": [\"3084084-42-1\"], \"rgt_cas\": [\"26189-59-3\", \"110-86-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3084084-40-9", "1227203-83-9"], "products": ["3084084-42-1"], "reagents": ["26189-59-3", "Pyridine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31375482", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 75.0, "time_h": 17.0, "yield_pct": 84.0}, "smiles": {"reactants": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.Nc1sc2c(c1C(=O)c1cnn(-c3ccc(Cl)cc3)c1)CCCC2", "products": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCCC3)c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "authors": "Ushiki, Yasunobu; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "doi": "10.1016/j.bmcl.2022.128572", "raw": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors | Ushiki, Yasunobu; et al | Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572. | 10.1016/j.bmcl.2022.128572"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-31375482", "1.1|Reagents: Thionyl chloride", "Solvents: Chloroform; 1 h, 75 °C", "1.2|Reagents: Pyridine", "Solvents: Chloroform; overnight, rt", "1.3|Reagents: Ammonium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "10.1021/acs.jmedchem.3c02184"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Pyridine|110-86-1+Thionyl chloride|7719-09-7/Chloroform|67-66-3+Water|7732-18-5", "cond_sig": "b1ba8879", "fam_sig": "855d9f87"}, "raw_data": {"raw_cas": "RCT: 1211517-48-4 + 2787516-58-7 | PRO: 2787520-04-9 | RGT: 7719-09-7 + 110-86-1 + 12125-02-9 | SOL: 67-66-3 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"authors\": \"Ushiki, Yasunobu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"reagents\": [\"Thionyl chloride\", \"Pyridine\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31375482\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Chloroform; 1 h, 75 °C\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Chloroform; overnight, rt\", \"1.3\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"423. Scheme 423 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"10.1021/acs.jmedchem.3c02184\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1211517-48-4\", \"2787516-58-7\"], \"pro_cas\": [\"2787520-04-9\"], \"rgt_cas\": [\"7719-09-7\", \"110-86-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\", \"7732-18-5\"], \"notes\": [\"inverse addition (stage 2)\"]}}", "enriched_names": {"reactants": ["1211517-48-4", "2787516-58-7"], "products": ["2787520-04-9"], "reagents": ["7719-09-7", "Pyridine", "12125-02-9"], "catalysts": [], "solvents": ["Chloroform", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31375486", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 75.0, "time_h": 18.0, "yield_pct": 94.0}, "smiles": {"reactants": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.CC(=O)N1CCc2c(sc(N)c2C(=O)c2cnn(-c3ccc(Cl)cc3)c2)C1", "products": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCN(C(C)=O)C3)c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "authors": "Ushiki, Yasunobu; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "doi": "10.1016/j.bmcl.2022.128572", "raw": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors | Ushiki, Yasunobu; et al | Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572. | 10.1016/j.bmcl.2022.128572"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-31375486", "1.1|Reagents: Thionyl chloride", "Solvents: Chloroform; 1 h, 75 °C", "1.2|Reagents: Pyridine", "Solvents: Chloroform; overnight, rt", "1.3|Reagents: Ammonium chloride", "Solvents: Water; rt", "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "By: Ushiki, Yasunobu; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "10.1016/j.bmcl.2022.128572"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Pyridine|110-86-1+Thionyl chloride|7719-09-7/Chloroform|67-66-3+Water|7732-18-5", "cond_sig": "b1ba8879", "fam_sig": "855d9f87"}, "raw_data": {"raw_cas": "RCT: 2227446-38-8 + 2227447-97-2 | PRO: 2227446-58-2 | RGT: 7719-09-7 + 110-86-1 + 12125-02-9 | SOL: 67-66-3 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"authors\": \"Ushiki, Yasunobu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"reagents\": [\"Thionyl chloride\", \"Pyridine\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31375486\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Chloroform; 1 h, 75 °C\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Chloroform; overnight, rt\", \"1.3\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"429. Scheme 429 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"By: Ushiki, Yasunobu; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"10.1016/j.bmcl.2022.128572\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2227446-38-8\", \"2227447-97-2\"], \"pro_cas\": [\"2227446-58-2\"], \"rgt_cas\": [\"7719-09-7\", \"110-86-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\", \"7732-18-5\"], \"notes\": [\"inverse addition (stage 2)\"]}}", "enriched_names": {"reactants": ["2227446-38-8", "2227447-97-2"], "products": ["2227446-58-2"], "reagents": ["7719-09-7", "Pyridine", "12125-02-9"], "catalysts": [], "solvents": ["Chloroform", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.061795", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31375489", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 75.0, "time_h": 17.0, "yield_pct": 100.0}, "smiles": {"reactants": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.CS(=O)(=O)N1CCc2c(sc(N)c2C(=O)c2cnn(-c3ccc(Cl)cc3)c2)C1", "products": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCN(S(C)(=O)=O)C3)c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "authors": "Ushiki, Yasunobu; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "doi": "10.1016/j.bmcl.2022.128572", "raw": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors | Ushiki, Yasunobu; et al | Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572. | 10.1016/j.bmcl.2022.128572"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-31375489", "1.1|Reagents: Thionyl chloride", "Solvents: Chloroform; 1 h, 75 °C", "1.2|Reagents: Pyridine", "Solvents: Chloroform; overnight, rt", "1.3|Reagents: Ammonium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2", "By: Heightman, Tom D.; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12286-12303.", "10.1021/acs.jmedchem.1c00905"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Pyridine|110-86-1+Thionyl chloride|7719-09-7/Chloroform|67-66-3+Water|7732-18-5", "cond_sig": "b1ba8879", "fam_sig": "855d9f87"}, "raw_data": {"raw_cas": "RCT: 2095692-22-9 + 2095725-95-2 | PRO: 2095720-08-2 | RGT: 7719-09-7 + 110-86-1 + 12125-02-9 | SOL: 67-66-3 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"authors\": \"Ushiki, Yasunobu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"reagents\": [\"Thionyl chloride\", \"Pyridine\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31375489\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Chloroform; 1 h, 75 °C\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Chloroform; overnight, rt\", \"1.3\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"443. Scheme 443 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2\", \"By: Heightman, Tom D.; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12286-12303.\", \"10.1021/acs.jmedchem.1c00905\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2095692-22-9\", \"2095725-95-2\"], \"pro_cas\": [\"2095720-08-2\"], \"rgt_cas\": [\"7719-09-7\", \"110-86-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\", \"7732-18-5\"], \"notes\": [\"inverse addition (stage 2)\"]}}", "enriched_names": {"reactants": ["2095692-22-9", "2095725-95-2"], "products": ["2095720-08-2"], "reagents": ["7719-09-7", "Pyridine", "12125-02-9"], "catalysts": [], "solvents": ["Chloroform", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.063798", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31375495", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 75.0, "time_h": 17.0, "yield_pct": 100.0}, "smiles": {"reactants": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)O)c1.Cl.Nc1sc2c(c1C(=O)c1cnn(-c3ccc(Cl)cc3)c1)CCN(C1CC1)C2", "products": "CCC(CC)N(CCN(C)C(=O)CCC(=O)OCc1ccccc1)Cc1cccc(C(=O)Nc2sc3c(c2C(=O)c2cnn(-c4ccc(Cl)cc4)c2)CCN(C2CC2)C3)c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "authors": "Ushiki, Yasunobu; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "doi": "10.1016/j.bmcl.2022.128572", "raw": "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors | Ushiki, Yasunobu; et al | Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572. | 10.1016/j.bmcl.2022.128572"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-31375495", "1.1|Reagents: Thionyl chloride", "Solvents: Chloroform; 1 h, 75 °C", "1.2|Reagents: Pyridine", "Solvents: Chloroform; overnight, rt", "1.3|Reagents: Ammonium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate", "By: Critcher, Douglas J.; et al", "Organic Process Research & Development (2024), 28(7), 2646-2658.", "10.1021/acs.oprd.4c00049"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Pyridine|110-86-1+Thionyl chloride|7719-09-7/Chloroform|67-66-3+Water|7732-18-5", "cond_sig": "b1ba8879", "fam_sig": "855d9f87"}, "raw_data": {"raw_cas": "RCT: 1437323-26-6 + 3034305-43-3 | PRO: 2412356-57-9 | RGT: 7719-09-7 + 110-86-1 + 12125-02-9 | SOL: 67-66-3 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"authors\": \"Ushiki, Yasunobu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"reagents\": [\"Thionyl chloride\", \"Pyridine\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31375495\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Chloroform; 1 h, 75 °C\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Chloroform; overnight, rt\", \"1.3\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"430. Scheme 430 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate\", \"By: Critcher, Douglas J.; et al\", \"Organic Process Research & Development (2024), 28(7), 2646-2658.\", \"10.1021/acs.oprd.4c00049\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1437323-26-6\", \"3034305-43-3\"], \"pro_cas\": [\"2412356-57-9\"], \"rgt_cas\": [\"7719-09-7\", \"110-86-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\", \"7732-18-5\"], \"notes\": [\"inverse addition (stage 2)\"]}}", "enriched_names": {"reactants": ["1437323-26-6", "3034305-43-3"], "products": ["2412356-57-9"], "reagents": ["7719-09-7", "Pyridine", "12125-02-9"], "catalysts": [], "solvents": ["Chloroform", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.063798", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31381010", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 90.0}, "smiles": {"reactants": "COC[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)[C@@H](N)CSC.Cl", "products": "COC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](CSC)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31381010", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "By: Sarkar, Dipayan; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "10.1021/acs.jmedchem.3c01431"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 616-79-5 + 109-85-3 | PRO: 1275562-02-1 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31381010\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"91. Scheme 91 (1 Reaction)\", \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"By: Sarkar, Dipayan; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"10.1021/acs.jmedchem.3c01431\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"616-79-5\", \"109-85-3\"], \"pro_cas\": [\"1275562-02-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["616-79-5", "109-85-3"], "products": ["1275562-02-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.063798", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31382127", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 5.0, "yield_pct": 93.0}, "smiles": {"reactants": "COC(=O)c1ccc(CN)cc1.Cl.CC(C)(C)OC(=O)NC1CCC(C(=O)O)CC1", "products": "COC(=O)c1ccc(CNC(=O)C2CCC(NC(=O)OC(C)(C)C)CC2)cc1"}, "reference": {"title": "Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT)", "authors": "Ding, Yun; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 41, 116216.", "doi": "10.1016/j.bmc.2021.116216", "raw": "Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT) | Ding, Yun; et al | Bioorganic & Medicinal Chemistry (2021), 41, 116216. | 10.1016/j.bmc.2021.116216"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-31382127", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 2 h, 0 °C; 3 h, rt", "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "By: Hiesinger, Kerstin; et al", "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "10.1021/acs.jmedchem.0c00561"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "4d85b4e8", "fam_sig": "964a70b8"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 2709014-52-6 | PRO: 2709014-24-2 | RGT: 7087-68-5 + 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT)\", \"authors\": \"Ding, Yun; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 41, 116216.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31382127\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 2 h, 0 °C; 3 h, rt\", \"220. Scheme 220 (1 Reaction)\", \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"By: Hiesinger, Kerstin; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"10.1021/acs.jmedchem.0c00561\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"2709014-52-6\"], \"pro_cas\": [\"2709014-24-2\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "2709014-52-6"], "products": ["2709014-24-2"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.063798", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31442449", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "2-Methyltetrahydrofuran", "cas": "96-47-9"}], "conditions": {"temperature_c": 60.0, "time_h": 16.5, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccncc1.Nc1ccccc1", "products": "O=C(Nc1ccccc1)c1ccncc1"}, "reference": {"title": "Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase", "authors": "Bagal, Sharan K.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(23), 17146-17183.", "doi": "10.1021/acs.jmedchem.1c01161", "raw": "Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase | Bagal, Sharan K.; et al | Journal of Medicinal Chemistry (2021), 64(23), 17146-17183. | 10.1021/acs.jmedchem.1c01161"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31442449", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: 2-Methyltetrahydrofuran; 25 °C; 30 min, 60 °C; 16 h, 60 °C", "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "By: Li, Bing-yan; et al", "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "10.1021/acs.jmedchem.3c02407"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/2-Methyltetrahydrofuran|96-47-9", "cond_sig": "a8ef00c6", "fam_sig": "587291c9"}, "raw_data": {"raw_cas": "RCT: 6232-88-8 + 109-73-9 | PRO: 118507-19-0 | RGT: 530-62-1 | SOL: 96-47-9", "raw_data_json": "{\"txt\": {\"title\": \"Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase\", \"authors\": \"Bagal, Sharan K.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(23), 17146-17183.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"2-Methyltetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31442449\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: 2-Methyltetrahydrofuran; 25 °C; 30 min, 60 °C; 16 h, 60 °C\", \"12. Scheme 12 (1 Reaction)\", \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"By: Li, Bing-yan; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"10.1021/acs.jmedchem.3c02407\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6232-88-8\", \"109-73-9\"], \"pro_cas\": [\"118507-19-0\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"96-47-9\"], \"notes\": [\"reaction conducted in the presence of air\"]}}", "enriched_names": {"reactants": ["6232-88-8", "109-73-9"], "products": ["118507-19-0"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["2-Methyltetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.063798", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31446392", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)OCc1ccccc1", "products": "CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OCc1ccccc1"}, "reference": {"title": "Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease", "authors": "Lee, Min Jae; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(15), 10934-10950.", "doi": "10.1021/acs.jmedchem.1c00291", "raw": "Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease | Lee, Min Jae; et al | Journal of Medicinal Chemistry (2021), 64(15), 10934-10950. | 10.1021/acs.jmedchem.1c00291"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31446392", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction", "By: Si, Ru; et al", "European Journal of Medicinal Chemistry (2023), 257, 115497.", "10.1016/j.ejmech.2023.115497"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "9b6b8417", "fam_sig": "584485f1"}, "raw_data": {"raw_cas": "RCT: 2067-33-6 + 1448297-52-6 | PRO: 2162120-79-6 | RGT: 2592-95-2 + 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease\", \"authors\": \"Lee, Min Jae; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(15), 10934-10950.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31446392\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; overnight, rt\", \"239. Scheme 239 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction\", \"By: Si, Ru; et al\", \"European Journal of Medicinal Chemistry (2023), 257, 115497.\", \"10.1016/j.ejmech.2023.115497\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2067-33-6\", \"1448297-52-6\"], \"pro_cas\": [\"2162120-79-6\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2067-33-6", "1448297-52-6"], "products": ["2162120-79-6"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.063798", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31490957", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "4-(Dimethylamino)pyridine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 12.0, "yield_pct": 80.0}, "smiles": {"reactants": "Nc1cccc([N+](=O)[O-])c1.O=C(O)c1ccc(OCCCc2ccccc2)cc1", "products": "O=C(Nc1cccc([N+](=O)[O-])c1)c1ccc(OCCCc2ccccc2)cc1"}, "reference": {"title": "Development and in-vitro Profiling of Dual FXR/LTA4H Modulators", "authors": "Schierle, Simone; et al", "citation": "ChemMedChem (2021), 16(15), 2366-2374.", "doi": "10.1002/cmdc.202100118", "raw": "Development and in-vitro Profiling of Dual FXR/LTA4H Modulators | Schierle, Simone; et al | ChemMedChem (2021), 16(15), 2366-2374. | 10.1002/cmdc.202100118"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31490957", "1.1|Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Chloroform, Dimethylformamide; 12 h, 50 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+4-(Dimethylamino)pyridine|+4-Dimethylaminopyridine|1122-58-3/Chloroform|67-66-3+Dimethylformamide|68-12-2", "cond_sig": "30883b9f", "fam_sig": "a2a8d594"}, "raw_data": {"raw_cas": "RCT: 3405-77-4 + 2760538-75-6 | PRO: 2760538-88-1 | RGT: 1122-58-3 + 25952-53-8 | SOL: 67-66-3 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development and in-vitro Profiling of Dual FXR/LTA4H Modulators\", \"authors\": \"Schierle, Simone; et al\", \"citation\": \"ChemMedChem (2021), 16(15), 2366-2374.\", \"reagents\": [\"4-(Dimethylamino)pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31490957\", \"1.1\", \"Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Chloroform, Dimethylformamide; 12 h, 50 °C\", \"253. Scheme 253 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3405-77-4\", \"2760538-75-6\"], \"pro_cas\": [\"2760538-88-1\"], \"rgt_cas\": [\"1122-58-3\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3405-77-4", "2760538-75-6"], "products": ["2760538-88-1"], "reagents": ["4-Dimethylaminopyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Chloroform", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.063798", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31490959", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "4-(Dimethylamino)pyridine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 12.0, "yield_pct": 80.0}, "smiles": {"reactants": "CCOC(=O)c1ccc(N)cc1.O=C(O)c1ccc(OCCCc2ccccc2)cc1", "products": "CCOC(=O)c1ccc(NC(=O)c2ccc(OCCCc3ccccc3)cc2)cc1"}, "reference": {"title": "Development and in-vitro Profiling of Dual FXR/LTA4H Modulators", "authors": "Schierle, Simone; et al", "citation": "ChemMedChem (2021), 16(15), 2366-2374.", "doi": "10.1002/cmdc.202100118", "raw": "Development and in-vitro Profiling of Dual FXR/LTA4H Modulators | Schierle, Simone; et al | ChemMedChem (2021), 16(15), 2366-2374. | 10.1002/cmdc.202100118"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31490959", "1.1|Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Chloroform, Dimethylformamide; 12 h, 50 °C", "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "By: Amblard, Franck; et al", "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "10.1016/j.bmc.2020.115952"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+4-(Dimethylamino)pyridine|+4-Dimethylaminopyridine|1122-58-3/Chloroform|67-66-3+Dimethylformamide|68-12-2", "cond_sig": "30883b9f", "fam_sig": "a2a8d594"}, "raw_data": {"raw_cas": "RCT: 3863-11-4 + 6973-60-0 | PRO: 1388765-64-7 | RGT: 1122-58-3 + 25952-53-8 | SOL: 67-66-3 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development and in-vitro Profiling of Dual FXR/LTA4H Modulators\", \"authors\": \"Schierle, Simone; et al\", \"citation\": \"ChemMedChem (2021), 16(15), 2366-2374.\", \"reagents\": [\"4-(Dimethylamino)pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31490959\", \"1.1\", \"Reagents: 4-(Dimethylamino)pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Chloroform, Dimethylformamide; 12 h, 50 °C\", \"205. Scheme 205 (1 Reaction)\", \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"By: Amblard, Franck; et al\", \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"10.1016/j.bmc.2020.115952\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3863-11-4\", \"6973-60-0\"], \"pro_cas\": [\"1388765-64-7\"], \"rgt_cas\": [\"1122-58-3\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3863-11-4", "6973-60-0"], "products": ["1388765-64-7"], "reagents": ["4-Dimethylaminopyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Chloroform", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.064803", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31495546", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,3-Dimethyl-2-imidazolidinone", "cas": "80-73-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 30.0, "time_h": 1.5, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1cnc(C(F)F)cn1.C[C@H]1OC[C@]2(c3cc(N)ccc3F)N=C(N)SC[C@H]12", "products": "C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12"}, "reference": {"title": "Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition Following Process Risk Mitigation Strategy", "authors": "Kim, Dae-Shik; et al", "citation": "Organic Process Research & Development (2022), 26(3), 804-816.", "doi": "10.1021/acs.oprd.1c00223", "raw": "Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition Following Process Risk Mitigation Strategy | Kim, Dae-Shik; et al | Organic Process Research & Development (2022), 26(3), 804-816. | 10.1021/acs.oprd.1c00223"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-31495546", "1.1|Reagents: Thionyl chloride", "Solvents: 1,3-Dimethyl-2-imidazolidinone, Water; < 10 °C; 4 - 10 °C; 10 °C → 0 °C; < 5 °C; 0.5 h, 15 - 20 °C", "1.2|Reagents: Sodium hydroxide", "Solvents: Water; > pH 10, < 30 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors", "By: Ma, Chunhua; et al", "Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.", "10.1021/acs.jmedchem.1c01559"], "signatures": {"cond_key": "none/none/NaOH|1310-73-2+Sodium hydroxide|+Thionyl chloride|7719-09-7/1,3-Dimethyl-2-imidazolidinone|80-73-9+Water|7732-18-5", "cond_sig": "8c7cc655", "fam_sig": "4c696dca"}, "raw_data": {"raw_cas": "RCT: 504-29-0 + 2557169-11-4 | PRO: 2557169-12-5 | RGT: 7719-09-7 + 1310-73-2 | SOL: 80-73-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition Following Process Risk Mitigation Strategy\", \"authors\": \"Kim, Dae-Shik; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(3), 804-816.\", \"reagents\": [\"Thionyl chloride\", \"Sodium hydroxide\"], \"catalysts\": [], \"solvents\": [\"1,3-Dimethyl-2-imidazolidinone\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31495546\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: 1,3-Dimethyl-2-imidazolidinone, Water; < 10 °C; 4 - 10 °C; 10 °C → 0 °C; < 5 °C; 0.5 h, 15 - 20 °C\", \"1.2\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; > pH 10, < 30 °C\", \"427. Scheme 427 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors\", \"By: Ma, Chunhua; et al\", \"Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.\", \"10.1021/acs.jmedchem.1c01559\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"504-29-0\", \"2557169-11-4\"], \"pro_cas\": [\"2557169-12-5\"], \"rgt_cas\": [\"7719-09-7\", \"1310-73-2\"], \"cat_cas\": [], \"sol_cas\": [\"80-73-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["504-29-0", "2557169-11-4"], "products": ["2557169-12-5"], "reagents": ["7719-09-7", "NaOH"], "catalysts": [], "solvents": ["80-73-9", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.064803", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31497669", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -20.0, "time_h": 12.5, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)/C=C/c1ccccc1.COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)/C=C/c1ccccc1"}, "reference": {"title": "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2", "authors": "Dai, Wenhao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.", "doi": "10.1021/acs.jmedchem.0c02258", "raw": "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2 | Dai, Wenhao; et al | Journal of Medicinal Chemistry (2022), 65(4), 2794-2808. | 10.1021/acs.jmedchem.0c02258"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31497669", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, -20 °C", "1.2|Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 89-86-1 + 772318-79-3 | PRO: 2892016-31-6 | RGT: 148893-10-1 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2\", \"authors\": \"Dai, Wenhao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31497669\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, -20 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C\", \"65. Scheme 65 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"89-86-1\", \"772318-79-3\"], \"pro_cas\": [\"2892016-31-6\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["89-86-1", "772318-79-3"], "products": ["2892016-31-6"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.064803", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31497680", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -20.0, "time_h": 12.5, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.COC(=O)[C@@H](N)C[C@@H]1CCNC1=O.Cl", "products": "COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2", "authors": "Dai, Wenhao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.", "doi": "10.1021/acs.jmedchem.0c02258", "raw": "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2 | Dai, Wenhao; et al | Journal of Medicinal Chemistry (2022), 65(4), 2794-2808. | 10.1021/acs.jmedchem.0c02258"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31497680", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, -20 °C", "1.2|Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain", "By: Hartz, Richard A.; et al", "Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.", "10.1021/acs.jmedchem.1c00472"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 16937-99-8 + 267648-14-6 | PRO: 1644249-91-1 | RGT: 148893-10-1 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2\", \"authors\": \"Dai, Wenhao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31497680\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, -20 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C\", \"93. Scheme 93 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain\", \"By: Hartz, Richard A.; et al\", \"Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.\", \"10.1021/acs.jmedchem.1c00472\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"16937-99-8\", \"267648-14-6\"], \"pro_cas\": [\"1644249-91-1\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["16937-99-8", "267648-14-6"], "products": ["1644249-91-1"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.065696", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31497747", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -20.0, "time_h": 12.5, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C"}, "reference": {"title": "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2", "authors": "Dai, Wenhao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.", "doi": "10.1021/acs.jmedchem.0c02258", "raw": "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2 | Dai, Wenhao; et al | Journal of Medicinal Chemistry (2022), 65(4), 2794-2808. | 10.1021/acs.jmedchem.0c02258"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31497747", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, -20 °C", "1.2|Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer", "By: Sun, Li-ping; et al", "Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.", "10.1021/acs.jmedchem.3c01210"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 623-04-1 + 159858-21-6 | PRO: 159858-22-7 | RGT: 148893-10-1 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2\", \"authors\": \"Dai, Wenhao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31497747\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, -20 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; -20 °C; 12 h, -20 °C\", \"185. Scheme 185 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer\", \"By: Sun, Li-ping; et al\", \"Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.\", \"10.1021/acs.jmedchem.3c01210\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"623-04-1\", \"159858-21-6\"], \"pro_cas\": [\"159858-22-7\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["623-04-1", "159858-21-6"], "products": ["159858-22-7"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.065696", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31510779", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 93.0}, "smiles": {"reactants": "N#CCN.COc1ccc(-c2ccc(C(=O)N(CC(=O)O)Cc3ccccc3)cc2)cc1", "products": "COc1ccc(-c2ccc(C(=O)N(CC(=O)NCC#N)Cc3ccccc3)cc2)cc1"}, "reference": {"title": "Nitrile-based peptoids as cysteine protease inhibitors", "authors": "Alves, Luana; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 41, 116211.", "doi": "10.1016/j.bmc.2021.116211", "raw": "Nitrile-based peptoids as cysteine protease inhibitors | Alves, Luana; et al | Bioorganic & Medicinal Chemistry (2021), 41, 116211. | 10.1016/j.bmc.2021.116211"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-31510779", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 16 h, rt", "Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing", "By: Li, Derun; et al", "Journal of Medicinal Chemistry (2022), 65(8), 6001-6016.", "10.1021/acs.jmedchem.1c01670"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 371-40-4 + 1393585-20-0 | PRO: 2306411-45-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Nitrile-based peptoids as cysteine protease inhibitors\", \"authors\": \"Alves, Luana; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 41, 116211.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31510779\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"245. Scheme 245 (1 Reaction)\", \"Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing\", \"By: Li, Derun; et al\", \"Journal of Medicinal Chemistry (2022), 65(8), 6001-6016.\", \"10.1021/acs.jmedchem.1c01670\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"371-40-4\", \"1393585-20-0\"], \"pro_cas\": [\"2306411-45-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["371-40-4", "1393585-20-0"], "products": ["2306411-45-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.065696", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31510782", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 94.0}, "smiles": {"reactants": "N#CC1(N)CC1.COc1ccc(-c2ccc(C(=O)N(CC(=O)O)Cc3ccccc3)cc2)cc1", "products": "COc1ccc(-c2ccc(C(=O)N(CC(=O)NC3(C#N)CC3)Cc3ccccc3)cc2)cc1"}, "reference": {"title": "Nitrile-based peptoids as cysteine protease inhibitors", "authors": "Alves, Luana; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 41, 116211.", "doi": "10.1016/j.bmc.2021.116211", "raw": "Nitrile-based peptoids as cysteine protease inhibitors | Alves, Luana; et al | Bioorganic & Medicinal Chemistry (2021), 41, 116211. | 10.1016/j.bmc.2021.116211"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-31510782", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 16 h, rt", "Design, synthesis, and in vitro protective effect evaluation of α-carboline derivatives against H2O2-induced cardiomyocyte injury", "By: Zhang, Rong-Hong; et al", "European Journal of Medicinal Chemistry (2022), 238, 114469.", "10.1016/j.ejmech.2022.114469"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 74-89-5 + 2240180-14-5 | PRO: 2775380-44-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Nitrile-based peptoids as cysteine protease inhibitors\", \"authors\": \"Alves, Luana; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 41, 116211.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31510782\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"331. Scheme 331 (1 Reaction)\", \"Design, synthesis, and in vitro protective effect evaluation of α-carboline derivatives against H2O2-induced cardiomyocyte injury\", \"By: Zhang, Rong-Hong; et al\", \"European Journal of Medicinal Chemistry (2022), 238, 114469.\", \"10.1016/j.ejmech.2022.114469\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"74-89-5\", \"2240180-14-5\"], \"pro_cas\": [\"2775380-44-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["74-89-5", "2240180-14-5"], "products": ["2775380-44-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.065696", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31542322", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 23.0, "time_h": 2.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1ccc(Cl)cc1C(F)(F)F.C[C@H](N)C1CC1", "products": "C[C@H](NC(=O)c1ccc(Cl)cc1C(F)(F)F)C1CC1"}, "reference": {"title": "Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)", "authors": "Mata, Guillaume; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1418-1444.", "doi": "10.1021/acs.jmedchem.1c01153", "raw": "Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ) | Mata, Guillaume; et al | Journal of Medicinal Chemistry (2022), 65(2), 1418-1444. | 10.1021/acs.jmedchem.1c01153"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31542322", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, 23 °C", "1.2|Reagents: Ammonium chloride", "Solvents: Water", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "By: Abram, Michal; et al", "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "10.1021/acs.jmedchem.2c00534"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "eb9a32e6", "fam_sig": "5f51edc3"}, "raw_data": {"raw_cas": "RCT: 7764-95-6 + 89-99-6 | PRO: 2506368-03-0 | RGT: 7087-68-5 + 148893-10-1 + 12125-02-9 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)\", \"authors\": \"Mata, Guillaume; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1418-1444.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31542322\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, 23 °C\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water\", \"124. Scheme 124 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"By: Abram, Michal; et al\", \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"10.1021/acs.jmedchem.2c00534\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7764-95-6\", \"89-99-6\"], \"pro_cas\": [\"2506368-03-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["7764-95-6", "89-99-6"], "products": ["2506368-03-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.065696", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31542523", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Sodium chloride", "cas": "7647-14-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 80.0, "time_h": 5.0, "yield_pct": 81.0}, "smiles": {"reactants": "Nc1ccccn1.CCOC(=O)c1nc([C@@H]2CCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)O)cc1", "products": "CCOC(=O)c1nc([C@@H]2CCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)Nc2ccccn2)cc1"}, "reference": {"title": "Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors", "authors": "Ma, Chunhua; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.", "doi": "10.1021/acs.jmedchem.1c01559", "raw": "Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors | Ma, Chunhua; et al | Journal of Medicinal Chemistry (2021), 64(21), 16242-16270. | 10.1021/acs.jmedchem.1c01559"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31542523", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 4 h, 80 °C", "1.2|Reagents: Sodium chloride", "Solvents: Water", "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "By: Ushiki, Yasunobu; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "10.1016/j.bmcl.2022.128572"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium chloride|7647-14-5/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "64c45164", "fam_sig": "57032ae1"}, "raw_data": {"raw_cas": "RCT: 2227446-38-8 + 2227448-07-7 | PRO: 2227446-68-4 | RGT: 7087-68-5 + 148893-10-1 + 7647-14-5 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors\", \"authors\": \"Ma, Chunhua; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31542523\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 4 h, 80 °C\", \"1.2\", \"Reagents: Sodium chloride\", \"Solvents: Water\", \"428. Scheme 428 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"By: Ushiki, Yasunobu; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"10.1016/j.bmcl.2022.128572\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2227446-38-8\", \"2227448-07-7\"], \"pro_cas\": [\"2227446-68-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7647-14-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2227446-38-8", "2227448-07-7"], "products": ["2227446-68-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "7647-14-5"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.065696", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31542534", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Sodium chloride", "cas": "7647-14-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 80.0, "time_h": 4.0, "yield_pct": 86.0}, "smiles": {"reactants": "CCc1ccnc(N)c1.CCOC(=O)c1nc([C@@H]2CCCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)O)cc1", "products": "CCOC(=O)c1nc([C@@H]2CCCCN2C(=O)OC(C)(C)C)[nH]c1-c1ccc(C(=O)Nc2cc(CC)ccn2)cc1"}, "reference": {"title": "Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors", "authors": "Ma, Chunhua; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.", "doi": "10.1021/acs.jmedchem.1c01559", "raw": "Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors | Ma, Chunhua; et al | Journal of Medicinal Chemistry (2021), 64(21), 16242-16270. | 10.1021/acs.jmedchem.1c01559"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-31542534", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 4 h, 80 °C; 80 °C → rt", "1.2|Reagents: Sodium chloride", "Solvents: Water; rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360", "By: Rueeger, Heinrich; et al", "Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.", "10.1021/acs.jmedchem.0c02143"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium chloride|7647-14-5/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "64c45164", "fam_sig": "57032ae1"}, "raw_data": {"raw_cas": "RCT: 30766-11-1 + 1262859-49-3 | PRO: 1262859-50-6 | RGT: 7087-68-5 + 148893-10-1 + 7647-14-5 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors\", \"authors\": \"Ma, Chunhua; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(21), 16242-16270.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31542534\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 4 h, 80 °C; 80 °C → rt\", \"1.2\", \"Reagents: Sodium chloride\", \"Solvents: Water; rt\", \"438. Scheme 438 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360\", \"By: Rueeger, Heinrich; et al\", \"Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.\", \"10.1021/acs.jmedchem.0c02143\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"30766-11-1\", \"1262859-49-3\"], \"pro_cas\": [\"1262859-50-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7647-14-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["30766-11-1", "1262859-49-3"], "products": ["1262859-50-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "7647-14-5"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.065696", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31542881", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 72.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1ccc(Cl)cc1.CC(C)(N)C1C2CC(O[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)CC21", "products": "CC(C)(NC(=O)c1ccc(Cl)cc1)C1C2CC(O[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)CC21"}, "reference": {"title": "Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme", "authors": "Hamilton, Matthew M.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(15), 11302-11329.", "doi": "10.1021/acs.jmedchem.1c00679", "raw": "Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme | Hamilton, Matthew M.; et al | Journal of Medicinal Chemistry (2021), 64(15), 11302-11329. | 10.1021/acs.jmedchem.1c00679"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-31542881", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 3 d, rt", "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis", "By: Zhao, Hongyi; et al", "Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.", "10.1021/acs.jmedchem.2c00718"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 13074-39-0 + 27746-02-7 | PRO: 1183504-44-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme\", \"authors\": \"Hamilton, Matthew M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(15), 11302-11329.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31542881\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 3 d, rt\", \"268. Scheme 268 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis\", \"By: Zhao, Hongyi; et al\", \"Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.\", \"10.1021/acs.jmedchem.2c00718\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13074-39-0\", \"27746-02-7\"], \"pro_cas\": [\"1183504-44-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13074-39-0", "27746-02-7"], "products": ["1183504-44-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545310", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cc(Cl)ccc1Cl.COC[C@H](N)C(=O)N[C@@H](CSC)C(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)c1cc(Cl)ccc1Cl)C(=O)N[C@@H](CSC)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545310", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors", "By: Feng, Zi-Qiang; et al", "European Journal of Medicinal Chemistry (2024), 266, 116113.", "10.1016/j.ejmech.2023.116113"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 98-98-6 + 3054131-11-9 | PRO: 3054131-12-0 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545310\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"396. Scheme 396 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors\", \"By: Feng, Zi-Qiang; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116113.\", \"10.1016/j.ejmech.2023.116113\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"98-98-6\", \"3054131-11-9\"], \"pro_cas\": [\"3054131-12-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["98-98-6", "3054131-11-9"], "products": ["3054131-12-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545313", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cc(Cl)ccc1Cl.COC[C@H](NC(=O)[C@@H](N)CSC)C(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545313", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "By: Ryu, SeongShick; et al", "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "10.1021/acs.jmedchem.1c01359"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 545432-97-1 + 23680-31-1 | PRO: 1863128-21-5 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545313\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"363. Scheme 363 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"By: Ryu, SeongShick; et al\", \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"10.1021/acs.jmedchem.1c01359\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"545432-97-1\", \"23680-31-1\"], \"pro_cas\": [\"1863128-21-5\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["545432-97-1", "23680-31-1"], "products": ["1863128-21-5"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545319", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cnccn1.COC[C@H](N)C(=O)N[C@@H](CSC)C(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)c1cnccn1)C(=O)N[C@@H](CSC)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545319", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core", "By: Garcia-Marin, Javier; et al", "ChemMedChem (2021), 16(18), 2895-2906.", "10.1002/cmdc.202100338"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 95-54-5 + 298-12-4 | PRO: 1196-57-2 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545319\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"175. Scheme 175 (1 Reaction)\", \"A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core\", \"By: Garcia-Marin, Javier; et al\", \"ChemMedChem (2021), 16(18), 2895-2906.\", \"10.1002/cmdc.202100338\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"95-54-5\", \"298-12-4\"], \"pro_cas\": [\"1196-57-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["95-54-5", "298-12-4"], "products": ["1196-57-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545320", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cc(Cl)ccc1Cl.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F", "products": "COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545320", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 383135-47-5 + 3032933-02-8 | PRO: 2983540-55-0 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545320\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"358. Scheme 358 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"383135-47-5\", \"3032933-02-8\"], \"pro_cas\": [\"2983540-55-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["383135-47-5", "3032933-02-8"], "products": ["2983540-55-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545322", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cnccn1.COC[C@H](NC(=O)[C@@H](N)CSC)C(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cnccn1)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545322", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "By: Guryanov, Ivan; et al", "Organic Process Research & Development (2021), 25(7), 1598-1611.", "10.1021/acs.oprd.1c00021"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 843666-40-0 + 45120-30-7 | PRO: 1188328-39-3 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545322\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"151. Scheme 151 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"By: Guryanov, Ivan; et al\", \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"10.1021/acs.oprd.1c00021\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"843666-40-0\", \"45120-30-7\"], \"pro_cas\": [\"1188328-39-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["843666-40-0", "45120-30-7"], "products": ["1188328-39-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545324", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cnccn1.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F", "products": "COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cnccn1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545324", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 3405-77-4 + 2760538-79-0 | PRO: 2760538-91-6 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545324\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"149. Scheme 149 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3405-77-4\", \"2760538-79-0\"], \"pro_cas\": [\"2760538-91-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3405-77-4", "2760538-79-0"], "products": ["2760538-91-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545325", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)no1.COC[C@H](NC(=O)[C@@H](N)CSC)C(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545325", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 3405-77-4 + 2760538-76-7 | PRO: 2760538-89-2 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545325\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"254. Scheme 254 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3405-77-4\", \"2760538-76-7\"], \"pro_cas\": [\"2760538-89-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3405-77-4", "2760538-76-7"], "products": ["2760538-89-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545329", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)no1.COC[C@H](N)C(=O)N[C@@H](CSC)C(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)c1cc(C)on1)C(=O)N[C@@H](CSC)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545329", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators", "By: Guzelj, Samo; et al", "Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.", "10.1021/acs.jmedchem.2c00808"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 2289702-51-6 + 4530-20-5 | PRO: 2289702-52-7 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545329\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"281. Scheme 281 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators\", \"By: Guzelj, Samo; et al\", \"Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.\", \"10.1021/acs.jmedchem.2c00808\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2289702-51-6\", \"4530-20-5\"], \"pro_cas\": [\"2289702-52-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2289702-51-6", "4530-20-5"], "products": ["2289702-52-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545333", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)no1.COC[C@H](NC(=O)CN)C(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545333", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 98-97-5 + 2760538-75-6 | PRO: 2760538-85-8 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545333\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"150. Scheme 150 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"98-97-5\", \"2760538-75-6\"], \"pro_cas\": [\"2760538-85-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["98-97-5", "2760538-75-6"], "products": ["2760538-85-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545336", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)no1.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F", "products": "COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545336", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities", "By: Huang, Ding; et al", "Journal of Medicinal Chemistry (2022), 65(14), 9955-9973.", "10.1021/acs.jmedchem.2c00640"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 1821-12-1 + 1345700-41-5 | PRO: 2820146-39-0 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545336\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"255. Scheme 255 (1 Reaction)\", \"A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities\", \"By: Huang, Ding; et al\", \"Journal of Medicinal Chemistry (2022), 65(14), 9955-9973.\", \"10.1021/acs.jmedchem.2c00640\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1821-12-1\", \"1345700-41-5\"], \"pro_cas\": [\"2820146-39-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1821-12-1", "1345700-41-5"], "products": ["2820146-39-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545339", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 8.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)no1.COC[C@H](N)C(=O)NCC(=O)OC.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)OC"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545339", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors", "By: Rullo, Mariagrazia; et al", "European Journal of Medicinal Chemistry (2023), 255, 115352.", "10.1016/j.ejmech.2023.115352"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 100-09-4 + 19335-11-6 | PRO: 710329-45-6 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545339\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"171. Scheme 171 (1 Reaction)\", \"Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors\", \"By: Rullo, Mariagrazia; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115352.\", \"10.1016/j.ejmech.2023.115352\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"100-09-4\", \"19335-11-6\"], \"pro_cas\": [\"710329-45-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["100-09-4", "19335-11-6"], "products": ["710329-45-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.067920", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545344", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1ncc(C(=O)O)s1.COC(=O)[C@H](CSC)NC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F", "products": "COC(=O)[C@H](CSC)NC(=O)[C@H](CSC)NC(=O)c1cnc(C)s1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545344", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "By: Chuang, Chihyuan; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "10.1021/acs.jmedchem.1c01290"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 5952-92-1 + 2364561-76-0 | PRO: 2364561-64-6 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545344\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"200. Scheme 200 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"By: Chuang, Chihyuan; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"10.1021/acs.jmedchem.1c01290\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5952-92-1\", \"2364561-76-0\"], \"pro_cas\": [\"2364561-64-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5952-92-1", "2364561-76-0"], "products": ["2364561-64-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545345", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)no1.COC(=O)CNC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F", "products": "COC(=O)CNC(=O)[C@H](CSC)NC(=O)c1cc(C)on1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545345", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 146093-46-1 | PRO: 3031471-30-1 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545345\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"191. Scheme 191 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"146093-46-1\"], \"pro_cas\": [\"3031471-30-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "146093-46-1"], "products": ["3031471-30-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545348", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 8.0, "yield_pct": 98.0}, "smiles": {"reactants": "Cc1ncc(C(=O)O)s1.COC(=O)CNC(=O)[C@@H](N)CSC.O=C(O)C(F)(F)F", "products": "COC(=O)CNC(=O)[C@H](CSC)NC(=O)c1cnc(C)s1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31545348", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors", "By: Rullo, Mariagrazia; et al", "European Journal of Medicinal Chemistry (2023), 255, 115352.", "10.1016/j.ejmech.2023.115352"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 619-58-9 + 19335-11-6 | PRO: 1293169-92-2 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545348\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; -5 °C; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"145. Scheme 145 (1 Reaction)\", \"Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors\", \"By: Rullo, Mariagrazia; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115352.\", \"10.1016/j.ejmech.2023.115352\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"619-58-9\", \"19335-11-6\"], \"pro_cas\": [\"1293169-92-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["619-58-9", "19335-11-6"], "products": ["1293169-92-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545365", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(Cl)ccc1Cl)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545365", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 619-58-9 + 2919713-61-2 | PRO: 2919713-71-4 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545365\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"272. Scheme 272 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"619-58-9\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-71-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["619-58-9", "2919713-61-2"], "products": ["2919713-71-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545371", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "CSC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F", "products": "CSC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545371", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer", "By: Sharma, Horrick; et al", "European Journal of Medicinal Chemistry (2024), 275, 116598.", "10.1016/j.ejmech.2024.116598"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 3043790-59-3 + 62882-11-5 | PRO: 3043790-32-2 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545371\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"477. Scheme 477 (1 Reaction)\", \"Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer\", \"By: Sharma, Horrick; et al\", \"European Journal of Medicinal Chemistry (2024), 275, 116598.\", \"10.1016/j.ejmech.2024.116598\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3043790-59-3\", \"62882-11-5\"], \"pro_cas\": [\"3043790-32-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3043790-59-3", "62882-11-5"], "products": ["3043790-32-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545372", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545372", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR", "By: Grossman, Scott; et al", "European Journal of Medicinal Chemistry (2020), 208, 112778.", "10.1016/j.ejmech.2020.112778"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 635-21-2 | PRO: 16064-14-5 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545372\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"439. Scheme 439 (1 Reaction)\", \"Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR\", \"By: Grossman, Scott; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112778.\", \"10.1016/j.ejmech.2020.112778\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"635-21-2\"], \"pro_cas\": [\"16064-14-5\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "635-21-2"], "products": ["16064-14-5"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545373", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "CSC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F", "products": "CSC[C@H](NC(=O)c1cc(C)on1)C(=O)N[C@@H](CSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545373", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Relative stereochemistry shown", "Absolute stereochemistry shown", "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure", "By: Cadilla, Rodolfo; et al", "Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.", "10.1016/j.bmc.2020.115791"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 1363381-26-3 + 2255314-45-3 | PRO: 2255312-50-4 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545373\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"159. Scheme 159 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Relative stereochemistry shown\", \"Absolute stereochemistry shown\", \"The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure\", \"By: Cadilla, Rodolfo; et al\", \"Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.\", \"10.1016/j.bmc.2020.115791\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1363381-26-3\", \"2255314-45-3\"], \"pro_cas\": [\"2255312-50-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1363381-26-3", "2255314-45-3"], "products": ["2255312-50-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545374", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 85.0}, "smiles": {"reactants": "COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)c1cc(C)on1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31545374", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia", "By: Ali, Imran; et al", "European Journal of Medicinal Chemistry (2024), 265, 116052.", "10.1016/j.ejmech.2023.116052"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 102-51-2 + 144-62-7 | PRO: 31910-18-6 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545374\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"99. Scheme 99 (1 Reaction)\", \"DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia\", \"By: Ali, Imran; et al\", \"European Journal of Medicinal Chemistry (2024), 265, 116052.\", \"10.1016/j.ejmech.2023.116052\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"102-51-2\", \"144-62-7\"], \"pro_cas\": [\"31910-18-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["102-51-2", "144-62-7"], "products": ["31910-18-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545377", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "CSC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cnc(C)s1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F", "products": "CSC[C@H](NC(=O)c1cnc(C)s1)C(=O)N[C@@H](CSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545377", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "By: Huang, Danling; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "10.1016/j.bmcl.2021.128006"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 857997-89-8 + 1092569-57-7 | PRO: 2656367-51-8 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545377\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"171. Scheme 171 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"By: Huang, Danling; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"10.1016/j.bmcl.2021.128006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"857997-89-8\", \"1092569-57-7\"], \"pro_cas\": [\"2656367-51-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["857997-89-8", "1092569-57-7"], "products": ["2656367-51-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545380", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545380", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 2519-61-1 + 36377-59-0 | PRO: 2565618-08-6 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545380\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"85. Scheme 85 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2519-61-1\", \"36377-59-0\"], \"pro_cas\": [\"2565618-08-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2519-61-1", "36377-59-0"], "products": ["2565618-08-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545381", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC[C@H](NC(=O)c1cnccn1)C(=O)N[C@@H](CSC)C(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)c1cnccn1)C(=O)N[C@@H](CSC)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545381", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction", "By: Wang, Yu; et al", "European Journal of Medicinal Chemistry (2022), 229, 113998.", "10.1016/j.ejmech.2021.113998"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 20776-51-6 | PRO: 77150-35-7 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545381\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"483. Scheme 483 (1 Reaction)\", \"Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction\", \"By: Wang, Yu; et al\", \"European Journal of Medicinal Chemistry (2022), 229, 113998.\", \"10.1016/j.ejmech.2021.113998\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"20776-51-6\"], \"pro_cas\": [\"77150-35-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "20776-51-6"], "products": ["77150-35-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545383", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)[C@H](CSC)NC(=O)c1cc(C)on1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545383", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S", "By: Rathman, Benjamin M.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.", "10.1016/j.bmcl.2020.127283"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 78-81-9 + 2364482-32-4 | PRO: 2429959-77-1 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545383\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"209. Scheme 209 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S\", \"By: Rathman, Benjamin M.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.\", \"10.1016/j.bmcl.2020.127283\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"78-81-9\", \"2364482-32-4\"], \"pro_cas\": [\"2429959-77-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["78-81-9", "2364482-32-4"], "products": ["2429959-77-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.069923", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545386", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)O.CC(C)C[C@H](N)C(=O)[C@@]1(C)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545386", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis", "By: Bendele, Alison M.; et al", "European Journal of Medicinal Chemistry (2021), 224, 113666.", "10.1016/j.ejmech.2021.113666"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 690998-35-7 + 1605324-71-7 | PRO: 1605324-86-4 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545386\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"472. Scheme 472 (1 Reaction)\", \"Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis\", \"By: Bendele, Alison M.; et al\", \"European Journal of Medicinal Chemistry (2021), 224, 113666.\", \"10.1016/j.ejmech.2021.113666\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"690998-35-7\", \"1605324-71-7\"], \"pro_cas\": [\"1605324-86-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["690998-35-7", "1605324-71-7"], "products": ["1605324-86-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31545392", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)O.C[C@]1(C(=O)[C@@H](N)Cc2ccccc2)CO1.O=C(O)C(F)(F)F", "products": "COC[C@H](NC(=O)CNC(=O)c1cc(C)on1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1"}, "reference": {"title": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "authors": "Zhang, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "doi": "10.1016/j.bmc.2021.116182", "raw": "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma | Zhang, Wen; et al | Bioorganic & Medicinal Chemistry (2021), 40, 116182. | 10.1016/j.bmc.2021.116182"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31545392", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -5 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C", "1.3|Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt", "Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors", "By: Shu, Lei; et al", "European Journal of Medicinal Chemistry (2020), 191, 112148pp..", "10.1016/j.ejmech.2020.112148"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 2412733-73-2 | PRO: 2412734-26-8 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"authors\": \"Zhang, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31545392\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -5 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 15 - 20 min, -5 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 0.5 h, -5 °C; 6 h, rt\", \"128. Scheme 128 (1 Reaction)\", \"Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors\", \"By: Shu, Lei; et al\", \"European Journal of Medicinal Chemistry (2020), 191, 112148pp..\", \"10.1016/j.ejmech.2020.112148\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"2412733-73-2\"], \"pro_cas\": [\"2412734-26-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "2412733-73-2"], "products": ["2412734-26-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31556145", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 0.0, "time_h": 5.5, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)CC12CC3CC(CC(C3)C1)C2.NCCCCO", "products": "O=C(CC12CC3CC(CC(C3)C1)C2)NCCCCO"}, "reference": {"title": "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway", "authors": "Rastelli, Ettore J.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.", "doi": "10.1016/j.bmcl.2021.128167", "raw": "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway | Rastelli, Ettore J.; et al | Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167. | 10.1016/j.bmcl.2021.128167"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-31556145", "1.1|Reagents: Thionyl chloride; 1.5 h, reflux", "1.2|Reagents: Triethylamine; 0 °C → rt; 4 h, rt", "Absolute stereochemistry shown", "Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains", "By: Fatma, Khushnood; et al", "ACS Medicinal Chemistry Letters (2024), 15(3), 388-395.", "10.1021/acsmedchemlett.3c00537"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/none", "cond_sig": "f00cbf21", "fam_sig": "60615bcc"}, "raw_data": {"raw_cas": "RCT: 186706-75-2 + 14860-64-1 | PRO: 3074623-69-8 | RGT: 7719-09-7 + 121-44-8", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway\", \"authors\": \"Rastelli, Ettore J.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31556145\", \"1.1\", \"Reagents: Thionyl chloride; 1.5 h, reflux\", \"1.2\", \"Reagents: Triethylamine; 0 °C → rt; 4 h, rt\", \"42. Scheme 42 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains\", \"By: Fatma, Khushnood; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(3), 388-395.\", \"10.1021/acsmedchemlett.3c00537\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"186706-75-2\", \"14860-64-1\"], \"pro_cas\": [\"3074623-69-8\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["186706-75-2", "14860-64-1"], "products": ["3074623-69-8"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31556160", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 0.0, "time_h": 13.5, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)CC12CC3CC(CC(C3)C1)C2.CC(C)(C)OC(=O)NCCCN", "products": "CC(C)(C)OC(=O)NCCCNC(=O)CC12CC3CC(CC(C3)C1)C2"}, "reference": {"title": "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway", "authors": "Rastelli, Ettore J.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.", "doi": "10.1016/j.bmcl.2021.128167", "raw": "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway | Rastelli, Ettore J.; et al | Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167. | 10.1016/j.bmcl.2021.128167"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-31556160", "1.1|Reagents: Thionyl chloride; 1.5 h, rt → reflux; reflux → rt", "1.2|Reagents: Triethylamine; 0 °C → rt; 12 h, rt", "On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System", "By: Fang, Zhengqi; et al", "Organic Process Research & Development (2024), 28(8), 3143-3151.", "10.1021/acs.oprd.4c00043"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/none", "cond_sig": "f00cbf21", "fam_sig": "60615bcc"}, "raw_data": {"raw_cas": "RCT: 95-74-9 + 18212-21-0 | PRO: 223580-51-6 | RGT: 7719-09-7 + 121-44-8", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway\", \"authors\": \"Rastelli, Ettore J.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31556160\", \"1.1\", \"Reagents: Thionyl chloride; 1.5 h, rt → reflux; reflux → rt\", \"1.2\", \"Reagents: Triethylamine; 0 °C → rt; 12 h, rt\", \"127. Scheme 127 (1 Reaction)\", \"On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System\", \"By: Fang, Zhengqi; et al\", \"Organic Process Research & Development (2024), 28(8), 3143-3151.\", \"10.1021/acs.oprd.4c00043\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"95-74-9\", \"18212-21-0\"], \"pro_cas\": [\"223580-51-6\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["95-74-9", "18212-21-0"], "products": ["223580-51-6"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31556162", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 11.0, "time_h": 13.5, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)CC12CC3CC(CC(C3)C1)C2.CC(C)(C)OC(=O)NCCOCCOCCN", "products": "CC(C)(C)OC(=O)NCCOCCOCCNC(=O)CC12CC3CC(CC(C3)C1)C2"}, "reference": {"title": "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway", "authors": "Rastelli, Ettore J.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.", "doi": "10.1016/j.bmcl.2021.128167", "raw": "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway | Rastelli, Ettore J.; et al | Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167. | 10.1016/j.bmcl.2021.128167"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-31556162", "1.1|Reagents: Thionyl chloride; 1.5 h, rt → reflux; reflux → rt", "1.2|Reagents: Triethylamine; 0 °C → rt; 12 h, rt", "[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins", "By: Liu, Longbin; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12003-12021.", "10.1021/acs.jmedchem.1c00667"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/none", "cond_sig": "f00cbf21", "fam_sig": "60615bcc"}, "raw_data": {"raw_cas": "RCT: 121-92-6 + 6628-77-9 | PRO: 1181057-77-1 | RGT: 7719-09-7 + 121-44-8", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway\", \"authors\": \"Rastelli, Ettore J.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31556162\", \"1.1\", \"Reagents: Thionyl chloride; 1.5 h, rt → reflux; reflux → rt\", \"1.2\", \"Reagents: Triethylamine; 0 °C → rt; 12 h, rt\", \"209. Scheme 209 (1 Reaction)\", \"[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins\", \"By: Liu, Longbin; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12003-12021.\", \"10.1021/acs.jmedchem.1c00667\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"121-92-6\", \"6628-77-9\"], \"pro_cas\": [\"1181057-77-1\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["121-92-6", "6628-77-9"], "products": ["1181057-77-1"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31592225", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)[C@@H]1CCCN1C(=O)OCc1ccccc1.COC(=O)[C@@H](N)CCSC.Cl", "products": "COC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1"}, "reference": {"title": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "authors": "Ryu, SeongShick; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "doi": "10.1021/acs.jmedchem.1c01359", "raw": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1 | Ryu, SeongShick; et al | Journal of Medicinal Chemistry (2022), 65(3), 1915-1932. | 10.1021/acs.jmedchem.1c01359"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-31592225", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.2|Reagents: Water", "Solvents: Ethyl acetate; rt", "Copyright © 2025 American Chemical Society (ACS). All Rights Reserved."], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6", "cond_sig": "cd19a930", "fam_sig": "ff9455e5"}, "raw_data": {"raw_cas": "RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 68-12-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"authors\": \"Ryu, SeongShick; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31592225\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.2\", \"Reagents: Water\", \"Solvents: Ethyl acetate; rt\", \"Copyright © 2025 American Chemical Society (ACS). All Rights Reserved.\"]}, \"rdf\": {\"rct_cas\": [], \"pro_cas\": [], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": [], "products": [], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dimethylformamide", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31592226", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O", "products": "COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O"}, "reference": {"title": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "authors": "Ryu, SeongShick; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "doi": "10.1021/acs.jmedchem.1c01359", "raw": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1 | Ryu, SeongShick; et al | Journal of Medicinal Chemistry (2022), 65(3), 1915-1932. | 10.1021/acs.jmedchem.1c01359"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31592226", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C; 3 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.3|Reagents: Water", "Solvents: Ethyl acetate; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2", "By: Pettus, Liping H.; et al", "Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.", "10.1021/acs.jmedchem.9b01034"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trifluoroacetic acid|76-05-1+Water|7732-18-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6", "cond_sig": "fc64d5c9", "fam_sig": "d91a9a00"}, "raw_data": {"raw_cas": "RCT: 1874241-01-6 + 74-89-5 | PRO: 1874240-91-1 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 75-09-2 + 68-12-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"authors\": \"Ryu, SeongShick; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31592226\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C; 3 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.3\", \"Reagents: Water\", \"Solvents: Ethyl acetate; rt\", \"289. Scheme 289 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2\", \"By: Pettus, Liping H.; et al\", \"Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.\", \"10.1021/acs.jmedchem.9b01034\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1874241-01-6\", \"74-89-5\"], \"pro_cas\": [\"1874240-91-1\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["1874241-01-6", "74-89-5"], "products": ["1874240-91-1"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31592253", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "C=CCOC(=O)[C@@H](NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O", "products": "C=CCOC(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O"}, "reference": {"title": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "authors": "Ryu, SeongShick; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "doi": "10.1021/acs.jmedchem.1c01359", "raw": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1 | Ryu, SeongShick; et al | Journal of Medicinal Chemistry (2022), 65(3), 1915-1932. | 10.1021/acs.jmedchem.1c01359"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31592253", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C; 3 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.3|Reagents: Water", "Solvents: Ethyl acetate; rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trifluoroacetic acid|76-05-1+Water|7732-18-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6", "cond_sig": "fc64d5c9", "fam_sig": "d91a9a00"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 32588-36-6 | PRO: 1195214-75-5 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 75-09-2 + 68-12-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"authors\": \"Ryu, SeongShick; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31592253\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C; 3 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.3\", \"Reagents: Water\", \"Solvents: Ethyl acetate; rt\", \"364. Scheme 364 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"32588-36-6\"], \"pro_cas\": [\"1195214-75-5\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "32588-36-6"], "products": ["1195214-75-5"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31592256", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 81.0}, "smiles": {"reactants": "C=CCOC(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O", "products": "C=CCOC(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21)[C@@H](C)O"}, "reference": {"title": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "authors": "Ryu, SeongShick; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "doi": "10.1021/acs.jmedchem.1c01359", "raw": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1 | Ryu, SeongShick; et al | Journal of Medicinal Chemistry (2022), 65(3), 1915-1932. | 10.1021/acs.jmedchem.1c01359"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31592256", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C; 3 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.3|Reagents: Water", "Solvents: Ethyl acetate; rt", "Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders", "By: Roehrig, Susanne; et al", "Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.", "10.1021/acs.jmedchem.3c00795"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trifluoroacetic acid|76-05-1+Water|7732-18-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6", "cond_sig": "fc64d5c9", "fam_sig": "d91a9a00"}, "raw_data": {"raw_cas": "RCT: 94-09-7 + 1630194-79-4 | PRO: 1630194-80-7 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 75-09-2 + 68-12-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"authors\": \"Ryu, SeongShick; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31592256\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C; 3 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.3\", \"Reagents: Water\", \"Solvents: Ethyl acetate; rt\", \"369. Scheme 369 (1 Reaction)\", \"Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders\", \"By: Roehrig, Susanne; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.\", \"10.1021/acs.jmedchem.3c00795\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"94-09-7\", \"1630194-79-4\"], \"pro_cas\": [\"1630194-80-7\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["94-09-7", "1630194-79-4"], "products": ["1630194-80-7"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31592277", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 90.0}, "smiles": {"reactants": "COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](C)O.CC(C)(C)OC(=O)N[C@@H](CCC(N)=O)C(=O)O", "products": "COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)OC(C)(C)C)[C@@H](C)O"}, "reference": {"title": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "authors": "Ryu, SeongShick; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "doi": "10.1021/acs.jmedchem.1c01359", "raw": "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1 | Ryu, SeongShick; et al | Journal of Medicinal Chemistry (2022), 65(3), 1915-1932. | 10.1021/acs.jmedchem.1c01359"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31592277", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C; 3 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.3|Reagents: Water", "Solvents: Ethyl acetate; rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trifluoroacetic acid|76-05-1+Water|7732-18-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6", "cond_sig": "fc64d5c9", "fam_sig": "d91a9a00"}, "raw_data": {"raw_cas": "RCT: 4442-54-0 + 2761157-96-2 | PRO: 2761157-45-1 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 75-09-2 + 68-12-2 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"authors\": \"Ryu, SeongShick; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31592277\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C; 3 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.3\", \"Reagents: Water\", \"Solvents: Ethyl acetate; rt\", \"355. Scheme 355 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4442-54-0\", \"2761157-96-2\"], \"pro_cas\": [\"2761157-45-1\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["4442-54-0", "2761157-96-2"], "products": ["2761157-45-1"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31592699", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 88.0}, "smiles": {"reactants": "CSc1ncc(C(=O)O)c(NC2CCCC2)n1.NCCCN1CCCC1=O", "products": "CSc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1"}, "reference": {"title": "Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase", "authors": "Russ, Nadine; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.", "doi": "10.1021/acs.jmedchem.1c00845", "raw": "Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase | Russ, Nadine; et al | Journal of Medicinal Chemistry (2021), 64(19), 14358-14376. | 10.1021/acs.jmedchem.1c00845"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-31592699", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.2|4 h, rt", "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "By: Zareba, Paula; et al", "European Journal of Medicinal Chemistry (2021), 221, 113512.", "10.1016/j.ejmech.2021.113512"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 64-19-7 + 2648234-33-5 | PRO: 2648234-38-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase\", \"authors\": \"Russ, Nadine; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31592699\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.2\", \"4 h, rt\", \"318. Scheme 318 (1 Reaction)\", \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"By: Zareba, Paula; et al\", \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"10.1016/j.ejmech.2021.113512\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-19-7\", \"2648234-33-5\"], \"pro_cas\": [\"2648234-38-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["Acetic Acid", "2648234-33-5"], "products": ["2648234-38-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31592708", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 89.0}, "smiles": {"reactants": "CSc1ncc(C(=O)O)c(NC2CCCC2)n1.NCCCN1CCOC1=O", "products": "CSc1ncc(C(=O)NCCCN2CCOC2=O)c(NC2CCCC2)n1"}, "reference": {"title": "Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase", "authors": "Russ, Nadine; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.", "doi": "10.1021/acs.jmedchem.1c00845", "raw": "Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase | Russ, Nadine; et al | Journal of Medicinal Chemistry (2021), 64(19), 14358-14376. | 10.1021/acs.jmedchem.1c00845"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-31592708", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.2|4 h, rt", "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "By: Zareba, Paula; et al", "European Journal of Medicinal Chemistry (2021), 221, 113512.", "10.1016/j.ejmech.2021.113512"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 64-19-7 + 2648234-35-7 | PRO: 2648234-40-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase\", \"authors\": \"Russ, Nadine; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31592708\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.2\", \"4 h, rt\", \"416. Scheme 416 (1 Reaction)\", \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"By: Zareba, Paula; et al\", \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"10.1016/j.ejmech.2021.113512\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-19-7\", \"2648234-35-7\"], \"pro_cas\": [\"2648234-40-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["Acetic Acid", "2648234-35-7"], "products": ["2648234-40-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593444", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.Cl.N[C@H](/C=C(/F)S(=O)(=O)Oc1ccccc1)CCc1ccccc1", "products": "CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(/F)S(=O)(=O)Oc1ccccc1)CCc1ccccc1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31593444", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 0 °C; 15 min, 0 °C", "1.2|Solvents: Dichloromethane; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "55f16cab", "fam_sig": "54223a0a"}, "raw_data": {"raw_cas": "RCT: 2387523-00-2 + 247068-85-5 | PRO: 2387523-24-0 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593444\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 0 °C; 15 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 12 h, rt\", \"471. Scheme 471 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387523-00-2\", \"247068-85-5\"], \"pro_cas\": [\"2387523-24-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387523-00-2", "247068-85-5"], "products": ["2387523-24-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.071926", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593448", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O.Cl.N[C@H](/C=C(\\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1", "products": "CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31593448", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 0 °C; 15 min, 0 °C", "1.2|Solvents: Dichloromethane; 12 h, rt", "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "By: Xu, Zhongren; et al", "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "10.1021/acs.jmedchem.3c00063"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "55f16cab", "fam_sig": "54223a0a"}, "raw_data": {"raw_cas": "RCT: 21256-18-8 + 2450-71-7 | PRO: 1050586-90-7 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593448\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 0 °C; 15 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 12 h, rt\", \"463. Scheme 463 (1 Reaction)\", \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"By: Xu, Zhongren; et al\", \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"10.1021/acs.jmedchem.3c00063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"21256-18-8\", \"2450-71-7\"], \"pro_cas\": [\"1050586-90-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["21256-18-8", "2450-71-7"], "products": ["1050586-90-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593451", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 83.0}, "smiles": {"reactants": "Cc1ccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)cc1.Cl.N[C@H](/C=C(\\F)S(=O)(=O)Oc1ccccc1)CCc1ccccc1", "products": "Cc1ccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)Oc2ccccc2)CCc2ccccc2)cc1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31593451", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 0 °C; 15 min, 0 °C", "1.2|Solvents: Dichloromethane; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective Synthesis of Edoxaban", "By: Ochiai, Hidenori; et al", "Organic Process Research & Development (2023), 27(8), 1517-1532.", "10.1021/acs.oprd.3c00189"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "55f16cab", "fam_sig": "54223a0a"}, "raw_data": {"raw_cas": "RCT: 720720-96-7 + 2964483-51-8 | PRO: 2812463-80-0 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593451\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 0 °C; 15 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 12 h, rt\", \"9. Scheme 9 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective Synthesis of Edoxaban\", \"By: Ochiai, Hidenori; et al\", \"Organic Process Research & Development (2023), 27(8), 1517-1532.\", \"10.1021/acs.oprd.3c00189\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"720720-96-7\", \"2964483-51-8\"], \"pro_cas\": [\"2812463-80-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["720720-96-7", "2964483-51-8"], "products": ["2812463-80-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593468", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cc(F)cc(F)c1.Cc1ccc(C[C@H](N)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)Oc2ccccc2)CCc2ccccc2)cc1.Cl", "products": "Cc1ccc(C[C@H](NC(=O)c2cc(F)cc(F)c2)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)Oc2ccccc2)CCc2ccccc2)cc1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31593468", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 15 min, 0 °C", "1.2|12 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 99-50-3 + 251105-80-3 | PRO: 2892016-11-2 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593468\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 15 min, 0 °C\", \"1.2\", \"12 h, rt\", \"61. Scheme 61 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"99-50-3\", \"251105-80-3\"], \"pro_cas\": [\"2892016-11-2\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["99-50-3", "251105-80-3"], "products": ["2892016-11-2"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593473", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1ccncc1.Cl.N[C@H](/C=C(\\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1", "products": "O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)Cc1ccccc1)CCc1ccccc1)c1ccncc1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31593473", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.2|12 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "3b6b91e4", "fam_sig": "868b32de"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 40432-84-6 | PRO: 2565618-06-4 | RGT: 2592-95-2 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593473\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.2\", \"12 h, rt\", \"23. Scheme 23 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"40432-84-6\"], \"pro_cas\": [\"2565618-06-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "40432-84-6"], "products": ["2565618-06-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593480", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cc(F)cc(F)c1.Cc1ccc(C[C@H](N)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)Cc2ccccc2)CCc2ccccc2)cc1.Cl", "products": "Cc1ccc(C[C@H](NC(=O)c2cc(F)cc(F)c2)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)Cc2ccccc2)CCc2ccccc2)cc1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31593480", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 15 min, 0 °C", "1.2|12 h, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2", "By: Dai, Wenhao; et al", "Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.", "10.1021/acs.jmedchem.0c02258"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 140-10-3 + 2640359-25-5 | PRO: 1065478-35-4 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593480\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 15 min, 0 °C\", \"1.2\", \"12 h, rt\", \"64. Scheme 64 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2\", \"By: Dai, Wenhao; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.\", \"10.1021/acs.jmedchem.0c02258\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"140-10-3\", \"2640359-25-5\"], \"pro_cas\": [\"1065478-35-4\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["140-10-3", "2640359-25-5"], "products": ["1065478-35-4"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593490", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cc(F)cc(F)c1.Cl.N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)c1ccccc1)CCc1ccccc1", "products": "O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)c1ccccc1)CCc1ccccc1)c1cc(F)cc(F)c1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-31593490", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 15 min, 0 °C", "1.2|12 h, rt", "Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine", "By: Jiang, Xueyang; et al", "European Journal of Medicinal Chemistry (2021), 223, 113663.", "10.1016/j.ejmech.2021.113663"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 1077-94-7 + 144222-22-0 | PRO: 1452520-76-1 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593490\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 15 min, 0 °C\", \"1.2\", \"12 h, rt\", \"51. Scheme 51 (1 Reaction)\", \"Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine\", \"By: Jiang, Xueyang; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113663.\", \"10.1016/j.ejmech.2021.113663\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1077-94-7\", \"144222-22-0\"], \"pro_cas\": [\"1452520-76-1\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1077-94-7", "144222-22-0"], "products": ["1452520-76-1"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593492", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1ccncc1.Cc1ccc(C[C@H](N)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)cc1.Cl", "products": "Cc1ccc(C[C@H](NC(=O)c2ccncc2)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)cc1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31593492", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 15 min, 0 °C", "1.2|12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma", "By: Zhou, Yi; et al", "Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.", "10.1021/acs.jmedchem.9b02161"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 13734-34-4 + 2415205-36-4 | PRO: 2415205-24-0 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593492\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 15 min, 0 °C\", \"1.2\", \"12 h, rt\", \"56. Scheme 56 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma\", \"By: Zhou, Yi; et al\", \"Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.\", \"10.1021/acs.jmedchem.9b02161\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-34-4\", \"2415205-36-4\"], \"pro_cas\": [\"2415205-24-0\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13734-34-4", "2415205-36-4"], "products": ["2415205-24-0"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31593501", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.25, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)OCCO2.Cc1cccc(C[C@H](N)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)c1.Cl", "products": "Cc1cccc(C[C@H](NC(=O)c2ccc3c(c2)OCCO3)C(=O)N[C@H](/C=C(\\F)S(=O)(=O)c2ccccc2)CCc2ccccc2)c1"}, "reference": {"title": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "authors": "Jung, Sascha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "doi": "10.1021/acs.jmedchem.1c01002", "raw": "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies | Jung, Sascha; et al | Journal of Medicinal Chemistry (2021), 64(16), 12322-12358. | 10.1021/acs.jmedchem.1c01002"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-31593501", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 15 min, 0 °C", "1.2|12 h, rt", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 2892557-07-0 + 104-94-9 | PRO: 2892557-15-0 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"authors\": \"Jung, Sascha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31593501\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 15 min, 0 °C\", \"1.2\", \"12 h, rt\", \"356. Scheme 356 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-07-0\", \"104-94-9\"], \"pro_cas\": [\"2892557-15-0\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-07-0", "104-94-9"], "products": ["2892557-15-0"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31605939", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 94.0}, "smiles": {"reactants": "COc1cc(-c2cccc(Cl)c2)cnc1C(=O)O.COC(=O)CN.Cl", "products": "COC(=O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1OC"}, "reference": {"title": "Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat", "authors": "Lin, Biyue; et al", "citation": "Organic Process Research & Development (2021), 25(4), 960-968.", "doi": "10.1021/acs.oprd.1c00004", "raw": "Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat | Lin, Biyue; et al | Organic Process Research & Development (2021), 25(4), 960-968. | 10.1021/acs.oprd.1c00004"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-31605939", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dichloromethane; 2 h, rt", "1.2|1 h, rt", "1.3|Solvents: Water; 2 h, rt", "Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives", "By: Guo, Wen-Ge; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 76, 129020.", "10.1016/j.bmcl.2022.129020"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "1f8bfdb2", "fam_sig": "61e854f8"}, "raw_data": {"raw_cas": "RCT: 62-56-6 + 7579-20-6 | PRO: 412341-42-5 | RGT: 530-62-1 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat\", \"authors\": \"Lin, Biyue; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(4), 960-968.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31605939\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"1 h, rt\", \"1.3\", \"Solvents: Water; 2 h, rt\", \"414. Scheme 414 (1 Reaction)\", \"Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives\", \"By: Guo, Wen-Ge; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 76, 129020.\", \"10.1016/j.bmcl.2022.129020\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"62-56-6\", \"7579-20-6\"], \"pro_cas\": [\"412341-42-5\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["62-56-6", "7579-20-6"], "products": ["412341-42-5"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31626786", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 80.0}, "smiles": {"reactants": "COc1cccc(N)c1.Nc1ccc([N+](=O)[O-])cc1C(=O)O", "products": "COc1cccc(NC(=O)c2cc([N+](=O)[O-])ccc2N)c1"}, "reference": {"title": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "authors": "Ryan, Michael C.; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "doi": "10.1021/acsmedchemlett.1c00539", "raw": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones | Ryan, Michael C.; et al | ACS Medicinal Chemistry Letters (2022), 13(4), 546-553. | 10.1021/acsmedchemlett.1c00539"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31626786", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 17 h, rt", "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors", "By: Trinh, Phuc N. H.; et al", "Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.", "10.1021/acs.jmedchem.0c02169"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 372-09-8 + 296277-76-4 | PRO: 1187960-54-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"authors\": \"Ryan, Michael C.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31626786\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 17 h, rt\", \"218. Scheme 218 (1 Reaction)\", \"Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors\", \"By: Trinh, Phuc N. H.; et al\", \"Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.\", \"10.1021/acs.jmedchem.0c02169\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"372-09-8\", \"296277-76-4\"], \"pro_cas\": [\"1187960-54-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["372-09-8", "296277-76-4"], "products": ["1187960-54-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31626791", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 80.0}, "smiles": {"reactants": "Nc1ccc(F)cc1.Nc1ccc([N+](=O)[O-])cc1C(=O)O", "products": "Nc1ccc([N+](=O)[O-])cc1C(=O)Nc1ccc(F)cc1"}, "reference": {"title": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "authors": "Ryan, Michael C.; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "doi": "10.1021/acsmedchemlett.1c00539", "raw": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones | Ryan, Michael C.; et al | ACS Medicinal Chemistry Letters (2022), 13(4), 546-553. | 10.1021/acsmedchemlett.1c00539"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31626791", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 17 h, rt", "Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27", "By: Pillaiyar, Thanigaimalai; et al", "European Journal of Medicinal Chemistry (2021), 225, 113777.", "10.1016/j.ejmech.2021.113777"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 50-84-0 + 782-45-6 | PRO: 313493-80-0 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"authors\": \"Ryan, Michael C.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31626791\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 17 h, rt\", \"141. Scheme 141 (1 Reaction)\", \"Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27\", \"By: Pillaiyar, Thanigaimalai; et al\", \"European Journal of Medicinal Chemistry (2021), 225, 113777.\", \"10.1016/j.ejmech.2021.113777\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"50-84-0\", \"782-45-6\"], \"pro_cas\": [\"313493-80-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["50-84-0", "782-45-6"], "products": ["313493-80-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31626793", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 100.0}, "smiles": {"reactants": "COc1ccc(N)cc1.N#Cc1ccc(N)c(C(=O)O)c1", "products": "COc1ccc(NC(=O)c2cc(C#N)ccc2N)cc1F"}, "reference": {"title": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "authors": "Ryan, Michael C.; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "doi": "10.1021/acsmedchemlett.1c00539", "raw": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones | Ryan, Michael C.; et al | ACS Medicinal Chemistry Letters (2022), 13(4), 546-553. | 10.1021/acsmedchemlett.1c00539"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-31626793", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 17 h, rt", "The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors", "By: Tajiri, Misato; et al", "European Journal of Medicinal Chemistry (2021), 215, 113289.", "10.1016/j.ejmech.2021.113289"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 1521-38-6 + 645-36-3 | PRO: 1494575-28-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"authors\": \"Ryan, Michael C.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31626793\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 17 h, rt\", \"222. Scheme 222 (1 Reaction)\", \"The total synthesis of berberine and selected analogues, and their evaluation as amyloid beta aggregation inhibitors\", \"By: Tajiri, Misato; et al\", \"European Journal of Medicinal Chemistry (2021), 215, 113289.\", \"10.1016/j.ejmech.2021.113289\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1521-38-6\", \"645-36-3\"], \"pro_cas\": [\"1494575-28-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1521-38-6", "645-36-3"], "products": ["1494575-28-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31626798", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 80.0}, "smiles": {"reactants": "Nc1ccccc1.Nc1ccc([N+](=O)[O-])cc1C(=O)O", "products": "Nc1ccc([N+](=O)[O-])cc1C(=O)Nc1ccccc1"}, "reference": {"title": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "authors": "Ryan, Michael C.; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "doi": "10.1021/acsmedchemlett.1c00539", "raw": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones | Ryan, Michael C.; et al | ACS Medicinal Chemistry Letters (2022), 13(4), 546-553. | 10.1021/acsmedchemlett.1c00539"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31626798", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 17 h, rt", "Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase", "By: Devine, R.; et al", "European Journal of Medicinal Chemistry (2020), 202, 112416.", "10.1016/j.ejmech.2020.112416"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 4653-11-6 + 455-14-1 | PRO: 2326943-98-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"authors\": \"Ryan, Michael C.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31626798\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 17 h, rt\", \"86. Scheme 86 (1 Reaction)\", \"Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase\", \"By: Devine, R.; et al\", \"European Journal of Medicinal Chemistry (2020), 202, 112416.\", \"10.1016/j.ejmech.2020.112416\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4653-11-6\", \"455-14-1\"], \"pro_cas\": [\"2326943-98-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4653-11-6", "455-14-1"], "products": ["2326943-98-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.073929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31626803", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 83.0}, "smiles": {"reactants": "Nc1ccccc1.Nc1cc([N+](=O)[O-])ccc1C(=O)O", "products": "Nc1cc([N+](=O)[O-])ccc1C(=O)Nc1ccccc1"}, "reference": {"title": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "authors": "Ryan, Michael C.; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "doi": "10.1021/acsmedchemlett.1c00539", "raw": "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones | Ryan, Michael C.; et al | ACS Medicinal Chemistry Letters (2022), 13(4), 546-553. | 10.1021/acsmedchemlett.1c00539"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31626803", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 17 h, rt", "Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer", "By: Fratta, Simone; et al", "European Journal of Medicinal Chemistry (2023), 250, 115170.", "10.1016/j.ejmech.2023.115170"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 617-89-0 + 217180-76-2 | PRO: 2920115-45-1 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"authors\": \"Ryan, Michael C.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31626803\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 17 h, rt\", \"78. Scheme 78 (1 Reaction)\", \"Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer\", \"By: Fratta, Simone; et al\", \"European Journal of Medicinal Chemistry (2023), 250, 115170.\", \"10.1016/j.ejmech.2023.115170\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"617-89-0\", \"217180-76-2\"], \"pro_cas\": [\"2920115-45-1\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["617-89-0", "217180-76-2"], "products": ["2920115-45-1"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.075933", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632725", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1.CN1CCOC[C@H]1C(=O)O", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCCN2C)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31632725", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 530-57-4 + 772318-79-3 | PRO: 2892016-35-0 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632725\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"166. Scheme 166 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"530-57-4\", \"772318-79-3\"], \"pro_cas\": [\"2892016-35-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["530-57-4", "772318-79-3"], "products": ["2892016-35-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.075933", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632729", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1.CN1CCOC[C@H]1C(=O)O", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C)S(=O)(=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-31632729", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Relative stereochemistry shown", "Relative stereochemistry shown", "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists", "By: Cooper, Martin; et al", "Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.", "10.1021/acs.jmedchem.0c00828"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 10241-97-1 + 2711028-00-9 | PRO: 2602442-12-4 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632729\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"179. Scheme 179 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists\", \"By: Cooper, Martin; et al\", \"Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.\", \"10.1021/acs.jmedchem.0c00828\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"10241-97-1\", \"2711028-00-9\"], \"pro_cas\": [\"2602442-12-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["10241-97-1", "2711028-00-9"], "products": ["2602442-12-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.075933", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632730", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1.CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(N)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-31632730", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives", "By: Chi, Lingling; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 92, 129389.", "10.1016/j.bmcl.2023.129389"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 2953073-26-0 + 186408-95-7 | PRO: 2953073-12-4 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632730\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"313. Scheme 313 (1 Reaction)\", \"Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives\", \"By: Chi, Lingling; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 92, 129389.\", \"10.1016/j.bmcl.2023.129389\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2953073-26-0\", \"186408-95-7\"], \"pro_cas\": [\"2953073-12-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2953073-26-0", "186408-95-7"], "products": ["2953073-12-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.075933", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632733", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1.CN1CCOC[C@H]1C(=O)O", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C)S(=O)(=O)c1ccc(O)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-31632733", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands", "By: Shaik, Anver Basha; et al", "Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.", "10.1021/acs.jmedchem.1c01353"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 496-41-3 + 3035975-21-1 | PRO: 3035975-23-3 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632733\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"153. Scheme 153 (1 Reaction)\", \"Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands\", \"By: Shaik, Anver Basha; et al\", \"Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.\", \"10.1021/acs.jmedchem.1c01353\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"496-41-3\", \"3035975-21-1\"], \"pro_cas\": [\"3035975-23-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["496-41-3", "3035975-21-1"], "products": ["3035975-23-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.075933", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632736", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 90.0}, "smiles": {"reactants": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1.CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCCN2C(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31632736", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design", "By: Krieger, Johannes; et al", "ChemMedChem (2023), 18(8), e202200615.", "10.1002/cmdc.202200615"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 2313230-59-8 + 3055533-14-4 | PRO: 3055532-94-7 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632736\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"324. Scheme 324 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design\", \"By: Krieger, Johannes; et al\", \"ChemMedChem (2023), 18(8), e202200615.\", \"10.1002/cmdc.202200615\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2313230-59-8\", \"3055533-14-4\"], \"pro_cas\": [\"3055532-94-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2313230-59-8", "3055533-14-4"], "products": ["3055532-94-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.075933", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632737", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(S(C)(=O)=O)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1COCCN1C(=O)OC(C)(C)C)S(=O)(=O)c1ccc(S(C)(=O)=O)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31632737", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers", "By: Cao, Chaoguo; et al", "Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.", "10.1021/acs.jmedchem.0c00821"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 1448189-98-7 + 6404-29-1 | PRO: 2412055-00-4 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632737\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"341. Scheme 341 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers\", \"By: Cao, Chaoguo; et al\", \"Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.\", \"10.1021/acs.jmedchem.0c00821\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1448189-98-7\", \"6404-29-1\"], \"pro_cas\": [\"2412055-00-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1448189-98-7", "6404-29-1"], "products": ["2412055-00-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.075933", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632739", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCOC[C@H]1C(=O)O.CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1", "products": "CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2COCCN2C(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-31632739", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 159005-71-7 + 783350-37-8 | PRO: 2765293-52-3 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632739\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"323. Scheme 323 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"159005-71-7\", \"783350-37-8\"], \"pro_cas\": [\"2765293-52-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["159005-71-7", "783350-37-8"], "products": ["2765293-52-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.077937", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632745", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1.CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CCO1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31632745", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "By: Stachura, Damian L.; et al", "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "10.1021/acsmedchemlett.2c00505"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 3731-52-0 + 3064695-54-8 | PRO: 3064695-44-6 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632745\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"264. Scheme 264 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"By: Stachura, Damian L.; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"10.1021/acsmedchemlett.2c00505\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3731-52-0\", \"3064695-54-8\"], \"pro_cas\": [\"3064695-44-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3731-52-0", "3064695-54-8"], "products": ["3064695-44-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.077937", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632749", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1.CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CCO1)S(=O)(=O)c1ccc(O)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-31632749", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "By: Zhou, Huiyu; et al", "European Journal of Medicinal Chemistry (2023), 255, 115389.", "10.1016/j.ejmech.2023.115389"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 72925-16-7 + 251105-80-3 | PRO: 2925287-37-0 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632749\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"218. Scheme 218 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"By: Zhou, Huiyu; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"10.1016/j.ejmech.2023.115389\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"72925-16-7\", \"251105-80-3\"], \"pro_cas\": [\"2925287-37-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["72925-16-7", "251105-80-3"], "products": ["2925287-37-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.077937", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632751", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 88.0}, "smiles": {"reactants": "CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1.CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CN(C(=O)OC(C)(C)C)CCO1)S(=O)(=O)c1ccc(N)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-31632751", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125", "By: Caroff, Eva; et al", "Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.", "10.1021/acs.jmedchem.2c00676"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 95-55-6 + 1646267-98-2 | PRO: 2816047-06-8 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632751\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"223. Scheme 223 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125\", \"By: Caroff, Eva; et al\", \"Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.\", \"10.1021/acs.jmedchem.2c00676\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"95-55-6\", \"1646267-98-2\"], \"pro_cas\": [\"2816047-06-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["95-55-6", "1646267-98-2"], "products": ["2816047-06-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.077937", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632756", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCO[C@@H](C(=O)O)C1.CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1", "products": "CNc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@H]2CN(C(=O)OC(C)(C)C)CCO2)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31632756", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Double bond geometry shown", "Double bond geometry shown", "Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines", "By: Marinovic, Marina; et al", "Bioorganic & Medicinal Chemistry (2023), 94, 117468.", "10.1016/j.bmc.2023.117468"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 14473-90-6 + 2521791-65-9 | PRO: 3056621-74-7 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632756\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"234. Scheme 234 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines\", \"By: Marinovic, Marina; et al\", \"Bioorganic & Medicinal Chemistry (2023), 94, 117468.\", \"10.1016/j.bmc.2023.117468\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"14473-90-6\", \"2521791-65-9\"], \"pro_cas\": [\"3056621-74-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["14473-90-6", "2521791-65-9"], "products": ["3056621-74-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.077937", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632768", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)CN1CCS(=O)(=O)CC1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CN2CCS(=O)(=O)CC2)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31632768", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "By: Meena, Chhuttan L.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "10.1016/j.bmcl.2020.127039"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 18942-49-9 + 2413279-26-0 | PRO: 2413279-27-1 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632768\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"29. Scheme 29 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"By: Meena, Chhuttan L.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"10.1016/j.bmcl.2020.127039\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"18942-49-9\", \"2413279-26-0\"], \"pro_cas\": [\"2413279-27-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["tert-Butyldimethylsilyl chloride", "2413279-26-0"], "products": ["2413279-27-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.077937", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632771", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)CN1CCS(=O)(=O)CC1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CN1CCS(=O)(=O)CC1)S(=O)(=O)c1ccc(O)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-31632771", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency", "By: Guzelj, Samo; et al", "ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.", "10.1021/acsmedchemlett.2c00121"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 3032888-49-3 + 4530-20-5 | PRO: 3032888-64-2 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632771\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"3. Scheme 3 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency\", \"By: Guzelj, Samo; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.\", \"10.1021/acsmedchemlett.2c00121\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3032888-49-3\", \"4530-20-5\"], \"pro_cas\": [\"3032888-64-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3032888-49-3", "4530-20-5"], "products": ["3032888-64-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.077937", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31632772", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)CN1CCS(=O)(=O)CC1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)CN1CCS(=O)(=O)CC1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2022), 233, 114251.", "doi": "10.1016/j.ejmech.2022.114251", "raw": "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2022), 233, 114251. | 10.1016/j.ejmech.2022.114251"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31632772", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 55-22-1 + 2761158-02-3 | PRO: 2761157-41-7 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31632772\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → 25 °C; 3 h, 25 °C\", \"55. Scheme 55 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55-22-1\", \"2761158-02-3\"], \"pro_cas\": [\"2761157-41-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["55-22-1", "2761158-02-3"], "products": ["2761157-41-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.079939", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31649924", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 19.0, "yield_pct": 85.0}, "smiles": {"reactants": "Nc1ccc(C(=O)O)c(F)c1.CN1CCC(N)CC1", "products": "CN1CCC(NC(=O)c2ccc(N)cc2F)CC1"}, "reference": {"title": "Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors", "authors": "Karim, Rezaul Md; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(21), 15772-15786.", "doi": "10.1021/acs.jmedchem.1c01096", "raw": "Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors | Karim, Rezaul Md; et al | Journal of Medicinal Chemistry (2021), 64(21), 15772-15786. | 10.1021/acs.jmedchem.1c01096"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31649924", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 30 min, rt", "1.2|18 h, rt", "1.3|Reagents: Sodium hydroxide", "Solvents: Water; 30 min, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)", "By: Mata, Guillaume; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1418-1444.", "10.1021/acs.jmedchem.1c01153"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+NaOH|1310-73-2+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6+Sodium hydroxide|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "3f4833ae", "fam_sig": "0fd0662d"}, "raw_data": {"raw_cas": "RCT: 142994-09-0 + 195604-39-8 | PRO: 2566572-51-6 | RGT: 7087-68-5 + 125700-67-6 + 1310-73-2 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors\", \"authors\": \"Karim, Rezaul Md; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(21), 15772-15786.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Sodium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31649924\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"18 h, rt\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 30 min, rt\", \"123. Scheme 123 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)\", \"By: Mata, Guillaume; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1418-1444.\", \"10.1021/acs.jmedchem.1c01153\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"142994-09-0\", \"195604-39-8\"], \"pro_cas\": [\"2566572-51-6\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\", \"1310-73-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["142994-09-0", "195604-39-8"], "products": ["2566572-51-6"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6", "NaOH"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.079939", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31657448", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 40.25, "yield_pct": 87.0}, "smiles": {"reactants": "Cc1cc(Cl)ccc1-c1ccc(C(=O)O)cc1.Cc1ccc(N2CCN(C)CC2)c2c1CC[C@H](N)C2", "products": "Cc1cc(Cl)ccc1-c1ccc(C(=O)N[C@H]2CCc3c(C)ccc(N4CCN(C)CC4)c3C2)cc1"}, "reference": {"title": "Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis", "authors": "Sutherland, Hamish S.; et al", "citation": "European Journal of Medicinal Chemistry (2022), 229, 114059.", "doi": "10.1016/j.ejmech.2021.114059", "raw": "Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis | Sutherland, Hamish S.; et al | European Journal of Medicinal Chemistry (2022), 229, 114059. | 10.1016/j.ejmech.2021.114059"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-31657448", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, rt", "1.2|40 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 2519-61-1 | PRO: 2565618-05-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis\", \"authors\": \"Sutherland, Hamish S.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 229, 114059.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31657448\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"40 h, rt\", \"43. Scheme 43 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"2519-61-1\"], \"pro_cas\": [\"2565618-05-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "2519-61-1"], "products": ["2565618-05-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.079939", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31670168", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": -20.0, "time_h": 15.0, "yield_pct": 90.0}, "smiles": {"reactants": "Nc1ccccc1NC1CC1.CC(C)(C)OC(=O)N[C@@H](CC1CCN(C(=O)OCc2ccccc2)CC1)C(=O)O", "products": "CC(C)(C)OC(=O)N[C@@H](CC1CCN(C(=O)OCc2ccccc2)CC1)C(=O)Nc1ccccc1NC1CC1"}, "reference": {"title": "Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum", "authors": "Teno, Naoki; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(3), 420-425.", "doi": "10.1021/acsmedchemlett.0c00640", "raw": "Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum | Teno, Naoki; et al | ACS Medicinal Chemistry Letters (2021), 12(3), 420-425. | 10.1021/acsmedchemlett.0c00640"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31670168", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; -20 °C; 15 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "By: Liu, Yonghua; et al", "European Journal of Medicinal Chemistry (2022), 228, 114033.", "10.1016/j.ejmech.2021.114033"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7+NaHCO3|144-55-8+Sodium bicarbonate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "e906a274", "fam_sig": "7cf9d12f"}, "raw_data": {"raw_cas": "RCT: 694499-26-8 + 3035807-47-4 | PRO: 2374752-21-1 | RGT: 121-44-8 + 25952-53-8 + 39968-33-7 + 144-55-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum\", \"authors\": \"Teno, Naoki; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(3), 420-425.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31670168\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; -20 °C; 15 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"147. Scheme 147 (1 Reaction)\", \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"By: Liu, Yonghua; et al\", \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"10.1016/j.ejmech.2021.114033\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"694499-26-8\", \"3035807-47-4\"], \"pro_cas\": [\"2374752-21-1\"], \"rgt_cas\": [\"121-44-8\", \"25952-53-8\", \"39968-33-7\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["694499-26-8", "3035807-47-4"], "products": ["2374752-21-1"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole", "NaHCO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.079939", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31670880", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 150.0, "time_h": 10.0, "yield_pct": 91.0}, "smiles": {"reactants": "NC=O.Nc1c(Br)cccc1C(=O)O", "products": "O=c1nc[nH]c2c(Br)cccc12"}, "reference": {"title": "Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction", "authors": "Wang, Yu; et al", "citation": "European Journal of Medicinal Chemistry (2022), 229, 113998.", "doi": "10.1016/j.ejmech.2021.113998", "raw": "Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction | Wang, Yu; et al | European Journal of Medicinal Chemistry (2022), 229, 113998. | 10.1016/j.ejmech.2021.113998"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-31670880", "1.1|6 h, 150 °C", "Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases", "By: Yang, Leifu; et al", "Journal of Medicinal Chemistry (2024), 67(7), 5662-5682.", "10.1021/acs.jmedchem.3c02302"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 2148-56-3 + 3473-63-0 | PRO: 60233-66-1", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction\", \"authors\": \"Wang, Yu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 229, 113998.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31670880\", \"1.1\", \"6 h, 150 °C\", \"484. Scheme 484 (2 Reactions)\", \"Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases\", \"By: Yang, Leifu; et al\", \"Journal of Medicinal Chemistry (2024), 67(7), 5662-5682.\", \"10.1021/acs.jmedchem.3c02302\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2148-56-3\", \"3473-63-0\"], \"pro_cas\": [\"60233-66-1\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["2148-56-3", "3473-63-0"], "products": ["60233-66-1"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.079939", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31683636", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 40.0, "time_h": 16.5, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)Cc1nnn[nH]1.Cc1ccc(C(=O)C[C@](N)(c2ccc(OCCCC(F)(F)F)cc2)C(F)(F)F)cc1", "products": "Cc1ccc(C(=O)C[C@](NC(=O)Cc2nnn[nH]2)(c2ccc(OCCCC(F)(F)F)cc2)C(F)(F)F)cc1"}, "reference": {"title": "Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272", "authors": "Kempson, James; et al", "citation": "Organic Process Research & Development (2022), 26(4), 1327-1335.", "doi": "10.1021/acs.oprd.2c00036", "raw": "Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272 | Kempson, James; et al | Organic Process Research & Development (2022), 26(4), 1327-1335. | 10.1021/acs.oprd.2c00036"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-31683636", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Tetrahydrofuran; 30 min, 0 °C; 16 h, 40 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway", "By: Zhang, Li-qiong; et al", "Bioorganic & Medicinal Chemistry (2023), 94, 117478.", "10.1016/j.bmc.2023.117478"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Tetrahydrofuran|109-99-9", "cond_sig": "3625a1ea", "fam_sig": "434e9a28"}, "raw_data": {"raw_cas": "RCT: 508-02-1 + 22888-59-1 | PRO: 2387339-93-5 | RGT: 538-75-0 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272\", \"authors\": \"Kempson, James; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(4), 1327-1335.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31683636\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Tetrahydrofuran; 30 min, 0 °C; 16 h, 40 °C\", \"130. Scheme 130 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway\", \"By: Zhang, Li-qiong; et al\", \"Bioorganic & Medicinal Chemistry (2023), 94, 117478.\", \"10.1016/j.bmc.2023.117478\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"508-02-1\", \"22888-59-1\"], \"pro_cas\": [\"2387339-93-5\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"scalable, optimization study, optimized on base, solvent and temperature\"]}}", "enriched_names": {"reactants": ["508-02-1", "22888-59-1"], "products": ["2387339-93-5"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.079939", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31702269", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 82.0}, "smiles": {"reactants": "CCOC(=O)CCCCN.Cl.C[C@@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)O", "products": "CCOC(=O)CCCCNC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)OC(C)(C)C"}, "reference": {"title": "Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma", "authors": "Rango, Enrico; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113653.", "doi": "10.1016/j.ejmech.2021.113653", "raw": "Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma | Rango, Enrico; et al | European Journal of Medicinal Chemistry (2021), 223, 113653. | 10.1016/j.ejmech.2021.113653"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-31702269", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 89-86-1 + 2415386-52-4 | PRO: 2892016-22-5 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma\", \"authors\": \"Rango, Enrico; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113653.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31702269\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 16 h, rt\", \"89. Scheme 89 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"89-86-1\", \"2415386-52-4\"], \"pro_cas\": [\"2892016-22-5\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["89-86-1", "2415386-52-4"], "products": ["2892016-22-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.079939", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31702986", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 88.0}, "smiles": {"reactants": "Nc1ccc(O)cc1.O=C(O)C1(C(=O)Nc2ccc(F)cc2)CC1", "products": "O=C(Nc1ccc(O)cc1)C1(C(=O)Nc2ccc(F)cc2)CC1"}, "reference": {"title": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "authors": "Huang, Daowei; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113648.", "doi": "10.1016/j.ejmech.2021.113648", "raw": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors | Huang, Daowei; et al | European Journal of Medicinal Chemistry (2021), 223, 113648. | 10.1016/j.ejmech.2021.113648"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-31702986", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 2 h, rt", "1.2|Reagents: Hydrochloric acid", "Solvents: Water; pH 5, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities", "By: Peiretti, Franck; et al", "Journal of Medicinal Chemistry (2020), 63(21), 13124-13139.", "10.1021/acs.jmedchem.0c01555"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Hydrochloric acid|7647-01-0/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "a5fe15e0", "fam_sig": "9f93ad20"}, "raw_data": {"raw_cas": "RCT: 1142-39-8 + 6306-52-1 | PRO: 2172908-60-8 | RGT: 25952-53-8 + 7647-01-0 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"authors\": \"Huang, Daowei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31702986\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 2 h, rt\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 5, rt\", \"162. Scheme 162 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities\", \"By: Peiretti, Franck; et al\", \"Journal of Medicinal Chemistry (2020), 63(21), 13124-13139.\", \"10.1021/acs.jmedchem.0c01555\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1142-39-8\", \"6306-52-1\"], \"pro_cas\": [\"2172908-60-8\"], \"rgt_cas\": [\"25952-53-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1142-39-8", "6306-52-1"], "products": ["2172908-60-8"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.081680", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31703026", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccccc1Nc1ccc(F)cc1.Nc1ccc(O)cc1", "products": "O=C(Nc1ccc(O)cc1)c1ccccc1Nc1ccc(F)cc1"}, "reference": {"title": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "authors": "Huang, Daowei; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113648.", "doi": "10.1016/j.ejmech.2021.113648", "raw": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors | Huang, Daowei; et al | European Journal of Medicinal Chemistry (2021), 223, 113648. | 10.1016/j.ejmech.2021.113648"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-31703026", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 4 h, rt", "Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline", "By: Nandakumar, Meganathan; et al", "Journal of Medicinal Chemistry (2023), 66(21), 14724-14734.", "10.1021/acs.jmedchem.3c01273"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dimethylformamide|68-12-2", "cond_sig": "bccbd135", "fam_sig": "58382d4e"}, "raw_data": {"raw_cas": "RCT: 88-68-6 + 934-60-1 | PRO: 733806-23-0 | RGT: 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"authors\": \"Huang, Daowei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31703026\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 4 h, rt\", \"179. Scheme 179 (1 Reaction)\", \"Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline\", \"By: Nandakumar, Meganathan; et al\", \"Journal of Medicinal Chemistry (2023), 66(21), 14724-14734.\", \"10.1021/acs.jmedchem.3c01273\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"88-68-6\", \"934-60-1\"], \"pro_cas\": [\"733806-23-0\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["88-68-6", "934-60-1"], "products": ["733806-23-0"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.081680", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31703028", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 83.0}, "smiles": {"reactants": "Nc1ccc(Oc2ccnc(Cl)c2)cc1.O=C(O)C1(C(=O)Nc2ccc(F)cc2)CC1", "products": "O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc(Cl)c3)cc2)CC1"}, "reference": {"title": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "authors": "Huang, Daowei; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113648.", "doi": "10.1016/j.ejmech.2021.113648", "raw": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors | Huang, Daowei; et al | European Journal of Medicinal Chemistry (2021), 223, 113648. | 10.1016/j.ejmech.2021.113648"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31703028", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 4 h, rt", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dimethylformamide|68-12-2", "cond_sig": "bccbd135", "fam_sig": "58382d4e"}, "raw_data": {"raw_cas": "RCT: 1417404-28-4 + 3196-73-4 | PRO: 2614242-14-5 | RGT: 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"authors\": \"Huang, Daowei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31703028\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 4 h, rt\", \"11. Scheme 11 (1 Reaction)\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1417404-28-4\", \"3196-73-4\"], \"pro_cas\": [\"2614242-14-5\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1417404-28-4", "3196-73-4"], "products": ["2614242-14-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31703039", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 94.0}, "smiles": {"reactants": "Cc1c(C(=O)O)c(=O)n(-c2ccccc2)n1C.Nc1ccc(O)cc1", "products": "Cc1c(C(=O)Nc2ccc(O)cc2)c(=O)n(-c2ccccc2)n1C"}, "reference": {"title": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "authors": "Huang, Daowei; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113648.", "doi": "10.1016/j.ejmech.2021.113648", "raw": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors | Huang, Daowei; et al | European Journal of Medicinal Chemistry (2021), 223, 113648. | 10.1016/j.ejmech.2021.113648"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-31703039", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 4 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury", "By: Cui, Yingjun; et al", "Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.", "10.1021/acs.jmedchem.1c01583"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dimethylformamide|68-12-2", "cond_sig": "bccbd135", "fam_sig": "58382d4e"}, "raw_data": {"raw_cas": "RCT: 16947-84-5 + 29582-96-5 | PRO: 2757278-18-3 | RGT: 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"authors\": \"Huang, Daowei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31703039\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 4 h, rt\", \"320. Scheme 320 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury\", \"By: Cui, Yingjun; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.\", \"10.1021/acs.jmedchem.1c01583\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"16947-84-5\", \"29582-96-5\"], \"pro_cas\": [\"2757278-18-3\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["16947-84-5", "29582-96-5"], "products": ["2757278-18-3"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31703041", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 95.0}, "smiles": {"reactants": "Nc1ccc(F)cc1.O=C(O)c1ccccc1Nc1ccc(O)cc1", "products": "O=C(Nc1ccc(F)cc1)c1ccccc1Nc1ccc(O)cc1"}, "reference": {"title": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "authors": "Huang, Daowei; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113648.", "doi": "10.1016/j.ejmech.2021.113648", "raw": "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors | Huang, Daowei; et al | European Journal of Medicinal Chemistry (2021), 223, 113648. | 10.1016/j.ejmech.2021.113648"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-31703041", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 4 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "By: Sharma, Sudripet; et al", "Organic Process Research & Development (2021), 25(8), 1960-1965.", "10.1021/acs.oprd.1c00203"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dimethylformamide|68-12-2", "cond_sig": "bccbd135", "fam_sig": "58382d4e"}, "raw_data": {"raw_cas": "RCT: 62-53-3 + 1685-33-2 | PRO: 126727-27-3 | RGT: 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"authors\": \"Huang, Daowei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31703041\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 4 h, rt\", \"177. Scheme 177 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"By: Sharma, Sudripet; et al\", \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"10.1021/acs.oprd.1c00203\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"62-53-3\", \"1685-33-2\"], \"pro_cas\": [\"126727-27-3\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["62-53-3", "1685-33-2"], "products": ["126727-27-3"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31713170", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)C(Cl)=C(Cl)Cl.CCNC(=O)c1cnn(-c2ccc(N)cc2)c1C(F)(F)F", "products": "CCNC(=O)c1cnn(-c2ccc(NC(=O)C(Cl)=C(Cl)Cl)cc2)c1C(F)(F)F"}, "reference": {"title": "Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity", "authors": "Zhang, Sicheng; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(4), 572-578.", "doi": "10.1021/acsmedchemlett.0c00571", "raw": "Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity | Zhang, Sicheng; et al | ACS Medicinal Chemistry Letters (2021), 12(4), 572-578. | 10.1021/acsmedchemlett.0c00571"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-31713170", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 4 h, rt → reflux", "1.2|Solvents: Tetrahydrofuran; 12 h, rt", "Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors", "By: Kim, Namkyoung; et al", "European Journal of Medicinal Chemistry (2023), 259, 115635.", "10.1016/j.ejmech.2023.115635"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9", "cond_sig": "838cdc68", "fam_sig": "5126f37c"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 58483-95-7 | PRO: 171178-47-5 | RGT: 7719-09-7 | CAT: 68-12-2 | SOL: 75-09-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity\", \"authors\": \"Zhang, Sicheng; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(4), 572-578.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31713170\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 4 h, rt → reflux\", \"1.2\", \"Solvents: Tetrahydrofuran; 12 h, rt\", \"37. Scheme 37 (1 Reaction)\", \"Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors\", \"By: Kim, Namkyoung; et al\", \"European Journal of Medicinal Chemistry (2023), 259, 115635.\", \"10.1016/j.ejmech.2023.115635\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"58483-95-7\"], \"pro_cas\": [\"171178-47-5\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "58483-95-7"], "products": ["171178-47-5"], "reagents": ["7719-09-7"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31751498", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1n[nH]c2ccc(Br)cc12.CC(C)(C)OC(=O)N1CCC(CN)CC1", "products": "CC(C)(C)OC(=O)N1CCC(CNC(=O)c2n[nH]c3ccc(Br)cc23)CC1"}, "reference": {"title": "Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine", "authors": "Jiang, Xueyang; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113663.", "doi": "10.1016/j.ejmech.2021.113663", "raw": "Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine | Jiang, Xueyang; et al | European Journal of Medicinal Chemistry (2021), 223, 113663. | 10.1016/j.ejmech.2021.113663"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-31751498", "1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dimethylformamide; 24 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors", "By: Yang, Kai S.; et al", "ChemMedChem (2021), 16(6), 942-948.", "10.1002/cmdc.202000924"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dimethylformamide|68-12-2", "cond_sig": "f86fe01c", "fam_sig": "36654deb"}, "raw_data": {"raw_cas": "RCT: 16966-09-9 + 17193-39-4 | PRO: 2481134-18-1 | RGT: 538-75-0 + 2592-95-2 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine\", \"authors\": \"Jiang, Xueyang; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113663.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31751498\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dimethylformamide; 24 h, rt\", \"52. Scheme 52 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A quick route to multiple highly potent SARS-CoV-2 main protease inhibitors\", \"By: Yang, Kai S.; et al\", \"ChemMedChem (2021), 16(6), 942-948.\", \"10.1002/cmdc.202000924\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"16966-09-9\", \"17193-39-4\"], \"pro_cas\": [\"2481134-18-1\"], \"rgt_cas\": [\"538-75-0\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["16966-09-9", "17193-39-4"], "products": ["2481134-18-1"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31751503", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCC(CC(=O)O)CC1.Nc1n[nH]c2cc(Br)ccc12", "products": "CC(C)(C)OC(=O)N1CCC(CC(=O)Nc2n[nH]c3cc(Br)ccc23)CC1"}, "reference": {"title": "Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine", "authors": "Jiang, Xueyang; et al", "citation": "European Journal of Medicinal Chemistry (2021), 223, 113663.", "doi": "10.1016/j.ejmech.2021.113663", "raw": "Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine | Jiang, Xueyang; et al | European Journal of Medicinal Chemistry (2021), 223, 113663. | 10.1016/j.ejmech.2021.113663"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31751503", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP", "Solvents: Dimethylformamide; 12 h, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "d7e17540", "fam_sig": "9fffd8e9"}, "raw_data": {"raw_cas": "RCT: 3075104-34-3 + 62965-35-9 | PRO: 3075104-45-6 | RGT: 2592-95-2 + 7087-68-5 + 128625-52-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine\", \"authors\": \"Jiang, Xueyang; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 223, 113663.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31751503\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, PyBOP\", \"Solvents: Dimethylformamide; 12 h, rt\", \"96. Scheme 96 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-34-3\", \"62965-35-9\"], \"pro_cas\": [\"3075104-45-6\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3075104-34-3", "62965-35-9"], "products": ["3075104-45-6"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31769035", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride", "cas": "3945-69-5", "role": "UNK"}], "solvents": [{"name": "Methanol", "cas": "67-56-1"}], "conditions": {"temperature_c": 0.0, "time_h": 16.083, "yield_pct": 83.0}, "smiles": {"reactants": "N#Cc1ccc(C(=O)O)nc1.CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(N)ccc2F)Cn2c(C#N)cnc21", "products": "CC(C)(C)OC(=O)NC1=N[C@](C)(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2c(C#N)cnc21"}, "reference": {"title": "A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo", "authors": "Peschiulli, Aldo; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(1), 76-83.", "doi": "10.1021/acsmedchemlett.1c00445", "raw": "A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo | Peschiulli, Aldo; et al | ACS Medicinal Chemistry Letters (2022), 13(1), 76-83. | 10.1021/acsmedchemlett.1c00445"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-31769035", "1.1|Reagents: 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride", "Solvents: Methanol; 5 min, rt; rt → 0 °C", "1.2|Solvents: Methanol; 0 °C → rt; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing", "By: Hobson, Adrian D.; et al", "Journal of Medicinal Chemistry (2023), 66(13), 9161-9173.", "10.1021/acs.jmedchem.3c00794"], "signatures": {"cond_key": "none/none/4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride|3945-69-5/Methanol|67-56-1", "cond_sig": "89883fac", "fam_sig": "fbadfb91"}, "raw_data": {"raw_cas": "RCT: 27317-69-7 + 2166375-82-0 | PRO: 2345733-79-9 | RGT: 3945-69-5 | SOL: 67-56-1", "raw_data_json": "{\"txt\": {\"title\": \"A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo\", \"authors\": \"Peschiulli, Aldo; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(1), 76-83.\", \"reagents\": [\"4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride\"], \"catalysts\": [], \"solvents\": [\"Methanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31769035\", \"1.1\", \"Reagents: 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride\", \"Solvents: Methanol; 5 min, rt; rt → 0 °C\", \"1.2\", \"Solvents: Methanol; 0 °C → rt; 16 h, rt\", \"448. Scheme 448 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing\", \"By: Hobson, Adrian D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(13), 9161-9173.\", \"10.1021/acs.jmedchem.3c00794\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"27317-69-7\", \"2166375-82-0\"], \"pro_cas\": [\"2345733-79-9\"], \"rgt_cas\": [\"3945-69-5\"], \"cat_cas\": [], \"sol_cas\": [\"67-56-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["27317-69-7", "2166375-82-0"], "products": ["2345733-79-9"], "reagents": ["3945-69-5"], "catalysts": [], "solvents": ["Methanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31806452", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "NUC"}, {"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 48.017, "yield_pct": 93.0}, "smiles": {"reactants": "Cc1cc(CNC(=O)c2cc(C(=O)O)ncn2)ccc1F.Cl.[2H]C([2H])(N)c1ccc(C(=O)OC)cc1", "products": "[2H]C([2H])(NC(=O)c1cc(C(=O)NCc2ccc(C(=O)OC)cc2)ncn1)c1ccc(F)c(C)c1"}, "reference": {"title": "Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis", "authors": "Bendele, Alison M.; et al", "citation": "European Journal of Medicinal Chemistry (2021), 224, 113666.", "doi": "10.1016/j.ejmech.2021.113666", "raw": "Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis | Bendele, Alison M.; et al | European Journal of Medicinal Chemistry (2021), 224, 113666. | 10.1016/j.ejmech.2021.113666"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-31806452", "1.1|Reagents: HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; > 1 min, rt", "1.2|Reagents: 4-Methylmorpholine; 48 h, rt", "Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis", "By: Li, Na; et al", "Journal of Medicinal Chemistry (2023), 66(19), 13428-13451.", "10.1021/acs.jmedchem.3c00696"], "signatures": {"cond_key": "none/none/1-Hydroxy-7-azabenzotriazole|39968-33-7+4-Methylmorpholine|+HATU|148893-10-1+N-Methylmorpholine|109-02-4+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "7d2ef10b", "fam_sig": "a8d00307"}, "raw_data": {"raw_cas": "RCT: 38041-19-9 + 3034891-94-3 | PRO: 3034891-87-4 | RGT: 39968-33-7 + 148893-10-1 + 109-02-4 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis\", \"authors\": \"Bendele, Alison M.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 224, 113666.\", \"reagents\": [\"HOAt\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"4-Methylmorpholine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31806452\", \"1.1\", \"Reagents: HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; > 1 min, rt\", \"1.2\", \"Reagents: 4-Methylmorpholine; 48 h, rt\", \"473. Scheme 473 (1 Reaction)\", \"Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis\", \"By: Li, Na; et al\", \"Journal of Medicinal Chemistry (2023), 66(19), 13428-13451.\", \"10.1021/acs.jmedchem.3c00696\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"38041-19-9\", \"3034891-94-3\"], \"pro_cas\": [\"3034891-87-4\"], \"rgt_cas\": [\"39968-33-7\", \"148893-10-1\", \"109-02-4\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["38041-19-9", "3034891-94-3"], "products": ["3034891-87-4"], "reagents": ["1-Hydroxy-7-azabenzotriazole", "HATU", "N-Methylmorpholine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31808459", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 80.0}, "smiles": {"reactants": "Cl.NC1CCCCc2cc(Br)ccc21.CC(C)(C)c1nnc(C(=O)O)o1.[K]", "products": "CC(C)(C)c1nnc(C(=O)NC2CCCCc3cc(Br)ccc32)o1"}, "reference": {"title": "Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis", "authors": "Hopkins, Brian T.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(2), 1206-1224.", "doi": "10.1021/acs.jmedchem.1c00926", "raw": "Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis | Hopkins, Brian T.; et al | Journal of Medicinal Chemistry (2022), 65(2), 1206-1224. | 10.1021/acs.jmedchem.1c00926"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31808459", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 4 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies", "By: Barlaam, Bernard; et al", "Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.", "10.1021/acs.jmedchem.0c01754"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 222530-34-9 + 84249-14-9 | PRO: 2057506-34-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis\", \"authors\": \"Hopkins, Brian T.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(2), 1206-1224.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31808459\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 4 h, rt\", \"385. Scheme 385 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies\", \"By: Barlaam, Bernard; et al\", \"Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.\", \"10.1021/acs.jmedchem.0c01754\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"222530-34-9\", \"84249-14-9\"], \"pro_cas\": [\"2057506-34-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["222530-34-9", "84249-14-9"], "products": ["2057506-34-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.082425", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31809349", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 87.0}, "smiles": {"reactants": "NC1CCC1.COc1cccc(OC)c1-c1cc(C(=O)N[C@@H](CCN2CCCCC2)CC(=O)O)nn1C1CCCC1.Cl", "products": "COc1cccc(OC)c1-c1cc(C(=O)N[C@@H](CCN2CCCCC2)CC(=O)NC2CCC2)nn1C1CCCC1.Cl"}, "reference": {"title": "Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice", "authors": "Narayanan, Sanju; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(6), 3006-3025.", "doi": "10.1021/acs.jmedchem.0c01448", "raw": "Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice | Narayanan, Sanju; et al | Journal of Medicinal Chemistry (2021), 64(6), 3006-3025. | 10.1021/acs.jmedchem.0c01448"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-31809349", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Acetonitrile; 4 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "PROTACs Targeting MLKL Protect Cells from Necroptosis", "By: Rathje, Oliver H.; et al", "Journal of Medicinal Chemistry (2023), 66(16), 11216-11236.", "10.1021/acs.jmedchem.3c00665"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+NaHCO3|144-55-8+Sodium bicarbonate|+Triethylamine|121-44-8/Acetonitrile|75-05-8+Water|7732-18-5", "cond_sig": "fbd97734", "fam_sig": "d77da5e7"}, "raw_data": {"raw_cas": "RCT: 191732-72-6 + 462100-06-7 | PRO: 2138440-80-7 | RGT: 121-44-8 + 94790-37-1 + 144-55-8 | SOL: 75-05-8 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice\", \"authors\": \"Narayanan, Sanju; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(6), 3006-3025.\", \"reagents\": [\"Triethylamine\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31809349\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Acetonitrile; 4 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"344. Scheme 344 (1 Reaction)\", \"PROTACs Targeting MLKL Protect Cells from Necroptosis\", \"By: Rathje, Oliver H.; et al\", \"Journal of Medicinal Chemistry (2023), 66(16), 11216-11236.\", \"10.1021/acs.jmedchem.3c00665\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"191732-72-6\", \"462100-06-7\"], \"pro_cas\": [\"2138440-80-7\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"7732-18-5\"], \"notes\": [\"product is further converted to HCl salt\"]}}", "enriched_names": {"reactants": ["191732-72-6", "462100-06-7"], "products": ["2138440-80-7"], "reagents": ["Triethylamine", "HBTU", "NaHCO3"], "catalysts": [], "solvents": ["Acetonitrile", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31814271", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Methanol", "cas": "67-56-1", "role": "UNK"}, {"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 45.0, "time_h": 19.0, "yield_pct": 87.0}, "smiles": {"reactants": "C=C[C@@H]1C[C@]1(N)C(=O)NS(=O)(=O)C1(C)CC1.Cl.CC(C)Oc1ccc(-c2nc(O[C@@H]3C[C@@H](C(=O)O)N(C(=O)OC(C)(C)C)C3)c3oc4ccccc4c3n2)cc1", "products": "C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2nc(-c3ccc(OC(C)C)cc3)nc3c2oc2ccccc23)CN1)C(=O)NS(=O)(=O)C1(C)CC1.Cl"}, "reference": {"title": "Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir", "authors": "Zhang, Weihong; et al", "citation": "Organic Process Research & Development (2022), 26(4), 1078-1093.", "doi": "10.1021/acs.oprd.1c00315", "raw": "Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir | Zhang, Weihong; et al | Organic Process Research & Development (2022), 26(4), 1078-1093. | 10.1021/acs.oprd.1c00315"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-31814271", "1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; < 10 °C; 3 h, < 10 °C", "1.2|Reagents: Methanol, Thionyl chloride", "Solvents: Tetrahydrofuran; < 40 °C; 16 h, 45 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores", "By: Patel, Bhautikkumar; et al", "ChemMedChem (2020), 15(15), 1429-1438.", "10.1002/cmdc.202000033"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+HATU|148893-10-1+Methanol|67-56-1+N-Methylmorpholine|109-02-4+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Thionyl chloride|7719-09-7/Tetrahydrofuran|109-99-9", "cond_sig": "75ead6e7", "fam_sig": "df996cea"}, "raw_data": {"raw_cas": "RCT: 2493230-04-7 + 68691-77-0 | PRO: 2493230-08-1 | RGT: 109-02-4 + 148893-10-1 + 67-56-1 + 7719-09-7 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir\", \"authors\": \"Zhang, Weihong; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(4), 1078-1093.\", \"reagents\": [\"4-Methylmorpholine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Methanol\", \"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31814271\", \"1.1\", \"Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; < 10 °C; 3 h, < 10 °C\", \"1.2\", \"Reagents: Methanol, Thionyl chloride\", \"Solvents: Tetrahydrofuran; < 40 °C; 16 h, 45 °C\", \"494. Scheme 494 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores\", \"By: Patel, Bhautikkumar; et al\", \"ChemMedChem (2020), 15(15), 1429-1438.\", \"10.1002/cmdc.202000033\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2493230-04-7\", \"68691-77-0\"], \"pro_cas\": [\"2493230-08-1\"], \"rgt_cas\": [\"109-02-4\", \"148893-10-1\", \"67-56-1\", \"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"optimization study (stage 1), optimized on base (stage 1), optimized on reagent (stage 1), optimized on solvent (stage 1), optimized on temperature (stage 1), optimized on time (stage 1)\"]}}", "enriched_names": {"reactants": ["2493230-04-7", "68691-77-0"], "products": ["2493230-08-1"], "reagents": ["N-Methylmorpholine", "HATU", "Methanol", "7719-09-7"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31824047", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 84.0}, "smiles": {"reactants": "COC(=O)[C@H](N)Cc1ccc(O)cc1.CC(C)(C)OC(=O)NCC(=O)O", "products": "COC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)OC(C)(C)C"}, "reference": {"title": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "authors": "Falkenstein, Markus; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "doi": "10.1016/j.bmc.2021.116462", "raw": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation | Falkenstein, Markus; et al | Bioorganic & Medicinal Chemistry (2021), 50, 116462. | 10.1016/j.bmc.2021.116462"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-31824047", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|16 h, rt", "Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors", "By: Jia, Haiyong; et al", "European Journal of Medicinal Chemistry (2020), 202, 112495.", "10.1016/j.ejmech.2020.112495"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 1780825-95-7 + 140-75-0 | PRO: 2460957-62-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"authors\": \"Falkenstein, Markus; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31824047\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"16 h, rt\", \"231. Scheme 231 (1 Reaction)\", \"Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors\", \"By: Jia, Haiyong; et al\", \"European Journal of Medicinal Chemistry (2020), 202, 112495.\", \"10.1016/j.ejmech.2020.112495\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1780825-95-7\", \"140-75-0\"], \"pro_cas\": [\"2460957-62-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1780825-95-7", "140-75-0"], "products": ["2460957-62-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31824053", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 86.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)(C)OC(=O)NCC(=O)O", "products": "COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)OC(C)(C)C"}, "reference": {"title": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "authors": "Falkenstein, Markus; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "doi": "10.1016/j.bmc.2021.116462", "raw": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation | Falkenstein, Markus; et al | Bioorganic & Medicinal Chemistry (2021), 50, 116462. | 10.1016/j.bmc.2021.116462"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-31824053", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|16 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "By: Falkenstein, Markus; et al", "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "10.1016/j.bmc.2021.116462"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 3410-66-0 + 4530-20-5 | PRO: 2413848-30-1 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"authors\": \"Falkenstein, Markus; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31824053\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"16 h, rt\", \"230. Scheme 230 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"By: Falkenstein, Markus; et al\", \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"10.1016/j.bmc.2021.116462\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3410-66-0\", \"4530-20-5\"], \"pro_cas\": [\"2413848-30-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3410-66-0", "4530-20-5"], "products": ["2413848-30-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31824054", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 93.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C"}, "reference": {"title": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "authors": "Falkenstein, Markus; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "doi": "10.1016/j.bmc.2021.116462", "raw": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation | Falkenstein, Markus; et al | Bioorganic & Medicinal Chemistry (2021), 50, 116462. | 10.1016/j.bmc.2021.116462"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-31824054", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease", "By: Kilpelainen, Tommi P.; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.", "10.1021/acs.jmedchem.3c00235"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 102879-51-6 + 204503-00-4 | PRO: 3007690-73-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"authors\": \"Falkenstein, Markus; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31824054\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"16 h, rt\", \"309. Scheme 309 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease\", \"By: Kilpelainen, Tommi P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.\", \"10.1021/acs.jmedchem.3c00235\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"102879-51-6\", \"204503-00-4\"], \"pro_cas\": [\"3007690-73-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["102879-51-6", "204503-00-4"], "products": ["3007690-73-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31824055", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 80.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O", "products": "COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "authors": "Falkenstein, Markus; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "doi": "10.1016/j.bmc.2021.116462", "raw": "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation | Falkenstein, Markus; et al | Bioorganic & Medicinal Chemistry (2021), 50, 116462. | 10.1016/j.bmc.2021.116462"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-31824055", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 50-79-3 + 2760538-76-7 | PRO: 2760538-83-6 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"authors\": \"Falkenstein, Markus; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31824055\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"16 h, rt\", \"357. Scheme 357 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"50-79-3\", \"2760538-76-7\"], \"pro_cas\": [\"2760538-83-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["50-79-3", "2760538-76-7"], "products": ["2760538-83-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31828433", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 5.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "NCCc1ccccc1.O=C(O)c1c[nH]nc1-c1ccc(Cl)c(Cl)c1", "products": "O=C(NCCc1ccccc1)c1c[nH]nc1-c1ccc(Cl)c(Cl)c1"}, "reference": {"title": "Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors", "authors": "Sturbaut, Manon; et al", "citation": "European Journal of Medicinal Chemistry (2021), 226, 113835.", "doi": "10.1016/j.ejmech.2021.113835", "raw": "Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors | Sturbaut, Manon; et al | European Journal of Medicinal Chemistry (2021), 226, 113835. | 10.1016/j.ejmech.2021.113835"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31828433", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; rt → 5 °C; overnight, 5 °C", "Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor", "By: Liu, Haixia; et al", "European Journal of Medicinal Chemistry (2022), 244, 114810.", "10.1016/j.ejmech.2022.114810"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 29241-62-1 + 39065-95-7 | PRO: 1491150-22-1 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors\", \"authors\": \"Sturbaut, Manon; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 226, 113835.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31828433\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; rt → 5 °C; overnight, 5 °C\", \"307. Scheme 307 (1 Reaction)\", \"Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor\", \"By: Liu, Haixia; et al\", \"European Journal of Medicinal Chemistry (2022), 244, 114810.\", \"10.1016/j.ejmech.2022.114810\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"29241-62-1\", \"39065-95-7\"], \"pro_cas\": [\"1491150-22-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["29241-62-1", "39065-95-7"], "products": ["1491150-22-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31857598", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": null, "time_h": 2.0, "yield_pct": 97.0}, "smiles": {"reactants": "Nc1ccccc1N.O=CC(=O)O", "products": "O=c1cnc2ccccc2[nH]1"}, "reference": {"title": "A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core", "authors": "Garcia-Marin, Javier; et al", "citation": "ChemMedChem (2021), 16(18), 2895-2906.", "doi": "10.1002/cmdc.202100338", "raw": "A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core | Garcia-Marin, Javier; et al | ChemMedChem (2021), 16(18), 2895-2906. | 10.1002/cmdc.202100338"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-31857598", "1.1|Solvents: Water; 2 h, reflux", "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "By: Huang, Daowei; et al", "European Journal of Medicinal Chemistry (2021), 223, 113648.", "10.1016/j.ejmech.2021.113648"], "signatures": {"cond_key": "none/none/none/Water|7732-18-5", "cond_sig": "f0570e4c", "fam_sig": "f0570e4c"}, "raw_data": {"raw_cas": "RCT: 371-40-4 + 98156-55-9 | PRO: 3037065-19-0 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core\", \"authors\": \"Garcia-Marin, Javier; et al\", \"citation\": \"ChemMedChem (2021), 16(18), 2895-2906.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31857598\", \"1.1\", \"Solvents: Water; 2 h, reflux\", \"176. Scheme 176 (1 Reaction)\", \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"By: Huang, Daowei; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"10.1016/j.ejmech.2021.113648\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"371-40-4\", \"98156-55-9\"], \"pro_cas\": [\"3037065-19-0\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["371-40-4", "98156-55-9"], "products": ["3037065-19-0"], "reagents": [], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31901528", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 7.417, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)CCCCCCCCCCCN", "products": "COC(=O)CCCCCCCCCCCNC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C"}, "reference": {"title": "Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis", "authors": "Houstecka, Radka; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.", "doi": "10.1021/acs.jmedchem.9b01351", "raw": "Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis | Houstecka, Radka; et al | Journal of Medicinal Chemistry (2020), 63(4), 1576-1596. | 10.1021/acs.jmedchem.9b01351"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-31901528", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 25 min, rt", "1.2|Solvents: Dimethylformamide; 6 h, rt", "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "By: Huang, Daowei; et al", "European Journal of Medicinal Chemistry (2021), 223, 113648.", "10.1016/j.ejmech.2021.113648"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "a5109a00", "fam_sig": "24dfcf20"}, "raw_data": {"raw_cas": "RCT: 123-30-8 + 849217-48-7 | PRO: 849217-60-3 | RGT: 7087-68-5 + 94790-37-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis\", \"authors\": \"Houstecka, Radka; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31901528\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 25 min, rt\", \"1.2\", \"Solvents: Dimethylformamide; 6 h, rt\", \"161. Scheme 161 (1 Reaction)\", \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"By: Huang, Daowei; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"10.1016/j.ejmech.2021.113648\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"123-30-8\", \"849217-48-7\"], \"pro_cas\": [\"849217-60-3\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["123-30-8", "849217-48-7"], "products": ["849217-60-3"], "reagents": ["N,N-Diisopropylethylamine", "HBTU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31901530", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.417, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1cccnc1)C(=O)O.COC(=O)CCCCCCCCCCCN", "products": "COC(=O)CCCCCCCCCCCNC(=O)[C@H](Cc1cccnc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis", "authors": "Houstecka, Radka; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.", "doi": "10.1021/acs.jmedchem.9b01351", "raw": "Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis | Houstecka, Radka; et al | Journal of Medicinal Chemistry (2020), 63(4), 1576-1596. | 10.1021/acs.jmedchem.9b01351"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-31901530", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 25 min, rt", "1.2|Solvents: Dimethylformamide; 6 h, rt", "Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers", "By: Ren, Junkang; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 78, 129046.", "10.1016/j.bmcl.2022.129046"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "a5109a00", "fam_sig": "24dfcf20"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 259809-49-9 | PRO: 2868276-65-5 | RGT: 7087-68-5 + 94790-37-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis\", \"authors\": \"Houstecka, Radka; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31901530\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 25 min, rt\", \"1.2\", \"Solvents: Dimethylformamide; 6 h, rt\", \"378. Scheme 378 (1 Reaction)\", \"Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers\", \"By: Ren, Junkang; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 78, 129046.\", \"10.1016/j.bmcl.2022.129046\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"259809-49-9\"], \"pro_cas\": [\"2868276-65-5\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "259809-49-9"], "products": ["2868276-65-5"], "reagents": ["N,N-Diisopropylethylamine", "HBTU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31909255", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 9.0, "yield_pct": 82.0}, "smiles": {"reactants": "CCCCCCCC/C=C\\CCCCCCCC(=O)O.Nc1cc2cccnc2c2ncccc12", "products": "CCCCCCCC/C=C\\CCCCCCCC(=O)Nc1cc2cccnc2c2ncccc12"}, "reference": {"title": "Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms", "authors": "Toscani, Anita; et al", "citation": "European Journal of Medicinal Chemistry (2021), 213, 113172.", "doi": "10.1016/j.ejmech.2021.113172", "raw": "Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms | Toscani, Anita; et al | European Journal of Medicinal Chemistry (2021), 213, 113172. | 10.1016/j.ejmech.2021.113172"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-31909255", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide; 3 h, reflux", "1.2|Solvents: Dichloromethane; rt", "1.3|Reagents: Triethylamine; 6 h, rt", "Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells", "By: Elsocht, Mathias; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 79, 129066.", "10.1016/j.bmcl.2022.129066"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "7e24dde3", "fam_sig": "465abb34"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 446-08-2 | PRO: 16499-56-2 | RGT: 7719-09-7 + 121-44-8 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms\", \"authors\": \"Toscani, Anita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 213, 113172.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31909255\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide; 3 h, reflux\", \"1.2\", \"Solvents: Dichloromethane; rt\", \"1.3\", \"Reagents: Triethylamine; 6 h, rt\", \"445. Scheme 445 (1 Reaction)\", \"Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells\", \"By: Elsocht, Mathias; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 79, 129066.\", \"10.1016/j.bmcl.2022.129066\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"446-08-2\"], \"pro_cas\": [\"16499-56-2\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "446-08-2"], "products": ["16499-56-2"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-31915608", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "COc1ccc2[nH]cc(CCN)c2c1.CC(C)(C)OC(=O)NCC(=O)O", "products": "COc1ccc2[nH]cc(CCNC(=O)CNC(=O)OC(C)(C)C)c2c1"}, "reference": {"title": "Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model", "authors": "He, Feng; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(7), 3794-3812.", "doi": "10.1021/acs.jmedchem.0c01940", "raw": "Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model | He, Feng; et al | Journal of Medicinal Chemistry (2021), 64(7), 3794-3812. | 10.1021/acs.jmedchem.0c01940"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-31915608", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Tetrahydrofuran; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum", "By: Kraft, Oliver; et al", "European Journal of Medicinal Chemistry (2021), 209, 112920.", "10.1016/j.ejmech.2020.112920"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Triethylamine|121-44-8/Tetrahydrofuran|109-99-9", "cond_sig": "6b756f2f", "fam_sig": "f8daacea"}, "raw_data": {"raw_cas": "RCT: 107277-31-6 + 107-15-3 | PRO: 2691784-99-1 | RGT: 121-44-8 + 25952-53-8 | CAT: 1122-58-3 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model\", \"authors\": \"He, Feng; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(7), 3794-3812.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-31915608\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Tetrahydrofuran; overnight, rt\", \"32. Scheme 32 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum\", \"By: Kraft, Oliver; et al\", \"European Journal of Medicinal Chemistry (2021), 209, 112920.\", \"10.1016/j.ejmech.2020.112920\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"107277-31-6\", \"107-15-3\"], \"pro_cas\": [\"2691784-99-1\"], \"rgt_cas\": [\"121-44-8\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["107277-31-6", "107-15-3"], "products": ["2691784-99-1"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32019465", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 86.0}, "smiles": {"reactants": "Nc1ccccc1N.COC(=O)COc1ccc(-c2nc3ccc(C(=O)O)cc3[nH]2)cc1", "products": "COC(=O)COc1ccc(-c2nc3ccc(C(=O)Nc4ccccc4N)cc3[nH]2)cc1"}, "reference": {"title": "Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity", "authors": "Chen, Chen; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3667-3683.", "doi": "10.1021/acs.jmedchem.1c02225", "raw": "Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity | Chen, Chen; et al | Journal of Medicinal Chemistry (2022), 65(4), 3667-3683. | 10.1021/acs.jmedchem.1c02225"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-32019465", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 6 - 8 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "By: Meena, Chhuttan L.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "10.1016/j.bmcl.2020.127039"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2", "cond_sig": "7dec0139", "fam_sig": "3e568a1e"}, "raw_data": {"raw_cas": "RCT: 18942-49-9 + 2413279-66-8 | PRO: 2413279-31-7 | RGT: 7087-68-5 + 125700-67-6 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity\", \"authors\": \"Chen, Chen; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3667-3683.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32019465\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 6 - 8 h, rt\", \"124. Scheme 124 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"By: Meena, Chhuttan L.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"10.1016/j.bmcl.2020.127039\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"18942-49-9\", \"2413279-66-8\"], \"pro_cas\": [\"2413279-31-7\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["tert-Butyldimethylsilyl chloride", "2413279-66-8"], "products": ["2413279-31-7"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32020154", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 6.0, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)CN.Nc1cccc(F)c1C(=O)O", "products": "CC(C)CNC(=O)c1c(N)cccc1F"}, "reference": {"title": "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease", "authors": "Li, Feng; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.", "doi": "10.1021/acs.jmedchem.0c01544", "raw": "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease | Li, Feng; et al | Journal of Medicinal Chemistry (2020), 63(22), 13973-13993. | 10.1021/acs.jmedchem.0c01544"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-32020154", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 6 h, rt", "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells", "By: Liang, Tao; et al", "Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.", "10.1021/acs.jmedchem.0c01454"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "004c71d2", "fam_sig": "6a8d59c1"}, "raw_data": {"raw_cas": "RCT: 586-89-0 + 6232-11-7 | PRO: 2718890-12-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease\", \"authors\": \"Li, Feng; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32020154\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 6 h, rt\", \"47. Scheme 47 (1 Reaction)\", \"HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells\", \"By: Liang, Tao; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.\", \"10.1021/acs.jmedchem.0c01454\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"586-89-0\", \"6232-11-7\"], \"pro_cas\": [\"2718890-12-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["586-89-0", "6232-11-7"], "products": ["2718890-12-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.084649", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32020159", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 6.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)N.Nc1cccc(F)c1C(=O)O", "products": "CC(C)NC(=O)c1c(N)cccc1F"}, "reference": {"title": "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease", "authors": "Li, Feng; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.", "doi": "10.1021/acs.jmedchem.0c01544", "raw": "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease | Li, Feng; et al | Journal of Medicinal Chemistry (2020), 63(22), 13973-13993. | 10.1021/acs.jmedchem.0c01544"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-32020159", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 6 h, rt", "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway", "By: Rastelli, Ettore J.; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.", "10.1016/j.bmcl.2021.128167"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "004c71d2", "fam_sig": "6a8d59c1"}, "raw_data": {"raw_cas": "RCT: 4942-47-6 + 13325-10-5 | PRO: 1972135-11-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease\", \"authors\": \"Li, Feng; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32020159\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 6 h, rt\", \"41. Scheme 41 (1 Reaction)\", \"Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway\", \"By: Rastelli, Ettore J.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.\", \"10.1016/j.bmcl.2021.128167\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4942-47-6\", \"13325-10-5\"], \"pro_cas\": [\"1972135-11-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["4942-47-6", "13325-10-5"], "products": ["1972135-11-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32020179", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 12.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1c(F)cccc1[N+](=O)[O-].NCc1ccccc1", "products": "O=C(NCc1ccccc1)c1c(F)cccc1[N+](=O)[O-]"}, "reference": {"title": "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease", "authors": "Li, Feng; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.", "doi": "10.1021/acs.jmedchem.0c01544", "raw": "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease | Li, Feng; et al | Journal of Medicinal Chemistry (2020), 63(22), 13973-13993. | 10.1021/acs.jmedchem.0c01544"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-32020179", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Tetrahydrofuran; 0 °C; 1 h, 0 °C; 5 h, 0 °C → rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 0 °C; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "By: Sampaio-Dias, Ivo E.; et al", "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "10.1021/acs.jmedchem.1c00252"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Oxalyl chloride|79-37-8/Tetrahydrofuran|109-99-9", "cond_sig": "88d941cc", "fam_sig": "6b84e4d8"}, "raw_data": {"raw_cas": "RCT: 1103527-41-8 + 5680-79-5 | PRO: 2732919-59-2 | RGT: 79-37-8 + 7087-68-5 | CAT: 68-12-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease\", \"authors\": \"Li, Feng; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.\", \"reagents\": [\"Oxalyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32020179\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Tetrahydrofuran; 0 °C; 1 h, 0 °C; 5 h, 0 °C → rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 0 °C; 6 h, rt\", \"137. Scheme 137 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"By: Sampaio-Dias, Ivo E.; et al\", \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"10.1021/acs.jmedchem.1c00252\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1103527-41-8\", \"5680-79-5\"], \"pro_cas\": [\"2732919-59-2\"], \"rgt_cas\": [\"79-37-8\", \"7087-68-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["1103527-41-8", "5680-79-5"], "products": ["2732919-59-2"], "reagents": ["79-37-8", "N,N-Diisopropylethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32038501", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 130.0, "time_h": 4.0, "yield_pct": 88.0}, "smiles": {"reactants": "NC=O.Nc1ccc(Br)cc1C(=O)O", "products": "O=c1nc[nH]c2ccc(Br)cc12"}, "reference": {"title": "Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition", "authors": "Yang, Huarong; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 46, 116346.", "doi": "10.1016/j.bmc.2021.116346", "raw": "Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition | Yang, Huarong; et al | Bioorganic & Medicinal Chemistry (2021), 46, 116346. | 10.1016/j.bmc.2021.116346"}, "original_text": ["Steps: 1, Yield: 88-95%", "CAS Reaction Number: 31-614-CAS-32038501", "1.1|4 h, 130 °C", "Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity", "By: Teng, Yu; et al", "European Journal of Medicinal Chemistry (2020), 208, 112865.", "10.1016/j.ejmech.2020.112865"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 3473-63-0 + 5794-88-7 | PRO: 32084-59-6", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition\", \"authors\": \"Yang, Huarong; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 46, 116346.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32038501\", \"1.1\", \"4 h, 130 °C\", \"441. Scheme 441 (1 Reaction)\", \"Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity\", \"By: Teng, Yu; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112865.\", \"10.1016/j.ejmech.2020.112865\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3473-63-0\", \"5794-88-7\"], \"pro_cas\": [\"32084-59-6\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["3473-63-0", "5794-88-7"], "products": ["32084-59-6"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32085759", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 84.0}, "smiles": {"reactants": "Nc1ccc(F)cc1.O=C(O)C1(c2ccc(Br)cc2)COC1", "products": "O=C(Nc1ccc(F)cc1)C1(c2ccc(Br)cc2)COC1"}, "reference": {"title": "Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing", "authors": "Li, Derun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(8), 6001-6016.", "doi": "10.1021/acs.jmedchem.1c01670", "raw": "Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing | Li, Derun; et al | Journal of Medicinal Chemistry (2022), 65(8), 6001-6016. | 10.1021/acs.jmedchem.1c01670"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-32085759", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C → rt; 1 h, rt", "1.2|Reagents: Water; rt", "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor", "By: Huestis, Malcolm P.; et al", "ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.", "10.1021/acsmedchemlett.1c00063"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "e0675df9", "fam_sig": "b547340e"}, "raw_data": {"raw_cas": "RCT: 872091-00-4 + 945244-29-1 | PRO: 2729996-48-7 | RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing\", \"authors\": \"Li, Derun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(8), 6001-6016.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32085759\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C → rt; 1 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"246. Scheme 246 (1 Reaction)\", \"Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor\", \"By: Huestis, Malcolm P.; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.\", \"10.1021/acsmedchemlett.1c00063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"872091-00-4\", \"945244-29-1\"], \"pro_cas\": [\"2729996-48-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"alternate reaction conditions gave 75% yield\"]}}", "enriched_names": {"reactants": ["872091-00-4", "945244-29-1"], "products": ["2729996-48-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32142486", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 90.0}, "smiles": {"reactants": "Nc1ccc(Cl)cc1Cl.O=C(O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1", "products": "O=C(Nc1ccc(Cl)cc1Cl)c1ccc(S(=O)(=O)Nc2ccccc2)cc1"}, "reference": {"title": "Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27", "authors": "Pillaiyar, Thanigaimalai; et al", "citation": "European Journal of Medicinal Chemistry (2021), 225, 113777.", "doi": "10.1016/j.ejmech.2021.113777", "raw": "Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27 | Pillaiyar, Thanigaimalai; et al | European Journal of Medicinal Chemistry (2021), 225, 113777. | 10.1016/j.ejmech.2021.113777"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-32142486", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 12 h, rt", "Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow", "By: Alder, Catherine M.; et al", "Organic Process Research & Development (2022), 26(2), 365-379.", "10.1021/acs.oprd.1c00422"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2138475-12-2 + 74-89-5 | PRO: 2138475-13-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27\", \"authors\": \"Pillaiyar, Thanigaimalai; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 225, 113777.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32142486\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 12 h, rt\", \"215. Scheme 215 (1 Reaction)\", \"Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow\", \"By: Alder, Catherine M.; et al\", \"Organic Process Research & Development (2022), 26(2), 365-379.\", \"10.1021/acs.oprd.1c00422\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2138475-12-2\", \"74-89-5\"], \"pro_cas\": [\"2138475-13-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2138475-12-2", "74-89-5"], "products": ["2138475-13-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32142514", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1ccc(Cl)cc1Cl.Nc1ccc(C(=O)Nc2ccccc2)cc1", "products": "O=C(Nc1ccccc1)c1ccc(NC(=O)c2ccc(Cl)cc2Cl)cc1"}, "reference": {"title": "Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27", "authors": "Pillaiyar, Thanigaimalai; et al", "citation": "European Journal of Medicinal Chemistry (2021), 225, 113777.", "doi": "10.1016/j.ejmech.2021.113777", "raw": "Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27 | Pillaiyar, Thanigaimalai; et al | European Journal of Medicinal Chemistry (2021), 225, 113777. | 10.1016/j.ejmech.2021.113777"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-32142514", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release", "By: Meiers, Joscha; et al", "Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.", "10.1021/acs.jmedchem.2c01214"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2462-31-9 + 15761-38-3 | PRO: 23632-78-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27\", \"authors\": \"Pillaiyar, Thanigaimalai; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 225, 113777.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32142514\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 12 h, rt\", \"142. Scheme 142 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release\", \"By: Meiers, Joscha; et al\", \"Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.\", \"10.1021/acs.jmedchem.2c01214\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2462-31-9\", \"15761-38-3\"], \"pro_cas\": [\"23632-78-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2462-31-9", "15761-38-3"], "products": ["23632-78-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32260332", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate", "cas": "56602-33-6", "role": "UNK"}, {"name": "BOP reagent", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 86.0}, "smiles": {"reactants": "CN.Cc1nc2[nH]c3ccccc3c2cc1C(=O)O", "products": "CNC(=O)c1cc2c(nc1C)[nH]c1ccccc12"}, "reference": {"title": "Design, synthesis, and in vitro protective effect evaluation of α-carboline derivatives against H2O2-induced cardiomyocyte injury", "authors": "Zhang, Rong-Hong; et al", "citation": "European Journal of Medicinal Chemistry (2022), 238, 114469.", "doi": "10.1016/j.ejmech.2022.114469", "raw": "Design, synthesis, and in vitro protective effect evaluation of α-carboline derivatives against H2O2-induced cardiomyocyte injury | Zhang, Rong-Hong; et al | European Journal of Medicinal Chemistry (2022), 238, 114469. | 10.1016/j.ejmech.2022.114469"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-32260332", "1.1|Reagents: Triethylamine, BOP reagent", "Solvents: Tetrahydrofuran, Water; 24 h, rt", "Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors", "By: Zheng, Jia; et al", "ACS Medicinal Chemistry Letters (2024), 15(11), 2019-2031.", "10.1021/acsmedchemlett.4c00431"], "signatures": {"cond_key": "none/none/(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate|56602-33-6+BOP reagent|+Triethylamine|121-44-8/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "a6b725ad", "fam_sig": "5d1c5e18"}, "raw_data": {"raw_cas": "RCT: 10272-07-8 + 486424-37-7 | PRO: 3062364-97-7 | RGT: 121-44-8 + 56602-33-6 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and in vitro protective effect evaluation of α-carboline derivatives against H2O2-induced cardiomyocyte injury\", \"authors\": \"Zhang, Rong-Hong; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 238, 114469.\", \"reagents\": [\"Triethylamine\", \"BOP reagent\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32260332\", \"1.1\", \"Reagents: Triethylamine, BOP reagent\", \"Solvents: Tetrahydrofuran, Water; 24 h, rt\", \"332. Scheme 332 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors\", \"By: Zheng, Jia; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(11), 2019-2031.\", \"10.1021/acsmedchemlett.4c00431\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"10272-07-8\", \"486424-37-7\"], \"pro_cas\": [\"3062364-97-7\"], \"rgt_cas\": [\"121-44-8\", \"56602-33-6\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["10272-07-8", "486424-37-7"], "products": ["3062364-97-7"], "reagents": ["Triethylamine", "(Benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32437851", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Na2CO3", "cas": "497-19-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium carbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 1.167, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.NCCC1CC1", "products": "CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)NCCC1CC1"}, "reference": {"title": "Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics", "authors": "Garsi, Jean-Baptiste; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(6), 949-954.", "doi": "10.1021/acsmedchemlett.2c00094", "raw": "Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics | Garsi, Jean-Baptiste; et al | ACS Medicinal Chemistry Letters (2022), 13(6), 949-954. | 10.1021/acsmedchemlett.2c00094"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-32437851", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 10 min, rt", "1.2|1 h, rt", "1.3|Reagents: Sodium carbonate", "Solvents: Water; rt", "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety", "By: Pandrala, Mallesh; et al", "Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.", "10.1021/acs.jmedchem.1c01853"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Na2CO3|497-19-8+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6+Sodium carbonate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "aadeeadf", "fam_sig": "b2303328"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 641571-11-1 | PRO: 1351670-02-4 | RGT: 7087-68-5 + 125700-67-6 + 497-19-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics\", \"authors\": \"Garsi, Jean-Baptiste; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(6), 949-954.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Sodium carbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32437851\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 10 min, rt\", \"1.2\", \"1 h, rt\", \"1.3\", \"Reagents: Sodium carbonate\", \"Solvents: Water; rt\", \"17. Scheme 17 (1 Reaction)\", \"Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety\", \"By: Pandrala, Mallesh; et al\", \"Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.\", \"10.1021/acs.jmedchem.1c01853\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"641571-11-1\"], \"pro_cas\": [\"1351670-02-4\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\", \"497-19-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "641571-11-1"], "products": ["1351670-02-4"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6", "Na2CO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32438839", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 17.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1cc2cccnc2n(Cc2ccc(F)c(F)c2)c1=O.NCC(=O)Nc1ccc2c(c1)CC(=O)N2", "products": "O=C(CNC(=O)c1cc2cccnc2n(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)CC(=O)N2"}, "reference": {"title": "Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile", "authors": "Sestito, Simona; et al", "citation": "European Journal of Medicinal Chemistry (2021), 226, 113895.", "doi": "10.1016/j.ejmech.2021.113895", "raw": "Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile | Sestito, Simona; et al | European Journal of Medicinal Chemistry (2021), 226, 113895. | 10.1016/j.ejmech.2021.113895"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-32438839", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 30 min, 0 °C", "1.2|30 min, 0 °C; 0 °C → rt; overnight, rt", "First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo", "By: Sharma, Sachin; et al", "Journal of Medicinal Chemistry (2024), 67(4), 2963-2985.", "10.1021/acs.jmedchem.3c02053"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2", "cond_sig": "7dec0139", "fam_sig": "3e568a1e"}, "raw_data": {"raw_cas": "RCT: 771579-27-2 + 3033571-02-4 | PRO: 3033571-04-6 | RGT: 7087-68-5 + 125700-67-6 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile\", \"authors\": \"Sestito, Simona; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 226, 113895.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32438839\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 30 min, 0 °C\", \"1.2\", \"30 min, 0 °C; 0 °C → rt; overnight, rt\", \"421. Scheme 421 (1 Reaction)\", \"First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo\", \"By: Sharma, Sachin; et al\", \"Journal of Medicinal Chemistry (2024), 67(4), 2963-2985.\", \"10.1021/acs.jmedchem.3c02053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"771579-27-2\", \"3033571-02-4\"], \"pro_cas\": [\"3033571-04-6\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["771579-27-2", "3033571-02-4"], "products": ["3033571-04-6"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32519335", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 100.0, "time_h": 0.2, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)C(=O)O.Nc1ccc(F)cc1N", "products": "O=c1[nH]c2ccc(F)cc2[nH]c1=O"}, "reference": {"title": "Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale", "authors": "McCoy, Michael A.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(10), 7246-7261.", "doi": "10.1021/acs.jmedchem.2c00228", "raw": "Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale | McCoy, Michael A.; et al | Journal of Medicinal Chemistry (2022), 65(10), 7246-7261. | 10.1021/acs.jmedchem.2c00228"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-32519335", "1.1|Reagents: Hydrochloric acid", "Solvents: Water; 80 °C → 100 °C; 0.2 h, 100 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease", "By: Amblard, Franck; et al", "European Journal of Medicinal Chemistry (2024), 268, 116263.", "10.1016/j.ejmech.2024.116263"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0/Water|7732-18-5", "cond_sig": "57361e42", "fam_sig": "f1a39bee"}, "raw_data": {"raw_cas": "RCT: 2666-93-5 + 65365-15-3 | PRO: 2148976-31-0 | RGT: 7647-01-0 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale\", \"authors\": \"McCoy, Michael A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(10), 7246-7261.\", \"reagents\": [\"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32519335\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; 80 °C → 100 °C; 0.2 h, 100 °C\", \"467. Scheme 467 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease\", \"By: Amblard, Franck; et al\", \"European Journal of Medicinal Chemistry (2024), 268, 116263.\", \"10.1016/j.ejmech.2024.116263\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2666-93-5\", \"65365-15-3\"], \"pro_cas\": [\"2148976-31-0\"], \"rgt_cas\": [\"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2666-93-5", "65365-15-3"], "products": ["2148976-31-0"], "reagents": ["Hydrochloric acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32532467", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.0, "yield_pct": 94.0}, "smiles": {"reactants": "COc1ccc(CC(=O)O)cc1OC.COC(=O)[C@@H](N)Cc1ccc(OC)c(OC)c1", "products": "COC(=O)[C@H](Cc1ccc(OC)c(OC)c1)NC(=O)Cc1ccc(OC)c(OC)c1"}, "reference": {"title": "Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors", "authors": "Liu, Zhihao; et al", "citation": "European Journal of Medicinal Chemistry (2022), 227, 113929.", "doi": "10.1016/j.ejmech.2021.113929", "raw": "Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors | Liu, Zhihao; et al | European Journal of Medicinal Chemistry (2022), 227, 113929. | 10.1016/j.ejmech.2021.113929"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-32532467", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 0 °C; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "By: Gotz, Marion G.; et al", "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "10.1021/acsmedchemlett.4c00017"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 1080-06-4 + 13139-15-6 | PRO: 18658-65-6 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors\", \"authors\": \"Liu, Zhihao; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 227, 113929.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32532467\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 0 °C; 12 h, rt\", \"312. Scheme 312 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"By: Gotz, Marion G.; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"10.1021/acsmedchemlett.4c00017\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1080-06-4\", \"13139-15-6\"], \"pro_cas\": [\"18658-65-6\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1080-06-4", "13139-15-6"], "products": ["18658-65-6"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32657022", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)[C@@H](Oc1ccccc1)[C@H](C)OC(=O)[C@H](C)NC(=O)OC(C)(C)C.COc1ccnc(C(=O)O)c1O", "products": "COc1ccnc(C(=O)N[C@@H](C)C(=O)O[C@@H](C)[C@H](Oc2ccccc2)C(C)C)c1O"}, "reference": {"title": "Discovery of florylpicoxamid, a mimic of a macrocyclic natural product", "authors": "Meyer, Kevin G.; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 50, 116455.", "doi": "10.1016/j.bmc.2021.116455", "raw": "Discovery of florylpicoxamid, a mimic of a macrocyclic natural product | Meyer, Kevin G.; et al | Bioorganic & Medicinal Chemistry (2021), 50, 116455. | 10.1016/j.bmc.2021.116455"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-32657022", "1.1|Reagents: Hydrochloric acid", "Solvents: 1,4-Dioxane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Dichloromethane; overnight, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo", "By: Zhang, Songxuan; et al", "European Journal of Medicinal Chemistry (2021), 213, 113185.", "10.1016/j.ejmech.2021.113185"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2", "cond_sig": "ffa9a521", "fam_sig": "b772d2f7"}, "raw_data": {"raw_cas": "RCT: 1330528-44-3 + 100-46-9 | PRO: 2603150-99-6 | RGT: 7647-01-0 + 7087-68-5 + 128625-52-5 | SOL: 123-91-1 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of florylpicoxamid, a mimic of a macrocyclic natural product\", \"authors\": \"Meyer, Kevin G.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 50, 116455.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32657022\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: 1,4-Dioxane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Dichloromethane; overnight, rt\", \"82. Scheme 82 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo\", \"By: Zhang, Songxuan; et al\", \"European Journal of Medicinal Chemistry (2021), 213, 113185.\", \"10.1016/j.ejmech.2021.113185\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1330528-44-3\", \"100-46-9\"], \"pro_cas\": [\"2603150-99-6\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1330528-44-3", "100-46-9"], "products": ["2603150-99-6"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["1,4-Dioxane", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32762773", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "NaOH", "cas": "1310-73-2", "role": "BASE"}, {"name": "Acetic Acid", "cas": "64-19-7", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 150.0, "time_h": 13.25, "yield_pct": 89.0}, "smiles": {"reactants": "NC(N)=O.Nc1ccccc1C(=O)O", "products": "O=c1[nH]c(=O)c2ccccc2[nH]1"}, "reference": {"title": "Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis", "authors": "Biteau, Nicolas G.; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 46, 116351.", "doi": "10.1016/j.bmc.2021.116351", "raw": "Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis | Biteau, Nicolas G.; et al | Bioorganic & Medicinal Chemistry (2021), 46, 116351. | 10.1016/j.bmc.2021.116351"}, "original_text": ["Steps: 1, Yield: 89-92%", "CAS Reaction Number: 31-614-CAS-32762773", "1.1|12 h, 150 °C; 150 °C → 100 °C", "1.2|Solvents: Water; 15 min, 100 °C; 100 °C → rt", "1.3|Reagents: Sodium hydroxide", "Solvents: Water; 1 h, rt", "1.4|Reagents: Acetic acid; pH 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Identification of highly potent and selective HTRA1 inhibitors", "By: Dennis, David G.; et al", "Bioorganic & Medicinal Chemistry Letters (2024), 109, 129814.", "10.1016/j.bmcl.2024.129814"], "signatures": {"cond_key": "none/none/Acetic Acid|64-19-7+NaOH|1310-73-2+Sodium hydroxide|/Water|7732-18-5", "cond_sig": "ba2bdd19", "fam_sig": "3154bc1f"}, "raw_data": {"raw_cas": "RCT: 7517-19-3 + 114873-03-9 | PRO: 3052551-80-8 | RGT: 1310-73-2 + 64-19-7 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis\", \"authors\": \"Biteau, Nicolas G.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 46, 116351.\", \"reagents\": [\"Sodium hydroxide\", \"Acetic acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32762773\", \"1.1\", \"12 h, 150 °C; 150 °C → 100 °C\", \"1.2\", \"Solvents: Water; 15 min, 100 °C; 100 °C → rt\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 1 h, rt\", \"1.4\", \"Reagents: Acetic acid; pH 5, rt\", \"342. Scheme 342 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Identification of highly potent and selective HTRA1 inhibitors\", \"By: Dennis, David G.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2024), 109, 129814.\", \"10.1016/j.bmcl.2024.129814\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7517-19-3\", \"114873-03-9\"], \"pro_cas\": [\"3052551-80-8\"], \"rgt_cas\": [\"1310-73-2\", \"64-19-7\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["7517-19-3", "114873-03-9"], "products": ["3052551-80-8"], "reagents": ["NaOH", "Acetic Acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-32762777", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "NaOH", "cas": "1310-73-2", "role": "BASE"}, {"name": "Acetic Acid", "cas": "64-19-7", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 150.0, "time_h": 13.25, "yield_pct": 95.0}, "smiles": {"reactants": "NC(N)=O.Cc1ccc(N)c(C(=O)O)c1", "products": "Cc1ccc2[nH]c(=O)[nH]c(=O)c2c1"}, "reference": {"title": "Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis", "authors": "Biteau, Nicolas G.; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 46, 116351.", "doi": "10.1016/j.bmc.2021.116351", "raw": "Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis | Biteau, Nicolas G.; et al | Bioorganic & Medicinal Chemistry (2021), 46, 116351. | 10.1016/j.bmc.2021.116351"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-32762777", "1.1|12 h, 150 °C; 150 °C → 100 °C", "1.2|Solvents: Water; 15 min, 100 °C; 100 °C → rt", "1.3|Reagents: Sodium hydroxide", "Solvents: Water; 1 h, rt", "1.4|Reagents: Acetic acid; pH 5, rt", "Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat", "By: Lin, Biyue; et al", "Organic Process Research & Development (2021), 25(4), 960-968.", "10.1021/acs.oprd.1c00004"], "signatures": {"cond_key": "none/none/Acetic Acid|64-19-7+NaOH|1310-73-2+Sodium hydroxide|/Water|7732-18-5", "cond_sig": "ba2bdd19", "fam_sig": "3154bc1f"}, "raw_data": {"raw_cas": "RCT: 2543978-01-2 + 5680-79-5 | PRO: 1007382-05-9 | RGT: 1310-73-2 + 64-19-7 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis\", \"authors\": \"Biteau, Nicolas G.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 46, 116351.\", \"reagents\": [\"Sodium hydroxide\", \"Acetic acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-32762777\", \"1.1\", \"12 h, 150 °C; 150 °C → 100 °C\", \"1.2\", \"Solvents: Water; 15 min, 100 °C; 100 °C → rt\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 1 h, rt\", \"1.4\", \"Reagents: Acetic acid; pH 5, rt\", \"413. Scheme 413 (1 Reaction)\", \"Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat\", \"By: Lin, Biyue; et al\", \"Organic Process Research & Development (2021), 25(4), 960-968.\", \"10.1021/acs.oprd.1c00004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2543978-01-2\", \"5680-79-5\"], \"pro_cas\": [\"1007382-05-9\"], \"rgt_cas\": [\"1310-73-2\", \"64-19-7\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2543978-01-2", "5680-79-5"], "products": ["1007382-05-9"], "reagents": ["NaOH", "Acetic Acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.086652", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33066357", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Lithium hydroxide", "cas": "1310-65-2", "role": "BASE"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCN.Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)O)[nH]c3ccc(Cl)cc23)c1", "products": "Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCNC(=O)OC(C)(C)C)[nH]c3ccc(Cl)cc23)c1"}, "reference": {"title": "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors", "authors": "Xu, Shujing; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 53, 116531.", "doi": "10.1016/j.bmc.2021.116531", "raw": "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors | Xu, Shujing; et al | Bioorganic & Medicinal Chemistry (2022), 53, 116531. | 10.1016/j.bmc.2021.116531"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-33066357", "1.1|Reagents: Lithium hydroxide", "Solvents: Tetrahydrofuran; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "By: Wang, Xu; et al", "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "10.1021/acs.jmedchem.4c02009"], "signatures": {"cond_key": "none/none/Lithium hydroxide|1310-65-2/Tetrahydrofuran|109-99-9", "cond_sig": "1b362897", "fam_sig": "e4f58214"}, "raw_data": {"raw_cas": "RCT: 3061154-72-8 + 101555-60-6 | PRO: 3061154-96-6 | RGT: 1310-65-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors\", \"authors\": \"Xu, Shujing; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 53, 116531.\", \"reagents\": [\"Lithium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33066357\", \"1.1\", \"Reagents: Lithium hydroxide\", \"Solvents: Tetrahydrofuran; 24 h, rt\", \"220. Scheme 220 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"By: Wang, Xu; et al\", \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"10.1021/acs.jmedchem.4c02009\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3061154-72-8\", \"101555-60-6\"], \"pro_cas\": [\"3061154-96-6\"], \"rgt_cas\": [\"1310-65-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3061154-72-8", "101555-60-6"], "products": ["3061154-96-6"], "reagents": ["1310-65-2"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33066360", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Lithium hydroxide", "cas": "1310-65-2", "role": "BASE"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCCN.Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)O)[nH]c3ccc(Cl)cc23)c1", "products": "Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NCCCNC(=O)OC(C)(C)C)[nH]c3ccc(Cl)cc23)c1"}, "reference": {"title": "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors", "authors": "Xu, Shujing; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 53, 116531.", "doi": "10.1016/j.bmc.2021.116531", "raw": "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors | Xu, Shujing; et al | Bioorganic & Medicinal Chemistry (2022), 53, 116531. | 10.1016/j.bmc.2021.116531"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-33066360", "1.1|Reagents: Lithium hydroxide", "Solvents: Tetrahydrofuran; 24 h, rt", "Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction", "By: Hec-Galazka, Aleksandra; et al", "ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.", "10.1021/acsmedchemlett.4c00042"], "signatures": {"cond_key": "none/none/Lithium hydroxide|1310-65-2/Tetrahydrofuran|109-99-9", "cond_sig": "1b362897", "fam_sig": "e4f58214"}, "raw_data": {"raw_cas": "RCT: 17874-79-2 + 3080149-47-6 | PRO: 3080149-48-7 | RGT: 1310-65-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors\", \"authors\": \"Xu, Shujing; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 53, 116531.\", \"reagents\": [\"Lithium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33066360\", \"1.1\", \"Reagents: Lithium hydroxide\", \"Solvents: Tetrahydrofuran; 24 h, rt\", \"258. Scheme 258 (1 Reaction)\", \"Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction\", \"By: Hec-Galazka, Aleksandra; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.\", \"10.1021/acsmedchemlett.4c00042\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"17874-79-2\", \"3080149-47-6\"], \"pro_cas\": [\"3080149-48-7\"], \"rgt_cas\": [\"1310-65-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["17874-79-2", "3080149-47-6"], "products": ["3080149-48-7"], "reagents": ["1310-65-2"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33066374", "reaction_type": "Other", "catalyst": {"core": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5"}], "generic": ["N-Diisopropylethylamine"], "ligands": [], "full_system": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5"}]}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": null, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCC(N)CC1.Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)O)[nH]c3ccc(Cl)cc23)c1", "products": "Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC3CCN(C(=O)OC(C)(C)C)CC3)[nH]c3ccc(Cl)cc23)c1"}, "reference": {"title": "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors", "authors": "Xu, Shujing; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 53, 116531.", "doi": "10.1016/j.bmc.2021.116531", "raw": "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors | Xu, Shujing; et al | Bioorganic & Medicinal Chemistry (2022), 53, 116531. | 10.1016/j.bmc.2021.116531"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-33066374", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Catalysts: Diisopropylethylamine", "Solvents: Dimethylformamide; rt", "Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors", "By: Xin, Zhili; et al", "ACS Medicinal Chemistry Letters (2020), 11(4), 485-490.", "10.1021/acsmedchemlett.9b00611"], "signatures": {"cond_key": "N-Diisopropylethylamine/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "c114c848", "fam_sig": "1f5188e6"}, "raw_data": {"raw_cas": "RCT: 2411382-98-2 + 1448427-99-3 | PRO: 2411383-00-9 | RGT: 148893-10-1 | CAT: 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors\", \"authors\": \"Xu, Shujing; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 53, 116531.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [\"Diisopropylethylamine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33066374\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Catalysts: Diisopropylethylamine\", \"Solvents: Dimethylformamide; rt\", \"351. Scheme 351 (1 Reaction)\", \"Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors\", \"By: Xin, Zhili; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(4), 485-490.\", \"10.1021/acsmedchemlett.9b00611\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2411382-98-2\", \"1448427-99-3\"], \"pro_cas\": [\"2411383-00-9\"], \"rgt_cas\": [\"148893-10-1\"], \"cat_cas\": [\"7087-68-5\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2411382-98-2", "1448427-99-3"], "products": ["2411383-00-9"], "reagents": ["HATU"], "catalysts": ["N,N-Diisopropylethylamine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33309068", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)c1cncc(Br)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N", "products": "Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cncc(Br)c1"}, "reference": {"title": "Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain", "authors": "van der Wildt, Berend; et al", "citation": "Bioorganic & Medicinal Chemistry (2021), 42, 116245.", "doi": "10.1016/j.bmc.2021.116245", "raw": "Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain | van der Wildt, Berend; et al | Bioorganic & Medicinal Chemistry (2021), 42, 116245. | 10.1016/j.bmc.2021.116245"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-33309068", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane, Tetrahydrofuran; 2 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; overnight, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Dichloromethane, Water; rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "416788c8", "fam_sig": "23a3b068"}, "raw_data": {"raw_cas": "RCT: 383135-47-5 + 3032933-01-7 | PRO: 2983540-56-1 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | CAT: 68-12-2 | SOL: 75-09-2 + 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain\", \"authors\": \"van der Wildt, Berend; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2021), 42, 116245.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33309068\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane, Tetrahydrofuran; 2 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; overnight, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Dichloromethane, Water; rt\", \"360. Scheme 360 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"383135-47-5\", \"3032933-01-7\"], \"pro_cas\": [\"2983540-56-1\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["383135-47-5", "3032933-01-7"], "products": ["2983540-56-1"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33408939", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 96.0}, "smiles": {"reactants": "Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(N)cc1.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C1CC1)C1CC1", "products": "Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C2CC2)C2CC2)cc1"}, "reference": {"title": "Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases", "authors": "Andrews, Mark D.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.", "doi": "10.1021/acs.jmedchem.2c00422", "raw": "Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases | Andrews, Mark D.; et al | Journal of Medicinal Chemistry (2022), 65(13), 8828-8842. | 10.1021/acs.jmedchem.2c00422"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-33408939", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 18 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology", "By: Lu, Min; et al", "ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388.", "10.1021/acsmedchemlett.1c00195"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 13734-41-3 + 2376707-33-2 | PRO: 2376705-18-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases\", \"authors\": \"Andrews, Mark D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33408939\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 18 h, rt\", \"169. Scheme 169 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology\", \"By: Lu, Min; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388.\", \"10.1021/acsmedchemlett.1c00195\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-41-3\", \"2376707-33-2\"], \"pro_cas\": [\"2376705-18-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13734-41-3", "2376707-33-2"], "products": ["2376705-18-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33408941", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 82.0}, "smiles": {"reactants": "CC(C)n1nccc1C(=O)O.Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(NC(=O)[C@@H](N)C(C2CC2)C2CC2)cc1", "products": "Cc1nn(COCC[Si](C)(C)C)c(C)c1-c1ccc(NC(=O)[C@@H](NC(=O)c2ccnn2C(C)C)C(C2CC2)C2CC2)cc1"}, "reference": {"title": "Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases", "authors": "Andrews, Mark D.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.", "doi": "10.1021/acs.jmedchem.2c00422", "raw": "Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases | Andrews, Mark D.; et al | Journal of Medicinal Chemistry (2022), 65(13), 8828-8842. | 10.1021/acs.jmedchem.2c00422"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-33408941", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 18 h, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 619-65-8 + 2919713-61-2 | PRO: 2919713-72-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases\", \"authors\": \"Andrews, Mark D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33408941\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 18 h, rt\", \"250. Scheme 250 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"619-65-8\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-72-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["619-65-8", "2919713-61-2"], "products": ["2919713-72-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33447248", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 94.0}, "smiles": {"reactants": "CN.CC(C)Nc1cc(Cl)ncc1C(=O)O", "products": "CNC(=O)c1cnc(Cl)cc1NC(C)C"}, "reference": {"title": "Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer", "authors": "Eno, Meredith S.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(14), 9662-9677.", "doi": "10.1021/acs.jmedchem.2c00704", "raw": "Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer | Eno, Meredith S.; et al | Journal of Medicinal Chemistry (2022), 65(14), 9662-9677. | 10.1021/acs.jmedchem.2c00704"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-33447248", "1.1|Reagents: Triethylamine, Hydrochloric acid, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, 25 °C", "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "By: Morozova, Alisa; et al", "European Journal of Medicinal Chemistry (2024), 266, 116101.", "10.1016/j.ejmech.2023.116101"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+Hydrochloric acid|7647-01-0+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "2bed08a9", "fam_sig": "25d8507b"}, "raw_data": {"raw_cas": "RCT: 753-90-2 + 30766-03-1 | PRO: 2922532-53-2 | RGT: 121-44-8 + 7647-01-0 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer\", \"authors\": \"Eno, Meredith S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(14), 9662-9677.\", \"reagents\": [\"Triethylamine\", \"Hydrochloric acid\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33447248\", \"1.1\", \"Reagents: Triethylamine, Hydrochloric acid, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, 25 °C\", \"44. Scheme 44 (1 Reaction)\", \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"By: Morozova, Alisa; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"10.1016/j.ejmech.2023.116101\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"753-90-2\", \"30766-03-1\"], \"pro_cas\": [\"2922532-53-2\"], \"rgt_cas\": [\"121-44-8\", \"7647-01-0\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["753-90-2", "30766-03-1"], "products": ["2922532-53-2"], "reagents": ["Triethylamine", "Hydrochloric acid", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33504028", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 1.0, "yield_pct": 81.0}, "smiles": {"reactants": "NCCCO.CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O", "products": "CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCCO"}, "reference": {"title": "Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA)", "authors": "Conlon, Patrick R.; et al", "citation": "Organic Process Research & Development (2022), 26(8), 2124-2137.", "doi": "10.1021/acs.oprd.1c00449", "raw": "Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA) | Conlon, Patrick R.; et al | Organic Process Research & Development (2022), 26(8), 2124-2137. | 10.1021/acs.oprd.1c00449"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-33504028", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 - 30 °C; 30 °C → 5 °C; 1 h, 0 - 5 °C", "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "By: Hiesinger, Kerstin; et al", "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "10.1021/acs.jmedchem.0c00561"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 91472-94-5 | PRO: 2709014-32-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA)\", \"authors\": \"Conlon, Patrick R.; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(8), 2124-2137.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33504028\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 - 30 °C; 30 °C → 5 °C; 1 h, 0 - 5 °C\", \"119. Scheme 119 (1 Reaction)\", \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"By: Hiesinger, Kerstin; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"10.1021/acs.jmedchem.0c00561\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"91472-94-5\"], \"pro_cas\": [\"2709014-32-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "91472-94-5"], "products": ["2709014-32-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33604392", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Toluene", "cas": "108-88-3"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 10.0, "time_h": 2.0, "yield_pct": 92.0}, "smiles": {"reactants": "O=C(O)c1cncc(Br)c1.Nc1ccc(OC(F)(F)F)cc1", "products": "O=C(Nc1ccc(OC(F)(F)F)cc1)c1cncc(Br)c1"}, "reference": {"title": "A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier", "authors": "Manley, Paul W.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128577.", "doi": "10.1016/j.bmcl.2022.128577", "raw": "A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier | Manley, Paul W.; et al | Bioorganic & Medicinal Chemistry Letters (2022), 59, 128577. | 10.1016/j.bmcl.2022.128577"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-33604392", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Toluene; 8 °C; 1.5 h, 8 °C", "1.2|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; -15 °C; 0.5 h, 10 °C", "Structural and Functional Study of the Klebsiella pneumoniae VapBC Toxin-Antitoxin System, Including the Development of an Inhibitor That Activates VapC", "By: Kang, Sung-Min; et al", "Journal of Medicinal Chemistry (2020), 63(22), 13669-13679.", "10.1021/acs.jmedchem.0c01118"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Thionyl chloride|7719-09-7/Tetrahydrofuran|109-99-9+Toluene|108-88-3", "cond_sig": "ec2aa2dd", "fam_sig": "e6a9a456"}, "raw_data": {"raw_cas": "RCT: 57-13-6 + 2803886-08-8 | PRO: 941068-17-3 | RGT: 7719-09-7 + 7087-68-5 | CAT: 68-12-2 | SOL: 108-88-3 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier\", \"authors\": \"Manley, Paul W.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128577.\", \"reagents\": [\"Thionyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Toluene\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33604392\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Toluene; 8 °C; 1.5 h, 8 °C\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; -15 °C; 0.5 h, 10 °C\", \"211. Scheme 211 (1 Reaction)\", \"Structural and Functional Study of the Klebsiella pneumoniae VapBC Toxin-Antitoxin System, Including the Development of an Inhibitor That Activates VapC\", \"By: Kang, Sung-Min; et al\", \"Journal of Medicinal Chemistry (2020), 63(22), 13669-13679.\", \"10.1021/acs.jmedchem.0c01118\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57-13-6\", \"2803886-08-8\"], \"pro_cas\": [\"941068-17-3\"], \"rgt_cas\": [\"7719-09-7\", \"7087-68-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"108-88-3\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["57-13-6", "2803886-08-8"], "products": ["941068-17-3"], "reagents": ["7719-09-7", "N,N-Diisopropylethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Toluene", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33804705", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 91.0}, "smiles": {"reactants": "C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1", "products": "C[C@@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1"}, "reference": {"title": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "authors": "Abram, Michal; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "doi": "10.1021/acs.jmedchem.2c00534", "raw": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo | Abram, Michal; et al | Journal of Medicinal Chemistry (2022), 65(17), 11703-11725. | 10.1021/acs.jmedchem.2c00534"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-33804705", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 15 min, rt", "1.2|Solvents: Dichloromethane; rt; 1 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "By: Abram, Michal; et al", "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "10.1021/acs.jmedchem.2c00534"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 15761-38-3 + 100-46-9 | PRO: 51814-55-2 | RGT: 538-75-0 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"authors\": \"Abram, Michal; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33804705\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"Solvents: Dichloromethane; rt; 1 h, rt\", \"58. Scheme 58 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"By: Abram, Michal; et al\", \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"10.1021/acs.jmedchem.2c00534\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15761-38-3\", \"100-46-9\"], \"pro_cas\": [\"51814-55-2\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["15761-38-3", "100-46-9"], "products": ["51814-55-2"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33822229", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 93.0}, "smiles": {"reactants": "O=C(O)c1cccc([N+](=O)[O-])c1.COc1ccc(N)cn1", "products": "COc1ccc(NC(=O)c2cccc([N+](=O)[O-])c2)cn1"}, "reference": {"title": "[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins", "authors": "Liu, Longbin; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12003-12021.", "doi": "10.1021/acs.jmedchem.1c00667", "raw": "[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins | Liu, Longbin; et al | Journal of Medicinal Chemistry (2021), 64(16), 12003-12021. | 10.1021/acs.jmedchem.1c00667"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-33822229", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 24 h, rt", "A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier", "By: Manley, Paul W.; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128577.", "10.1016/j.bmcl.2022.128577"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 20826-04-4 + 461-82-5 | PRO: 388571-71-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins\", \"authors\": \"Liu, Longbin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12003-12021.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33822229\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 24 h, rt\", \"210. Scheme 210 (1 Reaction)\", \"A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier\", \"By: Manley, Paul W.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128577.\", \"10.1016/j.bmcl.2022.128577\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"20826-04-4\", \"461-82-5\"], \"pro_cas\": [\"388571-71-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["20826-04-4", "461-82-5"], "products": ["388571-71-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33920075", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 40.0, "time_h": 48.0, "yield_pct": 89.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)cc1I.CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1", "products": "COc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1I"}, "reference": {"title": "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety", "authors": "Pandrala, Mallesh; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.", "doi": "10.1021/acs.jmedchem.1c01853", "raw": "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety | Pandrala, Mallesh; et al | Journal of Medicinal Chemistry (2022), 65(16), 10898-10919. | 10.1021/acs.jmedchem.1c01853"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-33920075", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; rt; 48 h, 40 °C", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 3471-31-6 | PRO: 1990303-96-2 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety\", \"authors\": \"Pandrala, Mallesh; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33920075\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; rt; 48 h, 40 °C\", \"457. Scheme 457 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"3471-31-6\"], \"pro_cas\": [\"1990303-96-2\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"alternate reaction conditions also shown\"]}}", "enriched_names": {"reactants": ["120-20-7", "3471-31-6"], "products": ["1990303-96-2"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33920089", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}, {"name": "4-(Dimethylamino)pyridine", "cas": ""}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}, {"name": "4-(Dimethylamino)pyridine", "cas": ""}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 21.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.Cc1cn(-c2cc(N)cc(C(F)(F)F)c2)cn1", "products": "Cc1cn(-c2cc(NC(=O)c3cccc(I)c3)cc(C(F)(F)F)c2)cn1"}, "reference": {"title": "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety", "authors": "Pandrala, Mallesh; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.", "doi": "10.1021/acs.jmedchem.1c01853", "raw": "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety | Pandrala, Mallesh; et al | Journal of Medicinal Chemistry (2022), 65(16), 10898-10919. | 10.1021/acs.jmedchem.1c01853"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-33920089", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide; rt; 5 h, reflux; reflux → rt", "1.2|Reagents: Diisopropylethylamine", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt", "1.3|Reagents: Water; rt", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Thionyl chloride|7719-09-7+Water|7732-18-5/Tetrahydrofuran|109-99-9", "cond_sig": "649c51bf", "fam_sig": "42486d2f"}, "raw_data": {"raw_cas": "RCT: 1417404-28-4 + 13031-60-2 | PRO: 2614242-20-3 | RGT: 7719-09-7 + 7087-68-5 + 7732-18-5 | CAT: 68-12-2 + 1122-58-3 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety\", \"authors\": \"Pandrala, Mallesh; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.\", \"reagents\": [\"Thionyl chloride\", \"Diisopropylethylamine\", \"Water\"], \"catalysts\": [\"Dimethylformamide\", \"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33920089\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide; rt; 5 h, reflux; reflux → rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt\", \"1.3\", \"Reagents: Water; rt\", \"18. Scheme 18 (1 Reaction)\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1417404-28-4\", \"13031-60-2\"], \"pro_cas\": [\"2614242-20-3\"], \"rgt_cas\": [\"7719-09-7\", \"7087-68-5\", \"7732-18-5\"], \"cat_cas\": [\"68-12-2\", \"1122-58-3\"], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"SOCl2 also used as solvent in stage 1\"]}}", "enriched_names": {"reactants": ["1417404-28-4", "13031-60-2"], "products": ["2614242-20-3"], "reagents": ["7719-09-7", "N,N-Diisopropylethylamine", "Water"], "catalysts": ["Dimethylformamide", "4-Dimethylaminopyridine"], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33920091", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}, {"name": "4-(Dimethylamino)pyridine", "cas": ""}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}, {"name": "4-(Dimethylamino)pyridine", "cas": ""}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 21.0, "yield_pct": 95.0}, "smiles": {"reactants": "Cc1ccc(C(=O)O)cc1I.Cc1cn(-c2cc(N)cc(C(F)(F)F)c2)cn1", "products": "Cc1cn(-c2cc(NC(=O)c3ccc(C)c(I)c3)cc(C(F)(F)F)c2)cn1"}, "reference": {"title": "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety", "authors": "Pandrala, Mallesh; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.", "doi": "10.1021/acs.jmedchem.1c01853", "raw": "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety | Pandrala, Mallesh; et al | Journal of Medicinal Chemistry (2022), 65(16), 10898-10919. | 10.1021/acs.jmedchem.1c01853"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-33920091", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide; rt; 5 h, reflux; reflux → rt", "1.2|Reagents: Diisopropylethylamine", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt", "1.3|Reagents: Water; rt", "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis", "By: Zhao, Hongyi; et al", "Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.", "10.1021/acs.jmedchem.2c00718"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Thionyl chloride|7719-09-7+Water|7732-18-5/Tetrahydrofuran|109-99-9", "cond_sig": "649c51bf", "fam_sig": "42486d2f"}, "raw_data": {"raw_cas": "RCT: 768-94-5 + 27746-02-7 + 24424-99-5 | PRO: 2290532-68-0 | RGT: 7719-09-7 + 7087-68-5 + 7732-18-5 | CAT: 68-12-2 + 1122-58-3 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety\", \"authors\": \"Pandrala, Mallesh; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.\", \"reagents\": [\"Thionyl chloride\", \"Diisopropylethylamine\", \"Water\"], \"catalysts\": [\"Dimethylformamide\", \"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33920091\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide; rt; 5 h, reflux; reflux → rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt\", \"1.3\", \"Reagents: Water; rt\", \"71. Scheme 71 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis\", \"By: Zhao, Hongyi; et al\", \"Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.\", \"10.1021/acs.jmedchem.2c00718\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"768-94-5\", \"27746-02-7\", \"24424-99-5\"], \"pro_cas\": [\"2290532-68-0\"], \"rgt_cas\": [\"7719-09-7\", \"7087-68-5\", \"7732-18-5\"], \"cat_cas\": [\"68-12-2\", \"1122-58-3\"], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"SOCl2 also used as solvent in stage 1\"]}}", "enriched_names": {"reactants": ["768-94-5", "27746-02-7", "tert-Butyl carbamate"], "products": ["2290532-68-0"], "reagents": ["7719-09-7", "N,N-Diisopropylethylamine", "Water"], "catalysts": ["Dimethylformamide", "4-Dimethylaminopyridine"], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.088655", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33986158", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 40.0, "time_h": 12.667, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)C(F)(F)c1ccc(Cl)cc1.CS(=O)(=O)O.NCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O", "products": "O=C1CCC(N2Cc3cc(CNC(=O)C(F)(F)c4ccc(Cl)cc4)ccc3C2=O)C(=O)N1"}, "reference": {"title": "Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009", "authors": "Zacuto, Michael J.; et al", "citation": "Organic Process Research & Development (2022), 26(9), 2739-2748.", "doi": "10.1021/acs.oprd.2c00199", "raw": "Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009 | Zacuto, Michael J.; et al | Organic Process Research & Development (2022), 26(9), 2739-2748. | 10.1021/acs.oprd.2c00199"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-33986158", "1.1|Reagents: 4-Methylmorpholine", "Solvents: Dimethylformamide; 10 min, 20 °C", "1.2|Reagents: Propylphosphonic anhydride", "Solvents: Dimethylformamide; 12 h, 20 °C → 40 °C; 30 min, 40 °C → 20 °C", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+N-Methylmorpholine|109-02-4+Propylphosphonic anhydride|68957-94-8/Dimethylformamide|68-12-2", "cond_sig": "ef64eaa9", "fam_sig": "72686096"}, "raw_data": {"raw_cas": "RCT: 535-80-8 + 2919713-61-2 | PRO: 2919713-69-0 | RGT: 109-02-4 + 68957-94-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009\", \"authors\": \"Zacuto, Michael J.; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(9), 2739-2748.\", \"reagents\": [\"4-Methylmorpholine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33986158\", \"1.1\", \"Reagents: 4-Methylmorpholine\", \"Solvents: Dimethylformamide; 10 min, 20 °C\", \"1.2\", \"Reagents: Propylphosphonic anhydride\", \"Solvents: Dimethylformamide; 12 h, 20 °C → 40 °C; 30 min, 40 °C → 20 °C\", \"297. Scheme 297 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"535-80-8\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-69-0\"], \"rgt_cas\": [\"109-02-4\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"optimization study, optimized on reagent, base and temperature\"]}}", "enriched_names": {"reactants": ["535-80-8", "2919713-61-2"], "products": ["2919713-69-0"], "reagents": ["N-Methylmorpholine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33998211", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)c1cc2c(Cl)cccc2s1.CN1CCC[C@@H](N)C1.Cl", "products": "CN1CCC[C@@H](NC(=O)c2cc3c(Cl)cccc3s2)C1"}, "reference": {"title": "Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin", "authors": "Schiffers, Ingo; et al", "citation": "Organic Process Research & Development (2022), 26(10), 2811-2822.", "doi": "10.1021/acs.oprd.2c00152", "raw": "Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin | Schiffers, Ingo; et al | Organic Process Research & Development (2022), 26(10), 2811-2822. | 10.1021/acs.oprd.2c00152"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-33998211", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; overnight, rt", "Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells", "By: Takashima, Katsuki; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.", "10.1016/j.bmcl.2022.129034"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4cfa4784", "fam_sig": "1c23a12a"}, "raw_data": {"raw_cas": "RCT: 2039-67-0 + 1800474-32-1 | PRO: 3049081-25-3 | RGT: 79-37-8 + 121-44-8 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin\", \"authors\": \"Schiffers, Ingo; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(10), 2811-2822.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33998211\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; overnight, rt\", \"303. Scheme 303 (1 Reaction)\", \"Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells\", \"By: Takashima, Katsuki; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.\", \"10.1016/j.bmcl.2022.129034\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2039-67-0\", \"1800474-32-1\"], \"pro_cas\": [\"3049081-25-3\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"product further converted into HCl salt\"]}}", "enriched_names": {"reactants": ["2039-67-0", "1800474-32-1"], "products": ["3049081-25-3"], "reagents": ["79-37-8", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-33998214", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)c1cc2cccc(Br)c2s1.Cl.N[C@@H]1CCCN(Cc2ccccc2)C1", "products": "O=C(N[C@@H]1CCCN(Cc2ccccc2)C1)c1cc2cccc(Br)c2s1"}, "reference": {"title": "Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin", "authors": "Schiffers, Ingo; et al", "citation": "Organic Process Research & Development (2022), 26(10), 2811-2822.", "doi": "10.1021/acs.oprd.2c00152", "raw": "Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin | Schiffers, Ingo; et al | Organic Process Research & Development (2022), 26(10), 2811-2822. | 10.1021/acs.oprd.2c00152"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-33998214", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; overnight, rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4cfa4784", "fam_sig": "1c23a12a"}, "raw_data": {"raw_cas": "RCT: 383135-47-5 + 2983540-60-7 | PRO: 2983540-57-2 | RGT: 79-37-8 + 121-44-8 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin\", \"authors\": \"Schiffers, Ingo; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(10), 2811-2822.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-33998214\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; overnight, rt\", \"389. Scheme 389 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"383135-47-5\", \"2983540-60-7\"], \"pro_cas\": [\"2983540-57-2\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"product further converted into HCl salt\"]}}", "enriched_names": {"reactants": ["383135-47-5", "2983540-60-7"], "products": ["2983540-57-2"], "reagents": ["79-37-8", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34006665", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.COc1cc(N)ccc1Br", "products": "COc1cc(NC(=O)[C@@H](CC(C)C)NC(=O)OC(C)(C)C)ccc1Br"}, "reference": {"title": "Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain", "authors": "Hartz, Richard A.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.", "doi": "10.1021/acs.jmedchem.1c00472", "raw": "Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain | Hartz, Richard A.; et al | Journal of Medicinal Chemistry (2021), 64(15), 11090-11128. | 10.1021/acs.jmedchem.1c00472"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34006665", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "By: Falkenstein, Markus; et al", "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "10.1016/j.bmc.2021.116462"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 1080-06-4 + 13734-34-4 | PRO: 66076-54-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain\", \"authors\": \"Hartz, Richard A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34006665\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 12 h, rt\", \"356. Scheme 356 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"By: Falkenstein, Markus; et al\", \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"10.1016/j.bmc.2021.116462\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1080-06-4\", \"13734-34-4\"], \"pro_cas\": [\"66076-54-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1080-06-4", "13734-34-4"], "products": ["66076-54-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34006692", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,2-Dichloroethane", "cas": "107-06-2"}], "conditions": {"temperature_c": 40.0, "time_h": 18.167, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.Nc1ccc(-c2cnco2)c(Br)c1", "products": "CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc(-c2cnco2)c(Br)c1"}, "reference": {"title": "Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain", "authors": "Hartz, Richard A.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.", "doi": "10.1021/acs.jmedchem.1c00472", "raw": "Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain | Hartz, Richard A.; et al | Journal of Medicinal Chemistry (2021), 64(15), 11090-11128. | 10.1021/acs.jmedchem.1c00472"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-34006692", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: 1,2-Dichloroethane; 10 min, rt; 18 h, 40 °C", "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "By: Liu, Yonghua; et al", "European Journal of Medicinal Chemistry (2022), 228, 114033.", "10.1016/j.ejmech.2021.114033"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/1,2-Dichloroethane|107-06-2", "cond_sig": "d8815ca6", "fam_sig": "407a9d04"}, "raw_data": {"raw_cas": "RCT: 694499-26-8 + 3035807-43-0 | PRO: 3035807-31-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 107-06-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain\", \"authors\": \"Hartz, Richard A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"1,2-Dichloroethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34006692\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: 1,2-Dichloroethane; 10 min, rt; 18 h, 40 °C\", \"94. Scheme 94 (1 Reaction)\", \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"By: Liu, Yonghua; et al\", \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"10.1016/j.ejmech.2021.114033\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"694499-26-8\", \"3035807-43-0\"], \"pro_cas\": [\"3035807-31-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"107-06-2\"], \"notes\": [\"alternate reaction conditions also shown\"]}}", "enriched_names": {"reactants": ["694499-26-8", "3035807-43-0"], "products": ["3035807-31-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["1,2-Dichloroethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105356", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 89.0}, "smiles": {"reactants": "C[C@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1", "products": "C[C@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1"}, "reference": {"title": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "authors": "Abram, Michal; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "doi": "10.1021/acs.jmedchem.2c00534", "raw": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo | Abram, Michal; et al | Journal of Medicinal Chemistry (2022), 65(17), 11703-11725. | 10.1021/acs.jmedchem.2c00534"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-34105356", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 15 min, rt", "1.2|Solvents: Dichloromethane; rt; 1 h, rt", "Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6", "By: Osko, Jeremy D.; et al", "Journal of Medicinal Chemistry (2020), 63(1), 295-308.", "10.1021/acs.jmedchem.9b01540"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 1138-80-3 + 5680-79-5 | PRO: 13437-63-3 | RGT: 538-75-0 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"authors\": \"Abram, Michal; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105356\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"Solvents: Dichloromethane; rt; 1 h, rt\", \"59. Scheme 59 (1 Reaction)\", \"Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6\", \"By: Osko, Jeremy D.; et al\", \"Journal of Medicinal Chemistry (2020), 63(1), 295-308.\", \"10.1021/acs.jmedchem.9b01540\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1138-80-3\", \"5680-79-5\"], \"pro_cas\": [\"13437-63-3\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1138-80-3", "5680-79-5"], "products": ["13437-63-3"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105360", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 92.0}, "smiles": {"reactants": "C[C@@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1F", "products": "C[C@@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1F"}, "reference": {"title": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "authors": "Abram, Michal; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "doi": "10.1021/acs.jmedchem.2c00534", "raw": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo | Abram, Michal; et al | Journal of Medicinal Chemistry (2022), 65(17), 11703-11725. | 10.1021/acs.jmedchem.2c00534"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-34105360", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 15 min, rt", "1.2|Solvents: Dichloromethane; rt; 1 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "By: Abram, Michal; et al", "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "10.1021/acs.jmedchem.2c00534"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 15761-38-3 + 89-99-6 | PRO: 2815216-21-6 | RGT: 538-75-0 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"authors\": \"Abram, Michal; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105360\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"Solvents: Dichloromethane; rt; 1 h, rt\", \"125. Scheme 125 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"By: Abram, Michal; et al\", \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"10.1021/acs.jmedchem.2c00534\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15761-38-3\", \"89-99-6\"], \"pro_cas\": [\"2815216-21-6\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["15761-38-3", "89-99-6"], "products": ["2815216-21-6"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105361", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.25, "yield_pct": 90.0}, "smiles": {"reactants": "C[C@H](NC(=O)OC(C)(C)C)C(=O)O.NCc1ccccc1F", "products": "C[C@H](NC(=O)OC(C)(C)C)C(=O)NCc1ccccc1F"}, "reference": {"title": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "authors": "Abram, Michal; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "doi": "10.1021/acs.jmedchem.2c00534", "raw": "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo | Abram, Michal; et al | Journal of Medicinal Chemistry (2022), 65(17), 11703-11725. | 10.1021/acs.jmedchem.2c00534"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34105361", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 15 min, rt", "1.2|Solvents: Dichloromethane; rt; 1 h, rt", "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway", "By: Rastelli, Ettore J.; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.", "10.1016/j.bmcl.2021.128167"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 4942-47-6 + 75178-96-0 | PRO: 2761207-05-8 | RGT: 538-75-0 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"authors\": \"Abram, Michal; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105361\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"Solvents: Dichloromethane; rt; 1 h, rt\", \"126. Scheme 126 (1 Reaction)\", \"Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway\", \"By: Rastelli, Ettore J.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.\", \"10.1016/j.bmcl.2021.128167\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4942-47-6\", \"75178-96-0\"], \"pro_cas\": [\"2761207-05-8\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4942-47-6", "75178-96-0"], "products": ["2761207-05-8"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105538", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 81.0}, "smiles": {"reactants": "Nc1ccccc1N.C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)O)CCN1C(=O)OC(C)(C)C", "products": "C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)Nc2ccccc2N)CCN1C(=O)OC(C)(C)C"}, "reference": {"title": "Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125", "authors": "Caroff, Eva; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.", "doi": "10.1021/acs.jmedchem.2c00676", "raw": "Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125 | Caroff, Eva; et al | Journal of Medicinal Chemistry (2022), 65(16), 10918-10933. | 10.1021/acs.jmedchem.2c00676"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-34105538", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist", "By: Glen, Angela; et al", "Bioorganic & Medicinal Chemistry Letters (2024), 100, 129629.", "10.1016/j.bmcl.2024.129629"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 1252907-86-0 + 3058618-68-8 | PRO: 3058618-70-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125\", \"authors\": \"Caroff, Eva; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105538\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 24 h, rt\", \"191. Scheme 191 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist\", \"By: Glen, Angela; et al\", \"Bioorganic & Medicinal Chemistry Letters (2024), 100, 129629.\", \"10.1016/j.bmcl.2024.129629\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1252907-86-0\", \"3058618-68-8\"], \"pro_cas\": [\"3058618-70-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1252907-86-0", "3058618-68-8"], "products": ["3058618-70-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105610", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 84.0}, "smiles": {"reactants": "Nc1ccccc1O.C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)O)CCN1C(=O)OC(C)(C)C", "products": "C[C@@H]1CN(c2sc(C(F)(F)F)nc2C(=O)Nc2ccccc2O)CCN1C(=O)OC(C)(C)C"}, "reference": {"title": "Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125", "authors": "Caroff, Eva; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.", "doi": "10.1021/acs.jmedchem.2c00676", "raw": "Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125 | Caroff, Eva; et al | Journal of Medicinal Chemistry (2022), 65(16), 10918-10933. | 10.1021/acs.jmedchem.2c00676"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-34105610", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1.5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "By: Wang, Xu; et al", "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "10.1021/acs.jmedchem.4c02009"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 3061154-95-5 + 101555-60-6 | PRO: 3061154-98-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125\", \"authors\": \"Caroff, Eva; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105610\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1.5 h, rt\", \"224. Scheme 224 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"By: Wang, Xu; et al\", \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"10.1021/acs.jmedchem.4c02009\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3061154-95-5\", \"101555-60-6\"], \"pro_cas\": [\"3061154-98-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3061154-95-5", "101555-60-6"], "products": ["3061154-98-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105800", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1ccc(F)nc1F.CC(C)(C)NS(=O)(=O)c1cccc(N)c1", "products": "CC(C)(C)NS(=O)(=O)c1cccc(NC(=O)c2ccc(F)nc2F)c1"}, "reference": {"title": "Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe", "authors": "Tamayo, Nuria A.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(6), 4972-4990.", "doi": "10.1021/acs.jmedchem.1c02030", "raw": "Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe | Tamayo, Nuria A.; et al | Journal of Medicinal Chemistry (2022), 65(6), 4972-4990. | 10.1021/acs.jmedchem.1c02030"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-34105800", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors", "By: Liu, Zhihao; et al", "European Journal of Medicinal Chemistry (2022), 227, 113929.", "10.1016/j.ejmech.2021.113929"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 93-40-3 + 78083-80-4 | PRO: 1089721-60-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe\", \"authors\": \"Tamayo, Nuria A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(6), 4972-4990.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105800\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"311. Scheme 311 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors\", \"By: Liu, Zhihao; et al\", \"European Journal of Medicinal Chemistry (2022), 227, 113929.\", \"10.1016/j.ejmech.2021.113929\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"93-40-3\", \"78083-80-4\"], \"pro_cas\": [\"1089721-60-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["93-40-3", "78083-80-4"], "products": ["1089721-60-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105912", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate", "cas": "132705-51-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Phosphorus(1+)", "cas": "", "role": "UNK"}, {"name": "bromotri-1-pyrrolidinyl-", "cas": "", "role": "UNK"}, {"name": "(T-4)-", "cas": "", "role": "UNK"}, {"name": "hexafluorophosphate(1-) (1:1)", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 86.0}, "smiles": {"reactants": "N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)O)c1.Nc1cc(F)cc(CO)c1", "products": "N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)Nc2cc(F)cc(CO)c2)c1"}, "reference": {"title": "Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)", "authors": "Kotian, Pravin L.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(17), 12453-12468.", "doi": "10.1021/acs.jmedchem.1c00511", "raw": "Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE) | Kotian, Pravin L.; et al | Journal of Medicinal Chemistry (2021), 64(17), 12453-12468. | 10.1021/acs.jmedchem.1c00511"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-34105912", "1.1|Reagents: Diisopropylethylamine, Phosphorus(1+), bromotri-1-pyrrolidinyl-, (T-4)-, hexafluorophosphate(1-) (1:1)", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate|132705-51-2+(T-4)-|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Phosphorus(1+)|+bromotri-1-pyrrolidinyl-|+hexafluorophosphate(1-) (1:1)|/Dimethylformamide|68-12-2", "cond_sig": "2b50d423", "fam_sig": "9a4af07d"}, "raw_data": {"raw_cas": "RCT: 1417404-28-4 + 5619-07-8 | PRO: 2614242-25-8 | RGT: 7087-68-5 + 132705-51-2 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)\", \"authors\": \"Kotian, Pravin L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(17), 12453-12468.\", \"reagents\": [\"Diisopropylethylamine\", \"Phosphorus(1+)\", \"bromotri-1-pyrrolidinyl-\", \"(T-4)-\", \"hexafluorophosphate(1-) (1:1)\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105912\", \"1.1\", \"Reagents: Diisopropylethylamine, Phosphorus(1+), bromotri-1-pyrrolidinyl-, (T-4)-, hexafluorophosphate(1-) (1:1)\", \"Solvents: Dimethylformamide; 16 h, rt\", \"109. Scheme 109 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1417404-28-4\", \"5619-07-8\"], \"pro_cas\": [\"2614242-25-8\"], \"rgt_cas\": [\"7087-68-5\", \"132705-51-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1417404-28-4", "5619-07-8"], "products": ["2614242-25-8"], "reagents": ["N,N-Diisopropylethylamine", "(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34105968", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)CCCc1ccccc1.CC(C)(C)OC(=O)NC(CN)(CN)CN", "products": "CC(C)(C)OC(=O)NC(CNC(=O)CCCc1ccccc1)(CNC(=O)CCCc1ccccc1)CNC(=O)CCCc1ccccc1"}, "reference": {"title": "A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities", "authors": "Huang, Ding; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(14), 9955-9973.", "doi": "10.1021/acs.jmedchem.2c00640", "raw": "A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities | Huang, Ding; et al | Journal of Medicinal Chemistry (2022), 65(14), 9955-9973. | 10.1021/acs.jmedchem.2c00640"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-34105968", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 5 h, rt", "Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers", "By: Braconi, Laura; et al", "European Journal of Medicinal Chemistry (2023), 259, 115716.", "10.1016/j.ejmech.2023.115716"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 118-41-2 + 39552-81-3 | PRO: 690987-99-6 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities\", \"authors\": \"Huang, Ding; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(14), 9955-9973.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34105968\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 5 h, rt\", \"256. Scheme 256 (1 Reaction)\", \"Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers\", \"By: Braconi, Laura; et al\", \"European Journal of Medicinal Chemistry (2023), 259, 115716.\", \"10.1016/j.ejmech.2023.115716\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"118-41-2\", \"39552-81-3\"], \"pro_cas\": [\"690987-99-6\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["118-41-2", "39552-81-3"], "products": ["690987-99-6"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.090656", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34106977", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 92.0}, "smiles": {"reactants": "CCc1cccc(CC)c1N.Cn1nc(C(=O)O)cc1-c1nc(Cl)nc2c1ccn2COCC[Si](C)(C)C", "products": "CCc1cccc(CC)c1NC(=O)c1cc(-c2nc(Cl)nc3c2ccn3COCC[Si](C)(C)C)n(C)n1"}, "reference": {"title": "Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity", "authors": "Elsner, Jan; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(17), 12670-12679.", "doi": "10.1021/acs.jmedchem.1c00635", "raw": "Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity | Elsner, Jan; et al | Journal of Medicinal Chemistry (2021), 64(17), 12670-12679. | 10.1021/acs.jmedchem.1c00635"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-34106977", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; overnight, rt", "1.2|Reagents: Water; rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "22371704", "fam_sig": "0b37e8d0"}, "raw_data": {"raw_cas": "RCT: 16732-73-3 + 2632874-83-8 | PRO: 2892485-70-8 | RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity\", \"authors\": \"Elsner, Jan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(17), 12670-12679.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34106977\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; overnight, rt\", \"1.2\", \"Reagents: Water; rt\", \"397. Scheme 397 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"16732-73-3\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-70-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["16732-73-3", "2632874-83-8"], "products": ["2892485-70-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.092659", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34107357", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.5, "yield_pct": 83.0}, "smiles": {"reactants": "C=C[C@@H]1C[C@]1(N)C(=O)NS(=O)(=O)C1(C)CC1.Cl.C=CCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](Oc2nc3cc(OC)ccc3nc2C)C[C@H]1C(=O)O", "products": "C=CCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](Oc2nc3cc(OC)ccc3nc2C)C[C@H]1C(=O)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C=C"}, "reference": {"title": "Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants", "authors": "Nageswara Rao, Desaboini; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 11972-11989.", "doi": "10.1021/acs.jmedchem.1c00554", "raw": "Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants | Nageswara Rao, Desaboini; et al | Journal of Medicinal Chemistry (2021), 64(16), 11972-11989. | 10.1021/acs.jmedchem.1c00554"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-34107357", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2.5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs", "By: Anderson, Niall A.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106.", "10.1016/j.bmcl.2020.127106"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2227366-26-7 + 2450305-24-3 | PRO: 2450305-26-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants\", \"authors\": \"Nageswara Rao, Desaboini; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 11972-11989.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34107357\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2.5 h, rt\", \"485. Scheme 485 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs\", \"By: Anderson, Niall A.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127106.\", \"10.1016/j.bmcl.2020.127106\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2227366-26-7\", \"2450305-24-3\"], \"pro_cas\": [\"2450305-26-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2227366-26-7", "2450305-24-3"], "products": ["2450305-26-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.092659", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34283447", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O.CCOC(=O)CC[C@@H](N)C(=O)OCC.Cl", "products": "CCOC(=O)CC[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)OC(C)(C)C)C(=O)OCC"}, "reference": {"title": "Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity", "authors": "Guzelj, Samo; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.", "doi": "10.1021/acs.jmedchem.1c00644", "raw": "Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity | Guzelj, Samo; et al | Journal of Medicinal Chemistry (2021), 64(11), 7809-7838. | 10.1021/acs.jmedchem.1c00644"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-34283447", "1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Ethyl acetate; 15 min, cooled", "1.2|Catalysts: 4-(Dimethylamino)pyridine; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "By: Fuchs, Natalie; et al", "ChemMedChem (2023), 18(15), e202300160.", "10.1002/cmdc.202300160"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+Triethylamine|121-44-8/Ethyl Acetate|141-78-6", "cond_sig": "fbb736df", "fam_sig": "88192398"}, "raw_data": {"raw_cas": "RCT: 55-22-1 + 2899-28-7 | PRO: 29523-23-7 | RGT: 121-44-8 + 538-75-0 + 2592-95-2 | CAT: 1122-58-3 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.\", \"reagents\": [\"Triethylamine\", \"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34283447\", \"1.1\", \"Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Ethyl acetate; 15 min, cooled\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; overnight, rt\", \"480. Scheme 480 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"By: Fuchs, Natalie; et al\", \"ChemMedChem (2023), 18(15), e202300160.\", \"10.1002/cmdc.202300160\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55-22-1\", \"2899-28-7\"], \"pro_cas\": [\"29523-23-7\"], \"rgt_cas\": [\"121-44-8\", \"538-75-0\", \"2592-95-2\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["55-22-1", "2899-28-7"], "products": ["29523-23-7"], "reagents": ["Triethylamine", "N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.092659", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34283448", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 92.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.CCOC(=O)CC[C@@H](NC(=O)[C@@H](N)COCc1ccccc1)C(=O)OCC.O=C(O)C(F)(F)F", "products": "CCOC(=O)CC[C@@H](NC(=O)[C@H](COCc1ccccc1)NC(=O)CNC(=O)OC(C)(C)C)C(=O)OCC"}, "reference": {"title": "Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity", "authors": "Guzelj, Samo; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.", "doi": "10.1021/acs.jmedchem.1c00644", "raw": "Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity | Guzelj, Samo; et al | Journal of Medicinal Chemistry (2021), 64(11), 7809-7838. | 10.1021/acs.jmedchem.1c00644"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-34283448", "1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Ethyl acetate; 15 min, cooled", "1.2|Catalysts: 4-(Dimethylamino)pyridine; overnight, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+Triethylamine|121-44-8/Ethyl Acetate|141-78-6", "cond_sig": "fbb736df", "fam_sig": "88192398"}, "raw_data": {"raw_cas": "RCT: 2882-15-7 + 36377-59-0 | PRO: 2565618-13-3 | RGT: 121-44-8 + 538-75-0 + 2592-95-2 | CAT: 1122-58-3 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.\", \"reagents\": [\"Triethylamine\", \"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34283448\", \"1.1\", \"Reagents: Triethylamine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Ethyl acetate; 15 min, cooled\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; overnight, rt\", \"59. Scheme 59 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2882-15-7\", \"36377-59-0\"], \"pro_cas\": [\"2565618-13-3\"], \"rgt_cas\": [\"121-44-8\", \"538-75-0\", \"2592-95-2\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["2882-15-7", "36377-59-0"], "products": ["2565618-13-3"], "reagents": ["Triethylamine", "N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.093328", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34334401", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": -10.0, "time_h": 20.0, "yield_pct": 94.0}, "smiles": {"reactants": "C=C[C@@H](C)C(=O)O.C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2c(N)cnn2C(F)F)ccn1", "products": "C=CC[C@H](NC(=O)OC(C)(C)C)c1cc(-c2c(NC(=O)[C@H](C)C=C)cnn2C(F)F)ccn1"}, "reference": {"title": "Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy", "authors": "Dilger, Andrew K.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(3), 1770-1785.", "doi": "10.1021/acs.jmedchem.1c00613", "raw": "Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy | Dilger, Andrew K.; et al | Journal of Medicinal Chemistry (2022), 65(3), 1770-1785. | 10.1021/acs.jmedchem.1c00613"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-34334401", "1.1|Reagents: Pyridine, Propylphosphonic anhydride", "Solvents: Ethyl acetate; -10 °C → rt; 20 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S", "By: Rathman, Benjamin M.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.", "10.1016/j.bmcl.2020.127283"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Pyridine|110-86-1/Ethyl Acetate|141-78-6", "cond_sig": "8c6e1da2", "fam_sig": "2425fcc8"}, "raw_data": {"raw_cas": "RCT: 78-81-9 + 2364482-32-4 | PRO: 2429959-78-2 | RGT: 110-86-1 + 68957-94-8 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy\", \"authors\": \"Dilger, Andrew K.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(3), 1770-1785.\", \"reagents\": [\"Pyridine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34334401\", \"1.1\", \"Reagents: Pyridine, Propylphosphonic anhydride\", \"Solvents: Ethyl acetate; -10 °C → rt; 20 h, rt\", \"204. Scheme 204 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthesis and biological evaluation of backbone-aminated analogs of gramicidin S\", \"By: Rathman, Benjamin M.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(15), 127283.\", \"10.1016/j.bmcl.2020.127283\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"78-81-9\", \"2364482-32-4\"], \"pro_cas\": [\"2429959-78-2\"], \"rgt_cas\": [\"110-86-1\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["78-81-9", "2364482-32-4"], "products": ["2429959-78-2"], "reagents": ["Pyridine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.093328", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382490", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1ccc(O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)c(O)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-34382490", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 36377-59-0 + 40432-84-6 | PRO: 2565618-11-1 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382490\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"62. Scheme 62 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36377-59-0\", \"40432-84-6\"], \"pro_cas\": [\"2565618-11-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36377-59-0", "40432-84-6"], "products": ["2565618-11-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.093328", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382491", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccc(O)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)cc1O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34382491", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis", "By: Yang, Liu; et al", "Journal of Medicinal Chemistry (2024), 67(3), 1914-1931.", "10.1021/acs.jmedchem.3c01703"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 57-13-6 + 635-21-2 | PRO: 1640-60-4 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382491\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"76. Scheme 76 (1 Reaction)\", \"Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis\", \"By: Yang, Liu; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 1914-1931.\", \"10.1021/acs.jmedchem.3c01703\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57-13-6\", \"635-21-2\"], \"pro_cas\": [\"1640-60-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["57-13-6", "635-21-2"], "products": ["1640-60-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.094346", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382493", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1ccccc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-34382493", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 80102-26-7 + 2761157-64-4 | PRO: 2761157-84-8 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382493\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"8. Scheme 8 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"80102-26-7\", \"2761157-64-4\"], \"pro_cas\": [\"2761157-84-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["80102-26-7", "2761157-64-4"], "products": ["2761157-84-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.094738", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382498", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1", "products": "COc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc([N+](=O)[O-])cc2)c(O)c1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34382498", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)", "By: Chen, Young; et al", "Journal of Medicinal Chemistry (2023), 66(23), 15750-15760.", "10.1021/acs.jmedchem.3c01137"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 3473-63-0 + 83506-93-8 | PRO: 205259-37-6 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382498\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"126. Scheme 126 (1 Reaction)\", \"Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)\", \"By: Chen, Young; et al\", \"Journal of Medicinal Chemistry (2023), 66(23), 15750-15760.\", \"10.1021/acs.jmedchem.3c01137\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3473-63-0\", \"83506-93-8\"], \"pro_cas\": [\"205259-37-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3473-63-0", "83506-93-8"], "products": ["205259-37-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.095173", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382499", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1ccc(O)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)cc1O)S(=O)(=O)c1ccc(C(F)(F)F)cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-34382499", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma", "By: Gonzalez-Cuesta, Manuel; et al", "Journal of Medicinal Chemistry (2023), 66(7), 4768-4783.", "10.1021/acs.jmedchem.2c01948"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 103213-32-7 + 124-22-1 | PRO: 3014485-89-0 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382499\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"90. Scheme 90 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma\", \"By: Gonzalez-Cuesta, Manuel; et al\", \"Journal of Medicinal Chemistry (2023), 66(7), 4768-4783.\", \"10.1021/acs.jmedchem.2c01948\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"103213-32-7\", \"124-22-1\"], \"pro_cas\": [\"3014485-89-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["103213-32-7", "124-22-1"], "products": ["3014485-89-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.095173", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382505", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 90.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1", "products": "COc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(C(F)(F)F)cc2)c(O)c1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34382505", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "By: Zhang, Yi; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "10.1021/acs.jmedchem.3c00504"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 2691175-30-9 + 771579-27-2 | PRO: 1403593-29-2 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382505\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"135. Scheme 135 (1 Reaction)\", \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"By: Zhang, Yi; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"10.1021/acs.jmedchem.3c00504\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2691175-30-9\", \"771579-27-2\"], \"pro_cas\": [\"1403593-29-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2691175-30-9", "771579-27-2"], "products": ["1403593-29-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.095173", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382506", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 88.0}, "smiles": {"reactants": "COc1cc(C(=O)O)cc(OC)c1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1", "products": "COc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(C(F)(F)F)cc2)cc(OC)c1O"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-34382506", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 251105-80-3 + 1315051-74-1 | PRO: 2765293-25-0 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382506\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"178. Scheme 178 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"251105-80-3\", \"1315051-74-1\"], \"pro_cas\": [\"2765293-25-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["251105-80-3", "1315051-74-1"], "products": ["2765293-25-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.095173", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382507", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1cc(O)cc(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(C(F)(F)F)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(O)cc(O)c1)S(=O)(=O)c1ccc(C(F)(F)F)cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-34382507", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 155480-08-3 + 159005-71-7 | PRO: 2765293-49-8 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382507\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"28. Scheme 28 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"155480-08-3\", \"159005-71-7\"], \"pro_cas\": [\"2765293-49-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["155480-08-3", "159005-71-7"], "products": ["2765293-49-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.096243", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382509", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1ccccc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1O)S(=O)(=O)c1ccc(F)cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-34382509", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity", "By: Guzelj, Samo; et al", "Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.", "10.1021/acs.jmedchem.1c00644"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 23680-31-1 + 1001-19-0 | PRO: 3031089-22-9 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382509\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"479. Scheme 479 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity\", \"By: Guzelj, Samo; et al\", \"Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.\", \"10.1021/acs.jmedchem.1c00644\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"23680-31-1\", \"1001-19-0\"], \"pro_cas\": [\"3031089-22-9\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["23680-31-1", "1001-19-0"], "products": ["3031089-22-9"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.096243", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382510", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)c1ccc(O)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(O)cc1O)S(=O)(=O)c1ccc(F)cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-34382510", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands", "By: Shaik, Anver Basha; et al", "Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.", "10.1021/acs.jmedchem.1c01353"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 1477-50-5 + 3035975-21-1 | PRO: 3035975-22-2 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382510\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"66. Scheme 66 (1 Reaction)\", \"Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands\", \"By: Shaik, Anver Basha; et al\", \"Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.\", \"10.1021/acs.jmedchem.1c01353\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1477-50-5\", \"3035975-21-1\"], \"pro_cas\": [\"3035975-22-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1477-50-5", "3035975-21-1"], "products": ["3035975-22-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.096243", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382512", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1cc(O)cc(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(O)cc(O)c1)S(=O)(=O)c1ccc(F)cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-34382512", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor", "By: Kato, Jun-ya; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 79, 129083.", "10.1016/j.bmcl.2022.129083"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 1609531-36-3 | PRO: 2921556-18-3 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382512\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"492. Scheme 492 (1 Reaction)\", \"Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor\", \"By: Kato, Jun-ya; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 79, 129083.\", \"10.1016/j.bmcl.2022.129083\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"1609531-36-3\"], \"pro_cas\": [\"2921556-18-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "1609531-36-3"], "products": ["2921556-18-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.096243", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382514", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 91.0}, "smiles": {"reactants": "COc1cc(C(=O)O)cc(OC)c1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1", "products": "COc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(F)cc2)cc(OC)c1O"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-34382514", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Relative stereochemistry shown", "Relative stereochemistry shown", "Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer", "By: Xiang, Weiguo; et al", "Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.", "10.1021/acs.jmedchem.1c00900"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 223535-95-3 + 2616553-29-6 | PRO: 2830636-79-6 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382514\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"167. Scheme 167 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer\", \"By: Xiang, Weiguo; et al\", \"Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.\", \"10.1021/acs.jmedchem.1c00900\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"223535-95-3\", \"2616553-29-6\"], \"pro_cas\": [\"2830636-79-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["223535-95-3", "2616553-29-6"], "products": ["2830636-79-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.096243", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382516", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 87.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)c(O)c1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1", "products": "COc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(F)cc2)c(O)c1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-34382516", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Relative stereochemistry shown", "Relative stereochemistry shown", "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure", "By: Cadilla, Rodolfo; et al", "Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.", "10.1016/j.bmc.2020.115791"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 899806-45-2 + 2255313-91-6 | PRO: 2255311-99-8 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382516\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"115. Scheme 115 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure\", \"By: Cadilla, Rodolfo; et al\", \"Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.\", \"10.1016/j.bmc.2020.115791\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"899806-45-2\", \"2255313-91-6\"], \"pro_cas\": [\"2255311-99-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["899806-45-2", "2255313-91-6"], "products": ["2255311-99-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.096243", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34382517", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.167, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1ccc(Cl)cc1O.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(F)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Cl)cc1O)S(=O)(=O)c1ccc(F)cc1"}, "reference": {"title": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "authors": "Hu, Shangjiu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "doi": "10.1016/j.bmc.2022.116760", "raw": "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants | Hu, Shangjiu; et al | Bioorganic & Medicinal Chemistry (2022), 64, 116760. | 10.1016/j.bmc.2022.116760"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-34382517", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C", "Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety", "By: Pandrala, Mallesh; et al", "Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.", "10.1021/acs.jmedchem.1c01853"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 82998-57-0 + 641571-11-1 | PRO: 926922-18-1 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"authors\": \"Hu, Shangjiu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34382517\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; 10 min, 0 °C; 1 h, 0 °C → 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 2 h, 25 °C\", \"70. Scheme 70 (1 Reaction)\", \"Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety\", \"By: Pandrala, Mallesh; et al\", \"Journal of Medicinal Chemistry (2022), 65(16), 10898-10919.\", \"10.1021/acs.jmedchem.1c01853\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"82998-57-0\", \"641571-11-1\"], \"pro_cas\": [\"926922-18-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["82998-57-0", "641571-11-1"], "products": ["926922-18-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.097256", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34405403", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.0, "yield_pct": 94.0}, "smiles": {"reactants": "CN.Cl.O=C(O)c1nnc(Cl)cc1Cl.[Li]", "products": "[2H]C([2H])([2H])NC(=O)c1nnc(Cl)cc1Cl"}, "reference": {"title": "Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases", "authors": "Liu, Fei; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(11), 1730-1738.", "doi": "10.1021/acsmedchemlett.2c00334", "raw": "Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases | Liu, Fei; et al | ACS Medicinal Chemistry Letters (2022), 13(11), 1730-1738. | 10.1021/acsmedchemlett.2c00334"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-34405403", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Dimethylformamide; 10 h, 25 °C", "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "By: Morozova, Alisa; et al", "European Journal of Medicinal Chemistry (2024), 266, 116101.", "10.1016/j.ejmech.2023.116101"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/Dimethylformamide|68-12-2", "cond_sig": "2ff811ef", "fam_sig": "2fb3add8"}, "raw_data": {"raw_cas": "RCT: 753-90-2 + 7311-63-9 | PRO: 1247648-41-4 | RGT: 7087-68-5 + 68957-94-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases\", \"authors\": \"Liu, Fei; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(11), 1730-1738.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34405403\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Dimethylformamide; 10 h, 25 °C\", \"26. Scheme 26 (1 Reaction)\", \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"By: Morozova, Alisa; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"10.1016/j.ejmech.2023.116101\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"753-90-2\", \"7311-63-9\"], \"pro_cas\": [\"1247648-41-4\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["753-90-2", "7311-63-9"], "products": ["1247648-41-4"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.097256", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34440323", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 21.0, "time_h": 2.0, "yield_pct": 96.0}, "smiles": {"reactants": "N[C@@H]1CCC[C@@H](O)C1.Cc1ccc(F)c2cc(C(=O)O)[nH]c12", "products": "Cc1ccc(F)c2cc(C(=O)N[C@@H]3CCC[C@@H](O)C3)[nH]c12"}, "reference": {"title": "Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies", "authors": "Lampe, John W.; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(10), 1539-1545.", "doi": "10.1021/acsmedchemlett.1c00272", "raw": "Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies | Lampe, John W.; et al | ACS Medicinal Chemistry Letters (2021), 12(10), 1539-1545. | 10.1021/acsmedchemlett.1c00272"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-34440323", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, 21 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand", "By: Amin, Toufiq Ul; et al", "Journal of Medicinal Chemistry (2022), 65(22), 15473-15486.", "10.1021/acs.jmedchem.2c01423"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 72-18-4 + 204251-24-1 + 55750-63-5 | PRO: 3034676-67-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies\", \"authors\": \"Lampe, John W.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(10), 1539-1545.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34440323\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, 21 °C\", \"423. Scheme 423 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand\", \"By: Amin, Toufiq Ul; et al\", \"Journal of Medicinal Chemistry (2022), 65(22), 15473-15486.\", \"10.1021/acs.jmedchem.2c01423\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"72-18-4\", \"204251-24-1\", \"55750-63-5\"], \"pro_cas\": [\"3034676-67-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["72-18-4", "204251-24-1", "55750-63-5"], "products": ["3034676-67-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.097256", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34491577", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 21.5, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1cc(-c2ccccc2)[nH]n1.COC(=O)c1ccc(C(C)N)cc1.Cl", "products": "COC(=O)c1ccc(C(C)NC(=O)c2cc(-c3ccccc3)n[nH]2)cc1"}, "reference": {"title": "Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe", "authors": "Roehm, Sandra; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(18), 13451-13474.", "doi": "10.1021/acs.jmedchem.1c00868", "raw": "Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe | Roehm, Sandra; et al | Journal of Medicinal Chemistry (2021), 64(18), 13451-13474. | 10.1021/acs.jmedchem.1c00868"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34491577", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 1.5 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 20 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin", "By: Schiffers, Ingo; et al", "Organic Process Research & Development (2022), 26(10), 2811-2822.", "10.1021/acs.oprd.2c00152"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 23967-57-9 + 1157849-50-7 | PRO: 2053549-47-4 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe\", \"authors\": \"Roehm, Sandra; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(18), 13451-13474.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34491577\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 1.5 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 20 h, rt\", \"302. Scheme 302 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin\", \"By: Schiffers, Ingo; et al\", \"Organic Process Research & Development (2022), 26(10), 2811-2822.\", \"10.1021/acs.oprd.2c00152\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"23967-57-9\", \"1157849-50-7\"], \"pro_cas\": [\"2053549-47-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["23967-57-9", "1157849-50-7"], "products": ["2053549-47-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.097256", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34504603", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "cas": "1075198-30-9", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "2-Methyltetrahydrofuran", "cas": "96-47-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 20.0, "time_h": 2.583, "yield_pct": 90.0}, "smiles": {"reactants": "C=CC(=O)N[C@H](Cc1ccc(OC)c(Cl)c1)C(=O)N[C@@H](C)C(C)(C)C(=O)O.C=CC[C@H](OC(=O)[C@@H](N)CC(C)(C)C)[C@H](C)COCc1ccc(OC)cc1", "products": "C=CC[C@H](OC(=O)[C@H](CC(C)(C)C)NC(=O)C(C)(C)[C@H](C)NC(=O)[C@@H](Cc1ccc(OC)c(Cl)c1)NC(=O)C=C)[C@H](C)COCc1ccc(OC)cc1"}, "reference": {"title": "Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate", "authors": "Bendelac, Audrey; et al", "citation": "Organic Process Research & Development (2022), 26(8), 2145-2154.", "doi": "10.1021/acs.oprd.2c00080", "raw": "Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate | Bendelac, Audrey; et al | Organic Process Research & Development (2022), 26(8), 2145-2154. | 10.1021/acs.oprd.2c00080"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34504603", "1.1|Reagents: N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "Solvents: 2-Methyltetrahydrofuran; 5 min, 20 °C", "1.2|Reagents: Diisopropylethylamine", "Solvents: 2-Methyltetrahydrofuran; 20 °C; 2.5 h, 20 °C", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water", "Relative stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.", "10.1021/acs.jmedchem.3c02183"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate|1075198-30-9+NaHCO3|144-55-8+Sodium bicarbonate|/2-Methyltetrahydrofuran|96-47-9+Water|7732-18-5", "cond_sig": "dcb7b535", "fam_sig": "9299f8f2"}, "raw_data": {"raw_cas": "RCT: 2787516-59-8 + 2787516-94-1 | PRO: 3083612-83-0 | RGT: 1075198-30-9 + 7087-68-5 + 144-55-8 | SOL: 96-47-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate\", \"authors\": \"Bendelac, Audrey; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(8), 2145-2154.\", \"reagents\": [\"N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\", \"Diisopropylethylamine\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"2-Methyltetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34504603\", \"1.1\", \"Reagents: N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\", \"Solvents: 2-Methyltetrahydrofuran; 5 min, 20 °C\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: 2-Methyltetrahydrofuran; 20 °C; 2.5 h, 20 °C\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water\", \"372. Scheme 372 (1 Reaction)\", \"Relative stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.\", \"10.1021/acs.jmedchem.3c02183\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2787516-59-8\", \"2787516-94-1\"], \"pro_cas\": [\"3083612-83-0\"], \"rgt_cas\": [\"1075198-30-9\", \"7087-68-5\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"96-47-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2787516-59-8", "2787516-94-1"], "products": ["3083612-83-0"], "reagents": ["1075198-30-9", "N,N-Diisopropylethylamine", "NaHCO3"], "catalysts": [], "solvents": ["2-Methyltetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.097256", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34513955", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 160.0, "time_h": 16.0, "yield_pct": 92.0}, "smiles": {"reactants": "NC(N)=O.Nc1ccccc1C(=O)O", "products": "O=c1[nH]c(=O)c2ccccc2[nH]1"}, "reference": {"title": "High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists", "authors": "Bolteau, Raphael; et al", "citation": "European Journal of Medicinal Chemistry (2022), 241, 114620.", "doi": "10.1016/j.ejmech.2022.114620", "raw": "High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists | Bolteau, Raphael; et al | European Journal of Medicinal Chemistry (2022), 241, 114620. | 10.1016/j.ejmech.2022.114620"}, "original_text": ["Steps: 1, Yield: 89-92%", "CAS Reaction Number: 31-614-CAS-34513955", "1.1|overnight, 160 °C", "Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis", "By: Biteau, Nicolas G.; et al", "Bioorganic & Medicinal Chemistry (2021), 46, 116351.", "10.1016/j.bmc.2021.116351"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 57-13-6 + 118-92-3 | PRO: 86-96-4", "raw_data_json": "{\"txt\": {\"title\": \"High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists\", \"authors\": \"Bolteau, Raphael; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 241, 114620.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34513955\", \"1.1\", \"overnight, 160 °C\", \"Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis\", \"By: Biteau, Nicolas G.; et al\", \"Bioorganic & Medicinal Chemistry (2021), 46, 116351.\", \"10.1016/j.bmc.2021.116351\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57-13-6\", \"118-92-3\"], \"pro_cas\": [\"86-96-4\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["57-13-6", "118-92-3"], "products": ["86-96-4"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.097256", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34513976", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "NaOH", "cas": "1310-73-2", "role": "BASE"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 160.0, "time_h": 16.0, "yield_pct": 84.0}, "smiles": {"reactants": "NC(N)=O.Nc1ccc(Br)cc1C(=O)O", "products": "O=c1[nH]c(=O)c2cc(Br)ccc2[nH]1"}, "reference": {"title": "High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists", "authors": "Bolteau, Raphael; et al", "citation": "European Journal of Medicinal Chemistry (2022), 241, 114620.", "doi": "10.1016/j.ejmech.2022.114620", "raw": "High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists | Bolteau, Raphael; et al | European Journal of Medicinal Chemistry (2022), 241, 114620. | 10.1016/j.ejmech.2022.114620"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-34513976", "1.1|overnight, 160 °C", "1.2|Reagents: Sodium hydroxide", "Solvents: Water; rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; acidified", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "By: Novotna, Katerina; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "10.1021/acs.jmedchem.3c01681"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+NaOH|1310-73-2+Sodium hydroxide|/Water|7732-18-5", "cond_sig": "392565fc", "fam_sig": "89468f2e"}, "raw_data": {"raw_cas": "RCT: 35661-39-3 + 2851863-10-8 | PRO: 2861234-16-2 | RGT: 1310-73-2 + 7647-01-0 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists\", \"authors\": \"Bolteau, Raphael; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 241, 114620.\", \"reagents\": [\"Sodium hydroxide\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34513976\", \"1.1\", \"overnight, 160 °C\", \"1.2\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; acidified\", \"78. Scheme 78 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"By: Novotna, Katerina; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"10.1021/acs.jmedchem.3c01681\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"35661-39-3\", \"2851863-10-8\"], \"pro_cas\": [\"2861234-16-2\"], \"rgt_cas\": [\"1310-73-2\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["35661-39-3", "2851863-10-8"], "products": ["2861234-16-2"], "reagents": ["NaOH", "Hydrochloric acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.097256", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34560348", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.5, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)CSSCC(=O)O.CCN(CC)C1=CC2OC3=CC(=[N+](CC)CC)C=CC3=C(c3ccccc3C(=O)NCCCCN)C2C=C1", "products": "CCN(CC)C1=CC2OC3=CC(=[N+](CC)CC)C=CC3=C(c3ccccc3C(=O)NCCCCNC(=O)CSSCC(=O)O)C2C=C1"}, "reference": {"title": "Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy", "authors": "Wang, Jin; et al", "citation": "European Journal of Medicinal Chemistry (2022), 230, 114120.", "doi": "10.1016/j.ejmech.2022.114120", "raw": "Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy | Wang, Jin; et al | European Journal of Medicinal Chemistry (2022), 230, 114120. | 10.1016/j.ejmech.2022.114120"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34560348", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|Reagents: Triethylamine; rt; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "By: Wang, Xu; et al", "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "10.1021/acs.jmedchem.4c02009"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4da6172b", "fam_sig": "2c09422f"}, "raw_data": {"raw_cas": "RCT: 3061155-03-8 + 3061155-30-1 | PRO: 3061155-36-7 | RGT: 2592-95-2 + 25952-53-8 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Tumor-microenvironmental-response Bi-functional molecules for efficient imaging and anti-tumor activity therapy\", \"authors\": \"Wang, Jin; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 230, 114120.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34560348\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"Reagents: Triethylamine; rt; 24 h, rt\", \"291. Scheme 291 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"By: Wang, Xu; et al\", \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"10.1021/acs.jmedchem.4c02009\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3061155-03-8\", \"3061155-30-1\"], \"pro_cas\": [\"3061155-36-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3061155-03-8", "3061155-30-1"], "products": ["3061155-36-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.098260", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34568026", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.667, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)O)cc2)CC1.N#Cc1ccc(O[C@H]2CC[C@H](N)CC2)cc1Cl", "products": "CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](Oc4ccc(C#N)c(Cl)c4)CC3)cc2)CC1"}, "reference": {"title": "Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer", "authors": "Xiang, Weiguo; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.", "doi": "10.1021/acs.jmedchem.1c00900", "raw": "Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer | Xiang, Weiguo; et al | Journal of Medicinal Chemistry (2021), 64(18), 13487-13509. | 10.1021/acs.jmedchem.1c00900"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34568026", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 10 min, basified, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 0.5 h, basified, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125", "By: Caroff, Eva; et al", "Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.", "10.1021/acs.jmedchem.2c00676"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 95-54-5 + 1646267-98-2 | PRO: 2835443-86-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer\", \"authors\": \"Xiang, Weiguo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34568026\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 10 min, basified, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 0.5 h, basified, rt\", \"190. Scheme 190 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125\", \"By: Caroff, Eva; et al\", \"Journal of Medicinal Chemistry (2022), 65(16), 10918-10933.\", \"10.1021/acs.jmedchem.2c00676\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"95-54-5\", \"1646267-98-2\"], \"pro_cas\": [\"2835443-86-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["95-54-5", "1646267-98-2"], "products": ["2835443-86-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.098260", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34568109", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.667, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(C2CCN(c3ccc(C(=O)O)cc3)CC2)CC1.CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](N)CC1", "products": "CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CCC(N4CCN(C(=O)OC(C)(C)C)CC4)CC3)cc2)CC1"}, "reference": {"title": "Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer", "authors": "Xiang, Weiguo; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.", "doi": "10.1021/acs.jmedchem.1c00900", "raw": "Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer | Xiang, Weiguo; et al | Journal of Medicinal Chemistry (2021), 64(18), 13487-13509. | 10.1021/acs.jmedchem.1c00900"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-34568109", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 10 min, basified, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 0.5 h, basified, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases", "By: Andrews, Mark D.; et al", "Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.", "10.1021/acs.jmedchem.2c00422"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2488667-98-5 + 2548967-22-0 | PRO: 2548974-55-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer\", \"authors\": \"Xiang, Weiguo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(18), 13487-13509.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34568109\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 10 min, basified, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 0.5 h, basified, rt\", \"168. Scheme 168 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases\", \"By: Andrews, Mark D.; et al\", \"Journal of Medicinal Chemistry (2022), 65(13), 8828-8842.\", \"10.1021/acs.jmedchem.2c00422\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2488667-98-5\", \"2548967-22-0\"], \"pro_cas\": [\"2548974-55-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2488667-98-5", "2548967-22-0"], "products": ["2548974-55-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.098260", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34588001", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 28.0, "time_h": 16.5, "yield_pct": 100.0}, "smiles": {"reactants": "N#Cc1cc(F)cc(C(=O)O)c1.C[C@H](N)c1ccccc1", "products": "C[C@H](NC(=O)c1cc(F)cc(C#N)c1)c1ccccc1"}, "reference": {"title": "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria", "authors": "de Lera Ruiz, Manuel; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.", "doi": "10.1021/acsmedchemlett.2c00355", "raw": "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria | de Lera Ruiz, Manuel; et al | ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754. | 10.1021/acsmedchemlett.2c00355"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-34588001", "1.1|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 30 min, rt", "1.2|16 h, 28 °C", "1.3|Reagents: Water", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "By: Sampaio-Dias, Ivo E.; et al", "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "10.1021/acs.jmedchem.1c00252"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Tetrahydrofuran|109-99-9", "cond_sig": "204af28a", "fam_sig": "db11c729"}, "raw_data": {"raw_cas": "RCT: 488-93-7 + 6306-52-1 | PRO: 1189054-05-4 | RGT: 7087-68-5 + 7732-18-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria\", \"authors\": \"de Lera Ruiz, Manuel; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.\", \"reagents\": [\"Diisopropylethylamine\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34588001\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 30 min, rt\", \"1.2\", \"16 h, 28 °C\", \"1.3\", \"Reagents: Water\", \"61. Scheme 61 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"By: Sampaio-Dias, Ivo E.; et al\", \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"10.1021/acs.jmedchem.1c00252\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"488-93-7\", \"6306-52-1\"], \"pro_cas\": [\"1189054-05-4\"], \"rgt_cas\": [\"7087-68-5\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["488-93-7", "6306-52-1"], "products": ["1189054-05-4"], "reagents": ["N,N-Diisopropylethylamine", "Water"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.099155", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34588037", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 20.5, "yield_pct": 83.0}, "smiles": {"reactants": "O=Cc1cccc(C(=O)O)c1.C[C@H](N)c1ccccc1", "products": "C[C@H](NC(=O)c1cccc(C=O)c1)c1ccccc1"}, "reference": {"title": "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria", "authors": "de Lera Ruiz, Manuel; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.", "doi": "10.1021/acsmedchemlett.2c00355", "raw": "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria | de Lera Ruiz, Manuel; et al | ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754. | 10.1021/acsmedchemlett.2c00355"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-34588037", "1.1|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 30 min, rt", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 16 h, 25 °C", "1.3|Reagents: Water; 25 °C", "1.4|Reagents: Hydrochloric acid", "Solvents: Tetrahydrofuran; 2 h, 25 °C", "1.5|Reagents: Water", "Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors", "By: Li, Zizhou; et al", "Journal of Medicinal Chemistry (2020), 63(8), 3956-3975.", "10.1021/acs.jmedchem.9b01784"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Tetrahydrofuran|109-99-9", "cond_sig": "bb07070b", "fam_sig": "a1fd67c2"}, "raw_data": {"raw_cas": "RCT: 870-24-6 + 90724-57-5 | PRO: 2411226-25-8 | RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 + 7647-01-0 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria\", \"authors\": \"de Lera Ruiz, Manuel; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34588037\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 30 min, rt\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 16 h, 25 °C\", \"1.3\", \"Reagents: Water; 25 °C\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Tetrahydrofuran; 2 h, 25 °C\", \"1.5\", \"Reagents: Water\", \"30. Scheme 30 (1 Reaction)\", \"Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors\", \"By: Li, Zizhou; et al\", \"Journal of Medicinal Chemistry (2020), 63(8), 3956-3975.\", \"10.1021/acs.jmedchem.9b01784\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"870-24-6\", \"90724-57-5\"], \"pro_cas\": [\"2411226-25-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["870-24-6", "90724-57-5"], "products": ["2411226-25-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water", "Hydrochloric acid"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34588150", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 22.0, "time_h": 5.0, "yield_pct": 88.0}, "smiles": {"reactants": "CC1(C)C[C@H](N)c2ccccc2O1.CCC1(CC)CC(=O)N([C@@H]2CCOc3ccc(C(=O)O)cc32)C(NC(=O)OC(C)(C)C)=N1", "products": "CCC1(CC)CC(=O)N([C@@H]2CCOc3ccc(C(=O)N[C@H]4CC(C)(C)Oc5ccccc54)cc32)C(NC(=O)OC(C)(C)C)=N1"}, "reference": {"title": "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria", "authors": "de Lera Ruiz, Manuel; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.", "doi": "10.1021/acsmedchemlett.2c00355", "raw": "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria | de Lera Ruiz, Manuel; et al | ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754. | 10.1021/acsmedchemlett.2c00355"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-34588150", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Tetrahydrofuran; 5 h, 22 °C", "1.2|Reagents: Water", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design", "By: Krieger, Johannes; et al", "ChemMedChem (2023), 18(8), e202200615.", "10.1002/cmdc.202200615"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Tetrahydrofuran|109-99-9", "cond_sig": "dae9f597", "fam_sig": "c8cdc9b7"}, "raw_data": {"raw_cas": "RCT: 202592-23-2 + 3055533-17-7 | PRO: 3055533-18-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 + 7732-18-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria\", \"authors\": \"de Lera Ruiz, Manuel; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34588150\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Tetrahydrofuran; 5 h, 22 °C\", \"1.2\", \"Reagents: Water\", \"446. Scheme 446 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design\", \"By: Krieger, Johannes; et al\", \"ChemMedChem (2023), 18(8), e202200615.\", \"10.1002/cmdc.202200615\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"202592-23-2\", \"3055533-17-7\"], \"pro_cas\": [\"3055533-18-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["202592-23-2", "3055533-17-7"], "products": ["3055533-18-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34601305", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.5, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1cc(F)cc(F)c1.Nc1cccc([N+](=O)[O-])c1", "products": "O=C(Nc1cccc([N+](=O)[O-])c1)c1cc(F)cc(F)c1"}, "reference": {"title": "Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors", "authors": "Wang, Xinyu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 72, 116995.", "doi": "10.1016/j.bmc.2022.116995", "raw": "Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors | Wang, Xinyu; et al | Bioorganic & Medicinal Chemistry (2022), 72, 116995. | 10.1016/j.bmc.2022.116995"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-34601305", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; rt; 30 min, rt", "1.2|10 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities", "By: Wang, Juan; et al", "European Journal of Medicinal Chemistry (2021), 215, 113267.", "10.1016/j.ejmech.2021.113267"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 7517-19-3 + 13139-15-6 | PRO: 15136-12-6 | RGT: 7087-68-5 + 148893-10-1 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors\", \"authors\": \"Wang, Xinyu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 72, 116995.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34601305\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; rt; 30 min, rt\", \"1.2\", \"10 h, rt\", \"94. Scheme 94 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities\", \"By: Wang, Juan; et al\", \"European Journal of Medicinal Chemistry (2021), 215, 113267.\", \"10.1016/j.ejmech.2021.113267\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7517-19-3\", \"13139-15-6\"], \"pro_cas\": [\"15136-12-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["7517-19-3", "13139-15-6"], "products": ["15136-12-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34601332", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.5, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)c1cc(F)cc(F)c1.CC(=O)c1cccc(N)c1", "products": "CC(=O)c1cccc(NC(=O)c2cc(F)cc(F)c2)c1"}, "reference": {"title": "Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors", "authors": "Wang, Xinyu; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 72, 116995.", "doi": "10.1016/j.bmc.2022.116995", "raw": "Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors | Wang, Xinyu; et al | Bioorganic & Medicinal Chemistry (2022), 72, 116995. | 10.1016/j.bmc.2022.116995"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34601332", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; rt; 30 min, rt", "1.2|10 h, rt", "Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors", "By: Leiris, Simon; et al", "ACS Medicinal Chemistry Letters (2021), 12(2), 217-227.", "10.1021/acsmedchemlett.0c00554"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 4760-34-3 | PRO: 2245166-17-8 | RGT: 7087-68-5 + 148893-10-1 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors\", \"authors\": \"Wang, Xinyu; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 72, 116995.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34601332\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; rt; 30 min, rt\", \"1.2\", \"10 h, rt\", \"84. Scheme 84 (1 Reaction)\", \"Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors\", \"By: Leiris, Simon; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(2), 217-227.\", \"10.1021/acsmedchemlett.0c00554\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"4760-34-3\"], \"pro_cas\": [\"2245166-17-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "4760-34-3"], "products": ["2245166-17-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34604232", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.5, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1cc(F)cc(F)c1.Nc1cccc([N+](=O)[O-])c1", "products": "O=C(Nc1cccc([N+](=O)[O-])c1)c1cc(F)cc(F)c1"}, "reference": {"title": "Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type ALK inhibitors with promising antitumor effects", "authors": "Cui, Youbao; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 75, 128990.", "doi": "10.1016/j.bmcl.2022.128990", "raw": "Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type ALK inhibitors with promising antitumor effects | Cui, Youbao; et al | Bioorganic & Medicinal Chemistry Letters (2022), 75, 128990. | 10.1016/j.bmcl.2022.128990"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-34604232", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 30 min, rt", "1.2|10 h, rt", "Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors", "By: Wang, Xinyu; et al", "Bioorganic & Medicinal Chemistry (2022), 72, 116995.", "10.1016/j.bmc.2022.116995"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 455-40-3 + 99-09-2 | PRO: 952898-80-5 | RGT: 7087-68-5 + 148893-10-1 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type ALK inhibitors with promising antitumor effects\", \"authors\": \"Cui, Youbao; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 75, 128990.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34604232\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"10 h, rt\", \"Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors\", \"By: Wang, Xinyu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 72, 116995.\", \"10.1016/j.bmc.2022.116995\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-40-3\", \"99-09-2\"], \"pro_cas\": [\"952898-80-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-40-3", "99-09-2"], "products": ["952898-80-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34609720", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate", "cas": "132705-51-2", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Phosphorus(1+)", "cas": "", "role": "UNK"}, {"name": "bromotri-1-pyrrolidinyl-", "cas": "", "role": "UNK"}, {"name": "(T-4)-", "cas": "", "role": "UNK"}, {"name": "hexafluorophosphate(1-) (1:1)", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 89.0}, "smiles": {"reactants": "N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)O)c1.Nc1cccc(C(O)(CCC2CC2)c2cccnc2)c1", "products": "N#Cc1cccc(-n2nc(C(F)(F)F)cc2C(=O)Nc2cccc(C(O)(CCC3CC3)c3cccnc3)c2)c1"}, "reference": {"title": "Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon", "authors": "Zhang, Weihe; et al", "citation": "Bioorganic & Medicinal Chemistry (2022), 73, 117035.", "doi": "10.1016/j.bmc.2022.117035", "raw": "Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon | Zhang, Weihe; et al | Bioorganic & Medicinal Chemistry (2022), 73, 117035. | 10.1016/j.bmc.2022.117035"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-34609720", "1.1|Reagents: Diisopropylethylamine, Phosphorus(1+), bromotri-1-pyrrolidinyl-, (T-4)-, hexafluorophosphate(1-) (1:1)", "Solvents: Dimethylformamide; 16 h, 25 °C", "1.2|Reagents: Water", "Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders", "By: Roehrig, Susanne; et al", "Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.", "10.1021/acs.jmedchem.3c00795"], "signatures": {"cond_key": "none/none/(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate|132705-51-2+(T-4)-|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Phosphorus(1+)|+Water|7732-18-5+bromotri-1-pyrrolidinyl-|+hexafluorophosphate(1-) (1:1)|/Dimethylformamide|68-12-2", "cond_sig": "662b26a5", "fam_sig": "792bbd0b"}, "raw_data": {"raw_cas": "RCT: 18144-47-3 + 1630193-84-8 | PRO: 1630193-87-1 | RGT: 7087-68-5 + 132705-51-2 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon\", \"authors\": \"Zhang, Weihe; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2022), 73, 117035.\", \"reagents\": [\"Diisopropylethylamine\", \"Phosphorus(1+)\", \"bromotri-1-pyrrolidinyl-\", \"(T-4)-\", \"hexafluorophosphate(1-) (1:1)\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34609720\", \"1.1\", \"Reagents: Diisopropylethylamine, Phosphorus(1+), bromotri-1-pyrrolidinyl-, (T-4)-, hexafluorophosphate(1-) (1:1)\", \"Solvents: Dimethylformamide; 16 h, 25 °C\", \"1.2\", \"Reagents: Water\", \"309. Scheme 309 (1 Reaction)\", \"Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders\", \"By: Roehrig, Susanne; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.\", \"10.1021/acs.jmedchem.3c00795\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"18144-47-3\", \"1630193-84-8\"], \"pro_cas\": [\"1630193-87-1\"], \"rgt_cas\": [\"7087-68-5\", \"132705-51-2\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["18144-47-3", "1630193-84-8"], "products": ["1630193-87-1"], "reagents": ["N,N-Diisopropylethylamine", "(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34611184", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 94.0}, "smiles": {"reactants": "O=C(O)[C@@H]1CCCN1C(=O)Cc1cccc2ccccc12.COC(=O)c1ccccc1NC(=O)[C@@H](N)CCCCNC(=O)OC(C)(C)C", "products": "COC(=O)c1ccccc1NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)[C@@H]1CCCN1C(=O)Cc1cccc2ccccc12"}, "reference": {"title": "Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1", "authors": "Zhou, Qilong; et al", "citation": "European Journal of Medicinal Chemistry (2022), 244, 114830.", "doi": "10.1016/j.ejmech.2022.114830", "raw": "Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1 | Zhou, Qilong; et al | European Journal of Medicinal Chemistry (2022), 244, 114830. | 10.1016/j.ejmech.2022.114830"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-34611184", "1.1|Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors", "By: Schulte, Christie A.; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 47, 128113.", "10.1016/j.bmcl.2021.128113"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+4-Methylmorpholine|+HATU|148893-10-1+N-Methylmorpholine|109-02-4+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "5e887ed3", "fam_sig": "06fc1ffc"}, "raw_data": {"raw_cas": "RCT: 1282673-31-7 + 2101630-08-2 | PRO: 2662603-15-6 | RGT: 109-02-4 + 25952-53-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1\", \"authors\": \"Zhou, Qilong; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 244, 114830.\", \"reagents\": [\"4-Methylmorpholine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34611184\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"359. Scheme 359 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors\", \"By: Schulte, Christie A.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 47, 128113.\", \"10.1016/j.bmcl.2021.128113\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1282673-31-7\", \"2101630-08-2\"], \"pro_cas\": [\"2662603-15-6\"], \"rgt_cas\": [\"109-02-4\", \"25952-53-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1282673-31-7", "2101630-08-2"], "products": ["2662603-15-6"], "reagents": ["N-Methylmorpholine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34611186", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Phosphorus oxychloride", "cas": "10025-87-3", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}], "solvents": [{"name": "Pyridine", "cas": "110-86-1"}], "conditions": {"temperature_c": -15.0, "time_h": 0.5, "yield_pct": 90.0}, "smiles": {"reactants": "COC(=O)c1ccccc1N.CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O", "products": "COC(=O)c1ccccc1NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1", "authors": "Zhou, Qilong; et al", "citation": "European Journal of Medicinal Chemistry (2022), 244, 114830.", "doi": "10.1016/j.ejmech.2022.114830", "raw": "Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1 | Zhou, Qilong; et al | European Journal of Medicinal Chemistry (2022), 244, 114830. | 10.1016/j.ejmech.2022.114830"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34611186", "1.1|Reagents: Phosphorus oxychloride", "Solvents: Pyridine; -15 °C; 30 min, -15 °C", "1.2|Reagents: Water; cooled", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "By: Novotna, Katerina; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "10.1021/acs.jmedchem.3c01681"], "signatures": {"cond_key": "none/none/Phosphorus oxychloride|10025-87-3+Water|7732-18-5/Pyridine|110-86-1", "cond_sig": "d0c99ed0", "fam_sig": "389420be"}, "raw_data": {"raw_cas": "RCT: 132684-59-4 + 2851863-10-8 | PRO: 2861234-22-0 | RGT: 10025-87-3 + 7732-18-5 | SOL: 110-86-1", "raw_data_json": "{\"txt\": {\"title\": \"Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1\", \"authors\": \"Zhou, Qilong; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 244, 114830.\", \"reagents\": [\"Phosphorus oxychloride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Pyridine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34611186\", \"1.1\", \"Reagents: Phosphorus oxychloride\", \"Solvents: Pyridine; -15 °C; 30 min, -15 °C\", \"1.2\", \"Reagents: Water; cooled\", \"236. Scheme 236 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"By: Novotna, Katerina; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"10.1021/acs.jmedchem.3c01681\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"132684-59-4\", \"2851863-10-8\"], \"pro_cas\": [\"2861234-22-0\"], \"rgt_cas\": [\"10025-87-3\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"110-86-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["132684-59-4", "2851863-10-8"], "products": ["2861234-22-0"], "reagents": ["10025-87-3", "Water"], "catalysts": [], "solvents": ["Pyridine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34611287", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}], "solvents": [], "conditions": {"temperature_c": 160.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "NC(N)=S.Nc1cnccc1C(=O)O", "products": "O=c1[nH]c(=S)[nH]c2cnccc12"}, "reference": {"title": "Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives", "authors": "Guo, Wen-Ge; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 76, 129020.", "doi": "10.1016/j.bmcl.2022.129020", "raw": "Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives | Guo, Wen-Ge; et al | Bioorganic & Medicinal Chemistry Letters (2022), 76, 129020. | 10.1016/j.bmcl.2022.129020"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-34611287", "1.1|16 h, 160 °C; 160 °C → 100 °C", "1.2|Reagents: Water", "Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase", "By: Russ, Nadine; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.", "10.1021/acs.jmedchem.1c00845"], "signatures": {"cond_key": "none/none/Water|7732-18-5/none", "cond_sig": "6eaa5e56", "fam_sig": "43041ace"}, "raw_data": {"raw_cas": "RCT: 1065075-68-4 + 1019391-02-6 | PRO: 2761545-99-5 | RGT: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives\", \"authors\": \"Guo, Wen-Ge; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 76, 129020.\", \"reagents\": [\"Water\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34611287\", \"1.1\", \"16 h, 160 °C; 160 °C → 100 °C\", \"1.2\", \"Reagents: Water\", \"415. Scheme 415 (1 Reaction)\", \"Design and Development of a Chemical Probe for Pseudokinase Ca2+/calmodulin-Dependent Ser/Thr Kinase\", \"By: Russ, Nadine; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14358-14376.\", \"10.1021/acs.jmedchem.1c00845\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1065075-68-4\", \"1019391-02-6\"], \"pro_cas\": [\"2761545-99-5\"], \"rgt_cas\": [\"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["1065075-68-4", "1019391-02-6"], "products": ["2761545-99-5"], "reagents": ["Water"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34628433", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Toluene", "cas": "108-88-3"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 80.0, "time_h": 17.5, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1cnc(Cl)c(Br)c1.Nc1ccc(OC(F)(F)Cl)cc1", "products": "O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(Cl)c(Br)c1"}, "reference": {"title": "Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor", "authors": "Liu, Haixia; et al", "citation": "European Journal of Medicinal Chemistry (2022), 244, 114810.", "doi": "10.1016/j.ejmech.2022.114810", "raw": "Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor | Liu, Haixia; et al | European Journal of Medicinal Chemistry (2022), 244, 114810. | 10.1016/j.ejmech.2022.114810"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-34628433", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Toluene; 1.5 h, 80 °C", "1.2|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; -16 °C; overnight, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "By: Falkenstein, Markus; et al", "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "10.1016/j.bmc.2021.116462"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Thionyl chloride|7719-09-7/Tetrahydrofuran|109-99-9+Toluene|108-88-3", "cond_sig": "ec2aa2dd", "fam_sig": "e6a9a456"}, "raw_data": {"raw_cas": "RCT: 1080-06-4 + 13734-41-3 | PRO: 25518-33-6 | RGT: 7719-09-7 + 7087-68-5 | CAT: 68-12-2 | SOL: 108-88-3 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor\", \"authors\": \"Liu, Haixia; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 244, 114810.\", \"reagents\": [\"Thionyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Toluene\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34628433\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Toluene; 1.5 h, 80 °C\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; -16 °C; overnight, rt\", \"308. Scheme 308 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"By: Falkenstein, Markus; et al\", \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"10.1016/j.bmc.2021.116462\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1080-06-4\", \"13734-41-3\"], \"pro_cas\": [\"25518-33-6\"], \"rgt_cas\": [\"7719-09-7\", \"7087-68-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"108-88-3\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["1080-06-4", "13734-41-3"], "products": ["25518-33-6"], "reagents": ["7719-09-7", "N,N-Diisopropylethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Toluene", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34637960", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1ccccc1.CC1(C)OB(c2ccc(N)cc2)OC1(C)C", "products": "CC1(C)OB(c2ccc(NC(=O)c3ccccc3)cc2)OC1(C)C"}, "reference": {"title": "Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3", "authors": "Deng, Lin; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(19), 13094-13111.", "doi": "10.1021/acs.jmedchem.2c00940", "raw": "Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3 | Deng, Lin; et al | Journal of Medicinal Chemistry (2022), 65(19), 13094-13111. | 10.1021/acs.jmedchem.2c00940"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-34637960", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; overnight, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "By: Sampaio-Dias, Ivo E.; et al", "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "10.1021/acs.jmedchem.1c00252"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 488-93-7 + 7517-19-3 | PRO: 2732919-57-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3\", \"authors\": \"Deng, Lin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(19), 13094-13111.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34637960\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; overnight, rt\", \"74. Scheme 74 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"By: Sampaio-Dias, Ivo E.; et al\", \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"10.1021/acs.jmedchem.1c00252\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"488-93-7\", \"7517-19-3\"], \"pro_cas\": [\"2732919-57-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["488-93-7", "7517-19-3"], "products": ["2732919-57-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34638576", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.167, "yield_pct": 86.0}, "smiles": {"reactants": "Cn1cc(C(=O)O)cn1.Cl.N#Cc1ccc2c(c1)CC[C@H]2N", "products": "Cn1cc(C(=O)N[C@@H]2CCc3cc(C#N)ccc32)cn1"}, "reference": {"title": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "authors": "Chuang, Chihyuan; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "doi": "10.1021/acs.jmedchem.1c01290", "raw": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy | Chuang, Chihyuan; et al | Journal of Medicinal Chemistry (2021), 64(19), 14142-14152. | 10.1021/acs.jmedchem.1c01290"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-34638576", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Solvents: Dimethylformamide; 10 min, rt", "1.2|overnight, rt", "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "By: Bayrak, Alp; et al", "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "10.1021/acs.jmedchem.2c01198"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "c6a486a8", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 4141-08-6 + 4530-20-5 | PRO: 2998587-28-1 | RGT: 1892-57-5 + 2592-95-2 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"authors\": \"Chuang, Chihyuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34638576\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Solvents: Dimethylformamide; 10 min, rt\", \"1.2\", \"overnight, rt\", \"202. Scheme 202 (1 Reaction)\", \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"By: Bayrak, Alp; et al\", \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"10.1021/acs.jmedchem.2c01198\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4141-08-6\", \"4530-20-5\"], \"pro_cas\": [\"2998587-28-1\"], \"rgt_cas\": [\"1892-57-5\", \"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["4141-08-6", "4530-20-5"], "products": ["2998587-28-1"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34638590", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.25, "yield_pct": 88.0}, "smiles": {"reactants": "Cn1cc(C(=O)O)cn1.CCc1nc(-c2ccc3c(c2)CC[C@H]3N)no1", "products": "CCc1nc(-c2ccc3c(c2)CC[C@H]3NC(=O)c2cnn(C)c2)no1"}, "reference": {"title": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "authors": "Chuang, Chihyuan; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "doi": "10.1021/acs.jmedchem.1c01290", "raw": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy | Chuang, Chihyuan; et al | Journal of Medicinal Chemistry (2021), 64(19), 14142-14152. | 10.1021/acs.jmedchem.1c01290"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-34638590", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, Diisopropylethylamine, HOAt", "Solvents: Dimethylformamide; 15 min, rt", "1.2|3 h, rt", "Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis", "By: Biteau, Nicolas G.; et al", "Bioorganic & Medicinal Chemistry (2021), 46, 116351.", "10.1016/j.bmc.2021.116351"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxy-7-azabenzotriazole|39968-33-7+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "f861fa99", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 57-13-6 + 2941-78-8 | PRO: 62484-16-6 | RGT: 1892-57-5 + 7087-68-5 + 39968-33-7 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"authors\": \"Chuang, Chihyuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Diisopropylethylamine\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34638590\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, Diisopropylethylamine, HOAt\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"3 h, rt\", \"412. Scheme 412 (1 Reaction)\", \"Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis\", \"By: Biteau, Nicolas G.; et al\", \"Bioorganic & Medicinal Chemistry (2021), 46, 116351.\", \"10.1016/j.bmc.2021.116351\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57-13-6\", \"2941-78-8\"], \"pro_cas\": [\"62484-16-6\"], \"rgt_cas\": [\"1892-57-5\", \"7087-68-5\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["57-13-6", "2941-78-8"], "products": ["62484-16-6"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "N,N-Diisopropylethylamine", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34638596", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "1,2-Dichloroethane", "cas": "107-06-2"}], "conditions": {"temperature_c": 10.0, "time_h": 18.0, "yield_pct": 93.0}, "smiles": {"reactants": "Cn1cc(C(=O)O)cn1.Cc1ccc(S(=O)(=O)O)cc1.N#Cc1ccc2c(c1)CC[C@H]2N", "products": "Cn1cc(C(=O)N[C@@H]2CCc3cc(C#N)ccc32)cn1"}, "reference": {"title": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "authors": "Chuang, Chihyuan; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "doi": "10.1021/acs.jmedchem.1c01290", "raw": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy | Chuang, Chihyuan; et al | Journal of Medicinal Chemistry (2021), 64(19), 14142-14152. | 10.1021/acs.jmedchem.1c01290"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-34638596", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: 1,2-Dichloroethane; rt; 2 h, rt", "1.2|rt → 0 °C", "1.3|Reagents: Triethylamine; < 10 °C; overnight, < 10 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "By: Chuang, Chihyuan; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "10.1021/acs.jmedchem.1c01290"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Triethylamine|121-44-8/1,2-Dichloroethane|107-06-2", "cond_sig": "164721e9", "fam_sig": "dfe2efb2"}, "raw_data": {"raw_cas": "RCT: 5952-92-1 + 903556-00-3 | PRO: 2364561-64-6 | RGT: 79-37-8 + 121-44-8 | CAT: 68-12-2 | SOL: 107-06-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"authors\": \"Chuang, Chihyuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"1,2-Dichloroethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34638596\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: 1,2-Dichloroethane; rt; 2 h, rt\", \"1.2\", \"rt → 0 °C\", \"1.3\", \"Reagents: Triethylamine; < 10 °C; overnight, < 10 °C\", \"201. Scheme 201 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"By: Chuang, Chihyuan; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"10.1021/acs.jmedchem.1c01290\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5952-92-1\", \"903556-00-3\"], \"pro_cas\": [\"2364561-64-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"107-06-2\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["5952-92-1", "903556-00-3"], "products": ["2364561-64-6"], "reagents": ["79-37-8", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["1,2-Dichloroethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34638611", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 38.0, "time_h": 16.25, "yield_pct": 94.0}, "smiles": {"reactants": "Cc1cc(C(=O)O)ccn1.CCc1nc(-c2ccc3c(c2)CC[C@H]3N)no1.Cl", "products": "CCc1nc(-c2ccc3c(c2)CC[C@H]3NC(=O)c2ccnc(C)c2)no1"}, "reference": {"title": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "authors": "Chuang, Chihyuan; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "doi": "10.1021/acs.jmedchem.1c01290", "raw": "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy | Chuang, Chihyuan; et al | Journal of Medicinal Chemistry (2021), 64(19), 14142-14152. | 10.1021/acs.jmedchem.1c01290"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-34638611", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|overnight, 38 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "By: Chuang, Chihyuan; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "10.1021/acs.jmedchem.1c01290"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 5952-92-1 + 2364560-36-9 | PRO: 2364554-48-1 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"authors\": \"Chuang, Chihyuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34638611\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"overnight, 38 °C\", \"411. Scheme 411 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"By: Chuang, Chihyuan; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"10.1021/acs.jmedchem.1c01290\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5952-92-1\", \"2364560-36-9\"], \"pro_cas\": [\"2364554-48-1\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5952-92-1", "2364560-36-9"], "products": ["2364554-48-1"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34684560", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "2,6-Lutidine", "cas": "108-48-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 90.0}, "smiles": {"reactants": "Nc1ccc(CO)cc1.C=CCOC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O", "products": "C=CCOC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)Nc1ccc(CO)cc1"}, "reference": {"title": "Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor", "authors": "Zhang, Yong; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(21), 15787-15798.", "doi": "10.1021/acs.jmedchem.0c02043", "raw": "Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor | Zhang, Yong; et al | Journal of Medicinal Chemistry (2021), 64(21), 15787-15798. | 10.1021/acs.jmedchem.0c02043"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34684560", "1.1|Reagents: 2,6-Lutidine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2", "By: Dai, Wenhao; et al", "Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.", "10.1021/acs.jmedchem.0c02258"], "signatures": {"cond_key": "none/none/2,6-Lutidine|108-48-5+HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "a66fa7ba", "fam_sig": "4d9c812a"}, "raw_data": {"raw_cas": "RCT: 13734-34-4 + 1429218-41-6 | PRO: 1831065-36-1 | RGT: 108-48-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor\", \"authors\": \"Zhang, Yong; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(21), 15787-15798.\", \"reagents\": [\"2,6-Lutidine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34684560\", \"1.1\", \"Reagents: 2,6-Lutidine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"92. Scheme 92 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2\", \"By: Dai, Wenhao; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.\", \"10.1021/acs.jmedchem.0c02258\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-34-4\", \"1429218-41-6\"], \"pro_cas\": [\"1831065-36-1\"], \"rgt_cas\": [\"108-48-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13734-34-4", "1429218-41-6"], "products": ["1831065-36-1"], "reagents": ["2,6-Lutidine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34698514", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)(N)CO.CCOc1cccnc1O[C@@H]1CCCN(c2ncc(C(=O)O)cn2)C1", "products": "CCOc1cccnc1O[C@@H]1CCCN(c2ncc(C(=O)NC(C)(C)CO)cn2)C1"}, "reference": {"title": "Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis", "authors": "Futatsugi, Kentaro; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(22), 15000-15013.", "doi": "10.1021/acs.jmedchem.2c01200", "raw": "Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis | Futatsugi, Kentaro; et al | Journal of Medicinal Chemistry (2022), 65(22), 15000-15013. | 10.1021/acs.jmedchem.2c01200"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-34698514", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 117-34-0 + 3026371-24-1 | PRO: 3026370-37-3 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis\", \"authors\": \"Futatsugi, Kentaro; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(22), 15000-15013.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34698514\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; overnight, rt\", \"201. Scheme 201 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"117-34-0\", \"3026371-24-1\"], \"pro_cas\": [\"3026370-37-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["117-34-0", "3026371-24-1"], "products": ["3026370-37-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34708767", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "C#CCCCCN.CC(C)(C)OC(=O)NC(=NCCCC[C@H](NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)C(=O)O)NC(=O)OC(C)(C)C", "products": "C#CCCCCNC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)[C@H](CCCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C"}, "reference": {"title": "Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents", "authors": "Mohy El Dine, Tharwat; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14728-14744.", "doi": "10.1021/acs.jmedchem.1c01241", "raw": "Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents | Mohy El Dine, Tharwat; et al | Journal of Medicinal Chemistry (2021), 64(19), 14728-14744. | 10.1021/acs.jmedchem.1c01241"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-34708767", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; rt → 0 °C", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 16 h, 0 °C → rt", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+NaHCO3|144-55-8+Sodium bicarbonate|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "9055c6dc", "fam_sig": "60b8f38e"}, "raw_data": {"raw_cas": "RCT: 114873-06-2 + 3026372-02-8 | PRO: 3026371-03-6 + 3026373-04-3 | RGT: 2592-95-2 + 25952-53-8 + 144-55-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents\", \"authors\": \"Mohy El Dine, Tharwat; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14728-14744.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34708767\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; rt → 0 °C\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 16 h, 0 °C → rt\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"74. Scheme 74 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"114873-06-2\", \"3026372-02-8\"], \"pro_cas\": [\"3026371-03-6\", \"3026373-04-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["114873-06-2", "3026372-02-8"], "products": ["3026371-03-6", "3026373-04-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34708798", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 92.0}, "smiles": {"reactants": "O=C(O)c1ncc(C(F)(F)F)cc1Cl.CC(C)(C)OC(=O)NC1=N[C@](C)(c2nc(N)ccc2F)CO[C@@]1(C)C(F)(F)F", "products": "CC(C)(C)OC(=O)NC1=N[C@](C)(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@]1(C)C(F)(F)F"}, "reference": {"title": "Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease", "authors": "Machauer, Rainer; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(20), 15262-15279.", "doi": "10.1021/acs.jmedchem.1c01300", "raw": "Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease | Machauer, Rainer; et al | Journal of Medicinal Chemistry (2021), 64(20), 15262-15279. | 10.1021/acs.jmedchem.1c01300"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-34708798", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; 18 h, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Double bond geometry shown", "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury", "By: Cui, Yingjun; et al", "Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.", "10.1021/acs.jmedchem.1c01583"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7/Dimethylformamide|68-12-2", "cond_sig": "5ac08243", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 2757278-40-1 + 1026823-61-9 | PRO: 2757278-25-2 | RGT: 25952-53-8 + 39968-33-7 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease\", \"authors\": \"Machauer, Rainer; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(20), 15262-15279.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34708798\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; 18 h, rt\", \"473. Scheme 473 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury\", \"By: Cui, Yingjun; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.\", \"10.1021/acs.jmedchem.1c01583\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2757278-40-1\", \"1026823-61-9\"], \"pro_cas\": [\"2757278-25-2\"], \"rgt_cas\": [\"25952-53-8\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"alternate reaction conditions also shown\"]}}", "enriched_names": {"reactants": ["2757278-40-1", "1026823-61-9"], "products": ["2757278-25-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34709092", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 12.5, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O[C@H](/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1)CC(=O)OCC[Si](C)(C)C.C/C=C(\\NC(=O)c1csc(CNC(=O)OC(C)(C)C)n1)C(=O)O", "products": "C/C=C(\\NC(=O)c1csc(CNC(=O)OC(C)(C)C)n1)C(=O)N[C@@H](CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O[C@H](/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1)CC(=O)OCC[Si](C)(C)C"}, "reference": {"title": "Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC)", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(7), 4020-4033.", "doi": "10.1021/acs.jmedchem.0c02161", "raw": "Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC) | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2021), 64(7), 4020-4033. | 10.1021/acs.jmedchem.0c02161"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-34709092", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 0 °C → rt; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360", "By: Rueeger, Heinrich; et al", "Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.", "10.1021/acs.jmedchem.0c02143"], "signatures": {"cond_key": "none/none/1-Hydroxy-7-azabenzotriazole|39968-33-7+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2", "cond_sig": "83f9f186", "fam_sig": "091df24a"}, "raw_data": {"raw_cas": "RCT: 1262859-70-0 + 1262860-49-0 | PRO: 1262859-72-2 | RGT: 76-05-1 + 7087-68-5 + 39968-33-7 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC)\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(7), 4020-4033.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"HOAt\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34709092\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 0 °C → rt; 12 h, rt\", \"456. Scheme 456 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360\", \"By: Rueeger, Heinrich; et al\", \"Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.\", \"10.1021/acs.jmedchem.0c02143\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1262859-70-0\", \"1262860-49-0\"], \"pro_cas\": [\"1262859-72-2\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"39968-33-7\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1262859-70-0", "1262860-49-0"], "products": ["1262859-72-2"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "1-Hydroxy-7-azabenzotriazole", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34716368", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 85.0}, "smiles": {"reactants": "NC(=O)c1ccccc1N.O=C(O)c1ccccn1", "products": "NC(=O)c1ccccc1NC(=O)c1ccccn1"}, "reference": {"title": "Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection", "authors": "Tawaraishi, Taisuke; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(2), 1221-1238.", "doi": "10.1021/acs.jmedchem.2c00775", "raw": "Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection | Tawaraishi, Taisuke; et al | Journal of Medicinal Chemistry (2023), 66(2), 1221-1238. | 10.1021/acs.jmedchem.2c00775"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34716368", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "3554dd99", "fam_sig": "6003ace2"}, "raw_data": {"raw_cas": "RCT: 40004-69-1 + 2760538-81-4 | PRO: 2760538-94-9 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection\", \"authors\": \"Tawaraishi, Taisuke; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(2), 1221-1238.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34716368\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 24 h, rt\", \"144. Scheme 144 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"40004-69-1\", \"2760538-81-4\"], \"pro_cas\": [\"2760538-94-9\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["40004-69-1", "2760538-81-4"], "products": ["2760538-94-9"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34870693", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.0, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCOCCOCCN.COc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H]([C@@H](C)C(=O)O)c1nnc(C)n1-2", "products": "COc1ccc2c(c1)C(c1ccc(Cl)cc1)=N[C@@H]([C@@H](C)C(=O)NCCOCCOCCNC(=O)OC(C)(C)C)c1nnc(C)n1-2"}, "reference": {"title": "Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag", "authors": "Nowak, Radoslaw P.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(15), 11637-11650.", "doi": "10.1021/acs.jmedchem.1c00958", "raw": "Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag | Nowak, Radoslaw P.; et al | Journal of Medicinal Chemistry (2021), 64(15), 11637-11650. | 10.1021/acs.jmedchem.1c00958"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34870693", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 0 °C; 2 h, rt", "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "By: Ushiki, Yasunobu; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "10.1016/j.bmcl.2022.128572"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 2227446-38-8 + 2227448-03-3 | PRO: 2227446-66-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag\", \"authors\": \"Nowak, Radoslaw P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(15), 11637-11650.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34870693\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 0 °C; 2 h, rt\", \"442. Scheme 442 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"By: Ushiki, Yasunobu; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"10.1016/j.bmcl.2022.128572\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2227446-38-8\", \"2227448-03-3\"], \"pro_cas\": [\"2227446-66-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2227446-38-8", "2227448-03-3"], "products": ["2227446-66-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34871210", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Proton sponge", "cas": "20734-58-1", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 70.0, "time_h": 1.0, "yield_pct": 93.0}, "smiles": {"reactants": "NCCc1ccccc1.CC(C)(C(=O)O)c1ccccc1[N+](=O)[O-]", "products": "CC(C)(C(=O)NCCc1ccccc1)c1ccccc1[N+](=O)[O-]"}, "reference": {"title": "Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells", "authors": "Takashima, Katsuki; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.", "doi": "10.1016/j.bmcl.2022.129034", "raw": "Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells | Takashima, Katsuki; et al | Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034. | 10.1016/j.bmcl.2022.129034"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-34871210", "1.1|Reagents: Proton sponge, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; 1 h, 70 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7+Proton sponge|20734-58-1/Dimethylformamide|68-12-2", "cond_sig": "f20fbe09", "fam_sig": "a154ac4f"}, "raw_data": {"raw_cas": "RCT: 114873-06-2 + 2450-71-7 | PRO: 3026371-08-1 | RGT: 20734-58-1 + 25952-53-8 + 39968-33-7 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells\", \"authors\": \"Takashima, Katsuki; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.\", \"reagents\": [\"Proton sponge\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34871210\", \"1.1\", \"Reagents: Proton sponge, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; 1 h, 70 °C\", \"117. Scheme 117 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"114873-06-2\", \"2450-71-7\"], \"pro_cas\": [\"3026371-08-1\"], \"rgt_cas\": [\"20734-58-1\", \"25952-53-8\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["114873-06-2", "2450-71-7"], "products": ["3026371-08-1"], "reagents": ["20734-58-1", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34871213", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Proton sponge", "cas": "20734-58-1", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 70.0, "time_h": 1.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1cccc(CCN)c1.COc1ccc([N+](=O)[O-])c(C(C)(C)C(=O)O)c1", "products": "COc1cccc(CCNC(=O)C(C)(C)c2cc(OC)ccc2[N+](=O)[O-])c1"}, "reference": {"title": "Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells", "authors": "Takashima, Katsuki; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.", "doi": "10.1016/j.bmcl.2022.129034", "raw": "Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells | Takashima, Katsuki; et al | Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034. | 10.1016/j.bmcl.2022.129034"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34871213", "1.1|Reagents: Proton sponge, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethylformamide; 1 h, 70 °C", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7+Proton sponge|20734-58-1/Dimethylformamide|68-12-2", "cond_sig": "f20fbe09", "fam_sig": "a154ac4f"}, "raw_data": {"raw_cas": "RCT: 2614241-26-6 + 74-89-5 | PRO: 2614243-24-0 | RGT: 20734-58-1 + 25952-53-8 + 39968-33-7 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells\", \"authors\": \"Takashima, Katsuki; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.\", \"reagents\": [\"Proton sponge\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34871213\", \"1.1\", \"Reagents: Proton sponge, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethylformamide; 1 h, 70 °C\", \"304. Scheme 304 (1 Reaction)\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2614241-26-6\", \"74-89-5\"], \"pro_cas\": [\"2614243-24-0\"], \"rgt_cas\": [\"20734-58-1\", \"25952-53-8\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2614241-26-6", "74-89-5"], "products": ["2614243-24-0"], "reagents": ["20734-58-1", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34894088", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 98.0}, "smiles": {"reactants": "CN.Cl.CC(C)(C)OC(=O)N1CCc2nc(C(=O)O)ccc2C1", "products": "CNC(=O)c1ccc2c(n1)CCN(C(=O)OC(C)(C)C)C2"}, "reference": {"title": "Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers", "authors": "Ren, Junkang; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2022), 78, 129046.", "doi": "10.1016/j.bmcl.2022.129046", "raw": "Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers | Ren, Junkang; et al | Bioorganic & Medicinal Chemistry Letters (2022), 78, 129046. | 10.1016/j.bmcl.2022.129046"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-34894088", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; overnight, rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "bf295312", "fam_sig": "0413a880"}, "raw_data": {"raw_cas": "RCT: 37902-59-3 + 40615-17-6 | PRO: 2416338-23-1 | RGT: 2592-95-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers\", \"authors\": \"Ren, Junkang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2022), 78, 129046.\", \"reagents\": [\"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34894088\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; overnight, rt\", \"379. Scheme 379 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"37902-59-3\", \"40615-17-6\"], \"pro_cas\": [\"2416338-23-1\"], \"rgt_cas\": [\"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["37902-59-3", "40615-17-6"], "products": ["2416338-23-1"], "reagents": ["1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34952224", "reaction_type": "Other", "catalyst": {"core": [{"name": "Tetrabutylammonium chloride", "cas": "1112-67-0"}], "generic": [], "ligands": [], "full_system": [{"name": "Tetrabutylammonium chloride", "cas": "1112-67-0"}]}, "reagents": [], "solvents": [{"name": "Toluene", "cas": "108-88-3"}, {"name": "Pyridine", "cas": "110-86-1"}], "conditions": {"temperature_c": 70.0, "time_h": 9.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccc(B(O)O)cc1.Nc1ccccn1", "products": "O=C(Nc1ccccn1)c1ccc(B(O)O)cc1"}, "reference": {"title": "Development of Commercial Manufacturing Processes for Acalabrutinib", "authors": "Bethel, Paul A.; et al", "citation": "Organic Process Research & Development (2022), 26(12), 3303-3311.", "doi": "10.1021/acs.oprd.2c00304", "raw": "Development of Commercial Manufacturing Processes for Acalabrutinib | Bethel, Paul A.; et al | Organic Process Research & Development (2022), 26(12), 3303-3311. | 10.1021/acs.oprd.2c00304"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-34952224", "1.1|Catalysts: Tetrabutylammonium chloride", "Solvents: Toluene; rt; rt → 70 °C; 6 h, 70 °C; 70 °C → 60 °C", "1.2|Solvents: Pyridine; rt → 70 °C; 3 h, 70 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594", "By: Aydin, Gulsevim; et al", "Organic Process Research & Development (2024), 28(2), 559-576.", "10.1021/acs.oprd.3c00393"], "signatures": {"cond_key": "none/none/none/Pyridine|110-86-1+Toluene|108-88-3", "cond_sig": "ef3d9ab3", "fam_sig": "ef3d9ab3"}, "raw_data": {"raw_cas": "RCT: 585-76-2 + 1072015-52-1 | PRO: 3058601-45-6 | CAT: 1112-67-0 | SOL: 108-88-3 + 110-86-1", "raw_data_json": "{\"txt\": {\"title\": \"Development of Commercial Manufacturing Processes for Acalabrutinib\", \"authors\": \"Bethel, Paul A.; et al\", \"citation\": \"Organic Process Research & Development (2022), 26(12), 3303-3311.\", \"reagents\": [], \"catalysts\": [\"Tetrabutylammonium chloride\"], \"solvents\": [\"Toluene\", \"Pyridine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34952224\", \"1.1\", \"Catalysts: Tetrabutylammonium chloride\", \"Solvents: Toluene; rt; rt → 70 °C; 6 h, 70 °C; 70 °C → 60 °C\", \"1.2\", \"Solvents: Pyridine; rt → 70 °C; 3 h, 70 °C\", \"80. Scheme 80 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594\", \"By: Aydin, Gulsevim; et al\", \"Organic Process Research & Development (2024), 28(2), 559-576.\", \"10.1021/acs.oprd.3c00393\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"585-76-2\", \"1072015-52-1\"], \"pro_cas\": [\"3058601-45-6\"], \"rgt_cas\": [], \"cat_cas\": [\"1112-67-0\"], \"sol_cas\": [\"108-88-3\", \"110-86-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["585-76-2", "1072015-52-1"], "products": ["3058601-45-6"], "reagents": [], "catalysts": ["1112-67-0"], "solvents": ["Toluene", "Pyridine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34952962", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 85.0}, "smiles": {"reactants": "Cc1ccc(C(=O)O)cc1Cl.NCCO", "products": "Cc1ccc(C(=O)NCCO)cc1Cl"}, "reference": {"title": "Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer", "authors": "Li, Xing; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(24), 16622-16639.", "doi": "10.1021/acs.jmedchem.2c01444", "raw": "Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer | Li, Xing; et al | Journal of Medicinal Chemistry (2022), 65(24), 16622-16639. | 10.1021/acs.jmedchem.2c01444"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-34952962", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 2 h, rt", "1.3|Solvents: Water; rt", "Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels", "By: Fernandez, Ariadna; et al", "ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.", "10.1021/acsmedchemlett.1c00416"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "1bf1507d", "fam_sig": "f81999cb"}, "raw_data": {"raw_cas": "RCT: 5794-88-7 + 75-04-7 | PRO: 1263377-68-9 | RGT: 79-37-8 + 121-44-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer\", \"authors\": \"Li, Xing; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(24), 16622-16639.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34952962\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"36. Scheme 36 (1 Reaction)\", \"Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels\", \"By: Fernandez, Ariadna; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(11), 1802-1809.\", \"10.1021/acsmedchemlett.1c00416\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5794-88-7\", \"75-04-7\"], \"pro_cas\": [\"1263377-68-9\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["5794-88-7", "75-04-7"], "products": ["1263377-68-9"], "reagents": ["79-37-8", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34955247", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 36.5, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NC/C=C/C(=O)N(Cc1ccccc1)Cc1ccccc1.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)NC/C=C/C(=O)N(Cc1ccccc1)Cc1ccccc1"}, "reference": {"title": "An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity", "authors": "Lemke, Carina; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(18), 13793-13806.", "doi": "10.1021/acs.jmedchem.1c01178", "raw": "An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity | Lemke, Carina; et al | Journal of Medicinal Chemistry (2021), 64(18), 13793-13806. | 10.1021/acs.jmedchem.1c01178"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-34955247", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 20 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dichloromethane", "1.3|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane, Water; 30 min, rt; 16 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists", "By: Mhamane, Tukaram B.; et al", "Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.", "10.1016/j.bmc.2023.117296"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "9fa1daca", "fam_sig": "8679e070"}, "raw_data": {"raw_cas": "RCT: 19238-66-5 + 15761-38-3 | PRO: 18814-49-8 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity\", \"authors\": \"Lemke, Carina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(18), 13793-13806.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34955247\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 20 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dichloromethane\", \"1.3\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane, Water; 30 min, rt; 16 h, rt\", \"298. Scheme 298 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists\", \"By: Mhamane, Tukaram B.; et al\", \"Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.\", \"10.1016/j.bmc.2023.117296\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19238-66-5\", \"15761-38-3\"], \"pro_cas\": [\"18814-49-8\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": [\"stage 2 and stage 3 combined at room temperature for 16 hours (stage 3)\"]}}", "enriched_names": {"reactants": ["19238-66-5", "15761-38-3"], "products": ["18814-49-8"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34972319", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Na2CO3", "cas": "497-19-8", "role": "UNK"}, {"name": "Sodium carbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 30.0, "time_h": 10.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)C1(c2ccccc2F)CC1.Nc1ccn(-c2ccnc(F)c2)n1", "products": "O=C(Nc1ccn(-c2ccnc(F)c2)n1)C1(c2ccccc2F)CC1"}, "reference": {"title": "Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1", "authors": "Come, Jon H.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(24), 17753-17776.", "doi": "10.1021/acs.jmedchem.1c00944", "raw": "Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1 | Come, Jon H.; et al | Journal of Medicinal Chemistry (2021), 64(24), 17753-17776. | 10.1021/acs.jmedchem.1c00944"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-34972319", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide; 1 h, rt; 3 h, rt → 30 °C", "1.2|Reagents: Triethylamine", "Solvents: Tetrahydrofuran; 1 h, 0 °C; < 8 °C; 5 h, rt", "1.3|Reagents: Water; rt", "1.4|Reagents: Sodium carbonate", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma", "By: Wang, Xueyuan; et al", "European Journal of Medicinal Chemistry (2023), 250, 115187.", "10.1016/j.ejmech.2023.115187"], "signatures": {"cond_key": "none/none/Na2CO3|497-19-8+Sodium carbonate|+Thionyl chloride|7719-09-7+Triethylamine|121-44-8+Water|7732-18-5/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "89e3260f", "fam_sig": "1de02940"}, "raw_data": {"raw_cas": "RCT: 50-79-3 + 2415205-29-5 | PRO: 3059678-96-2 | RGT: 7719-09-7 + 121-44-8 + 7732-18-5 + 497-19-8 | CAT: 68-12-2 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1\", \"authors\": \"Come, Jon H.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(24), 17753-17776.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\", \"Water\", \"Sodium carbonate\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34972319\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide; 1 h, rt; 3 h, rt → 30 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Tetrahydrofuran; 1 h, 0 °C; < 8 °C; 5 h, rt\", \"1.3\", \"Reagents: Water; rt\", \"1.4\", \"Reagents: Sodium carbonate\", \"Solvents: Water; rt\", \"80. Scheme 80 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma\", \"By: Wang, Xueyuan; et al\", \"European Journal of Medicinal Chemistry (2023), 250, 115187.\", \"10.1016/j.ejmech.2023.115187\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"50-79-3\", \"2415205-29-5\"], \"pro_cas\": [\"3059678-96-2\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\", \"7732-18-5\", \"497-19-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": [\"SOCl2 also used as solvent in stage 1,exothermic reaction in stage 2,gas evolution was observed in stage 1\"]}}", "enriched_names": {"reactants": ["50-79-3", "2415205-29-5"], "products": ["3059678-96-2"], "reagents": ["7719-09-7", "Triethylamine", "Water", "Na2CO3"], "catalysts": ["Dimethylformamide"], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34998057", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 19.0, "yield_pct": 81.0}, "smiles": {"reactants": "CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O", "products": "CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(C)C)C(=O)OCC"}, "reference": {"title": "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators", "authors": "Guzelj, Samo; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.", "doi": "10.1021/acs.jmedchem.2c00808", "raw": "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators | Guzelj, Samo; et al | Journal of Medicinal Chemistry (2022), 65(22), 15085-15101. | 10.1021/acs.jmedchem.2c00808"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-34998057", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C → rt; 3 h, rt", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → rt; overnight, rt", "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands", "By: Andreasson, Maans; et al", "Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.", "10.1021/acs.jmedchem.3c02127"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "c68e4a5c", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 95-54-5 + 113-24-6 | PRO: 14003-34-0 | RGT: 76-05-1 + 1892-57-5 + 2592-95-2 + 7087-68-5 | CAT: 1122-58-3 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.\", \"reagents\": [\"Trifluoroacetic acid\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34998057\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C → rt; 3 h, rt\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → rt; overnight, rt\", \"282. Scheme 282 (1 Reaction)\", \"Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands\", \"By: Andreasson, Maans; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.\", \"10.1021/acs.jmedchem.3c02127\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"95-54-5\", \"113-24-6\"], \"pro_cas\": [\"14003-34-0\"], \"rgt_cas\": [\"76-05-1\", \"1892-57-5\", \"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["95-54-5", "113-24-6"], "products": ["14003-34-0"], "reagents": ["Trifluoroacetic acid", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34998067", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 19.0, "yield_pct": 83.0}, "smiles": {"reactants": "CCOC(=O)[C@@H](CCC(=O)OCc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C.CC(C)(C)OC(=O)NCC(=O)O", "products": "CCOC(=O)[C@@H](CCC(=O)OCc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(C)C"}, "reference": {"title": "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators", "authors": "Guzelj, Samo; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.", "doi": "10.1021/acs.jmedchem.2c00808", "raw": "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators | Guzelj, Samo; et al | Journal of Medicinal Chemistry (2022), 65(22), 15085-15101. | 10.1021/acs.jmedchem.2c00808"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-34998067", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C → rt; 3 h, rt", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → rt; overnight, rt", "Double bond geometry shown", "Double bond geometry shown", "Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms", "By: Toscani, Anita; et al", "European Journal of Medicinal Chemistry (2021), 213, 113172.", "10.1016/j.ejmech.2021.113172"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "c68e4a5c", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 112-80-1 + 54258-41-2 | PRO: 2919143-32-9 | RGT: 76-05-1 + 1892-57-5 + 2592-95-2 + 7087-68-5 | CAT: 1122-58-3 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.\", \"reagents\": [\"Trifluoroacetic acid\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34998067\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C → rt; 3 h, rt\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → rt; overnight, rt\", \"444. Scheme 444 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Development of photoactivable phenanthroline-based manganese(I) CO-Releasing molecules (PhotoCORMs) active against ESKAPE bacteria and bacterial biofilms\", \"By: Toscani, Anita; et al\", \"European Journal of Medicinal Chemistry (2021), 213, 113172.\", \"10.1016/j.ejmech.2021.113172\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"112-80-1\", \"54258-41-2\"], \"pro_cas\": [\"2919143-32-9\"], \"rgt_cas\": [\"76-05-1\", \"1892-57-5\", \"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["112-80-1", "54258-41-2"], "products": ["2919143-32-9"], "reagents": ["Trifluoroacetic acid", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-34998076", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 19.0, "yield_pct": 98.0}, "smiles": {"reactants": "CCOC(=O)[C@H](CCC(=O)OCc1ccccc1)NC(=O)OC(C)(C)C.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "CCOC(=O)[C@@H](CCC(=O)OCc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C"}, "reference": {"title": "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators", "authors": "Guzelj, Samo; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.", "doi": "10.1021/acs.jmedchem.2c00808", "raw": "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators | Guzelj, Samo; et al | Journal of Medicinal Chemistry (2022), 65(22), 15085-15101. | 10.1021/acs.jmedchem.2c00808"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-34998076", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C → rt; 3 h, rt", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C → rt; overnight, rt", "Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors", "By: Specker, Edgar; et al", "Journal of Medicinal Chemistry (2022), 65(16), 11126-11149.", "10.1021/acs.jmedchem.2c00598"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "c68e4a5c", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 372-09-8 + 19757-64-3 | PRO: 75914-62-4 | RGT: 76-05-1 + 1892-57-5 + 2592-95-2 + 7087-68-5 | CAT: 1122-58-3 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.\", \"reagents\": [\"Trifluoroacetic acid\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-34998076\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C → rt; 3 h, rt\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C → rt; overnight, rt\", \"374. Scheme 374 (1 Reaction)\", \"Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors\", \"By: Specker, Edgar; et al\", \"Journal of Medicinal Chemistry (2022), 65(16), 11126-11149.\", \"10.1021/acs.jmedchem.2c00598\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"372-09-8\", \"19757-64-3\"], \"pro_cas\": [\"75914-62-4\"], \"rgt_cas\": [\"76-05-1\", \"1892-57-5\", \"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["372-09-8", "19757-64-3"], "products": ["75914-62-4"], "reagents": ["Trifluoroacetic acid", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35008193", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Pyridine", "cas": "110-86-1"}], "conditions": {"temperature_c": 0.0, "time_h": 12.0, "yield_pct": 86.0}, "smiles": {"reactants": "Nc1ccc(Cl)cc1.C[C@@H](C(=O)O)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1", "products": "C[C@@H](C(=O)Nc1ccc(Cl)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1"}, "reference": {"title": "Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma", "authors": "Bollu, Lakshmi R.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.", "doi": "10.1021/acs.jmedchem.2c00771", "raw": "Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma | Bollu, Lakshmi R.; et al | Journal of Medicinal Chemistry (2022), 65(23), 15642-15662. | 10.1021/acs.jmedchem.2c00771"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-35008193", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "Solvents: Pyridine; 0 °C; 12 h, rt", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice", "By: Belayet, Jawad B.; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3388-3403.", "10.1021/acs.jmedchem.1c01928"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|/Pyridine|110-86-1", "cond_sig": "59d6ed91", "fam_sig": "ebc42854"}, "raw_data": {"raw_cas": "RCT: 60687-33-4 + 2088322-33-0 | PRO: 3035200-66-6 | RGT: 1892-57-5 | SOL: 110-86-1", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma\", \"authors\": \"Bollu, Lakshmi R.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\"], \"catalysts\": [], \"solvents\": [\"Pyridine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35008193\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Solvents: Pyridine; 0 °C; 12 h, rt\", \"273. Scheme 273 (1 Reaction)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice\", \"By: Belayet, Jawad B.; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3388-3403.\", \"10.1021/acs.jmedchem.1c01928\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"60687-33-4\", \"2088322-33-0\"], \"pro_cas\": [\"3035200-66-6\"], \"rgt_cas\": [\"1892-57-5\"], \"cat_cas\": [], \"sol_cas\": [\"110-86-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["60687-33-4", "2088322-33-0"], "products": ["3035200-66-6"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide"], "catalysts": [], "solvents": ["Pyridine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35008196", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 12.0, "yield_pct": 95.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCC(Oc2ccc(N)cc2)CC1.C[C@@H](C(=O)O)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1", "products": "C[C@@H](C(=O)Nc1ccc(OC2CCN(C(=O)OC(C)(C)C)CC2)cc1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1"}, "reference": {"title": "Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma", "authors": "Bollu, Lakshmi R.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.", "doi": "10.1021/acs.jmedchem.2c00771", "raw": "Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma | Bollu, Lakshmi R.; et al | Journal of Medicinal Chemistry (2022), 65(23), 15642-15662. | 10.1021/acs.jmedchem.2c00771"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-35008196", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "Solvents: Tetrahydrofuran; 0 °C; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy", "By: Dilger, Andrew K.; et al", "Journal of Medicinal Chemistry (2022), 65(3), 1770-1785.", "10.1021/acs.jmedchem.1c00613"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|/Tetrahydrofuran|109-99-9", "cond_sig": "ea9dac9d", "fam_sig": "a13ba542"}, "raw_data": {"raw_cas": "RCT: 20626-49-7 + 1802431-20-4 | PRO: 1802431-21-5 | RGT: 1892-57-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma\", \"authors\": \"Bollu, Lakshmi R.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35008196\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Solvents: Tetrahydrofuran; 0 °C; 12 h, rt\", \"203. Scheme 203 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy\", \"By: Dilger, Andrew K.; et al\", \"Journal of Medicinal Chemistry (2022), 65(3), 1770-1785.\", \"10.1021/acs.jmedchem.1c00613\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"20626-49-7\", \"1802431-20-4\"], \"pro_cas\": [\"1802431-21-5\"], \"rgt_cas\": [\"1892-57-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["20626-49-7", "1802431-20-4"], "products": ["1802431-21-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35026067", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "UNK"}, {"name": "Ethyl 2-cyano-2-(hydroxyimino)acetate", "cas": "3849-21-6", "role": "UNK"}, {"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "UNK"}, {"name": "Triisopropylsilane", "cas": "6485-79-6", "role": "UNK"}, {"name": "2,2′-(Ethylenedioxy)diethanethiol", "cas": "14970-87-7", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Diisopropyl Ether", "cas": "108-20-3"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 90.0, "time_h": 24.733, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(N[C@@H](CS)C(=O)O)OCC1c2ccccc2-c2ccccc21.O=C(O)[C@@H]1CCCN1C(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)n1cc(C[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)c2ccccc21.CC(C)(C)OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.Cc1c(C)c(S(=O)(=O)NC(=N)NCCCC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)c(C)c2c1OC(C)(C)C2.O=C(O)CCSC(c1ccccc1)(c1ccccc1)c1ccccc1", "products": "N=C(N)NCCCC[C@H](NC(=O)CCS)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(N)=O"}, "reference": {"title": "An optimized safe process from bench to pilot cGMP production of API eptifibatide using a multigram-scale microwave-assisted solid-phase peptide synthesizer", "authors": "D’Ercole, Annunziata; et al", "citation": "Organic Process Research & Development (2021), 25(12), 2754-2771.", "doi": "10.1021/acs.oprd.1c00368", "raw": "An optimized safe process from bench to pilot cGMP production of API eptifibatide using a multigram-scale microwave-assisted solid-phase peptide synthesizer | D’Ercole, Annunziata; et al | Organic Process Research & Development (2021), 25(12), 2754-2771. | 10.1021/acs.oprd.1c00368"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-35026067", "1.1|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; 2 min, 90 °C", "1.2|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; 2 min, 90 °C", "1.3|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; 2 min, 90 °C", "1.4|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; 2 min, 90 °C", "1.5|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; 2 min, 90 °C", "1.6|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; 2 min, 90 °C", "1.7|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; 2 min, 90 °C", "1.8|Reagents: Trifluoroacetic acid", "Solvents: Diisopropyl ether; 3 - 24 h, 0 °C", "1.9|Reagents: Trifluoroacetic acid, Triisopropylsilane, 2,2′-(Ethylenedioxy)diethanethiol", "Solvents: Water; 30 min, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes", "By: Delahaye, Juliette; et al", "European Journal of Medicinal Chemistry (2023), 258, 115568.", "10.1016/j.ejmech.2023.115568"], "signatures": {"cond_key": "none/none/2,2′-(Ethylenedioxy)diethanethiol|14970-87-7+Diisopropylcarbodiimide|+Ethyl 2-cyano-2-(hydroxyimino)acetate|3849-21-6+N,N-Diisopropylcarbodiimide|693-13-0+Trifluoroacetic acid|76-05-1+Triisopropylsilane|6485-79-6/Diisopropyl Ether|108-20-3+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "796ba520", "fam_sig": "4d2c8ba7"}, "raw_data": {"raw_cas": "RCT: 5241-64-5 + 865650-19-7 | PRO: 865488-27-3 | RGT: 693-13-0 + 3849-21-6 + 76-05-1 + 6485-79-6 + 14970-87-7 | SOL: 68-12-2 + 108-20-3 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"An optimized safe process from bench to pilot cGMP production of API eptifibatide using a multigram-scale microwave-assisted solid-phase peptide synthesizer\", \"authors\": \"D’Ercole, Annunziata; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(12), 2754-2771.\", \"reagents\": [\"Diisopropylcarbodiimide\", \"Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Trifluoroacetic acid\", \"Triisopropylsilane\", \"2,2′-(Ethylenedioxy)diethanethiol\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Diisopropyl ether\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35026067\", \"1.1\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; 2 min, 90 °C\", \"1.2\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; 2 min, 90 °C\", \"1.3\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; 2 min, 90 °C\", \"1.4\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; 2 min, 90 °C\", \"1.5\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; 2 min, 90 °C\", \"1.6\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; 2 min, 90 °C\", \"1.7\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; 2 min, 90 °C\", \"1.8\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Diisopropyl ether; 3 - 24 h, 0 °C\", \"1.9\", \"Reagents: Trifluoroacetic acid, Triisopropylsilane, 2,2′-(Ethylenedioxy)diethanethiol\", \"Solvents: Water; 30 min, rt\", \"366. Scheme 366 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes\", \"By: Delahaye, Juliette; et al\", \"European Journal of Medicinal Chemistry (2023), 258, 115568.\", \"10.1016/j.ejmech.2023.115568\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5241-64-5\", \"865650-19-7\"], \"pro_cas\": [\"865488-27-3\"], \"rgt_cas\": [\"693-13-0\", \"3849-21-6\", \"76-05-1\", \"6485-79-6\", \"14970-87-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"108-20-3\", \"7732-18-5\"], \"notes\": [\"microwave irradiation, solid-supported reaction, peptide synthesizer used, 30 W used, Fmoc deprotection with piperidine/DMF, attachment to Rink amide resin in stage 1\"]}}", "enriched_names": {"reactants": ["5241-64-5", "865650-19-7"], "products": ["865488-27-3"], "reagents": ["N,N-Diisopropylcarbodiimide", "3849-21-6", "Trifluoroacetic acid", "6485-79-6", "14970-87-7"], "catalysts": [], "solvents": ["Dimethylformamide", "Diisopropyl Ether", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35037410", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 5.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1cccc(Br)c1.CN", "products": "CNC(=O)c1cccc(Br)c1"}, "reference": {"title": "Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates", "authors": "Ota, Yosuke; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(10), 1568-1573.", "doi": "10.1021/acsmedchemlett.2c00126", "raw": "Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates | Ota, Yosuke; et al | ACS Medicinal Chemistry Letters (2022), 13(10), 1568-1573. | 10.1021/acsmedchemlett.2c00126"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-35037410", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C; 4 h, rt", "1.2|Solvents: Tetrahydrofuran; 0 °C; 1 h, rt", "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "By: Li, Bing-yan; et al", "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "10.1021/acs.jmedchem.3c02407"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9", "cond_sig": "d75aac85", "fam_sig": "e8060687"}, "raw_data": {"raw_cas": "RCT: 6232-88-8 + 75-04-7 | PRO: 566885-71-0 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 75-09-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates\", \"authors\": \"Ota, Yosuke; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(10), 1568-1573.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35037410\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C; 4 h, rt\", \"1.2\", \"Solvents: Tetrahydrofuran; 0 °C; 1 h, rt\", \"4. Scheme 4 (1 Reaction)\", \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"By: Li, Bing-yan; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"10.1021/acs.jmedchem.3c02407\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6232-88-8\", \"75-04-7\"], \"pro_cas\": [\"566885-71-0\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["6232-88-8", "75-04-7"], "products": ["566885-71-0"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35038127", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 88.0}, "smiles": {"reactants": "Cl.NCC(=O)OCc1ccccc1.C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "C[C@H](NC(=O)OC(C)(C)C)C(=O)NCC(=O)OCc1ccccc1"}, "reference": {"title": "Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release", "authors": "Meiers, Joscha; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.", "doi": "10.1021/acs.jmedchem.2c01214", "raw": "Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release | Meiers, Joscha; et al | Journal of Medicinal Chemistry (2022), 65(20), 13988-14014. | 10.1021/acs.jmedchem.2c01214"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-35038127", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; rt; 5 h, rt", "Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection", "By: Tawaraishi, Taisuke; et al", "Journal of Medicinal Chemistry (2023), 66(2), 1221-1238.", "10.1021/acs.jmedchem.2c00775"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 88-68-6 + 98-98-6 | PRO: 157979-82-3 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release\", \"authors\": \"Meiers, Joscha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35038127\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; rt; 5 h, rt\", \"143. Scheme 143 (1 Reaction)\", \"Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection\", \"By: Tawaraishi, Taisuke; et al\", \"Journal of Medicinal Chemistry (2023), 66(2), 1221-1238.\", \"10.1021/acs.jmedchem.2c00775\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"88-68-6\", \"98-98-6\"], \"pro_cas\": [\"157979-82-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["88-68-6", "98-98-6"], "products": ["157979-82-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35038130", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 98.0}, "smiles": {"reactants": "C[C@H](N)C(=O)OCc1ccccc1.Cl.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)OCc1ccccc1"}, "reference": {"title": "Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release", "authors": "Meiers, Joscha; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.", "doi": "10.1021/acs.jmedchem.2c01214", "raw": "Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release | Meiers, Joscha; et al | Journal of Medicinal Chemistry (2022), 65(20), 13988-14014. | 10.1021/acs.jmedchem.2c01214"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-35038130", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; rt; 24 h, rt", "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "By: Hiesinger, Kerstin; et al", "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "10.1021/acs.jmedchem.0c00561"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 2709014-55-9 | PRO: 2709014-31-1 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release\", \"authors\": \"Meiers, Joscha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35038130\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; rt; 24 h, rt\", \"270. Scheme 270 (1 Reaction)\", \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"By: Hiesinger, Kerstin; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"10.1021/acs.jmedchem.0c00561\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"2709014-55-9\"], \"pro_cas\": [\"2709014-31-1\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "2709014-55-9"], "products": ["2709014-31-1"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35039294", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Piperidine", "cas": "110-89-4", "role": "UNK"}, {"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "UNK"}, {"name": "1,1,1,3,3,3-Hexafluoro-2-propanol", "cas": "920-66-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 21.583, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)[C@H](N)C(=O)O.CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.O.O=C(CCCCCN1C(=O)C=CC1=O)ON1C(=O)CCC1=O", "products": "CC(C)[C@H](NC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)CCCCCN1C(=O)C=CC1=O)C(=O)O"}, "reference": {"title": "Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand", "authors": "Amin, Toufiq Ul; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(22), 15473-15486.", "doi": "10.1021/acs.jmedchem.2c01423", "raw": "Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand | Amin, Toufiq Ul; et al | Journal of Medicinal Chemistry (2022), 65(22), 15473-15486. | 10.1021/acs.jmedchem.2c01423"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-35039294", "1.1|-", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 5 min, rt; 3 h, rt", "1.3|Reagents: Piperidine", "Solvents: Dimethylformamide; 30 min, rt", "1.4|Reagents: Diisopropylethylamine; overnight, rt", "1.5|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; rt", "1.6|Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol", "Solvents: Dichloromethane; 2 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1,1,1,3,3,3-Hexafluoro-2-propanol|920-66-1+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Piperidine|110-89-4+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "bb17cb0c", "fam_sig": "4b6f1ae3"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 1912-48-7 | PRO: 688759-87-7 | RGT: 7087-68-5 + 148893-10-1 + 110-89-4 + 76-05-1 + 920-66-1 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand\", \"authors\": \"Amin, Toufiq Ul; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(22), 15473-15486.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Piperidine\", \"Trifluoroacetic acid\", \"1,1,1,3,3,3-Hexafluoro-2-propanol\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35039294\", \"1.1\", \"-\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 5 min, rt; 3 h, rt\", \"1.3\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.4\", \"Reagents: Diisopropylethylamine; overnight, rt\", \"1.5\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; rt\", \"1.6\", \"Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol\", \"Solvents: Dichloromethane; 2 h, rt\", \"424. Scheme 424 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"1912-48-7\"], \"pro_cas\": [\"688759-87-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"110-89-4\", \"76-05-1\", \"920-66-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": [\"H-valine-2-chlorotrityl resin used (stage 1)\"]}}", "enriched_names": {"reactants": ["120-20-7", "1912-48-7"], "products": ["688759-87-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Piperidine", "Trifluoroacetic acid", "1,1,1,3,3,3-Hexafluoro-2-propanol"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35040165", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Methanol", "cas": "67-56-1"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.167, "yield_pct": 97.0}, "smiles": {"reactants": "CN.Cl.CNC(=O)c1cnc(Cl)cc1Nc1cccc(C(=O)O)c1OC", "products": "CNC(=O)c1cnc(Cl)cc1Nc1cccc(C(=O)NC)c1OC"}, "reference": {"title": "Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor", "authors": "Kato, Jun-ya; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 79, 129083.", "doi": "10.1016/j.bmcl.2022.129083", "raw": "Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor | Kato, Jun-ya; et al | Bioorganic & Medicinal Chemistry Letters (2023), 79, 129083. | 10.1016/j.bmcl.2022.129083"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-35040165", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 30 min, 0 °C", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 10 min, 0 °C; 17 h, rt", "1.3|Reagents: Sodium bicarbonate", "Solvents: Methanol, Ethyl acetate, Water; 30 min, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "By: Ryu, SeongShick; et al", "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "10.1021/acs.jmedchem.1c01359"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|/Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6+Methanol|67-56-1+Water|7732-18-5", "cond_sig": "ba291359", "fam_sig": "1973acd3"}, "raw_data": {"raw_cas": "RCT: 1148-11-4 + 2491-18-1 | PRO: 17445-57-7 | RGT: 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 68-12-2 + 67-56-1 + 141-78-6 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor\", \"authors\": \"Kato, Jun-ya; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 79, 129083.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Methanol\", \"Ethyl acetate\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35040165\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 30 min, 0 °C\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 10 min, 0 °C; 17 h, rt\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Methanol, Ethyl acetate, Water; 30 min, rt\", \"493. Scheme 493 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"By: Ryu, SeongShick; et al\", \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"10.1021/acs.jmedchem.1c01359\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1148-11-4\", \"2491-18-1\"], \"pro_cas\": [\"17445-57-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"67-56-1\", \"141-78-6\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1148-11-4", "2491-18-1"], "products": ["17445-57-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Methanol", "Ethyl Acetate", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35040293", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 155.0, "time_h": 16.0, "yield_pct": 86.0}, "smiles": {"reactants": "NC=O.Nc1ccc(F)cc1C(=O)O", "products": "O=c1nc[nH]c2ccc(F)cc12"}, "reference": {"title": "Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells", "authors": "Elsocht, Mathias; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 79, 129066.", "doi": "10.1016/j.bmcl.2022.129066", "raw": "Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells | Elsocht, Mathias; et al | Bioorganic & Medicinal Chemistry Letters (2023), 79, 129066. | 10.1016/j.bmcl.2022.129066"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-35040293", "1.1|overnight, 155 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement", "By: Barton, Linda S.; et al", "Bioorganic & Medicinal Chemistry (2024), 100, 117618.", "10.1016/j.bmc.2024.117618"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 7517-19-3 + 17543-58-7 | PRO: 3070097-03-6", "raw_data_json": "{\"txt\": {\"title\": \"Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells\", \"authors\": \"Elsocht, Mathias; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 79, 129066.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35040293\", \"1.1\", \"overnight, 155 °C\", \"446. Scheme 446 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement\", \"By: Barton, Linda S.; et al\", \"Bioorganic & Medicinal Chemistry (2024), 100, 117618.\", \"10.1016/j.bmc.2024.117618\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7517-19-3\", \"17543-58-7\"], \"pro_cas\": [\"3070097-03-6\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["7517-19-3", "17543-58-7"], "products": ["3070097-03-6"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35054318", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "WORKUP"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.083, "yield_pct": 82.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NC[C@H](NC(=O)OCc1ccccc1)C(=O)O.CCC[C@H](N)C(=O)OC", "products": "CCC[C@H](NC(=O)[C@H](CNC(=O)OC(C)(C)C)NC(=O)OCc1ccccc1)C(=O)OC"}, "reference": {"title": "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury", "authors": "Cui, Yingjun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.", "doi": "10.1021/acs.jmedchem.1c01583", "raw": "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury | Cui, Yingjun; et al | Journal of Medicinal Chemistry (2022), 65(4), 2971-2987. | 10.1021/acs.jmedchem.1c01583"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35054318", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Reagents: Diisopropylethylamine; overnight, rt", "1.3|Reagents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors", "By: Kikuchi, Fumiaki; et al", "Bioorganic & Medicinal Chemistry (2023), 93, 117462.", "10.1016/j.bmc.2023.117462"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "c283785a", "fam_sig": "9313a6b6"}, "raw_data": {"raw_cas": "RCT: 603-80-5 + 1791-13-5 | PRO: 3070238-05-7 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 + 7732-18-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury\", \"authors\": \"Cui, Yingjun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35054318\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; overnight, rt\", \"1.3\", \"Reagents: Water; rt\", \"321. Scheme 321 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors\", \"By: Kikuchi, Fumiaki; et al\", \"Bioorganic & Medicinal Chemistry (2023), 93, 117462.\", \"10.1016/j.bmc.2023.117462\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"603-80-5\", \"1791-13-5\"], \"pro_cas\": [\"3070238-05-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["603-80-5", "1791-13-5"], "products": ["3070238-05-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine", "Water"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35054320", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 80.0}, "smiles": {"reactants": "C=CCOc1ccc(C(=O)NCC(=O)O)cc1.CCC[C@H](NC(=O)[C@H](CNC(=O)OC(C)(C)C)NC(=O)[C@H](C)N)C(=O)OC", "products": "C=CCOc1ccc(C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CNC(=O)OC(C)(C)C)C(=O)N[C@@H](CCC)C(=O)OC)cc1"}, "reference": {"title": "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury", "authors": "Cui, Yingjun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.", "doi": "10.1021/acs.jmedchem.1c01583", "raw": "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury | Cui, Yingjun; et al | Journal of Medicinal Chemistry (2022), 65(4), 2971-2987. | 10.1021/acs.jmedchem.1c01583"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-35054320", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 0 °C; overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models", "By: Winter-Holt, Jon J.; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.", "10.1021/acs.jmedchem.1c01871"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 35661-40-6 + 95500-79-1 | PRO: 3037043-01-6 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury\", \"authors\": \"Cui, Yingjun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35054320\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 0 °C; overnight, rt\", \"68. Scheme 68 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models\", \"By: Winter-Holt, Jon J.; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.\", \"10.1021/acs.jmedchem.1c01871\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"35661-40-6\", \"95500-79-1\"], \"pro_cas\": [\"3037043-01-6\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["35661-40-6", "95500-79-1"], "products": ["3037043-01-6"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35054346", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 17.083, "yield_pct": 80.0}, "smiles": {"reactants": "CCC[C@H](NC(=O)[C@H](CNC(=O)OCC1c2ccccc2-c2ccccc21)NC(=O)[C@H](C)NC(=O)CNC(=O)c1ccc(O)cc1)C(=O)N[C@H](C(O[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](Cc1ccc(O[Si](C)(C)C(C)(C)C)cc1)c1nc(/C=C/C(=O)O)cs1)[C@@H](C)CC.C=CCOC(=O)[C@@H](N)CSC(c1ccccc1)(c1ccccc1)c1ccccc1", "products": "C=CCOC(=O)[C@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)NC(=O)/C=C/c1csc([C@H](Cc2ccc(O[Si](C)(C)C(C)(C)C)cc2)NC(=O)C(O[Si](C)(C)C(C)(C)C)[C@@H](NC(=O)[C@H](CCC)NC(=O)[C@H](CNC(=O)OCC2c3ccccc3-c3ccccc32)NC(=O)[C@H](C)NC(=O)CNC(=O)c2ccc(O)cc2)[C@@H](C)CC)n1"}, "reference": {"title": "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury", "authors": "Cui, Yingjun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.", "doi": "10.1021/acs.jmedchem.1c01583", "raw": "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury | Cui, Yingjun; et al | Journal of Medicinal Chemistry (2022), 65(4), 2971-2987. | 10.1021/acs.jmedchem.1c01583"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-35054346", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; overnight, rt", "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "By: Wang, Yuan-Yuan; et al", "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "10.1021/acs.jmedchem.2c02044"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "87124669", "fam_sig": "748b7b68"}, "raw_data": {"raw_cas": "RCT: 3035080-41-9 + 3035080-68-0 | PRO: 3035080-69-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury\", \"authors\": \"Cui, Yingjun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35054346\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; overnight, rt\", \"474. Scheme 474 (1 Reaction)\", \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"By: Wang, Yuan-Yuan; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"10.1021/acs.jmedchem.2c02044\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3035080-41-9\", \"3035080-68-0\"], \"pro_cas\": [\"3035080-69-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3035080-41-9", "3035080-68-0"], "products": ["3035080-69-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35110941", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.167, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2o1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc3ccccc3o2)cc1"}, "reference": {"title": "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2023), 246, 114981.", "doi": "10.1016/j.ejmech.2022.114981", "raw": "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2023), 246, 114981. | 10.1016/j.ejmech.2022.114981"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-35110941", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2023), 246, 114981.", "10.1016/j.ejmech.2022.114981"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 496-41-3 + 169280-56-2 | PRO: 2883496-14-6 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 246, 114981.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35110941\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt\", \"206. Scheme 206 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2023), 246, 114981.\", \"10.1016/j.ejmech.2022.114981\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"496-41-3\", \"169280-56-2\"], \"pro_cas\": [\"2883496-14-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["496-41-3", "169280-56-2"], "products": ["2883496-14-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35111050", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.167, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2o1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2ccccc2o1)S(=O)(=O)c1ccc(N)cc1"}, "reference": {"title": "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2023), 246, 114981.", "doi": "10.1016/j.ejmech.2022.114981", "raw": "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2023), 246, 114981. | 10.1016/j.ejmech.2022.114981"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-35111050", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "By: Stachura, Damian L.; et al", "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "10.1021/acsmedchemlett.2c00505"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 140401-57-6 + 3064695-54-8 | PRO: 3064695-46-8 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 246, 114981.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35111050\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt\", \"207. Scheme 207 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"By: Stachura, Damian L.; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"10.1021/acsmedchemlett.2c00505\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"140401-57-6\", \"3064695-54-8\"], \"pro_cas\": [\"3064695-46-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["140401-57-6", "3064695-54-8"], "products": ["3064695-46-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35111055", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.167, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2[nH]1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc3ccccc3[nH]2)cc1"}, "reference": {"title": "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors", "authors": "Zhu, Mei; et al", "citation": "European Journal of Medicinal Chemistry (2023), 246, 114981.", "doi": "10.1016/j.ejmech.2022.114981", "raw": "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors | Zhu, Mei; et al | European Journal of Medicinal Chemistry (2023), 246, 114981. | 10.1016/j.ejmech.2022.114981"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-35111055", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure", "By: Cadilla, Rodolfo; et al", "Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.", "10.1016/j.bmc.2020.115791"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 899806-45-2 + 2255314-49-7 | PRO: 2255312-46-8 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors\", \"authors\": \"Zhu, Mei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 246, 114981.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35111055\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 10 min, 0 °C; 0 °C → rt; 3 h, rt\", \"161. Scheme 161 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure\", \"By: Cadilla, Rodolfo; et al\", \"Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.\", \"10.1016/j.bmc.2020.115791\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"899806-45-2\", \"2255314-49-7\"], \"pro_cas\": [\"2255312-46-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["899806-45-2", "2255314-49-7"], "products": ["2255312-46-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35153686", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 8.25, "yield_pct": 97.0}, "smiles": {"reactants": "O=C(O)Cc1ccc(Cl)cc1.Cl.NCCc1nc2ccccc2[nH]1", "products": "O=C(Cc1ccc(Cl)cc1)NCCc1nc2ccccc2[nH]1"}, "reference": {"title": "Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease", "authors": "de Oliveira Rezende, Celso Junior; et al", "citation": "European Journal of Medicinal Chemistry (2023), 246, 114925.", "doi": "10.1016/j.ejmech.2022.114925", "raw": "Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease | de Oliveira Rezende, Celso Junior; et al | European Journal of Medicinal Chemistry (2023), 246, 114925. | 10.1016/j.ejmech.2022.114925"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-35153686", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dimethylformamide; 8 h, rt", "1.2|Solvents: Water; 15 min, rt", "A new chemotype with promise against Trypanosoma cruzi", "By: Wang, Xiaofang; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "10.1016/j.bmcl.2019.126778"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7f0be0ba", "fam_sig": "a1a30c15"}, "raw_data": {"raw_cas": "RCT: 462-08-8 + 925137-90-2 | PRO: 2335006-47-6 | RGT: 121-44-8 + 1892-57-5 + 2592-95-2 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease\", \"authors\": \"de Oliveira Rezende, Celso Junior; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 246, 114925.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35153686\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dimethylformamide; 8 h, rt\", \"1.2\", \"Solvents: Water; 15 min, rt\", \"193. Scheme 193 (1 Reaction)\", \"A new chemotype with promise against Trypanosoma cruzi\", \"By: Wang, Xiaofang; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"10.1016/j.bmcl.2019.126778\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"462-08-8\", \"925137-90-2\"], \"pro_cas\": [\"2335006-47-6\"], \"rgt_cas\": [\"121-44-8\", \"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["462-08-8", "925137-90-2"], "products": ["2335006-47-6"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35191378", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 86.0}, "smiles": {"reactants": "COCCN.O=C(O)c1cc(I)cc(CNc2ccc(Cl)c(O)c2)c1", "products": "COCCNC(=O)c1cc(I)cc(CNc2ccc(Cl)c(O)c2)c1"}, "reference": {"title": "DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry", "authors": "Xia, Bing; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(7), 1166-1172.", "doi": "10.1021/acsmedchemlett.1c00156", "raw": "DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry | Xia, Bing; et al | ACS Medicinal Chemistry Letters (2021), 12(7), 1166-1172. | 10.1021/acsmedchemlett.1c00156"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-35191378", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1.5 h, rt", "Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity", "By: Fang, Jing-jie; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.", "10.1021/acs.jmedchem.3c01351"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 404-26-2 + 364-76-1 | PRO: 3033385-12-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry\", \"authors\": \"Xia, Bing; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(7), 1166-1172.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35191378\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1.5 h, rt\", \"294. Scheme 294 (1 Reaction)\", \"Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity\", \"By: Fang, Jing-jie; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.\", \"10.1021/acs.jmedchem.3c01351\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"404-26-2\", \"364-76-1\"], \"pro_cas\": [\"3033385-12-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"incremental addition of 2-methoxyethylamine after 30 minutes\"]}}", "enriched_names": {"reactants": ["404-26-2", "364-76-1"], "products": ["3033385-12-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35200662", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": null, "time_h": 24.0, "yield_pct": 85.0}, "smiles": {"reactants": "Nc1cccc(Cl)c1C(=O)O.CC(=O)O.N=CN", "products": "O=c1nc[nH]c2cccc(Cl)c12"}, "reference": {"title": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino[2,3-f]quinazoline derivatives as EGFR-TKIs", "authors": "Qin, Xuemei; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 80, 129104.", "doi": "10.1016/j.bmcl.2022.129104", "raw": "Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino[2,3-f]quinazoline derivatives as EGFR-TKIs | Qin, Xuemei; et al | Bioorganic & Medicinal Chemistry Letters (2023), 80, 129104. | 10.1016/j.bmcl.2022.129104"}, "original_text": ["Steps: 1, Yield: 85-89%", "CAS Reaction Number: 31-614-CAS-35200662", "1.1|Solvents: Ethanol; 24 h, reflux", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/none/Ethanol|64-17-5", "cond_sig": "9fc9dc04", "fam_sig": "9fc9dc04"}, "raw_data": {"raw_cas": "RCT: 1912-48-7 + 36377-59-0 | PRO: 2565618-14-4 | SOL: 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino[2,3-f]quinazoline derivatives as EGFR-TKIs\", \"authors\": \"Qin, Xuemei; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 80, 129104.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35200662\", \"1.1\", \"Solvents: Ethanol; 24 h, reflux\", \"485. Scheme 485 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1912-48-7\", \"36377-59-0\"], \"pro_cas\": [\"2565618-14-4\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1912-48-7", "36377-59-0"], "products": ["2565618-14-4"], "reagents": [], "catalysts": [], "solvents": ["Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35231135", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 20.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1cccc(-c2ccccc2)c1.Cc1cc(N)no1", "products": "Cc1cc(NC(=O)c2cccc(-c3ccccc3)c2)no1"}, "reference": {"title": "Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening", "authors": "Lee, Sang-Woo; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3266-3305.", "doi": "10.1021/acs.jmedchem.1c01834", "raw": "Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening | Lee, Sang-Woo; et al | Journal of Medicinal Chemistry (2022), 65(4), 3266-3305. | 10.1021/acs.jmedchem.1c01834"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35231135", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 2 h, 0 °C", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 18 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; rt", "Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma", "By: Perry, Matthew W. D.; et al", "Journal of Medicinal Chemistry (2021), 64(12), 8053-8075.", "10.1021/acs.jmedchem.1c00434"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 21190-87-4 + 68076-36-8 | PRO: 2967959-89-1 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | CAT: 68-12-2 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening\", \"authors\": \"Lee, Sang-Woo; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3266-3305.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35231135\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 2 h, 0 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 18 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; rt\", \"181. Scheme 181 (1 Reaction)\", \"Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma\", \"By: Perry, Matthew W. D.; et al\", \"Journal of Medicinal Chemistry (2021), 64(12), 8053-8075.\", \"10.1021/acs.jmedchem.1c00434\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"21190-87-4\", \"68076-36-8\"], \"pro_cas\": [\"2967959-89-1\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["21190-87-4", "68076-36-8"], "products": ["2967959-89-1"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35272077", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 3.583, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1cnc2ccc(Cl)nn12.NCCc1ccccc1", "products": "O=C(NCCc1ccccc1)c1cnc2ccc(Cl)nn12"}, "reference": {"title": "Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors", "authors": "Li, Chuchu; et al", "citation": "European Journal of Medicinal Chemistry (2023), 247, 115030.", "doi": "10.1016/j.ejmech.2022.115030", "raw": "Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors | Li, Chuchu; et al | European Journal of Medicinal Chemistry (2023), 247, 115030. | 10.1016/j.ejmech.2022.115030"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-35272077", "1.1|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 15 min, rt", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 20 min, 0 °C", "1.3|0 °C → rt; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy", "By: Chuang, Chihyuan; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.", "10.1021/acs.jmedchem.1c01290"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "004c71d2", "fam_sig": "6a8d59c1"}, "raw_data": {"raw_cas": "RCT: 4021-11-8 + 2364561-75-9 | PRO: 2364556-52-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors\", \"authors\": \"Li, Chuchu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 247, 115030.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35272077\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 15 min, rt\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 20 min, 0 °C\", \"1.3\", \"0 °C → rt; 3 h, rt\", \"410. Scheme 410 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy\", \"By: Chuang, Chihyuan; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14142-14152.\", \"10.1021/acs.jmedchem.1c01290\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4021-11-8\", \"2364561-75-9\"], \"pro_cas\": [\"2364556-52-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["4021-11-8", "2364561-75-9"], "products": ["2364556-52-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35275925", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.25, "yield_pct": 92.0}, "smiles": {"reactants": "C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C.C#CCN", "products": "C#CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C"}, "reference": {"title": "Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates", "authors": "Saini, Varsha; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(22), 15312-15326.", "doi": "10.1021/acs.jmedchem.2c01293", "raw": "Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates | Saini, Varsha; et al | Journal of Medicinal Chemistry (2022), 65(22), 15312-15326. | 10.1021/acs.jmedchem.2c01293"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-35275925", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|rt; 24 h, rt", "Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP", "By: Wu, Fangrui; et al", "Journal of Medicinal Chemistry (2020), 63(9), 4716-4731.", "10.1021/acs.jmedchem.9b02164"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 6324-10-3 + 144222-22-0 | PRO: 2416928-81-7 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates\", \"authors\": \"Saini, Varsha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(22), 15312-15326.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35275925\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"rt; 24 h, rt\", \"316. Scheme 316 (1 Reaction)\", \"Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP\", \"By: Wu, Fangrui; et al\", \"Journal of Medicinal Chemistry (2020), 63(9), 4716-4731.\", \"10.1021/acs.jmedchem.9b02164\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6324-10-3\", \"144222-22-0\"], \"pro_cas\": [\"2416928-81-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["6324-10-3", "144222-22-0"], "products": ["2416928-81-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297620", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)C(c1ccc(C(F)(F)F)cc1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(C(F)(F)F)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35297620", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo", "By: Ojha, Ritu; et al", "European Journal of Medicinal Chemistry (2020), 190, 112086pp..", "10.1016/j.ejmech.2020.112086"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 3878-55-5 + 913000-10-9 | PRO: 2411955-16-1 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297620\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"357. Scheme 357 (1 Reaction)\", \"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo\", \"By: Ojha, Ritu; et al\", \"European Journal of Medicinal Chemistry (2020), 190, 112086pp..\", \"10.1016/j.ejmech.2020.112086\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3878-55-5\", \"913000-10-9\"], \"pro_cas\": [\"2411955-16-1\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3878-55-5", "913000-10-9"], "products": ["2411955-16-1"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297621", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)C(c1ccc(Cl)c(Cl)c1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(Cl)c(Cl)c2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-35297621", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process", "By: Smith, Daniel; et al", "Organic Process Research & Development (2020), 24(6), 1157-1163.", "10.1021/acs.oprd.0c00198"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 1159734-42-5 + 1217340-23-2 | PRO: 1217338-97-0 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297621\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"379. Scheme 379 (1 Reaction)\", \"Multigram Synthesis of BMS-929075, an Allosteric, Palm Site Inhibitor of HCV NS5B Replicase, Involving the Synthesis of a Highly Functionalized Benzofuran through a Telescoped Process\", \"By: Smith, Daniel; et al\", \"Organic Process Research & Development (2020), 24(6), 1157-1163.\", \"10.1021/acs.oprd.0c00198\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1159734-42-5\", \"1217340-23-2\"], \"pro_cas\": [\"1217338-97-0\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1159734-42-5", "1217340-23-2"], "products": ["1217338-97-0"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297623", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 82.0}, "smiles": {"reactants": "Cc1ccc(C(C(=O)O)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(C)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35297623", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009", "By: Zacuto, Michael J.; et al", "Organic Process Research & Development (2022), 26(9), 2739-2748.", "10.1021/acs.oprd.2c00199"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 475301-73-6 + 1158265-65-6 | PRO: 1860875-51-9 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297623\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"296. Scheme 296 (1 Reaction)\", \"Advancing Scalable Chemistry toward Novel CELMoDs: Process Development for the Synthesis of CC-90009\", \"By: Zacuto, Michael J.; et al\", \"Organic Process Research & Development (2022), 26(9), 2739-2748.\", \"10.1021/acs.oprd.2c00199\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"475301-73-6\", \"1158265-65-6\"], \"pro_cas\": [\"1860875-51-9\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["475301-73-6", "1158265-65-6"], "products": ["1860875-51-9"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297624", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)C(c1ccc(F)c(Cl)c1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(F)c(Cl)c2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-35297624", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation for the Multikilogram Synthesis of Emprumapimod", "By: Brearley, Christopher; et al", "Organic Process Research & Development (2024), 28(4), 1253-1259.", "10.1021/acs.oprd.4c00052"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 765914-40-7 + 3033928-61-6 | PRO: 765914-60-1 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297624\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"381. Scheme 381 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation for the Multikilogram Synthesis of Emprumapimod\", \"By: Brearley, Christopher; et al\", \"Organic Process Research & Development (2024), 28(4), 1253-1259.\", \"10.1021/acs.oprd.4c00052\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"765914-40-7\", \"3033928-61-6\"], \"pro_cas\": [\"765914-60-1\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["765914-40-7", "3033928-61-6"], "products": ["765914-60-1"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297626", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)C(c1ccc(F)c(F)c1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(F)c(F)c2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35297626", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 2892557-03-6 + 104-94-9 | PRO: 2892557-11-6 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297626\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"378. Scheme 378 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-03-6\", \"104-94-9\"], \"pro_cas\": [\"2892557-11-6\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-03-6", "104-94-9"], "products": ["2892557-11-6"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297627", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 86.0}, "smiles": {"reactants": "COc1ccc(C(C(=O)O)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(OC)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-35297627", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy", "By: Huber, Andrew D.; et al", "Journal of Medicinal Chemistry (2024), 67(20), 18549-18575.", "10.1021/acs.jmedchem.4c01926"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 3059971-30-8 + 33353-65-0 | PRO: 3059971-31-9 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297627\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"347. Scheme 347 (1 Reaction)\", \"First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy\", \"By: Huber, Andrew D.; et al\", \"Journal of Medicinal Chemistry (2024), 67(20), 18549-18575.\", \"10.1021/acs.jmedchem.4c01926\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3059971-30-8\", \"33353-65-0\"], \"pro_cas\": [\"3059971-31-9\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3059971-30-8", "33353-65-0"], "products": ["3059971-31-9"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297629", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)C(c1ccc(OC(F)(F)F)cc1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(OC(F)(F)F)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-35297629", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "By: Chen, Bei; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "10.1021/acs.jmedchem.3c01326"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 859124-22-4 + 1307702-36-8 | PRO: 3002420-80-3 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297629\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"374. Scheme 374 (1 Reaction)\", \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"By: Chen, Bei; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"10.1021/acs.jmedchem.3c01326\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"859124-22-4\", \"1307702-36-8\"], \"pro_cas\": [\"3002420-80-3\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["859124-22-4", "1307702-36-8"], "products": ["3002420-80-3"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35297639", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)C(c1ccc(F)cc1)N1CCN(c2ncnc3sc4c(c23)CCCC4)CC1.COc1ccc(N)cc1", "products": "COc1ccc(NC(=O)C(c2ccc(F)cc2)N2CCN(c3ncnc4sc5c(c34)CCCC5)CC2)cc1"}, "reference": {"title": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "authors": "Pal, Kavita; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115055.", "doi": "10.1016/j.ejmech.2022.115055", "raw": "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents | Pal, Kavita; et al | European Journal of Medicinal Chemistry (2023), 248, 115055. | 10.1016/j.ejmech.2022.115055"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-35297639", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|overnight, rt", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 2892557-00-3 + 104-94-9 | PRO: 2892557-08-1 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"authors\": \"Pal, Kavita; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35297639\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"346. Scheme 346 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-00-3\", \"104-94-9\"], \"pro_cas\": [\"2892557-08-1\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-00-3", "104-94-9"], "products": ["2892557-08-1"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.101929", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35314251", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)C(F)F.CCNC(=O)c1ccc(N[C@H]2CCN(C(=O)OC(C)(C)C)C[C@@H]2C)c(N)c1", "products": "CCNC(=O)c1ccc(N[C@H]2CCN(C(=O)OC(C)(C)C)C[C@@H]2C)c(NC(=O)C(F)F)c1"}, "reference": {"title": "Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4", "authors": "Londregan, Allyn T.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(1), 460-472.", "doi": "10.1021/acs.jmedchem.2c01421", "raw": "Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4 | Londregan, Allyn T.; et al | Journal of Medicinal Chemistry (2023), 66(1), 460-472. | 10.1021/acs.jmedchem.2c01421"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-35314251", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide, Tetrahydrofuran, Ethyl acetate; 0 °C → rt; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6+Tetrahydrofuran|109-99-9", "cond_sig": "a2cd8a7d", "fam_sig": "1459cdc3"}, "raw_data": {"raw_cas": "RCT: 117-34-0 + 3026372-08-4 + 3026373-07-6 | PRO: 3026372-19-7 + 3026372-21-1 | RGT: 7087-68-5 | SOL: 68-12-2 + 109-99-9 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4\", \"authors\": \"Londregan, Allyn T.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(1), 460-472.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35314251\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide, Tetrahydrofuran, Ethyl acetate; 0 °C → rt; 16 h, rt\", \"122. Scheme 122 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"117-34-0\", \"3026372-08-4\", \"3026373-07-6\"], \"pro_cas\": [\"3026372-19-7\", \"3026372-21-1\"], \"rgt_cas\": [\"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["117-34-0", "3026372-08-4", "3026373-07-6"], "products": ["3026372-19-7", "3026372-21-1"], "reagents": ["N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35314257", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 26.0, "yield_pct": 100.0}, "smiles": {"reactants": "CCN.Cl.Cc1cc2ccc(C(=O)O)cn2n1", "products": "CCNC(=O)c1ccc2cc(C)nn2c1"}, "reference": {"title": "Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4", "authors": "Londregan, Allyn T.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(1), 460-472.", "doi": "10.1021/acs.jmedchem.2c01421", "raw": "Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4 | Londregan, Allyn T.; et al | Journal of Medicinal Chemistry (2023), 66(1), 460-472. | 10.1021/acs.jmedchem.2c01421"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-35314257", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase", "By: Zhan, Zhengsheng; et al", "Journal of Medicinal Chemistry (2023), 66(1), 220-234.", "10.1021/acs.jmedchem.2c00962"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 598-10-7 + 1072-67-9 | PRO: 1250878-70-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4\", \"authors\": \"Londregan, Allyn T.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(1), 460-472.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35314257\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"109. Scheme 109 (1 Reaction)\", \"Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase\", \"By: Zhan, Zhengsheng; et al\", \"Journal of Medicinal Chemistry (2023), 66(1), 220-234.\", \"10.1021/acs.jmedchem.2c00962\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"598-10-7\", \"1072-67-9\"], \"pro_cas\": [\"1250878-70-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["598-10-7", "1072-67-9"], "products": ["1250878-70-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35336755", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.5, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)CCCCCCCBr.Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)cc1", "products": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCBr)C(C)(C)C)cc1"}, "reference": {"title": "Discovery of potent small molecule PROTACs targeting mutant EGFR", "authors": "Zhao, Hong-Yi; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112781.", "doi": "10.1016/j.ejmech.2020.112781", "raw": "Discovery of potent small molecule PROTACs targeting mutant EGFR | Zhao, Hong-Yi; et al | European Journal of Medicinal Chemistry (2020), 208, 112781. | 10.1016/j.ejmech.2020.112781"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-35336755", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 3.5 h, rt", "Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma", "By: Tseng, Hui-Ju; et al", "European Journal of Medicinal Chemistry (2023), 256, 115459.", "10.1016/j.ejmech.2023.115459"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 2927489-53-8 + 909871-48-3 | PRO: 2927489-57-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of potent small molecule PROTACs targeting mutant EGFR\", \"authors\": \"Zhao, Hong-Yi; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112781.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35336755\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 3.5 h, rt\", \"256. Scheme 256 (1 Reaction)\", \"Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma\", \"By: Tseng, Hui-Ju; et al\", \"European Journal of Medicinal Chemistry (2023), 256, 115459.\", \"10.1016/j.ejmech.2023.115459\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2927489-53-8\", \"909871-48-3\"], \"pro_cas\": [\"2927489-57-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2927489-53-8", "909871-48-3"], "products": ["2927489-57-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35396616", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 95.0}, "smiles": {"reactants": "CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O.C=CC[C@H]1[C@@H](C(=O)OC)N(C(=O)OC(C)(C)C)C[C@@H]1N", "products": "C=CC[C@@H]1[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)CN(C(=O)OC(C)(C)C)[C@@H]1C(=O)OC"}, "reference": {"title": "Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology", "authors": "Lu, Min; et al", "citation": "ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388.", "doi": "10.1021/acsmedchemlett.1c00195", "raw": "Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology | Lu, Min; et al | ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388. | 10.1021/acsmedchemlett.1c00195"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-35396616", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 2387522-95-2 + 1148157-29-2 | PRO: 2387523-22-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology\", \"authors\": \"Lu, Min; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2021), 12(9), 1380-1388.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35396616\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"170. Scheme 170 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-95-2\", \"1148157-29-2\"], \"pro_cas\": [\"2387523-22-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387522-95-2", "1148157-29-2"], "products": ["2387523-22-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431759", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 98.0}, "smiles": {"reactants": "COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)OC(C)(C)C)nc5ccccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21", "products": "COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5ccccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-35431759", "1.1|Reagents: Hydrochloric acid", "Solvents: Dichloromethane, 1,4-Dioxane; overnight, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530)", "By: Randolph, John T.; et al", "Journal of Medicinal Chemistry (2020), 63(19), 11034-11044.", "10.1021/acs.jmedchem.0c00956"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "50dc5325", "fam_sig": "80f08616"}, "raw_data": {"raw_cas": "RCT: 1207741-89-6 + 2227023-22-3 | PRO: 3036194-95-0 | RGT: 7647-01-0 + 7087-68-5 + 148893-10-1 | SOL: 75-09-2 + 123-91-1 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"1,4-Dioxane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431759\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Dichloromethane, 1,4-Dioxane; overnight, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"487. Scheme 487 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530)\", \"By: Randolph, John T.; et al\", \"Journal of Medicinal Chemistry (2020), 63(19), 11034-11044.\", \"10.1021/acs.jmedchem.0c00956\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1207741-89-6\", \"2227023-22-3\"], \"pro_cas\": [\"3036194-95-0\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"123-91-1\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1207741-89-6", "2227023-22-3"], "products": ["3036194-95-0"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane", "1,4-Dioxane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431762", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 12.0, "time_h": 4.5, "yield_pct": 88.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1cc(F)cc(F)c1.O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21", "products": "COC(=O)[C@H](Cc1cc(F)cc(F)c1)NC(=O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-35431762", "1.1|Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, HOAt", "Solvents: Dimethylformamide; 4.5 h, rt", "Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C", "By: Kettle, Jason G.; et al", "Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.", "10.1021/acs.jmedchem.2c00369"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxy-7-azabenzotriazole|39968-33-7+4-Methylmorpholine|+N-Methylmorpholine|109-02-4/Dimethylformamide|68-12-2", "cond_sig": "1ac5db70", "fam_sig": "7e1709e8"}, "raw_data": {"raw_cas": "RCT: 3473-63-0 + 1698535-33-9 | PRO: 2250340-29-3 | RGT: 109-02-4 + 1892-57-5 + 39968-33-7 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"4-Methylmorpholine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431762\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, HOAt\", \"Solvents: Dimethylformamide; 4.5 h, rt\", \"330. Scheme 330 (1 Reaction)\", \"Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C\", \"By: Kettle, Jason G.; et al\", \"Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.\", \"10.1021/acs.jmedchem.2c00369\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3473-63-0\", \"1698535-33-9\"], \"pro_cas\": [\"2250340-29-3\"], \"rgt_cas\": [\"109-02-4\", \"1892-57-5\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"incremental addition of EDC\"]}}", "enriched_names": {"reactants": ["3473-63-0", "1698535-33-9"], "products": ["2250340-29-3"], "reagents": ["N-Methylmorpholine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431767", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 97.0}, "smiles": {"reactants": "O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cc(F)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl", "products": "COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cc(F)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-35431767", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1626337-85-6 + 2896197-85-4 | PRO: 2896197-86-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431767\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"490. Scheme 490 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1626337-85-6\", \"2896197-85-4\"], \"pro_cas\": [\"2896197-86-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["1626337-85-6", "2896197-85-4"], "products": ["2896197-86-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431768", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cc(OC)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl", "products": "COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cc(OC)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-35431768", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir", "By: Zhang, Weihong; et al", "Organic Process Research & Development (2022), 26(4), 1078-1093.", "10.1021/acs.oprd.1c00315"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 853269-58-6 + 1315326-78-3 | PRO: 2763632-49-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431768\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"493. Scheme 493 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir\", \"By: Zhang, Weihong; et al\", \"Organic Process Research & Development (2022), 26(4), 1078-1093.\", \"10.1021/acs.oprd.1c00315\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"853269-58-6\", \"1315326-78-3\"], \"pro_cas\": [\"2763632-49-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["853269-58-6", "1315326-78-3"], "products": ["2763632-49-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431771", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5ccc(F)cc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl", "products": "COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5ccc(F)cc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-35431771", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1626337-85-6 + 2249975-17-3 | PRO: 2249975-18-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431771\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"489. Scheme 489 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1626337-85-6\", \"2249975-17-3\"], \"pro_cas\": [\"2249975-18-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["1626337-85-6", "2249975-17-3"], "products": ["2249975-18-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431775", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cc(Cl)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1", "products": "COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cc(Cl)ccc5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-35431775", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1626337-85-6 + 2896197-82-1 | PRO: 2896197-83-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431775\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"491. Scheme 491 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1626337-85-6\", \"2896197-82-1\"], \"pro_cas\": [\"2896197-83-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["1626337-85-6", "2896197-82-1"], "products": ["2896197-83-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431776", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.COc1ccc(CN(c2nn(C)c3c(-n4c([C@@H](N)Cc5cc(F)cc(F)c5)nc5cccc(F)c5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1.Cl", "products": "COc1ccc(CN(c2nn(C)c3c(-n4c([C@H](Cc5cc(F)cc(F)c5)NC(=O)Cn5nc(C(F)F)c6c5C(F)(F)[C@@H]5C[C@H]65)nc5cccc(F)c5c4=O)ccc(Cl)c23)S(C)(=O)=O)cc1"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-35431776", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1626337-85-6 + 2896197-74-1 | PRO: 2896197-75-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431776\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"492. Scheme 492 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1626337-85-6\", \"2896197-74-1\"], \"pro_cas\": [\"2896197-75-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["1626337-85-6", "2896197-74-1"], "products": ["2896197-75-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.112282", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35431795", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Ammonia", "cas": "7664-41-7", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Methanol", "cas": "67-56-1"}], "conditions": {"temperature_c": 25.0, "time_h": 3.5, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)Cn1nc(C(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.Cn1nc(NS(C)(=O)=O)c2c(Cl)ccc(-n3c([C@@H](N)Cc4cc(F)cc(F)c4)nc4cc(Br)ccc4c3=O)c21", "products": "Cn1nc(NS(C)(=O)=O)c2c(Cl)ccc(-n3c(C(Cc4cc(F)cc(F)c4)NC(=O)Cn4nc(C(F)F)c5c4C(F)(F)C4CC54)nc4cc(Br)ccc4c3=O)c21"}, "reference": {"title": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "authors": "Gillis, Eric P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "doi": "10.1021/acs.jmedchem.2c01732", "raw": "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold | Gillis, Eric P.; et al | Journal of Medicinal Chemistry (2023), 66(3), 1941-1954. | 10.1021/acs.jmedchem.2c01732"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-35431795", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, rt", "1.2|Reagents: Ammonia", "Solvents: Methanol; 30 min, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles", "By: Lao, Zhiqi; et al", "European Journal of Medicinal Chemistry (2023), 259, 115578.", "10.1016/j.ejmech.2023.115578"], "signatures": {"cond_key": "none/none/Ammonia|7664-41-7+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Methanol|67-56-1", "cond_sig": "37892c8e", "fam_sig": "a34882ae"}, "raw_data": {"raw_cas": "RCT: 3058079-02-7 + 79598-53-1 | PRO: 3058079-04-9 | RGT: 7087-68-5 + 148893-10-1 + 7664-41-7 | SOL: 68-12-2 + 67-56-1", "raw_data_json": "{\"txt\": {\"title\": \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"authors\": \"Gillis, Eric P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Ammonia\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Methanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35431795\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, rt\", \"1.2\", \"Reagents: Ammonia\", \"Solvents: Methanol; 30 min, rt\", \"483. Scheme 483 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles\", \"By: Lao, Zhiqi; et al\", \"European Journal of Medicinal Chemistry (2023), 259, 115578.\", \"10.1016/j.ejmech.2023.115578\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3058079-02-7\", \"79598-53-1\"], \"pro_cas\": [\"3058079-04-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7664-41-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"67-56-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["3058079-02-7", "79598-53-1"], "products": ["3058079-04-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "7664-41-7"], "catalysts": [], "solvents": ["Dimethylformamide", "Methanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.114591", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443131", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 40.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "Cc1cc(N)ccc1F.CC(C)(C)OC(=O)N1CCC[C@H](C(=O)O)C1", "products": "Cc1cc(NC(=O)[C@H]2CCCN(C(=O)OC(C)(C)C)C2)ccc1F"}, "reference": {"title": "Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice", "authors": "Yin, Jiaxin; et al", "citation": "European Journal of Medicinal Chemistry (2023), 249, 115141.", "doi": "10.1016/j.ejmech.2023.115141", "raw": "Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice | Yin, Jiaxin; et al | European Journal of Medicinal Chemistry (2023), 249, 115141. | 10.1016/j.ejmech.2023.115141"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-35443131", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; overnight, 40 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria", "By: Zhang, Yinyong; et al", "Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.", "10.1021/acs.jmedchem.4c00018"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 67-56-1 + 70277-02-0 + 3303-84-2 | PRO: 3078808-36-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice\", \"authors\": \"Yin, Jiaxin; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 249, 115141.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443131\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; overnight, 40 °C\", \"370. Scheme 370 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria\", \"By: Zhang, Yinyong; et al\", \"Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.\", \"10.1021/acs.jmedchem.4c00018\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"67-56-1\", \"70277-02-0\", \"3303-84-2\"], \"pro_cas\": [\"3078808-36-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["Methanol", "70277-02-0", "3303-84-2"], "products": ["3078808-36-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.114591", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443486", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 82.0}, "smiles": {"reactants": "CCC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "CCC(=O)Nc1ccc(-c2ccc(C(=O)N3CCc4cc(OC)c(OC)cc4C3)o2)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35443486", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "By: Pasqua, A. Elisa; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "10.1021/acs.jmedchem.3c00156"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 4442-54-0 + 1693735-21-5 | PRO: 1693735-22-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443486\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"262. Scheme 262 (1 Reaction)\", \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"By: Pasqua, A. Elisa; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"10.1021/acs.jmedchem.3c00156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4442-54-0\", \"1693735-21-5\"], \"pro_cas\": [\"1693735-22-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["4442-54-0", "1693735-21-5"], "products": ["1693735-22-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.114591", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443488", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 87.0}, "smiles": {"reactants": "CCCCC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "CCCCC(=O)Nc1ccc(-c2ccc(C(=O)N3CCc4cc(OC)c(OC)cc4C3)o2)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-35443488", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors", "By: Heitmann, Tyler; et al", "ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766.", "10.1021/acsmedchemlett.3c00409"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 864293-44-7 | PRO: 1616828-53-5 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443488\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"284. Scheme 284 (1 Reaction)\", \"Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors\", \"By: Heitmann, Tyler; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766.\", \"10.1021/acsmedchemlett.3c00409\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"864293-44-7\"], \"pro_cas\": [\"1616828-53-5\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "864293-44-7"], "products": ["1616828-53-5"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.115747", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443491", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 95.0}, "smiles": {"reactants": "CC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(C)=O)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-35443491", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "By: Stachura, Damian L.; et al", "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "10.1021/acsmedchemlett.2c00505"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 3731-51-9 + 3064695-54-8 | PRO: 3064695-45-7 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443491\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"246. Scheme 246 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"By: Stachura, Damian L.; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"10.1021/acsmedchemlett.2c00505\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3731-51-9\", \"3064695-54-8\"], \"pro_cas\": [\"3064695-45-7\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": [\"alternative reaction conditions gave lower yield\"]}}", "enriched_names": {"reactants": ["3731-51-9", "3064695-54-8"], "products": ["3064695-45-7"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.116753", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443493", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 88.0}, "smiles": {"reactants": "CC(C)C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C(C)C)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-35443493", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 2387522-92-9 + 1148157-29-2 | PRO: 2387523-12-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443493\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"271. Scheme 271 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-92-9\", \"1148157-29-2\"], \"pro_cas\": [\"2387523-12-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387522-92-9", "1148157-29-2"], "products": ["2387523-12-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.116753", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443495", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)(C)C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C(C)(C)C)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-35443495", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "By: Ryu, SeongShick; et al", "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "10.1021/acs.jmedchem.1c01359"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 2761691-58-9 + 23680-31-1 | PRO: 2761691-53-4 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443495\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"288. Scheme 288 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"By: Ryu, SeongShick; et al\", \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"10.1021/acs.jmedchem.1c01359\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2761691-58-9\", \"23680-31-1\"], \"pro_cas\": [\"2761691-53-4\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2761691-58-9", "23680-31-1"], "products": ["2761691-53-4"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.116753", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443497", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 81.0}, "smiles": {"reactants": "C/C=C/C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "C/C=C/C(=O)Nc1ccc(-c2ccc(C(=O)N3CCc4cc(OC)c(OC)cc4C3)o2)cc1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-35443497", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 109-52-4 + 2632874-83-8 | PRO: 2892485-51-5 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443497\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"283. Scheme 283 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"109-52-4\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-51-5\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["109-52-4", "2632874-83-8"], "products": ["2892485-51-5"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.116753", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443498", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)C=Cc1ccccc1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C=Cc4ccccc4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-35443498", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Relative stereochemistry shown", "Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow", "By: Alder, Catherine M.; et al", "Organic Process Research & Development (2022), 26(2), 365-379.", "10.1021/acs.oprd.1c00422"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 1048962-49-7 + 2138475-74-6 | PRO: 2139228-58-1 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443498\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"316. Scheme 316 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow\", \"By: Alder, Catherine M.; et al\", \"Organic Process Research & Development (2022), 26(2), 365-379.\", \"10.1021/acs.oprd.1c00422\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1048962-49-7\", \"2138475-74-6\"], \"pro_cas\": [\"2139228-58-1\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1048962-49-7", "2138475-74-6"], "products": ["2139228-58-1"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.116753", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443500", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 5.0, "yield_pct": 92.0}, "smiles": {"reactants": "O=C(O)C1CC1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C4CC4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-35443500", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "By: Sheppard, George S.; et al", "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "10.1021/acs.jmedchem.0c00628"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 1643671-68-4 + 75-04-7 | PRO: 1643671-69-5 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443500\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"280. Scheme 280 (1 Reaction)\", \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"By: Sheppard, George S.; et al\", \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"10.1021/acs.jmedchem.0c00628\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1643671-68-4\", \"75-04-7\"], \"pro_cas\": [\"1643671-69-5\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1643671-68-4", "75-04-7"], "products": ["1643671-69-5"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.116753", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443501", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)C1CCC1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C4CCC4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35443501", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 75-98-9 + 2632874-83-8 | PRO: 2892485-52-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443501\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"287. Scheme 287 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-98-9\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-52-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-98-9", "2632874-83-8"], "products": ["2892485-52-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.117951", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443502", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1cccc2ccccc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cccc5ccccc45)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35443502", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 621-82-9 + 2632874-83-8 | PRO: 2897680-77-0 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443502\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"315. Scheme 315 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"621-82-9\", \"2632874-83-8\"], \"pro_cas\": [\"2897680-77-0\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["621-82-9", "2632874-83-8"], "products": ["2897680-77-0"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.117951", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443503", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)Cc1cccc2ccccc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)Cc4cccc5ccccc45)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-35443503", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "By: Novotna, Katerina; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "10.1021/acs.jmedchem.3c01681"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 247113-86-6 + 2851863-10-8 | PRO: 2861234-24-2 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443503\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"328. Scheme 328 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"By: Novotna, Katerina; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"10.1021/acs.jmedchem.3c01681\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"247113-86-6\", \"2851863-10-8\"], \"pro_cas\": [\"2861234-24-2\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["247113-86-6", "2851863-10-8"], "products": ["2861234-24-2"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443504", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2o1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5ccccc5o4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35443504", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification", "By: Schafer, Gabriel; et al", "Organic Process Research & Development (2024), 28(6), 2103-2116.", "10.1021/acs.oprd.3c00446"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 1083224-23-0 + 3026294-17-4 | PRO: 3026294-18-5 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443504\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"335. Scheme 335 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification\", \"By: Schafer, Gabriel; et al\", \"Organic Process Research & Development (2024), 28(6), 2103-2116.\", \"10.1021/acs.oprd.3c00446\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1083224-23-0\", \"3026294-17-4\"], \"pro_cas\": [\"3026294-18-5\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1083224-23-0", "3026294-17-4"], "products": ["3026294-18-5"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443505", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1csc2ccccc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4csc5ccccc45)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-35443505", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "An optimized safe process from bench to pilot cGMP production of API eptifibatide using a multigram-scale microwave-assisted solid-phase peptide synthesizer", "By: D’Ercole, Annunziata; et al", "Organic Process Research & Development (2021), 25(12), 2754-2771.", "10.1021/acs.oprd.1c00368"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 135248-89-4 + 71989-31-6 + 143824-78-6 + 71989-14-5 + 29022-11-5 + 1159680-21-3 + 27144-18-9 | PRO: 135900-78-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443505\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"365. Scheme 365 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"An optimized safe process from bench to pilot cGMP production of API eptifibatide using a multigram-scale microwave-assisted solid-phase peptide synthesizer\", \"By: D’Ercole, Annunziata; et al\", \"Organic Process Research & Development (2021), 25(12), 2754-2771.\", \"10.1021/acs.oprd.1c00368\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"135248-89-4\", \"71989-31-6\", \"143824-78-6\", \"71989-14-5\", \"29022-11-5\", \"1159680-21-3\", \"27144-18-9\"], \"pro_cas\": [\"135900-78-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["135248-89-4", "71989-31-6", "143824-78-6", "71989-14-5", "29022-11-5", "1159680-21-3", "27144-18-9"], "products": ["135900-78-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443506", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)(C)CC(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)CC(C)(C)C)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-35443506", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 13205-47-5 + 2919713-61-2 | PRO: 2919713-79-2 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443506\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"293. Scheme 293 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13205-47-5\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-79-2\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["13205-47-5", "2919713-61-2"], "products": ["2919713-79-2"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443508", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2s1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5ccccc5s4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-35443508", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "By: Gotz, Marion G.; et al", "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "10.1021/acsmedchemlett.4c00017"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 3058604-41-1 + 3058604-56-8 | PRO: 3058604-57-9 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443508\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"361. Scheme 361 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"By: Gotz, Marion G.; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"10.1021/acsmedchemlett.4c00017\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3058604-41-1\", \"3058604-56-8\"], \"pro_cas\": [\"3058604-57-9\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3058604-41-1", "3058604-56-8"], "products": ["3058604-57-9"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443510", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2[nH]1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5ccccc5[nH]4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35443510", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity", "By: Peacock, Hayden; et al", "ChemMedChem (2020), 15(20), 1932-1939.", "10.1002/cmdc.202000474"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 23500-04-1 + 2973279-11-5 | PRO: 2973279-12-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443510\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"386. Scheme 386 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity\", \"By: Peacock, Hayden; et al\", \"ChemMedChem (2020), 15(20), 1932-1939.\", \"10.1002/cmdc.202000474\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"23500-04-1\", \"2973279-11-5\"], \"pro_cas\": [\"2973279-12-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["23500-04-1", "2973279-11-5"], "products": ["2973279-12-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443513", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)C1CCCC1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)C4CCCC4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-35443513", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 3721-95-7 + 2632874-83-8 | PRO: 2892485-55-9 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443513\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"286. Scheme 286 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3721-95-7\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-55-9\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3721-95-7", "2632874-83-8"], "products": ["2892485-55-9"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443514", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cc2cc(Cl)ccc2[nH]1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5cc(Cl)ccc5[nH]4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-35443514", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification", "By: Schafer, Gabriel; et al", "Organic Process Research & Development (2024), 28(6), 2103-2116.", "10.1021/acs.oprd.3c00446"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 1215107-61-1 + 2178053-39-7 | PRO: 2178053-40-0 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443514\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"411. Scheme 411 (2 Reactions)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification\", \"By: Schafer, Gabriel; et al\", \"Organic Process Research & Development (2024), 28(6), 2103-2116.\", \"10.1021/acs.oprd.3c00446\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1215107-61-1\", \"2178053-39-7\"], \"pro_cas\": [\"2178053-40-0\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1215107-61-1", "2178053-39-7"], "products": ["2178053-40-0"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443515", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 82.0}, "smiles": {"reactants": "COc1ccc2cc(C(=O)O)[nH]c2c1.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1ccc2cc(C(=O)Nc3ccc(-c4ccc(C(=O)N5CCc6cc(OC)c(OC)cc6C5)o4)cc3)[nH]c2c1"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35443515", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "By: Bothe, Ulrich; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "10.1021/acs.jmedchem.3c01714"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 131747-42-7 + 1799835-87-2 | PRO: 1799835-95-2 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443515\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"398. Scheme 398 (1 Reaction)\", \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"By: Bothe, Ulrich; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"10.1021/acs.jmedchem.3c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"131747-42-7\", \"1799835-87-2\"], \"pro_cas\": [\"1799835-95-2\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["131747-42-7", "1799835-87-2"], "products": ["1799835-95-2"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35443526", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 84.0}, "smiles": {"reactants": "Cc1cccc2[nH]c(C(=O)O)cc12.COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(N)cc3)o1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1ccc(-c3ccc(NC(=O)c4cc5c(C)cccc5[nH]4)cc3)o1)CC2"}, "reference": {"title": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "authors": "Yang, Zhikun; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115092.", "doi": "10.1016/j.ejmech.2023.115092", "raw": "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell | Yang, Zhikun; et al | European Journal of Medicinal Chemistry (2023), 248, 115092. | 10.1016/j.ejmech.2023.115092"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35443526", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations", "By: Thomson, Clare; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.", "10.1021/acs.jmedchem.4c00227"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 137654-20-7 + 3055872-81-3 | PRO: 3055872-90-4 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35443526\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"390. Scheme 390 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations\", \"By: Thomson, Clare; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.\", \"10.1021/acs.jmedchem.4c00227\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"137654-20-7\", \"3055872-81-3\"], \"pro_cas\": [\"3055872-90-4\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["137654-20-7", "3055872-81-3"], "products": ["3055872-90-4"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35464719", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylimidazole", "cas": "616-47-7", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "1-Methylimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 30.0, "time_h": 1.0, "yield_pct": 84.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CC(C)C.Cl.COc1cccc2[nH]c(C(=O)O)cc12", "products": "COC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1"}, "reference": {"title": "Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19", "authors": "Allais, Christophe; et al", "citation": "Organic Process Research & Development (2023), 27(12), 2223-2239.", "doi": "10.1021/acs.oprd.2c00375", "raw": "Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19 | Allais, Christophe; et al | Organic Process Research & Development (2023), 27(12), 2223-2239. | 10.1021/acs.oprd.2c00375"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35464719", "1.1|Reagents: 1-Methylimidazole", "Solvents: Acetonitrile; 0.5 - 1 h, 15 - 30 °C", "1.2|Reagents: Propylphosphonic anhydride", "Solvents: Acetonitrile; 15 - 30 °C", "Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction", "By: Ding, Jian; et al", "Journal of Medicinal Chemistry (2023), 66(12), 8310-8323.", "10.1021/acs.jmedchem.3c00787"], "signatures": {"cond_key": "none/none/1-Methylimidazole|+N-Methylimidazole|616-47-7+Propylphosphonic anhydride|68957-94-8/Acetonitrile|75-05-8", "cond_sig": "ae1cd31c", "fam_sig": "54f196b9"}, "raw_data": {"raw_cas": "RCT: 68254-08-0 + 1461655-72-0 | PRO: 3033748-36-3 | RGT: 616-47-7 + 68957-94-8 | SOL: 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19\", \"authors\": \"Allais, Christophe; et al\", \"citation\": \"Organic Process Research & Development (2023), 27(12), 2223-2239.\", \"reagents\": [\"1-Methylimidazole\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35464719\", \"1.1\", \"Reagents: 1-Methylimidazole\", \"Solvents: Acetonitrile; 0.5 - 1 h, 15 - 30 °C\", \"1.2\", \"Reagents: Propylphosphonic anhydride\", \"Solvents: Acetonitrile; 15 - 30 °C\", \"34. Scheme 34 (1 Reaction)\", \"Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction\", \"By: Ding, Jian; et al\", \"Journal of Medicinal Chemistry (2023), 66(12), 8310-8323.\", \"10.1021/acs.jmedchem.3c00787\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"68254-08-0\", \"1461655-72-0\"], \"pro_cas\": [\"3033748-36-3\"], \"rgt_cas\": [\"616-47-7\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["68254-08-0", "1461655-72-0"], "products": ["3033748-36-3"], "reagents": ["N-Methylimidazole", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35464726", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "2-Hydroxypyridine N-oxide", "cas": "13161-30-3", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Methyl Ethyl Ketone", "cas": "78-93-3"}], "conditions": {"temperature_c": 20.0, "time_h": 8.333, "yield_pct": 82.0}, "smiles": {"reactants": "COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)O)cc12.COC(=O)[C@@H](N)C[C@@H]1CCNC1=O.Cc1ccc(S(=O)(=O)O)cc1", "products": "COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1"}, "reference": {"title": "Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19", "authors": "Allais, Christophe; et al", "citation": "Organic Process Research & Development (2023), 27(12), 2223-2239.", "doi": "10.1021/acs.oprd.2c00375", "raw": "Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19 | Allais, Christophe; et al | Organic Process Research & Development (2023), 27(12), 2223-2239. | 10.1021/acs.oprd.2c00375"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35464726", "1.1|Reagents: Diisopropylethylamine, 2-Hydroxypyridine N-oxide, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Methyl ethyl ketone; rt → 0 °C; 20 min, 0 °C; 0 °C → 20 °C; 8 h, 20 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine", "By: Zhang, Liang; et al", "Journal of Medicinal Chemistry (2023), 66(6), 4150-4166.", "10.1021/acs.jmedchem.3c00006"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+2-Hydroxypyridine N-oxide|13161-30-3+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Methyl Ethyl Ketone|78-93-3", "cond_sig": "5bc5a137", "fam_sig": "3adfc859"}, "raw_data": {"raw_cas": "RCT: 99-66-1 + 122111-03-9 | PRO: 892128-60-8 | RGT: 7087-68-5 + 13161-30-3 + 25952-53-8 | SOL: 78-93-3", "raw_data_json": "{\"txt\": {\"title\": \"Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19\", \"authors\": \"Allais, Christophe; et al\", \"citation\": \"Organic Process Research & Development (2023), 27(12), 2223-2239.\", \"reagents\": [\"Diisopropylethylamine\", \"2-Hydroxypyridine N-oxide\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Methyl ethyl ketone\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35464726\", \"1.1\", \"Reagents: Diisopropylethylamine, 2-Hydroxypyridine N-oxide, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Methyl ethyl ketone; rt → 0 °C; 20 min, 0 °C; 0 °C → 20 °C; 8 h, 20 °C\", \"332. Scheme 332 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine\", \"By: Zhang, Liang; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 4150-4166.\", \"10.1021/acs.jmedchem.3c00006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"99-66-1\", \"122111-03-9\"], \"pro_cas\": [\"892128-60-8\"], \"rgt_cas\": [\"7087-68-5\", \"13161-30-3\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"78-93-3\"], \"notes\": []}}", "enriched_names": {"reactants": ["99-66-1", "122111-03-9"], "products": ["892128-60-8"], "reagents": ["N,N-Diisopropylethylamine", "13161-30-3", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Methyl Ethyl Ketone"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35473515", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 50.0, "time_h": 16.0, "yield_pct": 91.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCC(=O)O.CCOC(=O)c1sc(N)nc1C", "products": "CCOC(=O)c1sc(NC(=O)CCNC(=O)OC(C)(C)C)nc1C"}, "reference": {"title": "Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes", "authors": "Saint-Dizier, Francois; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.", "doi": "10.1021/acs.jmedchem.2c01591", "raw": "Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes | Saint-Dizier, Francois; et al | Journal of Medicinal Chemistry (2023), 66(4), 2622-2645. | 10.1021/acs.jmedchem.2c01591"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-35473515", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dimethylformamide; rt; overnight, 50 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit", "By: Zhan, Wenhu; et al", "Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.", "10.1021/acs.jmedchem.2c00733"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "ac220dd2", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 75-64-9 + 30925-18-9 | PRO: 1185984-32-0 | RGT: 1892-57-5 + 2592-95-2 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes\", \"authors\": \"Saint-Dizier, Francois; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35473515\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dimethylformamide; rt; overnight, 50 °C\", \"279. Scheme 279 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit\", \"By: Zhan, Wenhu; et al\", \"Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.\", \"10.1021/acs.jmedchem.2c00733\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-64-9\", \"30925-18-9\"], \"pro_cas\": [\"1185984-32-0\"], \"rgt_cas\": [\"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-64-9", "30925-18-9"], "products": ["1185984-32-0"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35473530", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 20.0, "yield_pct": 99.0}, "smiles": {"reactants": "COC(=O)CCN.Cl.Cc1nc(-c2cccc(C(=O)O)c2)no1", "products": "COC(=O)CCNC(=O)c1cccc(-c2noc(C)n2)c1"}, "reference": {"title": "Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes", "authors": "Saint-Dizier, Francois; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.", "doi": "10.1021/acs.jmedchem.2c01591", "raw": "Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes | Saint-Dizier, Francois; et al | Journal of Medicinal Chemistry (2023), 66(4), 2622-2645. | 10.1021/acs.jmedchem.2c01591"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-35473530", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 20 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain", "By: Gallo, Francesca; et al", "Journal of Medicinal Chemistry (2021), 64(7), 4117-4129.", "10.1021/acs.jmedchem.1c00003"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 623-04-1 + 70396-18-8 | PRO: 1884577-99-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes\", \"authors\": \"Saint-Dizier, Francois; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35473530\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 20 h, rt\", \"224. Scheme 224 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain\", \"By: Gallo, Francesca; et al\", \"Journal of Medicinal Chemistry (2021), 64(7), 4117-4129.\", \"10.1021/acs.jmedchem.1c00003\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"623-04-1\", \"70396-18-8\"], \"pro_cas\": [\"1884577-99-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["623-04-1", "70396-18-8"], "products": ["1884577-99-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35625641", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "Cn1cc(OCc2ccccc2)c(=O)cc1CN.O=C(O)CCCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1", "products": "Cn1cc(OCc2ccccc2)c(=O)cc1CNC(=O)CCCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1"}, "reference": {"title": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "authors": "Wang, Yuan-Yuan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "doi": "10.1021/acs.jmedchem.2c02044", "raw": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa | Wang, Yuan-Yuan; et al | Journal of Medicinal Chemistry (2023), 66(3), 2169-2193. | 10.1021/acs.jmedchem.2c02044"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-35625641", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: Dimethylaminopyridine", "Solvents: Dichloromethane; 16 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties", "By: Dragovich, Peter S.; et al", "Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.", "10.1021/acs.jmedchem.0c01845"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 2417371-30-1 + 1448297-52-6 | PRO: 2417371-31-2 | RGT: 2592-95-2 + 25952-53-8 | CAT: 57951-36-7 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"authors\": \"Wang, Yuan-Yuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"Dimethylaminopyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35625641\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: Dimethylaminopyridine\", \"Solvents: Dichloromethane; 16 h, 25 °C\", \"476. Scheme 476 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties\", \"By: Dragovich, Peter S.; et al\", \"Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.\", \"10.1021/acs.jmedchem.0c01845\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2417371-30-1\", \"1448297-52-6\"], \"pro_cas\": [\"2417371-31-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"57951-36-7\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2417371-30-1", "1448297-52-6"], "products": ["2417371-31-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["57951-36-7"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35625659", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 84.0}, "smiles": {"reactants": "NCc1ccccc1.O=C(O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1", "products": "O=C(CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1)NCc1ccccc1"}, "reference": {"title": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "authors": "Wang, Yuan-Yuan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "doi": "10.1021/acs.jmedchem.2c02044", "raw": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa | Wang, Yuan-Yuan; et al | Journal of Medicinal Chemistry (2023), 66(3), 2169-2193. | 10.1021/acs.jmedchem.2c02044"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35625659", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: Dimethylaminopyridine", "Solvents: Dichloromethane; 16 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus Integrase Inhibitor Dolutegravir Sodium", "By: Dietz, Jule-Philipp; et al", "Organic Process Research & Development (2021), 25(8), 1898-1910.", "10.1021/acs.oprd.1c00139"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 1246616-73-8 + 72235-52-0 | PRO: 1051375-19-9 | RGT: 2592-95-2 + 25952-53-8 | CAT: 57951-36-7 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"authors\": \"Wang, Yuan-Yuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"Dimethylaminopyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35625659\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: Dimethylaminopyridine\", \"Solvents: Dichloromethane; 16 h, 25 °C\", \"451. Scheme 451 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Six-Step Gram-Scale Synthesis of the Human Immunodeficiency Virus Integrase Inhibitor Dolutegravir Sodium\", \"By: Dietz, Jule-Philipp; et al\", \"Organic Process Research & Development (2021), 25(8), 1898-1910.\", \"10.1021/acs.oprd.1c00139\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1246616-73-8\", \"72235-52-0\"], \"pro_cas\": [\"1051375-19-9\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"57951-36-7\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1246616-73-8", "72235-52-0"], "products": ["1051375-19-9"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["57951-36-7"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35625660", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 84.0}, "smiles": {"reactants": "Cn1cc(OCc2ccccc2)c(=O)cc1CN.O=C(O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1", "products": "Cn1cc(OCc2ccccc2)c(=O)cc1CNC(=O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1"}, "reference": {"title": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "authors": "Wang, Yuan-Yuan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "doi": "10.1021/acs.jmedchem.2c02044", "raw": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa | Wang, Yuan-Yuan; et al | Journal of Medicinal Chemistry (2023), 66(3), 2169-2193. | 10.1021/acs.jmedchem.2c02044"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35625660", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: Dimethylaminopyridine", "Solvents: Dichloromethane; 16 h, 25 °C", "Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy", "By: Wu, Shanchao; et al", "Journal of Medicinal Chemistry (2022), 65(6), 4818-4831.", "10.1021/acs.jmedchem.1c02026"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 95-54-5 + 3037149-89-3 | PRO: 3037149-90-6 | RGT: 2592-95-2 + 25952-53-8 | CAT: 57951-36-7 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"authors\": \"Wang, Yuan-Yuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"Dimethylaminopyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35625660\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: Dimethylaminopyridine\", \"Solvents: Dichloromethane; 16 h, 25 °C\", \"481. Scheme 481 (1 Reaction)\", \"Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy\", \"By: Wu, Shanchao; et al\", \"Journal of Medicinal Chemistry (2022), 65(6), 4818-4831.\", \"10.1021/acs.jmedchem.1c02026\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"95-54-5\", \"3037149-89-3\"], \"pro_cas\": [\"3037149-90-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"57951-36-7\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["95-54-5", "3037149-89-3"], "products": ["3037149-90-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["57951-36-7"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35625672", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylaminopyridine", "cas": "57951-36-7"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1.Cc1cc(=O)c(OCc2ccccc2)cn1CCCN", "products": "Cc1cc(=O)c(OCc2ccccc2)cn1CCCNC(=O)CCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OCc2ccccc2)cn3C2CC2)CC1"}, "reference": {"title": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "authors": "Wang, Yuan-Yuan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "doi": "10.1021/acs.jmedchem.2c02044", "raw": "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa | Wang, Yuan-Yuan; et al | Journal of Medicinal Chemistry (2023), 66(3), 2169-2193. | 10.1021/acs.jmedchem.2c02044"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-35625672", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: Dimethylaminopyridine", "Solvents: Dichloromethane; 16 h, 25 °C", "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "By: Wang, Yuan-Yuan; et al", "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "10.1021/acs.jmedchem.2c02044"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 812653-97-7 + 3035080-42-0 | PRO: 3035080-49-7 | RGT: 2592-95-2 + 25952-53-8 | CAT: 57951-36-7 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"authors\": \"Wang, Yuan-Yuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"Dimethylaminopyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35625672\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: Dimethylaminopyridine\", \"Solvents: Dichloromethane; 16 h, 25 °C\", \"475. Scheme 475 (1 Reaction)\", \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"By: Wang, Yuan-Yuan; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"10.1021/acs.jmedchem.2c02044\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"812653-97-7\", \"3035080-42-0\"], \"pro_cas\": [\"3035080-49-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"57951-36-7\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["812653-97-7", "3035080-42-0"], "products": ["3035080-49-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["57951-36-7"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35647799", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 0.0, "time_h": 22.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccc(Cl)nn1.COC(=O)c1cc(F)c(F)cc1N", "products": "COC(=O)c1cc(F)c(F)cc1NC(=O)c1ccc(Cl)nn1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "authors": "Shan, Bin; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "doi": "10.1021/acs.jmedchem.2c01714", "raw": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists | Shan, Bin; et al | Journal of Medicinal Chemistry (2023), 66(5), 3327-3347. | 10.1021/acs.jmedchem.2c01714"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-35647799", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C; 6 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Acetonitrile; overnight, rt", "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "By: Pasqua, A. Elisa; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "10.1021/acs.jmedchem.3c00156"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Oxalyl chloride|79-37-8/Acetonitrile|75-05-8+Dichloromethane|75-09-2", "cond_sig": "ecd5a576", "fam_sig": "4d69375b"}, "raw_data": {"raw_cas": "RCT: 4442-54-0 + 119-32-4 | PRO: 1062259-61-3 | RGT: 79-37-8 + 7087-68-5 | CAT: 68-12-2 | SOL: 75-09-2 + 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"authors\": \"Shan, Bin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"reagents\": [\"Oxalyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35647799\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C; 6 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Acetonitrile; overnight, rt\", \"454. Scheme 454 (1 Reaction)\", \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"By: Pasqua, A. Elisa; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"10.1021/acs.jmedchem.3c00156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4442-54-0\", \"119-32-4\"], \"pro_cas\": [\"1062259-61-3\"], \"rgt_cas\": [\"79-37-8\", \"7087-68-5\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["4442-54-0", "119-32-4"], "products": ["1062259-61-3"], "reagents": ["79-37-8", "N,N-Diisopropylethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35647834", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Ethyl Acetate", "cas": "141-78-6", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,2-Dichloroethane", "cas": "107-06-2"}], "conditions": {"temperature_c": 80.0, "time_h": 11.0, "yield_pct": 84.0}, "smiles": {"reactants": "COC(=O)c1cc(OC)ccc1N.O=C(O)c1ccc(-c2ccnnc2)nn1", "products": "COC(=O)c1cc(OC)ccc1NC(=O)c1ccc(-c2ccnnc2)nn1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "authors": "Shan, Bin; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "doi": "10.1021/acs.jmedchem.2c01714", "raw": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists | Shan, Bin; et al | Journal of Medicinal Chemistry (2023), 66(5), 3327-3347. | 10.1021/acs.jmedchem.2c01714"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35647834", "1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: 1,2-Dichloroethane; 10 h, 80 °C", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Ethyl Acetate|141-78-6+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/1,2-Dichloroethane|107-06-2", "cond_sig": "f79bfb93", "fam_sig": "8ffc4910"}, "raw_data": {"raw_cas": "RCT: 36847-85-5 + 40615-17-6 | PRO: 2416338-33-3 | RGT: 141-78-6 + 7087-68-5 + 68957-94-8 | SOL: 107-06-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"authors\": \"Shan, Bin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"reagents\": [\"Ethyl acetate\", \"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"1,2-Dichloroethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35647834\", \"1.1\", \"Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: 1,2-Dichloroethane; 10 h, 80 °C\", \"487. Scheme 487 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36847-85-5\", \"40615-17-6\"], \"pro_cas\": [\"2416338-33-3\"], \"rgt_cas\": [\"141-78-6\", \"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"107-06-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36847-85-5", "40615-17-6"], "products": ["2416338-33-3"], "reagents": ["Ethyl Acetate", "N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["1,2-Dichloroethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35647835", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Ethyl Acetate", "cas": "141-78-6", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,2-Dichloroethane", "cas": "107-06-2"}], "conditions": {"temperature_c": 80.0, "time_h": 10.0, "yield_pct": 84.0}, "smiles": {"reactants": "COC(=O)c1ccc(OC)cc1N.O=C(O)c1ccc(-c2ccnnc2)nn1", "products": "COC(=O)c1ccc(OC)cc1NC(=O)c1ccc(-c2ccnnc2)nn1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "authors": "Shan, Bin; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "doi": "10.1021/acs.jmedchem.2c01714", "raw": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists | Shan, Bin; et al | Journal of Medicinal Chemistry (2023), 66(5), 3327-3347. | 10.1021/acs.jmedchem.2c01714"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-35647835", "1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: 1,2-Dichloroethane; 10 h, 80 °C", "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "By: Shan, Bin; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "10.1021/acs.jmedchem.2c01714"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Ethyl Acetate|141-78-6+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/1,2-Dichloroethane|107-06-2", "cond_sig": "f79bfb93", "fam_sig": "8ffc4910"}, "raw_data": {"raw_cas": "RCT: 52727-57-8 + 2913152-05-1 | PRO: 2913152-13-1 | RGT: 141-78-6 + 7087-68-5 + 68957-94-8 | SOL: 107-06-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"authors\": \"Shan, Bin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"reagents\": [\"Ethyl acetate\", \"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"1,2-Dichloroethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35647835\", \"1.1\", \"Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: 1,2-Dichloroethane; 10 h, 80 °C\", \"469. Scheme 469 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"By: Shan, Bin; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"10.1021/acs.jmedchem.2c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"52727-57-8\", \"2913152-05-1\"], \"pro_cas\": [\"2913152-13-1\"], \"rgt_cas\": [\"141-78-6\", \"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"107-06-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["52727-57-8", "2913152-05-1"], "products": ["2913152-13-1"], "reagents": ["Ethyl Acetate", "N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["1,2-Dichloroethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35647838", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Ethyl Acetate", "cas": "141-78-6", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,2-Dichloroethane", "cas": "107-06-2"}], "conditions": {"temperature_c": 80.0, "time_h": 10.0, "yield_pct": 92.0}, "smiles": {"reactants": "COC(=O)c1cc(OC)c(OC)cc1N.O=C(O)c1ccc(-c2ccnnc2)nn1", "products": "COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1ccc(-c2ccnnc2)nn1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "authors": "Shan, Bin; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "doi": "10.1021/acs.jmedchem.2c01714", "raw": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists | Shan, Bin; et al | Journal of Medicinal Chemistry (2023), 66(5), 3327-3347. | 10.1021/acs.jmedchem.2c01714"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-35647838", "1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: 1,2-Dichloroethane; 10 h, 80 °C", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Ethyl Acetate|141-78-6+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/1,2-Dichloroethane|107-06-2", "cond_sig": "f79bfb93", "fam_sig": "8ffc4910"}, "raw_data": {"raw_cas": "RCT: 3075103-43-1 + 94-75-7 | PRO: 3075103-52-2 | RGT: 141-78-6 + 7087-68-5 + 68957-94-8 | SOL: 107-06-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"authors\": \"Shan, Bin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"reagents\": [\"Ethyl acetate\", \"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"1,2-Dichloroethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35647838\", \"1.1\", \"Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: 1,2-Dichloroethane; 10 h, 80 °C\", \"112. Scheme 112 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075103-43-1\", \"94-75-7\"], \"pro_cas\": [\"3075103-52-2\"], \"rgt_cas\": [\"141-78-6\", \"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"107-06-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3075103-43-1", "94-75-7"], "products": ["3075103-52-2"], "reagents": ["Ethyl Acetate", "N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["1,2-Dichloroethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35647846", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Ethyl Acetate", "cas": "141-78-6", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,2-Dichloroethane", "cas": "107-06-2"}], "conditions": {"temperature_c": 80.0, "time_h": 10.0, "yield_pct": 81.0}, "smiles": {"reactants": "COC(=O)c1cc(Br)ccc1N.O=C(O)c1ccc(-c2ccnnc2)nn1", "products": "COC(=O)c1cc(Br)ccc1NC(=O)c1ccc(-c2ccnnc2)nn1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "authors": "Shan, Bin; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "doi": "10.1021/acs.jmedchem.2c01714", "raw": "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists | Shan, Bin; et al | Journal of Medicinal Chemistry (2023), 66(5), 3327-3347. | 10.1021/acs.jmedchem.2c01714"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-35647846", "1.1|Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: 1,2-Dichloroethane; 10 h, 80 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+Ethyl Acetate|141-78-6+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/1,2-Dichloroethane|107-06-2", "cond_sig": "f79bfb93", "fam_sig": "8ffc4910"}, "raw_data": {"raw_cas": "RCT: 13734-34-4 + 2761157-66-6 | PRO: 2761157-78-0 | RGT: 141-78-6 + 7087-68-5 + 68957-94-8 | SOL: 107-06-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"authors\": \"Shan, Bin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"reagents\": [\"Ethyl acetate\", \"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"1,2-Dichloroethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35647846\", \"1.1\", \"Reagents: Ethyl acetate, Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: 1,2-Dichloroethane; 10 h, 80 °C\", \"470. Scheme 470 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-34-4\", \"2761157-66-6\"], \"pro_cas\": [\"2761157-78-0\"], \"rgt_cas\": [\"141-78-6\", \"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"107-06-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13734-34-4", "2761157-66-6"], "products": ["2761157-78-0"], "reagents": ["Ethyl Acetate", "N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["1,2-Dichloroethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35966979", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": 25.0, "time_h": 3.333, "yield_pct": 85.0}, "smiles": {"reactants": "Nc1cc(Br)ccc1C(=O)O.CN", "products": "CNC(=O)c1ccc(Br)cc1N"}, "reference": {"title": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "authors": "Ashton, Trent D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "doi": "10.1021/acs.jmedchem.2c02092", "raw": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 | Ashton, Trent D.; et al | Journal of Medicinal Chemistry (2023), 66(5), 3540-3565. | 10.1021/acs.jmedchem.2c02092"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-35966979", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Tetrahydrofuran; 200 min, rt", "1.2|Solvents: Ethanol; 2 w, rt", "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "By: Ashton, Trent D.; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "10.1021/acs.jmedchem.2c02092"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Ethanol|64-17-5+Tetrahydrofuran|109-99-9", "cond_sig": "c4810f9b", "fam_sig": "8ae379bb"}, "raw_data": {"raw_cas": "RCT: 89-77-0 + 74-89-5 | PRO: 104775-66-8 | RGT: 530-62-1 | SOL: 109-99-9 + 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"authors\": \"Ashton, Trent D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35966979\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Tetrahydrofuran; 200 min, rt\", \"1.2\", \"Solvents: Ethanol; 2 w, rt\", \"15. Scheme 15 (1 Reaction)\", \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"By: Ashton, Trent D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"10.1021/acs.jmedchem.2c02092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"89-77-0\", \"74-89-5\"], \"pro_cas\": [\"104775-66-8\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["89-77-0", "74-89-5"], "products": ["104775-66-8"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35966982", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": 21.0, "time_h": 73.0, "yield_pct": 85.0}, "smiles": {"reactants": "Nc1cc(Cl)ccc1C(=O)O.CN", "products": "CNC(=O)c1ccc(Cl)cc1N"}, "reference": {"title": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "authors": "Ashton, Trent D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "doi": "10.1021/acs.jmedchem.2c02092", "raw": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 | Ashton, Trent D.; et al | Journal of Medicinal Chemistry (2023), 66(5), 3540-3565. | 10.1021/acs.jmedchem.2c02092"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-35966982", "1.1|Solvents: Tetrahydrofuran; 23 h, 21 °C", "1.2|Reagents: 1,1′-Carbonyldiimidazole; 25 h, 21 °C", "1.3|Solvents: Ethanol; 25 h, 21 °C", "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "By: Ashton, Trent D.; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "10.1021/acs.jmedchem.2c02092"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Ethanol|64-17-5+Tetrahydrofuran|109-99-9", "cond_sig": "c4810f9b", "fam_sig": "8ae379bb"}, "raw_data": {"raw_cas": "RCT: 446-32-2 + 74-89-5 | PRO: 917343-25-0 | RGT: 530-62-1 | SOL: 109-99-9 + 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"authors\": \"Ashton, Trent D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35966982\", \"1.1\", \"Solvents: Tetrahydrofuran; 23 h, 21 °C\", \"1.2\", \"Reagents: 1,1′-Carbonyldiimidazole; 25 h, 21 °C\", \"1.3\", \"Solvents: Ethanol; 25 h, 21 °C\", \"16. Scheme 16 (1 Reaction)\", \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"By: Ashton, Trent D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"10.1021/acs.jmedchem.2c02092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"446-32-2\", \"74-89-5\"], \"pro_cas\": [\"917343-25-0\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["446-32-2", "74-89-5"], "products": ["917343-25-0"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35966986", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": 25.0, "time_h": 40.0, "yield_pct": 82.0}, "smiles": {"reactants": "Nc1cc(F)ccc1C(=O)O.CN", "products": "CNC(=O)c1ccc(F)cc1N"}, "reference": {"title": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "authors": "Ashton, Trent D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "doi": "10.1021/acs.jmedchem.2c02092", "raw": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 | Ashton, Trent D.; et al | Journal of Medicinal Chemistry (2023), 66(5), 3540-3565. | 10.1021/acs.jmedchem.2c02092"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-35966986", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Tetrahydrofuran; 21 h, rt", "1.2|Solvents: Ethanol; 19 h, rt", "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "By: Xu, Zhongren; et al", "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "10.1021/acs.jmedchem.3c00063"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Ethanol|64-17-5+Tetrahydrofuran|109-99-9", "cond_sig": "c4810f9b", "fam_sig": "8ae379bb"}, "raw_data": {"raw_cas": "RCT: 86-87-3 + 2450-71-7 | PRO: 19762-30-2 | RGT: 530-62-1 | SOL: 109-99-9 + 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"authors\": \"Ashton, Trent D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35966986\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Tetrahydrofuran; 21 h, rt\", \"1.2\", \"Solvents: Ethanol; 19 h, rt\", \"17. Scheme 17 (1 Reaction)\", \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"By: Xu, Zhongren; et al\", \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"10.1021/acs.jmedchem.3c00063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"86-87-3\", \"2450-71-7\"], \"pro_cas\": [\"19762-30-2\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["86-87-3", "2450-71-7"], "products": ["19762-30-2"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35966990", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 95.0}, "smiles": {"reactants": "Nc1cccc(F)c1C(=O)O.CN.Cl", "products": "CNC(=O)c1c(N)cccc1F"}, "reference": {"title": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "authors": "Ashton, Trent D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "doi": "10.1021/acs.jmedchem.2c02092", "raw": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 | Ashton, Trent D.; et al | Journal of Medicinal Chemistry (2023), 66(5), 3540-3565. | 10.1021/acs.jmedchem.2c02092"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-35966990", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "By: Ashton, Trent D.; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "10.1021/acs.jmedchem.2c02092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 446-08-2 + 593-51-1 | PRO: 773846-62-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"authors\": \"Ashton, Trent D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35966990\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"22. Scheme 22 (1 Reaction)\", \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"By: Ashton, Trent D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"10.1021/acs.jmedchem.2c02092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"446-08-2\", \"593-51-1\"], \"pro_cas\": [\"773846-62-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["446-08-2", "593-51-1"], "products": ["773846-62-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35966994", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 97.0}, "smiles": {"reactants": "CN.Cl.Nc1c(F)cccc1C(=O)O", "products": "CNC(=O)c1cccc(F)c1N"}, "reference": {"title": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "authors": "Ashton, Trent D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "doi": "10.1021/acs.jmedchem.2c02092", "raw": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 | Ashton, Trent D.; et al | Journal of Medicinal Chemistry (2023), 66(5), 3540-3565. | 10.1021/acs.jmedchem.2c02092"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-35966994", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "By: Li, Bing-yan; et al", "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "10.1021/acs.jmedchem.3c02407"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 6232-88-8 + 109-85-3 | PRO: 1225949-34-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"authors\": \"Ashton, Trent D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35966994\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"19. Scheme 19 (1 Reaction)\", \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"By: Li, Bing-yan; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"10.1021/acs.jmedchem.3c02407\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6232-88-8\", \"109-85-3\"], \"pro_cas\": [\"1225949-34-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["6232-88-8", "109-85-3"], "products": ["1225949-34-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35966995", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 88.0}, "smiles": {"reactants": "Nc1ccc(F)cc1C(=O)O.CN.Cl", "products": "CNC(=O)c1cc(F)ccc1N"}, "reference": {"title": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "authors": "Ashton, Trent D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "doi": "10.1021/acs.jmedchem.2c02092", "raw": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 | Ashton, Trent D.; et al | Journal of Medicinal Chemistry (2023), 66(5), 3540-3565. | 10.1021/acs.jmedchem.2c02092"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-35966995", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B", "By: Lv, Gang; et al", "Bioorganic & Medicinal Chemistry (2023), 80, 117173.", "10.1016/j.bmc.2023.117173"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 157893-14-6 | PRO: 2211082-88-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"authors\": \"Ashton, Trent D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35966995\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"23. Scheme 23 (1 Reaction)\", \"Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B\", \"By: Lv, Gang; et al\", \"Bioorganic & Medicinal Chemistry (2023), 80, 117173.\", \"10.1016/j.bmc.2023.117173\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"157893-14-6\"], \"pro_cas\": [\"2211082-88-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "157893-14-6"], "products": ["2211082-88-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-35967000", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 96.0}, "smiles": {"reactants": "CN.Cl.Nc1ccc(Cl)cc1C(=O)O", "products": "CNC(=O)c1cc(Cl)ccc1N"}, "reference": {"title": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "authors": "Ashton, Trent D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "doi": "10.1021/acs.jmedchem.2c02092", "raw": "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 | Ashton, Trent D.; et al | Journal of Medicinal Chemistry (2023), 66(5), 3540-3565. | 10.1021/acs.jmedchem.2c02092"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-35967000", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "By: Ashton, Trent D.; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "10.1021/acs.jmedchem.2c02092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 434-76-4 + 593-51-1 | PRO: 869936-86-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"authors\": \"Ashton, Trent D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-35967000\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"21. Scheme 21 (1 Reaction)\", \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"By: Ashton, Trent D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"10.1021/acs.jmedchem.2c02092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"434-76-4\", \"593-51-1\"], \"pro_cas\": [\"869936-86-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["434-76-4", "593-51-1"], "products": ["869936-86-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36054210", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -10.0, "time_h": 13.167, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.CC(C)C[C@H](N)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C.O=C(O)C(F)(F)F", "products": "CC(C)C[C@H](NC(=O)CNC(=O)OC(C)(C)C)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C"}, "reference": {"title": "Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma", "authors": "Wang, Xueyuan; et al", "citation": "European Journal of Medicinal Chemistry (2023), 250, 115187.", "doi": "10.1016/j.ejmech.2023.115187", "raw": "Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma | Wang, Xueyuan; et al | European Journal of Medicinal Chemistry (2023), 250, 115187. | 10.1016/j.ejmech.2023.115187"}, "original_text": ["Steps: 1, Yield: 89-99%", "CAS Reaction Number: 31-614-CAS-36054210", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -10 °C", "1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, -10 °C; 12 h, rt", "High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists", "By: Bolteau, Raphael; et al", "European Journal of Medicinal Chemistry (2022), 241, 114620.", "10.1016/j.ejmech.2022.114620"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 57-13-6 + 118-92-3 | PRO: 86-96-4 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma\", \"authors\": \"Wang, Xueyuan; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 250, 115187.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36054210\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -10 °C\", \"1.2\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, -10 °C; 12 h, rt\", \"341. Scheme 341 (2 Reactions)\", \"High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists\", \"By: Bolteau, Raphael; et al\", \"European Journal of Medicinal Chemistry (2022), 241, 114620.\", \"10.1016/j.ejmech.2022.114620\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57-13-6\", \"118-92-3\"], \"pro_cas\": [\"86-96-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["57-13-6", "118-92-3"], "products": ["86-96-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36054230", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -10.0, "time_h": 13.167, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1cc(Cl)ccc1Cl.CC(C)C[C@H](NC(=O)CN)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C", "products": "CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1O[C@@H]2[C@@H]3C[C@H](C[C@]2(C)O1)C3(C)C"}, "reference": {"title": "Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma", "authors": "Wang, Xueyuan; et al", "citation": "European Journal of Medicinal Chemistry (2023), 250, 115187.", "doi": "10.1016/j.ejmech.2023.115187", "raw": "Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma | Wang, Xueyuan; et al | European Journal of Medicinal Chemistry (2023), 250, 115187. | 10.1016/j.ejmech.2023.115187"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-36054230", "1.1|Reagents: 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 10 min, -10 °C", "1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, -10 °C; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of florylpicoxamid, a mimic of a macrocyclic natural product", "By: Meyer, Kevin G.; et al", "Bioorganic & Medicinal Chemistry (2021), 50, 116455.", "10.1016/j.bmc.2021.116455"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 1962942-94-4 + 210300-09-7 | PRO: 1962946-97-9 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma\", \"authors\": \"Wang, Xueyuan; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 250, 115187.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36054230\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 10 min, -10 °C\", \"1.2\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, -10 °C; 12 h, rt\", \"81. Scheme 81 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of florylpicoxamid, a mimic of a macrocyclic natural product\", \"By: Meyer, Kevin G.; et al\", \"Bioorganic & Medicinal Chemistry (2021), 50, 116455.\", \"10.1016/j.bmc.2021.116455\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1962942-94-4\", \"210300-09-7\"], \"pro_cas\": [\"1962946-97-9\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1962942-94-4", "210300-09-7"], "products": ["1962946-97-9"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36116266", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 97.0}, "smiles": {"reactants": "O=C(N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CCCCCCCCCCCCN", "products": "CCCCCCCCCCCCNC(=O)[C@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma", "authors": "Gonzalez-Cuesta, Manuel; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(7), 4768-4783.", "doi": "10.1021/acs.jmedchem.2c01948", "raw": "Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma | Gonzalez-Cuesta, Manuel; et al | Journal of Medicinal Chemistry (2023), 66(7), 4768-4783. | 10.1021/acs.jmedchem.2c01948"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-36116266", "1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Tetrahydrofuran; rt", "1.2|18 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor", "By: Zhang, Yong; et al", "Journal of Medicinal Chemistry (2021), 64(21), 15787-15798.", "10.1021/acs.jmedchem.0c02043"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Tetrahydrofuran|109-99-9", "cond_sig": "a249eb2e", "fam_sig": "c2e3642e"}, "raw_data": {"raw_cas": "RCT: 623-04-1 + 146982-27-6 | PRO: 573698-75-6 | RGT: 538-75-0 + 2592-95-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma\", \"authors\": \"Gonzalez-Cuesta, Manuel; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(7), 4768-4783.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36116266\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Tetrahydrofuran; rt\", \"1.2\", \"18 h, rt\", \"91. Scheme 91 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor\", \"By: Zhang, Yong; et al\", \"Journal of Medicinal Chemistry (2021), 64(21), 15787-15798.\", \"10.1021/acs.jmedchem.0c02043\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"623-04-1\", \"146982-27-6\"], \"pro_cas\": [\"573698-75-6\"], \"rgt_cas\": [\"538-75-0\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["623-04-1", "146982-27-6"], "products": ["573698-75-6"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36136857", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 6.0, "yield_pct": 91.0}, "smiles": {"reactants": "C[C@H](C(=O)O)c1ccccc1.Cl.[N-]=[N+]=NC[C@H](N)c1ccc(OCC2CCC2)cc1", "products": "C[C@H](C(=O)N[C@@H](CN=[N+]=[N-])c1ccc(OCC2CCC2)cc1)c1ccccc1"}, "reference": {"title": "Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies", "authors": "Rahman, Toufiqur Md; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.", "doi": "10.1021/acs.jmedchem.1c01075", "raw": "Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies | Rahman, Toufiqur Md; et al | Journal of Medicinal Chemistry (2021), 64(16), 12397-12413. | 10.1021/acs.jmedchem.1c01075"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-36136857", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Acetonitrile; 0 °C; 5 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis", "By: Zimmermann, Thomas; et al", "Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.", "10.1021/acs.jmedchem.4c00230"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+NaHCO3|144-55-8+Sodium bicarbonate|+Triethylamine|121-44-8/Acetonitrile|75-05-8+Water|7732-18-5", "cond_sig": "fbd97734", "fam_sig": "d77da5e7"}, "raw_data": {"raw_cas": "RCT: 33233-67-9 + 37806-29-4 | PRO: 3052553-63-3 | RGT: 121-44-8 + 94790-37-1 + 144-55-8 | SOL: 75-05-8 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies\", \"authors\": \"Rahman, Toufiqur Md; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.\", \"reagents\": [\"Triethylamine\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36136857\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Acetonitrile; 0 °C; 5 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"266. Scheme 266 (1 Reaction)\", \"Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis\", \"By: Zimmermann, Thomas; et al\", \"Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.\", \"10.1021/acs.jmedchem.4c00230\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"33233-67-9\", \"37806-29-4\"], \"pro_cas\": [\"3052553-63-3\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["33233-67-9", "37806-29-4"], "products": ["3052553-63-3"], "reagents": ["Triethylamine", "HBTU", "NaHCO3"], "catalysts": [], "solvents": ["Acetonitrile", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36136965", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 6.0, "yield_pct": 100.0}, "smiles": {"reactants": "C[C@H](C(=O)O)c1ccccc1.CC[C@H](C)COc1ccc([C@@H](N)CN=[N+]=[N-])cc1.Cl", "products": "CC[C@H](C)COc1ccc([C@H](CN=[N+]=[N-])NC(=O)[C@@H](C)c2ccccc2)cc1"}, "reference": {"title": "Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies", "authors": "Rahman, Toufiqur Md; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.", "doi": "10.1021/acs.jmedchem.1c01075", "raw": "Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies | Rahman, Toufiqur Md; et al | Journal of Medicinal Chemistry (2021), 64(16), 12397-12413. | 10.1021/acs.jmedchem.1c01075"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36136965", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Acetonitrile; 0 °C; 5 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target", "By: Wilson, Caroline; et al", "Journal of Medicinal Chemistry (2022), 65(1), 409-423.", "10.1021/acs.jmedchem.1c01586"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+NaHCO3|144-55-8+Sodium bicarbonate|+Triethylamine|121-44-8/Acetonitrile|75-05-8+Water|7732-18-5", "cond_sig": "fbd97734", "fam_sig": "d77da5e7"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 23455-49-4 | PRO: 3036029-28-1 | RGT: 121-44-8 + 94790-37-1 + 144-55-8 | SOL: 75-05-8 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies\", \"authors\": \"Rahman, Toufiqur Md; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.\", \"reagents\": [\"Triethylamine\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36136965\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Acetonitrile; 0 °C; 5 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"227. Scheme 227 (1 Reaction)\", \"Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target\", \"By: Wilson, Caroline; et al\", \"Journal of Medicinal Chemistry (2022), 65(1), 409-423.\", \"10.1021/acs.jmedchem.1c01586\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"23455-49-4\"], \"pro_cas\": [\"3036029-28-1\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "23455-49-4"], "products": ["3036029-28-1"], "reagents": ["Triethylamine", "HBTU", "NaHCO3"], "catalysts": [], "solvents": ["Acetonitrile", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36137304", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 20.0, "time_h": 0.5, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](CCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CCCCOCc1ccccc1.Cl", "products": "COC(=O)[C@H](CCCCOCc1ccccc1)NC(=O)[C@H](CCc1ccccc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors", "authors": "Zhang, Hao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.", "doi": "10.1021/acs.jmedchem.2c00611", "raw": "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors | Zhang, Hao; et al | Journal of Medicinal Chemistry (2022), 65(13), 9350-9375. | 10.1021/acs.jmedchem.2c00611"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-36137304", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 10 min, 0 °C", "1.2|Solvents: Dimethylformamide; 0 °C; 20 min, 20 °C", "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "By: Shan, Bin; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "10.1021/acs.jmedchem.2c01714"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 5096-73-1 + 207346-42-7 | PRO: 2913151-80-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors\", \"authors\": \"Zhang, Hao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36137304\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 10 min, 0 °C\", \"1.2\", \"Solvents: Dimethylformamide; 0 °C; 20 min, 20 °C\", \"453. Scheme 453 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"By: Shan, Bin; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"10.1021/acs.jmedchem.2c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5096-73-1\", \"207346-42-7\"], \"pro_cas\": [\"2913151-80-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5096-73-1", "207346-42-7"], "products": ["2913151-80-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36137356", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 20.0, "time_h": 1.5, "yield_pct": 87.0}, "smiles": {"reactants": "Cl.N[C@@H](Cc1cccc(OCc2ccccc2)c1)C(=O)OCc1ccccc1.O=C(O)CCCBr", "products": "O=C(CCCBr)N[C@@H](Cc1cccc(OCc2ccccc2)c1)C(=O)OCc1ccccc1"}, "reference": {"title": "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors", "authors": "Zhang, Hao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.", "doi": "10.1021/acs.jmedchem.2c00611", "raw": "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors | Zhang, Hao; et al | Journal of Medicinal Chemistry (2022), 65(13), 9350-9375. | 10.1021/acs.jmedchem.2c00611"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-36137356", "1.1|Reagents: Thionyl chloride", "Solvents: Dimethylformamide, Dichloromethane; 1 h, 0 °C", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dichloromethane; 30 min, 20 °C", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models", "By: Winter-Holt, Jon J.; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.", "10.1021/acs.jmedchem.1c01871"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "53fb3422", "fam_sig": "8f5fb3cc"}, "raw_data": {"raw_cas": "RCT: 22483-09-6 + 35661-40-6 | PRO: 2387654-03-5 | RGT: 7719-09-7 + 7087-68-5 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors\", \"authors\": \"Zhang, Hao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.\", \"reagents\": [\"Thionyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36137356\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Dimethylformamide, Dichloromethane; 1 h, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dichloromethane; 30 min, 20 °C\", \"421. Scheme 421 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models\", \"By: Winter-Holt, Jon J.; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.\", \"10.1021/acs.jmedchem.1c01871\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"22483-09-6\", \"35661-40-6\"], \"pro_cas\": [\"2387654-03-5\"], \"rgt_cas\": [\"7719-09-7\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["22483-09-6", "35661-40-6"], "products": ["2387654-03-5"], "reagents": ["7719-09-7", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36137379", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 91.0}, "smiles": {"reactants": "NC1CCCC1.O=C(N[C@@H](CCCCO)C(=O)O)OCc1ccccc1", "products": "O=C(N[C@@H](CCCCO)C(=O)NC1CCCC1)OCc1ccccc1"}, "reference": {"title": "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors", "authors": "Zhang, Hao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.", "doi": "10.1021/acs.jmedchem.2c00611", "raw": "Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors | Zhang, Hao; et al | Journal of Medicinal Chemistry (2022), 65(13), 9350-9375. | 10.1021/acs.jmedchem.2c00611"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-36137379", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Dimethylformamide; 0 °C; 1 h, 0 °C", "1.2|Solvents: Water", "Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans", "By: Binjubair, Faizah A.; et al", "ChemMedChem (2020), 15(14), 1294-1309.", "10.1002/cmdc.202000250"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "b4cdd190", "fam_sig": "e8da6822"}, "raw_data": {"raw_cas": "RCT: 552-63-6 + 2503233-54-1 | PRO: 2503233-56-3 | RGT: 7087-68-5 + 68957-94-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors\", \"authors\": \"Zhang, Hao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(13), 9350-9375.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36137379\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Dimethylformamide; 0 °C; 1 h, 0 °C\", \"1.2\", \"Solvents: Water\", \"242. Scheme 242 (1 Reaction)\", \"Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans\", \"By: Binjubair, Faizah A.; et al\", \"ChemMedChem (2020), 15(14), 1294-1309.\", \"10.1002/cmdc.202000250\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"552-63-6\", \"2503233-54-1\"], \"pro_cas\": [\"2503233-56-3\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": [\"alternate reaction conditions also shown\"]}}", "enriched_names": {"reactants": ["552-63-6", "2503233-54-1"], "products": ["2503233-56-3"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36146371", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 98.0, "time_h": 28.167, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1c(F)cccc1Br.CC(C)(C)OC(=O)N1CCC(c2ccc3nc(N)n(C4CCCC4)c3c2)CC1", "products": "CC(C)(C)OC(=O)N1CCC(c2ccc3nc(NC(=O)c4c(F)cccc4Br)n(C4CCCC4)c3c2)CC1"}, "reference": {"title": "Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate", "authors": "Wu, Jiang-Ping; et al", "citation": "Organic Process Research & Development (2023), 27(4), 788-797.", "doi": "10.1021/acs.oprd.3c00050", "raw": "Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate | Wu, Jiang-Ping; et al | Organic Process Research & Development (2023), 27(4), 788-797. | 10.1021/acs.oprd.3c00050"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-36146371", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: 1,4-Dioxane; 1.5 h, 98 °C", "1.2|Reagents: 1-Hydroxybenzotriazole", "Solvents: 1,4-Dioxane; 24 h, 98 °C; 98 °C → 65 °C", "1.3|Solvents: Water; 40 min, 20 °C; 2 h", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1", "By: Ryu, SeongShick; et al", "Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.", "10.1021/acs.jmedchem.1c01359"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+1-Hydroxybenzotriazole|2592-95-2+N,N'-Carbonyldiimidazole|530-62-1/1,4-Dioxane|123-91-1+Water|7732-18-5", "cond_sig": "0436ce45", "fam_sig": "9cd08726"}, "raw_data": {"raw_cas": "RCT: 1863128-21-5 + 71989-18-9 | PRO: 1863128-23-7 | RGT: 530-62-1 + 2592-95-2 | SOL: 123-91-1 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate\", \"authors\": \"Wu, Jiang-Ping; et al\", \"citation\": \"Organic Process Research & Development (2023), 27(4), 788-797.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36146371\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: 1,4-Dioxane; 1.5 h, 98 °C\", \"1.2\", \"Reagents: 1-Hydroxybenzotriazole\", \"Solvents: 1,4-Dioxane; 24 h, 98 °C; 98 °C → 65 °C\", \"1.3\", \"Solvents: Water; 40 min, 20 °C; 2 h\", \"368. Scheme 368 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Novel macrocyclic peptidomimetics targeting the Polo-box domain of Polo-like kinase 1\", \"By: Ryu, SeongShick; et al\", \"Journal of Medicinal Chemistry (2022), 65(3), 1915-1932.\", \"10.1021/acs.jmedchem.1c01359\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1863128-21-5\", \"71989-18-9\"], \"pro_cas\": [\"1863128-23-7\"], \"rgt_cas\": [\"530-62-1\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1863128-21-5", "71989-18-9"], "products": ["1863128-23-7"], "reagents": ["N,N'-Carbonyldiimidazole", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["1,4-Dioxane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36209034", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 30.0, "time_h": 24.333, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1ccc(F)cc1.Nc1cccc(C(F)(F)F)c1", "products": "O=C(Nc1cccc(C(F)(F)F)c1)c1ccc(F)cc1"}, "reference": {"title": "Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni", "authors": "Kanyanta, Masebe; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.", "doi": "10.1016/j.bmcl.2023.129164", "raw": "Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni | Kanyanta, Masebe; et al | Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164. | 10.1016/j.bmcl.2023.129164"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-36209034", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 5 min, 0 °C; 0 °C → 30 °C; 15 min, 25 - 30 °C", "1.2|19 - 24 h, 25 - 30 °C", "Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors", "By: Yan, Yu-Hang; et al", "European Journal of Medicinal Chemistry (2023), 257, 115473.", "10.1016/j.ejmech.2023.115473"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 54060-30-9 | PRO: 913845-55-3 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni\", \"authors\": \"Kanyanta, Masebe; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36209034\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 5 min, 0 °C; 0 °C → 30 °C; 15 min, 25 - 30 °C\", \"1.2\", \"19 - 24 h, 25 - 30 °C\", \"67. Scheme 67 (1 Reaction)\", \"Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors\", \"By: Yan, Yu-Hang; et al\", \"European Journal of Medicinal Chemistry (2023), 257, 115473.\", \"10.1016/j.ejmech.2023.115473\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"54060-30-9\"], \"pro_cas\": [\"913845-55-3\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "54060-30-9"], "products": ["913845-55-3"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36209050", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 30.0, "time_h": 24.333, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)c1ccccc1.COc1ccc(N)cc1OC", "products": "COc1ccc(NC(=O)c2ccccc2)cc1OC"}, "reference": {"title": "Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni", "authors": "Kanyanta, Masebe; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.", "doi": "10.1016/j.bmcl.2023.129164", "raw": "Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni | Kanyanta, Masebe; et al | Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164. | 10.1016/j.bmcl.2023.129164"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36209050", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 5 min, 0 °C; 0 °C → 30 °C; 15 min, 25 - 30 °C", "1.2|19 - 24 h, 25 - 30 °C", "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor", "By: Huestis, Malcolm P.; et al", "ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.", "10.1021/acsmedchemlett.1c00063"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 515135-65-6 + 1266694-57-8 | PRO: 2729996-46-5 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni\", \"authors\": \"Kanyanta, Masebe; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36209050\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 5 min, 0 °C; 0 °C → 30 °C; 15 min, 25 - 30 °C\", \"1.2\", \"19 - 24 h, 25 - 30 °C\", \"106. Scheme 106 (1 Reaction)\", \"Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor\", \"By: Huestis, Malcolm P.; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(5), 791-797.\", \"10.1021/acsmedchemlett.1c00063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"515135-65-6\", \"1266694-57-8\"], \"pro_cas\": [\"2729996-46-5\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["515135-65-6", "1266694-57-8"], "products": ["2729996-46-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36226435", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 16.25, "yield_pct": 95.0}, "smiles": {"reactants": "C=CCN.O=C(O)CCCNC(=O)OCc1ccccc1", "products": "C=CCNC(=O)CCCNC(=O)OCc1ccccc1"}, "reference": {"title": "Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors", "authors": "Balestri, Lorenzo Jacopo Ilic; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(4), 417-424.", "doi": "10.1021/acsmedchemlett.2c00472", "raw": "Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors | Balestri, Lorenzo Jacopo Ilic; et al | ACS Medicinal Chemistry Letters (2023), 14(4), 417-424. | 10.1021/acsmedchemlett.2c00472"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-36226435", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, 0 °C; 16 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water", "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells", "By: Liang, Tao; et al", "Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.", "10.1021/acs.jmedchem.0c01454"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+Sodium bicarbonate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "1ba66fed", "fam_sig": "655a495c"}, "raw_data": {"raw_cas": "RCT: 586-89-0 + 29840-56-0 | PRO: 1385785-74-9 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 + 144-55-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors\", \"authors\": \"Balestri, Lorenzo Jacopo Ilic; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(4), 417-424.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36226435\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, 0 °C; 16 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water\", \"49. Scheme 49 (1 Reaction)\", \"HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells\", \"By: Liang, Tao; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.\", \"10.1021/acs.jmedchem.0c01454\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"586-89-0\", \"29840-56-0\"], \"pro_cas\": [\"1385785-74-9\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": [\"literature preparation\"]}}", "enriched_names": {"reactants": ["586-89-0", "29840-56-0"], "products": ["1385785-74-9"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "NaHCO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36300086", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "NCc1ccco1.[N-]=[N+]=NCCCCCCCC(=O)O", "products": "[N-]=[N+]=NCCCCCCCC(=O)NCc1ccco1"}, "reference": {"title": "Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer", "authors": "Fratta, Simone; et al", "citation": "European Journal of Medicinal Chemistry (2023), 250, 115170.", "doi": "10.1016/j.ejmech.2023.115170", "raw": "Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer | Fratta, Simone; et al | European Journal of Medicinal Chemistry (2023), 250, 115170. | 10.1016/j.ejmech.2023.115170"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-36300086", "1.1|Reagents: PyBOP", "Solvents: Dimethylformamide; rt → 0 °C", "1.2|Reagents: Diisopropylethylamine; 0 °C; 16 h, rt", "Development of Commercial Manufacturing Processes for Acalabrutinib", "By: Bethel, Paul A.; et al", "Organic Process Research & Development (2022), 26(12), 3303-3311.", "10.1021/acs.oprd.2c00304"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "1e417a35", "fam_sig": "e5aac3df"}, "raw_data": {"raw_cas": "RCT: 14047-29-1 + 504-29-0 | PRO: 850568-25-1 | RGT: 128625-52-5 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer\", \"authors\": \"Fratta, Simone; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 250, 115170.\", \"reagents\": [\"PyBOP\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36300086\", \"1.1\", \"Reagents: PyBOP\", \"Solvents: Dimethylformamide; rt → 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 0 °C; 16 h, rt\", \"79. Scheme 79 (1 Reaction)\", \"Development of Commercial Manufacturing Processes for Acalabrutinib\", \"By: Bethel, Paul A.; et al\", \"Organic Process Research & Development (2022), 26(12), 3303-3311.\", \"10.1021/acs.oprd.2c00304\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"14047-29-1\", \"504-29-0\"], \"pro_cas\": [\"850568-25-1\"], \"rgt_cas\": [\"128625-52-5\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["14047-29-1", "504-29-0"], "products": ["850568-25-1"], "reagents": ["Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36342034", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 85.0}, "smiles": {"reactants": "Cc1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)O)C(C)C)on1.Cl.NCc1ccc(-c2scnc2Cl)cc1", "products": "Cc1cc([C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3Cl)cc2)C(C)C)on1"}, "reference": {"title": "Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design", "authors": "Krieger, Johannes; et al", "citation": "ChemMedChem (2023), 18(8), e202200615.", "doi": "10.1002/cmdc.202200615", "raw": "Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design | Krieger, Johannes; et al | ChemMedChem (2023), 18(8), e202200615. | 10.1002/cmdc.202200615"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36342034", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "By: Stachura, Damian L.; et al", "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "10.1021/acsmedchemlett.2c00505"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 75178-96-0 + 3064695-54-8 | PRO: 3064695-55-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design\", \"authors\": \"Krieger, Johannes; et al\", \"citation\": \"ChemMedChem (2023), 18(8), e202200615.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36342034\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, rt\", \"325. Scheme 325 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"By: Stachura, Damian L.; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"10.1021/acsmedchemlett.2c00505\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75178-96-0\", \"3064695-54-8\"], \"pro_cas\": [\"3064695-55-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75178-96-0", "3064695-54-8"], "products": ["3064695-55-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36342043", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Lithium hydroxide", "cas": "1310-65-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 92.0}, "smiles": {"reactants": "Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)O)c1nnc(C)n1-2.COC(=O)[C@@H](c1cc(OCCCCCN)no1)C(C)C.Cl", "products": "Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCCOc1cc(C(C(=O)O)C(C)C)on1)c1nnc(C)n1-2"}, "reference": {"title": "Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design", "authors": "Krieger, Johannes; et al", "citation": "ChemMedChem (2023), 18(8), e202200615.", "doi": "10.1002/cmdc.202200615", "raw": "Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design | Krieger, Johannes; et al | ChemMedChem (2023), 18(8), e202200615. | 10.1002/cmdc.202200615"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-36342043", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "1.2|Reagents: Lithium hydroxide", "Solvents: Water; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo", "By: Peschiulli, Aldo; et al", "ACS Medicinal Chemistry Letters (2022), 13(1), 76-83.", "10.1021/acsmedchemlett.1c00445"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Lithium hydroxide|1310-65-2+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "812e1ef6", "fam_sig": "79e4a1c2"}, "raw_data": {"raw_cas": "RCT: 53234-55-2 + 1383742-80-0 | PRO: 1383742-91-3 | RGT: 7087-68-5 + 148893-10-1 + 1310-65-2 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design\", \"authors\": \"Krieger, Johannes; et al\", \"citation\": \"ChemMedChem (2023), 18(8), e202200615.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Lithium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36342043\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"1.2\", \"Reagents: Lithium hydroxide\", \"Solvents: Water; 2 h, rt\", \"447. Scheme 447 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo\", \"By: Peschiulli, Aldo; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(1), 76-83.\", \"10.1021/acsmedchemlett.1c00445\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"53234-55-2\", \"1383742-80-0\"], \"pro_cas\": [\"1383742-91-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"1310-65-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["53234-55-2", "1383742-80-0"], "products": ["1383742-91-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "1310-65-2"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36491257", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(O)cc1.CC(C)(C)OC(=O)N1CC[C@H](CC(=O)O)C1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C[C@H]1CCN(C(=O)OC(C)(C)C)C1)S(=O)(=O)c1ccc(O)cc1"}, "reference": {"title": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "authors": "Zhou, Huiyu; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115389.", "doi": "10.1016/j.ejmech.2023.115389", "raw": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant | Zhou, Huiyu; et al | European Journal of Medicinal Chemistry (2023), 255, 115389. | 10.1016/j.ejmech.2023.115389"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-36491257", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "By: Zhou, Huiyu; et al", "European Journal of Medicinal Chemistry (2023), 255, 115389.", "10.1016/j.ejmech.2023.115389"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 72925-16-7 + 169280-56-2 | PRO: 2925287-38-1 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"authors\": \"Zhou, Huiyu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36491257\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C\", \"176. Scheme 176 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"By: Zhou, Huiyu; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"10.1016/j.ejmech.2023.115389\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"72925-16-7\", \"169280-56-2\"], \"pro_cas\": [\"2925287-38-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["72925-16-7", "169280-56-2"], "products": ["2925287-38-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36491262", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 9.0, "yield_pct": 83.0}, "smiles": {"reactants": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1.CC(C)(C)OC(=O)N1CC[C@@H](CC(=O)O)C1", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)C[C@@H]2CCN(C(=O)OC(C)(C)C)C2)cc1"}, "reference": {"title": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "authors": "Zhou, Huiyu; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115389.", "doi": "10.1016/j.ejmech.2023.115389", "raw": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant | Zhou, Huiyu; et al | European Journal of Medicinal Chemistry (2023), 255, 115389. | 10.1016/j.ejmech.2023.115389"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-36491262", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C", "Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR", "By: Li, Yongtao; et al", "Journal of Medicinal Chemistry (2022), 65(24), 16829-16859.", "10.1021/acs.jmedchem.2c01640"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 342045-14-1 + 1267548-16-2 | PRO: 2883814-35-3 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"authors\": \"Zhou, Huiyu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36491262\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C\", \"196. Scheme 196 (1 Reaction)\", \"Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR\", \"By: Li, Yongtao; et al\", \"Journal of Medicinal Chemistry (2022), 65(24), 16829-16859.\", \"10.1021/acs.jmedchem.2c01640\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"342045-14-1\", \"1267548-16-2\"], \"pro_cas\": [\"2883814-35-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["342045-14-1", "1267548-16-2"], "products": ["2883814-35-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36491264", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 92.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CC[C@@H](C(=O)O)C1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCN(C(=O)OC(C)(C)C)C1)S(=O)(=O)c1ccc(N)cc1"}, "reference": {"title": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "authors": "Zhou, Huiyu; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115389.", "doi": "10.1016/j.ejmech.2023.115389", "raw": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant | Zhou, Huiyu; et al | European Journal of Medicinal Chemistry (2023), 255, 115389. | 10.1016/j.ejmech.2023.115389"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-36491264", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 530-57-4 + 2415386-52-4 | PRO: 2892016-27-0 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"authors\": \"Zhou, Huiyu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36491264\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C\", \"177. Scheme 177 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"530-57-4\", \"2415386-52-4\"], \"pro_cas\": [\"2892016-27-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["530-57-4", "2415386-52-4"], "products": ["2892016-27-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36491266", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CC[C@@H](C(=O)O)C1.COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@@H](N)Cc2ccccc2)cc1", "products": "COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCN(C(=O)OC(C)(C)C)C2)cc1"}, "reference": {"title": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "authors": "Zhou, Huiyu; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115389.", "doi": "10.1016/j.ejmech.2023.115389", "raw": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant | Zhou, Huiyu; et al | European Journal of Medicinal Chemistry (2023), 255, 115389. | 10.1016/j.ejmech.2023.115389"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-36491266", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C", "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "By: Zhang, Yi; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "10.1021/acs.jmedchem.3c00504"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 2691175-30-9 + 1438382-15-0 | PRO: 2691175-34-3 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"authors\": \"Zhou, Huiyu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36491266\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C\", \"193. Scheme 193 (1 Reaction)\", \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"By: Zhang, Yi; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"10.1021/acs.jmedchem.3c00504\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2691175-30-9\", \"1438382-15-0\"], \"pro_cas\": [\"2691175-34-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2691175-30-9", "1438382-15-0"], "products": ["2691175-34-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36491274", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CC[C@@H](C(=O)O)C1.CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1", "products": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCN(C(=O)OC(C)(C)C)C1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "authors": "Zhou, Huiyu; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115389.", "doi": "10.1016/j.ejmech.2023.115389", "raw": "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant | Zhou, Huiyu; et al | European Journal of Medicinal Chemistry (2023), 255, 115389. | 10.1016/j.ejmech.2023.115389"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-36491274", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C", "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors", "By: Xu, Shujing; et al", "Bioorganic & Medicinal Chemistry (2022), 53, 116531.", "10.1016/j.bmc.2021.116531"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 57260-73-8 + 473257-46-4 | PRO: 2649272-96-6 | RGT: 2592-95-2 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"authors\": \"Zhou, Huiyu; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36491274\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 0 °C; 8 h, 25 °C\", \"219. Scheme 219 (1 Reaction)\", \"Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors\", \"By: Xu, Shujing; et al\", \"Bioorganic & Medicinal Chemistry (2022), 53, 116531.\", \"10.1016/j.bmc.2021.116531\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57260-73-8\", \"473257-46-4\"], \"pro_cas\": [\"2649272-96-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["57260-73-8", "473257-46-4"], "products": ["2649272-96-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36512451", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Isobutyl chloroformate", "cas": "543-27-1", "role": "UNK"}, {"name": "Potassium bisulfate", "cas": "7646-93-7", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 94.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O.Cl.NCc1ccc(CNC(=O)OCc2ccccc2)cc1", "products": "CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccc(CNC(=O)OCc2ccccc2)cc1"}, "reference": {"title": "Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors", "authors": "Wiedemeyer, Simon J. A.; et al", "citation": "ChemMedChem (2023), 18(6), e202200632.", "doi": "10.1002/cmdc.202200632", "raw": "Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors | Wiedemeyer, Simon J. A.; et al | ChemMedChem (2023), 18(6), e202200632. | 10.1002/cmdc.202200632"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-36512451", "1.1|Reagents: 4-Methylmorpholine", "Solvents: Dimethylformamide, Tetrahydrofuran; rt → 0 °C", "1.2|Reagents: Isobutyl chloroformate; 90 min, 0 °C; 30 min, 0 °C; 2 h, rt", "1.3|Reagents: Potassium bisulfate", "Solvents: Ethyl acetate, Water; rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies", "By: Barlaam, Bernard; et al", "Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.", "10.1021/acs.jmedchem.0c01754"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+Isobutyl chloroformate|543-27-1+N-Methylmorpholine|109-02-4+Potassium bisulfate|7646-93-7/Dimethylformamide|68-12-2+Ethyl Acetate|141-78-6+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "fd57059c", "fam_sig": "fbab9c0a"}, "raw_data": {"raw_cas": "RCT: 222530-34-9 + 1187449-01-9 | PRO: 2057506-68-8 | RGT: 109-02-4 + 543-27-1 + 7646-93-7 | SOL: 68-12-2 + 109-99-9 + 141-78-6 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors\", \"authors\": \"Wiedemeyer, Simon J. A.; et al\", \"citation\": \"ChemMedChem (2023), 18(6), e202200632.\", \"reagents\": [\"4-Methylmorpholine\", \"Isobutyl chloroformate\", \"Potassium bisulfate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\", \"Ethyl acetate\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36512451\", \"1.1\", \"Reagents: 4-Methylmorpholine\", \"Solvents: Dimethylformamide, Tetrahydrofuran; rt → 0 °C\", \"1.2\", \"Reagents: Isobutyl chloroformate; 90 min, 0 °C; 30 min, 0 °C; 2 h, rt\", \"1.3\", \"Reagents: Potassium bisulfate\", \"Solvents: Ethyl acetate, Water; rt\", \"13. Scheme 13 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies\", \"By: Barlaam, Bernard; et al\", \"Journal of Medicinal Chemistry (2020), 63(24), 15564-15590.\", \"10.1021/acs.jmedchem.0c01754\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"222530-34-9\", \"1187449-01-9\"], \"pro_cas\": [\"2057506-68-8\"], \"rgt_cas\": [\"109-02-4\", \"543-27-1\", \"7646-93-7\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\", \"141-78-6\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["222530-34-9", "1187449-01-9"], "products": ["2057506-68-8"], "reagents": ["N-Methylmorpholine", "543-27-1", "7646-93-7"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran", "Ethyl Acetate", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36512482", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Isobutyl chloroformate", "cas": "543-27-1", "role": "UNK"}, {"name": "Potassium bisulfate", "cas": "7646-93-7", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.0, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)O.NCc1ccc(CNC(=O)C(F)(F)F)cc1", "products": "CC(C)(C)OC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccc(CNC(=O)C(F)(F)F)cc1"}, "reference": {"title": "Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors", "authors": "Wiedemeyer, Simon J. A.; et al", "citation": "ChemMedChem (2023), 18(6), e202200632.", "doi": "10.1002/cmdc.202200632", "raw": "Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors | Wiedemeyer, Simon J. A.; et al | ChemMedChem (2023), 18(6), e202200632. | 10.1002/cmdc.202200632"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-36512482", "1.1|Reagents: 4-Methylmorpholine", "Solvents: Dichloromethane, Tetrahydrofuran; rt → 0 °C", "1.2|Reagents: Isobutyl chloroformate", "Solvents: Dichloromethane; 90 min, 0 °C; 30 min, 0 °C; 0 °C → rt; overnight, rt", "1.3|Reagents: Potassium bisulfate", "Solvents: Ethyl acetate, Water; rt", "Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers", "By: Katayama, Katsushi; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127425.", "10.1016/j.bmcl.2020.127425"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+Isobutyl chloroformate|543-27-1+N-Methylmorpholine|109-02-4+Potassium bisulfate|7646-93-7/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "8a62704d", "fam_sig": "317f0d4e"}, "raw_data": {"raw_cas": "RCT: 14442-12-7 + 1211586-09-2 | PRO: 3054166-32-1 | RGT: 109-02-4 + 543-27-1 + 7646-93-7 | SOL: 75-09-2 + 109-99-9 + 141-78-6 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors\", \"authors\": \"Wiedemeyer, Simon J. A.; et al\", \"citation\": \"ChemMedChem (2023), 18(6), e202200632.\", \"reagents\": [\"4-Methylmorpholine\", \"Isobutyl chloroformate\", \"Potassium bisulfate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\", \"Ethyl acetate\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36512482\", \"1.1\", \"Reagents: 4-Methylmorpholine\", \"Solvents: Dichloromethane, Tetrahydrofuran; rt → 0 °C\", \"1.2\", \"Reagents: Isobutyl chloroformate\", \"Solvents: Dichloromethane; 90 min, 0 °C; 30 min, 0 °C; 0 °C → rt; overnight, rt\", \"1.3\", \"Reagents: Potassium bisulfate\", \"Solvents: Ethyl acetate, Water; rt\", \"460. Scheme 460 (1 Reaction)\", \"Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers\", \"By: Katayama, Katsushi; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127425.\", \"10.1016/j.bmcl.2020.127425\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"14442-12-7\", \"1211586-09-2\"], \"pro_cas\": [\"3054166-32-1\"], \"rgt_cas\": [\"109-02-4\", \"543-27-1\", \"7646-93-7\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"109-99-9\", \"141-78-6\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["14442-12-7", "1211586-09-2"], "products": ["3054166-32-1"], "reagents": ["N-Methylmorpholine", "543-27-1", "7646-93-7"], "catalysts": [], "solvents": ["Dichloromethane", "Tetrahydrofuran", "Ethyl Acetate", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36513480", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1cnc(Oc2ccccc2)nc1.CC(C)(C)OC(=O)C1CCN(c2ccc(N)cc2)CC1", "products": "CC(C)(C)OC(=O)C1CCN(c2ccc(NC(=O)c3cnc(Oc4ccccc4)nc3)cc2)CC1"}, "reference": {"title": "CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles", "authors": "Osawa, Hinata; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 84, 117259.", "doi": "10.1016/j.bmc.2023.117259", "raw": "CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles | Osawa, Hinata; et al | Bioorganic & Medicinal Chemistry (2023), 84, 117259. | 10.1016/j.bmc.2023.117259"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-36513480", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma", "By: Rango, Enrico; et al", "European Journal of Medicinal Chemistry (2021), 223, 113653.", "10.1016/j.ejmech.2021.113653"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 29840-57-1 + 183444-80-6 | PRO: 3033607-24-5 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles\", \"authors\": \"Osawa, Hinata; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 84, 117259.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36513480\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 5 h, rt\", \"88. Scheme 88 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma\", \"By: Rango, Enrico; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113653.\", \"10.1016/j.ejmech.2021.113653\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"29840-57-1\", \"183444-80-6\"], \"pro_cas\": [\"3033607-24-5\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["29840-57-1", "183444-80-6"], "products": ["3033607-24-5"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36550984", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 7.0, "yield_pct": 80.0}, "smiles": {"reactants": "C#CCN(C)CCCOc1ccc(N)cc1Cl.CC(C)c1cc(C(=O)O)c(OCc2ccccc2)cc1OCc1ccccc1", "products": "C#CCN(C)CCCOc1ccc(NC(=O)c2cc(C(C)C)c(OCc3ccccc3)cc2OCc2ccccc2)cc1Cl"}, "reference": {"title": "Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma", "authors": "Tseng, Hui-Ju; et al", "citation": "European Journal of Medicinal Chemistry (2023), 256, 115459.", "doi": "10.1016/j.ejmech.2023.115459", "raw": "Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma | Tseng, Hui-Ju; et al | European Journal of Medicinal Chemistry (2023), 256, 115459. | 10.1016/j.ejmech.2023.115459"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-36550984", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, rt; 30 min, rt", "1.2|6 h, rt", "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors", "By: Xu, Shujing; et al", "Bioorganic & Medicinal Chemistry (2022), 53, 116531.", "10.1016/j.bmc.2021.116531"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 75178-96-0 + 473257-46-4 | PRO: 2649272-98-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma\", \"authors\": \"Tseng, Hui-Ju; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 256, 115459.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36550984\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, rt; 30 min, rt\", \"1.2\", \"6 h, rt\", \"257. Scheme 257 (1 Reaction)\", \"Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors\", \"By: Xu, Shujing; et al\", \"Bioorganic & Medicinal Chemistry (2022), 53, 116531.\", \"10.1016/j.bmc.2021.116531\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75178-96-0\", \"473257-46-4\"], \"pro_cas\": [\"2649272-98-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75178-96-0", "473257-46-4"], "products": ["2649272-98-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36589101", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 72.0, "yield_pct": 100.0}, "smiles": {"reactants": "COc1ccc(-n2nccn2)c(C(=O)N2C(=O)CC[C@@]2(C)C(=O)O)c1.Nc1ccc(Cl)c(CO)c1N", "products": "COc1ccc(-n2nccn2)c(C(=O)N2C(=O)CC[C@@]2(C)C(=O)Nc2ccc(Cl)c(CO)c2N)c1"}, "reference": {"title": "CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol Metabolites", "authors": "Treiber, Alexander; et al", "citation": "ChemMedChem (2023), 18(10), e202300030.", "doi": "10.1002/cmdc.202300030", "raw": "CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol Metabolites | Treiber, Alexander; et al | ChemMedChem (2023), 18(10), e202300030. | 10.1002/cmdc.202300030"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36589101", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 d, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug", "By: Ross, Catherine L.; et al", "Journal of Medicinal Chemistry (2024), 67(11), 9599-9612.", "10.1021/acs.jmedchem.4c00724"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 93594-48-0 + 132873-57-5 | PRO: 3050771-83-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol Metabolites\", \"authors\": \"Treiber, Alexander; et al\", \"citation\": \"ChemMedChem (2023), 18(10), e202300030.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36589101\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 d, rt\", \"395. Scheme 395 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug\", \"By: Ross, Catherine L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 9599-9612.\", \"10.1021/acs.jmedchem.4c00724\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"93594-48-0\", \"132873-57-5\"], \"pro_cas\": [\"3050771-83-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["93594-48-0", "132873-57-5"], "products": ["3050771-83-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36693522", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 100.0}, "smiles": {"reactants": "Cc1ccc(S(=O)(=O)O)cc1.NCCC(=O)OCc1ccccc1.CC(C)(C)OC(=O)Nc1cccc(C(=O)O)c1", "products": "CC(C)(C)OC(=O)Nc1cccc(C(=O)NCCC(=O)OCc2ccccc2)c1"}, "reference": {"title": "Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation", "authors": "Tokarski, Robert J. II; et al", "citation": "European Journal of Medicinal Chemistry (2023), 254, 115342.", "doi": "10.1016/j.ejmech.2023.115342", "raw": "Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation | Tokarski, Robert J. II; et al | European Journal of Medicinal Chemistry (2023), 254, 115342. | 10.1016/j.ejmech.2023.115342"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36693522", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "By: Fuchs, Natalie; et al", "ChemMedChem (2023), 18(15), e202300160.", "10.1002/cmdc.202300160"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 66493-39-8 + 60025-25-4 | PRO: 3054992-14-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation\", \"authors\": \"Tokarski, Robert J. II; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 254, 115342.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36693522\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"348. Scheme 348 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"By: Fuchs, Natalie; et al\", \"ChemMedChem (2023), 18(15), e202300160.\", \"10.1002/cmdc.202300160\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"66493-39-8\", \"60025-25-4\"], \"pro_cas\": [\"3054992-14-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["66493-39-8", "60025-25-4"], "products": ["3054992-14-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36735488", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 80.0, "time_h": 6.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1ccccc1[N+](=O)[O-].CN.Cl", "products": "CNC(=O)c1ccccc1[N+](=O)[O-]"}, "reference": {"title": "Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents", "authors": "Cao, Longcai; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 85, 117241.", "doi": "10.1016/j.bmc.2023.117241", "raw": "Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents | Cao, Longcai; et al | Bioorganic & Medicinal Chemistry (2023), 85, 117241. | 10.1016/j.bmc.2023.117241"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-36735488", "1.1|Reagents: Thionyl chloride; 2 h, 80 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Acetonitrile; 4 h, 80 °C", "Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors", "By: Feng, Zi-Qiang; et al", "European Journal of Medicinal Chemistry (2024), 266, 116113.", "10.1016/j.ejmech.2023.116113"], "signatures": {"cond_key": "none/none/NaHCO3|144-55-8+Sodium bicarbonate|+Thionyl chloride|7719-09-7/Acetonitrile|75-05-8", "cond_sig": "177a51d1", "fam_sig": "4d3b0cb6"}, "raw_data": {"raw_cas": "RCT: 78-81-9 + 1798-06-7 | PRO: 3054131-08-4 | RGT: 7719-09-7 + 144-55-8 | SOL: 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents\", \"authors\": \"Cao, Longcai; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 85, 117241.\", \"reagents\": [\"Thionyl chloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36735488\", \"1.1\", \"Reagents: Thionyl chloride; 2 h, 80 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Acetonitrile; 4 h, 80 °C\", \"10. Scheme 10 (1 Reaction)\", \"Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors\", \"By: Feng, Zi-Qiang; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116113.\", \"10.1016/j.ejmech.2023.116113\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"78-81-9\", \"1798-06-7\"], \"pro_cas\": [\"3054131-08-4\"], \"rgt_cas\": [\"7719-09-7\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["78-81-9", "1798-06-7"], "products": ["3054131-08-4"], "reagents": ["7719-09-7", "NaHCO3"], "catalysts": [], "solvents": ["Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36772493", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": -15.0, "time_h": 3.833, "yield_pct": 89.0}, "smiles": {"reactants": "CS(=O)(=O)c1cccc(Nc2ncc(F)c(-c3c[nH]c4c(N)cccc34)n2)c1F.COC[C@H](C(=O)O)N1CCN(C)CC1.Cl", "products": "COC[C@H](C(=O)Nc1cccc2c(-c3nc(Nc4cccc(S(C)(=O)=O)c4F)ncc3F)c[nH]c12)N1CCN(C)CC1"}, "reference": {"title": "Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor", "authors": "Pithani, Subhash; et al", "citation": "Organic Process Research & Development (2023), 27(7), 1317-1329.", "doi": "10.1021/acs.oprd.3c00077", "raw": "Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor | Pithani, Subhash; et al | Organic Process Research & Development (2023), 27(7), 1317-1329. | 10.1021/acs.oprd.3c00077"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-36772493", "1.1|Reagents: Pyridine", "Solvents: Dimethylformamide; 5 min, -20 °C", "1.2|Reagents: Propylphosphonic anhydride; 75 min, < -15 °C", "1.3|Reagents: Water; 1 h, -15 °C; 30 min, -15 °C", "Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa", "By: Wang, Yuan-Yuan; et al", "Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.", "10.1021/acs.jmedchem.2c02044"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Pyridine|110-86-1+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "4ac59175", "fam_sig": "21d6c8bc"}, "raw_data": {"raw_cas": "RCT: 100-46-9 + 3035080-41-9 | PRO: 3035080-64-6 | RGT: 110-86-1 + 68957-94-8 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor\", \"authors\": \"Pithani, Subhash; et al\", \"citation\": \"Organic Process Research & Development (2023), 27(7), 1317-1329.\", \"reagents\": [\"Pyridine\", \"Propylphosphonic anhydride\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36772493\", \"1.1\", \"Reagents: Pyridine\", \"Solvents: Dimethylformamide; 5 min, -20 °C\", \"1.2\", \"Reagents: Propylphosphonic anhydride; 75 min, < -15 °C\", \"1.3\", \"Reagents: Water; 1 h, -15 °C; 30 min, -15 °C\", \"450. Scheme 450 (1 Reaction)\", \"Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa\", \"By: Wang, Yuan-Yuan; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 2169-2193.\", \"10.1021/acs.jmedchem.2c02044\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"100-46-9\", \"3035080-41-9\"], \"pro_cas\": [\"3035080-64-6\"], \"rgt_cas\": [\"110-86-1\", \"68957-94-8\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["100-46-9", "3035080-41-9"], "products": ["3035080-64-6"], "reagents": ["Pyridine", "Propylphosphonic anhydride", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36813239", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "C1CCC(NC2CCCCC2)CC1.CC(C)(C)OC(=O)NCCOCCOCC(=O)O.CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(N)cc4)cc23)c1F", "products": "CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(NC(=O)COCCOCCNC(=O)OC(C)(C)C)cc4)cc23)c1F"}, "reference": {"title": "A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells", "authors": "Barresi, Elisabetta; et al", "citation": "European Journal of Medicinal Chemistry (2023), 256, 115446.", "doi": "10.1016/j.ejmech.2023.115446", "raw": "A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells | Barresi, Elisabetta; et al | European Journal of Medicinal Chemistry (2023), 256, 115446. | 10.1016/j.ejmech.2023.115446"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-36813239", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Double bond geometry shown", "Double bond geometry shown", "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "By: Tang, Sheng; et al", "European Journal of Medicinal Chemistry (2024), 263, 115939.", "10.1016/j.ejmech.2023.115939"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 4653-11-6 + 2761180-24-7 + 625-35-4 | PRO: 3020728-52-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells\", \"authors\": \"Barresi, Elisabetta; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 256, 115446.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36813239\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"425. Scheme 425 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"By: Tang, Sheng; et al\", \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"10.1016/j.ejmech.2023.115939\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4653-11-6\", \"2761180-24-7\", \"625-35-4\"], \"pro_cas\": [\"3020728-52-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4653-11-6", "2761180-24-7", "625-35-4"], "products": ["3020728-52-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36826801", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 91.0}, "smiles": {"reactants": "CCN(c1cc([N+](=O)[O-])cc(C(=O)O)c1C)C1CCOCC1.Cc1cc(C)c(CN)c(=O)[nH]1", "products": "CCN(c1cc([N+](=O)[O-])cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1"}, "reference": {"title": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "authors": "Zhang, Yi; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "doi": "10.1021/acs.jmedchem.3c00504", "raw": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2 | Zhang, Yi; et al | Journal of Medicinal Chemistry (2023), 66(11), 7629-7644. | 10.1021/acs.jmedchem.3c00504"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-36826801", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, rt", "1.2|overnight, rt", "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "By: Pasqua, A. Elisa; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "10.1021/acs.jmedchem.3c00156"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 4442-54-0 + 1693733-61-7 | PRO: 1693731-14-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"authors\": \"Zhang, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36826801\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"overnight, rt\", \"173. Scheme 173 (1 Reaction)\", \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"By: Pasqua, A. Elisa; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"10.1021/acs.jmedchem.3c00156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4442-54-0\", \"1693733-61-7\"], \"pro_cas\": [\"1693731-14-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4442-54-0", "1693733-61-7"], "products": ["1693731-14-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36826816", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 88.0}, "smiles": {"reactants": "CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.CCCc1cc(C)[nH]c(=O)c1CN", "products": "CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(C#N)cc(N(CC)C2CCOCC2)c1C"}, "reference": {"title": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "authors": "Zhang, Yi; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "doi": "10.1021/acs.jmedchem.3c00504", "raw": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2 | Zhang, Yi; et al | Journal of Medicinal Chemistry (2023), 66(11), 7629-7644. | 10.1021/acs.jmedchem.3c00504"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-36826816", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, rt", "1.2|overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "By: Wang, Xu; et al", "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "10.1021/acs.jmedchem.4c02009"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 3061155-02-7 + 101555-60-6 | PRO: 3061155-05-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"authors\": \"Zhang, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36826816\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"overnight, rt\", \"163. Scheme 163 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"By: Wang, Xu; et al\", \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"10.1021/acs.jmedchem.4c02009\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3061155-02-7\", \"101555-60-6\"], \"pro_cas\": [\"3061155-05-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3061155-02-7", "101555-60-6"], "products": ["3061155-05-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36826818", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 90.0}, "smiles": {"reactants": "CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.Cc1cc(C)c(CN)c(=O)[nH]1", "products": "CCN(c1cc(C#N)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1"}, "reference": {"title": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "authors": "Zhang, Yi; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "doi": "10.1021/acs.jmedchem.3c00504", "raw": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2 | Zhang, Yi; et al | Journal of Medicinal Chemistry (2023), 66(11), 7629-7644. | 10.1021/acs.jmedchem.3c00504"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-36826818", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, rt", "1.2|overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers", "By: Cao, Chaoguo; et al", "Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.", "10.1021/acs.jmedchem.0c00821"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 13726-69-7 + 1448189-30-7 | PRO: 1448191-54-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"authors\": \"Zhang, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36826818\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"overnight, rt\", \"136. Scheme 136 (2 Reactions)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers\", \"By: Cao, Chaoguo; et al\", \"Journal of Medicinal Chemistry (2020), 63(19), 11012-11033.\", \"10.1021/acs.jmedchem.0c00821\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13726-69-7\", \"1448189-30-7\"], \"pro_cas\": [\"1448191-54-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13726-69-7", "1448189-30-7"], "products": ["1448191-54-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36826820", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 86.0}, "smiles": {"reactants": "CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.CSc1cc(C)[nH]c(=O)c1CN", "products": "CCN(c1cc(C#N)cc(C(=O)NCc2c(SC)cc(C)[nH]c2=O)c1C)C1CCOCC1"}, "reference": {"title": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "authors": "Zhang, Yi; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "doi": "10.1021/acs.jmedchem.3c00504", "raw": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2 | Zhang, Yi; et al | Journal of Medicinal Chemistry (2023), 66(11), 7629-7644. | 10.1021/acs.jmedchem.3c00504"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-36826820", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, rt", "1.2|overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2", "By: Dai, Wenhao; et al", "Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.", "10.1021/acs.jmedchem.0c02258"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 13734-41-3 + 2640359-25-5 | PRO: 2640359-27-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"authors\": \"Zhang, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36826820\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"overnight, rt\", \"184. Scheme 184 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-COV-2\", \"By: Dai, Wenhao; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 2794-2808.\", \"10.1021/acs.jmedchem.0c02258\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-41-3\", \"2640359-25-5\"], \"pro_cas\": [\"2640359-27-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13734-41-3", "2640359-25-5"], "products": ["2640359-27-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36826830", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 86.0}, "smiles": {"reactants": "CCN(c1cc(C#N)cc(C(=O)O)c1C)C1CCOCC1.COc1cc(C)[nH]c(=O)c1CN", "products": "CCN(c1cc(C#N)cc(C(=O)NCc2c(OC)cc(C)[nH]c2=O)c1C)C1CCOCC1"}, "reference": {"title": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "authors": "Zhang, Yi; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "doi": "10.1021/acs.jmedchem.3c00504", "raw": "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2 | Zhang, Yi; et al | Journal of Medicinal Chemistry (2023), 66(11), 7629-7644. | 10.1021/acs.jmedchem.3c00504"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-36826830", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, rt", "1.2|overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability", "By: Gao, Shenghua; et al", "Journal of Medicinal Chemistry (2023), 66(23), 16426-16440.", "10.1021/acs.jmedchem.3c01876"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 2768834-59-7 + 27757-85-3 | PRO: 2768834-60-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"authors\": \"Zhang, Yi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36826830\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"overnight, rt\", \"194. Scheme 194 (3 Reactions)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability\", \"By: Gao, Shenghua; et al\", \"Journal of Medicinal Chemistry (2023), 66(23), 16426-16440.\", \"10.1021/acs.jmedchem.3c01876\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2768834-59-7\", \"27757-85-3\"], \"pro_cas\": [\"2768834-60-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2768834-59-7", "27757-85-3"], "products": ["2768834-60-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36827354", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1cccc(I)c1.Nc1ccc2[nH]ncc2c1", "products": "O=C(Nc1ccc2[nH]ncc2c1)c1cccc(I)c1"}, "reference": {"title": "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors", "authors": "Rullo, Mariagrazia; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115352.", "doi": "10.1016/j.ejmech.2023.115352", "raw": "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors | Rullo, Mariagrazia; et al | European Journal of Medicinal Chemistry (2023), 255, 115352. | 10.1016/j.ejmech.2023.115352"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-36827354", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, rt", "1.2|overnight, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 6964-21-2 | PRO: 70474-53-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors\", \"authors\": \"Rullo, Mariagrazia; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115352.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36827354\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"overnight, rt\", \"164. Scheme 164 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"6964-21-2\"], \"pro_cas\": [\"70474-53-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "6964-21-2"], "products": ["70474-53-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36827360", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccc(I)cc1.Nc1ccc2[nH]ncc2c1", "products": "O=C(Nc1ccc2[nH]ncc2c1)c1ccc(I)cc1"}, "reference": {"title": "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors", "authors": "Rullo, Mariagrazia; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115352.", "doi": "10.1016/j.ejmech.2023.115352", "raw": "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors | Rullo, Mariagrazia; et al | European Journal of Medicinal Chemistry (2023), 255, 115352. | 10.1016/j.ejmech.2023.115352"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-36827360", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, rt", "1.2|overnight, rt", "Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK", "By: Srivastava, Anurag S.; et al", "ACS Medicinal Chemistry Letters (2020), 11(11), 2195-2203.", "10.1021/acsmedchemlett.0c00335"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 55289-36-6 + 1000567-55-4 | PRO: 2677780-41-3 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors\", \"authors\": \"Rullo, Mariagrazia; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115352.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36827360\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"overnight, rt\", \"146. Scheme 146 (1 Reaction)\", \"Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK\", \"By: Srivastava, Anurag S.; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(11), 2195-2203.\", \"10.1021/acsmedchemlett.0c00335\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55289-36-6\", \"1000567-55-4\"], \"pro_cas\": [\"2677780-41-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["55289-36-6", "1000567-55-4"], "products": ["2677780-41-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36827364", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 90.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)cc1.Nc1ccc2[nH]ncc2c1", "products": "COc1ccc(C(=O)Nc2ccc3[nH]ncc3c2)cc1"}, "reference": {"title": "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors", "authors": "Rullo, Mariagrazia; et al", "citation": "European Journal of Medicinal Chemistry (2023), 255, 115352.", "doi": "10.1016/j.ejmech.2023.115352", "raw": "Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors | Rullo, Mariagrazia; et al | European Journal of Medicinal Chemistry (2023), 255, 115352. | 10.1016/j.ejmech.2023.115352"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-36827364", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, rt", "1.2|overnight, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways", "By: Ma, Xiaoyu; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8791-8816.", "10.1021/acs.jmedchem.4c00131"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 2483-46-7 + 111-86-4 | PRO: 1378989-53-7 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors\", \"authors\": \"Rullo, Mariagrazia; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 255, 115352.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36827364\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"overnight, rt\", \"172. Scheme 172 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways\", \"By: Ma, Xiaoyu; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8791-8816.\", \"10.1021/acs.jmedchem.4c00131\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2483-46-7\", \"111-86-4\"], \"pro_cas\": [\"1378989-53-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2483-46-7", "111-86-4"], "products": ["1378989-53-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830487", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cccc(F)c1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5cccc(F)c5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-36830487", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 330-12-1 + 2919713-61-2 | PRO: 2919713-80-5 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830487\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"299. Scheme 299 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"330-12-1\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-80-5\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["330-12-1", "2919713-61-2"], "products": ["2919713-80-5"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830488", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1ccc(C(F)(F)F)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(C(F)(F)F)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-36830488", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon", "By: Zhang, Weihe; et al", "Bioorganic & Medicinal Chemistry (2022), 73, 117035.", "10.1016/j.bmc.2022.117035"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 209917-93-1 + 1809015-50-6 | PRO: 1809015-51-7 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830488\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"308. Scheme 308 (1 Reaction)\", \"Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon\", \"By: Zhang, Weihe; et al\", \"Bioorganic & Medicinal Chemistry (2022), 73, 117035.\", \"10.1016/j.bmc.2022.117035\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"209917-93-1\", \"1809015-50-6\"], \"pro_cas\": [\"1809015-51-7\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["209917-93-1", "1809015-50-6"], "products": ["1809015-51-7"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830489", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1cccc(Cl)c1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5cccc(Cl)c5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-36830489", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 455-38-9 + 2919713-61-2 | PRO: 2919713-66-7 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830489\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"298. Scheme 298 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-38-9\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-66-7\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-38-9", "2919713-61-2"], "products": ["2919713-66-7"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830490", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)c1ccccc1F.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5F)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-36830490", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability", "By: Zhang, Silong; et al", "Journal of Medicinal Chemistry (2023), 66(7), 4849-4867.", "10.1021/acs.jmedchem.2c02006"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 1197943-94-4 + 2924825-25-0 | PRO: 2924825-28-3 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830490\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"303. Scheme 303 (1 Reaction)\", \"Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability\", \"By: Zhang, Silong; et al\", \"Journal of Medicinal Chemistry (2023), 66(7), 4849-4867.\", \"10.1021/acs.jmedchem.2c02006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1197943-94-4\", \"2924825-25-0\"], \"pro_cas\": [\"2924825-28-3\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1197943-94-4", "2924825-25-0"], "products": ["2924825-28-3"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830491", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1ccc(F)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(F)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-36830491", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19", "By: Allerton, Charlotte M. N.; et al", "Journal of Medicinal Chemistry (2024), 67(16), 13550-13571.", "10.1021/acs.jmedchem.3c02469"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 2755951-93-8 + 3047146-06-2 | PRO: 3047146-09-5 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830491\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"277. Scheme 277 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19\", \"By: Allerton, Charlotte M. N.; et al\", \"Journal of Medicinal Chemistry (2024), 67(16), 13550-13571.\", \"10.1021/acs.jmedchem.3c02469\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2755951-93-8\", \"3047146-06-2\"], \"pro_cas\": [\"3047146-09-5\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2755951-93-8", "3047146-06-2"], "products": ["3047146-09-5"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830492", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 80.0}, "smiles": {"reactants": "N#Cc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(C#N)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-36830492", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 586-38-9 + 2919713-61-2 | PRO: 2919713-76-9 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830492\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"251. Scheme 251 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"586-38-9\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-76-9\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["586-38-9", "2919713-61-2"], "products": ["2919713-76-9"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830493", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)c1ccc(I)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(I)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36830493", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1", "By: Sabat, Mark; et al", "Journal of Medicinal Chemistry (2024), 67(12), 10306-10320.", "10.1021/acs.jmedchem.4c00743"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 77215-55-5 + 1557886-05-1 | PRO: 3085623-12-4 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830493\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"273. Scheme 273 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1\", \"By: Sabat, Mark; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 10306-10320.\", \"10.1021/acs.jmedchem.4c00743\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"77215-55-5\", \"1557886-05-1\"], \"pro_cas\": [\"3085623-12-4\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["77215-55-5", "1557886-05-1"], "products": ["3085623-12-4"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830494", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)c1ccccc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36830494", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 169280-56-2 + 884512-77-0 | PRO: 2765293-61-4 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830494\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"222. Scheme 222 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"169280-56-2\", \"884512-77-0\"], \"pro_cas\": [\"2765293-61-4\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["169280-56-2", "884512-77-0"], "products": ["2765293-61-4"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830495", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccc(Oc2ccccc2)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(Oc6ccccc6)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-36830495", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 169280-56-2 + 783350-37-8 | PRO: 2765293-55-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830495\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"312. Scheme 312 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"169280-56-2\", \"783350-37-8\"], \"pro_cas\": [\"2765293-55-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["169280-56-2", "783350-37-8"], "products": ["2765293-55-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830496", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1ccc(Br)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(Br)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-36830496", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 74-11-3 + 2919713-61-2 | PRO: 2919713-62-3 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830496\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"275. Scheme 275 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"74-11-3\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-62-3\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["74-11-3", "2919713-61-2"], "products": ["2919713-62-3"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830497", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 86.0}, "smiles": {"reactants": "COc1ccccc1C(=O)O.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5OC)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-36830497", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma", "By: Zhou, Yi; et al", "Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.", "10.1021/acs.jmedchem.9b02161"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 13139-14-5 + 2415205-36-4 | PRO: 2415205-26-2 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830497\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"305. Scheme 305 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma\", \"By: Zhou, Yi; et al\", \"Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.\", \"10.1021/acs.jmedchem.9b02161\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13139-14-5\", \"2415205-36-4\"], \"pro_cas\": [\"2415205-26-2\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["13139-14-5", "2415205-36-4"], "products": ["2415205-26-2"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830498", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1ccccc1Cl.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccccc5Cl)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-36830498", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 445-29-4 + 2919713-61-2 | PRO: 2919713-65-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830498\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"302. Scheme 302 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"445-29-4\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-65-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["445-29-4", "2919713-61-2"], "products": ["2919713-65-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830499", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1cccc(C(=O)O)c1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)c1"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36830499", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors", "By: Martinez-Gualda, Belen; et al", "Journal of Medicinal Chemistry (2020), 63(1), 349-368.", "10.1021/acs.jmedchem.9b01737"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 4299-70-1 + 35638-19-8 | PRO: 138424-03-0 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830499\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"252. Scheme 252 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors\", \"By: Martinez-Gualda, Belen; et al\", \"Journal of Medicinal Chemistry (2020), 63(1), 349-368.\", \"10.1021/acs.jmedchem.9b01737\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4299-70-1\", \"35638-19-8\"], \"pro_cas\": [\"138424-03-0\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["4299-70-1", "35638-19-8"], "products": ["138424-03-0"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830500", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)c1ccc(Cl)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(Cl)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-36830500", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 456-22-4 + 2919713-61-2 | PRO: 2919713-67-8 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830500\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"276. Scheme 276 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"456-22-4\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-67-8\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["456-22-4", "2919713-61-2"], "products": ["2919713-67-8"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830501", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 83.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1ccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)cc1"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-36830501", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease", "By: Lee, Min Jae; et al", "Journal of Medicinal Chemistry (2021), 64(15), 10934-10950.", "10.1021/acs.jmedchem.1c00291"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 15761-39-4 + 42406-77-9 | PRO: 2410547-63-4 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830501\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"238. Scheme 238 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease\", \"By: Lee, Min Jae; et al\", \"Journal of Medicinal Chemistry (2021), 64(15), 10934-10950.\", \"10.1021/acs.jmedchem.1c00291\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15761-39-4\", \"42406-77-9\"], \"pro_cas\": [\"2410547-63-4\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["15761-39-4", "42406-77-9"], "products": ["2410547-63-4"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830502", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)c1ccc(OC(F)(F)F)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(OC(F)(F)F)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-36830502", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia", "By: Hansen, Joshua D.; et al", "Journal of Medicinal Chemistry (2021), 64(4), 1835-1843.", "10.1021/acs.jmedchem.0c01489"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 475301-73-6 + 1010100-28-3 | PRO: 1860875-51-9 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830502\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"300. Scheme 300 (1 Reaction)\", \"CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia\", \"By: Hansen, Joshua D.; et al\", \"Journal of Medicinal Chemistry (2021), 64(4), 1835-1843.\", \"10.1021/acs.jmedchem.0c01489\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"475301-73-6\", \"1010100-28-3\"], \"pro_cas\": [\"1860875-51-9\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["475301-73-6", "1010100-28-3"], "products": ["1860875-51-9"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830503", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 87.0}, "smiles": {"reactants": "CCOc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "CCOc1ccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)cc1"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-36830503", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "By: Bothe, Ulrich; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "10.1021/acs.jmedchem.3c01714"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 131747-42-7 + 1799836-41-1 | PRO: 1799836-43-3 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830503\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"267. Scheme 267 (1 Reaction)\", \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"By: Bothe, Ulrich; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"10.1021/acs.jmedchem.3c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"131747-42-7\", \"1799836-41-1\"], \"pro_cas\": [\"1799836-43-3\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["131747-42-7", "1799836-41-1"], "products": ["1799836-43-3"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.118710", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830504", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)(C)Oc1ccc(C(=O)O)cc1.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5ccc(OC(C)(C)C)cc5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-36830504", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead", "By: Dayan Elshan, N. G. R.; et al", "Journal of Medicinal Chemistry (2024), 67(4), 2369-2378.", "10.1021/acs.jmedchem.3c01938"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 13139-15-6 + 2882939-05-9 | PRO: 2882939-04-8 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830504\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"294. Scheme 294 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead\", \"By: Dayan Elshan, N. G. R.; et al\", \"Journal of Medicinal Chemistry (2024), 67(4), 2369-2378.\", \"10.1021/acs.jmedchem.3c01938\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13139-15-6\", \"2882939-05-9\"], \"pro_cas\": [\"2882939-04-8\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["13139-15-6", "2882939-05-9"], "products": ["2882939-04-8"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.132490", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830505", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1cc(C(=O)O)cc(OC)c1OC.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(NC(=O)c5cc(OC)c(OC)c(OC)c5)cc4)ccc3[nH]1)CC2"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36830505", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 455-24-3 + 2919713-61-2 | PRO: 2919713-73-6 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830505\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"307. Scheme 307 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-24-3\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-73-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-24-3", "2919713-61-2"], "products": ["2919713-73-6"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.133490", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36830507", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 85.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)cc1OC.COc1cc2c(cc1OC)CN(C(=O)c1cc3cc(-c4ccc(N)cc4)ccc3[nH]1)CC2", "products": "COc1ccc(C(=O)Nc2ccc(-c3ccc4[nH]c(C(=O)N5CCc6cc(OC)c(OC)cc6C5)cc4c3)cc2)cc1OC"}, "reference": {"title": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "authors": "Yang, Zhikun; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "doi": "10.1021/acs.jmedchem.2c01999", "raw": "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity | Yang, Zhikun; et al | Journal of Medicinal Chemistry (2023), 66(8), 5550-5566. | 10.1021/acs.jmedchem.2c01999"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36830507", "1.1|Reagents: Oxalyl chloride", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 4 - 5, rt", "Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13", "By: Yang, Jianzhang; et al", "Journal of Medicinal Chemistry (2022), 65(16), 11066-11083.", "10.1021/acs.jmedchem.2c00384"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 79-08-3 + 19171-19-8 | PRO: 2351106-38-0 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"authors\": \"Yang, Zhikun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36830507\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 1 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 0.5 h, 0 °C; 2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 4 - 5, rt\", \"269. Scheme 269 (1 Reaction)\", \"Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13\", \"By: Yang, Jianzhang; et al\", \"Journal of Medicinal Chemistry (2022), 65(16), 11066-11083.\", \"10.1021/acs.jmedchem.2c00384\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"79-08-3\", \"19171-19-8\"], \"pro_cas\": [\"2351106-38-0\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["79-08-3", "19171-19-8"], "products": ["2351106-38-0"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.133490", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36846458", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)CNC(=O)OCc1ccccc1.CC(C)(C)OC(=O)[C@@H](N)Cc1ccc(O)cc1", "products": "CC(C)(C)OC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)OCc1ccccc1"}, "reference": {"title": "N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors", "authors": "Gade, Narendar Reddy; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(7), 943-948.", "doi": "10.1021/acsmedchemlett.3c00087", "raw": "N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors | Gade, Narendar Reddy; et al | ACS Medicinal Chemistry Letters (2023), 14(7), 943-948. | 10.1021/acsmedchemlett.3c00087"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36846458", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; overnight, rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 54012-55-4 + 40615-17-6 | PRO: 2416338-24-2 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors\", \"authors\": \"Gade, Narendar Reddy; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(7), 943-948.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36846458\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; overnight, rt\", \"382. Scheme 382 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"54012-55-4\", \"40615-17-6\"], \"pro_cas\": [\"2416338-24-2\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["54012-55-4", "40615-17-6"], "products": ["2416338-24-2"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.133490", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36873887", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 28.0, "yield_pct": 82.0}, "smiles": {"reactants": "CC(=O)N1CCC(C(=O)O)CC1.Cc1ccc(N)cc1Cl", "products": "CC(=O)N1CCC(C(=O)Nc2ccc(C)c(Cl)c2)CC1"}, "reference": {"title": "A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region", "authors": "Wang, Chao; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(15), 11460-11471.", "doi": "10.1021/acs.jmedchem.1c00781", "raw": "A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region | Wang, Chao; et al | Journal of Medicinal Chemistry (2021), 64(15), 11460-11471. | 10.1021/acs.jmedchem.1c00781"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-36873887", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Tetrahydrofuran; 4 h, rt", "1.2|24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide", "By: Sampaio-Dias, Ivo E.; et al", "Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.", "10.1021/acs.jmedchem.1c00252"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Tetrahydrofuran|109-99-9", "cond_sig": "86e9832a", "fam_sig": "47dee7bd"}, "raw_data": {"raw_cas": "RCT: 1103527-41-8 + 2491-20-5 | PRO: 2732919-61-6 | RGT: 530-62-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"A “Two-Birds-One-Stone” Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region\", \"authors\": \"Wang, Chao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(15), 11460-11471.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36873887\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Tetrahydrofuran; 4 h, rt\", \"1.2\", \"24 h, rt\", \"155. Scheme 155 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide\", \"By: Sampaio-Dias, Ivo E.; et al\", \"Journal of Medicinal Chemistry (2021), 64(9), 6209-6220.\", \"10.1021/acs.jmedchem.1c00252\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1103527-41-8\", \"2491-20-5\"], \"pro_cas\": [\"2732919-61-6\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["1103527-41-8", "2491-20-5"], "products": ["2732919-61-6"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.133490", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36966232", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.333, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccncc1"}, "reference": {"title": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "authors": "Fuchs, Natalie; et al", "citation": "ChemMedChem (2023), 18(15), e202300160.", "doi": "10.1002/cmdc.202300160", "raw": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer | Fuchs, Natalie; et al | ChemMedChem (2023), 18(15), e202300160. | 10.1002/cmdc.202300160"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-36966232", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C", "1.2|12 - 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "54e0bd73", "fam_sig": "3dfe5ca5"}, "raw_data": {"raw_cas": "RCT: 117-34-0 + 3026372-62-0 | PRO: 3026370-13-5 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"authors\": \"Fuchs, Natalie; et al\", \"citation\": \"ChemMedChem (2023), 18(15), e202300160.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36966232\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C\", \"1.2\", \"12 - 24 h, rt\", \"169. Scheme 169 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"117-34-0\", \"3026372-62-0\"], \"pro_cas\": [\"3026370-13-5\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["117-34-0", "3026372-62-0"], "products": ["3026370-13-5"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.133490", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36966237", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.333, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)CC(C)C.Cl", "products": "CCOC(=O)[C@H](CC(C)C)NC(=O)c1ccncc1"}, "reference": {"title": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "authors": "Fuchs, Natalie; et al", "citation": "ChemMedChem (2023), 18(15), e202300160.", "doi": "10.1002/cmdc.202300160", "raw": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer | Fuchs, Natalie; et al | ChemMedChem (2023), 18(15), e202300160. | 10.1002/cmdc.202300160"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36966237", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C", "1.2|12 - 24 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity", "By: Moreno-Yruela, Carlos; et al", "ACS Medicinal Chemistry Letters (2022), 13(5), 779-785.", "10.1021/acsmedchemlett.1c00702"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "54e0bd73", "fam_sig": "3dfe5ca5"}, "raw_data": {"raw_cas": "RCT: 140-10-3 + 6232-11-7 | PRO: 2222630-45-5 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"authors\": \"Fuchs, Natalie; et al\", \"citation\": \"ChemMedChem (2023), 18(15), e202300160.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36966237\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C\", \"1.2\", \"12 - 24 h, rt\", \"65. Scheme 65 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity\", \"By: Moreno-Yruela, Carlos; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(5), 779-785.\", \"10.1021/acsmedchemlett.1c00702\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"140-10-3\", \"6232-11-7\"], \"pro_cas\": [\"2222630-45-5\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["140-10-3", "6232-11-7"], "products": ["2222630-45-5"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.133490", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36966239", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.333, "yield_pct": 93.0}, "smiles": {"reactants": "O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)CC1CCCCC1", "products": "CCOC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccncc1"}, "reference": {"title": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "authors": "Fuchs, Natalie; et al", "citation": "ChemMedChem (2023), 18(15), e202300160.", "doi": "10.1002/cmdc.202300160", "raw": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer | Fuchs, Natalie; et al | ChemMedChem (2023), 18(15), e202300160. | 10.1002/cmdc.202300160"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-36966239", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C", "1.2|12 - 24 h, rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "54e0bd73", "fam_sig": "3dfe5ca5"}, "raw_data": {"raw_cas": "RCT: 5462-71-5 + 2983540-42-5 | PRO: 2983540-46-9 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"authors\": \"Fuchs, Natalie; et al\", \"citation\": \"ChemMedChem (2023), 18(15), e202300160.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36966239\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C\", \"1.2\", \"12 - 24 h, rt\", \"188. Scheme 188 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5462-71-5\", \"2983540-42-5\"], \"pro_cas\": [\"2983540-46-9\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5462-71-5", "2983540-42-5"], "products": ["2983540-46-9"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.134487", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36966240", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.333, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1ccccc1.CCOC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1"}, "reference": {"title": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "authors": "Fuchs, Natalie; et al", "citation": "ChemMedChem (2023), 18(15), e202300160.", "doi": "10.1002/cmdc.202300160", "raw": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer | Fuchs, Natalie; et al | ChemMedChem (2023), 18(15), e202300160. | 10.1002/cmdc.202300160"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-36966240", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C", "1.2|12 - 24 h, rt", "Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5", "By: Xiang, Honggang; et al", "Journal of Medicinal Chemistry (2023), 66(4), 2457-2476.", "10.1021/acs.jmedchem.2c01233"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "54e0bd73", "fam_sig": "3dfe5ca5"}, "raw_data": {"raw_cas": "RCT: 619-45-4 + 2051-95-8 | PRO: 1097185-95-9 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"authors\": \"Fuchs, Natalie; et al\", \"citation\": \"ChemMedChem (2023), 18(15), e202300160.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36966240\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C\", \"1.2\", \"12 - 24 h, rt\", \"113. Scheme 113 (1 Reaction)\", \"Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5\", \"By: Xiang, Honggang; et al\", \"Journal of Medicinal Chemistry (2023), 66(4), 2457-2476.\", \"10.1021/acs.jmedchem.2c01233\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"619-45-4\", \"2051-95-8\"], \"pro_cas\": [\"1097185-95-9\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["619-45-4", "2051-95-8"], "products": ["1097185-95-9"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.134487", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36966242", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.333, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1ccsc1.CCOC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccsc1"}, "reference": {"title": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "authors": "Fuchs, Natalie; et al", "citation": "ChemMedChem (2023), 18(15), e202300160.", "doi": "10.1002/cmdc.202300160", "raw": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer | Fuchs, Natalie; et al | ChemMedChem (2023), 18(15), e202300160. | 10.1002/cmdc.202300160"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-36966242", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C", "1.2|12 - 24 h, rt", "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "By: Hiesinger, Kerstin; et al", "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "10.1021/acs.jmedchem.0c00561"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "54e0bd73", "fam_sig": "3dfe5ca5"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 114667-11-7 | PRO: 2709014-26-4 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"authors\": \"Fuchs, Natalie; et al\", \"citation\": \"ChemMedChem (2023), 18(15), e202300160.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36966242\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C\", \"1.2\", \"12 - 24 h, rt\", \"159. Scheme 159 (1 Reaction)\", \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"By: Hiesinger, Kerstin; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"10.1021/acs.jmedchem.0c00561\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"114667-11-7\"], \"pro_cas\": [\"2709014-26-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "114667-11-7"], "products": ["2709014-26-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.134487", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36966243", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.333, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)c1ccncc1.CCOC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.Cl", "products": "CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccncc1"}, "reference": {"title": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "authors": "Fuchs, Natalie; et al", "citation": "ChemMedChem (2023), 18(15), e202300160.", "doi": "10.1002/cmdc.202300160", "raw": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer | Fuchs, Natalie; et al | ChemMedChem (2023), 18(15), e202300160. | 10.1002/cmdc.202300160"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36966243", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C", "1.2|12 - 24 h, rt", "Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors", "By: Shu, Lei; et al", "European Journal of Medicinal Chemistry (2020), 191, 112148pp..", "10.1016/j.ejmech.2020.112148"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "54e0bd73", "fam_sig": "3dfe5ca5"}, "raw_data": {"raw_cas": "RCT: 372-09-8 + 2412733-73-2 | PRO: 2412734-02-0 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"authors\": \"Fuchs, Natalie; et al\", \"citation\": \"ChemMedChem (2023), 18(15), e202300160.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36966243\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C\", \"1.2\", \"12 - 24 h, rt\", \"481. Scheme 481 (1 Reaction)\", \"Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors\", \"By: Shu, Lei; et al\", \"European Journal of Medicinal Chemistry (2020), 191, 112148pp..\", \"10.1016/j.ejmech.2020.112148\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"372-09-8\", \"2412733-73-2\"], \"pro_cas\": [\"2412734-02-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["372-09-8", "2412733-73-2"], "products": ["2412734-02-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.134487", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36966246", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 24.333, "yield_pct": 100.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)Nc1ccc(C(=O)O)cc1.CCOC(=O)[C@@H](N)CC1CCCCC1.Cl", "products": "CCOC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(NC(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "authors": "Fuchs, Natalie; et al", "citation": "ChemMedChem (2023), 18(15), e202300160.", "doi": "10.1002/cmdc.202300160", "raw": "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer | Fuchs, Natalie; et al | ChemMedChem (2023), 18(15), e202300160. | 10.1002/cmdc.202300160"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36966246", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C", "1.2|12 - 24 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models", "By: Winter-Holt, Jon J.; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.", "10.1021/acs.jmedchem.1c01871"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "54e0bd73", "fam_sig": "3dfe5ca5"}, "raw_data": {"raw_cas": "RCT: 35320-23-1 + 35661-40-6 | PRO: 3037043-04-9 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"authors\": \"Fuchs, Natalie; et al\", \"citation\": \"ChemMedChem (2023), 18(15), e202300160.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36966246\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide, Dichloromethane; 20 min, 0 °C\", \"1.2\", \"12 - 24 h, rt\", \"349. Scheme 349 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models\", \"By: Winter-Holt, Jon J.; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.\", \"10.1021/acs.jmedchem.1c01871\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"35320-23-1\", \"35661-40-6\"], \"pro_cas\": [\"3037043-04-9\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["35320-23-1", "35661-40-6"], "products": ["3037043-04-9"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.135488", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36967878", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)CCCCBr.Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)cc1", "products": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCBr)C(C)(C)C)cc1"}, "reference": {"title": "Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction", "authors": "Si, Ru; et al", "citation": "European Journal of Medicinal Chemistry (2023), 257, 115497.", "doi": "10.1016/j.ejmech.2023.115497", "raw": "Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction | Si, Ru; et al | European Journal of Medicinal Chemistry (2023), 257, 115497. | 10.1016/j.ejmech.2023.115497"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-36967878", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 0 °C; 1 h, rt", "Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells", "By: Comeo, Eleonora; et al", "Journal of Medicinal Chemistry (2021), 64(10), 6670-6695.", "10.1021/acs.jmedchem.0c02067"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 828-51-3 + 200557-55-7 | PRO: 2969809-75-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction\", \"authors\": \"Si, Ru; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 257, 115497.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36967878\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"240. Scheme 240 (1 Reaction)\", \"Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells\", \"By: Comeo, Eleonora; et al\", \"Journal of Medicinal Chemistry (2021), 64(10), 6670-6695.\", \"10.1021/acs.jmedchem.0c02067\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"828-51-3\", \"200557-55-7\"], \"pro_cas\": [\"2969809-75-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["828-51-3", "200557-55-7"], "products": ["2969809-75-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.135488", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-36975263", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.25, "yield_pct": 85.0}, "smiles": {"reactants": "Cc1cc(=O)c(C(=O)O)nn1-c1ccccc1.Cl.NCc1c(F)cc(Br)cc1F", "products": "Cc1cc(=O)c(C(=O)NCc2c(F)cc(Br)cc2F)nn1-c1ccccc1"}, "reference": {"title": "Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction", "authors": "Ding, Jian; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(12), 8310-8323.", "doi": "10.1021/acs.jmedchem.3c00787", "raw": "Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction | Ding, Jian; et al | Journal of Medicinal Chemistry (2023), 66(12), 8310-8323. | 10.1021/acs.jmedchem.3c00787"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-36975263", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.2|16 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor", "By: Taoda, Yoshiyuki; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547.", "10.1016/j.bmcl.2020.127547"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/Dimethylformamide|68-12-2", "cond_sig": "2ff811ef", "fam_sig": "2fb3add8"}, "raw_data": {"raw_cas": "RCT: 119736-17-3 + 779303-24-1 | PRO: 2640348-70-3 | RGT: 7087-68-5 + 68957-94-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction\", \"authors\": \"Ding, Jian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(12), 8310-8323.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-36975263\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.2\", \"16 h, rt\", \"35. Scheme 35 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor\", \"By: Taoda, Yoshiyuki; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127547.\", \"10.1016/j.bmcl.2020.127547\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"119736-17-3\", \"779303-24-1\"], \"pro_cas\": [\"2640348-70-3\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["119736-17-3", "779303-24-1"], "products": ["2640348-70-3"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.135488", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37041496", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 100.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCOCCN.COCCn1nc(C(=O)O)c2cc(Nc3nccc(-n4cc(C=O)c(C)n4)n3)ccc21", "products": "COCCn1nc(C(=O)NCCOCCNC(=O)OC(C)(C)C)c2cc(Nc3nccc(-n4cc(C=O)c(C)n4)n3)ccc21"}, "reference": {"title": "Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors", "authors": "Grimster, Neil P.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 91, 129352.", "doi": "10.1016/j.bmcl.2023.129352", "raw": "Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors | Grimster, Neil P.; et al | Bioorganic & Medicinal Chemistry Letters (2023), 91, 129352. | 10.1016/j.bmcl.2023.129352"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-37041496", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "By: Chen, Bei; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "10.1021/acs.jmedchem.3c01326"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1307702-36-8 + 3002420-86-9 | PRO: 3002420-82-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors\", \"authors\": \"Grimster, Neil P.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 91, 129352.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37041496\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"402. Scheme 402 (1 Reaction)\", \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"By: Chen, Bei; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"10.1021/acs.jmedchem.3c01326\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1307702-36-8\", \"3002420-86-9\"], \"pro_cas\": [\"3002420-82-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1307702-36-8", "3002420-86-9"], "products": ["3002420-82-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.135488", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37043002", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 0.0, "time_h": 26.0, "yield_pct": 83.0}, "smiles": {"reactants": "COc1ccc2cc([C@H](C)C(=O)O)ccc2c1.C#CCN", "products": "C#CCNC(=O)[C@@H](C)c1ccc2cc(OC)ccc2c1"}, "reference": {"title": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "authors": "Xu, Zhongren; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "doi": "10.1021/acs.jmedchem.3c00063", "raw": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer | Xu, Zhongren; et al | Journal of Medicinal Chemistry (2023), 66(12), 7813-7833. | 10.1021/acs.jmedchem.3c00063"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37043002", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C", "1.2|24 h, rt", "Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors", "By: Hou, Shaohua; et al", "European Journal of Medicinal Chemistry (2021), 220, 113482.", "10.1016/j.ejmech.2021.113482"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/none", "cond_sig": "3079b1cb", "fam_sig": "aba9bb74"}, "raw_data": {"raw_cas": "RCT: 455-24-3 + 591-19-5 | PRO: 447431-41-6 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8", "raw_data_json": "{\"txt\": {\"title\": \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"authors\": \"Xu, Zhongren; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37043002\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C\", \"1.2\", \"24 h, rt\", \"63. Scheme 63 (1 Reaction)\", \"Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors\", \"By: Hou, Shaohua; et al\", \"European Journal of Medicinal Chemistry (2021), 220, 113482.\", \"10.1016/j.ejmech.2021.113482\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-24-3\", \"591-19-5\"], \"pro_cas\": [\"447431-41-6\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["455-24-3", "591-19-5"], "products": ["447431-41-6"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.135488", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37043005", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 0.0, "time_h": 25.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc(S(C)=O)cc1.C#CCN", "products": "C#CCNC(=O)CC1=C(C)C(=Cc2ccc(S(C)=O)cc2)c2ccc(F)cc21"}, "reference": {"title": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "authors": "Xu, Zhongren; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "doi": "10.1021/acs.jmedchem.3c00063", "raw": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer | Xu, Zhongren; et al | Journal of Medicinal Chemistry (2023), 66(12), 7813-7833. | 10.1021/acs.jmedchem.3c00063"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37043005", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C", "1.2|24 h, rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/none", "cond_sig": "3079b1cb", "fam_sig": "aba9bb74"}, "raw_data": {"raw_cas": "RCT: 3740-52-1 + 2983540-42-5 | PRO: 2983540-43-6 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8", "raw_data_json": "{\"txt\": {\"title\": \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"authors\": \"Xu, Zhongren; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37043005\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C\", \"1.2\", \"24 h, rt\", \"262. Scheme 262 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3740-52-1\", \"2983540-42-5\"], \"pro_cas\": [\"2983540-43-6\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["3740-52-1", "2983540-42-5"], "products": ["2983540-43-6"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.136483", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37043008", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 0.0, "time_h": 25.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)Cc1cccc2ccccc12.C#CCN", "products": "C#CCNC(=O)Cc1cccc2ccccc12"}, "reference": {"title": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "authors": "Xu, Zhongren; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "doi": "10.1021/acs.jmedchem.3c00063", "raw": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer | Xu, Zhongren; et al | Journal of Medicinal Chemistry (2023), 66(12), 7813-7833. | 10.1021/acs.jmedchem.3c00063"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-37043008", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C", "1.2|24 h, rt", "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "By: Ashton, Trent D.; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "10.1021/acs.jmedchem.2c02092"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/none", "cond_sig": "3079b1cb", "fam_sig": "aba9bb74"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 825-22-9 | PRO: 1017789-26-2 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8", "raw_data_json": "{\"txt\": {\"title\": \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"authors\": \"Xu, Zhongren; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37043008\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C\", \"1.2\", \"24 h, rt\", \"18. Scheme 18 (1 Reaction)\", \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"By: Ashton, Trent D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"10.1021/acs.jmedchem.2c02092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"825-22-9\"], \"pro_cas\": [\"1017789-26-2\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "825-22-9"], "products": ["1017789-26-2"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.136483", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37043010", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 0.0, "time_h": 26.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.C#CCN", "products": "C#CCNC(=O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1"}, "reference": {"title": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "authors": "Xu, Zhongren; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "doi": "10.1021/acs.jmedchem.3c00063", "raw": "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer | Xu, Zhongren; et al | Journal of Medicinal Chemistry (2023), 66(12), 7813-7833. | 10.1021/acs.jmedchem.3c00063"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-37043010", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C", "1.2|24 h, rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/none", "cond_sig": "3079b1cb", "fam_sig": "aba9bb74"}, "raw_data": {"raw_cas": "RCT: 37902-60-6 + 40615-17-6 | PRO: 2416338-27-5 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8", "raw_data_json": "{\"txt\": {\"title\": \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"authors\": \"Xu, Zhongren; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37043010\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 1 h, 0 °C\", \"1.2\", \"24 h, rt\", \"464. Scheme 464 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"37902-60-6\", \"40615-17-6\"], \"pro_cas\": [\"2416338-27-5\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["37902-60-6", "40615-17-6"], "products": ["2416338-27-5"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.136483", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37102940", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1ccc(Br)cc1.CCCCCc1cc(OC)c(N)c(OC)c1", "products": "CCCCCc1cc(OC)c(NC(=O)c2ccc(Br)cc2)c(OC)c1"}, "reference": {"title": "Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)", "authors": "Jin, Fangjie; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 90, 117379.", "doi": "10.1016/j.bmc.2023.117379", "raw": "Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD) | Jin, Fangjie; et al | Bioorganic & Medicinal Chemistry (2023), 90, 117379. | 10.1016/j.bmc.2023.117379"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37102940", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, rt", "1.2|overnight, rt", "1.3|Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit", "By: Zhan, Wenhu; et al", "Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.", "10.1021/acs.jmedchem.2c00733"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "1db37e54", "fam_sig": "a8d8fb5f"}, "raw_data": {"raw_cas": "RCT: 75-64-9 + 30924-93-7 | PRO: 102651-05-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)\", \"authors\": \"Jin, Fangjie; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 90, 117379.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37102940\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"overnight, rt\", \"1.3\", \"Solvents: Water; rt\", \"286. Scheme 286 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit\", \"By: Zhan, Wenhu; et al\", \"Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.\", \"10.1021/acs.jmedchem.2c00733\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-64-9\", \"30924-93-7\"], \"pro_cas\": [\"102651-05-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-64-9", "30924-93-7"], "products": ["102651-05-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.136483", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37137463", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.333, "yield_pct": 83.0}, "smiles": {"reactants": "N#Cc1c(Nc2ccccc2)nc(SCC(=O)O)nc1-c1ccccc1.NCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1", "products": "N#Cc1c(Nc2ccccc2)nc(SCC(=O)NCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)nc1-c1ccccc1"}, "reference": {"title": "Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives", "authors": "Chi, Lingling; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 92, 129389.", "doi": "10.1016/j.bmcl.2023.129389", "raw": "Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives | Chi, Lingling; et al | Bioorganic & Medicinal Chemistry Letters (2023), 92, 129389. | 10.1016/j.bmcl.2023.129389"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37137463", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 20 min, rt", "1.2|4 h, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 86-55-5 + 2632874-83-8 | PRO: 2892485-65-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives\", \"authors\": \"Chi, Lingling; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 92, 129389.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37137463\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.2\", \"4 h, rt\", \"314. Scheme 314 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"86-55-5\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-65-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["86-55-5", "2632874-83-8"], "products": ["2892485-65-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.136483", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37155046", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 11.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cc(Br)cc(I)c1.CC[C@@H](N)c1ccccc1", "products": "CC[C@@H](NC(=O)c1cc(Br)cc(I)c1)c1ccccc1"}, "reference": {"title": "Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model", "authors": "Maddeboina, Krishnaiah; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(14), 9894-9915.", "doi": "10.1021/acs.jmedchem.3c00732", "raw": "Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model | Maddeboina, Krishnaiah; et al | Journal of Medicinal Chemistry (2023), 66(14), 9894-9915. | 10.1021/acs.jmedchem.3c00732"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-37155046", "1.1|Reagents: Thionyl chloride; 3 h, reflux", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; rt; rt → 0 °C; 8 h, rt", "Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor", "By: Li, Huiqiong; et al", "European Journal of Medicinal Chemistry (2024), 272, 116473.", "10.1016/j.ejmech.2024.116473"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "7e24dde3", "fam_sig": "465abb34"}, "raw_data": {"raw_cas": "RCT: 430-99-9 + 214360-73-3 | PRO: 2901130-88-7 | RGT: 7719-09-7 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model\", \"authors\": \"Maddeboina, Krishnaiah; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(14), 9894-9915.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37155046\", \"1.1\", \"Reagents: Thionyl chloride; 3 h, reflux\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; rt; rt → 0 °C; 8 h, rt\", \"71. Scheme 71 (1 Reaction)\", \"Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor\", \"By: Li, Huiqiong; et al\", \"European Journal of Medicinal Chemistry (2024), 272, 116473.\", \"10.1016/j.ejmech.2024.116473\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"430-99-9\", \"214360-73-3\"], \"pro_cas\": [\"2901130-88-7\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["430-99-9", "214360-73-3"], "products": ["2901130-88-7"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.136483", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37198975", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 91.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O.CCCC[C@@H](N)C(=O)OCc1ccc([N+](=O)[O-])cc1", "products": "CCCC[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)OCc1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes", "authors": "Delahaye, Juliette; et al", "citation": "European Journal of Medicinal Chemistry (2023), 258, 115568.", "doi": "10.1016/j.ejmech.2023.115568", "raw": "Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes | Delahaye, Juliette; et al | European Journal of Medicinal Chemistry (2023), 258, 115568. | 10.1016/j.ejmech.2023.115568"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-37198975", "1.1|Reagents: Triethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 30 min, rt", "1.2|Reagents: Trifluoroacetic acid", "Solvents: Dimethylformamide; overnight, rt", "Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate", "By: Wu, Jiang-Ping; et al", "Organic Process Research & Development (2023), 27(4), 788-797.", "10.1021/acs.oprd.3c00050"], "signatures": {"cond_key": "none/none/O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6+Triethylamine|121-44-8+Trifluoroacetic acid|76-05-1/Dimethylformamide|68-12-2", "cond_sig": "9856b785", "fam_sig": "0c3f62dc"}, "raw_data": {"raw_cas": "RCT: 2252-37-1 + 2922001-14-5 | PRO: 2922001-31-6 | RGT: 121-44-8 + 125700-67-6 + 76-05-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development, synthesis and evaluation of novel fluorescent Endothelin-B receptor probes\", \"authors\": \"Delahaye, Juliette; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 258, 115568.\", \"reagents\": [\"Triethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Trifluoroacetic acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37198975\", \"1.1\", \"Reagents: Triethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dimethylformamide; overnight, rt\", \"367. Scheme 367 (1 Reaction)\", \"Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate\", \"By: Wu, Jiang-Ping; et al\", \"Organic Process Research & Development (2023), 27(4), 788-797.\", \"10.1021/acs.oprd.3c00050\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2252-37-1\", \"2922001-14-5\"], \"pro_cas\": [\"2922001-31-6\"], \"rgt_cas\": [\"121-44-8\", \"125700-67-6\", \"76-05-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2252-37-1", "2922001-14-5"], "products": ["2922001-31-6"], "reagents": ["Triethylamine", "125700-67-6", "Trifluoroacetic acid"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.136483", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37200035", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "1,2-Dichloroethane", "cas": "107-06-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)[C@H]1CCc2ccccc2O1.C[C@@H](N)c1cccc2ccccc12", "products": "C[C@@H](NC(=O)[C@H]1CCc2ccccc2O1)c1cccc2ccccc12"}, "reference": {"title": "Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism", "authors": "Shukla, Manojkumar R.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(14), 9418-9444.", "doi": "10.1021/acs.jmedchem.3c00698", "raw": "Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism | Shukla, Manojkumar R.; et al | Journal of Medicinal Chemistry (2023), 66(14), 9418-9444. | 10.1021/acs.jmedchem.3c00698"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-37200035", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: 1,2-Dichloroethane; 0 °C → reflux", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 1 h, 0 °C", "Nitrile-based peptoids as cysteine protease inhibitors", "By: Alves, Luana; et al", "Bioorganic & Medicinal Chemistry (2021), 41, 116211.", "10.1016/j.bmc.2021.116211"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/1,2-Dichloroethane|107-06-2+Dichloromethane|75-09-2", "cond_sig": "8686a53b", "fam_sig": "5b9b1be5"}, "raw_data": {"raw_cas": "RCT: 196311-65-6 + 2759356-75-5 | PRO: 2760280-60-0 | RGT: 7719-09-7 + 121-44-8 | CAT: 68-12-2 | SOL: 107-06-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism\", \"authors\": \"Shukla, Manojkumar R.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(14), 9418-9444.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"1,2-Dichloroethane\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37200035\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: 1,2-Dichloroethane; 0 °C → reflux\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 1 h, 0 °C\", \"330. Scheme 330 (1 Reaction)\", \"Nitrile-based peptoids as cysteine protease inhibitors\", \"By: Alves, Luana; et al\", \"Bioorganic & Medicinal Chemistry (2021), 41, 116211.\", \"10.1016/j.bmc.2021.116211\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"196311-65-6\", \"2759356-75-5\"], \"pro_cas\": [\"2760280-60-0\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"107-06-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["196311-65-6", "2759356-75-5"], "products": ["2760280-60-0"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["1,2-Dichloroethane", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.137479", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37213507", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 85.0, "time_h": 9.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1nc(Cl)ccc1Cl.Nc1ccccc1", "products": "O=C(Nc1ccccc1)c1nc(Cl)ccc1Cl"}, "reference": {"title": "Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy", "authors": "Gu, Yun-Qiong; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(14), 9592-9606.", "doi": "10.1021/acs.jmedchem.3c00318", "raw": "Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy | Gu, Yun-Qiong; et al | Journal of Medicinal Chemistry (2023), 66(14), 9592-9606. | 10.1021/acs.jmedchem.3c00318"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-37213507", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide; 3 h, 85 °C", "1.2|Reagents: Triethylamine", "Solvents: Acetonitrile; 6 h, 80 °C", "Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors", "By: Karim, Rezaul Md; et al", "Journal of Medicinal Chemistry (2021), 64(21), 15772-15786.", "10.1021/acs.jmedchem.1c01096"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Acetonitrile|75-05-8", "cond_sig": "dd20e74e", "fam_sig": "0a1395f6"}, "raw_data": {"raw_cas": "RCT: 446-31-1 + 41838-46-4 | PRO: 957855-54-8 | RGT: 7719-09-7 + 121-44-8 | CAT: 68-12-2 | SOL: 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy\", \"authors\": \"Gu, Yun-Qiong; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(14), 9592-9606.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37213507\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide; 3 h, 85 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Acetonitrile; 6 h, 80 °C\", \"122. Scheme 122 (1 Reaction)\", \"Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors\", \"By: Karim, Rezaul Md; et al\", \"Journal of Medicinal Chemistry (2021), 64(21), 15772-15786.\", \"10.1021/acs.jmedchem.1c01096\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"446-31-1\", \"41838-46-4\"], \"pro_cas\": [\"957855-54-8\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["446-31-1", "41838-46-4"], "products": ["957855-54-8"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.137479", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37215001", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1ccccc1.Cl.O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccccc1[N+](=O)[O-]", "products": "COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccccc1[N+](=O)[O-]"}, "reference": {"title": "Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template", "authors": "Marciniak, Monika; et al", "citation": "European Journal of Medicinal Chemistry (2023), 258, 115587.", "doi": "10.1016/j.ejmech.2023.115587", "raw": "Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template | Marciniak, Monika; et al | European Journal of Medicinal Chemistry (2023), 258, 115587. | 10.1016/j.ejmech.2023.115587"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-37215001", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis", "By: Futatsugi, Kentaro; et al", "Journal of Medicinal Chemistry (2022), 65(22), 15000-15013.", "10.1021/acs.jmedchem.2c01200"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "c6a486a8", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 124-68-5 + 3034673-70-3 | PRO: 3034673-71-4 | RGT: 1892-57-5 + 2592-95-2 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template\", \"authors\": \"Marciniak, Monika; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 258, 115587.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37215001\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Solvents: Dimethylformamide; overnight, rt\", \"200. Scheme 200 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis\", \"By: Futatsugi, Kentaro; et al\", \"Journal of Medicinal Chemistry (2022), 65(22), 15000-15013.\", \"10.1021/acs.jmedchem.2c01200\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"124-68-5\", \"3034673-70-3\"], \"pro_cas\": [\"3034673-71-4\"], \"rgt_cas\": [\"1892-57-5\", \"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["124-68-5", "3034673-70-3"], "products": ["3034673-71-4"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.137479", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37217821", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "2,6-Lutidine", "cas": "108-48-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 15.0, "time_h": 15.0, "yield_pct": 89.0}, "smiles": {"reactants": "C[C@H](NC(=O)[C@H](C)NC(=O)OC(C)(C)C)C(=O)O.C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@H]1O[C@@H](c3ccc(Cc4cccc(N)c4)cc3)O[C@]12C(=O)CO", "products": "C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)Nc1cccc(Cc2ccc([C@@H]3O[C@@H]4C[C@H]5[C@@H]6CCC7=CC(=O)C=C[C@]7(C)[C@H]6[C@@H](O)C[C@]5(C)[C@]4(C(=O)CO)O3)cc2)c1"}, "reference": {"title": "Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing", "authors": "Hobson, Adrian D.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(13), 9161-9173.", "doi": "10.1021/acs.jmedchem.3c00794", "raw": "Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing | Hobson, Adrian D.; et al | Journal of Medicinal Chemistry (2023), 66(13), 9161-9173. | 10.1021/acs.jmedchem.3c00794"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-37217821", "1.1|Reagents: 2,6-Lutidine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 15 h, 15 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor", "By: Pithani, Subhash; et al", "Organic Process Research & Development (2023), 27(7), 1317-1329.", "10.1021/acs.oprd.3c00077"], "signatures": {"cond_key": "none/none/2,6-Lutidine|108-48-5+HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "950cef51", "fam_sig": "2d728222"}, "raw_data": {"raw_cas": "RCT: 2241040-29-7 + 2408851-66-9 | PRO: 2241039-81-4 | RGT: 108-48-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of Drug-Linker to Enable Long-term Storage of Antibody-Drug Conjugate for Subcutaneous Dosing\", \"authors\": \"Hobson, Adrian D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(13), 9161-9173.\", \"reagents\": [\"2,6-Lutidine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37217821\", \"1.1\", \"Reagents: 2,6-Lutidine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 15 h, 15 °C\", \"449. Scheme 449 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor\", \"By: Pithani, Subhash; et al\", \"Organic Process Research & Development (2023), 27(7), 1317-1329.\", \"10.1021/acs.oprd.3c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2241040-29-7\", \"2408851-66-9\"], \"pro_cas\": [\"2241039-81-4\"], \"rgt_cas\": [\"108-48-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["2241040-29-7", "2408851-66-9"], "products": ["2241039-81-4"], "reagents": ["2,6-Lutidine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.137479", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37259405", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.C#Cc1cccc(N)c1", "products": "C#Cc1cccc(NC(=O)CNC(=O)OC(C)(C)C)c1"}, "reference": {"title": "Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors", "authors": "Yan, Yu-Hang; et al", "citation": "European Journal of Medicinal Chemistry (2023), 257, 115473.", "doi": "10.1016/j.ejmech.2023.115473", "raw": "Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors | Yan, Yu-Hang; et al | European Journal of Medicinal Chemistry (2023), 257, 115473. | 10.1016/j.ejmech.2023.115473"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-37259405", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, rt", "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "By: Bayrak, Alp; et al", "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "10.1021/acs.jmedchem.2c01198"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 75-64-9 + 84358-13-4 | PRO: 1050585-74-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors\", \"authors\": \"Yan, Yu-Hang; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 257, 115473.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37259405\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, rt\", \"68. Scheme 68 (1 Reaction)\", \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"By: Bayrak, Alp; et al\", \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"10.1021/acs.jmedchem.2c01198\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-64-9\", \"84358-13-4\"], \"pro_cas\": [\"1050585-74-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-64-9", "84358-13-4"], "products": ["1050585-74-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.137479", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37263130", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}], "conditions": {"temperature_c": 25.0, "time_h": 108.083, "yield_pct": 88.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O.Nc1ccc(OCc2ccccc2)cc1", "products": "CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)Nc1ccc(OCc2ccccc2)cc1"}, "reference": {"title": "[18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging", "authors": "De Dominicis, Carlo; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(5), 933-939.", "doi": "10.1021/acsmedchemlett.9b00677", "raw": "[18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging | De Dominicis, Carlo; et al | ACS Medicinal Chemistry Letters (2020), 11(5), 933-939. | 10.1021/acsmedchemlett.9b00677"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-37263130", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylacetamide; 5 min, rt", "1.2|Reagents: Diisopropylethylamine; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)", "By: Wang, Jocelyn; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 96, 129492.", "10.1016/j.bmcl.2023.129492"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylacetamide|127-19-5", "cond_sig": "0956dd0b", "fam_sig": "5466c2e9"}, "raw_data": {"raw_cas": "RCT: 74-89-5 + 3053945-21-1 | PRO: 3053945-22-2 | RGT: 148893-10-1 + 7087-68-5 | SOL: 127-19-5", "raw_data_json": "{\"txt\": {\"title\": \"[18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging\", \"authors\": \"De Dominicis, Carlo; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(5), 933-939.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37263130\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylacetamide; 5 min, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; 12 h, rt\", \"41. Scheme 41 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)\", \"By: Wang, Jocelyn; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 96, 129492.\", \"10.1016/j.bmcl.2023.129492\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"74-89-5\", \"3053945-21-1\"], \"pro_cas\": [\"3053945-22-2\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["74-89-5", "3053945-21-1"], "products": ["3053945-22-2"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylacetamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.137479", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37263132", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Na2CO3", "cas": "497-19-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium carbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 95.0}, "smiles": {"reactants": "CC(C)(C)CC(=O)O.COC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "COC(=O)[C@H](Cc1ccccc1)NC(=O)CC(C)(C)C"}, "reference": {"title": "Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors", "authors": "Massaro, Chelsea; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(6), 2814-2832.", "doi": "10.1021/acs.jmedchem.9b00568", "raw": "Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors | Massaro, Chelsea; et al | Journal of Medicinal Chemistry (2020), 63(6), 2814-2832. | 10.1021/acs.jmedchem.9b00568"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-37263132", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 24 h, rt", "1.2|Reagents: Sodium carbonate", "Solvents: Water; rt", "Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy", "By: Zheng, Yang; et al", "Journal of Medicinal Chemistry (2024), 67(4), 2849-2863.", "10.1021/acs.jmedchem.3c01976"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+Na2CO3|497-19-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium carbonate|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f704d802", "fam_sig": "0e0557bd"}, "raw_data": {"raw_cas": "RCT: 1365354-76-2 + 74-89-5 | PRO: 3032452-60-8 | RGT: 7087-68-5 + 148893-10-1 + 497-19-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Serendipitous Discovery of Leucine and Methionine Depletion Agents during the Search for Polyamine Transport Inhibitors\", \"authors\": \"Massaro, Chelsea; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(6), 2814-2832.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium carbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37263132\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 24 h, rt\", \"1.2\", \"Reagents: Sodium carbonate\", \"Solvents: Water; rt\", \"51. Scheme 51 (1 Reaction)\", \"Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy\", \"By: Zheng, Yang; et al\", \"Journal of Medicinal Chemistry (2024), 67(4), 2849-2863.\", \"10.1021/acs.jmedchem.3c01976\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1365354-76-2\", \"74-89-5\"], \"pro_cas\": [\"3032452-60-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"497-19-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1365354-76-2", "74-89-5"], "products": ["3032452-60-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Na2CO3"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.137479", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37264191", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.167, "yield_pct": 83.0}, "smiles": {"reactants": "Cc1ccc(C(=O)O)cc1N.NCc1cccnc1", "products": "Cc1ccc(C(=O)NCc2cccnc2)cc1N"}, "reference": {"title": "Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site", "authors": "Lin, Songwen; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(24), 16372-16391.", "doi": "10.1021/acs.jmedchem.2c01208", "raw": "Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site | Lin, Songwen; et al | Journal of Medicinal Chemistry (2022), 65(24), 16372-16391. | 10.1021/acs.jmedchem.2c01208"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37264191", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; overnight, rt", "1.2|Solvents: Water; 10 min, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "65f98346", "fam_sig": "9c519356"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 75178-96-0 | PRO: 3031471-24-3 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site\", \"authors\": \"Lin, Songwen; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(24), 16372-16391.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37264191\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; overnight, rt\", \"1.2\", \"Solvents: Water; 10 min, rt\", \"100. Scheme 100 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"75178-96-0\"], \"pro_cas\": [\"3031471-24-3\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "75178-96-0"], "products": ["3031471-24-3"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.138476", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37268467", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "N-Methylmorpholine", "cas": "109-02-4"}, {"name": "4-Methylmorpholine", "cas": ""}], "conditions": {"temperature_c": 0.0, "time_h": 8.167, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)O.NCc1ccccc1", "products": "CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)NCc1ccccc1"}, "reference": {"title": "Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils", "authors": "Zhu, Di; et al", "citation": "European Journal of Medicinal Chemistry (2023), 258, 115619.", "doi": "10.1016/j.ejmech.2023.115619", "raw": "Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils | Zhu, Di; et al | European Journal of Medicinal Chemistry (2023), 258, 115619. | 10.1016/j.ejmech.2023.115619"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-37268467", "1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Tetrahydrofuran; 10 min, 0 °C", "1.2|Solvents: 4-Methylmorpholine; pH 8.0, rt; 8 h, rt", "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "By: Bothe, Ulrich; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "10.1021/acs.jmedchem.3c01714"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/4-Methylmorpholine|+N-Methylmorpholine|109-02-4+Tetrahydrofuran|109-99-9", "cond_sig": "90b63491", "fam_sig": "b4686338"}, "raw_data": {"raw_cas": "RCT: 69399-59-3 + 167011-35-0 | PRO: 3032481-75-4 | RGT: 538-75-0 + 2592-95-2 | SOL: 109-99-9 + 109-02-4", "raw_data_json": "{\"txt\": {\"title\": \"Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils\", \"authors\": \"Zhu, Di; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 258, 115619.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"4-Methylmorpholine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37268467\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Tetrahydrofuran; 10 min, 0 °C\", \"1.2\", \"Solvents: 4-Methylmorpholine; pH 8.0, rt; 8 h, rt\", \"339. Scheme 339 (1 Reaction)\", \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"By: Bothe, Ulrich; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"10.1021/acs.jmedchem.3c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"69399-59-3\", \"167011-35-0\"], \"pro_cas\": [\"3032481-75-4\"], \"rgt_cas\": [\"538-75-0\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"109-02-4\"], \"notes\": []}}", "enriched_names": {"reactants": ["69399-59-3", "167011-35-0"], "products": ["3032481-75-4"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Tetrahydrofuran", "N-Methylmorpholine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.138476", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37275693", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 15.833, "yield_pct": 81.0}, "smiles": {"reactants": "Cc1cccc(Nc2ccccc2C(=O)O)c1C.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]", "products": "CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)c1ccccc1Nc1cccc(C)c1C.[I-]"}, "reference": {"title": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "authors": "Vaidya, Sandeep; et al", "citation": "ChemMedChem (2023), 18(16), e202300097.", "doi": "10.1002/cmdc.202300097", "raw": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers | Vaidya, Sandeep; et al | ChemMedChem (2023), 18(16), e202300097. | 10.1002/cmdc.202300097"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-37275693", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 20 min, rt", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt", "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "By: Narayanan, Dilip; et al", "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "10.1021/acs.jmedchem.2c00830"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 6223-83-2 + 88831-43-0 | PRO: 3031559-98-2 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"authors\": \"Vaidya, Sandeep; et al\", \"citation\": \"ChemMedChem (2023), 18(16), e202300097.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37275693\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 20 min, rt\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt\", \"326. Scheme 326 (1 Reaction)\", \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"By: Narayanan, Dilip; et al\", \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"10.1021/acs.jmedchem.2c00830\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6223-83-2\", \"88831-43-0\"], \"pro_cas\": [\"3031559-98-2\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"inert in stage 2\"]}}", "enriched_names": {"reactants": ["6223-83-2", "88831-43-0"], "products": ["3031559-98-2"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.138476", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37275694", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 15.833, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)Cc1ccc(C(C)C(=O)O)cc1.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]", "products": "CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)C(C)c1ccc(CC(C)C)cc1.[I-]"}, "reference": {"title": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "authors": "Vaidya, Sandeep; et al", "citation": "ChemMedChem (2023), 18(16), e202300097.", "doi": "10.1002/cmdc.202300097", "raw": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers | Vaidya, Sandeep; et al | ChemMedChem (2023), 18(16), e202300097. | 10.1002/cmdc.202300097"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-37275694", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 20 min, rt", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 103-82-2 + 120-20-7 | PRO: 4876-02-2 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"authors\": \"Vaidya, Sandeep; et al\", \"citation\": \"ChemMedChem (2023), 18(16), e202300097.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37275694\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 20 min, rt\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt\", \"97. Scheme 97 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"103-82-2\", \"120-20-7\"], \"pro_cas\": [\"4876-02-2\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"inert in stage 2\"]}}", "enriched_names": {"reactants": ["103-82-2", "120-20-7"], "products": ["4876-02-2"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.138476", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37275697", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.833, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]", "products": "CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)C(C)c1cccc(C(=O)c2ccccc2)c1.[I-]"}, "reference": {"title": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "authors": "Vaidya, Sandeep; et al", "citation": "ChemMedChem (2023), 18(16), e202300097.", "doi": "10.1002/cmdc.202300097", "raw": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers | Vaidya, Sandeep; et al | ChemMedChem (2023), 18(16), e202300097. | 10.1002/cmdc.202300097"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-37275697", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 20 min, rt", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt", "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "By: Sheppard, George S.; et al", "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "10.1021/acs.jmedchem.0c00628"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 2138863-08-6 + 557-66-4 | PRO: 2702965-85-1 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"authors\": \"Vaidya, Sandeep; et al\", \"citation\": \"ChemMedChem (2023), 18(16), e202300097.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37275697\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 20 min, rt\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt\", \"186. Scheme 186 (1 Reaction)\", \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"By: Sheppard, George S.; et al\", \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"10.1021/acs.jmedchem.0c00628\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2138863-08-6\", \"557-66-4\"], \"pro_cas\": [\"2702965-85-1\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"inert in stage 2\"]}}", "enriched_names": {"reactants": ["2138863-08-6", "557-66-4"], "products": ["2702965-85-1"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.138476", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37275700", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 15.833, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]", "products": "CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)C(C)c1ccc2c(c1)[nH]c1ccc(Cl)cc12.[I-]"}, "reference": {"title": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "authors": "Vaidya, Sandeep; et al", "citation": "ChemMedChem (2023), 18(16), e202300097.", "doi": "10.1002/cmdc.202300097", "raw": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers | Vaidya, Sandeep; et al | ChemMedChem (2023), 18(16), e202300097. | 10.1002/cmdc.202300097"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-37275700", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 20 min, rt", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 13734-34-4 + 2761157-71-3 | PRO: 2761157-79-1 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"authors\": \"Vaidya, Sandeep; et al\", \"citation\": \"ChemMedChem (2023), 18(16), e202300097.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37275700\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 20 min, rt\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt\", \"462. Scheme 462 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13734-34-4\", \"2761157-71-3\"], \"pro_cas\": [\"2761157-79-1\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"inert in stage 2\"]}}", "enriched_names": {"reactants": ["13734-34-4", "2761157-71-3"], "products": ["2761157-79-1"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.138476", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37275703", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 15.833, "yield_pct": 89.0}, "smiles": {"reactants": "COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1.CCCCCCCCCCCC[N+](C)(CCN)CCCCCCCCCCCC.[I-]", "products": "CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CCNC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12.[I-]"}, "reference": {"title": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "authors": "Vaidya, Sandeep; et al", "citation": "ChemMedChem (2023), 18(16), e202300097.", "doi": "10.1002/cmdc.202300097", "raw": "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers | Vaidya, Sandeep; et al | ChemMedChem (2023), 18(16), e202300097. | 10.1002/cmdc.202300097"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-37275703", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Dichloromethane; 20 min, rt", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer", "By: Cordella, Fabiana; et al", "ChemMedChem (2024), 19(14), e202300727.", "10.1002/cmdc.202300727"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 77205-61-9 + 586410-15-3 | PRO: 3081937-81-4 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"authors\": \"Vaidya, Sandeep; et al\", \"citation\": \"ChemMedChem (2023), 18(16), e202300097.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37275703\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Dichloromethane; 20 min, rt\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 30 min, 0 °C; 0 °C → rt; 15 h, rt\", \"338. Scheme 338 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer\", \"By: Cordella, Fabiana; et al\", \"ChemMedChem (2024), 19(14), e202300727.\", \"10.1002/cmdc.202300727\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"77205-61-9\", \"586410-15-3\"], \"pro_cas\": [\"3081937-81-4\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"inert in stage 2\"]}}", "enriched_names": {"reactants": ["77205-61-9", "586410-15-3"], "products": ["3081937-81-4"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.138476", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37291176", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 22.0, "yield_pct": 92.0}, "smiles": {"reactants": "CN1CCc2nc(C(=O)O)sc2C1.Cl.Br.CN(C)C(=O)[C@H]1CC[C@@H](O)[C@H](N)C1", "products": "CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@H]3O)sc2C1"}, "reference": {"title": "Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective Synthesis of Edoxaban", "authors": "Ochiai, Hidenori; et al", "citation": "Organic Process Research & Development (2023), 27(8), 1517-1532.", "doi": "10.1021/acs.oprd.3c00189", "raw": "Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective Synthesis of Edoxaban | Ochiai, Hidenori; et al | Organic Process Research & Development (2023), 27(8), 1517-1532. | 10.1021/acs.oprd.3c00189"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-37291176", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 0 °C; 22 h, 25 °C", "Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors", "By: Huang, Daowei; et al", "European Journal of Medicinal Chemistry (2021), 223, 113648.", "10.1016/j.ejmech.2021.113648"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4da6172b", "fam_sig": "2c09422f"}, "raw_data": {"raw_cas": "RCT: 630125-70-1 + 849217-48-7 | PRO: 2211941-75-0 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Stereoinvertive Deoxyamination of trans-2-Aminocyclohexanol Using Bose-Mitsunobu Azidation and Staudinger Reaction for the Stereoselective Synthesis of Edoxaban\", \"authors\": \"Ochiai, Hidenori; et al\", \"citation\": \"Organic Process Research & Development (2023), 27(8), 1517-1532.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37291176\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 0 °C; 22 h, 25 °C\", \"10. Scheme 10 (1 Reaction)\", \"Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors\", \"By: Huang, Daowei; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113648.\", \"10.1016/j.ejmech.2021.113648\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"630125-70-1\", \"849217-48-7\"], \"pro_cas\": [\"2211941-75-0\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["630125-70-1", "849217-48-7"], "products": ["2211941-75-0"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.139474", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37335626", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Pivaloyl chloride", "cas": "3282-30-2", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 99.0}, "smiles": {"reactants": "O=C(O)CCc1c[nH]c2ccccc12.COC(=O)C(C)N.Cl", "products": "COC(=O)C(C)NC(=O)CCc1c[nH]c2ccccc12"}, "reference": {"title": "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease", "authors": "Kilpelainen, Tommi P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.", "doi": "10.1021/acs.jmedchem.3c00235", "raw": "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease | Kilpelainen, Tommi P.; et al | Journal of Medicinal Chemistry (2023), 66(11), 7475-7496. | 10.1021/acs.jmedchem.3c00235"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-37335626", "1.1|Reagents: Triethylamine, Pivaloyl chloride", "Solvents: Dichloromethane; 0 °C; 1 h, 0 °C", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C → rt; 3 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation", "By: Falkenstein, Markus; et al", "Bioorganic & Medicinal Chemistry (2021), 50, 116462.", "10.1016/j.bmc.2021.116462"], "signatures": {"cond_key": "none/none/Pivaloyl chloride|3282-30-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "132ac6e1", "fam_sig": "84197396"}, "raw_data": {"raw_cas": "RCT: 1080-06-4 + 4530-20-5 | PRO: 65160-62-5 | RGT: 121-44-8 + 3282-30-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease\", \"authors\": \"Kilpelainen, Tommi P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.\", \"reagents\": [\"Triethylamine\", \"Pivaloyl chloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37335626\", \"1.1\", \"Reagents: Triethylamine, Pivaloyl chloride\", \"Solvents: Dichloromethane; 0 °C; 1 h, 0 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C → rt; 3 h, rt\", \"229. Scheme 229 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation\", \"By: Falkenstein, Markus; et al\", \"Bioorganic & Medicinal Chemistry (2021), 50, 116462.\", \"10.1016/j.bmc.2021.116462\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1080-06-4\", \"4530-20-5\"], \"pro_cas\": [\"65160-62-5\"], \"rgt_cas\": [\"121-44-8\", \"3282-30-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1080-06-4", "4530-20-5"], "products": ["65160-62-5"], "reagents": ["Triethylamine", "3282-30-2"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.139474", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37335627", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Pivaloyl chloride", "cas": "3282-30-2", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 4.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)CCC(=O)N1CCCCCC1.COC(=O)C(C)N.Cl", "products": "COC(=O)C(C)NC(=O)CCC(=O)N1CCCCCC1"}, "reference": {"title": "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease", "authors": "Kilpelainen, Tommi P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.", "doi": "10.1021/acs.jmedchem.3c00235", "raw": "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease | Kilpelainen, Tommi P.; et al | Journal of Medicinal Chemistry (2023), 66(11), 7475-7496. | 10.1021/acs.jmedchem.3c00235"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-37335627", "1.1|Reagents: Triethylamine, Pivaloyl chloride", "Solvents: Dichloromethane; 0 °C; 1 h, 0 °C", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C → rt; 3 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine", "By: Aguirre-Renteria, Saul A.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.", "10.1016/j.bmcl.2020.127074"], "signatures": {"cond_key": "none/none/Pivaloyl chloride|3282-30-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "132ac6e1", "fam_sig": "84197396"}, "raw_data": {"raw_cas": "RCT: 5680-80-8 + 943-89-5 | PRO: 2414059-78-0 + 2414059-86-0 | RGT: 121-44-8 + 3282-30-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease\", \"authors\": \"Kilpelainen, Tommi P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.\", \"reagents\": [\"Triethylamine\", \"Pivaloyl chloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37335627\", \"1.1\", \"Reagents: Triethylamine, Pivaloyl chloride\", \"Solvents: Dichloromethane; 0 °C; 1 h, 0 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C → rt; 3 h, rt\", \"89. Scheme 89 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Synthesis and in vitro evaluation of antimycobacterial and cytotoxic activity of new α,β-unsaturated amide, oxazoline and oxazole derivatives from L-serine\", \"By: Aguirre-Renteria, Saul A.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(9), 127074.\", \"10.1016/j.bmcl.2020.127074\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5680-80-8\", \"943-89-5\"], \"pro_cas\": [\"2414059-78-0\", \"2414059-86-0\"], \"rgt_cas\": [\"121-44-8\", \"3282-30-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5680-80-8", "943-89-5"], "products": ["2414059-78-0", "2414059-86-0"], "reagents": ["Triethylamine", "3282-30-2"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.139474", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37335664", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)CCCc1ccccn1.C[C@H](N)C(=O)N1CCC[C@H]1C(N)=O.O=C(O)C(F)(F)F", "products": "C[C@H](NC(=O)CCCc1ccccn1)C(=O)N1CCC[C@H]1C(N)=O"}, "reference": {"title": "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease", "authors": "Kilpelainen, Tommi P.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.", "doi": "10.1021/acs.jmedchem.3c00235", "raw": "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease | Kilpelainen, Tommi P.; et al | Journal of Medicinal Chemistry (2023), 66(11), 7475-7496. | 10.1021/acs.jmedchem.3c00235"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-37335664", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 4 h, rt", "Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe", "By: Tamayo, Nuria A.; et al", "Journal of Medicinal Chemistry (2022), 65(6), 4972-4990.", "10.1021/acs.jmedchem.1c02030"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 171178-50-0 + 608523-94-0 | PRO: 2820400-44-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease\", \"authors\": \"Kilpelainen, Tommi P.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37335664\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 4 h, rt\", \"310. Scheme 310 (1 Reaction)\", \"Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe\", \"By: Tamayo, Nuria A.; et al\", \"Journal of Medicinal Chemistry (2022), 65(6), 4972-4990.\", \"10.1021/acs.jmedchem.1c02030\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"171178-50-0\", \"608523-94-0\"], \"pro_cas\": [\"2820400-44-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["171178-50-0", "608523-94-0"], "products": ["2820400-44-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.139474", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37375870", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 140.0, "time_h": 5.0, "yield_pct": 85.0}, "smiles": {"reactants": "NC=O.Nc1cnc(Cl)cc1C(=O)O", "products": "O=c1nc[nH]c2cnc(Cl)cc12"}, "reference": {"title": "Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors", "authors": "Kim, Namkyoung; et al", "citation": "European Journal of Medicinal Chemistry (2023), 259, 115635.", "doi": "10.1016/j.ejmech.2023.115635", "raw": "Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors | Kim, Namkyoung; et al | European Journal of Medicinal Chemistry (2023), 259, 115635. | 10.1016/j.ejmech.2023.115635"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-37375870", "1.1|5 h, 140 °C", "Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation", "By: Fioravanti, Rossella; et al", "ChemMedChem (2020), 15(7), 643-658.", "10.1002/cmdc.201900730"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 63254-88-6 + 1642574-87-5 | PRO: 2414143-93-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors\", \"authors\": \"Kim, Namkyoung; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 259, 115635.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37375870\", \"1.1\", \"5 h, 140 °C\", \"38. Scheme 38 (1 Reaction)\", \"Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation\", \"By: Fioravanti, Rossella; et al\", \"ChemMedChem (2020), 15(7), 643-658.\", \"10.1002/cmdc.201900730\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"63254-88-6\", \"1642574-87-5\"], \"pro_cas\": [\"2414143-93-2\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["63254-88-6", "1642574-87-5"], "products": ["2414143-93-2"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.139474", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37376179", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 91.0}, "smiles": {"reactants": "NC1CC1.O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1", "products": "O=C(CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1)NC1CC1"}, "reference": {"title": "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors", "authors": "Zhu, Junjie; et al", "citation": "European Journal of Medicinal Chemistry (2023), 259, 115666.", "doi": "10.1016/j.ejmech.2023.115666", "raw": "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors | Zhu, Junjie; et al | European Journal of Medicinal Chemistry (2023), 259, 115666. | 10.1016/j.ejmech.2023.115666"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-37376179", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; overnight, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "By: Chen, Yuanguang; et al", "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "10.1021/acs.jmedchem.3c02006"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+NaHCO3|144-55-8+Sodium bicarbonate|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "9055c6dc", "fam_sig": "60b8f38e"}, "raw_data": {"raw_cas": "RCT: 63984-02-1 + 3032415-34-9 | PRO: 3032415-35-0 | RGT: 2592-95-2 + 25952-53-8 + 144-55-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors\", \"authors\": \"Zhu, Junjie; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 259, 115666.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37376179\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; overnight, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"391. Scheme 391 (1 Reaction)\", \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"By: Chen, Yuanguang; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"10.1021/acs.jmedchem.3c02006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"63984-02-1\", \"3032415-34-9\"], \"pro_cas\": [\"3032415-35-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["63984-02-1", "3032415-34-9"], "products": ["3032415-35-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.139474", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37376180", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)(C)N.O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1", "products": "CC(C)(C)NC(=O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1"}, "reference": {"title": "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors", "authors": "Zhu, Junjie; et al", "citation": "European Journal of Medicinal Chemistry (2023), 259, 115666.", "doi": "10.1016/j.ejmech.2023.115666", "raw": "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors | Zhu, Junjie; et al | European Journal of Medicinal Chemistry (2023), 259, 115666. | 10.1016/j.ejmech.2023.115666"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-37376180", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; overnight, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation", "By: Tokarski, Robert J. II; et al", "European Journal of Medicinal Chemistry (2023), 254, 115342.", "10.1016/j.ejmech.2023.115342"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+NaHCO3|144-55-8+Sodium bicarbonate|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "9055c6dc", "fam_sig": "60b8f38e"}, "raw_data": {"raw_cas": "RCT: 27019-47-2 + 111331-82-9 | PRO: 135321-13-0 | RGT: 2592-95-2 + 25952-53-8 + 144-55-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors\", \"authors\": \"Zhu, Junjie; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 259, 115666.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37376180\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; overnight, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"347. Scheme 347 (1 Reaction)\", \"Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation\", \"By: Tokarski, Robert J. II; et al\", \"European Journal of Medicinal Chemistry (2023), 254, 115342.\", \"10.1016/j.ejmech.2023.115342\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"27019-47-2\", \"111331-82-9\"], \"pro_cas\": [\"135321-13-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["27019-47-2", "111331-82-9"], "products": ["135321-13-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.139474", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37376187", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1.CC(C)N.Cl", "products": "CC(C)NC(=O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1"}, "reference": {"title": "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors", "authors": "Zhu, Junjie; et al", "citation": "European Journal of Medicinal Chemistry (2023), 259, 115666.", "doi": "10.1016/j.ejmech.2023.115666", "raw": "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors | Zhu, Junjie; et al | European Journal of Medicinal Chemistry (2023), 259, 115666. | 10.1016/j.ejmech.2023.115666"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-37376187", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; overnight, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "By: Narayanan, Dilip; et al", "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "10.1021/acs.jmedchem.2c00830"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+NaHCO3|144-55-8+Sodium bicarbonate|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "9055c6dc", "fam_sig": "60b8f38e"}, "raw_data": {"raw_cas": "RCT: 6223-83-2 + 1001427-55-9 | PRO: 3031559-99-3 | RGT: 2592-95-2 + 25952-53-8 + 144-55-8 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors\", \"authors\": \"Zhu, Junjie; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 259, 115666.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37376187\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; overnight, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"323. Scheme 323 (1 Reaction)\", \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"By: Narayanan, Dilip; et al\", \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"10.1021/acs.jmedchem.2c00830\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6223-83-2\", \"1001427-55-9\"], \"pro_cas\": [\"3031559-99-3\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["6223-83-2", "1001427-55-9"], "products": ["3031559-99-3"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.140471", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37387770", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "UNK"}, {"name": "4-Dimethylaminopyridine", "cas": "1122-58-3", "role": "UNK"}, {"name": "4-(Dimethylamino)pyridine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 60.0, "time_h": 2.5, "yield_pct": 80.0}, "smiles": {"reactants": "COc1nn(-c2cncc(Br)c2)cc1C(=O)O.CC(C)n1cnnc1-c1cccc(N)n1", "products": "COc1nn(-c2cncc(Br)c2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1"}, "reference": {"title": "Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors", "authors": "Xin, Zhili; et al", "citation": "ACS Medicinal Chemistry Letters (2020), 11(4), 485-490.", "doi": "10.1021/acsmedchemlett.9b00611", "raw": "Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors | Xin, Zhili; et al | ACS Medicinal Chemistry Letters (2020), 11(4), 485-490. | 10.1021/acsmedchemlett.9b00611"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-37387770", "1.1|Reagents: Thionyl chloride; 2 h, pH 8, 60 °C", "1.2|Reagents: Pyridine", "Solvents: Dichloromethane; pH 8, rt", "1.3|Reagents: 4-(Dimethylamino)pyridine; 0.5 h, 29 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2", "By: Roussel, Emile; et al", "European Journal of Medicinal Chemistry (2020), 202, 112503.", "10.1016/j.ejmech.2020.112503"], "signatures": {"cond_key": "none/none/4-(Dimethylamino)pyridine|+4-Dimethylaminopyridine|1122-58-3+Pyridine|110-86-1+Thionyl chloride|7719-09-7/Dichloromethane|75-09-2", "cond_sig": "f64ab2e2", "fam_sig": "5cf7b950"}, "raw_data": {"raw_cas": "RCT: 1353747-19-9 + 7524-50-7 | PRO: 2454588-22-6 | RGT: 7719-09-7 + 110-86-1 + 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors\", \"authors\": \"Xin, Zhili; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2020), 11(4), 485-490.\", \"reagents\": [\"Thionyl chloride\", \"Pyridine\", \"4-(Dimethylamino)pyridine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37387770\", \"1.1\", \"Reagents: Thionyl chloride; 2 h, pH 8, 60 °C\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Dichloromethane; pH 8, rt\", \"1.3\", \"Reagents: 4-(Dimethylamino)pyridine; 0.5 h, 29 °C\", \"352. Scheme 352 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2\", \"By: Roussel, Emile; et al\", \"European Journal of Medicinal Chemistry (2020), 202, 112503.\", \"10.1016/j.ejmech.2020.112503\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1353747-19-9\", \"7524-50-7\"], \"pro_cas\": [\"2454588-22-6\"], \"rgt_cas\": [\"7719-09-7\", \"110-86-1\", \"1122-58-3\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1353747-19-9", "7524-50-7"], "products": ["2454588-22-6"], "reagents": ["7719-09-7", "Pyridine", "4-Dimethylaminopyridine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.140471", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37428756", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 93.0}, "smiles": {"reactants": "Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O.CC(C)(C)OC(=O)NCCOCCOCCOCC(=O)O", "products": "NCCOCCOCCOCC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O"}, "reference": {"title": "PROTACs Targeting MLKL Protect Cells from Necroptosis", "authors": "Rathje, Oliver H.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(16), 11216-11236.", "doi": "10.1021/acs.jmedchem.3c00665", "raw": "PROTACs Targeting MLKL Protect Cells from Necroptosis | Rathje, Oliver H.; et al | Journal of Medicinal Chemistry (2023), 66(16), 11216-11236. | 10.1021/acs.jmedchem.3c00665"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-37428756", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.2|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 30 min, rt", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "63908664", "fam_sig": "6fa828eb"}, "raw_data": {"raw_cas": "RCT: 2892557-06-9 + 104-94-9 | PRO: 2892557-14-9 | RGT: 7087-68-5 + 148893-10-1 + 76-05-1 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"PROTACs Targeting MLKL Protect Cells from Necroptosis\", \"authors\": \"Rathje, Oliver H.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(16), 11216-11236.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Trifluoroacetic acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37428756\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.2\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 30 min, rt\", \"345. Scheme 345 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-06-9\", \"104-94-9\"], \"pro_cas\": [\"2892557-14-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"76-05-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-06-9", "104-94-9"], "products": ["2892557-14-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Trifluoroacetic acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.140471", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37481032", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Formic acid", "cas": "64-18-6", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 145.0, "time_h": 8.0, "yield_pct": 87.0}, "smiles": {"reactants": "NC=O.Nc1cc(Br)ccc1C(=O)O", "products": "O=c1nc[nH]c2cc(Br)ccc12"}, "reference": {"title": "Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy", "authors": "Meng, Yangyang; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 11815-11830.", "doi": "10.1021/acs.jmedchem.3c00264", "raw": "Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy | Meng, Yangyang; et al | Journal of Medicinal Chemistry (2023), 66(17), 11815-11830. | 10.1021/acs.jmedchem.3c00264"}, "original_text": ["Steps: 1, Yield: 87-89%", "CAS Reaction Number: 31-614-CAS-37481032", "1.1|Reagents: Formic acid; 8 h, 145 °C", "Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists", "By: Bae, Inhwan; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 34, 127676.", "10.1016/j.bmcl.2020.127676"], "signatures": {"cond_key": "none/none/Formic acid|64-18-6/none", "cond_sig": "0ebba803", "fam_sig": "5ac82112"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 446-32-2 | PRO: 16499-57-3 | RGT: 64-18-6", "raw_data_json": "{\"txt\": {\"title\": \"Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy\", \"authors\": \"Meng, Yangyang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 11815-11830.\", \"reagents\": [\"Formic acid\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37481032\", \"1.1\", \"Reagents: Formic acid; 8 h, 145 °C\", \"431. Scheme 431 (1 Reaction)\", \"Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists\", \"By: Bae, Inhwan; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 34, 127676.\", \"10.1016/j.bmcl.2020.127676\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"446-32-2\"], \"pro_cas\": [\"16499-57-3\"], \"rgt_cas\": [\"64-18-6\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "446-32-2"], "products": ["16499-57-3"], "reagents": ["Formic acid"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.140471", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37616100", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}], "conditions": {"temperature_c": 25.0, "time_h": 23.0, "yield_pct": 84.0}, "smiles": {"reactants": "COc1cc(/C=C/C(=O)O)cc(OC)c1OC.COC(=O)Cc1ccc(N)cc1", "products": "COC(=O)Cc1ccc(NC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)cc1"}, "reference": {"title": "Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers", "authors": "Braconi, Laura; et al", "citation": "European Journal of Medicinal Chemistry (2023), 259, 115716.", "doi": "10.1016/j.ejmech.2023.115716", "raw": "Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers | Braconi, Laura; et al | European Journal of Medicinal Chemistry (2023), 259, 115716. | 10.1016/j.ejmech.2023.115716"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-37616100", "1.1|Reagents: Thionyl chloride", "Solvents: Chloroform; 5 h, reflux; reflux → rt", "1.2|Solvents: Chloroform; 18 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of 6-chloro-quinolin-2-one derivatives as novel FXIa inhibitors", "By: Wang, Yanshi; et al", "Bioorganic & Medicinal Chemistry Letters (2024), 99, 129610.", "10.1016/j.bmcl.2024.129610"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Chloroform|67-66-3", "cond_sig": "4ff98208", "fam_sig": "f73d2f9e"}, "raw_data": {"raw_cas": "RCT: 1759-53-1 + 65615-90-9 | PRO: 2423992-73-6 | RGT: 7719-09-7 | SOL: 67-66-3", "raw_data_json": "{\"txt\": {\"title\": \"Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers\", \"authors\": \"Braconi, Laura; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 259, 115716.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37616100\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Chloroform; 5 h, reflux; reflux → rt\", \"1.2\", \"Solvents: Chloroform; 18 h, rt\", \"276. Scheme 276 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of 6-chloro-quinolin-2-one derivatives as novel FXIa inhibitors\", \"By: Wang, Yanshi; et al\", \"Bioorganic & Medicinal Chemistry Letters (2024), 99, 129610.\", \"10.1016/j.bmcl.2024.129610\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1759-53-1\", \"65615-90-9\"], \"pro_cas\": [\"2423992-73-6\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\"], \"notes\": [\"stereoselective\"]}}", "enriched_names": {"reactants": ["1759-53-1", "65615-90-9"], "products": ["2423992-73-6"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Chloroform"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.140471", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37616116", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Chloroform", "cas": "67-66-3"}], "conditions": {"temperature_c": 25.0, "time_h": 23.0, "yield_pct": 94.0}, "smiles": {"reactants": "COc1cc(C(=O)O)cc(OC)c1OC.COC(=O)Cc1ccc(N)cc1", "products": "COC(=O)Cc1ccc(NC(=O)c2cc(OC)c(OC)c(OC)c2)cc1"}, "reference": {"title": "Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers", "authors": "Braconi, Laura; et al", "citation": "European Journal of Medicinal Chemistry (2023), 259, 115716.", "doi": "10.1016/j.ejmech.2023.115716", "raw": "Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers | Braconi, Laura; et al | European Journal of Medicinal Chemistry (2023), 259, 115716. | 10.1016/j.ejmech.2023.115716"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-37616116", "1.1|Reagents: Thionyl chloride", "Solvents: Chloroform; 5 h, reflux; reflux → rt", "1.2|Solvents: Chloroform; 18 h, rt", "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "By: Pasqua, A. Elisa; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "10.1021/acs.jmedchem.3c00156"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Chloroform|67-66-3", "cond_sig": "4ff98208", "fam_sig": "f73d2f9e"}, "raw_data": {"raw_cas": "RCT: 635-80-3 + 99-55-8 | PRO: 2015952-91-5 | RGT: 7719-09-7 | SOL: 67-66-3", "raw_data_json": "{\"txt\": {\"title\": \"Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers\", \"authors\": \"Braconi, Laura; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 259, 115716.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Chloroform\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37616116\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Chloroform; 5 h, reflux; reflux → rt\", \"1.2\", \"Solvents: Chloroform; 18 h, rt\", \"257. Scheme 257 (1 Reaction)\", \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"By: Pasqua, A. Elisa; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"10.1021/acs.jmedchem.3c00156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"635-80-3\", \"99-55-8\"], \"pro_cas\": [\"2015952-91-5\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"67-66-3\"], \"notes\": []}}", "enriched_names": {"reactants": ["635-80-3", "99-55-8"], "products": ["2015952-91-5"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Chloroform"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.140471", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37690207", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 96.0}, "smiles": {"reactants": "Cn1nc(C(=O)O)cc1-c1ccc(C(F)(F)F)cc1.NCC1CCCOC1", "products": "Cn1nc(C(=O)NCC2CCCOC2)cc1-c1ccc(C(F)(F)F)cc1"}, "reference": {"title": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "authors": "Christie, Louisa A.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "doi": "10.1021/acs.jmedchem.3c00630", "raw": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction | Christie, Louisa A.; et al | Journal of Medicinal Chemistry (2023), 66(17), 11718-11731. | 10.1021/acs.jmedchem.3c00630"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-37690207", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Tetrahydrofuran; 15 min, rt", "1.2|16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction", "By: Begnini, Fabio; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3473-3517.", "10.1021/acs.jmedchem.1c01975"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "2001d9e7", "fam_sig": "a3e71454"}, "raw_data": {"raw_cas": "RCT: 3037017-04-9 + 6368-20-3 | PRO: 3037017-05-0 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"authors\": \"Christie, Louisa A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37690207\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Tetrahydrofuran; 15 min, rt\", \"1.2\", \"16 h, rt\", \"49. Scheme 49 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction\", \"By: Begnini, Fabio; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3473-3517.\", \"10.1021/acs.jmedchem.1c01975\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3037017-04-9\", \"6368-20-3\"], \"pro_cas\": [\"3037017-05-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3037017-04-9", "6368-20-3"], "products": ["3037017-05-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.140471", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37690229", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.083, "yield_pct": 88.0}, "smiles": {"reactants": "Cn1nc(C(=O)O)cc1-c1ccc(C(F)(F)F)cc1Cl.CN1CCCC(N)C1", "products": "CN1CCCC(NC(=O)c2cc(-c3ccc(C(F)(F)F)cc3Cl)n(C)n2)C1"}, "reference": {"title": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "authors": "Christie, Louisa A.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "doi": "10.1021/acs.jmedchem.3c00630", "raw": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction | Christie, Louisa A.; et al | Journal of Medicinal Chemistry (2023), 66(17), 11718-11731. | 10.1021/acs.jmedchem.3c00630"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-37690229", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 5 min, rt", "1.2|16 h, rt", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "By: Bothe, Ulrich; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "10.1021/acs.jmedchem.3c01714"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "bfa3331d", "fam_sig": "b50f2a3f"}, "raw_data": {"raw_cas": "RCT: 167011-35-0 + 2217628-26-5 | PRO: 3032481-79-8 | RGT: 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"authors\": \"Christie, Louisa A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37690229\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 5 min, rt\", \"1.2\", \"16 h, rt\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"107. Scheme 107 (1 Reaction)\", \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"By: Bothe, Ulrich; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"10.1021/acs.jmedchem.3c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"167011-35-0\", \"2217628-26-5\"], \"pro_cas\": [\"3032481-79-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["167011-35-0", "2217628-26-5"], "products": ["3032481-79-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.141469", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37690250", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.083, "yield_pct": 83.0}, "smiles": {"reactants": "COc1ccc(-c2cc(C(=O)O)nn2C)c(Cl)c1.CN1CCC[C@H](N)C1", "products": "COc1ccc(-c2cc(C(=O)N[C@H]3CCCN(C)C3)nn2C)c(Cl)c1"}, "reference": {"title": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "authors": "Christie, Louisa A.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "doi": "10.1021/acs.jmedchem.3c00630", "raw": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction | Christie, Louisa A.; et al | Journal of Medicinal Chemistry (2023), 66(17), 11718-11731. | 10.1021/acs.jmedchem.3c00630"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37690250", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 5 min, rt", "1.2|16 h, rt", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4", "By: Londregan, Allyn T.; et al", "Journal of Medicinal Chemistry (2023), 66(1), 460-472.", "10.1021/acs.jmedchem.2c01421"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "bfa3331d", "fam_sig": "b50f2a3f"}, "raw_data": {"raw_cas": "RCT: 381-73-7 + 3034365-71-1 | PRO: 3034365-99-3 | RGT: 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"authors\": \"Christie, Louisa A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37690250\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 5 min, rt\", \"1.2\", \"16 h, rt\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"121. Scheme 121 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4\", \"By: Londregan, Allyn T.; et al\", \"Journal of Medicinal Chemistry (2023), 66(1), 460-472.\", \"10.1021/acs.jmedchem.2c01421\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"381-73-7\", \"3034365-71-1\"], \"pro_cas\": [\"3034365-99-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["381-73-7", "3034365-71-1"], "products": ["3034365-99-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.141469", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37690313", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.083, "yield_pct": 83.0}, "smiles": {"reactants": "[2H]C([2H])([2H])Oc1ccc(-c2cc(C(=O)O)nn2C([2H])([2H])[2H])c(Cl)c1.CC(C)(C)OC(=O)N1CCC[C@H](N)C1", "products": "[2H]C([2H])([2H])Oc1ccc(-c2cc(C(=O)N[C@H]3CCCN(C(=O)OC(C)(C)C)C3)nn2C([2H])([2H])[2H])c(Cl)c1"}, "reference": {"title": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "authors": "Christie, Louisa A.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "doi": "10.1021/acs.jmedchem.3c00630", "raw": "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction | Christie, Louisa A.; et al | Journal of Medicinal Chemistry (2023), 66(17), 11718-11731. | 10.1021/acs.jmedchem.3c00630"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37690313", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 5 min, rt", "1.2|16 h, rt", "1.3|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "bfa3331d", "fam_sig": "b50f2a3f"}, "raw_data": {"raw_cas": "RCT: 2215-77-2 + 2919713-61-2 | PRO: 2925367-79-7 | RGT: 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"authors\": \"Christie, Louisa A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37690313\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 5 min, rt\", \"1.2\", \"16 h, rt\", \"1.3\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"311. Scheme 311 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2215-77-2\", \"2919713-61-2\"], \"pro_cas\": [\"2925367-79-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2215-77-2", "2919713-61-2"], "products": ["2925367-79-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.141469", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37692131", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)c1ccc(N)cc1.COc1cn(C(C)C(=O)O)c(=O)cc1-c1cc(Cl)ccc1C#N", "products": "COc1cn(C(C)C(=O)Nc2ccc(C(=O)OC(C)(C)C)cc2)c(=O)cc1-c1cc(Cl)ccc1C#N"}, "reference": {"title": "Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders", "authors": "Roehrig, Susanne; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.", "doi": "10.1021/acs.jmedchem.3c00795", "raw": "Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders | Roehrig, Susanne; et al | Journal of Medicinal Chemistry (2023), 66(17), 12203-12224. | 10.1021/acs.jmedchem.3c00795"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37692131", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "By: Christie, Louisa A.; et al", "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "10.1021/acs.jmedchem.3c00630"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2919852-24-5 + 625471-18-3 | PRO: 3033432-04-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders\", \"authors\": \"Roehrig, Susanne; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37692131\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"310. Scheme 310 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"By: Christie, Louisa A.; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"10.1021/acs.jmedchem.3c00630\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2919852-24-5\", \"625471-18-3\"], \"pro_cas\": [\"3033432-04-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2919852-24-5", "625471-18-3"], "products": ["3033432-04-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.141469", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37692197", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "UNK"}, {"name": "Ethyl 2-cyano-2-(hydroxyimino)acetate", "cas": "3849-21-6", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 40.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "CCOC(=O)c1ccc(N)cc1.COCCC(C(=O)O)n1cc(OC)c(-c2cc(Cl)ccc2C#N)cc1=O", "products": "CCOC(=O)c1ccc(NC(=O)C(CCOC)n2cc(OC)c(-c3cc(Cl)ccc3C#N)cc2=O)cc1"}, "reference": {"title": "Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders", "authors": "Roehrig, Susanne; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.", "doi": "10.1021/acs.jmedchem.3c00795", "raw": "Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders | Roehrig, Susanne; et al | Journal of Medicinal Chemistry (2023), 66(17), 12203-12224. | 10.1021/acs.jmedchem.3c00795"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-37692197", "1.1|Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate", "Solvents: Dimethylformamide; rt; overnight, 40 °C", "Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C", "By: Kettle, Jason G.; et al", "Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.", "10.1021/acs.jmedchem.2c00369"], "signatures": {"cond_key": "none/none/Diisopropylcarbodiimide|+Ethyl 2-cyano-2-(hydroxyimino)acetate|3849-21-6+N,N-Diisopropylcarbodiimide|693-13-0/Dimethylformamide|68-12-2", "cond_sig": "5f4f4f21", "fam_sig": "bfe37a10"}, "raw_data": {"raw_cas": "RCT: 3473-63-0 + 2387928-70-1 | PRO: 2387928-71-2 | RGT: 693-13-0 + 3849-21-6 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders\", \"authors\": \"Roehrig, Susanne; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 12203-12224.\", \"reagents\": [\"Diisopropylcarbodiimide\", \"Ethyl 2-cyano-2-(hydroxyimino)acetate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37692197\", \"1.1\", \"Reagents: Diisopropylcarbodiimide, Ethyl 2-cyano-2-(hydroxyimino)acetate\", \"Solvents: Dimethylformamide; rt; overnight, 40 °C\", \"370. Scheme 370 (1 Reaction)\", \"Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C\", \"By: Kettle, Jason G.; et al\", \"Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.\", \"10.1021/acs.jmedchem.2c00369\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3473-63-0\", \"2387928-70-1\"], \"pro_cas\": [\"2387928-71-2\"], \"rgt_cas\": [\"693-13-0\", \"3849-21-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3473-63-0", "2387928-70-1"], "products": ["2387928-71-2"], "reagents": ["N,N-Diisopropylcarbodiimide", "3849-21-6"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.141469", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37713121", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline", "cas": "16357-59-8", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 72.0, "yield_pct": 91.0}, "smiles": {"reactants": "Nc1ccc(CO)cc1.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)O", "products": "CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)Nc1ccc(CO)cc1"}, "reference": {"title": "Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain", "authors": "Gallo, Francesca; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(7), 4117-4129.", "doi": "10.1021/acs.jmedchem.1c00003", "raw": "Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain | Gallo, Francesca; et al | Journal of Medicinal Chemistry (2021), 64(7), 4117-4129. | 10.1021/acs.jmedchem.1c00003"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-37713121", "1.1|Reagents: 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline", "Solvents: Tetrahydrofuran; 3 d, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline|16357-59-8/Tetrahydrofuran|109-99-9", "cond_sig": "773bb46c", "fam_sig": "5258f87a"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 144222-22-0 | PRO: 3031471-29-8 | RGT: 16357-59-8 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain\", \"authors\": \"Gallo, Francesca; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(7), 4117-4129.\", \"reagents\": [\"2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37713121\", \"1.1\", \"Reagents: 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline\", \"Solvents: Tetrahydrofuran; 3 d, rt\", \"225. Scheme 225 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"144222-22-0\"], \"pro_cas\": [\"3031471-29-8\"], \"rgt_cas\": [\"16357-59-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"in the dark\"]}}", "enriched_names": {"reactants": ["19337-97-4", "144222-22-0"], "products": ["3031471-29-8"], "reagents": ["16357-59-8"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.141469", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37713554", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 0.25, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)C(=O)CCc1cccnc1.NCc1cccnc1", "products": "O=C(CCc1cccnc1)C(=O)NCc1cccnc1"}, "reference": {"title": "Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei", "authors": "Scheuplein, Nicolas J.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.", "doi": "10.1021/acs.jmedchem.3c00458", "raw": "Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei | Scheuplein, Nicolas J.; et al | Journal of Medicinal Chemistry (2023), 66(13), 8876-8895. | 10.1021/acs.jmedchem.3c00458"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-37713554", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 15 min, 0 °C", "1.2|0 °C → rt; rt", "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "By: Fang, Wei; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "10.1021/acs.jmedchem.3c02063"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 6933-10-4 + 383135-47-5 | PRO: 1426804-76-3 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei\", \"authors\": \"Scheuplein, Nicolas J.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37713554\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 15 min, 0 °C\", \"1.2\", \"0 °C → rt; rt\", \"131. Scheme 131 (1 Reaction)\", \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"By: Fang, Wei; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"10.1021/acs.jmedchem.3c02063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6933-10-4\", \"383135-47-5\"], \"pro_cas\": [\"1426804-76-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["6933-10-4", "383135-47-5"], "products": ["1426804-76-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.141469", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37713576", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 97.25, "yield_pct": 95.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCCC[C@H]1C(=O)O.C=CCOC(=O)[C@@H](N)Cc1ccc(F)cc1.Cl", "products": "C=CCOC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H]1CCCCN1C(=O)OC(C)(C)C"}, "reference": {"title": "Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei", "authors": "Scheuplein, Nicolas J.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.", "doi": "10.1021/acs.jmedchem.3c00458", "raw": "Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei | Scheuplein, Nicolas J.; et al | Journal of Medicinal Chemistry (2023), 66(13), 8876-8895. | 10.1021/acs.jmedchem.3c00458"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-37713576", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 15 min, 0 °C", "1.2|0 °C → rt; 4 d, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models", "By: Kamakolanu, Uma Gayathri; et al", "Journal of Medicinal Chemistry (2020), 63(5), 2688-2704.", "10.1021/acs.jmedchem.9b02134"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "a95f47c8", "fam_sig": "8bdb6c72"}, "raw_data": {"raw_cas": "RCT: 1947-00-8 + 2685734-99-8 | PRO: 2411399-03-4 | RGT: 121-44-8 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei\", \"authors\": \"Scheuplein, Nicolas J.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37713576\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 15 min, 0 °C\", \"1.2\", \"0 °C → rt; 4 d, rt\", \"188. Scheme 188 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models\", \"By: Kamakolanu, Uma Gayathri; et al\", \"Journal of Medicinal Chemistry (2020), 63(5), 2688-2704.\", \"10.1021/acs.jmedchem.9b02134\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1947-00-8\", \"2685734-99-8\"], \"pro_cas\": [\"2411399-03-4\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1947-00-8", "2685734-99-8"], "products": ["2411399-03-4"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.142465", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37777542", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 15.167, "yield_pct": 80.0}, "smiles": {"reactants": "CC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)O.C[C@H](N)C(=O)Nc1cccc(C(=O)Oc2ccccc2)c1C#Cc1c(NC(=O)[C@H](C)N)cccc1C(=O)Oc1ccccc1.O=C(O)C(F)(F)F", "products": "CC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)Nc1cccc(C(=O)Oc2ccccc2)c1C#Cc1c(NC(=O)[C@H](C)NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(C)=O)cccc1C(=O)Oc1ccccc1"}, "reference": {"title": "Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity", "authors": "Peacock, Hayden; et al", "citation": "ChemMedChem (2020), 15(20), 1932-1939.", "doi": "10.1002/cmdc.202000474", "raw": "Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity | Peacock, Hayden; et al | ChemMedChem (2020), 15(20), 1932-1939. | 10.1002/cmdc.202000474"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-37777542", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; rt → 0 °C; 10 min, 0 °C", "1.2|Solvents: Dimethylformamide; 0 °C → rt; 15 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "An improved commercial process for the preparation of Lifitegrast", "By: Girkar, Arvind; et al", "Organic Process Research & Development (2024), 28(12), 4374-4379.", "10.1021/acs.oprd.4c00356"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "fa291214", "fam_sig": "1a2ac61a"}, "raw_data": {"raw_cas": "RCT: 851784-82-2 + 1194550-59-8 | PRO: 1194550-61-2 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity\", \"authors\": \"Peacock, Hayden; et al\", \"citation\": \"ChemMedChem (2020), 15(20), 1932-1939.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37777542\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; rt → 0 °C; 10 min, 0 °C\", \"1.2\", \"Solvents: Dimethylformamide; 0 °C → rt; 15 h, rt\", \"387. Scheme 387 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"An improved commercial process for the preparation of Lifitegrast\", \"By: Girkar, Arvind; et al\", \"Organic Process Research & Development (2024), 28(12), 4374-4379.\", \"10.1021/acs.oprd.4c00356\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"851784-82-2\", \"1194550-59-8\"], \"pro_cas\": [\"1194550-61-2\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["851784-82-2", "1194550-59-8"], "products": ["1194550-61-2"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.142465", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37832985", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 6.5, "yield_pct": 85.0}, "smiles": {"reactants": "COC(=O)[C@@]1(n2cc(CNC(=O)OC(C)(C)C)nn2)C[C@H](OC(C)=O)[C@@H](NC(C)=O)[C@H]([C@H](OC(C)=O)[C@@H](COC(C)=O)OC(C)=O)O1.[N-]=[N+]=NCCCCCC(=O)O", "products": "COC(=O)[C@@]1(n2cc(CNC(=O)CCCCCN=[N+]=[N-])nn2)C[C@H](OC(C)=O)[C@@H](NC(C)=O)[C@H]([C@H](OC(C)=O)[C@@H](COC(C)=O)OC(C)=O)O1"}, "reference": {"title": "Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles", "authors": "Lao, Zhiqi; et al", "citation": "European Journal of Medicinal Chemistry (2023), 259, 115578.", "doi": "10.1016/j.ejmech.2023.115578", "raw": "Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles | Lao, Zhiqi; et al | European Journal of Medicinal Chemistry (2023), 259, 115578. | 10.1016/j.ejmech.2023.115578"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-37832985", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0.5 h, 0 °C", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 6 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants", "By: Nageswara Rao, Desaboini; et al", "Journal of Medicinal Chemistry (2021), 64(16), 11972-11989.", "10.1021/acs.jmedchem.1c00554"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2", "cond_sig": "903d6072", "fam_sig": "c66dbfa8"}, "raw_data": {"raw_cas": "RCT: 853269-58-6 + 2109744-60-5 | PRO: 2109744-22-9 | RGT: 76-05-1 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles\", \"authors\": \"Lao, Zhiqi; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 259, 115578.\", \"reagents\": [\"Trifluoroacetic acid\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37832985\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0.5 h, 0 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 6 h, rt\", \"484. Scheme 484 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants\", \"By: Nageswara Rao, Desaboini; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 11972-11989.\", \"10.1021/acs.jmedchem.1c00554\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"853269-58-6\", \"2109744-60-5\"], \"pro_cas\": [\"2109744-22-9\"], \"rgt_cas\": [\"76-05-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["853269-58-6", "2109744-60-5"], "products": ["2109744-22-9"], "reagents": ["Trifluoroacetic acid", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.142465", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37842851", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 92.0}, "smiles": {"reactants": "Cc1c(O)cccc1C(=O)O.CC(C)(C)OC(=O)C[C@H](N)C(=O)OC(C)(C)C.Cl", "products": "Cc1c(O)cccc1C(=O)N[C@@H](CC(=O)OC(C)(C)C)C(=O)OC(C)(C)C"}, "reference": {"title": "Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors", "authors": "Kikuchi, Fumiaki; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 93, 117462.", "doi": "10.1016/j.bmc.2023.117462", "raw": "Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors | Kikuchi, Fumiaki; et al | Bioorganic & Medicinal Chemistry (2023), 93, 117462. | 10.1016/j.bmc.2023.117462"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-37842851", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors", "By: Zhu, Junjie; et al", "European Journal of Medicinal Chemistry (2023), 259, 115666.", "10.1016/j.ejmech.2023.115666"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "8a613c76", "fam_sig": "6003ace2"}, "raw_data": {"raw_cas": "RCT: 3705-42-8 + 15572-56-2 | PRO: 138594-81-7 | RGT: 121-44-8 + 1892-57-5 + 2592-95-2 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors\", \"authors\": \"Kikuchi, Fumiaki; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 93, 117462.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37842851\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dimethylformamide; overnight, rt\", \"322. Scheme 322 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors\", \"By: Zhu, Junjie; et al\", \"European Journal of Medicinal Chemistry (2023), 259, 115666.\", \"10.1016/j.ejmech.2023.115666\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3705-42-8\", \"15572-56-2\"], \"pro_cas\": [\"138594-81-7\"], \"rgt_cas\": [\"121-44-8\", \"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3705-42-8", "15572-56-2"], "products": ["138594-81-7"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.142465", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37843363", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "cas": "1075198-30-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 41.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)C[C@H](N)C(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@@H](C(=O)O)C(C)(C)C", "products": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)OC(C)(C)C"}, "reference": {"title": "Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties", "authors": "Tsuji, Kohei; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(19), 13516-13529.", "doi": "10.1021/acs.jmedchem.3c00777", "raw": "Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties | Tsuji, Kohei; et al | Journal of Medicinal Chemistry (2023), 66(19), 13516-13529. | 10.1021/acs.jmedchem.3c00777"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37843363", "1.1|Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "Solvents: Dichloromethane; 0 °C; 41 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate|1075198-30-9/Dichloromethane|75-09-2", "cond_sig": "70b43dbe", "fam_sig": "0e481db2"}, "raw_data": {"raw_cas": "RCT: 98-97-5 + 2760538-76-7 | PRO: 2760538-86-9 | RGT: 7087-68-5 + 1075198-30-9 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties\", \"authors\": \"Tsuji, Kohei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(19), 13516-13529.\", \"reagents\": [\"Diisopropylethylamine\", \"N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37843363\", \"1.1\", \"Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\", \"Solvents: Dichloromethane; 0 °C; 41 h, rt\", \"148. Scheme 148 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"98-97-5\", \"2760538-76-7\"], \"pro_cas\": [\"2760538-86-9\"], \"rgt_cas\": [\"7087-68-5\", \"1075198-30-9\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["98-97-5", "2760538-76-7"], "products": ["2760538-86-9"], "reagents": ["N,N-Diisopropylethylamine", "1075198-30-9"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.142465", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37912635", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.25, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccc(OC(F)(F)F)c1.COc1ccc2c3ccnc(C)c3n(CCN)c2c1", "products": "COc1ccc2c3ccnc(C)c3n(CCNC(=O)/C=C/c3cccc(OC(F)(F)F)c3)c2c1"}, "reference": {"title": "Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines", "authors": "Marinovic, Marina; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 94, 117468.", "doi": "10.1016/j.bmc.2023.117468", "raw": "Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines | Marinovic, Marina; et al | Bioorganic & Medicinal Chemistry (2023), 94, 117468. | 10.1016/j.bmc.2023.117468"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-37912635", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 15 min, rt", "1.2|1 - 2 h, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 1759-53-1 + 2632874-83-8 | PRO: 2892485-54-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines\", \"authors\": \"Marinovic, Marina; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 94, 117468.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37912635\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"1 - 2 h, rt\", \"279. Scheme 279 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1759-53-1\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-54-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1759-53-1", "2632874-83-8"], "products": ["2892485-54-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.142465", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37912636", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.25, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccc(Cl)c1.COc1ccc2c3ccnc(C)c3n(CCN)c2c1", "products": "COc1ccc2c3ccnc(C)c3n(CCNC(=O)/C=C/c3cccc(Cl)c3)c2c1"}, "reference": {"title": "Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines", "authors": "Marinovic, Marina; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 94, 117468.", "doi": "10.1016/j.bmc.2023.117468", "raw": "Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines | Marinovic, Marina; et al | Bioorganic & Medicinal Chemistry (2023), 94, 117468. | 10.1016/j.bmc.2023.117468"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-37912636", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 15 min, rt", "1.2|1 - 2 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1", "By: Zhou, Qilong; et al", "European Journal of Medicinal Chemistry (2022), 244, 114830.", "10.1016/j.ejmech.2022.114830"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 134-20-3 + 71989-26-9 | PRO: 3033295-76-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines\", \"authors\": \"Marinovic, Marina; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 94, 117468.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37912636\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 15 min, rt\", \"1.2\", \"1 - 2 h, rt\", \"235. Scheme 235 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1\", \"By: Zhou, Qilong; et al\", \"European Journal of Medicinal Chemistry (2022), 244, 114830.\", \"10.1016/j.ejmech.2022.114830\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"134-20-3\", \"71989-26-9\"], \"pro_cas\": [\"3033295-76-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["134-20-3", "71989-26-9"], "products": ["3033295-76-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.143463", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37984060", "reaction_type": "Other", "catalyst": {"core": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5"}], "generic": ["N-Diisopropylethylamine"], "ligands": [], "full_system": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5"}]}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": null, "yield_pct": 92.0}, "smiles": {"reactants": "NC1CCOCC1.O=C(O)CN1CCn2c(cc3sccc32)C1=O", "products": "O=C(CN1CCn2c(cc3sccc32)C1=O)NC1CCOCC1"}, "reference": {"title": "Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis", "authors": "Li, Na; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(19), 13428-13451.", "doi": "10.1021/acs.jmedchem.3c00696", "raw": "Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis | Li, Na; et al | Journal of Medicinal Chemistry (2023), 66(19), 13428-13451. | 10.1021/acs.jmedchem.3c00696"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-37984060", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Catalysts: Diisopropylethylamine", "Solvents: Dichloromethane; rt", "Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke", "By: Chen, Weilin; et al", "European Journal of Medicinal Chemistry (2023), 261, 115871.", "10.1016/j.ejmech.2023.115871"], "signatures": {"cond_key": "N-Diisopropylethylamine/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "a4cfff77", "fam_sig": "5d9a1242"}, "raw_data": {"raw_cas": "RCT: 2757502-15-9 + 57260-73-8 | PRO: 2757502-16-0 | RGT: 148893-10-1 | CAT: 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis\", \"authors\": \"Li, Na; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(19), 13428-13451.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [\"Diisopropylethylamine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37984060\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Catalysts: Diisopropylethylamine\", \"Solvents: Dichloromethane; rt\", \"474. Scheme 474 (1 Reaction)\", \"Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke\", \"By: Chen, Weilin; et al\", \"European Journal of Medicinal Chemistry (2023), 261, 115871.\", \"10.1016/j.ejmech.2023.115871\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2757502-15-9\", \"57260-73-8\"], \"pro_cas\": [\"2757502-16-0\"], \"rgt_cas\": [\"148893-10-1\"], \"cat_cas\": [\"7087-68-5\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2757502-15-9", "57260-73-8"], "products": ["2757502-16-0"], "reagents": ["HATU"], "catalysts": ["N,N-Diisopropylethylamine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.143463", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-37984123", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 60.0, "time_h": 6.0, "yield_pct": 86.0}, "smiles": {"reactants": "CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1.COC(=O)[C@@H](N)CCCNC(=N)N.Cl", "products": "COC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@]12CCC(C)(C)C[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2"}, "reference": {"title": "Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway", "authors": "Zhang, Li-qiong; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 94, 117478.", "doi": "10.1016/j.bmc.2023.117478", "raw": "Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway | Zhang, Li-qiong; et al | Bioorganic & Medicinal Chemistry (2023), 94, 117478. | 10.1016/j.bmc.2023.117478"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-37984123", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide, Tetrahydrofuran; 1 h, rt", "1.2|4 h, 60 °C", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 3 - 4", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Hydrochloric acid|7647-01-0+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "9debb41a", "fam_sig": "80dbd689"}, "raw_data": {"raw_cas": "RCT: 1417404-28-4 + 23150-65-4 | PRO: 1417404-44-4 | RGT: 121-44-8 + 94790-37-1 + 7647-01-0 | SOL: 68-12-2 + 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway\", \"authors\": \"Zhang, Li-qiong; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 94, 117478.\", \"reagents\": [\"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-37984123\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide, Tetrahydrofuran; 1 h, rt\", \"1.2\", \"4 h, 60 °C\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 3 - 4\", \"131. Scheme 131 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1417404-28-4\", \"23150-65-4\"], \"pro_cas\": [\"1417404-44-4\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1417404-28-4", "23150-65-4"], "products": ["1417404-44-4"], "reagents": ["Triethylamine", "HBTU", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.143463", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38045830", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 60.0, "time_h": 12.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1ccc(F)cc1.CCOC(=O)CSc1ccc(N)cc1", "products": "CCOC(=O)CSc1ccc(NC(=O)c2ccc(F)cc2)cc1"}, "reference": {"title": "Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7", "authors": "Li, Cuixia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(17), 11855-11868.", "doi": "10.1021/acs.jmedchem.2c01795", "raw": "Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7 | Li, Cuixia; et al | Journal of Medicinal Chemistry (2023), 66(17), 11855-11868. | 10.1021/acs.jmedchem.2c01795"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-38045830", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 12 h, 60 °C", "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "By: Vaidya, Sandeep; et al", "ChemMedChem (2023), 18(16), e202300097.", "10.1002/cmdc.202300097"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 15687-27-1 + 2128731-38-2 | PRO: 3055833-32-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7\", \"authors\": \"Li, Cuixia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(17), 11855-11868.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38045830\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 12 h, 60 °C\", \"96. Scheme 96 (1 Reaction)\", \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"By: Vaidya, Sandeep; et al\", \"ChemMedChem (2023), 18(16), e202300097.\", \"10.1002/cmdc.202300097\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15687-27-1\", \"2128731-38-2\"], \"pro_cas\": [\"3055833-32-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["15687-27-1", "2128731-38-2"], "products": ["3055833-32-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.143463", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38047630", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 80.0}, "smiles": {"reactants": "NC(=O)c1ccccc1N.Cc1cccc(C(=O)O)n1", "products": "Cc1cccc(C(=O)Nc2ccccc2C(N)=O)n1"}, "reference": {"title": "Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline", "authors": "Nandakumar, Meganathan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(21), 14724-14734.", "doi": "10.1021/acs.jmedchem.3c01273", "raw": "Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline | Nandakumar, Meganathan; et al | Journal of Medicinal Chemistry (2023), 66(21), 14724-14734. | 10.1021/acs.jmedchem.3c01273"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-38047630", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 4 h, rt", "Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening", "By: Lee, Sang-Woo; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3266-3305.", "10.1021/acs.jmedchem.1c01834"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "3554dd99", "fam_sig": "6003ace2"}, "raw_data": {"raw_cas": "RCT: 716-76-7 + 1072-67-9 | PRO: 2648596-72-7 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Dual inhibition of Mycobacterium tuberculosis and the host TGFBR1 by an anilinoquinazoline\", \"authors\": \"Nandakumar, Meganathan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(21), 14724-14734.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38047630\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 4 h, rt\", \"180. Scheme 180 (1 Reaction)\", \"Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening\", \"By: Lee, Sang-Woo; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3266-3305.\", \"10.1021/acs.jmedchem.1c01834\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"716-76-7\", \"1072-67-9\"], \"pro_cas\": [\"2648596-72-7\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["716-76-7", "1072-67-9"], "products": ["2648596-72-7"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.143463", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38064665", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 84.0}, "smiles": {"reactants": "Cc1cn2cc(N)cc(F)c2n1.CN(C(=O)OC(C)(C)C)[C@@H]1CCN(c2ccc(C(=O)O)nn2)C1", "products": "Cc1cn2cc(NC(=O)c3ccc(N4CC[C@@H](N(C)C(=O)OC(C)(C)C)C4)nn3)cc(F)c2n1"}, "reference": {"title": "Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease", "authors": "Liu, Longbin; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.", "doi": "10.1021/acs.jmedchem.3c01173", "raw": "Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease | Liu, Longbin; et al | Journal of Medicinal Chemistry (2023), 66(18), 13205-13246. | 10.1021/acs.jmedchem.3c01173"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-38064665", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice", "By: Narayanan, Sanju; et al", "Journal of Medicinal Chemistry (2021), 64(6), 3006-3025.", "10.1021/acs.jmedchem.0c01448"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "0a9d046a", "fam_sig": "5857e3b1"}, "raw_data": {"raw_cas": "RCT: 2516-34-9 + 2763783-96-4 | PRO: 1839557-08-2 | RGT: 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease\", \"authors\": \"Liu, Longbin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38064665\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"343. Scheme 343 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice\", \"By: Narayanan, Sanju; et al\", \"Journal of Medicinal Chemistry (2021), 64(6), 3006-3025.\", \"10.1021/acs.jmedchem.0c01448\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2516-34-9\", \"2763783-96-4\"], \"pro_cas\": [\"1839557-08-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2516-34-9", "2763783-96-4"], "products": ["1839557-08-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.143463", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38064680", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 99.0}, "smiles": {"reactants": "Cc1cn2cc(N)cc(F)c2n1.CN(C(=O)OC(C)(C)C)[C@@H]1CCN(c2cnc(C(=O)O)nc2)C1", "products": "Cc1cn2cc(NC(=O)c3ncc(N4CC[C@@H](N(C)C(=O)OC(C)(C)C)C4)cn3)cc(F)c2n1"}, "reference": {"title": "Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease", "authors": "Liu, Longbin; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.", "doi": "10.1021/acs.jmedchem.3c01173", "raw": "Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease | Liu, Longbin; et al | Journal of Medicinal Chemistry (2023), 66(18), 13205-13246. | 10.1021/acs.jmedchem.3c01173"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-38064680", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer", "By: Sun, Li-ping; et al", "Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.", "10.1021/acs.jmedchem.3c01210"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "a5109a00", "fam_sig": "24dfcf20"}, "raw_data": {"raw_cas": "RCT: 84000-11-3 + 177423-00-6 | PRO: 474645-25-5 | RGT: 7087-68-5 + 94790-37-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease\", \"authors\": \"Liu, Longbin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38064680\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 16 h, rt\", \"213. Scheme 213 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer\", \"By: Sun, Li-ping; et al\", \"Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.\", \"10.1021/acs.jmedchem.3c01210\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"84000-11-3\", \"177423-00-6\"], \"pro_cas\": [\"474645-25-5\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["84000-11-3", "177423-00-6"], "products": ["474645-25-5"], "reagents": ["N,N-Diisopropylethylamine", "HBTU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38094931", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.667, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(O)[C@H]1CC[C@H](N)CC1.O=C(O)c1cnc2nc(C3CC3)c(Cl)cc2c1", "products": "CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc3nc(C4CC4)c(Cl)cc3c2)CC1"}, "reference": {"title": "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure", "authors": "Cadilla, Rodolfo; et al", "citation": "Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.", "doi": "10.1016/j.bmc.2020.115791", "raw": "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure | Cadilla, Rodolfo; et al | Bioorganic & Medicinal Chemistry (2020), 28(23), 115791. | 10.1016/j.bmc.2020.115791"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-38094931", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 100 min, rt", "2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in-vitro cell-based and oncogenic kinase assessments", "By: El-Damasy, Ashraf K.; et al", "European Journal of Medicinal Chemistry (2020), 208, 112756.", "10.1016/j.ejmech.2020.112756"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 10349-57-2 + 2499499-66-8 | PRO: 2499499-58-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure\", \"authors\": \"Cadilla, Rodolfo; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38094931\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 100 min, rt\", \"116. Scheme 116 (1 Reaction)\", \"2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in-vitro cell-based and oncogenic kinase assessments\", \"By: El-Damasy, Ashraf K.; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112756.\", \"10.1016/j.ejmech.2020.112756\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"10349-57-2\", \"2499499-66-8\"], \"pro_cas\": [\"2499499-58-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["10349-57-2", "2499499-66-8"], "products": ["2499499-58-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38094932", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(O)[C@H]1CC[C@H](N)CC1.COc1nc2ncc(C(=O)O)cc2cc1Cl", "products": "COc1nc2ncc(C(=O)N[C@H]3CC[C@H](C(C)(C)O)CC3)cc2cc1Cl"}, "reference": {"title": "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure", "authors": "Cadilla, Rodolfo; et al", "citation": "Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.", "doi": "10.1016/j.bmc.2020.115791", "raw": "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure | Cadilla, Rodolfo; et al | Bioorganic & Medicinal Chemistry (2020), 28(23), 115791. | 10.1016/j.bmc.2020.115791"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-38094932", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 14 h, rt", "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "By: Zhang, Yi; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "10.1021/acs.jmedchem.3c00504"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2691175-30-9 + 1346575-64-1 | PRO: 2691175-32-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure\", \"authors\": \"Cadilla, Rodolfo; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38094932\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 14 h, rt\", \"162. Scheme 162 (1 Reaction)\", \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"By: Zhang, Yi; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"10.1021/acs.jmedchem.3c00504\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2691175-30-9\", \"1346575-64-1\"], \"pro_cas\": [\"2691175-32-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2691175-30-9", "1346575-64-1"], "products": ["2691175-32-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38094948", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.083, "yield_pct": 80.0}, "smiles": {"reactants": "C[C@]1(O)C[C@H](N)C1.C[C@H]1CCN1c1nc2ncc(C(=O)O)cc2cc1Cl.[Li]", "products": "C[C@H]1CCN1c1nc2ncc(C(=O)N[C@H]3C[C@](C)(O)C3)cc2cc1Cl"}, "reference": {"title": "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure", "authors": "Cadilla, Rodolfo; et al", "citation": "Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.", "doi": "10.1016/j.bmc.2020.115791", "raw": "The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure | Cadilla, Rodolfo; et al | Bioorganic & Medicinal Chemistry (2020), 28(23), 115791. | 10.1016/j.bmc.2020.115791"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-38094948", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 5 min, rt", "1.2|Reagents: Propylphosphonic anhydride; 16 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2023), 246, 114981.", "10.1016/j.ejmech.2022.114981"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/Dimethylformamide|68-12-2", "cond_sig": "2ff811ef", "fam_sig": "2fb3add8"}, "raw_data": {"raw_cas": "RCT: 1477-50-5 + 159005-71-7 | PRO: 2883496-21-5 | RGT: 7087-68-5 + 68957-94-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure\", \"authors\": \"Cadilla, Rodolfo; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2020), 28(23), 115791.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38094948\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 5 min, rt\", \"1.2\", \"Reagents: Propylphosphonic anhydride; 16 h, rt\", \"160. Scheme 160 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2023), 246, 114981.\", \"10.1016/j.ejmech.2022.114981\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1477-50-5\", \"159005-71-7\"], \"pro_cas\": [\"2883496-21-5\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1477-50-5", "159005-71-7"], "products": ["2883496-21-5"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38105797", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HBTU", "cas": "94790-37-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 17.5, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(C)[Si](Oc1cc(CC(=O)O)c(Br)cc1OCc1ccccc1)(c1ccccc1)c1ccccc1.NCCc1ccc(OCc2ccccc2)c(O)c1", "products": "CC(C)(C)[Si](Oc1cc(CC(=O)NCCc2ccc(OCc3ccccc3)c(O)c2)c(Br)cc1OCc1ccccc1)(c1ccccc1)c1ccccc1"}, "reference": {"title": "Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation", "authors": "Namballa, Hari K.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(14), 10060-10079.", "doi": "10.1021/acs.jmedchem.3c00976", "raw": "Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation | Namballa, Hari K.; et al | Journal of Medicinal Chemistry (2023), 66(14), 10060-10079. | 10.1021/acs.jmedchem.3c00976"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-38105797", "1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 30 min, rt", "1.2|Reagents: Diisopropylethylamine; 0 °C → rt; overnight, rt", "1.3|Reagents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "556adacb", "fam_sig": "d670dab7"}, "raw_data": {"raw_cas": "RCT: 99-10-5 + 2415386-52-4 | PRO: 2892016-23-6 | RGT: 94790-37-1 + 7087-68-5 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Selective Dopamine Receptor Ligands Derived from (-)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation\", \"authors\": \"Namballa, Hari K.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(14), 10060-10079.\", \"reagents\": [\"Diisopropylethylamine\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38105797\", \"1.1\", \"Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; 0 °C → rt; overnight, rt\", \"1.3\", \"Reagents: Water; rt\", \"27. Scheme 27 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"99-10-5\", \"2415386-52-4\"], \"pro_cas\": [\"2892016-23-6\"], \"rgt_cas\": [\"94790-37-1\", \"7087-68-5\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["99-10-5", "2415386-52-4"], "products": ["2892016-23-6"], "reagents": ["HBTU", "N,N-Diisopropylethylamine", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38113252", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Formamide", "cas": "75-12-7"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 150.0, "time_h": 20.0, "yield_pct": 97.0}, "smiles": {"reactants": "NC=O.Nc1ccc(Cl)cc1C(=O)O", "products": "O=c1nc[nH]c2ccc(Cl)cc12"}, "reference": {"title": "Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR", "authors": "Grossman, Scott; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112778.", "doi": "10.1016/j.ejmech.2020.112778", "raw": "Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR | Grossman, Scott; et al | European Journal of Medicinal Chemistry (2020), 208, 112778. | 10.1016/j.ejmech.2020.112778"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-38113252", "1.1|Solvents: Formamide; 16 h, 150 °C", "1.2|Solvents: Water", "Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition", "By: Fan, Chengcheng; et al", "European Journal of Medicinal Chemistry (2020), 190, 112108pp..", "10.1016/j.ejmech.2020.112108"], "signatures": {"cond_key": "none/none/none/Formamide|75-12-7+Water|7732-18-5", "cond_sig": "a7111eb0", "fam_sig": "a7111eb0"}, "raw_data": {"raw_cas": "RCT: 75-12-7 + 5794-88-7 | PRO: 32084-59-6 | SOL: 75-12-7 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR\", \"authors\": \"Grossman, Scott; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112778.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Formamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38113252\", \"1.1\", \"Solvents: Formamide; 16 h, 150 °C\", \"1.2\", \"Solvents: Water\", \"440. Scheme 440 (2 Reactions)\", \"Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition\", \"By: Fan, Chengcheng; et al\", \"European Journal of Medicinal Chemistry (2020), 190, 112108pp..\", \"10.1016/j.ejmech.2020.112108\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"75-12-7\", \"5794-88-7\"], \"pro_cas\": [\"32084-59-6\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"75-12-7\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["75-12-7", "5794-88-7"], "products": ["32084-59-6"], "reagents": [], "catalysts": [], "solvents": ["75-12-7", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38113256", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Formamide", "cas": "75-12-7"}], "conditions": {"temperature_c": 150.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "NC=O.Nc1cc(Cl)ccc1C(=O)O", "products": "O=c1nc[nH]c2cc(Cl)ccc12"}, "reference": {"title": "Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR", "authors": "Grossman, Scott; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112778.", "doi": "10.1016/j.ejmech.2020.112778", "raw": "Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR | Grossman, Scott; et al | European Journal of Medicinal Chemistry (2020), 208, 112778. | 10.1016/j.ejmech.2020.112778"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-38113256", "1.1|Solvents: Formamide; 15 h, 150 °C", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/none/Formamide|75-12-7", "cond_sig": "2518a245", "fam_sig": "2518a245"}, "raw_data": {"raw_cas": "RCT: 306935-75-1 + 40615-17-6 | PRO: 2416338-40-2 | SOL: 75-12-7", "raw_data_json": "{\"txt\": {\"title\": \"Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR\", \"authors\": \"Grossman, Scott; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112778.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Formamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38113256\", \"1.1\", \"Solvents: Formamide; 15 h, 150 °C\", \"433. Scheme 433 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"306935-75-1\", \"40615-17-6\"], \"pro_cas\": [\"2416338-40-2\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"75-12-7\"], \"notes\": []}}", "enriched_names": {"reactants": ["306935-75-1", "40615-17-6"], "products": ["2416338-40-2"], "reagents": [], "catalysts": [], "solvents": ["75-12-7"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38128116", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethyl Sulfoxide", "cas": "67-68-5"}], "conditions": {"temperature_c": 25.0, "time_h": 19.0, "yield_pct": 91.0}, "smiles": {"reactants": "COc1ccc(N)cc1.CC(C)(C)OC(=O)N1CCC[C@@H]1C(=O)O", "products": "COc1ccc(NC(=O)[C@H]2CCCN2C(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening", "authors": "Tian, Xinrong; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(21), 14391-14408.", "doi": "10.1021/acs.jmedchem.2c00670", "raw": "Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening | Tian, Xinrong; et al | Journal of Medicinal Chemistry (2022), 65(21), 14391-14408. | 10.1021/acs.jmedchem.2c00670"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-38128116", "1.1|Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt", "Solvents: Dimethyl sulfoxide; 18 h, rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxy-7-azabenzotriazole|39968-33-7+4-Methylmorpholine|+N-Methylmorpholine|109-02-4/Dimethyl Sulfoxide|67-68-5", "cond_sig": "33636145", "fam_sig": "fe3fb1f8"}, "raw_data": {"raw_cas": "RCT: 37902-58-2 + 40615-17-6 | PRO: 2416338-39-9 | RGT: 109-02-4 + 25952-53-8 + 39968-33-7 | SOL: 67-68-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening\", \"authors\": \"Tian, Xinrong; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(21), 14391-14408.\", \"reagents\": [\"4-Methylmorpholine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"HOAt\"], \"catalysts\": [], \"solvents\": [\"Dimethyl sulfoxide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38128116\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride, HOAt\", \"Solvents: Dimethyl sulfoxide; 18 h, rt\", \"351. Scheme 351 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"37902-58-2\", \"40615-17-6\"], \"pro_cas\": [\"2416338-39-9\"], \"rgt_cas\": [\"109-02-4\", \"25952-53-8\", \"39968-33-7\"], \"cat_cas\": [], \"sol_cas\": [\"67-68-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["37902-58-2", "40615-17-6"], "products": ["2416338-39-9"], "reagents": ["N-Methylmorpholine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxy-7-azabenzotriazole"], "catalysts": [], "solvents": ["Dimethyl Sulfoxide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.144460", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38145041", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Acetic anhydride", "cas": "108-24-7", "role": "UNK"}], "solvents": [], "conditions": {"temperature_c": 90.0, "time_h": 0.5, "yield_pct": 90.0}, "smiles": {"reactants": "NC(N)=O.O=C(O)CCN1CCC(C(=O)c2ccc(O)cc2)CC1", "products": "NC(=O)NC(=O)CCN1CCC(C(=O)c2ccc(O)cc2)CC1"}, "reference": {"title": "Structural and Functional Study of the Klebsiella pneumoniae VapBC Toxin-Antitoxin System, Including the Development of an Inhibitor That Activates VapC", "authors": "Kang, Sung-Min; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(22), 13669-13679.", "doi": "10.1021/acs.jmedchem.0c01118", "raw": "Structural and Functional Study of the Klebsiella pneumoniae VapBC Toxin-Antitoxin System, Including the Development of an Inhibitor That Activates VapC | Kang, Sung-Min; et al | Journal of Medicinal Chemistry (2020), 63(22), 13669-13679. | 10.1021/acs.jmedchem.0c01118"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38145041", "1.1|Reagents: Acetic anhydride; 30 min, rt → 90 °C", "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "By: Bothe, Ulrich; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "10.1021/acs.jmedchem.3c01714"], "signatures": {"cond_key": "none/none/Acetic anhydride|108-24-7/none", "cond_sig": "9e5d04c9", "fam_sig": "ea4731bf"}, "raw_data": {"raw_cas": "RCT: 3878-55-5 + 343942-49-4 | PRO: 3032481-80-1 | RGT: 108-24-7", "raw_data_json": "{\"txt\": {\"title\": \"Structural and Functional Study of the Klebsiella pneumoniae VapBC Toxin-Antitoxin System, Including the Development of an Inhibitor That Activates VapC\", \"authors\": \"Kang, Sung-Min; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(22), 13669-13679.\", \"reagents\": [\"Acetic anhydride\"], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38145041\", \"1.1\", \"Reagents: Acetic anhydride; 30 min, rt → 90 °C\", \"212. Scheme 212 (1 Reaction)\", \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"By: Bothe, Ulrich; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"10.1021/acs.jmedchem.3c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3878-55-5\", \"343942-49-4\"], \"pro_cas\": [\"3032481-80-1\"], \"rgt_cas\": [\"108-24-7\"], \"cat_cas\": [], \"sol_cas\": [], \"notes\": [\"Ac2O also act as solvent\"]}}", "enriched_names": {"reactants": ["3878-55-5", "343942-49-4"], "products": ["3032481-80-1"], "reagents": ["Acetic anhydride"], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.145458", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38145487", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Toluene", "cas": "108-88-3"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 110.0, "time_h": 20.5, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1ccc(Br)o1.Cc1cc(F)ccc1N", "products": "Cc1cc(F)ccc1NC(=O)c1ccc(Br)o1"}, "reference": {"title": "Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis", "authors": "Mohamed, Abdelrahman; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.", "doi": "10.1021/acs.jmedchem.2c00589", "raw": "Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis | Mohamed, Abdelrahman; et al | Journal of Medicinal Chemistry (2022), 65(17), 11726-11744. | 10.1021/acs.jmedchem.2c00589"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-38145487", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Toluene; 4 h, 110 °C; 110 °C → rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 30 min, 0 °C; 0 °C → rt; overnight, rt", "Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates", "By: Cardwell, Patrick A.; et al", "Bioorganic & Medicinal Chemistry (2024), 104, 117712.", "10.1016/j.bmc.2024.117712"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Dichloromethane|75-09-2+Toluene|108-88-3", "cond_sig": "83a99bf3", "fam_sig": "705ceb81"}, "raw_data": {"raw_cas": "RCT: 96-99-1 + 73648-11-0 | PRO: 3063821-91-7 | RGT: 7719-09-7 + 121-44-8 | CAT: 68-12-2 | SOL: 108-88-3 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis\", \"authors\": \"Mohamed, Abdelrahman; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Toluene\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38145487\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Toluene; 4 h, 110 °C; 110 °C → rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 30 min, 0 °C; 0 °C → rt; overnight, rt\", \"236. Scheme 236 (1 Reaction)\", \"Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates\", \"By: Cardwell, Patrick A.; et al\", \"Bioorganic & Medicinal Chemistry (2024), 104, 117712.\", \"10.1016/j.bmc.2024.117712\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"96-99-1\", \"73648-11-0\"], \"pro_cas\": [\"3063821-91-7\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"108-88-3\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["96-99-1", "73648-11-0"], "products": ["3063821-91-7"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Toluene", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.145458", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38145506", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)c1ccc(Br)o1.Cc1ncccc1N", "products": "Cc1ncccc1NC(=O)c1ccc(Br)o1"}, "reference": {"title": "Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis", "authors": "Mohamed, Abdelrahman; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.", "doi": "10.1021/acs.jmedchem.2c00589", "raw": "Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis | Mohamed, Abdelrahman; et al | Journal of Medicinal Chemistry (2022), 65(17), 11726-11744. | 10.1021/acs.jmedchem.2c00589"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-38145506", "1.1|Reagents: Dicyclohexylcarbodiimide", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 0 °C; overnight, rt", "1.2|Reagents: Water; rt", "Absolute stereochemistry shown,", "Rotation (+)", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles", "By: Sanna, Vanna; et al", "ACS Medicinal Chemistry Letters (2020), 11(5), 857-861.", "10.1021/acsmedchemlett.9b00648"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "c957ee5b", "fam_sig": "83034970"}, "raw_data": {"raw_cas": "RCT: 1200-22-2 + 2418023-78-4 | PRO: 2418022-46-3 | RGT: 538-75-0 + 7732-18-5 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis\", \"authors\": \"Mohamed, Abdelrahman; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"Water\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38145506\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 0 °C; overnight, rt\", \"1.2\", \"Reagents: Water; rt\", \"240. Scheme 240 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles\", \"By: Sanna, Vanna; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(5), 857-861.\", \"10.1021/acsmedchemlett.9b00648\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1200-22-2\", \"2418023-78-4\"], \"pro_cas\": [\"2418022-46-3\"], \"rgt_cas\": [\"538-75-0\", \"7732-18-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1200-22-2", "2418023-78-4"], "products": ["2418022-46-3"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "Water"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.145458", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38147434", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "N-Hydroxysuccinimide", "cas": "6066-82-6", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)CCC(=O)Nc1cccc2ccccc12.NCCN", "products": "NCCNC(=O)CCC(=O)Nc1cccc2ccccc12"}, "reference": {"title": "A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease", "authors": "Rivera-Marrero, Suchitil; et al", "citation": "Bioorganic & Medicinal Chemistry (2020), 28(20), 115700.", "doi": "10.1016/j.bmc.2020.115700", "raw": "A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease | Rivera-Marrero, Suchitil; et al | Bioorganic & Medicinal Chemistry (2020), 28(20), 115700. | 10.1016/j.bmc.2020.115700"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-38147434", "1.1|Reagents: Dicyclohexylcarbodiimide, N-Hydroxysuccinimide", "Solvents: 1,4-Dioxane; 3 h, reflux", "1.2|1 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+N-Hydroxysuccinimide|6066-82-6/1,4-Dioxane|123-91-1", "cond_sig": "a2569ced", "fam_sig": "3ec415d6"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 51857-17-1 | PRO: 3031471-26-5 | RGT: 538-75-0 + 6066-82-6 | SOL: 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease\", \"authors\": \"Rivera-Marrero, Suchitil; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2020), 28(20), 115700.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"N-Hydroxysuccinimide\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38147434\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, N-Hydroxysuccinimide\", \"Solvents: 1,4-Dioxane; 3 h, reflux\", \"1.2\", \"1 h, rt\", \"111. Scheme 111 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"51857-17-1\"], \"pro_cas\": [\"3031471-26-5\"], \"rgt_cas\": [\"538-75-0\", \"6066-82-6\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "51857-17-1"], "products": ["3031471-26-5"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "N-Hydroxysuccinimide"], "catalysts": [], "solvents": ["1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.145458", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38164670", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dimethyl Sulfoxide", "cas": "67-68-5"}], "conditions": {"temperature_c": 25.0, "time_h": 20.5, "yield_pct": 90.0}, "smiles": {"reactants": "Nc1c(C(=O)O)cnn1-c1ccccc1.COC(=O)c1ccc(CN)cc1.Cl", "products": "COC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1"}, "reference": {"title": "Selective targeting of the αC and DFG-out pocket in p38 MAPK", "authors": "Roehm, Sandra; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112721.", "doi": "10.1016/j.ejmech.2020.112721", "raw": "Selective targeting of the αC and DFG-out pocket in p38 MAPK | Roehm, Sandra; et al | European Journal of Medicinal Chemistry (2020), 208, 112721. | 10.1016/j.ejmech.2020.112721"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38164670", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dimethyl sulfoxide, Dimethylformamide; 20 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity", "By: Yamada, Yousuke; et al", "Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.", "10.1021/acs.jmedchem.0c01215"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethyl Sulfoxide|67-68-5+Dimethylformamide|68-12-2", "cond_sig": "da32d69e", "fam_sig": "0164791b"}, "raw_data": {"raw_cas": "RCT: 1535-73-5 + 5241-66-7 | PRO: 2682842-39-1 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2 + 67-68-5", "raw_data_json": "{\"txt\": {\"title\": \"Selective targeting of the αC and DFG-out pocket in p38 MAPK\", \"authors\": \"Roehm, Sandra; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112721.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dimethyl sulfoxide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38164670\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethyl sulfoxide, Dimethylformamide; 20 h, rt\", \"314. Scheme 314 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity\", \"By: Yamada, Yousuke; et al\", \"Journal of Medicinal Chemistry (2020), 63(23), 14805-14820.\", \"10.1021/acs.jmedchem.0c01215\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1535-73-5\", \"5241-66-7\"], \"pro_cas\": [\"2682842-39-1\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"67-68-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1535-73-5", "5241-66-7"], "products": ["2682842-39-1"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide", "Dimethyl Sulfoxide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.145458", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38179436", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Benzyl chloroformate", "cas": "1609-47-8", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diethyl dicarbonate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)[C@@H](C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21.CC[C@H](C)[C@@H]([C@@H](CC(=O)OC(C)(C)C)OC)N(C)C(=O)[C@@H](N)C(C)C", "products": "CC[C@H](C)[C@@H]([C@@H](CC(=O)OC(C)(C)C)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCC1c2ccccc2-c2ccccc21)C(C)C"}, "reference": {"title": "hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer", "authors": "Sun, Li-ping; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.", "doi": "10.1021/acs.jmedchem.3c01210", "raw": "hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer | Sun, Li-ping; et al | Journal of Medicinal Chemistry (2023), 66(21), 14700-14715. | 10.1021/acs.jmedchem.3c01210"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-38179436", "1.1|Reagents: Diethyl dicarbonate, Diisopropylethylamine", "Solvents: Ethyl acetate; overnight, rt", "1.2|Reagents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "By: Wang, Xu; et al", "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "10.1021/acs.jmedchem.4c02009"], "signatures": {"cond_key": "none/none/Benzyl chloroformate|1609-47-8+Diethyl dicarbonate|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Ethyl Acetate|141-78-6", "cond_sig": "a1db1ed8", "fam_sig": "c7865e9c"}, "raw_data": {"raw_cas": "RCT: 3061154-94-4 + 101555-60-6 | PRO: 3061154-97-7 | RGT: 1609-47-8 + 7087-68-5 + 7732-18-5 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer\", \"authors\": \"Sun, Li-ping; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.\", \"reagents\": [\"Diethyl dicarbonate\", \"Diisopropylethylamine\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38179436\", \"1.1\", \"Reagents: Diethyl dicarbonate, Diisopropylethylamine\", \"Solvents: Ethyl acetate; overnight, rt\", \"1.2\", \"Reagents: Water; rt\", \"214. Scheme 214 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"By: Wang, Xu; et al\", \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"10.1021/acs.jmedchem.4c02009\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3061154-94-4\", \"101555-60-6\"], \"pro_cas\": [\"3061154-97-7\"], \"rgt_cas\": [\"1609-47-8\", \"7087-68-5\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["3061154-94-4", "101555-60-6"], "products": ["3061154-97-7"], "reagents": ["Benzyl chloroformate", "N,N-Diisopropylethylamine", "Water"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.145458", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38179439", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline", "cas": "16357-59-8", "role": "UNK"}], "solvents": [{"name": "Methanol", "cas": "67-56-1"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 87.0}, "smiles": {"reactants": "Nc1ccc(CO)cc1.CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCCNC(N)=O)C(=O)O", "products": "CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1"}, "reference": {"title": "hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer", "authors": "Sun, Li-ping; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.", "doi": "10.1021/acs.jmedchem.3c01210", "raw": "hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer | Sun, Li-ping; et al | Journal of Medicinal Chemistry (2023), 66(21), 14700-14715. | 10.1021/acs.jmedchem.3c01210"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-38179439", "1.1|Reagents: 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline", "Solvents: Methanol, Dichloromethane; 5 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (+)", "Betulinic acid derived amides are highly cytotoxic, apoptotic and selective", "By: Hoenke, Sophie; et al", "European Journal of Medicinal Chemistry (2020), 207, 112815.", "10.1016/j.ejmech.2020.112815"], "signatures": {"cond_key": "none/none/2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline|16357-59-8/Dichloromethane|75-09-2+Methanol|67-56-1", "cond_sig": "6deb1b9b", "fam_sig": "a1637334"}, "raw_data": {"raw_cas": "RCT: 2511353-36-7 + 100-46-9 | PRO: 2511353-37-8 | RGT: 16357-59-8 | SOL: 67-56-1 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer\", \"authors\": \"Sun, Li-ping; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(21), 14700-14715.\", \"reagents\": [\"2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline\"], \"catalysts\": [], \"solvents\": [\"Methanol\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38179439\", \"1.1\", \"Reagents: 2-Ethoxy-1-(ethoxycarbonyl)-1,2-dihydroquinoline\", \"Solvents: Methanol, Dichloromethane; 5 h, rt\", \"186. Scheme 186 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Betulinic acid derived amides are highly cytotoxic, apoptotic and selective\", \"By: Hoenke, Sophie; et al\", \"European Journal of Medicinal Chemistry (2020), 207, 112815.\", \"10.1016/j.ejmech.2020.112815\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2511353-36-7\", \"100-46-9\"], \"pro_cas\": [\"2511353-37-8\"], \"rgt_cas\": [\"16357-59-8\"], \"cat_cas\": [], \"sol_cas\": [\"67-56-1\", \"75-09-2\"], \"notes\": [\"in the dark\"]}}", "enriched_names": {"reactants": ["2511353-36-7", "100-46-9"], "products": ["2511353-37-8"], "reagents": ["16357-59-8"], "catalysts": [], "solvents": ["Methanol", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.146456", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38180209", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": null, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(=O)O.N=CN.Nc1cc(F)c(F)cc1C(=O)O", "products": "O=c1nc[nH]c2cc(F)c(F)cc12"}, "reference": {"title": "Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)", "authors": "Chen, Young; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(23), 15750-15760.", "doi": "10.1021/acs.jmedchem.3c01137", "raw": "Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2) | Chen, Young; et al | Journal of Medicinal Chemistry (2023), 66(23), 15750-15760. | 10.1021/acs.jmedchem.3c01137"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-38180209", "1.1|Solvents: Ethanol; overnight, reflux", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/none/Ethanol|64-17-5", "cond_sig": "9fc9dc04", "fam_sig": "9fc9dc04"}, "raw_data": {"raw_cas": "RCT: 2387523-00-2 + 1148157-29-2 | PRO: 2387523-25-1 | SOL: 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)\", \"authors\": \"Chen, Young; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(23), 15750-15760.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38180209\", \"1.1\", \"Solvents: Ethanol; overnight, reflux\", \"127. Scheme 127 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387523-00-2\", \"1148157-29-2\"], \"pro_cas\": [\"2387523-25-1\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387523-00-2", "1148157-29-2"], "products": ["2387523-25-1"], "reagents": [], "catalysts": [], "solvents": ["Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.146456", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38181050", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 65.0, "time_h": 6.0, "yield_pct": 86.0}, "smiles": {"reactants": "Nc1cc(Cl)cc(Cl)c1OCc1ccc(C(=O)O)cc1.CC(C)(C)OC(=O)NCCN", "products": "CC(C)(C)OC(=O)NCCNC(=O)c1ccc(COc2c(N)cc(Cl)cc2Cl)cc1"}, "reference": {"title": "Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke", "authors": "Chen, Weilin; et al", "citation": "European Journal of Medicinal Chemistry (2023), 261, 115871.", "doi": "10.1016/j.ejmech.2023.115871", "raw": "Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke | Chen, Weilin; et al | European Journal of Medicinal Chemistry (2023), 261, 115871. | 10.1016/j.ejmech.2023.115871"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-38181050", "1.1|Reagents: Thionyl chloride; rt → 65 °C; 2 h, 65 °C", "1.2|Solvents: Dichloromethane; 4 h, 20 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "By: Guryanov, Ivan; et al", "Organic Process Research & Development (2021), 25(7), 1598-1611.", "10.1021/acs.oprd.1c00021"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2", "cond_sig": "87555a68", "fam_sig": "f919c211"}, "raw_data": {"raw_cas": "RCT: 1118767-16-0 + 657-27-2 | PRO: 2682856-38-6 | RGT: 7719-09-7 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke\", \"authors\": \"Chen, Weilin; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 261, 115871.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38181050\", \"1.1\", \"Reagents: Thionyl chloride; rt → 65 °C; 2 h, 65 °C\", \"1.2\", \"Solvents: Dichloromethane; 4 h, 20 °C\", \"475. Scheme 475 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"By: Guryanov, Ivan; et al\", \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"10.1021/acs.oprd.1c00021\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1118767-16-0\", \"657-27-2\"], \"pro_cas\": [\"2682856-38-6\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1118767-16-0", "657-27-2"], "products": ["2682856-38-6"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.146456", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38257722", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "CN.CN(C)C(=O)[C@@H](NC(=O)c1cc(C(=O)O)ccc1-c1ccc(C(F)(F)F)cc1)c1cccc(C(F)(F)F)c1", "products": "CNC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(C(=O)N[C@H](C(=O)N(C)C)c2cccc(C(F)(F)F)c2)c1"}, "reference": {"title": "Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)", "authors": "Wang, Jocelyn; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 96, 129492.", "doi": "10.1016/j.bmcl.2023.129492", "raw": "Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D) | Wang, Jocelyn; et al | Bioorganic & Medicinal Chemistry Letters (2023), 96, 129492. | 10.1016/j.bmcl.2023.129492"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-38257722", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis", "By: Sutherland, Hamish S.; et al", "European Journal of Medicinal Chemistry (2022), 229, 114059.", "10.1016/j.ejmech.2021.114059"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1100361-06-5 + 3035854-55-5 | PRO: 3035854-56-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)\", \"authors\": \"Wang, Jocelyn; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 96, 129492.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38257722\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"42. Scheme 42 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis\", \"By: Sutherland, Hamish S.; et al\", \"European Journal of Medicinal Chemistry (2022), 229, 114059.\", \"10.1016/j.ejmech.2021.114059\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1100361-06-5\", \"3035854-55-5\"], \"pro_cas\": [\"3035854-56-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"sealed tube used\"]}}", "enriched_names": {"reactants": ["1100361-06-5", "3035854-55-5"], "products": ["3035854-56-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.146456", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259020", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 5.667, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(N[C@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]", "products": "CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "authors": "Novotna, Katerina; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "doi": "10.1021/acs.jmedchem.3c01681", "raw": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery | Novotna, Katerina; et al | Journal of Medicinal Chemistry (2023), 66(22), 15493-15510. | 10.1021/acs.jmedchem.3c01681"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-38259020", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 5 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "By: Meena, Chhuttan L.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "10.1016/j.bmcl.2020.127039"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 18942-49-9 + 2413279-63-5 | PRO: 2413279-29-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"authors\": \"Novotna, Katerina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259020\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 5 h, rt\", \"232. Scheme 232 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"By: Meena, Chhuttan L.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"10.1016/j.bmcl.2020.127039\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"18942-49-9\", \"2413279-63-5\"], \"pro_cas\": [\"2413279-29-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["tert-Butyldimethylsilyl chloride", "2413279-63-5"], "products": ["2413279-29-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.146456", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259023", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 4.167, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(N[C@@H](Cc1ccc(C(F)(F)F)cc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]", "products": "CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@H](Cc1ccc(C(F)(F)F)cc1)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "authors": "Novotna, Katerina; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "doi": "10.1021/acs.jmedchem.3c01681", "raw": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery | Novotna, Katerina; et al | Journal of Medicinal Chemistry (2023), 66(22), 15493-15510. | 10.1021/acs.jmedchem.3c01681"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-38259023", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 3.5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 473567-59-8 + 1626337-85-6 | PRO: 2249977-10-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"authors\": \"Novotna, Katerina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259023\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 3.5 h, rt\", \"329. Scheme 329 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"473567-59-8\", \"1626337-85-6\"], \"pro_cas\": [\"2249977-10-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["473567-59-8", "1626337-85-6"], "products": ["2249977-10-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.146456", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259024", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.667, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(N[C@@H](Cc1cccc(F)c1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]", "products": "CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@H](Cc1cccc(F)c1)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "authors": "Novotna, Katerina; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "doi": "10.1021/acs.jmedchem.3c01681", "raw": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery | Novotna, Katerina; et al | Journal of Medicinal Chemistry (2023), 66(22), 15493-15510. | 10.1021/acs.jmedchem.3c01681"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38259024", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 783350-37-8 + 2765293-23-8 | PRO: 2765293-56-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"authors\": \"Novotna, Katerina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259024\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 16 h, rt\", \"322. Scheme 322 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"783350-37-8\", \"2765293-23-8\"], \"pro_cas\": [\"2765293-56-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["783350-37-8", "2765293-23-8"], "products": ["2765293-56-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.146456", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259026", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.167, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(N[C@@H](CCc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]", "products": "CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)[C@H](CCc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "authors": "Novotna, Katerina; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "doi": "10.1021/acs.jmedchem.3c01681", "raw": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery | Novotna, Katerina; et al | Journal of Medicinal Chemistry (2023), 66(22), 15493-15510. | 10.1021/acs.jmedchem.3c01681"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-38259026", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 1.5 h, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 100-09-4 + 2919713-61-2 | PRO: 2919713-77-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"authors\": \"Novotna, Katerina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259026\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 1.5 h, rt\", \"237. Scheme 237 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"100-09-4\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-77-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["100-09-4", "2919713-61-2"], "products": ["2919713-77-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.147453", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259029", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.667, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]", "products": "CC(C)(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCC(=O)C=[N+]=[N-])C(=O)OC(C)(C)C"}, "reference": {"title": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "authors": "Novotna, Katerina; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "doi": "10.1021/acs.jmedchem.3c01681", "raw": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery | Novotna, Katerina; et al | Journal of Medicinal Chemistry (2023), 66(22), 15493-15510. | 10.1021/acs.jmedchem.3c01681"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38259029", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 16 h, rt", "Absolute stereochemistry shown", "Relative stereochemistry shown", "Absolute stereochemistry shown", "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen", "By: Hekking, Koen F. W.; et al", "Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.", "10.1021/acs.jmedchem.3c02206"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 327156-95-6 + 3076055-76-7 | PRO: 3076055-77-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"authors\": \"Novotna, Katerina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259029\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 16 h, rt\", \"155. Scheme 155 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Relative stereochemistry shown\", \"Absolute stereochemistry shown\", \"Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen\", \"By: Hekking, Koen F. W.; et al\", \"Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.\", \"10.1021/acs.jmedchem.3c02206\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"327156-95-6\", \"3076055-76-7\"], \"pro_cas\": [\"3076055-77-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["327156-95-6", "3076055-76-7"], "products": ["3076055-77-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.147453", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259030", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 4.667, "yield_pct": 98.0}, "smiles": {"reactants": "C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]", "products": "C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@@H](CCC(=O)C=[N+]=[N-])C(=O)OC(C)(C)C"}, "reference": {"title": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "authors": "Novotna, Katerina; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "doi": "10.1021/acs.jmedchem.3c01681", "raw": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery | Novotna, Katerina; et al | Journal of Medicinal Chemistry (2023), 66(22), 15493-15510. | 10.1021/acs.jmedchem.3c01681"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-38259030", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 4 h, rt", "Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1", "By: Come, Jon H.; et al", "Journal of Medicinal Chemistry (2021), 64(24), 17753-17776.", "10.1021/acs.jmedchem.1c00944"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 306298-00-0 + 2227482-43-9 | PRO: 2227482-41-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"authors\": \"Novotna, Katerina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259030\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 4 h, rt\", \"79. Scheme 79 (1 Reaction)\", \"Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1\", \"By: Come, Jon H.; et al\", \"Journal of Medicinal Chemistry (2021), 64(24), 17753-17776.\", \"10.1021/acs.jmedchem.1c00944\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"306298-00-0\", \"2227482-43-9\"], \"pro_cas\": [\"2227482-41-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["306298-00-0", "2227482-43-9"], "products": ["2227482-41-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.147453", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259031", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.667, "yield_pct": 92.0}, "smiles": {"reactants": "O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-]", "products": "CC(C)(C)OC(=O)[C@H](CCC(=O)C=[N+]=[N-])NC(=O)CNC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "authors": "Novotna, Katerina; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "doi": "10.1021/acs.jmedchem.3c01681", "raw": "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery | Novotna, Katerina; et al | Journal of Medicinal Chemistry (2023), 66(22), 15493-15510. | 10.1021/acs.jmedchem.3c01681"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-38259031", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 5 min, 0 °C", "1.2|Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 2 h, rt", "Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist", "By: Baska, Ferenc; et al", "Journal of Medicinal Chemistry (2024), 67(1), 643-673.", "10.1021/acs.jmedchem.3c01868"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 2355306-36-2 | PRO: 2355306-37-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"authors\": \"Novotna, Katerina; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259031\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 5 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 5 min, 0 °C; 30 min, 0 °C; 2 h, rt\", \"46. Scheme 46 (1 Reaction)\", \"Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist\", \"By: Baska, Ferenc; et al\", \"Journal of Medicinal Chemistry (2024), 67(1), 643-673.\", \"10.1021/acs.jmedchem.3c01868\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2355306-36-2\"], \"pro_cas\": [\"2355306-37-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2355306-36-2"], "products": ["2355306-37-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.147453", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259246", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 20.0, "time_h": 16.0, "yield_pct": 84.0}, "smiles": {"reactants": "NC1CCOCC1.C[C@@]1(C(=O)O)COCCN1c1nc(-c2cccc3[nH]ccc23)ncc1F", "products": "C[C@@]1(C(=O)NC2CCOCC2)COCCN1c1nc(-c2cccc3[nH]ccc23)ncc1F"}, "reference": {"title": "Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy", "authors": "Murphy, Sean T.; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550.", "doi": "10.1021/acsmedchemlett.3c00351", "raw": "Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy | Murphy, Sean T.; et al | ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550. | 10.1021/acsmedchemlett.3c00351"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-38259246", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 16 h, 20 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag", "By: Nowak, Radoslaw P.; et al", "Journal of Medicinal Chemistry (2021), 64(15), 11637-11650.", "10.1021/acs.jmedchem.1c00958"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 153086-78-3 + 2865130-01-2 | PRO: 2757046-11-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free-Wilson Analysis for Improved In Vivo Efficacy\", \"authors\": \"Murphy, Sean T.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(11), 1544-1550.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259246\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 16 h, 20 °C\", \"441. Scheme 441 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structure-Guided Design of a “Bump-and-Hole” Bromodomain-Based Degradation Tag\", \"By: Nowak, Radoslaw P.; et al\", \"Journal of Medicinal Chemistry (2021), 64(15), 11637-11650.\", \"10.1021/acs.jmedchem.1c00958\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"153086-78-3\", \"2865130-01-2\"], \"pro_cas\": [\"2757046-11-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["153086-78-3", "2865130-01-2"], "products": ["2757046-11-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.147453", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259318", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccc(NC(=O)C(F)(F)F)cc1.Nc1ccc(F)c([N+](=O)[O-])c1", "products": "O=C(Nc1ccc(F)c([N+](=O)[O-])c1)c1ccc(NC(=O)C(F)(F)F)cc1"}, "reference": {"title": "Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity", "authors": "Fang, Jing-jie; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.", "doi": "10.1021/acs.jmedchem.3c01351", "raw": "Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity | Fang, Jing-jie; et al | Journal of Medicinal Chemistry (2023), 66(22), 15288-15308. | 10.1021/acs.jmedchem.3c01351"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38259318", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Tetrahydrofuran; 8 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Tetrahydrofuran; rt; 4 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities", "By: Wang, Juan; et al", "European Journal of Medicinal Chemistry (2021), 215, 113267.", "10.1016/j.ejmech.2021.113267"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Tetrahydrofuran|109-99-9", "cond_sig": "bed5d4ba", "fam_sig": "5e45683b"}, "raw_data": {"raw_cas": "RCT: 15761-38-3 + 17355-19-0 | PRO: 1263359-83-6 | RGT: 79-37-8 + 121-44-8 | CAT: 68-12-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity\", \"authors\": \"Fang, Jing-jie; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259318\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Tetrahydrofuran; 8 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Tetrahydrofuran; rt; 4 h, rt\", \"295. Scheme 295 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities\", \"By: Wang, Juan; et al\", \"European Journal of Medicinal Chemistry (2021), 215, 113267.\", \"10.1016/j.ejmech.2021.113267\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15761-38-3\", \"17355-19-0\"], \"pro_cas\": [\"1263359-83-6\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["15761-38-3", "17355-19-0"], "products": ["1263359-83-6"], "reagents": ["79-37-8", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.147453", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38259319", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Sodium borohydride", "cas": "16940-66-2", "role": "UNK"}, {"name": "4-(Dimethylamino)pyridine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Ethanol", "cas": "64-17-5"}, {"name": "Methanol", "cas": "67-56-1"}], "conditions": {"temperature_c": 0.0, "time_h": 12.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)Cc1cccc(OC(F)(F)F)c1.Nc1cc(NC(=O)c2ccc(NC(=O)C(F)(F)F)cc2)ccc1F", "products": "Nc1ccc(C(=O)Nc2ccc(F)c(NC(=O)Cc3cccc(OC(F)(F)F)c3)c2)cc1"}, "reference": {"title": "Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity", "authors": "Fang, Jing-jie; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.", "doi": "10.1021/acs.jmedchem.3c01351", "raw": "Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity | Fang, Jing-jie; et al | Journal of Medicinal Chemistry (2023), 66(22), 15288-15308. | 10.1021/acs.jmedchem.3c01351"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-38259319", "1.1|Reagents: 4-(Dimethylamino)pyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 8 h, rt", "1.2|Reagents: Sodium borohydride", "Solvents: Ethanol, Methanol; 1 h, 0 °C; 2 h, 0 °C → rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/4-(Dimethylamino)pyridine|+4-Dimethylaminopyridine|1122-58-3+HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium borohydride|16940-66-2/Dimethylformamide|68-12-2+Ethanol|64-17-5+Methanol|67-56-1", "cond_sig": "7b50ddbc", "fam_sig": "63915ca1"}, "raw_data": {"raw_cas": "RCT: 36847-86-6 + 40615-17-6 | PRO: 2416338-35-5 | RGT: 1122-58-3 + 148893-10-1 + 16940-66-2 | SOL: 68-12-2 + 64-17-5 + 67-56-1", "raw_data_json": "{\"txt\": {\"title\": \"Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity\", \"authors\": \"Fang, Jing-jie; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.\", \"reagents\": [\"4-(Dimethylamino)pyridine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium borohydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Ethanol\", \"Methanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38259319\", \"1.1\", \"Reagents: 4-(Dimethylamino)pyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 8 h, rt\", \"1.2\", \"Reagents: Sodium borohydride\", \"Solvents: Ethanol, Methanol; 1 h, 0 °C; 2 h, 0 °C → rt\", \"448. Scheme 448 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36847-86-6\", \"40615-17-6\"], \"pro_cas\": [\"2416338-35-5\"], \"rgt_cas\": [\"1122-58-3\", \"148893-10-1\", \"16940-66-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"64-17-5\", \"67-56-1\"], \"notes\": [\"intermediate yield 42% (stage 1)\"]}}", "enriched_names": {"reactants": ["36847-86-6", "40615-17-6"], "products": ["2416338-35-5"], "reagents": ["4-Dimethylaminopyridine", "HATU", "Sodium borohydride"], "catalysts": [], "solvents": ["Dimethylformamide", "Ethanol", "Methanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.147453", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38275827", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 23.0, "time_h": 19.5, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2[nH]1.CC(C)(C)OC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "CC(C)(C)OC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc2ccccc2[nH]1"}, "reference": {"title": "Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors", "authors": "Jelisejevs, Daniels; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2023), 96, 129530.", "doi": "10.1016/j.bmcl.2023.129530", "raw": "Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors | Jelisejevs, Daniels; et al | Bioorganic & Medicinal Chemistry Letters (2023), 96, 129530. | 10.1016/j.bmcl.2023.129530"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-38275827", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 30 min, 0 °C; 19 h, 23 °C", "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis", "By: Zhao, Hongyi; et al", "Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.", "10.1021/acs.jmedchem.2c00718"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "00c3ed65", "fam_sig": "886b0b98"}, "raw_data": {"raw_cas": "RCT: 5452-37-9 + 27746-02-7 + 24424-99-5 | PRO: 2290532-73-7 | RGT: 7087-68-5 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors\", \"authors\": \"Jelisejevs, Daniels; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2023), 96, 129530.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38275827\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 30 min, 0 °C; 19 h, 23 °C\", \"428. Scheme 428 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis\", \"By: Zhao, Hongyi; et al\", \"Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.\", \"10.1021/acs.jmedchem.2c00718\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5452-37-9\", \"27746-02-7\", \"24424-99-5\"], \"pro_cas\": [\"2290532-73-7\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5452-37-9", "27746-02-7", "tert-Butyl carbamate"], "products": ["2290532-73-7"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.148450", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38374432", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.333, "yield_pct": 88.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O.CC(C)C[C@H](N)C(=O)NCC(=O)NC12CC3CC(CC(C3)C1)C2.O=C(O)C(F)(F)F", "products": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)C(=O)NCC(=O)NC12CC3CC(CC(C3)C1)C2"}, "reference": {"title": "Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors", "authors": "Silva-Reis, Sara C.; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663.", "doi": "10.1021/acsmedchemlett.3c00264", "raw": "Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors | Silva-Reis, Sara C.; et al | ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663. | 10.1021/acsmedchemlett.3c00264"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-38374432", "1.1|Reagents: Triethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 15 - 20 min, rt", "1.2|2 h, rt", "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "By: Liu, Yonghua; et al", "European Journal of Medicinal Chemistry (2022), 228, 114033.", "10.1016/j.ejmech.2021.114033"], "signatures": {"cond_key": "none/none/O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "3e9289bf", "fam_sig": "91ec7240"}, "raw_data": {"raw_cas": "RCT: 694499-26-8 + 3035807-44-1 | PRO: 3035807-32-7 | RGT: 121-44-8 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors\", \"authors\": \"Silva-Reis, Sara C.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663.\", \"reagents\": [\"Triethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38374432\", \"1.1\", \"Reagents: Triethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 15 - 20 min, rt\", \"1.2\", \"2 h, rt\", \"101. Scheme 101 (1 Reaction)\", \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"By: Liu, Yonghua; et al\", \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"10.1016/j.ejmech.2021.114033\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"694499-26-8\", \"3035807-44-1\"], \"pro_cas\": [\"3035807-32-7\"], \"rgt_cas\": [\"121-44-8\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["694499-26-8", "3035807-44-1"], "products": ["3035807-32-7"], "reagents": ["Triethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.148450", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38408158", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 11.0, "yield_pct": 87.0}, "smiles": {"reactants": "COc1ccc2cc(C(=O)O)oc2c1.NCC(=O)O", "products": "COc1ccc2cc(C(=O)NCC(=O)O)oc2c1"}, "reference": {"title": "Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis", "authors": "Zhou, Zi-ying; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(3), 1742-1760.", "doi": "10.1021/acs.jmedchem.2c01377", "raw": "Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis | Zhou, Zi-ying; et al | Journal of Medicinal Chemistry (2023), 66(3), 1742-1760. | 10.1021/acs.jmedchem.2c01377"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-38408158", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 1 h, rt", "1.2|10 h, rt", "Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors", "By: Sturbaut, Manon; et al", "European Journal of Medicinal Chemistry (2021), 226, 113835.", "10.1016/j.ejmech.2021.113835"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 64-04-0 + 1152543-93-5 | PRO: 2763775-65-9 | RGT: 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Efficacy, Mechanism, and Structure-Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis\", \"authors\": \"Zhou, Zi-ying; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(3), 1742-1760.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38408158\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"10 h, rt\", \"306. Scheme 306 (1 Reaction)\", \"Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors\", \"By: Sturbaut, Manon; et al\", \"European Journal of Medicinal Chemistry (2021), 226, 113835.\", \"10.1016/j.ejmech.2021.113835\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-04-0\", \"1152543-93-5\"], \"pro_cas\": [\"2763775-65-9\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["64-04-0", "1152543-93-5"], "products": ["2763775-65-9"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.148450", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38469848", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 81.0}, "smiles": {"reactants": "NC1CCC(=O)NC1=O.CC(C)(C)OC(=O)Nc1ccc(C(=O)O)cc1", "products": "CC(C)(C)OC(=O)Nc1ccc(C(=O)NC2CCC(=O)NC2=O)cc1"}, "reference": {"title": "Design and synthesis of novel cereblon binders for use in targeted protein degradation", "authors": "Norris, Stephen; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.", "doi": "10.1021/acs.jmedchem.3c01848", "raw": "Design and synthesis of novel cereblon binders for use in targeted protein degradation | Norris, Stephen; et al | Journal of Medicinal Chemistry (2023), 66(23), 16388-16409. | 10.1021/acs.jmedchem.3c01848"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-38469848", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 1912-47-6 | PRO: 2565618-07-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and synthesis of novel cereblon binders for use in targeted protein degradation\", \"authors\": \"Norris, Stephen; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38469848\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, rt\", \"393. Scheme 393 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"1912-47-6\"], \"pro_cas\": [\"2565618-07-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "1912-47-6"], "products": ["2565618-07-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.149448", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38469900", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 90.0}, "smiles": {"reactants": "NC1CCC(=O)NC1=O.CC(C)(C)OC(=O)NCc1ccc(C(=O)O)cc1", "products": "CC(C)(C)OC(=O)NCc1ccc(C(=O)NC2CCC(=O)NC2=O)cc1"}, "reference": {"title": "Design and synthesis of novel cereblon binders for use in targeted protein degradation", "authors": "Norris, Stephen; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.", "doi": "10.1021/acs.jmedchem.3c01848", "raw": "Design and synthesis of novel cereblon binders for use in targeted protein degradation | Norris, Stephen; et al | Journal of Medicinal Chemistry (2023), 66(23), 16388-16409. | 10.1021/acs.jmedchem.3c01848"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38469900", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 2 h, rt", "1.2|Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin", "By: Schiffers, Ingo; et al", "Organic Process Research & Development (2022), 26(10), 2811-2822.", "10.1021/acs.oprd.2c00152"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "1db37e54", "fam_sig": "a8d8fb5f"}, "raw_data": {"raw_cas": "RCT: 19075-59-3 + 876160-18-8 | PRO: 2831364-37-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design and synthesis of novel cereblon binders for use in targeted protein degradation\", \"authors\": \"Norris, Stephen; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38469900\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 2 h, rt\", \"1.2\", \"Solvents: Water; rt\", \"388. Scheme 388 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin\", \"By: Schiffers, Ingo; et al\", \"Organic Process Research & Development (2022), 26(10), 2811-2822.\", \"10.1021/acs.oprd.2c00152\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19075-59-3\", \"876160-18-8\"], \"pro_cas\": [\"2831364-37-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["19075-59-3", "876160-18-8"], "products": ["2831364-37-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.149448", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38476171", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 18.25, "yield_pct": 92.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](CC(=O)O)c1ccccc1.CN", "products": "CNC(=O)C[C@H](NC(=O)OC(C)(C)C)c1ccccc1"}, "reference": {"title": "Discovery of Nanomolar DCAF1 Small Molecule Ligands", "authors": "Li, Alice Shi Ming; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(7), 5041-5060.", "doi": "10.1021/acs.jmedchem.2c02132", "raw": "Discovery of Nanomolar DCAF1 Small Molecule Ligands | Li, Alice Shi Ming; et al | Journal of Medicinal Chemistry (2023), 66(7), 5041-5060. | 10.1021/acs.jmedchem.2c02132"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-38476171", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, rt", "1.2|Solvents: Tetrahydrofuran; 18 h, rt", "Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents", "By: Imran Ahamad, Mohd.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(11), 127138.", "10.1016/j.bmcl.2020.127138"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9", "cond_sig": "ec1a0320", "fam_sig": "1abbcdec"}, "raw_data": {"raw_cas": "RCT: 1562348-91-7 + 107-10-8 | PRO: 2415251-33-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Nanomolar DCAF1 Small Molecule Ligands\", \"authors\": \"Li, Alice Shi Ming; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(7), 5041-5060.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38476171\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"Solvents: Tetrahydrofuran; 18 h, rt\", \"55. Scheme 55 (1 Reaction)\", \"Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents\", \"By: Imran Ahamad, Mohd.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(11), 127138.\", \"10.1016/j.bmcl.2020.127138\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1562348-91-7\", \"107-10-8\"], \"pro_cas\": [\"2415251-33-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["1562348-91-7", "107-10-8"], "products": ["2415251-33-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.149448", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38556002", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "WORKUP"}, {"name": "Iron", "cas": "7439-89-6", "role": "UNK"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethanol", "cas": "64-17-5"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 100.0, "time_h": 17.517, "yield_pct": 86.0}, "smiles": {"reactants": "COc1ccc(CCCC(=O)O)cc1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].CCCC(=O)Cl", "products": "CCCC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4ccc(OC)cc4)cc3F)ncnc2cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "authors": "Tang, Sheng; et al", "citation": "European Journal of Medicinal Chemistry (2024), 263, 115939.", "doi": "10.1016/j.ejmech.2023.115939", "raw": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC | Tang, Sheng; et al | European Journal of Medicinal Chemistry (2024), 263, 115939. | 10.1016/j.ejmech.2023.115939"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-38556002", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0.5 h, 0 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane; 0.5 h, rt", "1.3|1 min, rt; 3 h, rt", "1.4|Reagents: Iron, Ammonium chloride", "Solvents: Ethanol, Water; 1.5 h, 100 °C", "1.5|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process Development and Scale-up", "By: Wagner, Anna M.; et al", "Organic Process Research & Development (2024), 28(8), 3382-3395.", "10.1021/acs.oprd.4c00242"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Iron|7439-89-6+NaHCO3|144-55-8+Oxalyl chloride|79-37-8+Sodium bicarbonate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Ethanol|64-17-5+Water|7732-18-5", "cond_sig": "6feb307a", "fam_sig": "70f6c7e9"}, "raw_data": {"raw_cas": "RCT: 1620056-83-8 + 2375019-85-3 | PRO: 2375020-19-0 | RGT: 79-37-8 + 144-55-8 + 7439-89-6 + 12125-02-9 | CAT: 68-12-2 | SOL: 75-09-2 + 64-17-5 + 7732-18-5 + 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"authors\": \"Tang, Sheng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"reagents\": [\"Oxalyl chloride\", \"Sodium bicarbonate\", \"Iron\", \"Ammonium chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Ethanol\", \"Water\", \"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38556002\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0.5 h, 0 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.3\", \"1 min, rt; 3 h, rt\", \"1.4\", \"Reagents: Iron, Ammonium chloride\", \"Solvents: Ethanol, Water; 1.5 h, 100 °C\", \"1.5\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt\", \"413. Scheme 413 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process Development and Scale-up\", \"By: Wagner, Anna M.; et al\", \"Organic Process Research & Development (2024), 28(8), 3382-3395.\", \"10.1021/acs.oprd.4c00242\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1620056-83-8\", \"2375019-85-3\"], \"pro_cas\": [\"2375020-19-0\"], \"rgt_cas\": [\"79-37-8\", \"144-55-8\", \"7439-89-6\", \"12125-02-9\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"64-17-5\", \"7732-18-5\", \"123-91-1\"], \"notes\": [\"solution from stage 1 and 2 prepared separately and added in stage 3\"]}}", "enriched_names": {"reactants": ["1620056-83-8", "2375019-85-3"], "products": ["2375020-19-0"], "reagents": ["79-37-8", "NaHCO3", "Iron", "12125-02-9"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Ethanol", "Water", "1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.150446", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38556004", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "WORKUP"}, {"name": "Iron", "cas": "7439-89-6", "role": "UNK"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethanol", "cas": "64-17-5"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 100.0, "time_h": 17.517, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)CCCc1cccs1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].C=CC(=O)Cl", "products": "C=CC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4cccs4)cc3F)ncnc2cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "authors": "Tang, Sheng; et al", "citation": "European Journal of Medicinal Chemistry (2024), 263, 115939.", "doi": "10.1016/j.ejmech.2023.115939", "raw": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC | Tang, Sheng; et al | European Journal of Medicinal Chemistry (2024), 263, 115939. | 10.1016/j.ejmech.2023.115939"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-38556004", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0.5 h, 0 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane; 0.5 h, rt", "1.3|1 min, rt; 3 h, rt", "1.4|Reagents: Iron, Ammonium chloride", "Solvents: Ethanol, Water; 1.5 h, 100 °C", "1.5|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt", "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "By: Tang, Sheng; et al", "European Journal of Medicinal Chemistry (2024), 263, 115939.", "10.1016/j.ejmech.2023.115939"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Iron|7439-89-6+NaHCO3|144-55-8+Oxalyl chloride|79-37-8+Sodium bicarbonate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Ethanol|64-17-5+Water|7732-18-5", "cond_sig": "6feb307a", "fam_sig": "70f6c7e9"}, "raw_data": {"raw_cas": "RCT: 4653-11-6 + 2761180-24-7 + 141-75-3 | PRO: 3020728-54-2 | RGT: 79-37-8 + 144-55-8 + 7439-89-6 + 12125-02-9 | CAT: 68-12-2 | SOL: 75-09-2 + 64-17-5 + 7732-18-5 + 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"authors\": \"Tang, Sheng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"reagents\": [\"Oxalyl chloride\", \"Sodium bicarbonate\", \"Iron\", \"Ammonium chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Ethanol\", \"Water\", \"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38556004\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0.5 h, 0 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.3\", \"1 min, rt; 3 h, rt\", \"1.4\", \"Reagents: Iron, Ammonium chloride\", \"Solvents: Ethanol, Water; 1.5 h, 100 °C\", \"1.5\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt\", \"419. Scheme 419 (1 Reaction)\", \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"By: Tang, Sheng; et al\", \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"10.1016/j.ejmech.2023.115939\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4653-11-6\", \"2761180-24-7\", \"141-75-3\"], \"pro_cas\": [\"3020728-54-2\"], \"rgt_cas\": [\"79-37-8\", \"144-55-8\", \"7439-89-6\", \"12125-02-9\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"64-17-5\", \"7732-18-5\", \"123-91-1\"], \"notes\": [\"solution from stage 1 and 2 prepared separately and added in stage 3\"]}}", "enriched_names": {"reactants": ["4653-11-6", "2761180-24-7", "141-75-3"], "products": ["3020728-54-2"], "reagents": ["79-37-8", "NaHCO3", "Iron", "12125-02-9"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Ethanol", "Water", "1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.150446", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38556005", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "WORKUP"}, {"name": "Iron", "cas": "7439-89-6", "role": "UNK"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethanol", "cas": "64-17-5"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 100.0, "time_h": 17.517, "yield_pct": 88.0}, "smiles": {"reactants": "COc1ccc(CCCC(=O)O)cc1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].CCCCC(=O)Cl", "products": "CCCCC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4ccc(OC)cc4)cc3F)ncnc2cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "authors": "Tang, Sheng; et al", "citation": "European Journal of Medicinal Chemistry (2024), 263, 115939.", "doi": "10.1016/j.ejmech.2023.115939", "raw": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC | Tang, Sheng; et al | European Journal of Medicinal Chemistry (2024), 263, 115939. | 10.1016/j.ejmech.2023.115939"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-38556005", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0.5 h, 0 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane; 0.5 h, rt", "1.3|1 min, rt; 3 h, rt", "1.4|Reagents: Iron, Ammonium chloride", "Solvents: Ethanol, Water; 1.5 h, 100 °C", "1.5|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Early Process Development of an LPAR1 Antagonist, GS-2278", "By: Kadunce, Nathaniel; et al", "Organic Process Research & Development (2024), 28(11), 4099-4113.", "10.1021/acs.oprd.4c00369"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Iron|7439-89-6+NaHCO3|144-55-8+Oxalyl chloride|79-37-8+Sodium bicarbonate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Ethanol|64-17-5+Water|7732-18-5", "cond_sig": "6feb307a", "fam_sig": "70f6c7e9"}, "raw_data": {"raw_cas": "RCT: 306960-77-0 + 3063593-11-0 | PRO: 2750508-72-4 | RGT: 79-37-8 + 144-55-8 + 7439-89-6 + 12125-02-9 | CAT: 68-12-2 | SOL: 75-09-2 + 64-17-5 + 7732-18-5 + 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"authors\": \"Tang, Sheng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"reagents\": [\"Oxalyl chloride\", \"Sodium bicarbonate\", \"Iron\", \"Ammonium chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Ethanol\", \"Water\", \"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38556005\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0.5 h, 0 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.3\", \"1 min, rt; 3 h, rt\", \"1.4\", \"Reagents: Iron, Ammonium chloride\", \"Solvents: Ethanol, Water; 1.5 h, 100 °C\", \"1.5\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt\", \"415. Scheme 415 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Early Process Development of an LPAR1 Antagonist, GS-2278\", \"By: Kadunce, Nathaniel; et al\", \"Organic Process Research & Development (2024), 28(11), 4099-4113.\", \"10.1021/acs.oprd.4c00369\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"306960-77-0\", \"3063593-11-0\"], \"pro_cas\": [\"2750508-72-4\"], \"rgt_cas\": [\"79-37-8\", \"144-55-8\", \"7439-89-6\", \"12125-02-9\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"64-17-5\", \"7732-18-5\", \"123-91-1\"], \"notes\": [\"solution from stage 1 and 2 prepared separately and added in stage 3\"]}}", "enriched_names": {"reactants": ["306960-77-0", "3063593-11-0"], "products": ["2750508-72-4"], "reagents": ["79-37-8", "NaHCO3", "Iron", "12125-02-9"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Ethanol", "Water", "1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.150446", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38556008", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "WORKUP"}, {"name": "Iron", "cas": "7439-89-6", "role": "UNK"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethanol", "cas": "64-17-5"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 100.0, "time_h": 17.517, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)CCCc1cccs1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].C/C=C/C(=O)Cl", "products": "C/C=C/C(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4cccs4)cc3F)ncnc2cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "authors": "Tang, Sheng; et al", "citation": "European Journal of Medicinal Chemistry (2024), 263, 115939.", "doi": "10.1016/j.ejmech.2023.115939", "raw": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC | Tang, Sheng; et al | European Journal of Medicinal Chemistry (2024), 263, 115939. | 10.1016/j.ejmech.2023.115939"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-38556008", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0.5 h, 0 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane; 0.5 h, rt", "1.3|1 min, rt; 3 h, rt", "1.4|Reagents: Iron, Ammonium chloride", "Solvents: Ethanol, Water; 1.5 h, 100 °C", "1.5|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition Following Process Risk Mitigation Strategy", "By: Kim, Dae-Shik; et al", "Organic Process Research & Development (2022), 26(3), 804-816.", "10.1021/acs.oprd.1c00223"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Iron|7439-89-6+NaHCO3|144-55-8+Oxalyl chloride|79-37-8+Sodium bicarbonate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Ethanol|64-17-5+Water|7732-18-5", "cond_sig": "6feb307a", "fam_sig": "70f6c7e9"}, "raw_data": {"raw_cas": "RCT: 1174321-06-2 + 1388651-24-8 | PRO: 1388651-30-6 | RGT: 79-37-8 + 144-55-8 + 7439-89-6 + 12125-02-9 | CAT: 68-12-2 | SOL: 75-09-2 + 64-17-5 + 7732-18-5 + 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"authors\": \"Tang, Sheng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"reagents\": [\"Oxalyl chloride\", \"Sodium bicarbonate\", \"Iron\", \"Ammonium chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Ethanol\", \"Water\", \"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38556008\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0.5 h, 0 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.3\", \"1 min, rt; 3 h, rt\", \"1.4\", \"Reagents: Iron, Ammonium chloride\", \"Solvents: Ethanol, Water; 1.5 h, 100 °C\", \"1.5\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt\", \"426. Scheme 426 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synthesis of BACE1 Inhibitors E2609/E2071 via Oxime-Olefin Cycloaddition Following Process Risk Mitigation Strategy\", \"By: Kim, Dae-Shik; et al\", \"Organic Process Research & Development (2022), 26(3), 804-816.\", \"10.1021/acs.oprd.1c00223\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1174321-06-2\", \"1388651-24-8\"], \"pro_cas\": [\"1388651-30-6\"], \"rgt_cas\": [\"79-37-8\", \"144-55-8\", \"7439-89-6\", \"12125-02-9\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"64-17-5\", \"7732-18-5\", \"123-91-1\"], \"notes\": [\"solution from stage 1 and 2 prepared separately and added in stage 3\"]}}", "enriched_names": {"reactants": ["1174321-06-2", "1388651-24-8"], "products": ["1388651-30-6"], "reagents": ["79-37-8", "NaHCO3", "Iron", "12125-02-9"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Ethanol", "Water", "1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.150446", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38556015", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "WORKUP"}, {"name": "Iron", "cas": "7439-89-6", "role": "UNK"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethanol", "cas": "64-17-5"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 100.0, "time_h": 17.517, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)CCCc1cccs1.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].CCCC(=O)Cl", "products": "CCCC(=O)Nc1cc2c(Oc3ccc(NC(=O)CCCc4cccs4)cc3F)ncnc2cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "authors": "Tang, Sheng; et al", "citation": "European Journal of Medicinal Chemistry (2024), 263, 115939.", "doi": "10.1016/j.ejmech.2023.115939", "raw": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC | Tang, Sheng; et al | European Journal of Medicinal Chemistry (2024), 263, 115939. | 10.1016/j.ejmech.2023.115939"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-38556015", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0.5 h, 0 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane; 0.5 h, rt", "1.3|1 min, rt; 3 h, rt", "1.4|Reagents: Iron, Ammonium chloride", "Solvents: Ethanol, Water; 1.5 h, 100 °C", "1.5|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt", "Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile", "By: Sestito, Simona; et al", "European Journal of Medicinal Chemistry (2021), 226, 113895.", "10.1016/j.ejmech.2021.113895"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Iron|7439-89-6+NaHCO3|144-55-8+Oxalyl chloride|79-37-8+Sodium bicarbonate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Ethanol|64-17-5+Water|7732-18-5", "cond_sig": "6feb307a", "fam_sig": "70f6c7e9"}, "raw_data": {"raw_cas": "RCT: 2302023-74-9 + 938353-92-5 | PRO: 2169270-96-4 | RGT: 79-37-8 + 144-55-8 + 7439-89-6 + 12125-02-9 | CAT: 68-12-2 | SOL: 75-09-2 + 64-17-5 + 7732-18-5 + 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"authors\": \"Tang, Sheng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"reagents\": [\"Oxalyl chloride\", \"Sodium bicarbonate\", \"Iron\", \"Ammonium chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Ethanol\", \"Water\", \"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38556015\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0.5 h, 0 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.3\", \"1 min, rt; 3 h, rt\", \"1.4\", \"Reagents: Iron, Ammonium chloride\", \"Solvents: Ethanol, Water; 1.5 h, 100 °C\", \"1.5\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt\", \"420. Scheme 420 (1 Reaction)\", \"Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile\", \"By: Sestito, Simona; et al\", \"European Journal of Medicinal Chemistry (2021), 226, 113895.\", \"10.1016/j.ejmech.2021.113895\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2302023-74-9\", \"938353-92-5\"], \"pro_cas\": [\"2169270-96-4\"], \"rgt_cas\": [\"79-37-8\", \"144-55-8\", \"7439-89-6\", \"12125-02-9\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"64-17-5\", \"7732-18-5\", \"123-91-1\"], \"notes\": [\"solution from stage 1 and 2 prepared separately and added in stage 3\"]}}", "enriched_names": {"reactants": ["2302023-74-9", "938353-92-5"], "products": ["2169270-96-4"], "reagents": ["79-37-8", "NaHCO3", "Iron", "12125-02-9"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Ethanol", "Water", "1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.150446", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38556017", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "WORKUP"}, {"name": "Iron", "cas": "7439-89-6", "role": "UNK"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethanol", "cas": "64-17-5"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 110.0, "time_h": 18.767, "yield_pct": 84.0}, "smiles": {"reactants": "Cc1nc(-c2ccccc2)sc1C(=O)O.COc1cc2ncnc(Oc3ccc(N)cc3F)c2cc1[N+](=O)[O-].C/C=C/C(=O)Cl", "products": "C/C=C/C(=O)Nc1cc2c(Oc3ccc(NC(=O)c4sc(-c5ccccc5)nc4C)cc3F)ncnc2cc1OC"}, "reference": {"title": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "authors": "Tang, Sheng; et al", "citation": "European Journal of Medicinal Chemistry (2024), 263, 115939.", "doi": "10.1016/j.ejmech.2023.115939", "raw": "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC | Tang, Sheng; et al | European Journal of Medicinal Chemistry (2024), 263, 115939. | 10.1016/j.ejmech.2023.115939"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-38556017", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0.5 h, 0 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane; 0.5 h, rt", "1.3|1 min, rt; 5 h, rt", "1.4|Reagents: Iron, Ammonium chloride", "Solvents: Ethanol, Water; 45 min, 110 °C", "1.5|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt", "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors", "By: Trinh, Phuc N. H.; et al", "Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.", "10.1021/acs.jmedchem.0c02169"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Iron|7439-89-6+NaHCO3|144-55-8+Oxalyl chloride|79-37-8+Sodium bicarbonate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2+Ethanol|64-17-5+Water|7732-18-5", "cond_sig": "6feb307a", "fam_sig": "70f6c7e9"}, "raw_data": {"raw_cas": "RCT: 3032112-39-0 + 88192-19-2 | PRO: 2972951-72-5 | RGT: 79-37-8 + 144-55-8 + 7439-89-6 + 12125-02-9 | CAT: 68-12-2 | SOL: 75-09-2 + 64-17-5 + 7732-18-5 + 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"authors\": \"Tang, Sheng; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"reagents\": [\"Oxalyl chloride\", \"Sodium bicarbonate\", \"Iron\", \"Ammonium chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Ethanol\", \"Water\", \"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38556017\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0.5 h, 0 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.3\", \"1 min, rt; 5 h, rt\", \"1.4\", \"Reagents: Iron, Ammonium chloride\", \"Solvents: Ethanol, Water; 45 min, 110 °C\", \"1.5\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, 1,4-Dioxane; 12 h, rt\", \"458. Scheme 458 (1 Reaction)\", \"Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors\", \"By: Trinh, Phuc N. H.; et al\", \"Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.\", \"10.1021/acs.jmedchem.0c02169\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3032112-39-0\", \"88192-19-2\"], \"pro_cas\": [\"2972951-72-5\"], \"rgt_cas\": [\"79-37-8\", \"144-55-8\", \"7439-89-6\", \"12125-02-9\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"64-17-5\", \"7732-18-5\", \"123-91-1\"], \"notes\": [\"solution from stage 1 and 2 prepared separately and added in stage 3\"]}}", "enriched_names": {"reactants": ["3032112-39-0", "88192-19-2"], "products": ["2972951-72-5"], "reagents": ["79-37-8", "NaHCO3", "Iron", "12125-02-9"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Ethanol", "Water", "1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.150446", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38559346", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 10.5, "yield_pct": 91.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)O)C1.NCc1cccs1", "products": "CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)NCc2cccs2)C1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability", "authors": "Gao, Shenghua; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(23), 16426-16440.", "doi": "10.1021/acs.jmedchem.3c01876", "raw": "Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability | Gao, Shenghua; et al | Journal of Medicinal Chemistry (2023), 66(23), 16426-16440. | 10.1021/acs.jmedchem.3c01876"}, "original_text": ["Steps: 1, Yield: 89-91%", "CAS Reaction Number: 31-614-CAS-38559346", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|10 h, rt", "Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors", "By: Gao, Shenghua; et al", "Journal of Medicinal Chemistry (2022), 65(24), 16902-16917.", "10.1021/acs.jmedchem.2c01716"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 2768834-59-7 + 27757-85-3 | PRO: 2768834-60-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability\", \"authors\": \"Gao, Shenghua; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(23), 16426-16440.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38559346\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"10 h, rt\", \"Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors\", \"By: Gao, Shenghua; et al\", \"Journal of Medicinal Chemistry (2022), 65(24), 16902-16917.\", \"10.1021/acs.jmedchem.2c01716\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2768834-59-7\", \"27757-85-3\"], \"pro_cas\": [\"2768834-60-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"literature preparation\"]}}", "enriched_names": {"reactants": ["2768834-59-7", "27757-85-3"], "products": ["2768834-60-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.151693", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38589174", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.0, "yield_pct": 92.0}, "smiles": {"reactants": "COc1ccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)cc1.Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1", "products": "COc1ccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)cc1"}, "reference": {"title": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "authors": "Chen, Bei; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "doi": "10.1021/acs.jmedchem.3c01326", "raw": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis | Chen, Bei; et al | Journal of Medicinal Chemistry (2023), 66(24), 16680-16693. | 10.1021/acs.jmedchem.3c01326"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-38589174", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 10 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 107-93-7 + 2632874-83-8 | PRO: 2897680-78-1 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"authors\": \"Chen, Bei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38589174\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 10 h, rt\", \"282. Scheme 282 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"107-93-7\", \"2632874-83-8\"], \"pro_cas\": [\"2897680-78-1\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["107-93-7", "2632874-83-8"], "products": ["2897680-78-1"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.151693", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38589175", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.0, "yield_pct": 94.0}, "smiles": {"reactants": "COc1cccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c1.Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1", "products": "COc1cccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c1"}, "reference": {"title": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "authors": "Chen, Bei; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "doi": "10.1021/acs.jmedchem.3c01326", "raw": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis | Chen, Bei; et al | Journal of Medicinal Chemistry (2023), 66(24), 16680-16693. | 10.1021/acs.jmedchem.3c01326"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-38589175", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 10 h, rt", "Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia", "By: Fukuda, Takeshi; et al", "Bioorganic & Medicinal Chemistry Letters (2024), 108, 129799.", "10.1016/j.bmcl.2024.129799"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 1192587-51-1 + 623-33-6 | PRO: 1192587-52-2 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"authors\": \"Chen, Bei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38589175\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 10 h, rt\", \"349. Scheme 349 (1 Reaction)\", \"Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia\", \"By: Fukuda, Takeshi; et al\", \"Bioorganic & Medicinal Chemistry Letters (2024), 108, 129799.\", \"10.1016/j.bmcl.2024.129799\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1192587-51-1\", \"623-33-6\"], \"pro_cas\": [\"1192587-52-2\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1192587-51-1", "623-33-6"], "products": ["1192587-52-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.151693", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38589176", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.0, "yield_pct": 90.0}, "smiles": {"reactants": "Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1.COc1cccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c1OC", "products": "COc1cccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c1OC"}, "reference": {"title": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "authors": "Chen, Bei; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "doi": "10.1021/acs.jmedchem.3c01326", "raw": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis | Chen, Bei; et al | Journal of Medicinal Chemistry (2023), 66(24), 16680-16693. | 10.1021/acs.jmedchem.3c01326"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38589176", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 10 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2", "By: Pettus, Liping H.; et al", "Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.", "10.1021/acs.jmedchem.9b01034"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 36070-80-1 + 1874240-21-7 | PRO: 1874238-49-9 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"authors\": \"Chen, Bei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38589176\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 10 h, rt\", \"403. Scheme 403 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2\", \"By: Pettus, Liping H.; et al\", \"Journal of Medicinal Chemistry (2020), 63(5), 2263-2281.\", \"10.1021/acs.jmedchem.9b01034\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"36070-80-1\", \"1874240-21-7\"], \"pro_cas\": [\"1874238-49-9\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["36070-80-1", "1874240-21-7"], "products": ["1874238-49-9"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.151693", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38589178", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 15.0, "yield_pct": 91.0}, "smiles": {"reactants": "COc1ccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)cc1OC.Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1", "products": "COc1ccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)cc1OC"}, "reference": {"title": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "authors": "Chen, Bei; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "doi": "10.1021/acs.jmedchem.3c01326", "raw": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis | Chen, Bei; et al | Journal of Medicinal Chemistry (2023), 66(24), 16680-16693. | 10.1021/acs.jmedchem.3c01326"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-38589178", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 10 h, rt", "Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors", "By: Watanabe, Hitoshi; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 40, 127911.", "10.1016/j.bmcl.2021.127911"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 2241432-77-7 | PRO: 2241432-78-8 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"authors\": \"Chen, Bei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38589178\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 10 h, rt\", \"375. Scheme 375 (1 Reaction)\", \"Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors\", \"By: Watanabe, Hitoshi; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 40, 127911.\", \"10.1016/j.bmcl.2021.127911\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2241432-77-7\"], \"pro_cas\": [\"2241432-78-8\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2241432-77-7"], "products": ["2241432-78-8"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.151693", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38589179", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.0, "yield_pct": 93.0}, "smiles": {"reactants": "Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1.COc1ccc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c(OC)c1", "products": "COc1ccc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c(OC)c1"}, "reference": {"title": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "authors": "Chen, Bei; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "doi": "10.1021/acs.jmedchem.3c01326", "raw": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis | Chen, Bei; et al | Journal of Medicinal Chemistry (2023), 66(24), 16680-16693. | 10.1021/acs.jmedchem.3c01326"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-38589179", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 10 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology", "By: Dack, Kevin N.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402.", "10.1016/j.bmcl.2020.127402"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 625471-18-3 + 2089131-21-3 | PRO: 2089131-40-6 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"authors\": \"Chen, Bei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38589179\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 10 h, rt\", \"392. Scheme 392 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology\", \"By: Dack, Kevin N.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402.\", \"10.1016/j.bmcl.2020.127402\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"625471-18-3\", \"2089131-21-3\"], \"pro_cas\": [\"2089131-40-6\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["625471-18-3", "2089131-21-3"], "products": ["2089131-40-6"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.151693", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38589180", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 10.0, "yield_pct": 91.0}, "smiles": {"reactants": "Nc1ccc(CN2CCC(N3CCCCC3)CC2)cc1.COc1cc(OC)cc(-c2nc(C(=O)O)cc3c2[nH]c2ccccc23)c1", "products": "COc1cc(OC)cc(-c2nc(C(=O)Nc3ccc(CN4CCC(N5CCCCC5)CC4)cc3)cc3c2[nH]c2ccccc23)c1"}, "reference": {"title": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "authors": "Chen, Bei; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "doi": "10.1021/acs.jmedchem.3c01326", "raw": "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis | Chen, Bei; et al | Journal of Medicinal Chemistry (2023), 66(24), 16680-16693. | 10.1021/acs.jmedchem.3c01326"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-38589180", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 10 h, rt", "AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2", "By: Narjes, Frank; et al", "Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.", "10.1021/acs.jmedchem.1c01197"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 722-92-9 + 2101238-13-3 | PRO: 2101238-05-3 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"authors\": \"Chen, Bei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38589180\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 10 h, rt\", \"363. Scheme 363 (1 Reaction)\", \"AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2\", \"By: Narjes, Frank; et al\", \"Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.\", \"10.1021/acs.jmedchem.1c01197\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"722-92-9\", \"2101238-13-3\"], \"pro_cas\": [\"2101238-05-3\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["722-92-9", "2101238-13-3"], "products": ["2101238-05-3"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.151693", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38624463", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 2.5, "yield_pct": 88.0}, "smiles": {"reactants": "Nc1ccc([N+](=O)[O-])cc1C(=O)O.CCCCN", "products": "CCCCNC(=O)c1cc([N+](=O)[O-])ccc1N"}, "reference": {"title": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "authors": "Sarkar, Dipayan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "doi": "10.1021/acs.jmedchem.3c01431", "raw": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis | Sarkar, Dipayan; et al | Journal of Medicinal Chemistry (2023), 66(24), 16728-16761. | 10.1021/acs.jmedchem.3c01431"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-38624463", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 25 - 30 °C", "1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C", "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "By: Ryan, Michael C.; et al", "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "10.1021/acsmedchemlett.1c00539"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 62-53-3 + 619-17-0 | PRO: 2284567-70-8 | RGT: 148893-10-1 + 121-44-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"authors\": \"Sarkar, Dipayan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38624463\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 25 - 30 °C\", \"1.2\", \"Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C\", \"77. Scheme 77 (1 Reaction)\", \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"By: Ryan, Michael C.; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"10.1021/acsmedchemlett.1c00539\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"62-53-3\", \"619-17-0\"], \"pro_cas\": [\"2284567-70-8\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["62-53-3", "619-17-0"], "products": ["2284567-70-8"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.152697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38624465", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 2.5, "yield_pct": 85.0}, "smiles": {"reactants": "Nc1ccc([N+](=O)[O-])cc1C(=O)O.NCCN1CCCCC1", "products": "Nc1ccc([N+](=O)[O-])cc1C(=O)NCCN1CCCCC1"}, "reference": {"title": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "authors": "Sarkar, Dipayan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "doi": "10.1021/acs.jmedchem.3c01431", "raw": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis | Sarkar, Dipayan; et al | Journal of Medicinal Chemistry (2023), 66(24), 16728-16761. | 10.1021/acs.jmedchem.3c01431"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-38624465", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 25 - 30 °C", "1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C", "Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis", "By: Van der Plas, Steven E.; et al", "Journal of Medicinal Chemistry (2021), 64(1), 343-353.", "10.1021/acs.jmedchem.0c01796"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 3832-24-4 + 870997-85-6 | PRO: 2055018-42-1 | RGT: 148893-10-1 + 121-44-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"authors\": \"Sarkar, Dipayan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38624465\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 25 - 30 °C\", \"1.2\", \"Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C\", \"197. Scheme 197 (1 Reaction)\", \"Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis\", \"By: Van der Plas, Steven E.; et al\", \"Journal of Medicinal Chemistry (2021), 64(1), 343-353.\", \"10.1021/acs.jmedchem.0c01796\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3832-24-4\", \"870997-85-6\"], \"pro_cas\": [\"2055018-42-1\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3832-24-4", "870997-85-6"], "products": ["2055018-42-1"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.152697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38624467", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 2.5, "yield_pct": 90.0}, "smiles": {"reactants": "Nc1ccc([N+](=O)[O-])cc1C(=O)O.COCCN", "products": "COCCNC(=O)c1cc([N+](=O)[O-])ccc1N"}, "reference": {"title": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "authors": "Sarkar, Dipayan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "doi": "10.1021/acs.jmedchem.3c01431", "raw": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis | Sarkar, Dipayan; et al | Journal of Medicinal Chemistry (2023), 66(24), 16728-16761. | 10.1021/acs.jmedchem.3c01431"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-38624467", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 25 - 30 °C", "1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C", "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "By: Sarkar, Dipayan; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "10.1021/acs.jmedchem.3c01431"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 616-79-5 + 108-00-9 | PRO: 1442089-34-0 | RGT: 148893-10-1 + 121-44-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"authors\": \"Sarkar, Dipayan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38624467\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 25 - 30 °C\", \"1.2\", \"Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C\", \"92. Scheme 92 (1 Reaction)\", \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"By: Sarkar, Dipayan; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"10.1021/acs.jmedchem.3c01431\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"616-79-5\", \"108-00-9\"], \"pro_cas\": [\"1442089-34-0\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["616-79-5", "108-00-9"], "products": ["1442089-34-0"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.152697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38624468", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 2.5, "yield_pct": 86.0}, "smiles": {"reactants": "Nc1ccc([N+](=O)[O-])cc1C(=O)O.NCCN1CCOCC1", "products": "Nc1ccc([N+](=O)[O-])cc1C(=O)NCCN1CCOCC1"}, "reference": {"title": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "authors": "Sarkar, Dipayan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "doi": "10.1021/acs.jmedchem.3c01431", "raw": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis | Sarkar, Dipayan; et al | Journal of Medicinal Chemistry (2023), 66(24), 16728-16761. | 10.1021/acs.jmedchem.3c01431"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-38624468", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 25 - 30 °C", "1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C", "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "By: Liu, Yonghua; et al", "European Journal of Medicinal Chemistry (2022), 228, 114033.", "10.1016/j.ejmech.2021.114033"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 99-98-9 + 156629-52-6 | PRO: 3035807-27-0 | RGT: 148893-10-1 + 121-44-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"authors\": \"Sarkar, Dipayan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38624468\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 25 - 30 °C\", \"1.2\", \"Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C\", \"260. Scheme 260 (1 Reaction)\", \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"By: Liu, Yonghua; et al\", \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"10.1016/j.ejmech.2021.114033\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"99-98-9\", \"156629-52-6\"], \"pro_cas\": [\"3035807-27-0\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["99-98-9", "156629-52-6"], "products": ["3035807-27-0"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.152697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38624469", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 2.5, "yield_pct": 86.0}, "smiles": {"reactants": "Nc1ccc([N+](=O)[O-])cc1C(=O)O.NCCCN1CCOCC1", "products": "Nc1ccc([N+](=O)[O-])cc1C(=O)NCCCN1CCOCC1"}, "reference": {"title": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "authors": "Sarkar, Dipayan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "doi": "10.1021/acs.jmedchem.3c01431", "raw": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis | Sarkar, Dipayan; et al | Journal of Medicinal Chemistry (2023), 66(24), 16728-16761. | 10.1021/acs.jmedchem.3c01431"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-38624469", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 25 - 30 °C", "1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma", "By: Bollu, Lakshmi R.; et al", "Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.", "10.1021/acs.jmedchem.2c00771"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 106-47-8 + 1923836-34-3 | PRO: 1923833-60-6 | RGT: 148893-10-1 + 121-44-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"authors\": \"Sarkar, Dipayan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38624469\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 25 - 30 °C\", \"1.2\", \"Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C\", \"272. Scheme 272 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma\", \"By: Bollu, Lakshmi R.; et al\", \"Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.\", \"10.1021/acs.jmedchem.2c00771\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"106-47-8\", \"1923836-34-3\"], \"pro_cas\": [\"1923833-60-6\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["106-47-8", "1923836-34-3"], "products": ["1923833-60-6"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.152697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38624474", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 2.5, "yield_pct": 85.0}, "smiles": {"reactants": "Nc1ccc([N+](=O)[O-])cc1C(=O)O.CN(C)CCN", "products": "CN(C)CCNC(=O)c1cc([N+](=O)[O-])ccc1N"}, "reference": {"title": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "authors": "Sarkar, Dipayan; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "doi": "10.1021/acs.jmedchem.3c01431", "raw": "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis | Sarkar, Dipayan; et al | Journal of Medicinal Chemistry (2023), 66(24), 16728-16761. | 10.1021/acs.jmedchem.3c01431"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-38624474", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 25 - 30 °C", "1.2|Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C", "Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type ALK inhibitors with promising antitumor effects", "By: Cui, Youbao; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 75, 128990.", "10.1016/j.bmcl.2022.128990"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 455-40-3 + 99-09-2 | PRO: 952898-80-5 | RGT: 148893-10-1 + 121-44-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"authors\": \"Sarkar, Dipayan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38624474\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 25 - 30 °C\", \"1.2\", \"Reagents: Triethylamine; 25 - 30 °C; 1.5 h, 25 - 30 °C\", \"93. Scheme 93 (2 Reactions)\", \"Fragment-based discovery of novel phenyltriazolyl derivatives as allosteric type ALK inhibitors with promising antitumor effects\", \"By: Cui, Youbao; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 75, 128990.\", \"10.1016/j.bmcl.2022.128990\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-40-3\", \"99-09-2\"], \"pro_cas\": [\"952898-80-5\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-40-3", "99-09-2"], "products": ["952898-80-5"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.153701", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38625390", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 200.0, "time_h": 4.0, "yield_pct": 84.0}, "smiles": {"reactants": "NC=O.COc1cc(Br)cc(C(=O)O)c1N", "products": "COc1cc(Br)cc2c(=O)nc[nH]c12"}, "reference": {"title": "Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors", "authors": "Heitmann, Tyler; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766.", "doi": "10.1021/acsmedchemlett.3c00409", "raw": "Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors | Heitmann, Tyler; et al | ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766. | 10.1021/acsmedchemlett.3c00409"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-38625390", "1.1|4 h, rt → 200 °C", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 3400-45-1 + 2632874-83-8 | PRO: 2892485-56-0", "raw_data_json": "{\"txt\": {\"title\": \"Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors\", \"authors\": \"Heitmann, Tyler; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(12), 1760-1766.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38625390\", \"1.1\", \"4 h, rt → 200 °C\", \"285. Scheme 285 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3400-45-1\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-56-0\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["3400-45-1", "2632874-83-8"], "products": ["2892485-56-0"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.153701", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38700934", "reaction_type": "Other", "catalyst": {"core": [{"name": "N-Methylmorpholine", "cas": "109-02-4"}], "generic": [], "ligands": [], "full_system": [{"name": "N-Methylmorpholine", "cas": "109-02-4"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 91.0}, "smiles": {"reactants": "CN.Cl.CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)O)cc2)CC1", "products": "CNC(=O)c1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)cc1"}, "reference": {"title": "Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment", "authors": "Zhang, Wenqiang; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(1), 322-348.", "doi": "10.1021/acs.jmedchem.3c01417", "raw": "Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment | Zhang, Wenqiang; et al | Journal of Medicinal Chemistry (2024), 67(1), 322-348. | 10.1021/acs.jmedchem.3c01417"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-38700934", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-Methylmorpholine", "Solvents: Dimethylformamide; 2 h, rt", "1.2|Reagents: Water; rt", "Optimization of a series of potent, selective and orally bioavailable SYK inhibitors", "By: Grimster, Neil P.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433.", "10.1016/j.bmcl.2020.127433"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "7db3ea2e", "fam_sig": "88b3ccf2"}, "raw_data": {"raw_cas": "RCT: 1363382-25-5 + 74-89-5 | PRO: 3050907-75-7 | RGT: 2592-95-2 + 25952-53-8 + 7732-18-5 | CAT: 109-02-4 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment\", \"authors\": \"Zhang, Wenqiang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(1), 322-348.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [\"4-Methylmorpholine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38700934\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-Methylmorpholine\", \"Solvents: Dimethylformamide; 2 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"183. Scheme 183 (1 Reaction)\", \"Optimization of a series of potent, selective and orally bioavailable SYK inhibitors\", \"By: Grimster, Neil P.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433.\", \"10.1016/j.bmcl.2020.127433\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1363382-25-5\", \"74-89-5\"], \"pro_cas\": [\"3050907-75-7\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [\"109-02-4\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1363382-25-5", "74-89-5"], "products": ["3050907-75-7"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": ["N-Methylmorpholine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.153701", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38701167", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylimidazole", "cas": "616-47-7", "role": "BASE"}, {"name": "Piperidine", "cas": "110-89-4", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1-Methylimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 95.0}, "smiles": {"reactants": "CCS(=O)(=O)Cl.CCN1[C@@H](CC(C)(C)C)[C@](CNC(=O)OCC2c3ccccc3-c3ccccc32)(c2ccc(Cl)cc2F)[C@@H](c2cccc(Cl)c2)[C@@H]1C(=O)O.COC(=O)c1ccc(N)c(OC)c1", "products": "CCN1[C@@H](CC(C)(C)C)[C@](CN)(c2ccc(Cl)cc2F)[C@@H](c2cccc(Cl)c2)[C@@H]1C(=O)Nc1ccc(C(=O)OC)cc1OC"}, "reference": {"title": "Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy", "authors": "Cheng, Jing; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(24), 16991-17025.", "doi": "10.1021/acs.jmedchem.3c01815", "raw": "Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy | Cheng, Jing; et al | Journal of Medicinal Chemistry (2023), 66(24), 16991-17025. | 10.1021/acs.jmedchem.3c01815"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-38701167", "1.1|Reagents: 1-Methylimidazole", "Solvents: Dichloromethane; 30 min, rt", "1.2|2 h, rt", "1.3|Solvents: Water; rt", "1.4|Reagents: Piperidine", "Solvents: Dimethylformamide; 30 min, rt", "1.5|Reagents: Hydrochloric acid", "Solvents: Water; rt", "Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors", "By: Corminboeuf, Olivier; et al", "ChemMedChem (2024), 19(2), e202300606.", "10.1002/cmdc.202300606"], "signatures": {"cond_key": "none/none/1-Methylimidazole|+Hydrochloric acid|7647-01-0+N-Methylimidazole|616-47-7+Piperidine|110-89-4/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "5388fd86", "fam_sig": "0db9148d"}, "raw_data": {"raw_cas": "RCT: 56-40-6 + 2139973-67-2 | PRO: 3055274-64-8 | RGT: 616-47-7 + 110-89-4 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy\", \"authors\": \"Cheng, Jing; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(24), 16991-17025.\", \"reagents\": [\"1-Methylimidazole\", \"Piperidine\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38701167\", \"1.1\", \"Reagents: 1-Methylimidazole\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"2 h, rt\", \"1.3\", \"Solvents: Water; rt\", \"1.4\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.5\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; rt\", \"406. Scheme 406 (1 Reaction)\", \"Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors\", \"By: Corminboeuf, Olivier; et al\", \"ChemMedChem (2024), 19(2), e202300606.\", \"10.1002/cmdc.202300606\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"56-40-6\", \"2139973-67-2\"], \"pro_cas\": [\"3055274-64-8\"], \"rgt_cas\": [\"616-47-7\", \"110-89-4\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\", \"68-12-2\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["56-40-6", "2139973-67-2"], "products": ["3055274-64-8"], "reagents": ["N-Methylimidazole", "Piperidine", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.154697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38824564", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "NaOH", "cas": "1310-73-2", "role": "BASE"}, {"name": "(+)-Tartaric acid", "cas": "87-69-4", "role": "UNK"}, {"name": "Ammonia", "cas": "7664-41-7", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 75.0, "time_h": 84.0, "yield_pct": 94.0}, "smiles": {"reactants": "NCC(=O)O.COc1cc(Br)cc2c(=O)oc(=O)[nH]c12", "products": "COc1cc(Br)cc2c1NC(=O)CNC2=O"}, "reference": {"title": "Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors", "authors": "Corminboeuf, Olivier; et al", "citation": "ChemMedChem (2024), 19(2), e202300606.", "doi": "10.1002/cmdc.202300606", "raw": "Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors | Corminboeuf, Olivier; et al | ChemMedChem (2024), 19(2), e202300606. | 10.1002/cmdc.202300606"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-38824564", "1.1|Reagents: Sodium hydroxide", "Solvents: Water; 18 h, 75 °C", "1.2|Reagents: (+)-Tartaric acid; 2 d, 75 °C; 18 h, 75 °C", "1.3|Reagents: Ammonia", "Solvents: Water; pH 7", "Absolute stereochemistry shown", "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension", "By: Vakalopoulos, Alexandros; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.", "10.1021/acs.jmedchem.2c02082"], "signatures": {"cond_key": "none/none/(+)-Tartaric acid|87-69-4+Ammonia|7664-41-7+NaOH|1310-73-2+Sodium hydroxide|/Water|7732-18-5", "cond_sig": "2377eb0b", "fam_sig": "3b624271"}, "raw_data": {"raw_cas": "RCT: 3844-54-0 + 1415501-19-7 | PRO: 1609081-95-9 | RGT: 1310-73-2 + 87-69-4 + 7664-41-7 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors\", \"authors\": \"Corminboeuf, Olivier; et al\", \"citation\": \"ChemMedChem (2024), 19(2), e202300606.\", \"reagents\": [\"Sodium hydroxide\", \"(+)-Tartaric acid\", \"Ammonia\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38824564\", \"1.1\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 18 h, 75 °C\", \"1.2\", \"Reagents: (+)-Tartaric acid; 2 d, 75 °C; 18 h, 75 °C\", \"1.3\", \"Reagents: Ammonia\", \"Solvents: Water; pH 7\", \"407. Scheme 407 (1 Reaction)\", \"Absolute stereochemistry shown\", \"New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension\", \"By: Vakalopoulos, Alexandros; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.\", \"10.1021/acs.jmedchem.2c02082\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3844-54-0\", \"1415501-19-7\"], \"pro_cas\": [\"1609081-95-9\"], \"rgt_cas\": [\"1310-73-2\", \"87-69-4\", \"7664-41-7\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3844-54-0", "1415501-19-7"], "products": ["1609081-95-9"], "reagents": ["NaOH", "87-69-4", "7664-41-7"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.154697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38825292", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 72.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1cccc(C(F)(F)F)n1.CC(C)(C)OC(=O)n1ncc2cc(N)c(Cl)cc21", "products": "CC(C)(C)OC(=O)n1ncc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(Cl)cc21"}, "reference": {"title": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "authors": "Bothe, Ulrich; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.3c01714", "raw": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839 | Bothe, Ulrich; et al | Journal of Medicinal Chemistry (2024), 67(2), 1225-1242. | 10.1021/acs.jmedchem.3c01714"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-38825292", "1.1|Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dimethylformamide; 3 d, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "8a613c76", "fam_sig": "6003ace2"}, "raw_data": {"raw_cas": "RCT: 93-07-2 + 2919713-61-2 | PRO: 2919713-81-6 | RGT: 121-44-8 + 1892-57-5 + 2592-95-2 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"authors\": \"Bothe, Ulrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"reagents\": [\"Triethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38825292\", \"1.1\", \"Reagents: Triethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dimethylformamide; 3 d, rt\", \"268. Scheme 268 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"93-07-2\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-81-6\"], \"rgt_cas\": [\"121-44-8\", \"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"incremental addition of 6-(trifluoromethyl)pyridine-2-carboxylic acid and HOBt\"]}}", "enriched_names": {"reactants": ["93-07-2", "2919713-61-2"], "products": ["2919713-81-6"], "reagents": ["Triethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.154697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38825334", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Triethylamine", "cas": "121-44-8"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1cccc(C(F)(F)F)n1.CCOC(=O)Cn1cc2cc(N)c(OCc3ccccc3)cc2n1", "products": "CCOC(=O)Cn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(OCc3ccccc3)cc2n1"}, "reference": {"title": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "authors": "Bothe, Ulrich; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.3c01714", "raw": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839 | Bothe, Ulrich; et al | Journal of Medicinal Chemistry (2024), 67(2), 1225-1242. | 10.1021/acs.jmedchem.3c01714"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-38825334", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Solvents: Tetrahydrofuran, Triethylamine; 24 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma", "By: Chang, Qi; et al", "Journal of Medicinal Chemistry (2024), 67(4), 2466-2486.", "10.1021/acs.jmedchem.3c01468"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2/Tetrahydrofuran|109-99-9+Triethylamine|121-44-8", "cond_sig": "40561b1d", "fam_sig": "8effea4a"}, "raw_data": {"raw_cas": "RCT: 34622-39-4 + 3032646-77-5 | PRO: 3032646-78-6 | RGT: 1892-57-5 + 2592-95-2 | SOL: 109-99-9 + 121-44-8", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"authors\": \"Bothe, Ulrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Triethylamine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38825334\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Tetrahydrofuran, Triethylamine; 24 h, 25 °C\", \"399. Scheme 399 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma\", \"By: Chang, Qi; et al\", \"Journal of Medicinal Chemistry (2024), 67(4), 2466-2486.\", \"10.1021/acs.jmedchem.3c01468\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"34622-39-4\", \"3032646-77-5\"], \"pro_cas\": [\"3032646-78-6\"], \"rgt_cas\": [\"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"121-44-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["34622-39-4", "3032646-77-5"], "products": ["3032646-78-6"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Triethylamine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.154697", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38825401", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 81.0}, "smiles": {"reactants": "COc1cc(N)c(N)cc1[N+](=O)[O-].O=C(O)C1CCCS(=O)(=O)C1", "products": "COc1cc(NC(=O)C2CCCS(=O)(=O)C2)c(N)cc1[N+](=O)[O-]"}, "reference": {"title": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "authors": "Bothe, Ulrich; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.3c01714", "raw": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839 | Bothe, Ulrich; et al | Journal of Medicinal Chemistry (2024), 67(2), 1225-1242. | 10.1021/acs.jmedchem.3c01714"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-38825401", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 24 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma", "By: Zhou, Yi; et al", "Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.", "10.1021/acs.jmedchem.9b02161"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Tetrahydrofuran|109-99-9", "cond_sig": "36372e80", "fam_sig": "b1cd8ef3"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 2415205-36-4 | PRO: 2415205-25-1 | RGT: 121-44-8 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"authors\": \"Bothe, Ulrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38825401\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 24 h, 25 °C\", \"340. Scheme 340 (2 Reactions)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma\", \"By: Zhou, Yi; et al\", \"Journal of Medicinal Chemistry (2020), 63(9), 4701-4715.\", \"10.1021/acs.jmedchem.9b02161\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"2415205-36-4\"], \"pro_cas\": [\"2415205-25-1\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "2415205-36-4"], "products": ["2415205-25-1"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.155695", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38825422", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)C1CCCS(=O)(=O)C1.CNc1cc(NC(=O)OC(C)(C)C)c(OC)cc1N", "products": "CNc1cc(NC(=O)OC(C)(C)C)c(OC)cc1NC(=O)C1CCCS(=O)(=O)C1"}, "reference": {"title": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "authors": "Bothe, Ulrich; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.3c01714", "raw": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839 | Bothe, Ulrich; et al | Journal of Medicinal Chemistry (2024), 67(2), 1225-1242. | 10.1021/acs.jmedchem.3c01714"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-38825422", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, 25 °C", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; pH 8", "Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)", "By: Kotian, Pravin L.; et al", "Journal of Medicinal Chemistry (2021), 64(17), 12453-12468.", "10.1021/acs.jmedchem.1c00511"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "0ab5626a", "fam_sig": "eaab2ddd"}, "raw_data": {"raw_cas": "RCT: 209917-93-1 + 1565613-80-0 | PRO: 1809016-27-0 | RGT: 121-44-8 + 148893-10-1 + 144-55-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"authors\": \"Bothe, Ulrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38825422\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, 25 °C\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; pH 8\", \"108. Scheme 108 (1 Reaction)\", \"Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)\", \"By: Kotian, Pravin L.; et al\", \"Journal of Medicinal Chemistry (2021), 64(17), 12453-12468.\", \"10.1021/acs.jmedchem.1c00511\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"209917-93-1\", \"1565613-80-0\"], \"pro_cas\": [\"1809016-27-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["209917-93-1", "1565613-80-0"], "products": ["1809016-27-0"], "reagents": ["Triethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.155695", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38825440", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 6.0, "yield_pct": 81.0}, "smiles": {"reactants": "COC(=O)CCC(=O)O.CNc1ccc(C(=O)OC)cc1N", "products": "CNc1ccc(C(=O)OC)cc1NC(=O)CCC(=O)OC"}, "reference": {"title": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "authors": "Bothe, Ulrich; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.3c01714", "raw": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839 | Bothe, Ulrich; et al | Journal of Medicinal Chemistry (2024), 67(2), 1225-1242. | 10.1021/acs.jmedchem.3c01714"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-38825440", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 6 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 3405-77-4 + 2760538-81-4 | PRO: 2760538-92-7 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"authors\": \"Bothe, Ulrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38825440\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 6 h, 25 °C\", \"190. Scheme 190 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3405-77-4\", \"2760538-81-4\"], \"pro_cas\": [\"2760538-92-7\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3405-77-4", "2760538-81-4"], "products": ["2760538-92-7"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.155695", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38825448", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 97.0}, "smiles": {"reactants": "COC(=O)CCC(=O)O.CCNc1ccc(C(=O)OC)cc1N", "products": "CCNc1ccc(C(=O)OC)cc1NC(=O)CCC(=O)OC"}, "reference": {"title": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "authors": "Bothe, Ulrich; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "doi": "10.1021/acs.jmedchem.3c01714", "raw": "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839 | Bothe, Ulrich; et al | Journal of Medicinal Chemistry (2024), 67(2), 1225-1242. | 10.1021/acs.jmedchem.3c01714"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-38825448", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 24 h, 25 °C", "Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis", "By: Zimmermann, Thomas; et al", "Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.", "10.1021/acs.jmedchem.4c00230"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 33233-67-9 + 6850-57-3 | PRO: 2971723-52-9 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"authors\": \"Bothe, Ulrich; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38825448\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 24 h, 25 °C\", \"213. Scheme 213 (1 Reaction)\", \"Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis\", \"By: Zimmermann, Thomas; et al\", \"Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.\", \"10.1021/acs.jmedchem.4c00230\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"33233-67-9\", \"6850-57-3\"], \"pro_cas\": [\"2971723-52-9\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["33233-67-9", "6850-57-3"], "products": ["2971723-52-9"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.155695", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38927965", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethyl Sulfoxide", "cas": "67-68-5"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 30.0, "time_h": 4.5, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)c1cc(-c2ccc(F)cc2F)on1.COC(=O)[C@@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1N.O=C(O)C(F)(F)F", "products": "COC(=O)[C@@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1NC(=O)c1cc(-c2ccc(F)cc2F)on1"}, "reference": {"title": "Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification", "authors": "Schafer, Gabriel; et al", "citation": "Organic Process Research & Development (2024), 28(6), 2103-2116.", "doi": "10.1021/acs.oprd.3c00446", "raw": "Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification | Schafer, Gabriel; et al | Organic Process Research & Development (2024), 28(6), 2103-2116. | 10.1021/acs.oprd.3c00446"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-38927965", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethyl sulfoxide; 30 min, 20 - 25 °C; 30 min, 20 - 25 °C", "1.2|Solvents: Dimethyl sulfoxide; 30 min, 20 - 25 °C; 1 h, 20 - 25 °C", "1.3|Solvents: Water; 1 h, 20 - 30 °C; 1 h, 20 - 25 °C", "Development of a Scalable, Racemic first Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers", "By: Schafer, Gabriel; et al", "Organic Process Research & Development (2024), 28(6), 2090-2102.", "10.1021/acs.oprd.3c00445"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Dimethyl Sulfoxide|67-68-5+Water|7732-18-5", "cond_sig": "601cc3ea", "fam_sig": "56b34b39"}, "raw_data": {"raw_cas": "RCT: 1083224-23-0 + 3026554-59-3 | PRO: 3026294-19-6 | RGT: 530-62-1 | SOL: 67-68-5 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification\", \"authors\": \"Schafer, Gabriel; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(6), 2103-2116.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Dimethyl sulfoxide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38927965\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethyl sulfoxide; 30 min, 20 - 25 °C; 30 min, 20 - 25 °C\", \"1.2\", \"Solvents: Dimethyl sulfoxide; 30 min, 20 - 25 °C; 1 h, 20 - 25 °C\", \"1.3\", \"Solvents: Water; 1 h, 20 - 30 °C; 1 h, 20 - 25 °C\", \"336. Scheme 336 (1 Reaction)\", \"Development of a Scalable, Racemic first Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers\", \"By: Schafer, Gabriel; et al\", \"Organic Process Research & Development (2024), 28(6), 2090-2102.\", \"10.1021/acs.oprd.3c00445\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1083224-23-0\", \"3026554-59-3\"], \"pro_cas\": [\"3026294-19-6\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"67-68-5\", \"7732-18-5\"], \"notes\": [\"e.r. 99.7:0.3\"]}}", "enriched_names": {"reactants": ["1083224-23-0", "3026554-59-3"], "products": ["3026294-19-6"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Dimethyl Sulfoxide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.156692", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38927970", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylimidazole", "cas": "616-47-7", "role": "BASE"}, {"name": "Tetramethylchloroformamidinium hexafluorophosphate", "cas": "94790-35-9", "role": "UNK"}, {"name": "1-Methylimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 75.0, "time_h": 4.0, "yield_pct": 87.0}, "smiles": {"reactants": "Cl.NC1(c2ncccn2)CC1.CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)O)C1", "products": "CC(C)(C)OC(=O)N1CC[C@H](NC(=O)c2cc(-c3ccc(F)cc3F)on2)[C@@H](C(=O)NC2(c3ncccn3)CC2)C1"}, "reference": {"title": "Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification", "authors": "Schafer, Gabriel; et al", "citation": "Organic Process Research & Development (2024), 28(6), 2103-2116.", "doi": "10.1021/acs.oprd.3c00446", "raw": "Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification | Schafer, Gabriel; et al | Organic Process Research & Development (2024), 28(6), 2103-2116. | 10.1021/acs.oprd.3c00446"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-38927970", "1.1|Reagents: 1-Methylimidazole, Tetramethylchloroformamidinium hexafluorophosphate", "Solvents: Acetonitrile; 45 min, < 30 °C; 30 min, 20 - 25 °C", "1.2|Solvents: Water; 25 °C → 75 °C; 45 min, 75 °C; 1 h, 75 °C → 25 °C; 1 h, 20 - 25 °C", "Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239", "By: Richard-Bildstein, Sylvia; et al", "Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.", "10.1021/acs.jmedchem.0c01588"], "signatures": {"cond_key": "none/none/1-Methylimidazole|+N-Methylimidazole|616-47-7+Tetramethylchloroformamidinium hexafluorophosphate|94790-35-9/Acetonitrile|75-05-8+Water|7732-18-5", "cond_sig": "1c6be3a2", "fam_sig": "23613915"}, "raw_data": {"raw_cas": "RCT: 1215107-61-1 + 2178053-39-7 | PRO: 2178053-40-0 | RGT: 616-47-7 + 94790-35-9 | SOL: 75-05-8 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Development of a Scalable, Stereoselective second Generation Route for CXCR7 Antagonist ACT-1004-1239 via Chiral Enamine Reduction and a Novel Telescoped Sequence of Transesterification, cis-to-trans-Epimerization and Saponification\", \"authors\": \"Schafer, Gabriel; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(6), 2103-2116.\", \"reagents\": [\"1-Methylimidazole\", \"Tetramethylchloroformamidinium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38927970\", \"1.1\", \"Reagents: 1-Methylimidazole, Tetramethylchloroformamidinium hexafluorophosphate\", \"Solvents: Acetonitrile; 45 min, < 30 °C; 30 min, 20 - 25 °C\", \"1.2\", \"Solvents: Water; 25 °C → 75 °C; 45 min, 75 °C; 1 h, 75 °C → 25 °C; 1 h, 20 - 25 °C\", \"Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239\", \"By: Richard-Bildstein, Sylvia; et al\", \"Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.\", \"10.1021/acs.jmedchem.0c01588\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1215107-61-1\", \"2178053-39-7\"], \"pro_cas\": [\"2178053-40-0\"], \"rgt_cas\": [\"616-47-7\", \"94790-35-9\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"7732-18-5\"], \"notes\": [\"alternative reaction conditions shown\"]}}", "enriched_names": {"reactants": ["1215107-61-1", "2178053-39-7"], "products": ["2178053-40-0"], "reagents": ["N-Methylimidazole", "94790-35-9"], "catalysts": [], "solvents": ["Acetonitrile", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.156692", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38928206", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 35.0, "time_h": 2.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1cc(-c2ccc(F)cc2F)on1.COC(=O)C1CN(C(=O)OC(C)(C)C)CCC1N.O=C(O)C(F)(F)F", "products": "COC(=O)C1CN(C(=O)OC(C)(C)C)CCC1NC(=O)c1cc(-c2ccc(F)cc2F)on1"}, "reference": {"title": "Development of a Scalable, Racemic first Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers", "authors": "Schafer, Gabriel; et al", "citation": "Organic Process Research & Development (2024), 28(6), 2090-2102.", "doi": "10.1021/acs.oprd.3c00445", "raw": "Development of a Scalable, Racemic first Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers | Schafer, Gabriel; et al | Organic Process Research & Development (2024), 28(6), 2090-2102. | 10.1021/acs.oprd.3c00445"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-38928206", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 15 min, 20 - 30 °C", "1.2|Reagents: Propylphosphonic anhydride", "Solvents: Dimethylformamide; 45 min, 35 °C; 30 min, 20 - 25 °C", "1.3|Reagents: Sodium hydroxide", "Solvents: Water; 30 min, 35 °C", "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "By: Vaidya, Sandeep; et al", "ChemMedChem (2023), 18(16), e202300097.", "10.1002/cmdc.202300097"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+NaOH|1310-73-2+Propylphosphonic anhydride|68957-94-8+Sodium hydroxide|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "2556bed7", "fam_sig": "ca72d32e"}, "raw_data": {"raw_cas": "RCT: 53-86-1 + 2128731-38-2 | PRO: 3055833-34-3 | RGT: 7087-68-5 + 68957-94-8 + 1310-73-2 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Development of a Scalable, Racemic first Generation Route for CXCR7 Antagonist ACT-1004-1239 via cis-to-trans Epimerization and Subsequent Separation of Enantiomers\", \"authors\": \"Schafer, Gabriel; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(6), 2090-2102.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\", \"Sodium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38928206\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 15 min, 20 - 30 °C\", \"1.2\", \"Reagents: Propylphosphonic anhydride\", \"Solvents: Dimethylformamide; 45 min, 35 °C; 30 min, 20 - 25 °C\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 30 min, 35 °C\", \"337. Scheme 337 (1 Reaction)\", \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"By: Vaidya, Sandeep; et al\", \"ChemMedChem (2023), 18(16), e202300097.\", \"10.1002/cmdc.202300097\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"53-86-1\", \"2128731-38-2\"], \"pro_cas\": [\"3055833-34-3\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\", \"1310-73-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": [\"stereoselective (cis:trans = 2:1)\"]}}", "enriched_names": {"reactants": ["53-86-1", "2128731-38-2"], "products": ["3055833-34-3"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride", "NaOH"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.156692", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-38940080", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Potassium bisulfate", "cas": "7646-93-7", "role": "BASE"}, {"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}, {"name": "K2CO3", "cas": "584-08-7", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "Potassium carbonate", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Toluene", "cas": "108-88-3"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Isopropanol", "cas": "67-63-0"}], "conditions": {"temperature_c": 10.0, "time_h": 26.5, "yield_pct": 94.0}, "smiles": {"reactants": "COC(=O)CC[C@@H](CC(=O)O)c1noc([C@H]2C[C@@H](CC(C)(C)C)C2)c1C1CC1.C[C@H](N)c1ccccc1.Cc1ccc(N)c(Cl)c1", "products": "Cc1ccc(NC(=O)C[C@H](CCC(=O)O)c2noc([C@H]3C[C@@H](CC(C)(C)C)C3)c2C2CC2)c(Cl)c1"}, "reference": {"title": "Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced Dynamic Resolution", "authors": "Takiguchi, Hiromu; et al", "citation": "Organic Process Research & Development (2023), 27(12), 2355-2364.", "doi": "10.1021/acs.oprd.3c00320", "raw": "Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced Dynamic Resolution | Takiguchi, Hiromu; et al | Organic Process Research & Development (2023), 27(12), 2355-2364. | 10.1021/acs.oprd.3c00320"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-38940080", "1.1|Reagents: Potassium bisulfate", "Solvents: Toluene, Water; 30 min, rt", "1.2|Reagents: Thionyl chloride", "Solvents: Toluene; 1 h, rt", "1.3|Reagents: Potassium carbonate", "Solvents: Toluene, Water; 1 h, < 10 °C", "1.4|Reagents: Hydrochloric acid", "Solvents: Water", "1.5|Reagents: Sodium hydroxide", "Solvents: Isopropanol, Water; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+K2CO3|584-08-7+NaOH|1310-73-2+Potassium bisulfate|7646-93-7+Potassium carbonate|+Sodium hydroxide|+Thionyl chloride|7719-09-7/Isopropanol|67-63-0+Toluene|108-88-3+Water|7732-18-5", "cond_sig": "b137d8af", "fam_sig": "ce5f4c73"}, "raw_data": {"raw_cas": "RCT: 114873-06-2 + 3026371-64-9 | PRO: 3026370-76-0 | RGT: 7646-93-7 + 7719-09-7 + 584-08-7 + 7647-01-0 + 1310-73-2 | SOL: 108-88-3 + 7732-18-5 + 67-63-0", "raw_data_json": "{\"txt\": {\"title\": \"Practical Synthesis of Chiral 3-(Hydroxyiminomethyl)adipic Acid, a Key Intermediate of the ROR-γ Inhibitor JTE-151, via Crystallization-Induced Dynamic Resolution\", \"authors\": \"Takiguchi, Hiromu; et al\", \"citation\": \"Organic Process Research & Development (2023), 27(12), 2355-2364.\", \"reagents\": [\"Potassium bisulfate\", \"Thionyl chloride\", \"Potassium carbonate\", \"Hydrochloric acid\", \"Sodium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Toluene\", \"Water\", \"Isopropanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-38940080\", \"1.1\", \"Reagents: Potassium bisulfate\", \"Solvents: Toluene, Water; 30 min, rt\", \"1.2\", \"Reagents: Thionyl chloride\", \"Solvents: Toluene; 1 h, rt\", \"1.3\", \"Reagents: Potassium carbonate\", \"Solvents: Toluene, Water; 1 h, < 10 °C\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water\", \"1.5\", \"Reagents: Sodium hydroxide\", \"Solvents: Isopropanol, Water; 24 h, rt\", \"119. Scheme 119 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"114873-06-2\", \"3026371-64-9\"], \"pro_cas\": [\"3026370-76-0\"], \"rgt_cas\": [\"7646-93-7\", \"7719-09-7\", \"584-08-7\", \"7647-01-0\", \"1310-73-2\"], \"cat_cas\": [], \"sol_cas\": [\"108-88-3\", \"7732-18-5\", \"67-63-0\"], \"notes\": [\"inverse addition (stage 3)\"]}}", "enriched_names": {"reactants": ["114873-06-2", "3026371-64-9"], "products": ["3026370-76-0"], "reagents": ["7646-93-7", "7719-09-7", "K2CO3", "Hydrochloric acid", "NaOH"], "catalysts": [], "solvents": ["Toluene", "Water", "Isopropanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.156692", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39000609", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}], "conditions": {"temperature_c": 0.0, "time_h": 2.5, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)(C)C[C@H]1C[C@@H](c2cnn(C(CCCOCc3ccccc3)CC(=O)O)c2C2CC2)C1.Cc1ccc(N)c(Cl)c1", "products": "Cc1ccc(NC(=O)CC(CCCOCc2ccccc2)n2ncc([C@H]3C[C@@H](CC(C)(C)C)C3)c2C2CC2)c(Cl)c1"}, "reference": {"title": "Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development", "authors": "Maeba, Takaki; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 952-970.", "doi": "10.1021/acs.jmedchem.3c01933", "raw": "Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development | Maeba, Takaki; et al | Journal of Medicinal Chemistry (2024), 67(2), 952-970. | 10.1021/acs.jmedchem.3c01933"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-39000609", "1.1|Reagents: Thionyl chloride", "Solvents: Dimethylacetamide; 1 h, 0 °C", "1.2|0 °C; 1.5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "By: Gotz, Marion G.; et al", "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "10.1021/acsmedchemlett.4c00017"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dimethylacetamide|127-19-5", "cond_sig": "6e6ac17d", "fam_sig": "c9100a30"}, "raw_data": {"raw_cas": "RCT: 3058604-53-5 + 13139-15-6 | PRO: 3058604-54-6 | RGT: 7719-09-7 | SOL: 127-19-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development\", \"authors\": \"Maeba, Takaki; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 952-970.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39000609\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Dimethylacetamide; 1 h, 0 °C\", \"1.2\", \"0 °C; 1.5 h, rt\", \"254. Scheme 254 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"By: Gotz, Marion G.; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"10.1021/acsmedchemlett.4c00017\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3058604-53-5\", \"13139-15-6\"], \"pro_cas\": [\"3058604-54-6\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3058604-53-5", "13139-15-6"], "products": ["3058604-54-6"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Dimethylacetamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.156692", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39000809", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": null, "time_h": 5.0, "yield_pct": 99.0}, "smiles": {"reactants": "COc1ccc(N)c(N)c1.O=C(O)C(=O)O", "products": "COc1ccc2[nH]c(=O)c(=O)[nH]c2c1"}, "reference": {"title": "DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia", "authors": "Ali, Imran; et al", "citation": "European Journal of Medicinal Chemistry (2024), 265, 116052.", "doi": "10.1016/j.ejmech.2023.116052", "raw": "DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia | Ali, Imran; et al | European Journal of Medicinal Chemistry (2024), 265, 116052. | 10.1016/j.ejmech.2023.116052"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-39000809", "1.1|Reagents: Hydrochloric acid", "Solvents: Water; 5 h, reflux", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors", "By: Silva-Reis, Sara C.; et al", "ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663.", "10.1021/acsmedchemlett.3c00264"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0/Water|7732-18-5", "cond_sig": "57361e42", "fam_sig": "f1a39bee"}, "raw_data": {"raw_cas": "RCT: 15761-39-4 + 3056144-83-0 | PRO: 3056144-84-1 | RGT: 7647-01-0 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia\", \"authors\": \"Ali, Imran; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 265, 116052.\", \"reagents\": [\"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39000809\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; 5 h, reflux\", \"100. Scheme 100 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors\", \"By: Silva-Reis, Sara C.; et al\", \"ACS Medicinal Chemistry Letters (2023), 14(12), 1656-1663.\", \"10.1021/acsmedchemlett.3c00264\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15761-39-4\", \"3056144-83-0\"], \"pro_cas\": [\"3056144-84-1\"], \"rgt_cas\": [\"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["15761-39-4", "3056144-83-0"], "products": ["3056144-84-1"], "reagents": ["Hydrochloric acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.157689", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39000832", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 20.0, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NC(CC(=O)O)Cc1cc(Cl)ccc1N", "products": "CC(C)(C)OC(=O)NC1CC(=O)Nc2ccc(Cl)cc2C1"}, "reference": {"title": "Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist", "authors": "Baska, Ferenc; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(1), 643-673.", "doi": "10.1021/acs.jmedchem.3c01868", "raw": "Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist | Baska, Ferenc; et al | Journal of Medicinal Chemistry (2024), 67(1), 643-673. | 10.1021/acs.jmedchem.3c01868"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-39000832", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Solvents: Dimethylformamide; 20 h, rt", "1.2|Reagents: Sodium bicarbonate", "Solvents: Water; rt", "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "By: Pasqua, A. Elisa; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "10.1021/acs.jmedchem.3c00156"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+Sodium bicarbonate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "e8190992", "fam_sig": "655a495c"}, "raw_data": {"raw_cas": "RCT: 4442-54-0 + 364-76-1 | PRO: 353761-46-3 | RGT: 1892-57-5 + 2592-95-2 + 7087-68-5 + 144-55-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist\", \"authors\": \"Baska, Ferenc; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(1), 643-673.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39000832\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Solvents: Dimethylformamide; 20 h, rt\", \"1.2\", \"Reagents: Sodium bicarbonate\", \"Solvents: Water; rt\", \"47. Scheme 47 (1 Reaction)\", \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"By: Pasqua, A. Elisa; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"10.1021/acs.jmedchem.3c00156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4442-54-0\", \"364-76-1\"], \"pro_cas\": [\"353761-46-3\"], \"rgt_cas\": [\"1892-57-5\", \"2592-95-2\", \"7087-68-5\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["4442-54-0", "364-76-1"], "products": ["353761-46-3"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "NaHCO3"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.157689", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39011906", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(=O)Nc1ccc(C(C)(C)C)cc1N.COc1ccc(OC)c(-n2nnc(C(=O)O)c2C)c1", "products": "COc1ccc(OC)c(-n2nnc(C(=O)Nc3cc(C(C)(C)C)ccc3NC(C)=O)c2C)c1"}, "reference": {"title": "Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR", "authors": "Li, Yongtao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(24), 16829-16859.", "doi": "10.1021/acs.jmedchem.2c01640", "raw": "Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR | Li, Yongtao; et al | Journal of Medicinal Chemistry (2022), 65(24), 16829-16859. | 10.1021/acs.jmedchem.2c01640"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39011906", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins", "By: Sindhikara, Dan; et al", "Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.", "10.1021/acs.jmedchem.0c01500"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 2452190-20-2 | PRO: 2452190-21-3 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR\", \"authors\": \"Li, Yongtao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(24), 16829-16859.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39011906\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; overnight, rt\", \"197. Scheme 197 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Automated design of macrocycles for therapeutic applications: From small molecules to peptides and proteins\", \"By: Sindhikara, Dan; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 12100-12115.\", \"10.1021/acs.jmedchem.0c01500\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2452190-20-2\"], \"pro_cas\": [\"2452190-21-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2452190-20-2"], "products": ["2452190-21-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.157689", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39012245", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 48.75, "yield_pct": 97.0}, "smiles": {"reactants": "COC(=O)CCCCCCCCCCC(=O)O.CC(C)(C)OC(=O)CCOCC(N)(COCCC(=O)OC(C)(C)C)COCCC(=O)OC(C)(C)C", "products": "COC(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)OC(C)(C)C)(COCCC(=O)OC(C)(C)C)COCCC(=O)OC(C)(C)C"}, "reference": {"title": "Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways", "authors": "Kandasamy, Pachamuthu; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(4), 2506-2523.", "doi": "10.1021/acs.jmedchem.2c01337", "raw": "Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways | Kandasamy, Pachamuthu; et al | Journal of Medicinal Chemistry (2023), 66(4), 2506-2523. | 10.1021/acs.jmedchem.2c01337"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-39012245", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine", "Solvents: Dimethylformamide, Dichloromethane; 15 min, rt; 30 min, rt; 2 d, rt", "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "By: Ryan, Michael C.; et al", "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "10.1021/acsmedchemlett.1c00539"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "11e0806b", "fam_sig": "6c93c6d4"}, "raw_data": {"raw_cas": "RCT: 536-90-3 + 616-79-5 | PRO: 1442089-40-8 | RGT: 2592-95-2 + 7087-68-5 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways\", \"authors\": \"Kandasamy, Pachamuthu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(4), 2506-2523.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39012245\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Solvents: Dimethylformamide, Dichloromethane; 15 min, rt; 30 min, rt; 2 d, rt\", \"217. Scheme 217 (1 Reaction)\", \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"By: Ryan, Michael C.; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"10.1021/acsmedchemlett.1c00539\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"536-90-3\", \"616-79-5\"], \"pro_cas\": [\"1442089-40-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["536-90-3", "616-79-5"], "products": ["1442089-40-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.157689", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39026996", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 40.0, "time_h": 8.25, "yield_pct": 81.0}, "smiles": {"reactants": "Cc1[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)O.CC(C)(C)OC(=O)N1CC[C@H](N)C1", "products": "Cc1[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N[C@H]1CCN(C(=O)OC(C)(C)C)C1"}, "reference": {"title": "Economical and Practical Process Development for a Novel Multitarget Tyrosine Kinase Inhibitor Vorolanib", "authors": "Xiu, Xiaomeng; et al", "citation": "Organic Process Research & Development (2024), 28(2), 492-499.", "doi": "10.1021/acs.oprd.3c00311", "raw": "Economical and Practical Process Development for a Novel Multitarget Tyrosine Kinase Inhibitor Vorolanib | Xiu, Xiaomeng; et al | Organic Process Research & Development (2024), 28(2), 492-499. | 10.1021/acs.oprd.3c00311"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39026996", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|Reagents: 1-Hydroxybenzotriazole; rt → 40 °C; 8 h, 40 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy", "By: Cheng, Jing; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16991-17025.", "10.1021/acs.jmedchem.3c01815"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 594-44-5 + 3035578-69-6 + 41608-64-4 | PRO: 3035578-70-9 | RGT: 7087-68-5 + 25952-53-8 + 2592-95-2 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Economical and Practical Process Development for a Novel Multitarget Tyrosine Kinase Inhibitor Vorolanib\", \"authors\": \"Xiu, Xiaomeng; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(2), 492-499.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39026996\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"Reagents: 1-Hydroxybenzotriazole; rt → 40 °C; 8 h, 40 °C\", \"405. Scheme 405 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy\", \"By: Cheng, Jing; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16991-17025.\", \"10.1021/acs.jmedchem.3c01815\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"594-44-5\", \"3035578-69-6\", \"41608-64-4\"], \"pro_cas\": [\"3035578-70-9\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"optimization study, optimized on reagent, optimized on solvent, optimized on stoichiometry of reactants, optimized on temperature, optimized on time\"]}}", "enriched_names": {"reactants": ["594-44-5", "3035578-69-6", "41608-64-4"], "products": ["3035578-70-9"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.157689", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39099371", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Methanol", "cas": "67-56-1"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 55.0, "time_h": 0.75, "yield_pct": 88.0}, "smiles": {"reactants": "Nc1ncc(Cl)nc1C(=O)O.CCOC(=O)CN.Cl", "products": "CCOC(=O)CNC(=O)c1nc(Cl)cnc1N"}, "reference": {"title": "Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis", "authors": "Betzemeier, Bodo; et al", "citation": "European Journal of Medicinal Chemistry (2024), 265, 116038.", "doi": "10.1016/j.ejmech.2023.116038", "raw": "Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis | Betzemeier, Bodo; et al | European Journal of Medicinal Chemistry (2024), 265, 116038. | 10.1016/j.ejmech.2023.116038"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-39099371", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Acetonitrile; 55 °C", "1.2|Reagents: Diisopropylethylamine; 45 min, 55 °C", "1.3|Reagents: Sodium hydroxide", "Solvents: Methanol, Water; 50 °C", "Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis", "By: Lu, Ran; et al", "European Journal of Medicinal Chemistry (2021), 216, 113313.", "10.1016/j.ejmech.2021.113313"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Diisopropylethylamine|+N,N'-Carbonyldiimidazole|530-62-1+N,N-Diisopropylethylamine|7087-68-5+NaOH|1310-73-2+Sodium hydroxide|/Acetonitrile|75-05-8+Methanol|67-56-1+Water|7732-18-5", "cond_sig": "27c19804", "fam_sig": "dde73a3d"}, "raw_data": {"raw_cas": "RCT: 99-94-5 + 706791-83-5 | PRO: 2630379-59-6 | RGT: 530-62-1 + 7087-68-5 + 1310-73-2 | SOL: 75-05-8 + 67-56-1 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis\", \"authors\": \"Betzemeier, Bodo; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 265, 116038.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Diisopropylethylamine\", \"Sodium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Methanol\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39099371\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Acetonitrile; 55 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 45 min, 55 °C\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Methanol, Water; 50 °C\", \"134. Scheme 134 (1 Reaction)\", \"Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis\", \"By: Lu, Ran; et al\", \"European Journal of Medicinal Chemistry (2021), 216, 113313.\", \"10.1016/j.ejmech.2021.113313\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"99-94-5\", \"706791-83-5\"], \"pro_cas\": [\"2630379-59-6\"], \"rgt_cas\": [\"530-62-1\", \"7087-68-5\", \"1310-73-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"67-56-1\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["99-94-5", "706791-83-5"], "products": ["2630379-59-6"], "reagents": ["N,N'-Carbonyldiimidazole", "N,N-Diisopropylethylamine", "NaOH"], "catalysts": [], "solvents": ["Acetonitrile", "Methanol", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.157689", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39099375", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Isopropanol", "cas": "67-63-0"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 50.0, "time_h": 3.5, "yield_pct": 93.0}, "smiles": {"reactants": "Nc1ncc(Cl)nc1C(=O)NCC(=O)O.CCNc1cc(OCC(=O)OC(C)C)ccc1N.Cl", "products": "CCNc1cc(OCC(=O)OC(C)C)ccc1NC(=O)CNC(=O)c1nc(Cl)cnc1N"}, "reference": {"title": "Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis", "authors": "Betzemeier, Bodo; et al", "citation": "European Journal of Medicinal Chemistry (2024), 265, 116038.", "doi": "10.1016/j.ejmech.2023.116038", "raw": "Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis | Betzemeier, Bodo; et al | European Journal of Medicinal Chemistry (2024), 265, 116038. | 10.1016/j.ejmech.2023.116038"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-39099375", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Acetonitrile; 1 h, 50 °C; 50 °C → rt", "1.2|Reagents: Hydrochloric acid", "Solvents: Acetonitrile; 1.5 h, rt", "1.3|Solvents: Isopropanol, Water; 1 h, 40 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template", "By: Marciniak, Monika; et al", "European Journal of Medicinal Chemistry (2023), 258, 115587.", "10.1016/j.ejmech.2023.115587"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Hydrochloric acid|7647-01-0+N,N'-Carbonyldiimidazole|530-62-1/Acetonitrile|75-05-8+Isopropanol|67-63-0+Water|7732-18-5", "cond_sig": "de54fce5", "fam_sig": "ab451c64"}, "raw_data": {"raw_cas": "RCT: 7524-50-7 + 866187-04-4 | PRO: 3052255-81-6 | RGT: 530-62-1 + 7647-01-0 | SOL: 75-05-8 + 67-63-0 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis\", \"authors\": \"Betzemeier, Bodo; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 265, 116038.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Isopropanol\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39099375\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Acetonitrile; 1 h, 50 °C; 50 °C → rt\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: Acetonitrile; 1.5 h, rt\", \"1.3\", \"Solvents: Isopropanol, Water; 1 h, 40 °C\", \"199. Scheme 199 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template\", \"By: Marciniak, Monika; et al\", \"European Journal of Medicinal Chemistry (2023), 258, 115587.\", \"10.1016/j.ejmech.2023.115587\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7524-50-7\", \"866187-04-4\"], \"pro_cas\": [\"3052255-81-6\"], \"rgt_cas\": [\"530-62-1\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"67-63-0\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["7524-50-7", "866187-04-4"], "products": ["3052255-81-6"], "reagents": ["N,N'-Carbonyldiimidazole", "Hydrochloric acid"], "catalysts": [], "solvents": ["Acetonitrile", "Isopropanol", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.157689", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39101046", "reaction_type": "Other", "catalyst": {"core": [{"name": "Propylphosphonic anhydride", "cas": "68957-94-8"}], "generic": [], "ligands": [], "full_system": [{"name": "Propylphosphonic anhydride", "cas": "68957-94-8"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 2.5, "yield_pct": 99.0}, "smiles": {"reactants": "O=C(O)c1cccc(C(F)(F)F)n1.COC(=O)c1cc2[nH]ncc2cc1N", "products": "COC(=O)c1cc2[nH]ncc2cc1NC(=O)c1cccc(C(F)(F)F)n1"}, "reference": {"title": "Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma", "authors": "Weiss, Matthew M.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.", "doi": "10.1021/acs.jmedchem.3c01823", "raw": "Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma | Weiss, Matthew M.; et al | Journal of Medicinal Chemistry (2024), 67(13), 10548-10566. | 10.1021/acs.jmedchem.3c01823"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-39101046", "1.1|Reagents: Diisopropylethylamine", "Catalysts: Propylphosphonic anhydride", "Solvents: Tetrahydrofuran; 2 h, 0 - 5 °C", "1.2|Solvents: Water; 0.5 h, 25 °C", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "00de15b2", "fam_sig": "3a5b0c1f"}, "raw_data": {"raw_cas": "RCT: 1417404-28-4 + 343-94-2 | PRO: 2614241-47-1 | RGT: 7087-68-5 | CAT: 68957-94-8 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma\", \"authors\": \"Weiss, Matthew M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [\"Propylphosphonic anhydride\"], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39101046\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Catalysts: Propylphosphonic anhydride\", \"Solvents: Tetrahydrofuran; 2 h, 0 - 5 °C\", \"1.2\", \"Solvents: Water; 0.5 h, 25 °C\", \"141. Scheme 141 (1 Reaction)\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1417404-28-4\", \"343-94-2\"], \"pro_cas\": [\"2614241-47-1\"], \"rgt_cas\": [\"7087-68-5\"], \"cat_cas\": [\"68957-94-8\"], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1417404-28-4", "343-94-2"], "products": ["2614241-47-1"], "reagents": ["N,N-Diisopropylethylamine"], "catalysts": ["Propylphosphonic anhydride"], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.158686", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39101188", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 85.0}, "smiles": {"reactants": "COC(=O)c1cc(N)c(I)cc1Br.O=C(O)[C@H]1CC[C@H](COCc2ccccc2)CC1", "products": "COC(=O)c1cc(NC(=O)[C@H]2CC[C@H](COCc3ccccc3)CC2)c(I)cc1Br"}, "reference": {"title": "Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma", "authors": "Weiss, Matthew M.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.", "doi": "10.1021/acs.jmedchem.3c01823", "raw": "Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma | Weiss, Matthew M.; et al | Journal of Medicinal Chemistry (2024), 67(13), 10548-10566. | 10.1021/acs.jmedchem.3c01823"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-39101188", "1.1|Reagents: Pyridine, Propylphosphonic anhydride", "Solvents: Dichloromethane; 2 h, 0 °C", "Relative stereochemistry shown", "Relative stereochemistry shown", "GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins", "By: Watson, Robert J.; et al", "Journal of Medicinal Chemistry (2020), 63(17), 9045-9069.", "10.1021/acs.jmedchem.0c00614"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "3bbd7614", "fam_sig": "60d0a306"}, "raw_data": {"raw_cas": "RCT: 2560515-61-7 + 108-91-8 | PRO: 2540590-96-1 | RGT: 110-86-1 + 68957-94-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma\", \"authors\": \"Weiss, Matthew M.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.\", \"reagents\": [\"Pyridine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39101188\", \"1.1\", \"Reagents: Pyridine, Propylphosphonic anhydride\", \"Solvents: Dichloromethane; 2 h, 0 °C\", \"426. Scheme 426 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins\", \"By: Watson, Robert J.; et al\", \"Journal of Medicinal Chemistry (2020), 63(17), 9045-9069.\", \"10.1021/acs.jmedchem.0c00614\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2560515-61-7\", \"108-91-8\"], \"pro_cas\": [\"2540590-96-1\"], \"rgt_cas\": [\"110-86-1\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2560515-61-7", "108-91-8"], "products": ["2540590-96-1"], "reagents": ["Pyridine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.158686", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39174684", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 82.0}, "smiles": {"reactants": "Cc1cc(C)c(CN)c(=O)[nH]1.CCN(c1cc(-c2cccc(NC(=O)c3cc(C(C)C)c(OCc4ccccc4)cc3OCc3ccccc3)c2)cc(C(=O)O)c1C)C1CCOCC1", "products": "CCN(c1cc(-c2cccc(NC(=O)c3cc(C(C)C)c(OCc4ccccc4)cc3OCc3ccccc3)c2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1"}, "reference": {"title": "First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo", "authors": "Sharma, Sachin; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(4), 2963-2985.", "doi": "10.1021/acs.jmedchem.3c02053", "raw": "First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo | Sharma, Sachin; et al | Journal of Medicinal Chemistry (2024), 67(4), 2963-2985. | 10.1021/acs.jmedchem.3c02053"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-39174684", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; rt; 3 h, rt", "Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors", "By: Ushiki, Yasunobu; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.", "10.1016/j.bmcl.2022.128572"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 2227446-38-8 + 2227447-99-4 | PRO: 2227446-61-7 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo\", \"authors\": \"Sharma, Sachin; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(4), 2963-2985.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39174684\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; rt; 3 h, rt\", \"422. Scheme 422 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 1H-pyrazole-4-carbonyl-4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as gut-selective NaPi2b inhibitors\", \"By: Ushiki, Yasunobu; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 59, 128572.\", \"10.1016/j.bmcl.2022.128572\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2227446-38-8\", \"2227447-99-4\"], \"pro_cas\": [\"2227446-61-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2227446-38-8", "2227447-99-4"], "products": ["2227446-61-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.158686", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39174753", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Acetic Acid", "cas": "64-19-7", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 81.0}, "smiles": {"reactants": "Nc1ccccc1N.CC(=O)C(=O)O.[Na]", "products": "Cc1nc2ccccc2[nH]c1=O"}, "reference": {"title": "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands", "authors": "Andreasson, Maans; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.", "doi": "10.1021/acs.jmedchem.3c02127", "raw": "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands | Andreasson, Maans; et al | Journal of Medicinal Chemistry (2024), 67(3), 2202-2219. | 10.1021/acs.jmedchem.3c02127"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39174753", "1.1|Reagents: Acetic acid", "Solvents: Water; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Mining Natural Products for Macrocycles to Drug Difficult Targets", "By: Begnini, Fabio; et al", "Journal of Medicinal Chemistry (2021), 64(2), 1054-1072.", "10.1021/acs.jmedchem.0c01569"], "signatures": {"cond_key": "none/none/Acetic Acid|64-19-7/Water|7732-18-5", "cond_sig": "309fa313", "fam_sig": "1a549453"}, "raw_data": {"raw_cas": "RCT: 2696272-82-7 + 4530-20-5 | PRO: 2696272-86-1 | RGT: 64-19-7 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands\", \"authors\": \"Andreasson, Maans; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.\", \"reagents\": [\"Acetic acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39174753\", \"1.1\", \"Reagents: Acetic acid\", \"Solvents: Water; 3 h, rt\", \"283. Scheme 283 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Mining Natural Products for Macrocycles to Drug Difficult Targets\", \"By: Begnini, Fabio; et al\", \"Journal of Medicinal Chemistry (2021), 64(2), 1054-1072.\", \"10.1021/acs.jmedchem.0c01569\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2696272-82-7\", \"4530-20-5\"], \"pro_cas\": [\"2696272-86-1\"], \"rgt_cas\": [\"64-19-7\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2696272-82-7", "4530-20-5"], "products": ["2696272-86-1"], "reagents": ["Acetic Acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.158686", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39174754", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Acetic Acid", "cas": "64-19-7", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 82.0}, "smiles": {"reactants": "CC(=O)C(=O)O.[Na].Cc1cc(N)c(N)cc1C", "products": "Cc1cc2nc(C)c(=O)[nH]c2cc1C"}, "reference": {"title": "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands", "authors": "Andreasson, Maans; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.", "doi": "10.1021/acs.jmedchem.3c02127", "raw": "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands | Andreasson, Maans; et al | Journal of Medicinal Chemistry (2024), 67(3), 2202-2219. | 10.1021/acs.jmedchem.3c02127"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-39174754", "1.1|Reagents: Acetic acid", "Solvents: Water; 3 h, rt", "Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity", "By: Patel, Bhautikkumar; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.", "10.1016/j.bmcl.2021.127853"], "signatures": {"cond_key": "none/none/Acetic Acid|64-19-7/Water|7732-18-5", "cond_sig": "309fa313", "fam_sig": "1a549453"}, "raw_data": {"raw_cas": "RCT: 2627559-46-8 + 62-53-3 | PRO: 2627559-47-9 | RGT: 64-19-7 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands\", \"authors\": \"Andreasson, Maans; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.\", \"reagents\": [\"Acetic acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39174754\", \"1.1\", \"Reagents: Acetic acid\", \"Solvents: Water; 3 h, rt\", \"405. Scheme 405 (1 Reaction)\", \"Design, synthesis and bioactivity evaluation of novel pyrazole linked phenylthiazole derivatives in context of antibacterial activity\", \"By: Patel, Bhautikkumar; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 39, 127853.\", \"10.1016/j.bmcl.2021.127853\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2627559-46-8\", \"62-53-3\"], \"pro_cas\": [\"2627559-47-9\"], \"rgt_cas\": [\"64-19-7\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2627559-46-8", "62-53-3"], "products": ["2627559-47-9"], "reagents": ["Acetic Acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.158686", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39174762", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Acetic Acid", "cas": "64-19-7", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 94.0}, "smiles": {"reactants": "CC(=O)C(=O)O.[Na].Nc1cc(Cl)c(Cl)cc1N", "products": "Cc1nc2cc(Cl)c(Cl)cc2[nH]c1=O"}, "reference": {"title": "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands", "authors": "Andreasson, Maans; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.", "doi": "10.1021/acs.jmedchem.3c02127", "raw": "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands | Andreasson, Maans; et al | Journal of Medicinal Chemistry (2024), 67(3), 2202-2219. | 10.1021/acs.jmedchem.3c02127"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-39174762", "1.1|Reagents: Acetic acid", "Solvents: Water; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Acetic Acid|64-19-7/Water|7732-18-5", "cond_sig": "309fa313", "fam_sig": "1a549453"}, "raw_data": {"raw_cas": "RCT: 2387522-99-6 + 1148157-29-2 | PRO: 2387523-23-9 | RGT: 64-19-7 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands\", \"authors\": \"Andreasson, Maans; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.\", \"reagents\": [\"Acetic acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39174762\", \"1.1\", \"Reagents: Acetic acid\", \"Solvents: Water; overnight, rt\", \"98. Scheme 98 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-99-6\", \"1148157-29-2\"], \"pro_cas\": [\"2387523-23-9\"], \"rgt_cas\": [\"64-19-7\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387522-99-6", "1148157-29-2"], "products": ["2387523-23-9"], "reagents": ["Acetic Acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.158686", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39179130", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.5, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)C[C@@H]1CCNC1=O", "products": "COC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1"}, "reference": {"title": "Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2", "authors": "Grifagni, Deborah; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.", "doi": "10.1021/acsmedchemlett.3c00498", "raw": "Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2 | Grifagni, Deborah; et al | ACS Medicinal Chemistry Letters (2024), 15(2), 250-257. | 10.1021/acsmedchemlett.3c00498"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-39179130", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0.5 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 2387522-94-1 + 247068-85-5 | PRO: 2387523-10-4 | RGT: 148893-10-1 + 121-44-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2\", \"authors\": \"Grifagni, Deborah; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39179130\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0.5 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dimethylformamide; 16 h, rt\", \"84. Scheme 84 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-94-1\", \"247068-85-5\"], \"pro_cas\": [\"2387523-10-4\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387522-94-1", "247068-85-5"], "products": ["2387523-10-4"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.158686", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39179136", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylcarbodiimide", "cas": "693-13-0", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylcarbodiimide", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 83.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1ccccc1.Cl.CC(C)[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C"}, "reference": {"title": "Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2", "authors": "Grifagni, Deborah; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.", "doi": "10.1021/acsmedchemlett.3c00498", "raw": "Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2 | Grifagni, Deborah; et al | ACS Medicinal Chemistry Letters (2024), 15(2), 250-257. | 10.1021/acsmedchemlett.3c00498"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-39179136", "1.1|Reagents: Diisopropylcarbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine", "Solvents: Dimethylformamide; 0 °C; 0 °C → rt; 16 h, rt", "Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit", "By: Rianjongdee, Francesco; et al", "Journal of Medicinal Chemistry (2021), 64(15), 10806-10833.", "10.1021/acs.jmedchem.1c00412"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylcarbodiimide|+Diisopropylethylamine|+N,N-Diisopropylcarbodiimide|693-13-0+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "76f81bf6", "fam_sig": "cfde27fb"}, "raw_data": {"raw_cas": "RCT: 677762-39-9 + 3963-62-0 | PRO: 2752331-29-4 | RGT: 693-13-0 + 2592-95-2 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2\", \"authors\": \"Grifagni, Deborah; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.\", \"reagents\": [\"Diisopropylcarbodiimide\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39179136\", \"1.1\", \"Reagents: Diisopropylcarbodiimide, 1-Hydroxybenzotriazole, Diisopropylethylamine\", \"Solvents: Dimethylformamide; 0 °C; 0 °C → rt; 16 h, rt\", \"251. Scheme 251 (1 Reaction)\", \"Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit\", \"By: Rianjongdee, Francesco; et al\", \"Journal of Medicinal Chemistry (2021), 64(15), 10806-10833.\", \"10.1021/acs.jmedchem.1c00412\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"677762-39-9\", \"3963-62-0\"], \"pro_cas\": [\"2752331-29-4\"], \"rgt_cas\": [\"693-13-0\", \"2592-95-2\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["677762-39-9", "3963-62-0"], "products": ["2752331-29-4"], "reagents": ["N,N-Diisopropylcarbodiimide", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.159683", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39179504", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Water", "cas": "7732-18-5", "role": "WORKUP"}, {"name": "NaOH", "cas": "1310-73-2", "role": "BASE"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 150.0, "time_h": 5.333, "yield_pct": 90.0}, "smiles": {"reactants": "NC(N)=O.Nc1ccc(Cl)cc1C(=O)O", "products": "O=c1[nH]c(=O)c2cc(Cl)ccc2[nH]1"}, "reference": {"title": "Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis", "authors": "Yang, Liu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 1914-1931.", "doi": "10.1021/acs.jmedchem.3c01703", "raw": "Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis | Yang, Liu; et al | Journal of Medicinal Chemistry (2024), 67(3), 1914-1931. | 10.1021/acs.jmedchem.3c01703"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-39179504", "1.1|5 h, rt → 150 °C; 150 °C → 100 °C", "1.2|Reagents: Water; 10 min, 100 °C", "1.3|Reagents: Sodium hydroxide", "Solvents: Water; 10 min, 100 °C", "1.4|Reagents: Hydrochloric acid", "Solvents: Water; pH 3", "High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists", "By: Bolteau, Raphael; et al", "European Journal of Medicinal Chemistry (2022), 241, 114620.", "10.1016/j.ejmech.2022.114620"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+NaOH|1310-73-2+Sodium hydroxide|+Water|7732-18-5/Water|7732-18-5", "cond_sig": "ca28c915", "fam_sig": "7bcdbcc2"}, "raw_data": {"raw_cas": "RCT: 57-13-6 + 5794-88-7 | PRO: 88145-89-5 | RGT: 7732-18-5 + 1310-73-2 + 7647-01-0 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis\", \"authors\": \"Yang, Liu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 1914-1931.\", \"reagents\": [\"Water\", \"Sodium hydroxide\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39179504\", \"1.1\", \"5 h, rt → 150 °C; 150 °C → 100 °C\", \"1.2\", \"Reagents: Water; 10 min, 100 °C\", \"1.3\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 10 min, 100 °C\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 3\", \"77. Scheme 77 (1 Reaction)\", \"High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists\", \"By: Bolteau, Raphael; et al\", \"European Journal of Medicinal Chemistry (2022), 241, 114620.\", \"10.1016/j.ejmech.2022.114620\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57-13-6\", \"5794-88-7\"], \"pro_cas\": [\"88145-89-5\"], \"rgt_cas\": [\"7732-18-5\", \"1310-73-2\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["57-13-6", "5794-88-7"], "products": ["88145-89-5"], "reagents": ["Water", "NaOH", "Hydrochloric acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.159683", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39248128", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 94.0}, "smiles": {"reactants": "COC(=O)CCCCN.CC12CC3CC(C)(C1)CC(NC(=O)Nc1ccc(C(=O)O)cc1)(C3)C2", "products": "COC(=O)CCCCNC(=O)c1ccc(NC(=O)NC23CC4CC(C)(CC(C)(C4)C2)C3)cc1"}, "reference": {"title": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "authors": "Chen, Yuanguang; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "doi": "10.1021/acs.jmedchem.3c02006", "raw": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality | Chen, Yuanguang; et al | Journal of Medicinal Chemistry (2024), 67(3), 2095-2117. | 10.1021/acs.jmedchem.3c02006"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-39248128", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 2 h, rt", "Design and synthesis of novel cereblon binders for use in targeted protein degradation", "By: Norris, Stephen; et al", "Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.", "10.1021/acs.jmedchem.3c01848"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4da6172b", "fam_sig": "2c09422f"}, "raw_data": {"raw_cas": "RCT: 2353-44-8 + 66493-39-8 | PRO: 2845386-65-2 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"authors\": \"Chen, Yuanguang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39248128\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 2 h, rt\", \"392. Scheme 392 (1 Reaction)\", \"Design and synthesis of novel cereblon binders for use in targeted protein degradation\", \"By: Norris, Stephen; et al\", \"Journal of Medicinal Chemistry (2023), 66(23), 16388-16409.\", \"10.1021/acs.jmedchem.3c01848\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2353-44-8\", \"66493-39-8\"], \"pro_cas\": [\"2845386-65-2\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2353-44-8", "66493-39-8"], "products": ["2845386-65-2"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.159683", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39248129", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 91.0}, "smiles": {"reactants": "COC(=O)CCCCCN.CC12CC3CC(C)(C1)CC(NC(=O)Nc1ccc(C(=O)O)cc1)(C3)C2", "products": "COC(=O)CCCCCNC(=O)c1ccc(NC(=O)NC23CC4CC(C)(CC(C)(C4)C2)C3)cc1"}, "reference": {"title": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "authors": "Chen, Yuanguang; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "doi": "10.1021/acs.jmedchem.3c02006", "raw": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality | Chen, Yuanguang; et al | Journal of Medicinal Chemistry (2024), 67(3), 2095-2117. | 10.1021/acs.jmedchem.3c02006"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-39248129", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 2 h, rt", "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras", "By: Takwale, Akshay D.; et al", "European Journal of Medicinal Chemistry (2020), 208, 112769.", "10.1016/j.ejmech.2020.112769"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4da6172b", "fam_sig": "2c09422f"}, "raw_data": {"raw_cas": "RCT: 610-37-7 + 24666-56-6 | PRO: 1924692-26-1 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"authors\": \"Chen, Yuanguang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39248129\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 2 h, rt\", \"401. Scheme 401 (1 Reaction)\", \"Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras\", \"By: Takwale, Akshay D.; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112769.\", \"10.1016/j.ejmech.2020.112769\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"610-37-7\", \"24666-56-6\"], \"pro_cas\": [\"1924692-26-1\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["610-37-7", "24666-56-6"], "products": ["1924692-26-1"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.159683", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39248143", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 96.0}, "smiles": {"reactants": "COC(=O)CCCCCCN.CC12CC3CC(C)(C1)CC(NC(=O)Nc1ccc(C(=O)O)cc1)(C3)C2", "products": "COC(=O)CCCCCCNC(=O)c1ccc(NC(=O)NC23CC4CC(C)(CC(C)(C4)C2)C3)cc1"}, "reference": {"title": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "authors": "Chen, Yuanguang; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "doi": "10.1021/acs.jmedchem.3c02006", "raw": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality | Chen, Yuanguang; et al | Journal of Medicinal Chemistry (2024), 67(3), 2095-2117. | 10.1021/acs.jmedchem.3c02006"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-39248143", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 2 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors", "By: Meena, Chhuttan L.; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.", "10.1016/j.bmcl.2020.127039"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4da6172b", "fam_sig": "2c09422f"}, "raw_data": {"raw_cas": "RCT: 18942-49-9 + 923012-11-7 | PRO: 2413279-28-2 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"authors\": \"Chen, Yuanguang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39248143\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 2 h, rt\", \"398. Scheme 398 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Novel cilengitide-based cyclic RGD peptides as αvβ3 integrin inhibitors\", \"By: Meena, Chhuttan L.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127039.\", \"10.1016/j.bmcl.2020.127039\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"18942-49-9\", \"923012-11-7\"], \"pro_cas\": [\"2413279-28-2\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["tert-Butyldimethylsilyl chloride", "923012-11-7"], "products": ["2413279-28-2"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.159683", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39248170", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 82.0}, "smiles": {"reactants": "COC(=O)CCN.CC(C)(C)OC(=O)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1", "products": "COC(=O)CCNC(=O)c1ccc(O[C@H]2CC[C@H](NC(=O)OC(C)(C)C)CC2)cc1"}, "reference": {"title": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "authors": "Chen, Yuanguang; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "doi": "10.1021/acs.jmedchem.3c02006", "raw": "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality | Chen, Yuanguang; et al | Journal of Medicinal Chemistry (2024), 67(3), 2095-2117. | 10.1021/acs.jmedchem.3c02006"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-39248170", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators", "By: Guzelj, Samo; et al", "Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.", "10.1021/acs.jmedchem.2c00808"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 83173-71-1 + 13734-41-3 | PRO: 2768856-81-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"authors\": \"Chen, Yuanguang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39248170\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 2 h, rt\", \"373. Scheme 373 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators\", \"By: Guzelj, Samo; et al\", \"Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.\", \"10.1021/acs.jmedchem.2c00808\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"83173-71-1\", \"13734-41-3\"], \"pro_cas\": [\"2768856-81-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["83173-71-1", "13734-41-3"], "products": ["2768856-81-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.159683", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39248679", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "4-Dimethylaminopyridine", "cas": "1122-58-3", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}, {"name": "4-(Dimethylamino)pyridine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)CN.O=C(O)Cc1ccc(I)cc1", "products": "CC(C)CNC(=O)Cc1ccc(I)cc1"}, "reference": {"title": "Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors", "authors": "Feng, Zi-Qiang; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116113.", "doi": "10.1016/j.ejmech.2023.116113", "raw": "Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors | Feng, Zi-Qiang; et al | European Journal of Medicinal Chemistry (2024), 266, 116113. | 10.1016/j.ejmech.2023.116113"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39248679", "1.1|Reagents: Triethylamine, Dicyclohexylcarbodiimide, 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 3 h, rt", "Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase", "By: Bagal, Sharan K.; et al", "Journal of Medicinal Chemistry (2021), 64(23), 17146-17183.", "10.1021/acs.jmedchem.1c01161"], "signatures": {"cond_key": "none/none/4-(Dimethylamino)pyridine|+4-Dimethylaminopyridine|1122-58-3+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "c4e36088", "fam_sig": "46116fad"}, "raw_data": {"raw_cas": "RCT: 55-22-1 + 62-53-3 | PRO: 3034-31-9 | RGT: 121-44-8 + 538-75-0 + 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors\", \"authors\": \"Feng, Zi-Qiang; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116113.\", \"reagents\": [\"Triethylamine\", \"Dicyclohexylcarbodiimide\", \"4-(Dimethylamino)pyridine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39248679\", \"1.1\", \"Reagents: Triethylamine, Dicyclohexylcarbodiimide, 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 3 h, rt\", \"11. Scheme 11 (1 Reaction)\", \"Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase\", \"By: Bagal, Sharan K.; et al\", \"Journal of Medicinal Chemistry (2021), 64(23), 17146-17183.\", \"10.1021/acs.jmedchem.1c01161\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55-22-1\", \"62-53-3\"], \"pro_cas\": [\"3034-31-9\"], \"rgt_cas\": [\"121-44-8\", \"538-75-0\", \"1122-58-3\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["55-22-1", "62-53-3"], "products": ["3034-31-9"], "reagents": ["Triethylamine", "N,N-Dicyclohexylcarbodiimide", "4-Dimethylaminopyridine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.159683", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39248683", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccccn1.Nc1cccc(/C=C/c2ccc(NC(=O)NCC3CCOCC3)cc2)c1", "products": "O=C(NCC1CCOCC1)Nc1ccc(/C=C/c2cccc(NC(=O)c3ccccn3)c2)cc1"}, "reference": {"title": "Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors", "authors": "Feng, Zi-Qiang; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116113.", "doi": "10.1016/j.ejmech.2023.116113", "raw": "Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors | Feng, Zi-Qiang; et al | European Journal of Medicinal Chemistry (2024), 266, 116113. | 10.1016/j.ejmech.2023.116113"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39248683", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality", "By: Chen, Yuanguang; et al", "Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.", "10.1021/acs.jmedchem.3c02006"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 39979-08-3 + 3032415-34-9 | PRO: 3032415-37-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors\", \"authors\": \"Feng, Zi-Qiang; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116113.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39248683\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"397. Scheme 397 (1 Reaction)\", \"Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality\", \"By: Chen, Yuanguang; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 2095-2117.\", \"10.1021/acs.jmedchem.3c02006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"39979-08-3\", \"3032415-34-9\"], \"pro_cas\": [\"3032415-37-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["39979-08-3", "3032415-34-9"], "products": ["3032415-37-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.160681", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256028", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 90.0}, "smiles": {"reactants": "Cc1cc(N)ccc1Br.CCS(=O)(=O)c1ccc(CC(=O)O)cc1", "products": "CCS(=O)(=O)c1ccc(CC(=O)Nc2ccc(Br)c(C)c2)cc1"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-39256028", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability", "By: Meta, Mergim; et al", "ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.", "10.1021/acsmedchemlett.4c00050"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 55-22-1 + 17193-39-4 | PRO: 3085792-09-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256028\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"132. Scheme 132 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability\", \"By: Meta, Mergim; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.\", \"10.1021/acsmedchemlett.4c00050\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55-22-1\", \"17193-39-4\"], \"pro_cas\": [\"3085792-09-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["55-22-1", "17193-39-4"], "products": ["3085792-09-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.160681", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256044", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "N#Cc1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(C#N)cc2)cc1C"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-39256044", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839", "By: Bothe, Ulrich; et al", "Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.", "10.1021/acs.jmedchem.3c01714"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 3878-55-5 + 66315-16-0 | PRO: 2161389-27-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256044\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"189. Scheme 189 (1 Reaction)\", \"Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839\", \"By: Bothe, Ulrich; et al\", \"Journal of Medicinal Chemistry (2024), 67(2), 1225-1242.\", \"10.1021/acs.jmedchem.3c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3878-55-5\", \"66315-16-0\"], \"pro_cas\": [\"2161389-27-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3878-55-5", "66315-16-0"], "products": ["2161389-27-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.160681", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256047", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 93.0}, "smiles": {"reactants": "N#Cc1cccc(CC(=O)O)c1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2cccc(C#N)c2)cc1C"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-39256047", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "By: Liu, Yonghua; et al", "European Journal of Medicinal Chemistry (2022), 228, 114033.", "10.1016/j.ejmech.2021.114033"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 89-41-8 + 99-98-9 | PRO: 349402-03-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256047\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"195. Scheme 195 (1 Reaction)\", \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"By: Liu, Yonghua; et al\", \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"10.1016/j.ejmech.2021.114033\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"89-41-8\", \"99-98-9\"], \"pro_cas\": [\"349402-03-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["89-41-8", "99-98-9"], "products": ["349402-03-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.160681", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256049", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)Cc1ccccc1[N+](=O)[O-].C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccccc2[N+](=O)[O-])cc1C"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-39256049", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors", "By: Kawanami, Toshio; et al", "ACS Medicinal Chemistry Letters (2020), 11(2), 188-194.", "10.1021/acsmedchemlett.9b00578"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1257446-29-9 + 15026-17-2 | PRO: 1257443-64-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256049\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"263. Scheme 263 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors\", \"By: Kawanami, Toshio; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(2), 188-194.\", \"10.1021/acsmedchemlett.9b00578\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1257446-29-9\", \"15026-17-2\"], \"pro_cas\": [\"1257443-64-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1257446-29-9", "15026-17-2"], "products": ["1257443-64-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.160681", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256063", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C(F)(F)F", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1C(F)(F)F"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-39256063", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors", "By: Zhu, Junjie; et al", "European Journal of Medicinal Chemistry (2023), 259, 115666.", "10.1016/j.ejmech.2023.115666"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 765-30-0 + 3705-42-8 | PRO: 2559759-42-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256063\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"390. Scheme 390 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors\", \"By: Zhu, Junjie; et al\", \"European Journal of Medicinal Chemistry (2023), 259, 115666.\", \"10.1016/j.ejmech.2023.115666\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"765-30-0\", \"3705-42-8\"], \"pro_cas\": [\"2559759-42-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["765-30-0", "3705-42-8"], "products": ["2559759-42-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.160681", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256065", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "Cc1ncc(C(=O)O)cn1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1C", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)c2cnc(C)nc2)cc1C"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39256065", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)", "By: Jin, Fangjie; et al", "Bioorganic & Medicinal Chemistry (2023), 90, 117379.", "10.1016/j.bmc.2023.117379"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 586-76-5 + 3019990-12-3 | PRO: 3049477-28-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256065\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"285. Scheme 285 (1 Reaction)\", \"Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)\", \"By: Jin, Fangjie; et al\", \"Bioorganic & Medicinal Chemistry (2023), 90, 117379.\", \"10.1016/j.bmc.2023.117379\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"586-76-5\", \"3019990-12-3\"], \"pro_cas\": [\"3049477-28-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["586-76-5", "3019990-12-3"], "products": ["3049477-28-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.160681", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256072", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-39256072", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis", "By: Mohamed, Abdelrahman; et al", "Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.", "10.1021/acs.jmedchem.2c00589"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 585-70-6 + 452-71-1 | PRO: 895665-61-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256072\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"235. Scheme 235 (1 Reaction)\", \"Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis\", \"By: Mohamed, Abdelrahman; et al\", \"Journal of Medicinal Chemistry (2022), 65(17), 11726-11744.\", \"10.1021/acs.jmedchem.2c00589\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"585-70-6\", \"452-71-1\"], \"pro_cas\": [\"895665-61-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["585-70-6", "452-71-1"], "products": ["895665-61-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.161678", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256075", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 94.0}, "smiles": {"reactants": "CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1Cl", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1Cl"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-39256075", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain", "By: van der Wildt, Berend; et al", "Bioorganic & Medicinal Chemistry (2021), 42, 116245.", "10.1016/j.bmc.2021.116245"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 20826-04-4 + 30069-31-9 | PRO: 2095848-27-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256075\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"359. Scheme 359 (1 Reaction)\", \"Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain\", \"By: van der Wildt, Berend; et al\", \"Bioorganic & Medicinal Chemistry (2021), 42, 116245.\", \"10.1016/j.bmc.2021.116245\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"20826-04-4\", \"30069-31-9\"], \"pro_cas\": [\"2095848-27-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["20826-04-4", "30069-31-9"], "products": ["2095848-27-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.161678", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256076", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 87.0}, "smiles": {"reactants": "CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cc1F", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cc1F"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-39256076", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors", "By: Aylott, Helen E.; et al", "Journal of Medicinal Chemistry (2021), 64(6), 3249-3281.", "10.1021/acs.jmedchem.0c02156"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2748688-40-4 + 75-04-7 | PRO: 2748687-69-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256076\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"361. Scheme 361 (1 Reaction)\", \"Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors\", \"By: Aylott, Helen E.; et al\", \"Journal of Medicinal Chemistry (2021), 64(6), 3249-3281.\", \"10.1021/acs.jmedchem.0c02156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2748688-40-4\", \"75-04-7\"], \"pro_cas\": [\"2748687-69-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2748688-40-4", "75-04-7"], "products": ["2748687-69-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.161678", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39256077", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 81.0}, "smiles": {"reactants": "CCS(=O)(=O)c1ccc(CC(=O)O)cc1.C=CC(=O)Nc1ccccc1-c1ccc(N)cn1", "products": "C=CC(=O)Nc1ccccc1-c1ccc(NC(=O)Cc2ccc(S(=O)(=O)CC)cc2)cn1"}, "reference": {"title": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer", "authors": "Fang, Wei; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.", "doi": "10.1021/acs.jmedchem.3c02063", "raw": "Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer | Fang, Wei; et al | Journal of Medicinal Chemistry (2024), 67(2), 1481-1499. | 10.1021/acs.jmedchem.3c02063"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39256077", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents", "By: Li, Baihui; et al", "European Journal of Medicinal Chemistry (2020), 195, 112278.", "10.1016/j.ejmech.2020.112278"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 198879-80-0 + 40615-17-6 | PRO: 2416338-36-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer\", \"authors\": \"Fang, Wei; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(2), 1481-1499.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39256077\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"490. Scheme 490 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents\", \"By: Li, Baihui; et al\", \"European Journal of Medicinal Chemistry (2020), 195, 112278.\", \"10.1016/j.ejmech.2020.112278\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"198879-80-0\", \"40615-17-6\"], \"pro_cas\": [\"2416338-36-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["198879-80-0", "40615-17-6"], "products": ["2416338-36-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.161678", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39283196", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}, {"name": "Sodium chloride", "cas": "7647-14-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Anisole", "cas": "100-66-3"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 80.0, "time_h": 12.0, "yield_pct": 86.0}, "smiles": {"reactants": "O=C(O)c1cccc(Br)c1.Cl.N[C@@H]1CCOC1", "products": "O=C(N[C@@H]1CCOC1)c1cccc(Br)c1"}, "reference": {"title": "Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594", "authors": "Aydin, Gulsevim; et al", "citation": "Organic Process Research & Development (2024), 28(2), 559-576.", "doi": "10.1021/acs.oprd.3c00393", "raw": "Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594 | Aydin, Gulsevim; et al | Organic Process Research & Development (2024), 28(2), 559-576. | 10.1021/acs.oprd.3c00393"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-39283196", "1.1|Reagents: Diisopropylethylamine, Thionyl chloride", "Solvents: Anisole; 1 h, rt → 80 °C; 3 h, 80 °C", "1.2|Reagents: Diisopropylethylamine", "Solvents: Anisole; 2 h, 50 °C; 3 h, 50 °C", "1.3|Reagents: Sodium chloride", "Solvents: Water; 50 °C; 3 h, 60 °C", "Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections", "By: Chen, Wei-Chia; et al", "Journal of Medicinal Chemistry (2020), 63(3), 1313-1327.", "10.1021/acs.jmedchem.9b01779"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Sodium chloride|7647-14-5+Thionyl chloride|7719-09-7/Anisole|100-66-3+Water|7732-18-5", "cond_sig": "560a9c17", "fam_sig": "31e6bab8"}, "raw_data": {"raw_cas": "RCT: 62-53-3 + 366-77-8 | PRO: 38752-59-9 | RGT: 7087-68-5 + 7719-09-7 + 7647-14-5 | SOL: 100-66-3 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594\", \"authors\": \"Aydin, Gulsevim; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(2), 559-576.\", \"reagents\": [\"Diisopropylethylamine\", \"Thionyl chloride\", \"Sodium chloride\"], \"catalysts\": [], \"solvents\": [\"Anisole\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39283196\", \"1.1\", \"Reagents: Diisopropylethylamine, Thionyl chloride\", \"Solvents: Anisole; 1 h, rt → 80 °C; 3 h, 80 °C\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Anisole; 2 h, 50 °C; 3 h, 50 °C\", \"1.3\", \"Reagents: Sodium chloride\", \"Solvents: Water; 50 °C; 3 h, 60 °C\", \"81. Scheme 81 (1 Reaction)\", \"Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections\", \"By: Chen, Wei-Chia; et al\", \"Journal of Medicinal Chemistry (2020), 63(3), 1313-1327.\", \"10.1021/acs.jmedchem.9b01779\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"62-53-3\", \"366-77-8\"], \"pro_cas\": [\"38752-59-9\"], \"rgt_cas\": [\"7087-68-5\", \"7719-09-7\", \"7647-14-5\"], \"cat_cas\": [], \"sol_cas\": [\"100-66-3\", \"7732-18-5\"], \"notes\": [\"stereoselective\"]}}", "enriched_names": {"reactants": ["62-53-3", "366-77-8"], "products": ["38752-59-9"], "reagents": ["N,N-Diisopropylethylamine", "7719-09-7", "7647-14-5"], "catalysts": [], "solvents": ["100-66-3", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.161678", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39283200", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "K2CO3", "cas": "584-08-7", "role": "BASE"}, {"name": "Sodium chloride", "cas": "7647-14-5", "role": "UNK"}, {"name": "Pivaloyl chloride", "cas": "3282-30-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Potassium carbonate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "2-Methyltetrahydrofuran", "cas": "96-47-9"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 30.0, "time_h": 31.0, "yield_pct": 93.0}, "smiles": {"reactants": "C[C@H](N)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2.O=C(O)c1ccco1.CC(F)(F)C(=O)O", "products": "C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2"}, "reference": {"title": "Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594", "authors": "Aydin, Gulsevim; et al", "citation": "Organic Process Research & Development (2024), 28(2), 559-576.", "doi": "10.1021/acs.oprd.3c00393", "raw": "Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594 | Aydin, Gulsevim; et al | Organic Process Research & Development (2024), 28(2), 559-576. | 10.1021/acs.oprd.3c00393"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-39283200", "1.1|Reagents: Potassium carbonate", "Solvents: 2-Methyltetrahydrofuran; 8 h, 25 °C", "1.2|Reagents: Sodium chloride", "Solvents: Water; 2 h, 20 - 30 °C", "1.3|Reagents: Pivaloyl chloride, Diisopropylethylamine", "Solvents: Acetonitrile; rt → 0 °C; 5 h, 0 °C", "1.4|6 h, 0 °C; 10 h, 0 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria", "By: Zhang, Yinyong; et al", "Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.", "10.1021/acs.jmedchem.4c00018"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+K2CO3|584-08-7+N,N-Diisopropylethylamine|7087-68-5+Pivaloyl chloride|3282-30-2+Potassium carbonate|+Sodium chloride|7647-14-5/2-Methyltetrahydrofuran|96-47-9+Acetonitrile|75-05-8+Water|7732-18-5", "cond_sig": "3e65d409", "fam_sig": "6485cfeb"}, "raw_data": {"raw_cas": "RCT: 6011-14-9 + 3078809-46-5 | PRO: 3078809-47-6 | RGT: 584-08-7 + 7647-14-5 + 3282-30-2 + 7087-68-5 | SOL: 96-47-9 + 7732-18-5 + 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594\", \"authors\": \"Aydin, Gulsevim; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(2), 559-576.\", \"reagents\": [\"Potassium carbonate\", \"Sodium chloride\", \"Pivaloyl chloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"2-Methyltetrahydrofuran\", \"Water\", \"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39283200\", \"1.1\", \"Reagents: Potassium carbonate\", \"Solvents: 2-Methyltetrahydrofuran; 8 h, 25 °C\", \"1.2\", \"Reagents: Sodium chloride\", \"Solvents: Water; 2 h, 20 - 30 °C\", \"1.3\", \"Reagents: Pivaloyl chloride, Diisopropylethylamine\", \"Solvents: Acetonitrile; rt → 0 °C; 5 h, 0 °C\", \"1.4\", \"6 h, 0 °C; 10 h, 0 °C\", \"465. Scheme 465 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria\", \"By: Zhang, Yinyong; et al\", \"Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.\", \"10.1021/acs.jmedchem.4c00018\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6011-14-9\", \"3078809-46-5\"], \"pro_cas\": [\"3078809-47-6\"], \"rgt_cas\": [\"584-08-7\", \"7647-14-5\", \"3282-30-2\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"96-47-9\", \"7732-18-5\", \"75-05-8\"], \"notes\": [\"stereoselective, intermediate from stage 2 added to stage 4\"]}}", "enriched_names": {"reactants": ["6011-14-9", "3078809-46-5"], "products": ["3078809-47-6"], "reagents": ["K2CO3", "7647-14-5", "3282-30-2", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["2-Methyltetrahydrofuran", "Water", "Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.161678", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39325781", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 92.0}, "smiles": {"reactants": "O=C1CCC[C@@H](C(=O)O)N1.Cc1noc(C)c1-c1ccc(NC2CCN(C(=O)OCc3ccccc3)CC2)c(N)c1", "products": "Cc1noc(C)c1-c1ccc(NC2CCN(C(=O)OCc3ccccc3)CC2)c(NC(=O)[C@@H]2CCCC(=O)N2)c1"}, "reference": {"title": "Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma", "authors": "Chang, Qi; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(4), 2466-2486.", "doi": "10.1021/acs.jmedchem.3c01468", "raw": "Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma | Chang, Qi; et al | Journal of Medicinal Chemistry (2024), 67(4), 2466-2486. | 10.1021/acs.jmedchem.3c01468"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-39325781", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties", "By: Dragovich, Peter S.; et al", "Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.", "10.1021/acs.jmedchem.0c01845"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 202592-23-2 + 2417371-67-4 | PRO: 2417371-68-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma\", \"authors\": \"Chang, Qi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(4), 2466-2486.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39325781\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"400. Scheme 400 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties\", \"By: Dragovich, Peter S.; et al\", \"Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.\", \"10.1021/acs.jmedchem.0c01845\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"202592-23-2\", \"2417371-67-4\"], \"pro_cas\": [\"2417371-68-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["202592-23-2", "2417371-67-4"], "products": ["2417371-68-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.162675", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39325848", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "1,4-Dioxane", "cas": "123-91-1"}], "conditions": {"temperature_c": 0.0, "time_h": 6.0, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O.Cl.N[C@@H](C[C@@H]1CCNC1=O)C(=O)COc1c(F)c(F)cc(F)c1F", "products": "CC(C)C[C@H](N)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COc1c(F)c(F)cc(F)c1F.Cl"}, "reference": {"title": "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead", "authors": "Dayan Elshan, N. G. R.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(4), 2369-2378.", "doi": "10.1021/acs.jmedchem.3c01938", "raw": "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead | Dayan Elshan, N. G. R.; et al | Journal of Medicinal Chemistry (2024), 67(4), 2369-2378. | 10.1021/acs.jmedchem.3c01938"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-39325848", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 4 h, rt", "1.2|Reagents: Hydrochloric acid", "Solvents: 1,4-Dioxane; 0 °C; 2 h, rt", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/1,4-Dioxane|123-91-1+Dimethylformamide|68-12-2", "cond_sig": "ae4f7c26", "fam_sig": "e335a29d"}, "raw_data": {"raw_cas": "RCT: 2892557-01-4 + 104-94-9 | PRO: 2892557-09-2 | RGT: 7087-68-5 + 148893-10-1 + 7647-01-0 | SOL: 68-12-2 + 123-91-1", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead\", \"authors\": \"Dayan Elshan, N. G. R.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(4), 2369-2378.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"1,4-Dioxane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39325848\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 4 h, rt\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: 1,4-Dioxane; 0 °C; 2 h, rt\", \"295. Scheme 295 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-01-4\", \"104-94-9\"], \"pro_cas\": [\"2892557-09-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"123-91-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-01-4", "104-94-9"], "products": ["2892557-09-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "1,4-Dioxane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.162675", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39327163", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)c1ccc(Br)o1.NCC(F)(F)F", "products": "O=C(NCC(F)(F)F)c1ccc(Br)o1"}, "reference": {"title": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "authors": "Morozova, Alisa; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116101.", "doi": "10.1016/j.ejmech.2023.116101", "raw": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties | Morozova, Alisa; et al | European Journal of Medicinal Chemistry (2024), 266, 116101. | 10.1016/j.ejmech.2023.116101"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-39327163", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 14 h, rt", "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease", "By: Li, Feng; et al", "Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.", "10.1021/acs.jmedchem.0c01544"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 78-81-9 + 434-76-4 | PRO: 1880139-21-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"authors\": \"Morozova, Alisa; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39327163\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 14 h, rt\", \"46. Scheme 46 (1 Reaction)\", \"Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease\", \"By: Li, Feng; et al\", \"Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.\", \"10.1021/acs.jmedchem.0c01544\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"78-81-9\", \"434-76-4\"], \"pro_cas\": [\"1880139-21-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["78-81-9", "434-76-4"], "products": ["1880139-21-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.162675", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39327164", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 96.0}, "smiles": {"reactants": "NCC(F)(F)F.O=C(O)c1ccc(Br)s1", "products": "O=C(NCC(F)(F)F)c1ccc(Br)s1"}, "reference": {"title": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "authors": "Morozova, Alisa; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116101.", "doi": "10.1016/j.ejmech.2023.116101", "raw": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties | Morozova, Alisa; et al | European Journal of Medicinal Chemistry (2024), 266, 116101. | 10.1016/j.ejmech.2023.116101"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-39327164", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 14 h, rt", "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "By: Li, Bing-yan; et al", "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "10.1021/acs.jmedchem.3c02407"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 6232-88-8 + 5332-73-0 | PRO: 1108194-39-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"authors\": \"Morozova, Alisa; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39327164\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 14 h, rt\", \"27. Scheme 27 (1 Reaction)\", \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"By: Li, Bing-yan; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"10.1021/acs.jmedchem.3c02407\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6232-88-8\", \"5332-73-0\"], \"pro_cas\": [\"1108194-39-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["6232-88-8", "5332-73-0"], "products": ["1108194-39-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.162675", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39327165", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 15.0, "yield_pct": 99.0}, "smiles": {"reactants": "NCC(F)(F)F.O=C(O)c1ccnc(Br)c1", "products": "O=C(NCC(F)(F)F)c1ccnc(Br)c1"}, "reference": {"title": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "authors": "Morozova, Alisa; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116101.", "doi": "10.1016/j.ejmech.2023.116101", "raw": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties | Morozova, Alisa; et al | European Journal of Medicinal Chemistry (2024), 266, 116101. | 10.1016/j.ejmech.2023.116101"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-39327165", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 14 h, rt", "Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer", "By: Zhang, Xing Xing; et al", "Journal of Medicinal Chemistry (2022), 65(18), 12095-12123.", "10.1021/acs.jmedchem.2c00820"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 42287-90-1 + 62-53-3 | PRO: 1459714-80-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"authors\": \"Morozova, Alisa; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39327165\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 14 h, rt\", \"34. Scheme 34 (1 Reaction)\", \"Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer\", \"By: Zhang, Xing Xing; et al\", \"Journal of Medicinal Chemistry (2022), 65(18), 12095-12123.\", \"10.1021/acs.jmedchem.2c00820\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"42287-90-1\", \"62-53-3\"], \"pro_cas\": [\"1459714-80-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["42287-90-1", "62-53-3"], "products": ["1459714-80-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.162675", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39327166", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 89.0}, "smiles": {"reactants": "NCC(F)(F)F.O=C(O)c1cc(Br)cs1", "products": "O=C(NCC(F)(F)F)c1cc(Br)cs1"}, "reference": {"title": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "authors": "Morozova, Alisa; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116101.", "doi": "10.1016/j.ejmech.2023.116101", "raw": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties | Morozova, Alisa; et al | European Journal of Medicinal Chemistry (2024), 266, 116101. | 10.1016/j.ejmech.2023.116101"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-39327166", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 14 h, rt", "From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase", "By: Juillet, Charlotte; et al", "Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.", "10.1021/acs.jmedchem.0c02064"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2450-71-7 + 6324-10-3 | PRO: 1097429-88-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"authors\": \"Morozova, Alisa; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39327166\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 14 h, rt\", \"39. Scheme 39 (1 Reaction)\", \"From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase\", \"By: Juillet, Charlotte; et al\", \"Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.\", \"10.1021/acs.jmedchem.0c02064\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2450-71-7\", \"6324-10-3\"], \"pro_cas\": [\"1097429-88-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2450-71-7", "6324-10-3"], "products": ["1097429-88-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.162675", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39327168", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 85.0}, "smiles": {"reactants": "NCC(F)(F)F.O=C(O)c1cnc(Br)s1", "products": "O=C(NCC(F)(F)F)c1cnc(Br)s1"}, "reference": {"title": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "authors": "Morozova, Alisa; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116101.", "doi": "10.1016/j.ejmech.2023.116101", "raw": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties | Morozova, Alisa; et al | European Journal of Medicinal Chemistry (2024), 266, 116101. | 10.1016/j.ejmech.2023.116101"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-39327168", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 14 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria", "By: de Lera Ruiz, Manuel; et al", "ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.", "10.1021/acsmedchemlett.2c00355"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 619-21-6 + 2627-86-3 | PRO: 2852783-67-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"authors\": \"Morozova, Alisa; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39327168\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 14 h, rt\", \"29. Scheme 29 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria\", \"By: de Lera Ruiz, Manuel; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.\", \"10.1021/acsmedchemlett.2c00355\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"619-21-6\", \"2627-86-3\"], \"pro_cas\": [\"2852783-67-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["619-21-6", "2627-86-3"], "products": ["2852783-67-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.162675", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39327172", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 91.0}, "smiles": {"reactants": "NCC(F)(F)F.O=C(O)c1cc(Br)ccn1", "products": "O=C(NCC(F)(F)F)c1cc(Br)ccn1"}, "reference": {"title": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "authors": "Morozova, Alisa; et al", "citation": "European Journal of Medicinal Chemistry (2024), 266, 116101.", "doi": "10.1016/j.ejmech.2023.116101", "raw": "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties | Morozova, Alisa; et al | European Journal of Medicinal Chemistry (2024), 266, 116101. | 10.1016/j.ejmech.2023.116101"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-39327172", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 14 h, rt", "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "By: Morozova, Alisa; et al", "European Journal of Medicinal Chemistry (2024), 266, 116101.", "10.1016/j.ejmech.2023.116101"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 585-70-6 + 753-90-2 | PRO: 1250040-96-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"authors\": \"Morozova, Alisa; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39327172\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 14 h, rt\", \"45. Scheme 45 (1 Reaction)\", \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"By: Morozova, Alisa; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"10.1016/j.ejmech.2023.116101\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"585-70-6\", \"753-90-2\"], \"pro_cas\": [\"1250040-96-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["585-70-6", "753-90-2"], "products": ["1250040-96-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.163673", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39410607", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": 0.0, "time_h": 19.0, "yield_pct": 88.0}, "smiles": {"reactants": "CC(C)c1n[nH]c(C(=O)O)c1[N+](=O)[O-].CN", "products": "CNC(=O)c1[nH]nc(C(C)C)c1[N+](=O)[O-]"}, "reference": {"title": "Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy", "authors": "Zheng, Yang; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(4), 2849-2863.", "doi": "10.1021/acs.jmedchem.3c01976", "raw": "Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy | Zheng, Yang; et al | Journal of Medicinal Chemistry (2024), 67(4), 2849-2863. | 10.1021/acs.jmedchem.3c01976"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-39410607", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Tetrahydrofuran; 0 °C; 1 h, 0 °C; 0 °C → rt", "1.2|Solvents: Ethanol; 0 °C; 18 h, rt", "HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells", "By: Liang, Tao; et al", "Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.", "10.1021/acs.jmedchem.0c01454"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Ethanol|64-17-5+Tetrahydrofuran|109-99-9", "cond_sig": "d3b299fa", "fam_sig": "cbe6f0f5"}, "raw_data": {"raw_cas": "RCT: 586-89-0 + 17994-94-4 | PRO: 2718890-11-8 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 109-99-9 + 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy\", \"authors\": \"Zheng, Yang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(4), 2849-2863.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Tetrahydrofuran\", \"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39410607\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Tetrahydrofuran; 0 °C; 1 h, 0 °C; 0 °C → rt\", \"1.2\", \"Solvents: Ethanol; 0 °C; 18 h, rt\", \"52. Scheme 52 (1 Reaction)\", \"HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells\", \"By: Liang, Tao; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 12083-12099.\", \"10.1021/acs.jmedchem.0c01454\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"586-89-0\", \"17994-94-4\"], \"pro_cas\": [\"2718890-11-8\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"109-99-9\", \"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["586-89-0", "17994-94-4"], "products": ["2718890-11-8"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Tetrahydrofuran", "Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.163673", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39485373", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Calcium chloride", "cas": "10043-52-4", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 48.5, "yield_pct": 100.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CC(C)C.Cl.O=C(N[C@@H](Cc1ccc(F)cc1)C(=O)O)OCc1ccccc1", "products": "COC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)OCc1ccccc1"}, "reference": {"title": "Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement", "authors": "Barton, Linda S.; et al", "citation": "Bioorganic & Medicinal Chemistry (2024), 100, 117618.", "doi": "10.1016/j.bmc.2024.117618", "raw": "Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement | Barton, Linda S.; et al | Bioorganic & Medicinal Chemistry (2024), 100, 117618. | 10.1016/j.bmc.2024.117618"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-39485373", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 d, rt", "1.2|Reagents: Sodium bicarbonate, Calcium chloride", "Solvents: Water; 30 min, rt", "Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity", "By: Fang, Jing-jie; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.", "10.1021/acs.jmedchem.3c01351"], "signatures": {"cond_key": "none/none/Calcium chloride|10043-52-4+HATU|148893-10-1+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "3ea1aad4", "fam_sig": "986bd23d"}, "raw_data": {"raw_cas": "RCT: 203302-97-0 + 3033385-15-5 | PRO: 3033385-17-7 | RGT: 121-44-8 + 148893-10-1 + 144-55-8 + 10043-52-4 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement\", \"authors\": \"Barton, Linda S.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2024), 100, 117618.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\", \"Calcium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39485373\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 d, rt\", \"1.2\", \"Reagents: Sodium bicarbonate, Calcium chloride\", \"Solvents: Water; 30 min, rt\", \"447. Scheme 447 (1 Reaction)\", \"Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity\", \"By: Fang, Jing-jie; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15288-15308.\", \"10.1021/acs.jmedchem.3c01351\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"203302-97-0\", \"3033385-15-5\"], \"pro_cas\": [\"3033385-17-7\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\", \"144-55-8\", \"10043-52-4\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["203302-97-0", "3033385-15-5"], "products": ["3033385-17-7"], "reagents": ["Triethylamine", "HATU", "NaHCO3", "10043-52-4"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.163673", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39486271", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 60.0, "time_h": 19.0, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)c1ncccc1-n1nccn1.CC1(C)C2CCC1(CS(=O)(=O)O)C(=O)C2.CCc1nc(C(F)(F)F)cnc1N[C@@H]1CCC[C@H]1N", "products": "CCc1nc(C(F)(F)F)cnc1N[C@@H]1CCC[C@H]1NC(=O)c1ncccc1-n1nccn1"}, "reference": {"title": "Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist", "authors": "Glen, Angela; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2024), 100, 129629.", "doi": "10.1016/j.bmcl.2024.129629", "raw": "Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist | Glen, Angela; et al | Bioorganic & Medicinal Chemistry Letters (2024), 100, 129629. | 10.1016/j.bmcl.2024.129629"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-39486271", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylacetamide; rt → 40 °C; 5 h, 40 °C", "1.2|Solvents: Water; 1 h, 60 °C; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "By: Zhou, Huiyu; et al", "European Journal of Medicinal Chemistry (2023), 255, 115389.", "10.1016/j.ejmech.2023.115389"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Dimethylacetamide|127-19-5+Water|7732-18-5", "cond_sig": "fc8109d0", "fam_sig": "37a75d51"}, "raw_data": {"raw_cas": "RCT: 72925-16-7 + 159005-71-7 | PRO: 2925287-34-7 | RGT: 7087-68-5 + 94790-37-1 | SOL: 127-19-5 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist\", \"authors\": \"Glen, Angela; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2024), 100, 129629.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39486271\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylacetamide; rt → 40 °C; 5 h, 40 °C\", \"1.2\", \"Solvents: Water; 1 h, 60 °C; 12 h, rt\", \"192. Scheme 192 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"By: Zhou, Huiyu; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"10.1016/j.ejmech.2023.115389\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"72925-16-7\", \"159005-71-7\"], \"pro_cas\": [\"2925287-34-7\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["72925-16-7", "159005-71-7"], "products": ["2925287-34-7"], "reagents": ["N,N-Diisopropylethylamine", "HBTU"], "catalysts": [], "solvents": ["Dimethylacetamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.163673", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39561294", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.75, "yield_pct": 91.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NC(CCCCN)C(=O)O.[N-]=[N+]=Nc1ccc(N)cc1", "products": "[N-]=[N+]=Nc1ccc(NC(=O)[C@@H](N)CCCCN)cc1"}, "reference": {"title": "Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains", "authors": "Fatma, Khushnood; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(3), 388-395.", "doi": "10.1021/acsmedchemlett.3c00537", "raw": "Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains | Fatma, Khushnood; et al | ACS Medicinal Chemistry Letters (2024), 15(3), 388-395. | 10.1021/acsmedchemlett.3c00537"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-39561294", "1.1|Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Dichloromethane; 45 min, rt", "1.2|Solvents: Dichloromethane; rt; 12 h, rt", "Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer", "By: Eno, Meredith S.; et al", "Journal of Medicinal Chemistry (2022), 65(14), 9662-9677.", "10.1021/acs.jmedchem.2c00704"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "7cadbfe9", "fam_sig": "f6c1957f"}, "raw_data": {"raw_cas": "RCT: 74-89-5 + 1447226-47-2 | PRO: 2808391-84-4 | RGT: 538-75-0 + 2592-95-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains\", \"authors\": \"Fatma, Khushnood; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(3), 388-395.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39561294\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Dichloromethane; 45 min, rt\", \"1.2\", \"Solvents: Dichloromethane; rt; 12 h, rt\", \"43. Scheme 43 (1 Reaction)\", \"Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer\", \"By: Eno, Meredith S.; et al\", \"Journal of Medicinal Chemistry (2022), 65(14), 9662-9677.\", \"10.1021/acs.jmedchem.2c00704\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"74-89-5\", \"1447226-47-2\"], \"pro_cas\": [\"2808391-84-4\"], \"rgt_cas\": [\"538-75-0\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["74-89-5", "1447226-47-2"], "products": ["2808391-84-4"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.163673", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39627218", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.5, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1ccccc1Nc1ccccc1.COc1ccc(CN)cc1", "products": "COc1ccc(CNC(=O)c2ccccc2Nc2ccccc2)cc1"}, "reference": {"title": "N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression", "authors": "Li, Junfang; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(15), 10481-10505.", "doi": "10.1021/acs.jmedchem.2c00635", "raw": "N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression | Li, Junfang; et al | Journal of Medicinal Chemistry (2022), 65(15), 10481-10505. | 10.1021/acs.jmedchem.2c00635"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-39627218", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 0.5 h, rt", "1.2|Reagents: Triethylamine; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "By: Fuchs, Natalie; et al", "ChemMedChem (2023), 18(15), e202300160.", "10.1002/cmdc.202300160"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4da6172b", "fam_sig": "2c09422f"}, "raw_data": {"raw_cas": "RCT: 88-13-1 + 3182-93-2 | PRO: 3054992-07-0 | RGT: 2592-95-2 + 25952-53-8 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression\", \"authors\": \"Li, Junfang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(15), 10481-10505.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39627218\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 0.5 h, rt\", \"1.2\", \"Reagents: Triethylamine; 24 h, rt\", \"158. Scheme 158 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"By: Fuchs, Natalie; et al\", \"ChemMedChem (2023), 18(15), e202300160.\", \"10.1002/cmdc.202300160\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"88-13-1\", \"3182-93-2\"], \"pro_cas\": [\"3054992-07-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["88-13-1", "3182-93-2"], "products": ["3054992-07-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.163673", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39628847", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)N.CC(C)(C)OC(=O)N[C@@H](CC(=O)O)C(=O)OCc1ccccc1", "products": "CC(C)(C)NC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)OCc1ccccc1"}, "reference": {"title": "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit", "authors": "Zhan, Wenhu; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.", "doi": "10.1021/acs.jmedchem.2c00733", "raw": "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit | Zhan, Wenhu; et al | Journal of Medicinal Chemistry (2023), 66(2), 1172-1185. | 10.1021/acs.jmedchem.2c00733"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-39628847", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 0 °C → rt; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 3405-77-4 + 2387522-87-2 | PRO: 2760538-87-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit\", \"authors\": \"Zhan, Wenhu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39628847\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 0 °C → rt; 2 h, rt\", \"280. Scheme 280 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3405-77-4\", \"2387522-87-2\"], \"pro_cas\": [\"2760538-87-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3405-77-4", "2387522-87-2"], "products": ["2760538-87-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.163673", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39636683", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}], "solvents": [{"name": "2-Methyltetrahydrofuran", "cas": "96-47-9"}, {"name": "Pyridine", "cas": "110-86-1"}], "conditions": {"temperature_c": 40.0, "time_h": 14.0, "yield_pct": 81.0}, "smiles": {"reactants": "COc1cc(N)ccn1.O=C(O)c1ccc(C(F)(F)F)cc1F", "products": "COc1cc(NC(=O)c2ccc(C(F)(F)F)cc2F)ccn1"}, "reference": {"title": "Discovery of a novel series of pyridone amides as NaV1.8 inhibitors", "authors": "Wang, Yanfang; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2024), 101, 129655.", "doi": "10.1016/j.bmcl.2024.129655", "raw": "Discovery of a novel series of pyridone amides as NaV1.8 inhibitors | Wang, Yanfang; et al | Bioorganic & Medicinal Chemistry Letters (2024), 101, 129655. | 10.1016/j.bmcl.2024.129655"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-39636683", "1.1|Reagents: Triethylamine, Propylphosphonic anhydride", "Solvents: 2-Methyltetrahydrofuran, Pyridine; 14 h, 40 °C", "Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes", "By: Saint-Dizier, Francois; et al", "Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.", "10.1021/acs.jmedchem.2c01591"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Triethylamine|121-44-8/2-Methyltetrahydrofuran|96-47-9+Pyridine|110-86-1", "cond_sig": "44b81711", "fam_sig": "025850e5"}, "raw_data": {"raw_cas": "RCT: 3303-84-2 + 7210-76-6 | PRO: 2864201-16-9 | RGT: 121-44-8 + 68957-94-8 | SOL: 96-47-9 + 110-86-1", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a novel series of pyridone amides as NaV1.8 inhibitors\", \"authors\": \"Wang, Yanfang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2024), 101, 129655.\", \"reagents\": [\"Triethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"2-Methyltetrahydrofuran\", \"Pyridine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39636683\", \"1.1\", \"Reagents: Triethylamine, Propylphosphonic anhydride\", \"Solvents: 2-Methyltetrahydrofuran, Pyridine; 14 h, 40 °C\", \"278. Scheme 278 (1 Reaction)\", \"Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes\", \"By: Saint-Dizier, Francois; et al\", \"Journal of Medicinal Chemistry (2023), 66(4), 2622-2645.\", \"10.1021/acs.jmedchem.2c01591\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3303-84-2\", \"7210-76-6\"], \"pro_cas\": [\"2864201-16-9\"], \"rgt_cas\": [\"121-44-8\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"96-47-9\", \"110-86-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["3303-84-2", "7210-76-6"], "products": ["2864201-16-9"], "reagents": ["Triethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["2-Methyltetrahydrofuran", "Pyridine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.164670", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39636949", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 7.5, "yield_pct": 80.0}, "smiles": {"reactants": "COC(=O)CCCCCCC(=O)O.Nc1cc(C=O)ccc1O", "products": "COC(=O)CCCCCCC(=O)Nc1cc(C=O)ccc1O"}, "reference": {"title": "Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer", "authors": "He, Pei; et al", "citation": "European Journal of Medicinal Chemistry (2024), 268, 116236.", "doi": "10.1016/j.ejmech.2024.116236", "raw": "Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer | He, Pei; et al | European Journal of Medicinal Chemistry (2024), 268, 116236. | 10.1016/j.ejmech.2024.116236"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-39636949", "1.1|Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 30 min, rt", "1.2|6 h, rt", "Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei", "By: Scheuplein, Nicolas J.; et al", "Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.", "10.1021/acs.jmedchem.3c00458"], "signatures": {"cond_key": "none/none/HBTU|94790-37-1+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "a19ce9ed", "fam_sig": "a7e41d80"}, "raw_data": {"raw_cas": "RCT: 780750-43-8 + 3731-52-0 | PRO: 2984600-54-4 | RGT: 121-44-8 + 94790-37-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer\", \"authors\": \"He, Pei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 268, 116236.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39636949\", \"1.1\", \"Reagents: Triethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 30 min, rt\", \"1.2\", \"6 h, rt\", \"130. Scheme 130 (1 Reaction)\", \"Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei\", \"By: Scheuplein, Nicolas J.; et al\", \"Journal of Medicinal Chemistry (2023), 66(13), 8876-8895.\", \"10.1021/acs.jmedchem.3c00458\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"780750-43-8\", \"3731-52-0\"], \"pro_cas\": [\"2984600-54-4\"], \"rgt_cas\": [\"121-44-8\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["780750-43-8", "3731-52-0"], "products": ["2984600-54-4"], "reagents": ["Triethylamine", "HBTU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.164670", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39656177", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)C1CC1.COC(=O)[C@H](Cc1ccc(N)cc1)NC(=O)OC(C)(C)C", "products": "COC(=O)[C@H](Cc1ccc(NC(=O)C2CC2)cc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Design, synthesis and biological evaluation of 6-chloro-quinolin-2-one derivatives as novel FXIa inhibitors", "authors": "Wang, Yanshi; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2024), 99, 129610.", "doi": "10.1016/j.bmcl.2024.129610", "raw": "Design, synthesis and biological evaluation of 6-chloro-quinolin-2-one derivatives as novel FXIa inhibitors | Wang, Yanshi; et al | Bioorganic & Medicinal Chemistry Letters (2024), 99, 129610. | 10.1016/j.bmcl.2024.129610"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-39656177", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; rt; overnight, rt", "Discovery of a novel series of pyridone amides as NaV1.8 inhibitors", "By: Wang, Yanfang; et al", "Bioorganic & Medicinal Chemistry Letters (2024), 101, 129655.", "10.1016/j.bmcl.2024.129655"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "1e417a35", "fam_sig": "e5aac3df"}, "raw_data": {"raw_cas": "RCT: 20265-39-8 + 115029-24-8 | PRO: 1620847-67-7 | RGT: 7087-68-5 + 128625-52-5 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of 6-chloro-quinolin-2-one derivatives as novel FXIa inhibitors\", \"authors\": \"Wang, Yanshi; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2024), 99, 129610.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39656177\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; rt; overnight, rt\", \"277. Scheme 277 (1 Reaction)\", \"Discovery of a novel series of pyridone amides as NaV1.8 inhibitors\", \"By: Wang, Yanfang; et al\", \"Bioorganic & Medicinal Chemistry Letters (2024), 101, 129655.\", \"10.1016/j.bmcl.2024.129655\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"20265-39-8\", \"115029-24-8\"], \"pro_cas\": [\"1620847-67-7\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["20265-39-8", "115029-24-8"], "products": ["1620847-67-7"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.164670", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39721304", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CC(C)C.O=C(N[C@@H](Cc1cccc2ccccc12)C(=O)O)OCc1ccccc1", "products": "COC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)OCc1ccccc1"}, "reference": {"title": "Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease", "authors": "Amblard, Franck; et al", "citation": "European Journal of Medicinal Chemistry (2024), 268, 116263.", "doi": "10.1016/j.ejmech.2024.116263", "raw": "Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease | Amblard, Franck; et al | European Journal of Medicinal Chemistry (2024), 268, 116263. | 10.1016/j.ejmech.2024.116263"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-39721304", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; overnight, rt", "Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists", "By: Shan, Bin; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.", "10.1021/acs.jmedchem.2c01714"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "cdc05954", "fam_sig": "618f9e59"}, "raw_data": {"raw_cas": "RCT: 50413-30-4 + 2913152-05-1 | PRO: 2913152-09-5 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease\", \"authors\": \"Amblard, Franck; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 268, 116263.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39721304\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; overnight, rt\", \"468. Scheme 468 (1 Reaction)\", \"Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists\", \"By: Shan, Bin; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3327-3347.\", \"10.1021/acs.jmedchem.2c01714\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"50413-30-4\", \"2913152-05-1\"], \"pro_cas\": [\"2913152-09-5\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["50413-30-4", "2913152-05-1"], "products": ["2913152-09-5"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.164670", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39736960", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "cas": "1075198-30-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)C12CC3CC(CC(C3)C1)C2.CCCn1c(=O)c(N)c(N)n(Cc2ccccc2)c1=O", "products": "CCCn1c(=O)c(NC(=O)C23CC4CC(CC(C4)C2)C3)c(N)n(Cc2ccccc2)c1=O"}, "reference": {"title": "Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells", "authors": "Comeo, Eleonora; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(10), 6670-6695.", "doi": "10.1021/acs.jmedchem.0c02067", "raw": "Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells | Comeo, Eleonora; et al | Journal of Medicinal Chemistry (2021), 64(10), 6670-6695. | 10.1021/acs.jmedchem.0c02067"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-39736960", "1.1|Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, rt", "Double bond geometry shown", "Double bond geometry shown", "Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action", "By: Marinovic, Marina; et al", "European Journal of Medicinal Chemistry (2021), 224, 113687.", "10.1016/j.ejmech.2021.113687"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate|1075198-30-9/Dimethylformamide|68-12-2", "cond_sig": "f1a6d156", "fam_sig": "9d1b9042"}, "raw_data": {"raw_cas": "RCT: 940-62-5 + 2685741-31-3 | PRO: 2685741-69-7 | RGT: 7087-68-5 + 1075198-30-9 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells\", \"authors\": \"Comeo, Eleonora; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(10), 6670-6695.\", \"reagents\": [\"Diisopropylethylamine\", \"N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39736960\", \"1.1\", \"Reagents: Diisopropylethylamine, N-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino(morpholino)uronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, rt\", \"241. Scheme 241 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action\", \"By: Marinovic, Marina; et al\", \"European Journal of Medicinal Chemistry (2021), 224, 113687.\", \"10.1016/j.ejmech.2021.113687\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"940-62-5\", \"2685741-31-3\"], \"pro_cas\": [\"2685741-69-7\"], \"rgt_cas\": [\"7087-68-5\", \"1075198-30-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["940-62-5", "2685741-31-3"], "products": ["2685741-69-7"], "reagents": ["N,N-Diisopropylethylamine", "1075198-30-9"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.164670", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39787033", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "K2CO3", "cas": "584-08-7", "role": "UNK"}, {"name": "Potassium carbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.5, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)/C=C/c1ccccc1.COC(=O)c1ccc(CN)cc1.Cl", "products": "COC(=O)c1ccc(CNC(=O)/C=C/c2ccccc2)cc1"}, "reference": {"title": "Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity", "authors": "Moreno-Yruela, Carlos; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(5), 779-785.", "doi": "10.1021/acsmedchemlett.1c00702", "raw": "Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity | Moreno-Yruela, Carlos; et al | ACS Medicinal Chemistry Letters (2022), 13(5), 779-785. | 10.1021/acsmedchemlett.1c00702"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-39787033", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; rt; 2.5 h, rt; rt → 0 °C", "1.2|Reagents: Potassium carbonate", "Solvents: Ethyl acetate, Water; 0 °C; 0 °C → rt; overnight, rt", "Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni", "By: Kanyanta, Masebe; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.", "10.1016/j.bmcl.2023.129164"], "signatures": {"cond_key": "none/none/K2CO3|584-08-7+Oxalyl chloride|79-37-8+Potassium carbonate|/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6+Water|7732-18-5", "cond_sig": "2b21f329", "fam_sig": "2140be4c"}, "raw_data": {"raw_cas": "RCT: 456-22-4 + 98-16-8 | PRO: 2054-00-4 | RGT: 79-37-8 + 584-08-7 | CAT: 68-12-2 | SOL: 75-09-2 + 141-78-6 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity\", \"authors\": \"Moreno-Yruela, Carlos; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(5), 779-785.\", \"reagents\": [\"Oxalyl chloride\", \"Potassium carbonate\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Ethyl acetate\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39787033\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; rt; 2.5 h, rt; rt → 0 °C\", \"1.2\", \"Reagents: Potassium carbonate\", \"Solvents: Ethyl acetate, Water; 0 °C; 0 °C → rt; overnight, rt\", \"66. Scheme 66 (1 Reaction)\", \"Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni\", \"By: Kanyanta, Masebe; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.\", \"10.1016/j.bmcl.2023.129164\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"456-22-4\", \"98-16-8\"], \"pro_cas\": [\"2054-00-4\"], \"rgt_cas\": [\"79-37-8\", \"584-08-7\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"141-78-6\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["456-22-4", "98-16-8"], "products": ["2054-00-4"], "reagents": ["79-37-8", "K2CO3"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Ethyl Acetate", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.164670", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39824402", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Isopropanol", "cas": "67-63-0"}], "conditions": {"temperature_c": 20.0, "time_h": 17.333, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)O)cc21.CN(C)CC[C@H](N)C(N)=O.O=C(O)/C=C\\C(=O)O", "products": "CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)N[C@@H](CCN(C)C)C(N)=O)cc21"}, "reference": {"title": "Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation for the Multikilogram Synthesis of Emprumapimod", "authors": "Brearley, Christopher; et al", "citation": "Organic Process Research & Development (2024), 28(4), 1253-1259.", "doi": "10.1021/acs.oprd.4c00052", "raw": "Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation for the Multikilogram Synthesis of Emprumapimod | Brearley, Christopher; et al | Organic Process Research & Development (2024), 28(4), 1253-1259. | 10.1021/acs.oprd.4c00052"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-39824402", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Tetrahydrofuran; 20 min, 20 °C; 1 h, 20 °C", "1.2|Reagents: Triethylamine", "Solvents: Isopropanol, Tetrahydrofuran; 16 h, 20 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection", "By: Sun, Li-Qiang; et al", "Journal of Medicinal Chemistry (2020), 63(23), 14740-14760.", "10.1021/acs.jmedchem.0c01296"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1+Triethylamine|121-44-8/Isopropanol|67-63-0+Tetrahydrofuran|109-99-9", "cond_sig": "c54d6a92", "fam_sig": "619f0524"}, "raw_data": {"raw_cas": "RCT: 853269-58-6 + 1606150-64-4 | PRO: 3037829-13-0 | RGT: 530-62-1 + 121-44-8 | SOL: 109-99-9 + 67-63-0", "raw_data_json": "{\"txt\": {\"title\": \"Development and Scale-Up of a Key Copper-Catalyzed Biaryl Ether Formation for the Multikilogram Synthesis of Emprumapimod\", \"authors\": \"Brearley, Christopher; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(4), 1253-1259.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Isopropanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39824402\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Tetrahydrofuran; 20 min, 20 °C; 1 h, 20 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Isopropanol, Tetrahydrofuran; 16 h, 20 °C\", \"382. Scheme 382 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection\", \"By: Sun, Li-Qiang; et al\", \"Journal of Medicinal Chemistry (2020), 63(23), 14740-14760.\", \"10.1021/acs.jmedchem.0c01296\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"853269-58-6\", \"1606150-64-4\"], \"pro_cas\": [\"3037829-13-0\"], \"rgt_cas\": [\"530-62-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"67-63-0\"], \"notes\": [\"alternative preparation shown\"]}}", "enriched_names": {"reactants": ["853269-58-6", "1606150-64-4"], "products": ["3037829-13-0"], "reagents": ["N,N'-Carbonyldiimidazole", "Triethylamine"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Isopropanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.164670", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39864674", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 20.0, "time_h": 15.0, "yield_pct": 91.0}, "smiles": {"reactants": "N[C@H]1[C@@H](C(=O)OCc2ccccc2)[C@@H]2C=C[C@H]1C2.CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)O)c(OC)cc2F)CC1", "products": "CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)N[C@H]3[C@@H](C(=O)OCc4ccccc4)[C@@H]4C=C[C@H]3C4)c(OC)cc2F)CC1"}, "reference": {"title": "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.", "doi": "10.1021/acs.jmedchem.3c02183", "raw": "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4442-4462. | 10.1021/acs.jmedchem.3c02183"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-39864674", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 h, 20 °C", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2892557-04-7 + 104-94-9 | PRO: 2892557-12-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39864674\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 h, 20 °C\", \"373. Scheme 373 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-04-7\", \"104-94-9\"], \"pro_cas\": [\"2892557-12-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-04-7", "104-94-9"], "products": ["2892557-12-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.166667", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39864678", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 20.0, "time_h": 3.0, "yield_pct": 86.0}, "smiles": {"reactants": "COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)O.N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1cccc(S(=O)(=O)C(F)(F)F)c1", "products": "COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1cccc(S(=O)(=O)C(F)(F)F)c1"}, "reference": {"title": "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.", "doi": "10.1021/acs.jmedchem.3c02183", "raw": "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4442-4462. | 10.1021/acs.jmedchem.3c02183"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-39864678", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, 20 °C", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Double bond geometry shown", "The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria", "By: de Lera Ruiz, Manuel; et al", "ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.", "10.1021/acsmedchemlett.2c00355"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 235423-04-8 + 2853450-31-2 | PRO: 2853450-40-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39864678\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, 20 °C\", \"445. Scheme 445 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria\", \"By: de Lera Ruiz, Manuel; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(11), 1745-1754.\", \"10.1021/acsmedchemlett.2c00355\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"235423-04-8\", \"2853450-31-2\"], \"pro_cas\": [\"2853450-40-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["235423-04-8", "2853450-31-2"], "products": ["2853450-40-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.166667", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39864712", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 30.0, "time_h": 14.017, "yield_pct": 84.0}, "smiles": {"reactants": "COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)O.Cl.N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1ccc(F)c(S(F)(F)(F)(F)F)c1", "products": "COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)Nc1ccc(F)c(S(F)(F)(F)(F)F)c1"}, "reference": {"title": "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.", "doi": "10.1021/acs.jmedchem.3c02183", "raw": "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4442-4462. | 10.1021/acs.jmedchem.3c02183"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-39864712", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 min, 20 °C; 14 h, 30 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2", "By: Roussel, Emile; et al", "European Journal of Medicinal Chemistry (2020), 202, 112503.", "10.1016/j.ejmech.2020.112503"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1353747-19-9 + 7524-52-9 | PRO: 2454588-23-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39864712\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 min, 20 °C; 14 h, 30 °C\", \"432. Scheme 432 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2\", \"By: Roussel, Emile; et al\", \"European Journal of Medicinal Chemistry (2020), 202, 112503.\", \"10.1016/j.ejmech.2020.112503\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1353747-19-9\", \"7524-52-9\"], \"pro_cas\": [\"2454588-23-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1353747-19-9", "7524-52-9"], "products": ["2454588-23-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.166667", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39875252", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 87.0}, "smiles": {"reactants": "COC(=O)[C@H]1CC[C@H](N)CC1.Cc1ccc2cc1OC/C=C\\C/N=C1/N=CC(C(=O)O)=C(N1)N2", "products": "COC(=O)[C@H]1CC[C@H](NC(=O)C2=C3N/C(=N\\C/C=C\\COc4cc(ccc4C)N3)N=C2)CC1"}, "reference": {"title": "Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors", "authors": "Kong, Deyu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(7), 5866-5882.", "doi": "10.1021/acs.jmedchem.4c00148", "raw": "Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors | Kong, Deyu; et al | Journal of Medicinal Chemistry (2024), 67(7), 5866-5882. | 10.1021/acs.jmedchem.4c00148"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-39875252", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 16 h, 25 °C", "1.2|Reagents: Water; 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "By: Novotna, Katerina; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "10.1021/acs.jmedchem.3c01681"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "61e525d9", "fam_sig": "4ae4ae30"}, "raw_data": {"raw_cas": "RCT: 86123-10-6 + 2851863-10-8 | PRO: 3032404-37-5 | RGT: 7087-68-5 + 125700-67-6 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors\", \"authors\": \"Kong, Deyu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(7), 5866-5882.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39875252\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 16 h, 25 °C\", \"1.2\", \"Reagents: Water; 25 °C\", \"231. Scheme 231 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"By: Novotna, Katerina; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"10.1021/acs.jmedchem.3c01681\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"86123-10-6\", \"2851863-10-8\"], \"pro_cas\": [\"3032404-37-5\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["86123-10-6", "2851863-10-8"], "products": ["3032404-37-5"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.166667", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39877262", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 83.0}, "smiles": {"reactants": "Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(S(=O)(=O)O)c12.[Na].CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@H](C)CCCn1cc(CCCCC(=O)O)nn1", "products": "CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@@H](C)CCCn1cc(CCCCC(=O)Nc2cc(S(=O)(=O)O)cc3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)nn1.[Na]"}, "reference": {"title": "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites", "authors": "Belouin, Audrey; et al", "citation": "Bioorganic & Medicinal Chemistry (2024), 98, 117553.", "doi": "10.1016/j.bmc.2023.117553", "raw": "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites | Belouin, Audrey; et al | Bioorganic & Medicinal Chemistry (2024), 98, 117553. | 10.1016/j.bmc.2023.117553"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-39877262", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition", "By: Rajabi, Nima; et al", "ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892.", "10.1021/acsmedchemlett.9b00580"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1857308-63-4 + 2407529-05-7 | PRO: 2448494-11-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites\", \"authors\": \"Belouin, Audrey; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2024), 98, 117553.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39877262\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 24 h, rt\", \"479. Scheme 479 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition\", \"By: Rajabi, Nima; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(10), 1886-1892.\", \"10.1021/acsmedchemlett.9b00580\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1857308-63-4\", \"2407529-05-7\"], \"pro_cas\": [\"2448494-11-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1857308-63-4", "2407529-05-7"], "products": ["2448494-11-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.166667", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39877263", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 90.0}, "smiles": {"reactants": "Nc1ccc(OCCCS(=O)(=O)O)cc1.[Na].CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@@H](C)CCCn1cc(CCCCC(=O)O)nn1", "products": "CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@H](C)CCCn1cc(CCCCC(=O)Nc2ccc(OCCCS(=O)(=O)O)cc2)nn1.[Na]"}, "reference": {"title": "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites", "authors": "Belouin, Audrey; et al", "citation": "Bioorganic & Medicinal Chemistry (2024), 98, 117553.", "doi": "10.1016/j.bmc.2023.117553", "raw": "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites | Belouin, Audrey; et al | Bioorganic & Medicinal Chemistry (2024), 98, 117553. | 10.1016/j.bmc.2023.117553"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-39877263", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 24 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites", "By: Belouin, Audrey; et al", "Bioorganic & Medicinal Chemistry (2024), 98, 117553.", "10.1016/j.bmc.2023.117553"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 58480-39-0 + 3036050-17-3 | PRO: 3036050-24-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites\", \"authors\": \"Belouin, Audrey; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2024), 98, 117553.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39877263\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 24 h, rt\", \"468. Scheme 468 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites\", \"By: Belouin, Audrey; et al\", \"Bioorganic & Medicinal Chemistry (2024), 98, 117553.\", \"10.1016/j.bmc.2023.117553\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"58480-39-0\", \"3036050-17-3\"], \"pro_cas\": [\"3036050-24-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["58480-39-0", "3036050-17-3"], "products": ["3036050-24-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.166667", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39877281", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 84.0}, "smiles": {"reactants": "Nc1ccc(OCCCS(=O)(=O)O)cc1.[Na].CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@H](C)CCCn1cc(CCCCC(=O)O)nn1", "products": "CC(C)OC(=O)[C@H](O[C@@H]1O[C@H](COCc2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](O[C@H](Cc2ccccc2)C(=O)OCc2ccccc2)[C@H]1OC(=O)c1ccccc1)[C@@H](O[C@@H]1O[C@@H](C)[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1)C(=O)O[C@@H](C)CCCn1cc(CCCCC(=O)Nc2ccc(OCCCS(=O)(=O)O)cc2)nn1.[Na]"}, "reference": {"title": "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites", "authors": "Belouin, Audrey; et al", "citation": "Bioorganic & Medicinal Chemistry (2024), 98, 117553.", "doi": "10.1016/j.bmc.2023.117553", "raw": "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites | Belouin, Audrey; et al | Bioorganic & Medicinal Chemistry (2024), 98, 117553. | 10.1016/j.bmc.2023.117553"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-39877281", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Early Development, Scale-Up, and Reverse-Phase Purification of a Highly Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug Conjugates", "By: Holte, Dane; et al", "Organic Process Research & Development (2021), 25(4), 799-809.", "10.1021/acs.oprd.0c00497"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 55750-53-3 + 2467802-98-6 | PRO: 2467803-01-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites\", \"authors\": \"Belouin, Audrey; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2024), 98, 117553.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39877281\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 24 h, rt\", \"469. Scheme 469 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Early Development, Scale-Up, and Reverse-Phase Purification of a Highly Potent Pyrrolobenzodiazepine Dimer, SG3259, for Use in Antibody-Drug Conjugates\", \"By: Holte, Dane; et al\", \"Organic Process Research & Development (2021), 25(4), 799-809.\", \"10.1021/acs.oprd.0c00497\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55750-53-3\", \"2467802-98-6\"], \"pro_cas\": [\"2467803-01-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["55750-53-3", "2467802-98-6"], "products": ["2467803-01-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.166667", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39884154", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 6.5, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)O)C1.NCc1cccs1", "products": "CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)NCc2cccs2)C1"}, "reference": {"title": "Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity", "authors": "Gao, Shenghua; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(19), 13343-13364.", "doi": "10.1021/acs.jmedchem.2c01146", "raw": "Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity | Gao, Shenghua; et al | Journal of Medicinal Chemistry (2022), 65(19), 13343-13364. | 10.1021/acs.jmedchem.2c01146"}, "original_text": ["Steps: 1, Yield: 89-91%", "CAS Reaction Number: 31-614-CAS-39884154", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|Reagents: Diisopropylethylamine; 6 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "By: Zhou, Huiyu; et al", "European Journal of Medicinal Chemistry (2023), 255, 115389.", "10.1016/j.ejmech.2023.115389"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 159005-71-7 + 204688-61-9 | PRO: 2925287-32-5 | RGT: 148893-10-1 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity\", \"authors\": \"Gao, Shenghua; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(19), 13343-13364.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39884154\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 6 h, rt\", \"195. Scheme 195 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"By: Zhou, Huiyu; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"10.1016/j.ejmech.2023.115389\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"159005-71-7\", \"204688-61-9\"], \"pro_cas\": [\"2925287-32-5\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["159005-71-7", "204688-61-9"], "products": ["2925287-32-5"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39885681", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "NC1C2CC3CC(C2)CC1C3.O=C(O)c1cc(Br)c[nH]1", "products": "O=C(NC1C2CC3CC(C2)CC1C3)c1cc(Br)c[nH]1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis", "authors": "Zhao, Hongyi; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.", "doi": "10.1021/acs.jmedchem.2c00718", "raw": "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis | Zhao, Hongyi; et al | Journal of Medicinal Chemistry (2022), 65(15), 10534-10553. | 10.1021/acs.jmedchem.2c00718"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-39885681", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; overnight, rt", "1.2|Solvents: Water; cooled", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release", "By: Meiers, Joscha; et al", "Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.", "10.1021/acs.jmedchem.2c01214"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "c485356d", "fam_sig": "9c52a3c5"}, "raw_data": {"raw_cas": "RCT: 5557-83-5 + 13139-15-6 | PRO: 66415-01-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis\", \"authors\": \"Zhao, Hongyi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39885681\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; overnight, rt\", \"1.2\", \"Solvents: Water; cooled\", \"269. Scheme 269 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release\", \"By: Meiers, Joscha; et al\", \"Journal of Medicinal Chemistry (2022), 65(20), 13988-14014.\", \"10.1021/acs.jmedchem.2c01214\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5557-83-5\", \"13139-15-6\"], \"pro_cas\": [\"66415-01-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["5557-83-5", "13139-15-6"], "products": ["66415-01-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39885789", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 32.0, "yield_pct": 90.0}, "smiles": {"reactants": "NC12CC3CC(CC(C3)C1)C2.O=C(O)c1cc(Br)c[nH]1.CC(C)(C)OC(=O)OC(=O)OC(C)(C)C", "products": "CC(C)(C)OC(=O)n1cc(Br)cc1C(=O)NC12CC3CC(CC(C3)C1)C2"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis", "authors": "Zhao, Hongyi; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.", "doi": "10.1021/acs.jmedchem.2c00718", "raw": "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis | Zhao, Hongyi; et al | Journal of Medicinal Chemistry (2022), 65(15), 10534-10553. | 10.1021/acs.jmedchem.2c00718"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-39885789", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; overnight, rt", "1.2|Solvents: Water; rt", "1.3|Reagents: Triethylamine", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; overnight, rt", "Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction", "By: Hec-Galazka, Aleksandra; et al", "ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.", "10.1021/acsmedchemlett.4c00042"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Triethylamine|121-44-8/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "73688c47", "fam_sig": "28199251"}, "raw_data": {"raw_cas": "RCT: 17874-79-2 + 2630973-82-7 | PRO: 2921717-68-0 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 + 121-44-8 | CAT: 1122-58-3 | SOL: 68-12-2 + 7732-18-5 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis\", \"authors\": \"Zhao, Hongyi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Triethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\", \"Water\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39885789\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; overnight, rt\", \"1.2\", \"Solvents: Water; rt\", \"1.3\", \"Reagents: Triethylamine\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; overnight, rt\", \"72. Scheme 72 (1 Reaction)\", \"Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction\", \"By: Hec-Galazka, Aleksandra; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.\", \"10.1021/acsmedchemlett.4c00042\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"17874-79-2\", \"2630973-82-7\"], \"pro_cas\": [\"2921717-68-0\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\", \"121-44-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\", \"7732-18-5\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["17874-79-2", "2630973-82-7"], "products": ["2921717-68-0"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Triethylamine"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide", "Water", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39885797", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 32.0, "yield_pct": 86.0}, "smiles": {"reactants": "NC1CCCCCCC1.O=C(O)c1cc(Br)c[nH]1.CC(C)(C)OC(=O)OC(=O)OC(C)(C)C", "products": "CC(C)(C)OC(=O)n1cc(Br)cc1C(=O)NC1CCCCCCC1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis", "authors": "Zhao, Hongyi; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.", "doi": "10.1021/acs.jmedchem.2c00718", "raw": "Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis | Zhao, Hongyi; et al | Journal of Medicinal Chemistry (2022), 65(15), 10534-10553. | 10.1021/acs.jmedchem.2c00718"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-39885797", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; overnight, rt", "1.2|Solvents: Water; rt", "1.3|Reagents: Triethylamine", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; overnight, rt", "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "By: Zareba, Paula; et al", "European Journal of Medicinal Chemistry (2021), 221, 113512.", "10.1016/j.ejmech.2021.113512"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Triethylamine|121-44-8/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "73688c47", "fam_sig": "28199251"}, "raw_data": {"raw_cas": "RCT: 64-19-7 + 2648234-34-6 | PRO: 2648234-39-1 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 + 121-44-8 | CAT: 1122-58-3 | SOL: 68-12-2 + 7732-18-5 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis\", \"authors\": \"Zhao, Hongyi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(15), 10534-10553.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Triethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\", \"Water\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39885797\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; overnight, rt\", \"1.2\", \"Solvents: Water; rt\", \"1.3\", \"Reagents: Triethylamine\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; overnight, rt\", \"429. Scheme 429 (1 Reaction)\", \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"By: Zareba, Paula; et al\", \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"10.1016/j.ejmech.2021.113512\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-19-7\", \"2648234-34-6\"], \"pro_cas\": [\"2648234-39-1\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\", \"121-44-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\", \"7732-18-5\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["Acetic Acid", "2648234-34-6"], "products": ["2648234-39-1"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Triethylamine"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide", "Water", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39925568", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)OC(C)(C)C)C(N)=O.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C)C(N)=O"}, "reference": {"title": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "authors": "Gotz, Marion G.; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "doi": "10.1021/acsmedchemlett.4c00017", "raw": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome | Gotz, Marion G.; et al | ACS Medicinal Chemistry Letters (2024), 15(4), 533-539. | 10.1021/acsmedchemlett.4c00017"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-39925568", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of potent small molecule PROTACs targeting mutant EGFR", "By: Zhao, Hong-Yi; et al", "European Journal of Medicinal Chemistry (2020), 208, 112781.", "10.1016/j.ejmech.2020.112781"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "b4b329bc", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 17696-11-6 + 1448297-52-6 | PRO: 2408342-03-8 | RGT: 76-05-1 + 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"authors\": \"Gotz, Marion G.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"reagents\": [\"Trifluoroacetic acid\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39925568\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt\", \"255. Scheme 255 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of potent small molecule PROTACs targeting mutant EGFR\", \"By: Zhao, Hong-Yi; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112781.\", \"10.1016/j.ejmech.2020.112781\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"17696-11-6\", \"1448297-52-6\"], \"pro_cas\": [\"2408342-03-8\"], \"rgt_cas\": [\"76-05-1\", \"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["17696-11-6", "1448297-52-6"], "products": ["2408342-03-8"], "reagents": ["Trifluoroacetic acid", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39925573", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 14.0, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)C[C@H](NC(=O)OC(C)(C)C)C(N)=O.CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O", "products": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)OC(C)(C)C)C(N)=O"}, "reference": {"title": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "authors": "Gotz, Marion G.; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "doi": "10.1021/acsmedchemlett.4c00017", "raw": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome | Gotz, Marion G.; et al | ACS Medicinal Chemistry Letters (2024), 15(4), 533-539. | 10.1021/acsmedchemlett.4c00017"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-39925573", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant", "By: Zhou, Huiyu; et al", "European Journal of Medicinal Chemistry (2023), 255, 115389.", "10.1016/j.ejmech.2023.115389"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "b4b329bc", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 157567-13-0 + 204688-60-8 | PRO: 2925287-31-4 | RGT: 76-05-1 + 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"authors\": \"Gotz, Marion G.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"reagents\": [\"Trifluoroacetic acid\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39925573\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt\", \"175. Scheme 175 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant\", \"By: Zhou, Huiyu; et al\", \"European Journal of Medicinal Chemistry (2023), 255, 115389.\", \"10.1016/j.ejmech.2023.115389\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"157567-13-0\", \"204688-60-8\"], \"pro_cas\": [\"2925287-31-4\"], \"rgt_cas\": [\"76-05-1\", \"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["157567-13-0", "204688-60-8"], "products": ["2925287-31-4"], "reagents": ["Trifluoroacetic acid", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39925583", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])c(F)c1)C(=O)O.CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H](N)CC(C)C)C(N)=O.O=C(O)C(F)(F)F", "products": "CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])c(F)c1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)N[C@@H](CC(C)C)C(N)=O"}, "reference": {"title": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "authors": "Gotz, Marion G.; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "doi": "10.1021/acsmedchemlett.4c00017", "raw": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome | Gotz, Marion G.; et al | ACS Medicinal Chemistry Letters (2024), 15(4), 533-539. | 10.1021/acsmedchemlett.4c00017"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-39925583", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt", "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "By: Chen, Bei; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "10.1021/acs.jmedchem.3c01326"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 1307702-36-8 + 2088194-00-5 | PRO: 3002420-84-7 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"authors\": \"Gotz, Marion G.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39925583\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 12 h, pH 8 - 9, rt\", \"362. Scheme 362 (1 Reaction)\", \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"By: Chen, Bei; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"10.1021/acs.jmedchem.3c01326\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1307702-36-8\", \"2088194-00-5\"], \"pro_cas\": [\"3002420-84-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1307702-36-8", "2088194-00-5"], "products": ["3002420-84-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39925599", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)Cc1ccc(O)cc1.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C"}, "reference": {"title": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "authors": "Gotz, Marion G.; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "doi": "10.1021/acsmedchemlett.4c00017", "raw": "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome | Gotz, Marion G.; et al | ACS Medicinal Chemistry Letters (2024), 15(4), 533-539. | 10.1021/acsmedchemlett.4c00017"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-39925599", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; overnight, pH 8 - 9, rt", "Selective targeting of the αC and DFG-out pocket in p38 MAPK", "By: Roehm, Sandra; et al", "European Journal of Medicinal Chemistry (2020), 208, 112721.", "10.1016/j.ejmech.2020.112721"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 51649-80-0 + 6232-11-7 | PRO: 2410792-53-7 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"authors\": \"Gotz, Marion G.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39925599\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; overnight, pH 8 - 9, rt\", \"313. Scheme 313 (1 Reaction)\", \"Selective targeting of the αC and DFG-out pocket in p38 MAPK\", \"By: Roehm, Sandra; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112721.\", \"10.1016/j.ejmech.2020.112721\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"51649-80-0\", \"6232-11-7\"], \"pro_cas\": [\"2410792-53-7\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["51649-80-0", "6232-11-7"], "products": ["2410792-53-7"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39930090", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.5, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)OCCO2.Cc1ccc(N)cc1[N+](=O)[O-]", "products": "Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1[N+](=O)[O-]"}, "reference": {"title": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "authors": "Pasqua, A. Elisa; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "doi": "10.1021/acs.jmedchem.3c00156", "raw": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies | Pasqua, A. Elisa; et al | Journal of Medicinal Chemistry (2023), 66(8), 5907-5936. | 10.1021/acs.jmedchem.3c00156"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-39930090", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; rt; 3.5 h, rt", "1.2|Reagents: Pyridine", "Solvents: Dichloromethane; rt; 2 h, rt", "Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity", "By: Karki, Anupam; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.", "10.1016/j.bmcl.2020.127053"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "d80a1ca6", "fam_sig": "852bc406"}, "raw_data": {"raw_cas": "RCT: 66949-40-4 + 22231-61-4 | PRO: 2412564-68-0 | RGT: 79-37-8 + 110-86-1 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"authors\": \"Pasqua, A. Elisa; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"reagents\": [\"Oxalyl chloride\", \"Pyridine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39930090\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; rt; 3.5 h, rt\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Dichloromethane; rt; 2 h, rt\", \"455. Scheme 455 (1 Reaction)\", \"Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity\", \"By: Karki, Anupam; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.\", \"10.1016/j.bmcl.2020.127053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"66949-40-4\", \"22231-61-4\"], \"pro_cas\": [\"2412564-68-0\"], \"rgt_cas\": [\"79-37-8\", \"110-86-1\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["66949-40-4", "22231-61-4"], "products": ["2412564-68-0"], "reagents": ["79-37-8", "Pyridine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39945512", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Toluene", "cas": "108-88-3"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 65.0, "time_h": 21.0, "yield_pct": 94.0}, "smiles": {"reactants": "O=C(O)c1c(Cl)ccnc1Cl.C[C@@H](N)CO", "products": "C[C@H](CCl)NC(=O)c1c(Cl)ccnc1Cl"}, "reference": {"title": "Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate", "authors": "Critcher, Douglas J.; et al", "citation": "Organic Process Research & Development (2024), 28(7), 2646-2658.", "doi": "10.1021/acs.oprd.4c00049", "raw": "Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate | Critcher, Douglas J.; et al | Organic Process Research & Development (2024), 28(7), 2646-2658. | 10.1021/acs.oprd.4c00049"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-39945512", "1.1|Catalysts: Dimethylformamide", "Solvents: Toluene; rt → 65 °C", "1.2|Reagents: Thionyl chloride; 2 h, 65 °C; 16 h, 65 °C; 65 °C → 25 °C", "1.3|Reagents: Triethylamine", "Solvents: Dichloromethane; < 35 °C; 0.5 h, 20 °C", "1.4|Reagents: Thionyl chloride", "Solvents: Dichloromethane; 1.5 h, 15 °C; 1 h, 35 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model", "By: Maddeboina, Krishnaiah; et al", "Journal of Medicinal Chemistry (2023), 66(14), 9894-9915.", "10.1021/acs.jmedchem.3c00732"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Dichloromethane|75-09-2+Toluene|108-88-3", "cond_sig": "83a99bf3", "fam_sig": "705ceb81"}, "raw_data": {"raw_cas": "RCT: 188815-32-9 + 3082-64-2 | PRO: 3028287-93-3 | RGT: 7719-09-7 + 121-44-8 | CAT: 68-12-2 | SOL: 108-88-3 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate\", \"authors\": \"Critcher, Douglas J.; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(7), 2646-2658.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Toluene\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39945512\", \"1.1\", \"Catalysts: Dimethylformamide\", \"Solvents: Toluene; rt → 65 °C\", \"1.2\", \"Reagents: Thionyl chloride; 2 h, 65 °C; 16 h, 65 °C; 65 °C → 25 °C\", \"1.3\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; < 35 °C; 0.5 h, 20 °C\", \"1.4\", \"Reagents: Thionyl chloride\", \"Solvents: Dichloromethane; 1.5 h, 15 °C; 1 h, 35 °C\", \"70. Scheme 70 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model\", \"By: Maddeboina, Krishnaiah; et al\", \"Journal of Medicinal Chemistry (2023), 66(14), 9894-9915.\", \"10.1021/acs.jmedchem.3c00732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"188815-32-9\", \"3082-64-2\"], \"pro_cas\": [\"3028287-93-3\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"108-88-3\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["188815-32-9", "3082-64-2"], "products": ["3028287-93-3"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Toluene", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39945521", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "NaOH", "cas": "1310-73-2", "role": "BASE"}, {"name": "2-Hydroxypyridine N-oxide", "cas": "13161-30-3", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Acetonitrile", "cas": "75-05-8"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 20.0, "yield_pct": 82.0}, "smiles": {"reactants": "CC(C)n1cc(C(=O)O)c(=O)n(-c2ccc(F)cc2)c1=O.C[C@H](CO)Nc1n[nH]c2nccc(Oc3ccc(N)cc3F)c12.Cl", "products": "CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@H](C)CO)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O"}, "reference": {"title": "Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate", "authors": "Critcher, Douglas J.; et al", "citation": "Organic Process Research & Development (2024), 28(7), 2646-2658.", "doi": "10.1021/acs.oprd.4c00049", "raw": "Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate | Critcher, Douglas J.; et al | Organic Process Research & Development (2024), 28(7), 2646-2658. | 10.1021/acs.oprd.4c00049"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-39945521", "1.1|Reagents: Sodium hydroxide, 2-Hydroxypyridine N-oxide, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Acetonitrile, Water; 20 h, 25 °C", "Absolute stereochemistry shown", "Relative stereochemistry shown", "Absolute stereochemistry shown", "Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.", "10.1021/acs.jmedchem.3c02183"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+2-Hydroxypyridine N-oxide|13161-30-3+NaOH|1310-73-2+Sodium hydroxide|/Acetonitrile|75-05-8+Water|7732-18-5", "cond_sig": "f7018742", "fam_sig": "97ce6485"}, "raw_data": {"raw_cas": "RCT: 2787516-56-5 + 2787518-02-7 | PRO: 3083612-99-8 | RGT: 1310-73-2 + 13161-30-3 + 25952-53-8 | SOL: 75-05-8 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate\", \"authors\": \"Critcher, Douglas J.; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(7), 2646-2658.\", \"reagents\": [\"Sodium hydroxide\", \"2-Hydroxypyridine N-oxide\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Acetonitrile\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39945521\", \"1.1\", \"Reagents: Sodium hydroxide, 2-Hydroxypyridine N-oxide, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Acetonitrile, Water; 20 h, 25 °C\", \"431. Scheme 431 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Relative stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4442-4462.\", \"10.1021/acs.jmedchem.3c02183\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2787516-56-5\", \"2787518-02-7\"], \"pro_cas\": [\"3083612-99-8\"], \"rgt_cas\": [\"1310-73-2\", \"13161-30-3\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-05-8\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2787516-56-5", "2787518-02-7"], "products": ["3083612-99-8"], "reagents": ["NaOH", "13161-30-3", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Acetonitrile", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39975883", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 90.0}, "smiles": {"reactants": "Cl.NCc1cccc(B(O)O)c1.CC(C)(C)NC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "CC(C)(C)NC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)NCc1cccc(B(O)O)c1"}, "reference": {"title": "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit", "authors": "Zhan, Wenhu; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.", "doi": "10.1021/acs.jmedchem.2c00733", "raw": "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit | Zhan, Wenhu; et al | Journal of Medicinal Chemistry (2023), 66(2), 1172-1185. | 10.1021/acs.jmedchem.2c00733"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-39975883", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; overnight, rt", "Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy", "By: Abyar, Selda; et al", "Journal of Medicinal Chemistry (2024), 67(13), 11086-11102.", "10.1021/acs.jmedchem.4c00589"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 58933-52-1 + 462-08-8 | PRO: 1262991-47-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit\", \"authors\": \"Zhan, Wenhu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39975883\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; overnight, rt\", \"288. Scheme 288 (1 Reaction)\", \"Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy\", \"By: Abyar, Selda; et al\", \"Journal of Medicinal Chemistry (2024), 67(13), 11086-11102.\", \"10.1021/acs.jmedchem.4c00589\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"58933-52-1\", \"462-08-8\"], \"pro_cas\": [\"1262991-47-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["58933-52-1", "462-08-8"], "products": ["1262991-47-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39975902", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)(C)N.CC(C)(C)OC(=O)N[C@@H](CCC(=O)O)C(=O)OCc1ccccc1", "products": "CC(C)(C)NC(=O)CC[C@H](NC(=O)OC(C)(C)C)C(=O)OCc1ccccc1"}, "reference": {"title": "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit", "authors": "Zhan, Wenhu; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.", "doi": "10.1021/acs.jmedchem.2c00733", "raw": "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit | Zhan, Wenhu; et al | Journal of Medicinal Chemistry (2023), 66(2), 1172-1185. | 10.1021/acs.jmedchem.2c00733"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-39975902", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; 0 °C → rt; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit", "By: Zhan, Wenhu; et al", "Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.", "10.1021/acs.jmedchem.2c00733"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 352525-94-1 + 2095522-71-5 | PRO: 2892822-10-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit\", \"authors\": \"Zhan, Wenhu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39975902\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; 0 °C → rt; overnight, rt\", \"287. Scheme 287 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit\", \"By: Zhan, Wenhu; et al\", \"Journal of Medicinal Chemistry (2023), 66(2), 1172-1185.\", \"10.1021/acs.jmedchem.2c00733\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"352525-94-1\", \"2095522-71-5\"], \"pro_cas\": [\"2892822-10-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["352525-94-1", "2095522-71-5"], "products": ["2892822-10-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-39977098", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 13.0, "yield_pct": 86.0}, "smiles": {"reactants": "COC(=O)CCCCCCC(=O)O.C#CCN(C)CCCOc1ccc(N)cc1Cl", "products": "C#CCN(C)CCCOc1ccc(NC(=O)CCCCCCC(=O)OC)cc1Cl"}, "reference": {"title": "N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment", "authors": "Mehndiratta, Samir; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(3), 2208-2224.", "doi": "10.1021/acs.jmedchem.1c01726", "raw": "N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment | Mehndiratta, Samir; et al | Journal of Medicinal Chemistry (2022), 65(3), 2208-2224. | 10.1021/acs.jmedchem.1c01726"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-39977098", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 12 h, rt", "1.2|Reagents: Water; rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "10.1021/acs.jmedchem.3c02184"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "556adacb", "fam_sig": "d670dab7"}, "raw_data": {"raw_cas": "RCT: 1245647-53-3 + 1335478-96-0 | PRO: 2787517-62-6 | RGT: 7087-68-5 + 94790-37-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment\", \"authors\": \"Mehndiratta, Samir; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(3), 2208-2224.\", \"reagents\": [\"Diisopropylethylamine\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-39977098\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 12 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"376. Scheme 376 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"10.1021/acs.jmedchem.3c02184\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1245647-53-3\", \"1335478-96-0\"], \"pro_cas\": [\"2787517-62-6\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1245647-53-3", "1335478-96-0"], "products": ["2787517-62-6"], "reagents": ["N,N-Diisopropylethylamine", "HBTU", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40064533", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 7.667, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)CCc1cccc(Br)c1.Nc1ccccc1", "products": "O=C(CCc1cccc(Br)c1)Nc1ccccc1"}, "reference": {"title": "Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer", "authors": "Zhang, Xing Xing; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(18), 12095-12123.", "doi": "10.1021/acs.jmedchem.2c00820", "raw": "Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer | Zhang, Xing Xing; et al | Journal of Medicinal Chemistry (2022), 65(18), 12095-12123. | 10.1021/acs.jmedchem.2c00820"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-40064533", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 40 min, 25 °C", "1.2|Catalysts: 4-(Dimethylamino)pyridine; 7 h, 25 °C", "Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer", "By: Li, Xing; et al", "Journal of Medicinal Chemistry (2022), 65(24), 16622-16639.", "10.1021/acs.jmedchem.2c01444"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 5162-82-3 + 141-43-5 | PRO: 431925-37-0 | RGT: 7087-68-5 + 148893-10-1 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer\", \"authors\": \"Zhang, Xing Xing; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(18), 12095-12123.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40064533\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 40 min, 25 °C\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine; 7 h, 25 °C\", \"35. Scheme 35 (1 Reaction)\", \"Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer\", \"By: Li, Xing; et al\", \"Journal of Medicinal Chemistry (2022), 65(24), 16622-16639.\", \"10.1021/acs.jmedchem.2c01444\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5162-82-3\", \"141-43-5\"], \"pro_cas\": [\"431925-37-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5162-82-3", "141-43-5"], "products": ["431925-37-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40087715", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 15.0, "yield_pct": 91.0}, "smiles": {"reactants": "Nc1ccccc1C(=O)O.CN", "products": "CNC(=O)c1ccccc1N"}, "reference": {"title": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "authors": "Bayrak, Alp; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "doi": "10.1021/acs.jmedchem.2c01198", "raw": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation | Bayrak, Alp; et al | Journal of Medicinal Chemistry (2022), 65(19), 13365-13384. | 10.1021/acs.jmedchem.2c01198"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-40087715", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 3 h, rt", "1.2|Solvents: Water; rt; 12 h, rt", "1.3|Reagents: Ammonium chloride", "Solvents: Water; rt", "Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates", "By: Ota, Yosuke; et al", "ACS Medicinal Chemistry Letters (2022), 13(10), 1568-1573.", "10.1021/acsmedchemlett.2c00126"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Ammonium chloride|12125-02-9/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "9c89935b", "fam_sig": "fa60d3d7"}, "raw_data": {"raw_cas": "RCT: 585-76-2 + 74-89-5 | PRO: 49834-22-2 | RGT: 2592-95-2 + 25952-53-8 + 12125-02-9 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"authors\": \"Bayrak, Alp; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40087715\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 3 h, rt\", \"1.2\", \"Solvents: Water; rt; 12 h, rt\", \"1.3\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"3. Scheme 3 (1 Reaction)\", \"Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates\", \"By: Ota, Yosuke; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(10), 1568-1573.\", \"10.1021/acsmedchemlett.2c00126\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"585-76-2\", \"74-89-5\"], \"pro_cas\": [\"49834-22-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["585-76-2", "74-89-5"], "products": ["49834-22-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "12125-02-9"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40093181", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 80.0, "time_h": 3.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)c1cc(Cl)ccc1N.O=C(O)CSCc1cc(C(F)(F)F)cc(C(F)(F)F)c1", "products": "CC(C)(C)OC(=O)c1ccccc1NC(=O)CSCc1cc(C(F)(F)F)cc(C(F)(F)F)c1"}, "reference": {"title": "Identification of ss-Glucocerebrosidase Activators for Glucosylceramide hydrolysis", "authors": "Schulze, Monika-Sarah E. D.; et al", "citation": "ChemMedChem (2024), 19(7), e202300548.", "doi": "10.1002/cmdc.202300548", "raw": "Identification of ss-Glucocerebrosidase Activators for Glucosylceramide hydrolysis | Schulze, Monika-Sarah E. D.; et al | ChemMedChem (2024), 19(7), e202300548. | 10.1002/cmdc.202300548"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40093181", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Dimethylformamide; rt; 3 h, 80 °C; 80 °C → rt", "1.2|Solvents: Water; 0 °C", "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "By: Vaidya, Sandeep; et al", "ChemMedChem (2023), 18(16), e202300097.", "10.1002/cmdc.202300097"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "b4cdd190", "fam_sig": "e8da6822"}, "raw_data": {"raw_cas": "RCT: 61-68-7 + 2128731-38-2 | PRO: 3055833-26-3 | RGT: 7087-68-5 + 68957-94-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Identification of ss-Glucocerebrosidase Activators for Glucosylceramide hydrolysis\", \"authors\": \"Schulze, Monika-Sarah E. D.; et al\", \"citation\": \"ChemMedChem (2024), 19(7), e202300548.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40093181\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Dimethylformamide; rt; 3 h, 80 °C; 80 °C → rt\", \"1.2\", \"Solvents: Water; 0 °C\", \"325. Scheme 325 (1 Reaction)\", \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"By: Vaidya, Sandeep; et al\", \"ChemMedChem (2023), 18(16), e202300097.\", \"10.1002/cmdc.202300097\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"61-68-7\", \"2128731-38-2\"], \"pro_cas\": [\"3055833-26-3\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["61-68-7", "2128731-38-2"], "products": ["3055833-26-3"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131683", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)Cc1ccc(O)cc1.CC(C)(C)OC(=O)CC[C@@H](N)C(=O)OC(C)(C)C.Cl", "products": "CC(C)(C)OC(=O)CC[C@H](NC(=O)Cc1ccc(O)cc1)C(=O)OC(C)(C)C"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity", "authors": "Ikeda, Zenichi; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.", "doi": "10.1021/acs.jmedchem.2c00463", "raw": "Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity | Ikeda, Zenichi; et al | Journal of Medicinal Chemistry (2022), 65(12), 8456-8477. | 10.1021/acs.jmedchem.2c00463"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-40131683", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; overnight, rt", "1.2|Solvents: Water; rt", "Nitrile-based peptoids as cysteine protease inhibitors", "By: Alves, Luana; et al", "Bioorganic & Medicinal Chemistry (2021), 41, 116211.", "10.1016/j.bmc.2021.116211"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "0dbc3eed", "fam_sig": "a1a30c15"}, "raw_data": {"raw_cas": "RCT: 540-61-4 + 2759356-75-5 | PRO: 2760280-59-7 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity\", \"authors\": \"Ikeda, Zenichi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131683\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; overnight, rt\", \"1.2\", \"Solvents: Water; rt\", \"244. Scheme 244 (1 Reaction)\", \"Nitrile-based peptoids as cysteine protease inhibitors\", \"By: Alves, Luana; et al\", \"Bioorganic & Medicinal Chemistry (2021), 41, 116211.\", \"10.1016/j.bmc.2021.116211\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"540-61-4\", \"2759356-75-5\"], \"pro_cas\": [\"2760280-59-7\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["540-61-4", "2759356-75-5"], "products": ["2760280-59-7"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131686", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)Cc1ccc(O)cc1.CC(C)(C)OC(=O)C[C@H](N)C(=O)OC(C)(C)C.Cl", "products": "CC(C)(C)OC(=O)C[C@H](NC(=O)Cc1ccc(O)cc1)C(=O)OC(C)(C)C"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity", "authors": "Ikeda, Zenichi; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.", "doi": "10.1021/acs.jmedchem.2c00463", "raw": "Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity | Ikeda, Zenichi; et al | Journal of Medicinal Chemistry (2022), 65(12), 8456-8477. | 10.1021/acs.jmedchem.2c00463"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-40131686", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; overnight, rt", "1.2|Reagents: Water; rt", "Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans", "By: Binjubair, Faizah A.; et al", "ChemMedChem (2020), 15(14), 1294-1309.", "10.1002/cmdc.202000250"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "604db6ad", "fam_sig": "9a5591be"}, "raw_data": {"raw_cas": "RCT: 552-63-6 + 2494197-42-9 | PRO: 2494197-33-8 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 + 7732-18-5 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity\", \"authors\": \"Ikeda, Zenichi; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(12), 8456-8477.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Water\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131686\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; overnight, rt\", \"1.2\", \"Reagents: Water; rt\", \"233. Scheme 233 (1 Reaction)\", \"Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans\", \"By: Binjubair, Faizah A.; et al\", \"ChemMedChem (2020), 15(14), 1294-1309.\", \"10.1002/cmdc.202000250\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"552-63-6\", \"2494197-42-9\"], \"pro_cas\": [\"2494197-33-8\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\", \"7732-18-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["552-63-6", "2494197-42-9"], "products": ["2494197-33-8"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Water"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131864", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 6.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCN", "products": "CC(C)(C)OC(=O)NCCNC(=O)/C=C/c1cccnc1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40131864", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease", "By: Yang, Bowen; et al", "Journal of Medicinal Chemistry (2022), 65(23), 15770-15788.", "10.1021/acs.jmedchem.2c01334"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 13535-01-8 | PRO: 2731006-60-1 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131864\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"102. Scheme 102 (1 Reaction)\", \"Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease\", \"By: Yang, Bowen; et al\", \"Journal of Medicinal Chemistry (2022), 65(23), 15770-15788.\", \"10.1021/acs.jmedchem.2c01334\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"13535-01-8\"], \"pro_cas\": [\"2731006-60-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "13535-01-8"], "products": ["2731006-60-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131881", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCCN", "products": "CC(C)(C)OC(=O)NCCCNC(=O)/C=C/c1cccnc1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-40131881", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 57260-73-8 | PRO: 2521770-65-8 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131881\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"101. Scheme 101 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"57260-73-8\"], \"pro_cas\": [\"2521770-65-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "57260-73-8"], "products": ["2521770-65-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131889", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCc1ccc(CN)cc1", "products": "CC(C)(C)OC(=O)NCc1ccc(CNC(=O)/C=C/c2cccnc2)cc1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40131889", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression", "By: Li, Junfang; et al", "Journal of Medicinal Chemistry (2022), 65(15), 10481-10505.", "10.1021/acs.jmedchem.2c00635"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 91-40-7 + 2393-23-9 | PRO: 1354149-98-6 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131889\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"157. Scheme 157 (1 Reaction)\", \"N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression\", \"By: Li, Junfang; et al\", \"Journal of Medicinal Chemistry (2022), 65(15), 10481-10505.\", \"10.1021/acs.jmedchem.2c00635\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"91-40-7\", \"2393-23-9\"], \"pro_cas\": [\"1354149-98-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["91-40-7", "2393-23-9"], "products": ["1354149-98-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131890", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCCCN", "products": "CC(C)(C)OC(=O)NCCCCNC(=O)/C=C/c1cccnc1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40131890", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4", "By: Londregan, Allyn T.; et al", "Journal of Medicinal Chemistry (2023), 66(1), 460-472.", "10.1021/acs.jmedchem.2c01421"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 557-66-4 + 1502267-08-4 | PRO: 3034366-02-1 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131890\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"108. Scheme 108 (1 Reaction)\", \"Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4\", \"By: Londregan, Allyn T.; et al\", \"Journal of Medicinal Chemistry (2023), 66(1), 460-472.\", \"10.1021/acs.jmedchem.2c01421\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"557-66-4\", \"1502267-08-4\"], \"pro_cas\": [\"3034366-02-1\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["557-66-4", "1502267-08-4"], "products": ["3034366-02-1"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131897", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)N1CCC(CN)CC1", "products": "CC(C)(C)OC(=O)N1CCC(CNC(=O)/C=C/c2cccnc2)CC1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-40131897", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies", "By: Rahman, Toufiqur Md; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.", "10.1021/acs.jmedchem.1c01075"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 7782-24-3 + 2821859-79-2 | PRO: 2821859-81-6 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131897\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"226. Scheme 226 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies\", \"By: Rahman, Toufiqur Md; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12397-12413.\", \"10.1021/acs.jmedchem.1c01075\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7782-24-3\", \"2821859-79-2\"], \"pro_cas\": [\"2821859-81-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["7782-24-3", "2821859-79-2"], "products": ["2821859-81-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131898", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)N1CCC(N)CC1", "products": "CC(C)(C)OC(=O)N1CCC(NC(=O)/C=C/c2cccnc2)CC1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-40131898", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury", "By: Pang, Haiying; et al", "European Journal of Medicinal Chemistry (2020), 197, 112314.", "10.1016/j.ejmech.2020.112314"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 59-67-6 + 5367-52-2 | PRO: 2485702-39-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131898\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"238. Scheme 238 (1 Reaction)\", \"Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury\", \"By: Pang, Haiying; et al\", \"European Journal of Medicinal Chemistry (2020), 197, 112314.\", \"10.1016/j.ejmech.2020.112314\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"59-67-6\", \"5367-52-2\"], \"pro_cas\": [\"2485702-39-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["59-67-6", "5367-52-2"], "products": ["2485702-39-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131901", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)NCCCCCCN", "products": "CC(C)(C)OC(=O)NCCCCCCNC(=O)/C=C/c1cccnc1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-40131901", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "By: Fuchs, Natalie; et al", "ChemMedChem (2023), 18(15), e202300160.", "10.1002/cmdc.202300160"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 65-85-0 + 3182-93-2 | PRO: 7200-18-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131901\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"112. Scheme 112 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"By: Fuchs, Natalie; et al\", \"ChemMedChem (2023), 18(15), e202300160.\", \"10.1002/cmdc.202300160\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"65-85-0\", \"3182-93-2\"], \"pro_cas\": [\"7200-18-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["65-85-0", "3182-93-2"], "products": ["7200-18-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131908", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CC(C)(C)OC(=O)N1CCC(CCN)CC1", "products": "CC(C)(C)OC(=O)N1CCC(CCNC(=O)/C=C/c2cccnc2)CC1"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-40131908", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease", "By: de Oliveira Rezende, Celso Junior; et al", "European Journal of Medicinal Chemistry (2023), 246, 114925.", "10.1016/j.ejmech.2022.114925"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 1878-66-6 + 4499-07-4 | PRO: 448233-07-6 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131908\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"192. Scheme 192 (1 Reaction)\", \"Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease\", \"By: de Oliveira Rezende, Celso Junior; et al\", \"European Journal of Medicinal Chemistry (2023), 246, 114925.\", \"10.1016/j.ejmech.2022.114925\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1878-66-6\", \"4499-07-4\"], \"pro_cas\": [\"448233-07-6\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1878-66-6", "4499-07-4"], "products": ["448233-07-6"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40131929", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 9.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)/C=C/c1cccnc1.CN(CCN)C(=O)OC(C)(C)C", "products": "CN(CCNC(=O)/C=C/c1cccnc1)C(=O)OC(C)(C)C"}, "reference": {"title": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "authors": "Zhang, Kuojun; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "doi": "10.1021/acs.jmedchem.2c00077", "raw": "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer | Zhang, Kuojun; et al | Journal of Medicinal Chemistry (2022), 65(11), 7746-7769. | 10.1021/acs.jmedchem.2c00077"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-40131929", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 3 - 5 h, rt", "Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease", "By: Li, Feng; et al", "Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.", "10.1021/acs.jmedchem.0c01544"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 385-02-4 + 100-46-9 | PRO: 120275-71-0 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"authors\": \"Zhang, Kuojun; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40131929\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 3 - 5 h, rt\", \"136. Scheme 136 (1 Reaction)\", \"Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease\", \"By: Li, Feng; et al\", \"Journal of Medicinal Chemistry (2020), 63(22), 13973-13993.\", \"10.1021/acs.jmedchem.0c01544\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"385-02-4\", \"100-46-9\"], \"pro_cas\": [\"120275-71-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["385-02-4", "100-46-9"], "products": ["120275-71-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40132270", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 23.0, "time_h": 2.0, "yield_pct": 88.0}, "smiles": {"reactants": "Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)O)c1nnc(C)n1-2.CC(C)(C)OC(=O)COCC#CC#CCN", "products": "Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC#CC#CCOCC(=O)OC(C)(C)C)c1nnc(C)n1-2"}, "reference": {"title": "Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties", "authors": "Dragovich, Peter S.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.", "doi": "10.1021/acs.jmedchem.0c01845", "raw": "Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties | Dragovich, Peter S.; et al | Journal of Medicinal Chemistry (2021), 64(5), 2534-2575. | 10.1021/acs.jmedchem.0c01845"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-40132270", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, 23 °C", "Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors", "By: Grimster, Neil P.; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 91, 129352.", "10.1016/j.bmcl.2023.129352"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 127828-22-2 + 3050715-36-8 | PRO: 3050715-37-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties\", \"authors\": \"Dragovich, Peter S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40132270\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, 23 °C\", \"401. Scheme 401 (1 Reaction)\", \"Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors\", \"By: Grimster, Neil P.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 91, 129352.\", \"10.1016/j.bmcl.2023.129352\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"127828-22-2\", \"3050715-36-8\"], \"pro_cas\": [\"3050715-37-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["127828-22-2", "3050715-36-8"], "products": ["3050715-37-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40132273", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 23.0, "time_h": 2.5, "yield_pct": 87.0}, "smiles": {"reactants": "Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCC#CC#CCOCC(=O)O)c1nnc(C)n1-2.Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)cc1", "products": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCC#CC#CCNC(=O)C[C@@H]2N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc32)C(C)(C)C)cc1"}, "reference": {"title": "Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties", "authors": "Dragovich, Peter S.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.", "doi": "10.1021/acs.jmedchem.0c01845", "raw": "Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties | Dragovich, Peter S.; et al | Journal of Medicinal Chemistry (2021), 64(5), 2534-2575. | 10.1021/acs.jmedchem.0c01845"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-40132273", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, 23 °C", "1.2|2 h, 23 °C", "Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C", "By: Kettle, Jason G.; et al", "Journal of Medicinal Chemistry (2020), 63(9), 4468-4483.", "10.1021/acs.jmedchem.9b01720"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2349395-32-8 | PRO: 2349395-37-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties\", \"authors\": \"Dragovich, Peter S.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(5), 2534-2575.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40132273\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, 23 °C\", \"1.2\", \"2 h, 23 °C\", \"477. Scheme 477 (1 Reaction)\", \"Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C\", \"By: Kettle, Jason G.; et al\", \"Journal of Medicinal Chemistry (2020), 63(9), 4468-4483.\", \"10.1021/acs.jmedchem.9b01720\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2349395-32-8\"], \"pro_cas\": [\"2349395-37-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2349395-32-8"], "products": ["2349395-37-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40132684", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 92.0}, "smiles": {"reactants": "CCOP(=O)(CC(=O)O)OCC.CN(C)/C=N/c1ccc(N)cc1C#N", "products": "CCOP(=O)(CC(=O)Nc1ccc(/N=C/N(C)C)c(C#N)c1)OCC"}, "reference": {"title": "Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment", "authors": "Li, Di; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(7), 5334-5354.", "doi": "10.1021/acs.jmedchem.1c00710", "raw": "Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment | Li, Di; et al | Journal of Medicinal Chemistry (2022), 65(7), 5334-5354. | 10.1021/acs.jmedchem.1c00710"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-40132684", "1.1|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 1 h, rt", "1.2|Solvents: Water; rt", "Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones", "By: Ryan, Michael C.; et al", "ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.", "10.1021/acsmedchemlett.1c00539"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "ec9661ab", "fam_sig": "f7b5dc36"}, "raw_data": {"raw_cas": "RCT: 371-40-4 + 616-79-5 | PRO: 1442088-54-1 | RGT: 7087-68-5 + 25952-53-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment\", \"authors\": \"Li, Di; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(7), 5334-5354.\", \"reagents\": [\"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40132684\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.2\", \"Solvents: Water; rt\", \"140. Scheme 140 (1 Reaction)\", \"Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones\", \"By: Ryan, Michael C.; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(4), 546-553.\", \"10.1021/acsmedchemlett.1c00539\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"371-40-4\", \"616-79-5\"], \"pro_cas\": [\"1442088-54-1\"], \"rgt_cas\": [\"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["371-40-4", "616-79-5"], "products": ["1442088-54-1"], "reagents": ["N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40188144", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Ethanol", "cas": "64-17-5"}, {"name": "Isopropanol", "cas": "67-63-0"}], "conditions": {"temperature_c": 100.0, "time_h": 16.0, "yield_pct": 80.0}, "smiles": {"reactants": "CC(=O)O.N=CN.Nc1c(F)c(Br)c(Cl)c(F)c1C(=O)O", "products": "O=c1nc[nH]c2c(F)c(Br)c(Cl)c(F)c12"}, "reference": {"title": "Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C", "authors": "Kettle, Jason G.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.", "doi": "10.1021/acs.jmedchem.2c00369", "raw": "Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C | Kettle, Jason G.; et al | Journal of Medicinal Chemistry (2022), 65(9), 6940-6952. | 10.1021/acs.jmedchem.2c00369"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40188144", "1.1|Solvents: Ethanol, Isopropanol; rt; overnight, 100 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate", "By: Bendelac, Audrey; et al", "Organic Process Research & Development (2022), 26(8), 2145-2154.", "10.1021/acs.oprd.2c00080"], "signatures": {"cond_key": "none/none/none/Ethanol|64-17-5+Isopropanol|67-63-0", "cond_sig": "f2b803a2", "fam_sig": "f2b803a2"}, "raw_data": {"raw_cas": "RCT: 2097444-45-4 + 2097444-35-2 | PRO: 2097445-21-9 | SOL: 64-17-5 + 67-63-0", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C\", \"authors\": \"Kettle, Jason G.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Ethanol\", \"Isopropanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40188144\", \"1.1\", \"Solvents: Ethanol, Isopropanol; rt; overnight, 100 °C\", \"371. Scheme 371 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Fit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate\", \"By: Bendelac, Audrey; et al\", \"Organic Process Research & Development (2022), 26(8), 2145-2154.\", \"10.1021/acs.oprd.2c00080\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2097444-45-4\", \"2097444-35-2\"], \"pro_cas\": [\"2097445-21-9\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"64-17-5\", \"67-63-0\"], \"notes\": []}}", "enriched_names": {"reactants": ["2097444-45-4", "2097444-35-2"], "products": ["2097445-21-9"], "reagents": [], "catalysts": [], "solvents": ["Ethanol", "Isopropanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40188152", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": null, "time_h": 16.0, "yield_pct": 90.0}, "smiles": {"reactants": "CC(=O)O.N=CN.Nc1c(F)c(Br)cc(F)c1C(=O)O", "products": "O=c1nc[nH]c2c(F)c(Br)cc(F)c12"}, "reference": {"title": "Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C", "authors": "Kettle, Jason G.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.", "doi": "10.1021/acs.jmedchem.2c00369", "raw": "Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C | Kettle, Jason G.; et al | Journal of Medicinal Chemistry (2022), 65(9), 6940-6952. | 10.1021/acs.jmedchem.2c00369"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-40188152", "1.1|Solvents: Ethanol; 16 h, reflux", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19", "By: Allais, Christophe; et al", "Organic Process Research & Development (2023), 27(12), 2223-2239.", "10.1021/acs.oprd.2c00375"], "signatures": {"cond_key": "none/none/none/Ethanol|64-17-5", "cond_sig": "9fc9dc04", "fam_sig": "9fc9dc04"}, "raw_data": {"raw_cas": "RCT: 2713439-23-5 + 2720867-05-8 | PRO: 2648754-93-0 | SOL: 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12C\", \"authors\": \"Kettle, Jason G.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(9), 6940-6952.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40188152\", \"1.1\", \"Solvents: Ethanol; 16 h, reflux\", \"331. Scheme 331 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19\", \"By: Allais, Christophe; et al\", \"Organic Process Research & Development (2023), 27(12), 2223-2239.\", \"10.1021/acs.oprd.2c00375\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2713439-23-5\", \"2720867-05-8\"], \"pro_cas\": [\"2648754-93-0\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2713439-23-5", "2720867-05-8"], "products": ["2648754-93-0"], "reagents": [], "catalysts": [], "solvents": ["Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40188463", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 75.0, "time_h": 8.0, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)CBr.Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O", "products": "O=C1CCC(N2C(=O)c3cccc(NC(=O)CBr)c3C2=O)C(=O)N1"}, "reference": {"title": "Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13", "authors": "Yang, Jianzhang; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(16), 11066-11083.", "doi": "10.1021/acs.jmedchem.2c00384", "raw": "Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13 | Yang, Jianzhang; et al | Journal of Medicinal Chemistry (2022), 65(16), 11066-11083. | 10.1021/acs.jmedchem.2c00384"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40188463", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C → rt; 3 h, rt", "1.2|Solvents: Tetrahydrofuran; 5 h, 75 °C", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9", "cond_sig": "d75aac85", "fam_sig": "e8060687"}, "raw_data": {"raw_cas": "RCT: 79-31-2 + 2632874-83-8 | PRO: 2892485-50-4 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 75-09-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13\", \"authors\": \"Yang, Jianzhang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(16), 11066-11083.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40188463\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C → rt; 3 h, rt\", \"1.2\", \"Solvents: Tetrahydrofuran; 5 h, 75 °C\", \"270. Scheme 270 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"79-31-2\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-50-4\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["79-31-2", "2632874-83-8"], "products": ["2892485-50-4"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40188682", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Propylphosphonic acid", "cas": "4672-38-2", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1cccc(Br)n1.CC(C)(C)OC(=O)NCCCCN", "products": "CC(C)(C)OC(=O)NCCCCNC(=O)c1cccc(Br)n1"}, "reference": {"title": "Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma", "authors": "Perry, Matthew W. D.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(12), 8053-8075.", "doi": "10.1021/acs.jmedchem.1c00434", "raw": "Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma | Perry, Matthew W. D.; et al | Journal of Medicinal Chemistry (2021), 64(12), 8053-8075. | 10.1021/acs.jmedchem.1c00434"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-40188682", "1.1|Reagents: Triethylamine, Propylphosphonic acid", "Solvents: Ethyl acetate; overnight, rt", "1.2|Reagents: Water; rt", "Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment", "By: Zhang, Wenqiang; et al", "Journal of Medicinal Chemistry (2024), 67(1), 322-348.", "10.1021/acs.jmedchem.3c01417"], "signatures": {"cond_key": "none/none/Propylphosphonic acid|4672-38-2+Triethylamine|121-44-8+Water|7732-18-5/Ethyl Acetate|141-78-6", "cond_sig": "5665dbe4", "fam_sig": "17f2b3e1"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 162046-66-4 | PRO: 1797985-94-4 | RGT: 121-44-8 + 4672-38-2 + 7732-18-5 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma\", \"authors\": \"Perry, Matthew W. D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(12), 8053-8075.\", \"reagents\": [\"Triethylamine\", \"Propylphosphonic acid\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40188682\", \"1.1\", \"Reagents: Triethylamine, Propylphosphonic acid\", \"Solvents: Ethyl acetate; overnight, rt\", \"1.2\", \"Reagents: Water; rt\", \"182. Scheme 182 (1 Reaction)\", \"Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment\", \"By: Zhang, Wenqiang; et al\", \"Journal of Medicinal Chemistry (2024), 67(1), 322-348.\", \"10.1021/acs.jmedchem.3c01417\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"162046-66-4\"], \"pro_cas\": [\"1797985-94-4\"], \"rgt_cas\": [\"121-44-8\", \"4672-38-2\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "162046-66-4"], "products": ["1797985-94-4"], "reagents": ["Triethylamine", "4672-38-2", "Water"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40189380", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trimethylolpropane", "cas": "77-99-6", "role": "BASE"}, {"name": "1-Hydroxy-7-azabenzotriazole", "cas": "39968-33-7", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Lithium hydroxide", "cas": "1310-65-2", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 37.0, "yield_pct": 89.0}, "smiles": {"reactants": "CCC(OC(=O)[C@H](C)[C@@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@H](C)[C@@H](O[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O)[C@](C)(O)C[C@@H](C)CN(C)C(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1)C(C)=O.CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O", "products": "CO[C@]1(C)C[C@H](O[C@@H]([C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)C(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@@H](N)C(C)C)[C@@H](C)C(=O)O)O[C@@H](C)[C@@H]1O"}, "reference": {"title": "Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction", "authors": "Kostrun, Sanja; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(12), 8354-8383.", "doi": "10.1021/acs.jmedchem.1c00327", "raw": "Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction | Kostrun, Sanja; et al | Journal of Medicinal Chemistry (2021), 64(12), 8354-8383. | 10.1021/acs.jmedchem.1c00327"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-40189380", "1.1|Reagents: Trimethylolpropane, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, rt", "1.2|20 h, rt", "1.3|Reagents: Lithium hydroxide", "Solvents: Tetrahydrofuran, Water; rt; overnight, rt", "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors", "By: Trinh, Phuc N. H.; et al", "Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.", "10.1021/acs.jmedchem.0c02169"], "signatures": {"cond_key": "none/none/1-Hydroxy-7-azabenzotriazole|39968-33-7+HATU|148893-10-1+Lithium hydroxide|1310-65-2+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Trimethylolpropane|77-99-6/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "b9171e4a", "fam_sig": "b91df17f"}, "raw_data": {"raw_cas": "RCT: 3032112-39-0 + 88192-20-5 | PRO: 2938292-10-3 | RGT: 77-99-6 + 39968-33-7 + 148893-10-1 + 1310-65-2 | SOL: 75-09-2 + 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction\", \"authors\": \"Kostrun, Sanja; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(12), 8354-8383.\", \"reagents\": [\"Trimethylolpropane\", \"HOAt\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Lithium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40189380\", \"1.1\", \"Reagents: Trimethylolpropane, HOAt, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.2\", \"20 h, rt\", \"1.3\", \"Reagents: Lithium hydroxide\", \"Solvents: Tetrahydrofuran, Water; rt; overnight, rt\", \"463. Scheme 463 (1 Reaction)\", \"Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors\", \"By: Trinh, Phuc N. H.; et al\", \"Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.\", \"10.1021/acs.jmedchem.0c02169\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3032112-39-0\", \"88192-20-5\"], \"pro_cas\": [\"2938292-10-3\"], \"rgt_cas\": [\"77-99-6\", \"39968-33-7\", \"148893-10-1\", \"1310-65-2\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3032112-39-0", "88192-20-5"], "products": ["2938292-10-3"], "reagents": ["77-99-6", "1-Hydroxy-7-azabenzotriazole", "HATU", "1310-65-2"], "catalysts": [], "solvents": ["Dichloromethane", "Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40275713", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.833, "yield_pct": 85.0}, "smiles": {"reactants": "CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)O)(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O.[N-]=[N+]=NCCCN", "products": "CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)NCCCN=[N+]=[N-])(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O"}, "reference": {"title": "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors", "authors": "Trinh, Phuc N. H.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.", "doi": "10.1021/acs.jmedchem.0c02169", "raw": "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors | Trinh, Phuc N. H.; et al | Journal of Medicinal Chemistry (2021), 64(12), 8161-8178. | 10.1021/acs.jmedchem.0c02169"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-40275713", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 5 min, rt", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt", "1.3|rt; 2.5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists", "By: Ding, Dong; et al", "European Journal of Medicinal Chemistry (2024), 278, 116792.", "10.1016/j.ejmech.2024.116792"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 3061506-83-7 + 3061506-85-9 | PRO: 3061506-84-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors\", \"authors\": \"Trinh, Phuc N. H.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40275713\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 5 min, rt\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt\", \"1.3\", \"rt; 2.5 h, rt\", \"459. Scheme 459 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists\", \"By: Ding, Dong; et al\", \"European Journal of Medicinal Chemistry (2024), 278, 116792.\", \"10.1016/j.ejmech.2024.116792\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3061506-83-7\", \"3061506-85-9\"], \"pro_cas\": [\"3061506-84-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3061506-83-7", "3061506-85-9"], "products": ["3061506-84-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40275716", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.833, "yield_pct": 98.0}, "smiles": {"reactants": "CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)O)(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O.[N-]=[N+]=NCCCCN", "products": "CCCCn1c(=O)c2[nH]c(C34CCC(C(=O)NCCCCN=[N+]=[N-])(CC3)CC4)nc2n(Cc2ccc(OC)cc2OC)c1=O"}, "reference": {"title": "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors", "authors": "Trinh, Phuc N. H.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.", "doi": "10.1021/acs.jmedchem.0c02169", "raw": "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors | Trinh, Phuc N. H.; et al | Journal of Medicinal Chemistry (2021), 64(12), 8161-8178. | 10.1021/acs.jmedchem.0c02169"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-40275716", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 5 min, rt", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt", "1.3|rt; 2.5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594", "By: Aydin, Gulsevim; et al", "Organic Process Research & Development (2024), 28(2), 559-576.", "10.1021/acs.oprd.3c00393"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 3028971-78-7 + 373-96-6 | PRO: 1196509-60-0 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors\", \"authors\": \"Trinh, Phuc N. H.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40275716\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 5 min, rt\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 15 min, rt\", \"1.3\", \"rt; 2.5 h, rt\", \"464. Scheme 464 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Metal catalyzed C-N bond forming reaction selection and process development for the manufacture of AZD7594\", \"By: Aydin, Gulsevim; et al\", \"Organic Process Research & Development (2024), 28(2), 559-576.\", \"10.1021/acs.oprd.3c00393\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3028971-78-7\", \"373-96-6\"], \"pro_cas\": [\"1196509-60-0\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3028971-78-7", "373-96-6"], "products": ["1196509-60-0"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40275737", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Acetic anhydride", "cas": "108-24-7"}], "conditions": {"temperature_c": 70.0, "time_h": 1.5, "yield_pct": 84.0}, "smiles": {"reactants": "N#CCC(=O)O.COc1ccc(CNC(N)=O)c(OC)c1", "products": "COc1ccc(CNC(=O)NC(=O)CC#N)c(OC)c1"}, "reference": {"title": "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors", "authors": "Trinh, Phuc N. H.; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.", "doi": "10.1021/acs.jmedchem.0c02169", "raw": "Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors | Trinh, Phuc N. H.; et al | Journal of Medicinal Chemistry (2021), 64(12), 8161-8178. | 10.1021/acs.jmedchem.0c02169"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-40275737", "1.1|Solvents: Acetic anhydride; rt → 70 °C; 1.5 h, 70 °C", "Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT)", "By: Ding, Yun; et al", "Bioorganic & Medicinal Chemistry (2021), 41, 116216.", "10.1016/j.bmc.2021.116216"], "signatures": {"cond_key": "none/none/none/Acetic anhydride|108-24-7", "cond_sig": "1b5c958b", "fam_sig": "1b5c958b"}, "raw_data": {"raw_cas": "RCT: 6232-11-7 + 130309-46-5 | PRO: 2760730-69-4 | SOL: 108-24-7", "raw_data_json": "{\"txt\": {\"title\": \"Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors\", \"authors\": \"Trinh, Phuc N. H.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(12), 8161-8178.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Acetic anhydride\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40275737\", \"1.1\", \"Solvents: Acetic anhydride; rt → 70 °C; 1.5 h, 70 °C\", \"219. Scheme 219 (1 Reaction)\", \"Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT)\", \"By: Ding, Yun; et al\", \"Bioorganic & Medicinal Chemistry (2021), 41, 116216.\", \"10.1016/j.bmc.2021.116216\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6232-11-7\", \"130309-46-5\"], \"pro_cas\": [\"2760730-69-4\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"108-24-7\"], \"notes\": []}}", "enriched_names": {"reactants": ["6232-11-7", "130309-46-5"], "products": ["2760730-69-4"], "reagents": [], "catalysts": [], "solvents": ["Acetic anhydride"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40278904", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": -5.0, "time_h": 6.5, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)CCC(=O)N(CCOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)CCOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21.CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OCCOCCOCCOC(=O)[C@@H](N)CCCCNC(=O)OC(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C", "products": "CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OCCOCCOCCOC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)CCC(=O)N(CCOC(=O)CCCC[C@@H]5SC[C@@H]6NC(=O)N[C@@H]65)CCOC(=O)CCCC[C@@H]5SC[C@@H]6NC(=O)N[C@@H]65)CC[C@]4(C)[C@H]3CC[C@]12C"}, "reference": {"title": "Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer", "authors": "Tang, Baolan; et al", "citation": "European Journal of Medicinal Chemistry (2020), 193, 112204.", "doi": "10.1016/j.ejmech.2020.112204", "raw": "Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer | Tang, Baolan; et al | European Journal of Medicinal Chemistry (2020), 193, 112204. | 10.1016/j.ejmech.2020.112204"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40278904", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Dichloromethane; 30 min, -5 °C", "1.2|Solvents: Dichloromethane; -5 °C; 6 h, -5 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction", "By: Kostrun, Sanja; et al", "Journal of Medicinal Chemistry (2021), 64(12), 8354-8383.", "10.1021/acs.jmedchem.1c00327"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "87124669", "fam_sig": "748b7b68"}, "raw_data": {"raw_cas": "RCT: 3032117-82-8 + 68858-20-8 | PRO: 3037120-74-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer\", \"authors\": \"Tang, Baolan; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 193, 112204.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40278904\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Dichloromethane; 30 min, -5 °C\", \"1.2\", \"Solvents: Dichloromethane; -5 °C; 6 h, -5 °C\", \"462. Scheme 462 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction\", \"By: Kostrun, Sanja; et al\", \"Journal of Medicinal Chemistry (2021), 64(12), 8354-8383.\", \"10.1021/acs.jmedchem.1c00327\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3032117-82-8\", \"68858-20-8\"], \"pro_cas\": [\"3037120-74-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3032117-82-8", "68858-20-8"], "products": ["3037120-74-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40310343", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 94.0}, "smiles": {"reactants": "Cl.N#Cc1ccc(O[C@H]2CC[C@H](N)CC2)cc1Cl.CC(C)(C)[Si](C)(C)OCC1CCN(c2ccc(C(=O)O)nn2)CC1", "products": "CC(C)(C)[Si](C)(C)OCC1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](Oc4ccc(C#N)c(Cl)c4)CC3)nn2)CC1"}, "reference": {"title": "Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer", "authors": "Yang, Yifei; et al", "citation": "European Journal of Medicinal Chemistry (2024), 271, 116400.", "doi": "10.1016/j.ejmech.2024.116400", "raw": "Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer | Yang, Yifei; et al | European Journal of Medicinal Chemistry (2024), 271, 116400. | 10.1016/j.ejmech.2024.116400"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40310343", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; 4 h, 25 °C", "Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2", "By: Zhang, Yi; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.", "10.1021/acs.jmedchem.3c00504"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "004c71d2", "fam_sig": "6a8d59c1"}, "raw_data": {"raw_cas": "RCT: 2691175-30-9 + 2326563-29-3 | PRO: 2691175-36-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer\", \"authors\": \"Yang, Yifei; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 271, 116400.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40310343\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; 4 h, 25 °C\", \"183. Scheme 183 (1 Reaction)\", \"Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2\", \"By: Zhang, Yi; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7629-7644.\", \"10.1021/acs.jmedchem.3c00504\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2691175-30-9\", \"2326563-29-3\"], \"pro_cas\": [\"2691175-36-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["2691175-30-9", "2326563-29-3"], "products": ["2691175-36-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40311346", "reaction_type": "Other", "catalyst": {"core": [{"name": "HATU", "cas": "148893-10-1"}], "generic": [], "ligands": [], "full_system": [{"name": "HATU", "cas": "148893-10-1"}]}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 84.0}, "smiles": {"reactants": "COc1ccc(OC)c(/C=C/C(=O)O)c1.Nc1nc2ccccc2s1", "products": "COc1ccc(OC)c(/C=C/C(=O)Nc2nc3ccccc3s2)c1"}, "reference": {"title": "In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole", "authors": "Zhao, Ya-Dong; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2024), 105, 129752.", "doi": "10.1016/j.bmcl.2024.129752", "raw": "In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole | Zhao, Ya-Dong; et al | Bioorganic & Medicinal Chemistry Letters (2024), 105, 129752. | 10.1016/j.bmcl.2024.129752"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-40311346", "1.1|Reagents: Triethylamine", "Catalysts: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, rt", "1.2|Solvents: Dichloromethane; 30 min, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators", "By: Guzelj, Samo; et al", "Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.", "10.1021/acs.jmedchem.2c00808"], "signatures": {"cond_key": "none/none/Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "bdfeb876", "fam_sig": "cf063ffc"}, "raw_data": {"raw_cas": "RCT: 2768856-81-9 + 4530-20-5 | PRO: 2768856-83-1 | RGT: 121-44-8 | CAT: 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole\", \"authors\": \"Zhao, Ya-Dong; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2024), 105, 129752.\", \"reagents\": [\"Triethylamine\"], \"catalysts\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40311346\", \"1.1\", \"Reagents: Triethylamine\", \"Catalysts: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"Solvents: Dichloromethane; 30 min, rt\", \"443. Scheme 443 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators\", \"By: Guzelj, Samo; et al\", \"Journal of Medicinal Chemistry (2022), 65(22), 15085-15101.\", \"10.1021/acs.jmedchem.2c00808\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2768856-81-9\", \"4530-20-5\"], \"pro_cas\": [\"2768856-83-1\"], \"rgt_cas\": [\"121-44-8\"], \"cat_cas\": [\"148893-10-1\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2768856-81-9", "4530-20-5"], "products": ["2768856-83-1"], "reagents": ["Triethylamine"], "catalysts": ["HATU"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40329134", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 94.0}, "smiles": {"reactants": "CC(C)(C)N.Nc1cc(C(F)(F)F)ccc1C(=O)O", "products": "CC(C)(C)NC(=O)c1ccc(C(F)(F)F)cc1N"}, "reference": {"title": "Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis", "authors": "Yu, Wei-Chieh; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(15), 10528-10557.", "doi": "10.1021/acs.jmedchem.3c00644", "raw": "Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis | Yu, Wei-Chieh; et al | Journal of Medicinal Chemistry (2023), 66(15), 10528-10557. | 10.1021/acs.jmedchem.3c00644"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40329134", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 2 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo", "By: Abram, Michal; et al", "Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.", "10.1021/acs.jmedchem.2c00534"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dimethylformamide|68-12-2", "cond_sig": "4bbe8df4", "fam_sig": "7874bdda"}, "raw_data": {"raw_cas": "RCT: 7764-95-6 + 100-46-9 | PRO: 140866-04-2 | RGT: 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis\", \"authors\": \"Yu, Wei-Chieh; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(15), 10528-10557.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40329134\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 2 h, rt\", \"57. Scheme 57 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo\", \"By: Abram, Michal; et al\", \"Journal of Medicinal Chemistry (2022), 65(17), 11703-11725.\", \"10.1021/acs.jmedchem.2c00534\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7764-95-6\", \"100-46-9\"], \"pro_cas\": [\"140866-04-2\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["7764-95-6", "100-46-9"], "products": ["140866-04-2"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40329369", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 91.0}, "smiles": {"reactants": "Cn1cc2cc(C(=O)O)ccc2n1.CCOc1ncc(N)c(Nc2ccc(OC(F)F)cc2)n1", "products": "CCOc1ncc(NC(=O)c2ccc3nn(C)cc3c2)c(Nc2ccc(OC(F)F)cc2)n1"}, "reference": {"title": "Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability", "authors": "Zhang, Silong; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(7), 4849-4867.", "doi": "10.1021/acs.jmedchem.2c02006", "raw": "Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability | Zhang, Silong; et al | Journal of Medicinal Chemistry (2023), 66(7), 4849-4867. | 10.1021/acs.jmedchem.2c02006"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-40329369", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; rt; 3 h, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 579-75-9 + 2919713-61-2 | PRO: 2919713-75-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability\", \"authors\": \"Zhang, Silong; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(7), 4849-4867.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40329369\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; rt; 3 h, rt\", \"304. Scheme 304 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"579-75-9\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-75-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["579-75-9", "2919713-61-2"], "products": ["2919713-75-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40331891", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 20.0, "time_h": 16.0, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)CN.COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)O", "products": "COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)NCC(C)C"}, "reference": {"title": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "doi": "10.1021/acs.jmedchem.3c02184", "raw": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4419-4441. | 10.1021/acs.jmedchem.3c02184"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-40331891", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 16 h, 20 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol Metabolites", "By: Treiber, Alexander; et al", "ChemMedChem (2023), 18(10), e202300030.", "10.1002/cmdc.202300030"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 3055189-26-6 + 3055189-27-7 | PRO: 3055189-25-5 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40331891\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 16 h, 20 °C\", \"394. Scheme 394 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4-Hydroxypiperidinol Metabolites\", \"By: Treiber, Alexander; et al\", \"ChemMedChem (2023), 18(10), e202300030.\", \"10.1002/cmdc.202300030\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3055189-26-6\", \"3055189-27-7\"], \"pro_cas\": [\"3055189-25-5\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3055189-26-6", "3055189-27-7"], "products": ["3055189-25-5"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40331892", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 20.0, "time_h": 3.0, "yield_pct": 99.0}, "smiles": {"reactants": "CC(C)(CN)C(F)(F)F.COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)O", "products": "COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OC(C)(C)C)CC2)cc1C(=O)N[C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C(=O)NCC(C)(C)C(F)(F)F"}, "reference": {"title": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "doi": "10.1021/acs.jmedchem.3c02184", "raw": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4419-4441. | 10.1021/acs.jmedchem.3c02184"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-40331892", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 3 h, 20 °C", "A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells", "By: Barresi, Elisabetta; et al", "European Journal of Medicinal Chemistry (2023), 256, 115446.", "10.1016/j.ejmech.2023.115446"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 560088-79-1 + 2230957-10-3 | PRO: 2260975-50-4 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40331892\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 3 h, 20 °C\", \"424. Scheme 424 (1 Reaction)\", \"A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells\", \"By: Barresi, Elisabetta; et al\", \"European Journal of Medicinal Chemistry (2023), 256, 115446.\", \"10.1016/j.ejmech.2023.115446\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"560088-79-1\", \"2230957-10-3\"], \"pro_cas\": [\"2260975-50-4\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["560088-79-1", "2230957-10-3"], "products": ["2260975-50-4"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40331900", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 60.0, "time_h": 15.0, "yield_pct": 87.0}, "smiles": {"reactants": "CC(C)(C)CN.CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)N[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C(=O)O)c(OC)cc2F)CC1", "products": "CCOC(=O)[C@H]1CC[C@@H](Oc2cc(C(=O)N[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C(=O)NCC(C)(C)C)c(OC)cc2F)CC1"}, "reference": {"title": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "doi": "10.1021/acs.jmedchem.3c02184", "raw": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4419-4441. | 10.1021/acs.jmedchem.3c02184"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-40331900", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 20 °C; 15 h, 60 °C", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "3554dd99", "fam_sig": "6003ace2"}, "raw_data": {"raw_cas": "RCT: 1477-50-5 + 2632874-83-8 | PRO: 2892485-59-3 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40331900\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 20 °C; 15 h, 60 °C\", \"385. Scheme 385 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1477-50-5\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-59-3\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1477-50-5", "2632874-83-8"], "products": ["2892485-59-3"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40332110", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.167, "yield_pct": 98.0}, "smiles": {"reactants": "CC1(CN)CCC1.Cl.CC(C)(C)OC(=O)N[C@H]1[C@@H](C(=O)O)[C@H]2C=C[C@@H]1CC2", "products": "CC1(CNC(=O)[C@@H]2[C@H](NC(=O)OC(C)(C)C)[C@@H]3C=C[C@H]2CC3)CCC1"}, "reference": {"title": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "doi": "10.1021/acs.jmedchem.3c02184", "raw": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4419-4441. | 10.1021/acs.jmedchem.3c02184"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-40332110", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 10 min, rt", "1.2|Reagents: Water; rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis", "By: Houstecka, Radka; et al", "Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.", "10.1021/acs.jmedchem.9b01351"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "e0675df9", "fam_sig": "b547340e"}, "raw_data": {"raw_cas": "RCT: 117142-26-4 + 53005-24-6 | PRO: 2580940-08-3 | RGT: 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40332110\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 10 min, rt\", \"1.2\", \"Reagents: Water; rt\", \"377. Scheme 377 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis\", \"By: Houstecka, Radka; et al\", \"Journal of Medicinal Chemistry (2020), 63(4), 1576-1596.\", \"10.1021/acs.jmedchem.9b01351\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"117142-26-4\", \"53005-24-6\"], \"pro_cas\": [\"2580940-08-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["117142-26-4", "53005-24-6"], "products": ["2580940-08-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40332116", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 100.0}, "smiles": {"reactants": "COC(=O)[C@@H]1[C@H](N)[C@H]2C=C[C@@H]1C2.Cl.COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)OCc3cccc4ccccc34)CC2)cc1C(=O)O", "products": "COC(=O)[C@@H]1[C@H](NC(=O)c2cc(O[C@H]3CC[C@@](C)(C(=O)OCc4cccc5ccccc45)CC3)c(F)cc2OC)[C@H]2C=C[C@@H]1C2"}, "reference": {"title": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "authors": "Granberg, Kenneth L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "doi": "10.1021/acs.jmedchem.3c02184", "raw": "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure | Granberg, Kenneth L.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4419-4441. | 10.1021/acs.jmedchem.3c02184"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40332116", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C → rt; 2 h, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 18474-57-2 + 2632874-83-8 | PRO: 2892485-77-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"authors\": \"Granberg, Kenneth L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40332116\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C → rt; 2 h, rt\", \"389. Scheme 389 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"18474-57-2\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-77-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["18474-57-2", "2632874-83-8"], "products": ["2892485-77-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40388161", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Pyridinium p-toluenesulfonate", "cas": "24057-28-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 40.0, "time_h": 4.5, "yield_pct": 95.0}, "smiles": {"reactants": "N#C[C@@H]1CC(F)(F)CN1C(=O)CN.O=C(O)c1ccnc2ccc(OCC(CF)OC3CCCCO3)cc12", "products": "N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCC(O)CF)cc12"}, "reference": {"title": "Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein", "authors": "Tanc, Muhammet; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(9), 7068-7087.", "doi": "10.1021/acs.jmedchem.3c02402", "raw": "Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein | Tanc, Muhammet; et al | Journal of Medicinal Chemistry (2024), 67(9), 7068-7087. | 10.1021/acs.jmedchem.3c02402"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-40388161", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, rt; 2 h, rt", "1.2|Reagents: Pyridinium p-toluenesulfonate", "Solvents: Tetrahydrofuran, Water; 2 h, 40 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "10.1021/acs.jmedchem.3c02184"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Pyridinium p-toluenesulfonate|24057-28-1/Dimethylformamide|68-12-2+Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "b632691e", "fam_sig": "5259f3ae"}, "raw_data": {"raw_cas": "RCT: 5813-64-9 + 2787516-91-8 | PRO: 2787520-22-1 | RGT: 7087-68-5 + 148893-10-1 + 24057-28-1 | SOL: 68-12-2 + 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein\", \"authors\": \"Tanc, Muhammet; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(9), 7068-7087.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Pyridinium p-toluenesulfonate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40388161\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, rt; 2 h, rt\", \"1.2\", \"Reagents: Pyridinium p-toluenesulfonate\", \"Solvents: Tetrahydrofuran, Water; 2 h, 40 °C\", \"384. Scheme 384 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"10.1021/acs.jmedchem.3c02184\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5813-64-9\", \"2787516-91-8\"], \"pro_cas\": [\"2787520-22-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"24057-28-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["5813-64-9", "2787516-91-8"], "products": ["2787520-22-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "24057-28-1"], "catalysts": [], "solvents": ["Dimethylformamide", "Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40401252", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 8.0, "yield_pct": 99.0}, "smiles": {"reactants": "NCc1ccccc1.CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O", "products": "CC(C)(C)OC(=O)NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)NCc1ccccc1"}, "reference": {"title": "A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer", "authors": "Zhu, Di; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(10), 7973-7994.", "doi": "10.1021/acs.jmedchem.4c00030", "raw": "A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer | Zhu, Di; et al | Journal of Medicinal Chemistry (2024), 67(10), 7973-7994. | 10.1021/acs.jmedchem.4c00030"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-40401252", "1.1|Reagents: 4-Methylmorpholine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole", "Solvents: Tetrahydrofuran; pH 8, 0 °C; 8 h, 0 °C", "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras", "By: Takwale, Akshay D.; et al", "European Journal of Medicinal Chemistry (2020), 208, 112769.", "10.1016/j.ejmech.2020.112769"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+4-Methylmorpholine|+Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+N-Methylmorpholine|109-02-4/Tetrahydrofuran|109-99-9", "cond_sig": "d7293c6c", "fam_sig": "33b400e2"}, "raw_data": {"raw_cas": "RCT: 434-76-4 + 24666-56-6 | PRO: 2250289-24-6 | RGT: 109-02-4 + 538-75-0 + 2592-95-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer\", \"authors\": \"Zhu, Di; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(10), 7973-7994.\", \"reagents\": [\"4-Methylmorpholine\", \"Dicyclohexylcarbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40401252\", \"1.1\", \"Reagents: 4-Methylmorpholine, Dicyclohexylcarbodiimide, 1-Hydroxybenzotriazole\", \"Solvents: Tetrahydrofuran; pH 8, 0 °C; 8 h, 0 °C\", \"368. Scheme 368 (1 Reaction)\", \"Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras\", \"By: Takwale, Akshay D.; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112769.\", \"10.1016/j.ejmech.2020.112769\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"434-76-4\", \"24666-56-6\"], \"pro_cas\": [\"2250289-24-6\"], \"rgt_cas\": [\"109-02-4\", \"538-75-0\", \"2592-95-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["434-76-4", "24666-56-6"], "products": ["2250289-24-6"], "reagents": ["N-Methylmorpholine", "N,N-Dicyclohexylcarbodiimide", "1-Hydroxybenzotriazole"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40410330", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 9.5, "yield_pct": 89.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)O)C1.NCc1cccs1", "products": "CC(C)(C)OC(=O)N1CCN(c2ccc(Cl)c(Cl)c2)[C@H](C(=O)NCc2cccs2)C1"}, "reference": {"title": "Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors", "authors": "Gao, Shenghua; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(24), 16902-16917.", "doi": "10.1021/acs.jmedchem.2c01716", "raw": "Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors | Gao, Shenghua; et al | Journal of Medicinal Chemistry (2022), 65(24), 16902-16917. | 10.1021/acs.jmedchem.2c01716"}, "original_text": ["Steps: 1, Yield: 89-91%", "CAS Reaction Number: 31-614-CAS-40410330", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|Reagents: Diisopropylethylamine; 9 h, rt", "Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity", "By: Gao, Shenghua; et al", "Journal of Medicinal Chemistry (2022), 65(19), 13343-13364.", "10.1021/acs.jmedchem.2c01146"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 2768834-59-7 + 27757-85-3 | PRO: 2768834-60-0 | RGT: 148893-10-1 + 7087-68-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors\", \"authors\": \"Gao, Shenghua; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(24), 16902-16917.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40410330\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 9 h, rt\", \"Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity\", \"By: Gao, Shenghua; et al\", \"Journal of Medicinal Chemistry (2022), 65(19), 13343-13364.\", \"10.1021/acs.jmedchem.2c01146\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2768834-59-7\", \"27757-85-3\"], \"pro_cas\": [\"2768834-60-0\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2768834-59-7", "27757-85-3"], "products": ["2768834-60-0"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40411251", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "N-Hydroxysuccinimide", "cas": "6066-82-6", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(NCCc1nc(-c2nc(C(=O)O)cs2)cs1)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)NCCCCN(CCCN)C(=O)OC(C)(C)C", "products": "CC(C)(C)OC(=O)NCCCCN(CCCNC(=O)c1csc(-c2csc(CCNC(=O)OCC3c4ccccc4-c4ccccc43)n2)n1)C(=O)OC(C)(C)C"}, "reference": {"title": "Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs", "authors": "Maucort, Chloe; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(15), 10639-10657.", "doi": "10.1021/acs.jmedchem.3c00797", "raw": "Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs | Maucort, Chloe; et al | Journal of Medicinal Chemistry (2023), 66(15), 10639-10657. | 10.1021/acs.jmedchem.3c00797"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-40411251", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, N-Hydroxysuccinimide", "Solvents: Dimethylformamide, Dichloromethane; 4 h, rt", "1.2|4 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structure-activity relationships of bis-intercalating peptides and their application as antibody-drug conjugate payloads", "By: Petersen, Mark E.; et al", "Journal of Medicinal Chemistry (2023), 66(12), 8288-8309.", "10.1021/acs.jmedchem.3c00760"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+N-Hydroxysuccinimide|6066-82-6/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "38b20a66", "fam_sig": "9203f416"}, "raw_data": {"raw_cas": "RCT: 86069-86-5 + 185968-90-5 + 84000-11-3 + 77128-70-2 + 29022-11-5 + 131570-56-4 | PRO: 3068605-50-2 | RGT: 1892-57-5 + 6066-82-6 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs\", \"authors\": \"Maucort, Chloe; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(15), 10639-10657.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"N-Hydroxysuccinimide\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40411251\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, N-Hydroxysuccinimide\", \"Solvents: Dimethylformamide, Dichloromethane; 4 h, rt\", \"1.2\", \"4 h, rt\", \"320. Scheme 320 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structure-activity relationships of bis-intercalating peptides and their application as antibody-drug conjugate payloads\", \"By: Petersen, Mark E.; et al\", \"Journal of Medicinal Chemistry (2023), 66(12), 8288-8309.\", \"10.1021/acs.jmedchem.3c00760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"86069-86-5\", \"185968-90-5\", \"84000-11-3\", \"77128-70-2\", \"29022-11-5\", \"131570-56-4\"], \"pro_cas\": [\"3068605-50-2\"], \"rgt_cas\": [\"1892-57-5\", \"6066-82-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["86069-86-5", "185968-90-5", "84000-11-3", "77128-70-2", "29022-11-5", "131570-56-4"], "products": ["3068605-50-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "N-Hydroxysuccinimide"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40459765", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 80.0}, "smiles": {"reactants": "C[C@H](N)c1cccc(Br)n1.Cl.O=C(O)c1ccc2c(-c3ccc(C(F)(F)F)cc3)cccc2c1", "products": "C[C@H](NC(=O)c1ccc2c(-c3ccc(C(F)(F)F)cc3)cccc2c1)c1cccc(Br)n1"}, "reference": {"title": "Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders", "authors": "Li, Huajie; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(5), 631-639.", "doi": "10.1021/acsmedchemlett.4c00029", "raw": "Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders | Li, Huajie; et al | ACS Medicinal Chemistry Letters (2024), 15(5), 631-639. | 10.1021/acsmedchemlett.4c00029"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40459765", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Tetrahydrofuran; overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism", "By: Shukla, Manojkumar R.; et al", "Journal of Medicinal Chemistry (2023), 66(14), 9418-9444.", "10.1021/acs.jmedchem.3c00698"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "2001d9e7", "fam_sig": "a3e71454"}, "raw_data": {"raw_cas": "RCT: 83780-47-6 + 3886-70-2 | PRO: 1451373-92-4 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders\", \"authors\": \"Li, Huajie; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(5), 631-639.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40459765\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Tetrahydrofuran; overnight, rt\", \"329. Scheme 329 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism\", \"By: Shukla, Manojkumar R.; et al\", \"Journal of Medicinal Chemistry (2023), 66(14), 9418-9444.\", \"10.1021/acs.jmedchem.3c00698\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"83780-47-6\", \"3886-70-2\"], \"pro_cas\": [\"1451373-92-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["83780-47-6", "3886-70-2"], "products": ["1451373-92-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40470986", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 34.0, "yield_pct": 90.0}, "smiles": {"reactants": "C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]12.COC(=O)CCCCCN.Cl", "products": "C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCC(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]12"}, "reference": {"title": "Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase", "authors": "Lv, Lijuan; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(9), 7385-7405.", "doi": "10.1021/acs.jmedchem.4c00222", "raw": "Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase | Lv, Lijuan; et al | Journal of Medicinal Chemistry (2024), 67(9), 7385-7405. | 10.1021/acs.jmedchem.4c00222"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-40470986", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 4 h, rt", "1.2|30 h, rt", "Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer", "By: Byun, Woong Sub; et al", "Journal of Medicinal Chemistry (2023), 66(4), 3106-3133.", "10.1021/acs.jmedchem.2c01115"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "fbdbce72", "fam_sig": "d408bf51"}, "raw_data": {"raw_cas": "RCT: 3034176-23-0 + 61-54-1 | PRO: 3034176-24-1 | RGT: 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase\", \"authors\": \"Lv, Lijuan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(9), 7385-7405.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40470986\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 4 h, rt\", \"1.2\", \"30 h, rt\", \"417. Scheme 417 (1 Reaction)\", \"Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer\", \"By: Byun, Woong Sub; et al\", \"Journal of Medicinal Chemistry (2023), 66(4), 3106-3133.\", \"10.1021/acs.jmedchem.2c01115\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3034176-23-0\", \"61-54-1\"], \"pro_cas\": [\"3034176-24-1\"], \"rgt_cas\": [\"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3034176-23-0", "61-54-1"], "products": ["3034176-24-1"], "reagents": ["N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40472116", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "BASE"}, {"name": "N-Hydroxysuccinimide", "cas": "6066-82-6", "role": "UNK"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 21.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccc(Cl)c([N+](=O)[O-])c1.Br.NCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]", "products": "O=C(NCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)c1ccc(Cl)c([N+](=O)[O-])c1.[Cl-]"}, "reference": {"title": "Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates", "authors": "Cardwell, Patrick A.; et al", "citation": "Bioorganic & Medicinal Chemistry (2024), 104, 117712.", "doi": "10.1016/j.bmc.2024.117712", "raw": "Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates | Cardwell, Patrick A.; et al | Bioorganic & Medicinal Chemistry (2024), 104, 117712. | 10.1016/j.bmc.2024.117712"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40472116", "1.1|Reagents: Dicyclohexylcarbodiimide, N-Hydroxysuccinimide", "Solvents: Dichloromethane; 0 °C → rt; 2 h, rt", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 19 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.", "10.1021/acs.jmedchem.2c00077"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0+N-Hydroxysuccinimide|6066-82-6+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "b3c0682f", "fam_sig": "39f26bca"}, "raw_data": {"raw_cas": "RCT: 19337-97-4 + 87120-72-7 | PRO: 3031471-28-7 | RGT: 538-75-0 + 6066-82-6 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Human mitochondrial glutathione transferases: Kinetic parameters and accommodation of a mitochondria-targeting group in substrates\", \"authors\": \"Cardwell, Patrick A.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2024), 104, 117712.\", \"reagents\": [\"Dicyclohexylcarbodiimide\", \"N-Hydroxysuccinimide\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40472116\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide, N-Hydroxysuccinimide\", \"Solvents: Dichloromethane; 0 °C → rt; 2 h, rt\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 19 h, rt\", \"237. Scheme 237 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2022), 65(11), 7746-7769.\", \"10.1021/acs.jmedchem.2c00077\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"19337-97-4\", \"87120-72-7\"], \"pro_cas\": [\"3031471-28-7\"], \"rgt_cas\": [\"538-75-0\", \"6066-82-6\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["19337-97-4", "87120-72-7"], "products": ["3031471-28-7"], "reagents": ["N,N-Dicyclohexylcarbodiimide", "N-Hydroxysuccinimide", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40478600", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.Nc1cncc(Br)c1", "products": "CC(C)(C)OC(=O)NCC(=O)Nc1cncc(Br)c1"}, "reference": {"title": "Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease", "authors": "Yang, Bowen; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(23), 15770-15788.", "doi": "10.1021/acs.jmedchem.2c01334", "raw": "Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease | Yang, Bowen; et al | Journal of Medicinal Chemistry (2022), 65(23), 15770-15788. | 10.1021/acs.jmedchem.2c01334"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-40478600", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 8 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide", "By: Guryanov, Ivan; et al", "Organic Process Research & Development (2021), 25(7), 1598-1611.", "10.1021/acs.oprd.1c00021"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 57-10-3 + 45120-30-7 | PRO: 536721-25-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Novel N-(5-(Pyridin-3-yl)-1H-indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease\", \"authors\": \"Yang, Bowen; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(23), 15770-15788.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40478600\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 8 h, rt\", \"103. Scheme 103 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Copper(II) lysinate and pseudoproline assistance in the convergent synthesis of the GLP-1 receptor agonists Liraglutide and Semaglutide\", \"By: Guryanov, Ivan; et al\", \"Organic Process Research & Development (2021), 25(7), 1598-1611.\", \"10.1021/acs.oprd.1c00021\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57-10-3\", \"45120-30-7\"], \"pro_cas\": [\"536721-25-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"key intermediate\"]}}", "enriched_names": {"reactants": ["57-10-3", "45120-30-7"], "products": ["536721-25-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40478987", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HBTU", "cas": "94790-37-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 89.0}, "smiles": {"reactants": "C#CCOc1ccc2[nH]c3c(C(=O)c4ccc(Br)cc4)nc(C(=O)O)cc3c2c1.NCCc1c[nH]c2ccccc12", "products": "C#CCOc1ccc2[nH]c3c(C(=O)c4ccc(Br)cc4)nc(C(=O)NCCc4c[nH]c5ccccc45)cc3c2c1"}, "reference": {"title": "Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer", "authors": "Byun, Woong Sub; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(4), 3106-3133.", "doi": "10.1021/acs.jmedchem.2c01115", "raw": "Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer | Byun, Woong Sub; et al | Journal of Medicinal Chemistry (2023), 66(4), 3106-3133. | 10.1021/acs.jmedchem.2c01115"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-40478987", "1.1|Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 1 h, 25 °C", "1.2|Reagents: Diisopropylethylamine; 3 h, 25 °C", "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "By: Tang, Sheng; et al", "European Journal of Medicinal Chemistry (2024), 263, 115939.", "10.1016/j.ejmech.2023.115939"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "a5109a00", "fam_sig": "24dfcf20"}, "raw_data": {"raw_cas": "RCT: 4653-11-6 + 2761180-24-7 + 814-68-6 | PRO: 3020728-51-9 | RGT: 94790-37-1 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer\", \"authors\": \"Byun, Woong Sub; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(4), 3106-3133.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40478987\", \"1.1\", \"Reagents: 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 1 h, 25 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 3 h, 25 °C\", \"418. Scheme 418 (1 Reaction)\", \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"By: Tang, Sheng; et al\", \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"10.1016/j.ejmech.2023.115939\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4653-11-6\", \"2761180-24-7\", \"814-68-6\"], \"pro_cas\": [\"3020728-51-9\"], \"rgt_cas\": [\"94790-37-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4653-11-6", "2761180-24-7", "814-68-6"], "products": ["3020728-51-9"], "reagents": ["HBTU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40486251", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)O)cc2)CC1.CC1(C)[C@H](N)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1.Cl", "products": "CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)N[C@H]3C(C)(C)[C@H](Oc4ccc(C#N)c(Cl)c4)C3(C)C)cc2)CC1"}, "reference": {"title": "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras", "authors": "Takwale, Akshay D.; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112769.", "doi": "10.1016/j.ejmech.2020.112769", "raw": "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras | Takwale, Akshay D.; et al | European Journal of Medicinal Chemistry (2020), 208, 112769. | 10.1016/j.ejmech.2020.112769"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40486251", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 12 h, rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 86-87-3 + 2632874-83-8 | PRO: 2892485-67-3 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras\", \"authors\": \"Takwale, Akshay D.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40486251\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 12 h, rt\", \"327. Scheme 327 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"86-87-3\", \"2632874-83-8\"], \"pro_cas\": [\"2892485-67-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["86-87-3", "2632874-83-8"], "products": ["2892485-67-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40486257", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 93.0}, "smiles": {"reactants": "O=C(O)c1cc(O)ccc1[N+](=O)[O-].Cl.NC1CCC(=O)NC1=O", "products": "O=C1CCC(NC(=O)c2cc(O)ccc2[N+](=O)[O-])C(=O)N1"}, "reference": {"title": "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras", "authors": "Takwale, Akshay D.; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112769.", "doi": "10.1016/j.ejmech.2020.112769", "raw": "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras | Takwale, Akshay D.; et al | European Journal of Medicinal Chemistry (2020), 208, 112769. | 10.1016/j.ejmech.2020.112769"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-40486257", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 12 h, rt", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Process Development for the Synthesis of a Monobactam Antibiotic-LYS228", "By: Fei, Zhongbo; et al", "Organic Process Research & Development (2020), 24(3), 363-370.", "10.1021/acs.oprd.9b00330"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 1225209-44-8 + 3140-73-6 + 1810053-36-1 | PRO: 63910-63-4 + 1810054-28-4 + 2412189-91-2 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras\", \"authors\": \"Takwale, Akshay D.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40486257\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 12 h, rt\", \"402. Scheme 402 (1 Reaction)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Process Development for the Synthesis of a Monobactam Antibiotic-LYS228\", \"By: Fei, Zhongbo; et al\", \"Organic Process Research & Development (2020), 24(3), 363-370.\", \"10.1021/acs.oprd.9b00330\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1225209-44-8\", \"3140-73-6\", \"1810053-36-1\"], \"pro_cas\": [\"63910-63-4\", \"1810054-28-4\", \"2412189-91-2\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1225209-44-8", "3140-73-6", "1810053-36-1"], "products": ["63910-63-4", "1810054-28-4", "2412189-91-2"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40486260", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 94.0}, "smiles": {"reactants": "Nc1cccc(F)c1C(=O)O.Cl.NC1CCC(=O)NC1=O", "products": "Nc1cccc(F)c1C(=O)NC1CCC(=O)NC1=O"}, "reference": {"title": "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras", "authors": "Takwale, Akshay D.; et al", "citation": "European Journal of Medicinal Chemistry (2020), 208, 112769.", "doi": "10.1016/j.ejmech.2020.112769", "raw": "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras | Takwale, Akshay D.; et al | European Journal of Medicinal Chemistry (2020), 208, 112769. | 10.1016/j.ejmech.2020.112769"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40486260", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice", "By: Yin, Jiaxin; et al", "European Journal of Medicinal Chemistry (2023), 249, 115141.", "10.1016/j.ejmech.2023.115141"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 452-69-7 + 88495-54-9 | PRO: 1705585-08-5 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras\", \"authors\": \"Takwale, Akshay D.; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2020), 208, 112769.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40486260\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 12 h, rt\", \"369. Scheme 369 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice\", \"By: Yin, Jiaxin; et al\", \"European Journal of Medicinal Chemistry (2023), 249, 115141.\", \"10.1016/j.ejmech.2023.115141\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"452-69-7\", \"88495-54-9\"], \"pro_cas\": [\"1705585-08-5\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["452-69-7", "88495-54-9"], "products": ["1705585-08-5"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40533936", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 94.0}, "smiles": {"reactants": "Cl.NC(=O)[C@@H](N)C[C@@H]1CCCNC1=O.COC(=O)N[C@H](C(=O)N1C[C@H](C(F)(F)F)C[C@H]1C(=O)O)C(C)C", "products": "COC(=O)N[C@H](C(=O)N1C[C@H](C(F)(F)F)C[C@H]1C(=O)N[C@@H](C[C@@H]1CCCNC1=O)C(N)=O)C(C)C"}, "reference": {"title": "A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19", "authors": "Allerton, Charlotte M. N.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(16), 13550-13571.", "doi": "10.1021/acs.jmedchem.3c02469", "raw": "A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19 | Allerton, Charlotte M. N.; et al | Journal of Medicinal Chemistry (2024), 67(16), 13550-13571. | 10.1021/acs.jmedchem.3c02469"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40533936", "1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Acetonitrile; 0 °C → rt; overnight, rt", "Double bond geometry shown", "Double bond geometry shown", "Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines", "By: Marinovic, Marina; et al", "Bioorganic & Medicinal Chemistry (2023), 94, 117468.", "10.1016/j.bmc.2023.117468"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+HATU|148893-10-1+N-Methylmorpholine|109-02-4+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Acetonitrile|75-05-8+Dimethylformamide|68-12-2", "cond_sig": "309e8db4", "fam_sig": "a3c70891"}, "raw_data": {"raw_cas": "RCT: 175675-63-5 + 2521791-65-9 | PRO: 3056621-75-8 | RGT: 109-02-4 + 148893-10-1 | SOL: 68-12-2 + 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19\", \"authors\": \"Allerton, Charlotte M. N.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(16), 13550-13571.\", \"reagents\": [\"4-Methylmorpholine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40533936\", \"1.1\", \"Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Acetonitrile; 0 °C → rt; overnight, rt\", \"278. Scheme 278 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines\", \"By: Marinovic, Marina; et al\", \"Bioorganic & Medicinal Chemistry (2023), 94, 117468.\", \"10.1016/j.bmc.2023.117468\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"175675-63-5\", \"2521791-65-9\"], \"pro_cas\": [\"3056621-75-8\"], \"rgt_cas\": [\"109-02-4\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["175675-63-5", "2521791-65-9"], "products": ["3056621-75-8"], "reagents": ["N-Methylmorpholine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40576482", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 72.667, "yield_pct": 91.0}, "smiles": {"reactants": "COCC(NC(=O)OC(C)(C)C)C(=O)O.Nc1nnc(Cc2ccc([N+](=O)[O-])cc2)s1", "products": "COCC(NC(=O)OC(C)(C)C)C(=O)Nc1nnc(Cc2ccc([N+](=O)[O-])cc2)s1"}, "reference": {"title": "Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21", "authors": "Goericke, Fabian; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.", "doi": "10.1021/acs.jmedchem.2c01933", "raw": "Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21 | Goericke, Fabian; et al | Journal of Medicinal Chemistry (2023), 66(5), 3431-3447. | 10.1021/acs.jmedchem.2c01933"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-40576482", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 40 min, rt", "1.2|3 d, rt", "Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity", "By: Zareba, Paula; et al", "European Journal of Medicinal Chemistry (2021), 221, 113512.", "10.1016/j.ejmech.2021.113512"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 64-19-7 + 2648234-37-9 | PRO: 2648234-42-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21\", \"authors\": \"Goericke, Fabian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40576482\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 40 min, rt\", \"1.2\", \"3 d, rt\", \"344. Scheme 344 (1 Reaction)\", \"Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity\", \"By: Zareba, Paula; et al\", \"European Journal of Medicinal Chemistry (2021), 221, 113512.\", \"10.1016/j.ejmech.2021.113512\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-19-7\", \"2648234-37-9\"], \"pro_cas\": [\"2648234-42-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["Acetic Acid", "2648234-37-9"], "products": ["2648234-42-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40576505", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "COC[C@@H](NC(=O)OC(C)(C)C)C(=O)O.N#Cc1ccc(Cc2nnc(N)s2)cc1", "products": "COC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1nnc(Cc2ccc(C#N)cc2)s1"}, "reference": {"title": "Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21", "authors": "Goericke, Fabian; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.", "doi": "10.1021/acs.jmedchem.2c01933", "raw": "Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21 | Goericke, Fabian; et al | Journal of Medicinal Chemistry (2023), 66(5), 3431-3447. | 10.1021/acs.jmedchem.2c01933"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-40576505", "1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe", "By: Roehm, Sandra; et al", "Journal of Medicinal Chemistry (2021), 64(18), 13451-13474.", "10.1021/acs.jmedchem.1c00868"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+HATU|148893-10-1+N-Methylmorpholine|109-02-4+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "0249269f", "fam_sig": "33326d02"}, "raw_data": {"raw_cas": "RCT: 5071-61-4 + 934388-45-1 | PRO: 2837055-71-5 | RGT: 109-02-4 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21\", \"authors\": \"Goericke, Fabian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.\", \"reagents\": [\"4-Methylmorpholine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40576505\", \"1.1\", \"Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"301. Scheme 301 (1 Reaction)\", \"Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe\", \"By: Roehm, Sandra; et al\", \"Journal of Medicinal Chemistry (2021), 64(18), 13451-13474.\", \"10.1021/acs.jmedchem.1c00868\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5071-61-4\", \"934388-45-1\"], \"pro_cas\": [\"2837055-71-5\"], \"rgt_cas\": [\"109-02-4\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5071-61-4", "934388-45-1"], "products": ["2837055-71-5"], "reagents": ["N-Methylmorpholine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40577093", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 97.0}, "smiles": {"reactants": "CCCC[C@H](N)C(=O)OC.Cl.Cc1nc2c(OCc3c(F)cccc3F)cccn2c1C(=O)O", "products": "CCCCC(NC(=O)c1c(C)nc2c(OCc3c(F)cccc3F)cccn12)C(=O)OC"}, "reference": {"title": "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension", "authors": "Vakalopoulos, Alexandros; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.", "doi": "10.1021/acs.jmedchem.2c02082", "raw": "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension | Vakalopoulos, Alexandros; et al | Journal of Medicinal Chemistry (2023), 66(11), 7280-7303. | 10.1021/acs.jmedchem.2c02082"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-40577093", "1.1|Reagents: 4-Methylmorpholine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dichloromethane; 4 h, rt", "Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor", "By: M. Serafim, Ricardo A.; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3173-3192.", "10.1021/acs.jmedchem.1c01165"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+N-Methylmorpholine|109-02-4+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dichloromethane|75-09-2", "cond_sig": "e4fe54a9", "fam_sig": "39ebb2f0"}, "raw_data": {"raw_cas": "RCT: 2645399-49-9 + 579-66-8 | PRO: 2645399-50-2 | RGT: 109-02-4 + 125700-67-6 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension\", \"authors\": \"Vakalopoulos, Alexandros; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.\", \"reagents\": [\"4-Methylmorpholine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40577093\", \"1.1\", \"Reagents: 4-Methylmorpholine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dichloromethane; 4 h, rt\", \"408. Scheme 408 (1 Reaction)\", \"Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor\", \"By: M. Serafim, Ricardo A.; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3173-3192.\", \"10.1021/acs.jmedchem.1c01165\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2645399-49-9\", \"579-66-8\"], \"pro_cas\": [\"2645399-50-2\"], \"rgt_cas\": [\"109-02-4\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2645399-49-9", "579-66-8"], "products": ["2645399-50-2"], "reagents": ["N-Methylmorpholine", "125700-67-6"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40577123", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 2.5, "yield_pct": 81.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(N)c1ccc(F)c(F)c1.Cc1nc2c(OCc3c(F)cccc3F)cccn2c1C(=O)O", "products": "Cc1nc2c(OCc3c(F)cccc3F)cccn2c1C(=O)NC(CNC(=O)OC(C)(C)C)c1ccc(F)c(F)c1"}, "reference": {"title": "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension", "authors": "Vakalopoulos, Alexandros; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.", "doi": "10.1021/acs.jmedchem.2c02082", "raw": "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension | Vakalopoulos, Alexandros; et al | Journal of Medicinal Chemistry (2023), 66(11), 7280-7303. | 10.1021/acs.jmedchem.2c02082"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40577123", "1.1|Reagents: 4-Methylmorpholine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 2 h, rt", "1.2|Solvents: Water; 30 min, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1", "By: Lu, Jian; et al", "Journal of Medicinal Chemistry (2020), 63(22), 13878-13898.", "10.1021/acs.jmedchem.0c01475"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+N-Methylmorpholine|109-02-4+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "74355bda", "fam_sig": "ebe7089c"}, "raw_data": {"raw_cas": "RCT: 67381-04-8 + 151838-62-9 | PRO: 2736457-96-6 | RGT: 109-02-4 + 125700-67-6 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension\", \"authors\": \"Vakalopoulos, Alexandros; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.\", \"reagents\": [\"4-Methylmorpholine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40577123\", \"1.1\", \"Reagents: 4-Methylmorpholine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 2 h, rt\", \"1.2\", \"Solvents: Water; 30 min, rt\", \"471. Scheme 471 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1\", \"By: Lu, Jian; et al\", \"Journal of Medicinal Chemistry (2020), 63(22), 13878-13898.\", \"10.1021/acs.jmedchem.0c01475\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"67381-04-8\", \"151838-62-9\"], \"pro_cas\": [\"2736457-96-6\"], \"rgt_cas\": [\"109-02-4\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["67381-04-8", "151838-62-9"], "products": ["2736457-96-6"], "reagents": ["N-Methylmorpholine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40577125", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 17.083, "yield_pct": 96.0}, "smiles": {"reactants": "Cc1cc(OCc2c(F)cccc2F)c2nc(C)c(C(=O)O)n2c1.CC[C@@](C)(CN)NC(=O)OCc1ccccc1", "products": "CC[C@@](C)(CNC(=O)c1c(C)nc2c(OCc3c(F)cccc3F)cc(C)cn12)NC(=O)OCc1ccccc1"}, "reference": {"title": "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension", "authors": "Vakalopoulos, Alexandros; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.", "doi": "10.1021/acs.jmedchem.2c02082", "raw": "New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension | Vakalopoulos, Alexandros; et al | Journal of Medicinal Chemistry (2023), 66(11), 7280-7303. | 10.1021/acs.jmedchem.2c02082"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-40577125", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 20 min, rt", "1.2|overnight, rt", "1.3|Solvents: Water; 45 min, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC)", "By: Zhang, Kuojun; et al", "Journal of Medicinal Chemistry (2021), 64(7), 4020-4033.", "10.1021/acs.jmedchem.0c02161"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "1db37e54", "fam_sig": "a8d8fb5f"}, "raw_data": {"raw_cas": "RCT: 2844372-19-4 + 1370372-48-7 | PRO: 2844372-20-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension\", \"authors\": \"Vakalopoulos, Alexandros; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(11), 7280-7303.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40577125\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.2\", \"overnight, rt\", \"1.3\", \"Solvents: Water; 45 min, rt\", \"455. Scheme 455 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC)\", \"By: Zhang, Kuojun; et al\", \"Journal of Medicinal Chemistry (2021), 64(7), 4020-4033.\", \"10.1021/acs.jmedchem.0c02161\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2844372-19-4\", \"1370372-48-7\"], \"pro_cas\": [\"2844372-20-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2844372-19-4", "1370372-48-7"], "products": ["2844372-20-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40578331", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 17.0, "yield_pct": 85.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)OCCO2.Nc1ccc(F)c([N+](=O)[O-])c1", "products": "O=C(Nc1ccc(F)c([N+](=O)[O-])c1)c1ccc2c(c1)OCCO2"}, "reference": {"title": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "authors": "Pasqua, A. Elisa; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "doi": "10.1021/acs.jmedchem.3c00156", "raw": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies | Pasqua, A. Elisa; et al | Journal of Medicinal Chemistry (2023), 66(8), 5907-5936. | 10.1021/acs.jmedchem.3c00156"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-40578331", "1.1|Reagents: Oxalyl chloride, Pyridine", "Solvents: Dichloromethane; 1 h, 0 °C", "1.2|Reagents: Pyridine", "Solvents: Dichloromethane; 16 h, 0 °C", "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "By: Christie, Louisa A.; et al", "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "10.1021/acs.jmedchem.3c00630"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "d80a1ca6", "fam_sig": "852bc406"}, "raw_data": {"raw_cas": "RCT: 1781314-21-3 + 7179-99-9 | PRO: 3033431-98-7 | RGT: 79-37-8 + 110-86-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"authors\": \"Pasqua, A. Elisa; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"reagents\": [\"Oxalyl chloride\", \"Pyridine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40578331\", \"1.1\", \"Reagents: Oxalyl chloride, Pyridine\", \"Solvents: Dichloromethane; 1 h, 0 °C\", \"1.2\", \"Reagents: Pyridine\", \"Solvents: Dichloromethane; 16 h, 0 °C\", \"48. Scheme 48 (1 Reaction)\", \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"By: Christie, Louisa A.; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"10.1021/acs.jmedchem.3c00630\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1781314-21-3\", \"7179-99-9\"], \"pro_cas\": [\"3033431-98-7\"], \"rgt_cas\": [\"79-37-8\", \"110-86-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1781314-21-3", "7179-99-9"], "products": ["3033431-98-7"], "reagents": ["79-37-8", "Pyridine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40578368", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 20.0, "time_h": 5.0, "yield_pct": 88.0}, "smiles": {"reactants": "Cc1ccc2cc(C(=O)O)ccc2n1.Cc1ccc([N+](=O)[O-])cc1N", "products": "Cc1ccc2cc(C(=O)Nc3cc([N+](=O)[O-])ccc3C)ccc2n1"}, "reference": {"title": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "authors": "Pasqua, A. Elisa; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "doi": "10.1021/acs.jmedchem.3c00156", "raw": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies | Pasqua, A. Elisa; et al | Journal of Medicinal Chemistry (2023), 66(8), 5907-5936. | 10.1021/acs.jmedchem.3c00156"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-40578368", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; rt; 3 h, 20 °C", "1.2|Reagents: Pyridine; 2 h, rt", "Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure", "By: Velcicky, Juraj; et al", "Journal of Medicinal Chemistry (2020), 63(17), 9856-9875.", "10.1021/acs.jmedchem.0c01020"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "d80a1ca6", "fam_sig": "852bc406"}, "raw_data": {"raw_cas": "RCT: 4655-10-1 + 134-20-3 | PRO: 2711750-25-1 | RGT: 79-37-8 + 110-86-1 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"authors\": \"Pasqua, A. Elisa; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"reagents\": [\"Oxalyl chloride\", \"Pyridine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40578368\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; rt; 3 h, 20 °C\", \"1.2\", \"Reagents: Pyridine; 2 h, rt\", \"258. Scheme 258 (1 Reaction)\", \"Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure\", \"By: Velcicky, Juraj; et al\", \"Journal of Medicinal Chemistry (2020), 63(17), 9856-9875.\", \"10.1021/acs.jmedchem.0c01020\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4655-10-1\", \"134-20-3\"], \"pro_cas\": [\"2711750-25-1\"], \"rgt_cas\": [\"79-37-8\", \"110-86-1\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"pyridine also used as a solvent in stage 2\"]}}", "enriched_names": {"reactants": ["4655-10-1", "134-20-3"], "products": ["2711750-25-1"], "reagents": ["79-37-8", "Pyridine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40578370", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 20.0, "time_h": 6.0, "yield_pct": 88.0}, "smiles": {"reactants": "Cc1ccc2cc(C(=O)O)ccc2n1.Nc1cc([N+](=O)[O-])ccc1Cl", "products": "Cc1ccc2cc(C(=O)Nc3cc([N+](=O)[O-])ccc3Cl)ccc2n1"}, "reference": {"title": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "authors": "Pasqua, A. Elisa; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "doi": "10.1021/acs.jmedchem.3c00156", "raw": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies | Pasqua, A. Elisa; et al | Journal of Medicinal Chemistry (2023), 66(8), 5907-5936. | 10.1021/acs.jmedchem.3c00156"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-40578370", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; rt; 3 h, 20 °C", "1.2|Reagents: Pyridine; 2 h", "Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain", "By: Sheppard, George S.; et al", "Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.", "10.1021/acs.jmedchem.0c00628"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "d80a1ca6", "fam_sig": "852bc406"}, "raw_data": {"raw_cas": "RCT: 1622303-52-9 + 74-89-5 | PRO: 2138864-22-7 | RGT: 79-37-8 + 110-86-1 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"authors\": \"Pasqua, A. Elisa; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"reagents\": [\"Oxalyl chloride\", \"Pyridine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40578370\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; rt; 3 h, 20 °C\", \"1.2\", \"Reagents: Pyridine; 2 h\", \"334. Scheme 334 (1 Reaction)\", \"Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain\", \"By: Sheppard, George S.; et al\", \"Journal of Medicinal Chemistry (2020), 63(10), 5585-5623.\", \"10.1021/acs.jmedchem.0c00628\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1622303-52-9\", \"74-89-5\"], \"pro_cas\": [\"2138864-22-7\"], \"rgt_cas\": [\"79-37-8\", \"110-86-1\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1622303-52-9", "74-89-5"], "products": ["2138864-22-7"], "reagents": ["79-37-8", "Pyridine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40578371", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)OCCO2.Cc1ccc2cc(C(=O)Nc3cc(N)ccc3C)ccc2n1", "products": "Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1"}, "reference": {"title": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "authors": "Pasqua, A. Elisa; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "doi": "10.1021/acs.jmedchem.3c00156", "raw": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies | Pasqua, A. Elisa; et al | Journal of Medicinal Chemistry (2023), 66(8), 5907-5936. | 10.1021/acs.jmedchem.3c00156"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-40578371", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; rt; overnight, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome", "By: Gotz, Marion G.; et al", "ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.", "10.1021/acsmedchemlett.4c00017"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 70533-96-9 + 119768-45-5 | PRO: 3058604-53-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"authors\": \"Pasqua, A. Elisa; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40578371\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; rt; overnight, rt\", \"174. Scheme 174 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome\", \"By: Gotz, Marion G.; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(4), 533-539.\", \"10.1021/acsmedchemlett.4c00017\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"70533-96-9\", \"119768-45-5\"], \"pro_cas\": [\"3058604-53-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["70533-96-9", "119768-45-5"], "products": ["3058604-53-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40578485", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Pyridine", "cas": "110-86-1", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 20.0, "time_h": 75.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccc2c(c1)OCCO2.Cc1ccc2cc(C(=O)Nc3cc(N)ccc3Br)ccc2n1", "products": "Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3Br)ccc2n1"}, "reference": {"title": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "authors": "Pasqua, A. Elisa; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "doi": "10.1021/acs.jmedchem.3c00156", "raw": "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies | Pasqua, A. Elisa; et al | Journal of Medicinal Chemistry (2023), 66(8), 5907-5936. | 10.1021/acs.jmedchem.3c00156"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40578485", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; rt; 3 h, 20 °C", "1.2|Reagents: Pyridine; 72 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8+Pyridine|110-86-1/Dichloromethane|75-09-2", "cond_sig": "d80a1ca6", "fam_sig": "852bc406"}, "raw_data": {"raw_cas": "RCT: 251105-80-3 + 884512-77-0 | PRO: 2765293-60-3 | RGT: 79-37-8 + 110-86-1 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"authors\": \"Pasqua, A. Elisa; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"reagents\": [\"Oxalyl chloride\", \"Pyridine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40578485\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; rt; 3 h, 20 °C\", \"1.2\", \"Reagents: Pyridine; 72 h, rt\", \"263. Scheme 263 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"251105-80-3\", \"884512-77-0\"], \"pro_cas\": [\"2765293-60-3\"], \"rgt_cas\": [\"79-37-8\", \"110-86-1\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"pyridine also used as a solvent in stage 2\"]}}", "enriched_names": {"reactants": ["251105-80-3", "884512-77-0"], "products": ["2765293-60-3"], "reagents": ["79-37-8", "Pyridine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40592502", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Acetic anhydride", "cas": "108-24-7", "role": "BASE"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 95.0, "time_h": 5.0, "yield_pct": 92.0}, "smiles": {"reactants": "N#CCC(=O)O.NC(=O)NC1CC1", "products": "Nc1cc(=O)[nH]c(=O)n1C1CC1"}, "reference": {"title": "Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors", "authors": "Specker, Edgar; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(16), 11126-11149.", "doi": "10.1021/acs.jmedchem.2c00598", "raw": "Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors | Specker, Edgar; et al | Journal of Medicinal Chemistry (2022), 65(16), 11126-11149. | 10.1021/acs.jmedchem.2c00598"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-40592502", "1.1|Reagents: Acetic anhydride; 80 °C → 95 °C; 2 h, 95 °C", "1.2|Reagents: Sodium hydroxide", "Solvents: Water; 80 °C; 3 h, 80 °C", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; pH 7", "N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment", "By: Mehndiratta, Samir; et al", "Journal of Medicinal Chemistry (2022), 65(3), 2208-2224.", "10.1021/acs.jmedchem.1c01726"], "signatures": {"cond_key": "none/none/Acetic anhydride|108-24-7+Hydrochloric acid|7647-01-0+NaOH|1310-73-2+Sodium hydroxide|/Water|7732-18-5", "cond_sig": "40eb2fd1", "fam_sig": "53bad93d"}, "raw_data": {"raw_cas": "RCT: 3946-32-5 + 2927489-53-8 | PRO: 3031466-60-8 | RGT: 108-24-7 + 1310-73-2 + 7647-01-0 | SOL: 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors\", \"authors\": \"Specker, Edgar; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(16), 11126-11149.\", \"reagents\": [\"Acetic anhydride\", \"Sodium hydroxide\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40592502\", \"1.1\", \"Reagents: Acetic anhydride; 80 °C → 95 °C; 2 h, 95 °C\", \"1.2\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 80 °C; 3 h, 80 °C\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; pH 7\", \"375. Scheme 375 (1 Reaction)\", \"N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment\", \"By: Mehndiratta, Samir; et al\", \"Journal of Medicinal Chemistry (2022), 65(3), 2208-2224.\", \"10.1021/acs.jmedchem.1c01726\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3946-32-5\", \"2927489-53-8\"], \"pro_cas\": [\"3031466-60-8\"], \"rgt_cas\": [\"108-24-7\", \"1310-73-2\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3946-32-5", "2927489-53-8"], "products": ["3031466-60-8"], "reagents": ["Acetic anhydride", "NaOH", "Hydrochloric acid"], "catalysts": [], "solvents": ["Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40615614", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 80.0}, "smiles": {"reactants": "COC(=O)c1ccc(N)cc1.O=C(O)CCC(=O)c1ccccc1", "products": "COC(=O)c1ccc(NC(=O)CCC(=O)c2ccccc2)cc1"}, "reference": {"title": "Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5", "authors": "Xiang, Honggang; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(4), 2457-2476.", "doi": "10.1021/acs.jmedchem.2c01233", "raw": "Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5 | Xiang, Honggang; et al | Journal of Medicinal Chemistry (2023), 66(4), 2457-2476. | 10.1021/acs.jmedchem.2c01233"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40615614", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 2 h, 0 °C", "Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity", "By: Karki, Anupam; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.", "10.1016/j.bmcl.2020.127053"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|/Dichloromethane|75-09-2", "cond_sig": "5495b07e", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 66949-40-4 + 64-04-0 | PRO: 2412564-61-3 | RGT: 1892-57-5 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5\", \"authors\": \"Xiang, Honggang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(4), 2457-2476.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40615614\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 2 h, 0 °C\", \"114. Scheme 114 (1 Reaction)\", \"Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity\", \"By: Karki, Anupam; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(8), 127053.\", \"10.1016/j.bmcl.2020.127053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"66949-40-4\", \"64-04-0\"], \"pro_cas\": [\"2412564-61-3\"], \"rgt_cas\": [\"1892-57-5\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["66949-40-4", "64-04-0"], "products": ["2412564-61-3"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40620103", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Pyridine", "cas": "110-86-1"}], "conditions": {"temperature_c": 50.0, "time_h": 19.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(NCc1ccc(C(=O)O)cc1)OCc1ccccc1.Nc1cccnc1", "products": "O=C(NCc1ccc(C(=O)Nc2cccnc2)cc1)OCc1ccccc1"}, "reference": {"title": "Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy", "authors": "Abyar, Selda; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(13), 11086-11102.", "doi": "10.1021/acs.jmedchem.4c00589", "raw": "Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy | Abyar, Selda; et al | Journal of Medicinal Chemistry (2024), 67(13), 11086-11102. | 10.1021/acs.jmedchem.4c00589"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-40620103", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Tetrahydrofuran; rt; 3 h, 50 °C", "1.2|Solvents: Pyridine; rt; 16 h, rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "A new chemotype with promise against Trypanosoma cruzi", "By: Wang, Xiaofang; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "10.1016/j.bmcl.2019.126778"], "signatures": {"cond_key": "none/none/Oxalyl chloride|79-37-8/Pyridine|110-86-1+Tetrahydrofuran|109-99-9", "cond_sig": "2e44317d", "fam_sig": "0dc76e8c"}, "raw_data": {"raw_cas": "RCT: 462-08-8 + 744248-54-2 | PRO: 2581115-34-4 | RGT: 79-37-8 | CAT: 68-12-2 | SOL: 109-99-9 + 110-86-1", "raw_data_json": "{\"txt\": {\"title\": \"Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy\", \"authors\": \"Abyar, Selda; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(13), 11086-11102.\", \"reagents\": [\"Oxalyl chloride\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Tetrahydrofuran\", \"Pyridine\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40620103\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Tetrahydrofuran; rt; 3 h, 50 °C\", \"1.2\", \"Solvents: Pyridine; rt; 16 h, rt\", \"289. Scheme 289 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"A new chemotype with promise against Trypanosoma cruzi\", \"By: Wang, Xiaofang; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"10.1016/j.bmcl.2019.126778\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"462-08-8\", \"744248-54-2\"], \"pro_cas\": [\"2581115-34-4\"], \"rgt_cas\": [\"79-37-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"109-99-9\", \"110-86-1\"], \"notes\": []}}", "enriched_names": {"reactants": ["462-08-8", "744248-54-2"], "products": ["2581115-34-4"], "reagents": ["79-37-8"], "catalysts": ["Dimethylformamide"], "solvents": ["Tetrahydrofuran", "Pyridine"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40640691", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 2.5, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)C1(C(=O)O)CC1.Cc1cc(N)no1", "products": "Cc1cc(NC(=O)C2(C(=O)O)CC2)no1"}, "reference": {"title": "Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase", "authors": "Zhan, Zhengsheng; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(1), 220-234.", "doi": "10.1021/acs.jmedchem.2c00962", "raw": "Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase | Zhan, Zhengsheng; et al | Journal of Medicinal Chemistry (2023), 66(1), 220-234. | 10.1021/acs.jmedchem.2c00962"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-40640691", "1.1|Reagents: Triethylamine", "Solvents: Tetrahydrofuran; 30 min, 0 °C", "1.2|Reagents: Thionyl chloride; 30 min, 0 °C", "1.3|Solvents: Tetrahydrofuran; 0 °C; 1.5 h, 0 °C", "A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease", "By: Rivera-Marrero, Suchitil; et al", "Bioorganic & Medicinal Chemistry (2020), 28(20), 115700.", "10.1016/j.bmc.2020.115700"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Tetrahydrofuran|109-99-9", "cond_sig": "ce059264", "fam_sig": "75d8cfcb"}, "raw_data": {"raw_cas": "RCT: 37642-93-6 + 107-15-3 | PRO: 1252687-41-4 | RGT: 121-44-8 + 7719-09-7 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase\", \"authors\": \"Zhan, Zhengsheng; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(1), 220-234.\", \"reagents\": [\"Triethylamine\", \"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40640691\", \"1.1\", \"Reagents: Triethylamine\", \"Solvents: Tetrahydrofuran; 30 min, 0 °C\", \"1.2\", \"Reagents: Thionyl chloride; 30 min, 0 °C\", \"1.3\", \"Solvents: Tetrahydrofuran; 0 °C; 1.5 h, 0 °C\", \"110. Scheme 110 (1 Reaction)\", \"A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer’s disease\", \"By: Rivera-Marrero, Suchitil; et al\", \"Bioorganic & Medicinal Chemistry (2020), 28(20), 115700.\", \"10.1016/j.bmc.2020.115700\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"37642-93-6\", \"107-15-3\"], \"pro_cas\": [\"1252687-41-4\"], \"rgt_cas\": [\"121-44-8\", \"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["37642-93-6", "107-15-3"], "products": ["1252687-41-4"], "reagents": ["Triethylamine", "7719-09-7"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40640858", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 85.0}, "smiles": {"reactants": "CNC(=O)c1ccccc1N.CN(CC(=O)O)C(=O)OC(C)(C)C", "products": "CNC(=O)c1ccccc1NC(=O)CN(C)C(=O)OC(C)(C)C"}, "reference": {"title": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "authors": "Bayrak, Alp; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "doi": "10.1021/acs.jmedchem.2c01198", "raw": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation | Bayrak, Alp; et al | Journal of Medicinal Chemistry (2022), 65(19), 13365-13384. | 10.1021/acs.jmedchem.2c01198"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-40640858", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (-)", "Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2", "By: Grifagni, Deborah; et al", "ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.", "10.1021/acsmedchemlett.3c00498"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 7524-50-7 + 13734-41-3 | PRO: 20902-47-0 | RGT: 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"authors\": \"Bayrak, Alp; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40640858\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 12 h, rt\", \"250. Scheme 250 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Development of a GC-376 Based Peptidomimetic PROTAC as a Degrader of 3-Chymotrypsin-like Protease of SARS-CoV-2\", \"By: Grifagni, Deborah; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(2), 250-257.\", \"10.1021/acsmedchemlett.3c00498\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7524-50-7\", \"13734-41-3\"], \"pro_cas\": [\"20902-47-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["7524-50-7", "13734-41-3"], "products": ["20902-47-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40640859", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 85.0}, "smiles": {"reactants": "CNC(=O)c1ccccc1N.CC(C)(C)OC(=O)NCC(=O)O", "products": "CNC(=O)c1ccccc1NC(=O)CNC(=O)OC(C)(C)C"}, "reference": {"title": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "authors": "Bayrak, Alp; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "doi": "10.1021/acs.jmedchem.2c01198", "raw": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation | Bayrak, Alp; et al | Journal of Medicinal Chemistry (2022), 65(19), 13365-13384. | 10.1021/acs.jmedchem.2c01198"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-40640859", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 12 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown,", "Rotation (+)", "Synthesis and Biological Evaluation of CF3Se-Substituted α-Amino Acid Derivatives", "By: Han, Zhou-Zhou; et al", "ChemMedChem (2021), 16(20), 3177-3180.", "10.1002/cmdc.202100451"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 2788-84-3 + 13734-34-4 | PRO: 34290-59-0 | RGT: 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"authors\": \"Bayrak, Alp; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40640859\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 12 h, rt\", \"203. Scheme 203 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Synthesis and Biological Evaluation of CF3Se-Substituted α-Amino Acid Derivatives\", \"By: Han, Zhou-Zhou; et al\", \"ChemMedChem (2021), 16(20), 3177-3180.\", \"10.1002/cmdc.202100451\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2788-84-3\", \"13734-34-4\"], \"pro_cas\": [\"34290-59-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2788-84-3", "13734-34-4"], "products": ["34290-59-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40640896", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)(C)N.CC(C)(C)OC(=O)N1CCC(C(=O)O)CC1", "products": "CC(C)(C)NC(=O)C1CCN(C(=O)OC(C)(C)C)CC1"}, "reference": {"title": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation", "authors": "Bayrak, Alp; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.", "doi": "10.1021/acs.jmedchem.2c01198", "raw": "Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation | Bayrak, Alp; et al | Journal of Medicinal Chemistry (2022), 65(19), 13365-13384. | 10.1021/acs.jmedchem.2c01198"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-40640896", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 16 h, rt", "1.2|Reagents: Water; rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate", "By: Critcher, Douglas J.; et al", "Organic Process Research & Development (2024), 28(7), 2646-2658.", "10.1021/acs.oprd.4c00049"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8+Water|7732-18-5/Dichloromethane|75-09-2", "cond_sig": "88aeb9cb", "fam_sig": "d5502e07"}, "raw_data": {"raw_cas": "RCT: 262423-77-8 + 35320-23-1 | PRO: 3034305-31-9 | RGT: 121-44-8 + 148893-10-1 + 7732-18-5 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation\", \"authors\": \"Bayrak, Alp; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(19), 13365-13384.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40640896\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 16 h, rt\", \"1.2\", \"Reagents: Water; rt\", \"69. Scheme 69 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate\", \"By: Critcher, Douglas J.; et al\", \"Organic Process Research & Development (2024), 28(7), 2646-2658.\", \"10.1021/acs.oprd.4c00049\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"262423-77-8\", \"35320-23-1\"], \"pro_cas\": [\"3034305-31-9\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["262423-77-8", "35320-23-1"], "products": ["3034305-31-9"], "reagents": ["Triethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40642152", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 65.0, "time_h": 120.0, "yield_pct": 86.0}, "smiles": {"reactants": "CN1CCN(c2ccc(Nc3ncc4c(n3)-n3ccc(C(=O)O)c3CC4)c([N+](=O)[O-])c2)CC1.Cl.CCc1cccc(CC)c1N", "products": "CCc1cccc(CC)c1NC(=O)c1ccn2c1CCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3[N+](=O)[O-])nc1-2"}, "reference": {"title": "Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor", "authors": "M. Serafim, Ricardo A.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3173-3192.", "doi": "10.1021/acs.jmedchem.1c01165", "raw": "Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor | M. Serafim, Ricardo A.; et al | Journal of Medicinal Chemistry (2022), 65(4), 3173-3192. | 10.1021/acs.jmedchem.1c01165"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-40642152", "1.1|Reagents: Thionyl chloride", "Solvents: Dichloromethane; 0 °C; 48 h, rt", "1.2|Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Acetonitrile; 72 h, 65 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors", "By: Li, Bryan; et al", "Organic Process Research & Development (2021), 25(6), 1440-1453.", "10.1021/acs.oprd.1c00126"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Acetonitrile|75-05-8+Dichloromethane|75-09-2", "cond_sig": "5c91ab3c", "fam_sig": "13f22bf9"}, "raw_data": {"raw_cas": "RCT: 1174323-34-2 + 1818341-12-6 | PRO: 1818341-22-8 | RGT: 7719-09-7 | CAT: 1122-58-3 | SOL: 75-09-2 + 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor\", \"authors\": \"M. Serafim, Ricardo A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3173-3192.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\", \"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40642152\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Dichloromethane; 0 °C; 48 h, rt\", \"1.2\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Acetonitrile; 72 h, 65 °C\", \"409. Scheme 409 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor-Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors\", \"By: Li, Bryan; et al\", \"Organic Process Research & Development (2021), 25(6), 1440-1453.\", \"10.1021/acs.oprd.1c00126\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1174323-34-2\", \"1818341-12-6\"], \"pro_cas\": [\"1818341-22-8\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\", \"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["1174323-34-2", "1818341-12-6"], "products": ["1818341-22-8"], "reagents": ["7719-09-7"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane", "Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40642694", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethyl Sulfoxide", "cas": "67-68-5"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 97.0}, "smiles": {"reactants": "CCCC(CCC)C(=O)O.Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1", "products": "CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1"}, "reference": {"title": "Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine", "authors": "Zhang, Liang; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 4150-4166.", "doi": "10.1021/acs.jmedchem.3c00006", "raw": "Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine | Zhang, Liang; et al | Journal of Medicinal Chemistry (2023), 66(6), 4150-4166. | 10.1021/acs.jmedchem.3c00006"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-40642694", "1.1|Reagents: 4-Methylmorpholine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethyl sulfoxide, Dimethylformamide; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239", "By: Richard-Bildstein, Sylvia; et al", "Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.", "10.1021/acs.jmedchem.0c01588"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+4-Methylmorpholine|+N-Methylmorpholine|109-02-4/Dimethyl Sulfoxide|67-68-5+Dimethylformamide|68-12-2", "cond_sig": "c6f091ec", "fam_sig": "5401b6f9"}, "raw_data": {"raw_cas": "RCT: 859855-38-2 + 1083224-23-0 | PRO: 2178053-38-6 | RGT: 109-02-4 + 2592-95-2 + 25952-53-8 | SOL: 67-68-5 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine\", \"authors\": \"Zhang, Liang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 4150-4166.\", \"reagents\": [\"4-Methylmorpholine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethyl sulfoxide\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40642694\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethyl sulfoxide, Dimethylformamide; 12 h, rt\", \"333. Scheme 333 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239\", \"By: Richard-Bildstein, Sylvia; et al\", \"Journal of Medicinal Chemistry (2020), 63(24), 15864-15882.\", \"10.1021/acs.jmedchem.0c01588\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"859855-38-2\", \"1083224-23-0\"], \"pro_cas\": [\"2178053-38-6\"], \"rgt_cas\": [\"109-02-4\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"67-68-5\", \"68-12-2\"], \"notes\": [\"alternate reaction conditions also shown\"]}}", "enriched_names": {"reactants": ["859855-38-2", "1083224-23-0"], "products": ["2178053-38-6"], "reagents": ["N-Methylmorpholine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethyl Sulfoxide", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40674244", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 17.083, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)Cc1nnn[nH]1.Cc1ccc(C(=O)C[C@](N)(c2ccc(OCCCCCC(F)(F)F)cc2)C(F)(F)F)cc1", "products": "Cc1ccc(C(=O)C[C@](NC(=O)Cc2nnn[nH]2)(c2ccc(OCCCCCC(F)(F)F)cc2)C(F)(F)F)cc1"}, "reference": {"title": "Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders", "authors": "Turdi, Huji; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(19), 14773-14792.", "doi": "10.1021/acs.jmedchem.1c01356", "raw": "Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders | Turdi, Huji; et al | Journal of Medicinal Chemistry (2021), 64(19), 14773-14792. | 10.1021/acs.jmedchem.1c01356"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-40674244", "1.1|Reagents: Dicyclohexylcarbodiimide", "Solvents: Tetrahydrofuran; 5 min, 0 °C; 1 h, 0 °C; 0 °C → rt; overnight, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Tetrahydrofuran|109-99-9", "cond_sig": "3625a1ea", "fam_sig": "434e9a28"}, "raw_data": {"raw_cas": "RCT: 3075104-37-6 + 62965-35-9 | PRO: 3075104-48-9 | RGT: 538-75-0 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders\", \"authors\": \"Turdi, Huji; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(19), 14773-14792.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40674244\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Solvents: Tetrahydrofuran; 5 min, 0 °C; 1 h, 0 °C; 0 °C → rt; overnight, rt\", \"143. Scheme 143 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-37-6\", \"62965-35-9\"], \"pro_cas\": [\"3075104-48-9\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3075104-37-6", "62965-35-9"], "products": ["3075104-48-9"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40674680", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.0, "yield_pct": 97.0}, "smiles": {"reactants": "C#CCCCC(=O)O.COC(=O)[C@@H](N)Cc1ccc(Oc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)cc1", "products": "C#CCCCC(=O)N[C@@H](Cc1ccc(Oc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)cc1)C(=O)OC"}, "reference": {"title": "Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections", "authors": "Fei, Yue; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(17), 9127-9135.", "doi": "10.1021/acs.jmedchem.9b01832", "raw": "Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections | Fei, Yue; et al | Journal of Medicinal Chemistry (2020), 63(17), 9127-9135. | 10.1021/acs.jmedchem.9b01832"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-40674680", "1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+HBTU|94790-37-1+N-Methylmorpholine|109-02-4/Dimethylformamide|68-12-2", "cond_sig": "39d1d9a0", "fam_sig": "cd89fdb0"}, "raw_data": {"raw_cas": "RCT: 3075104-41-2 + 62965-35-9 | PRO: 3075104-52-5 | RGT: 109-02-4 + 94790-37-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections\", \"authors\": \"Fei, Yue; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(17), 9127-9135.\", \"reagents\": [\"4-Methylmorpholine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40674680\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; overnight, rt\", \"150. Scheme 150 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-41-2\", \"62965-35-9\"], \"pro_cas\": [\"3075104-52-5\"], \"rgt_cas\": [\"109-02-4\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3075104-41-2", "62965-35-9"], "products": ["3075104-52-5"], "reagents": ["N-Methylmorpholine", "HBTU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40675401", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 87.0}, "smiles": {"reactants": "C=C[C@@H]1C[C@]1(N)C(=O)NS(=O)(=O)C1(C)CC1.Cl.C=CCC[C@@H](C)C[C@@H](CC)[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)O", "products": "C=CCC[C@@H](C)C[C@@H](CC)[C@H](NC(=O)OC(C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@]1(C(=O)NS(=O)(=O)C2(C)CC2)C[C@H]1C=C"}, "reference": {"title": "Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection", "authors": "Sun, Li-Qiang; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(23), 14740-14760.", "doi": "10.1021/acs.jmedchem.0c01296", "raw": "Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection | Sun, Li-Qiang; et al | Journal of Medicinal Chemistry (2020), 63(23), 14740-14760. | 10.1021/acs.jmedchem.0c01296"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-40675401", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 18 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein", "By: Tanc, Muhammet; et al", "Journal of Medicinal Chemistry (2024), 67(9), 7068-7087.", "10.1021/acs.jmedchem.3c02402"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 1448440-39-8 + 3056228-30-6 | PRO: 3056228-32-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection\", \"authors\": \"Sun, Li-Qiang; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(23), 14740-14760.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40675401\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 18 h, rt\", \"383. Scheme 383 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein\", \"By: Tanc, Muhammet; et al\", \"Journal of Medicinal Chemistry (2024), 67(9), 7068-7087.\", \"10.1021/acs.jmedchem.3c02402\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1448440-39-8\", \"3056228-30-6\"], \"pro_cas\": [\"3056228-32-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1448440-39-8", "3056228-30-6"], "products": ["3056228-32-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676279", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)C(c1ccccc1)c1ccccc1.Cc1cccc(C[C@H](N)C(=O)NCC#N)c1.O=C(O)C(F)(F)F", "products": "Cc1cccc(C[C@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCC#N)c1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40676279", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "By: Vaidya, Sandeep; et al", "ChemMedChem (2023), 18(16), e202300097.", "10.1002/cmdc.202300097"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 22071-15-4 + 2128731-38-2 | PRO: 3055833-28-5 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676279\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"185. Scheme 185 (1 Reaction)\", \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"By: Vaidya, Sandeep; et al\", \"ChemMedChem (2023), 18(16), e202300097.\", \"10.1002/cmdc.202300097\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"22071-15-4\", \"2128731-38-2\"], \"pro_cas\": [\"3055833-28-5\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["22071-15-4", "2128731-38-2"], "products": ["3055833-28-5"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676289", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)C(c1ccccc1)c1ccccc1.C#CCNC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F", "products": "C#CCNC(=O)[C@H](Cc1cccc(C)c1)NC(=O)C(c1ccccc1)c1ccccc1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40676289", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 3405-77-4 + 2760538-77-8 | PRO: 2760538-90-5 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676289\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"170. Scheme 170 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3405-77-4\", \"2760538-77-8\"], \"pro_cas\": [\"2760538-90-5\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3405-77-4", "2760538-77-8"], "products": ["2760538-90-5"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676290", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)C(c1ccccc1)c1ccccc1.C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@@H](N)Cc2cccc(C)c2)C(N)=O)c1.O=C(O)C(F)(F)F", "products": "C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@H](Cc2cccc(C)c2)NC(=O)C(c2ccccc2)c2ccccc2)C(N)=O)c1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40676290", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma", "By: Weiss, Matthew M.; et al", "Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.", "10.1021/acs.jmedchem.3c01823"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 131747-42-7 + 1000373-79-4 | PRO: 1799836-52-4 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676290\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"140. Scheme 140 (1 Reaction)\", \"Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma\", \"By: Weiss, Matthew M.; et al\", \"Journal of Medicinal Chemistry (2024), 67(13), 10548-10566.\", \"10.1021/acs.jmedchem.3c01823\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"131747-42-7\", \"1000373-79-4\"], \"pro_cas\": [\"1799836-52-4\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["131747-42-7", "1000373-79-4"], "products": ["1799836-52-4"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676296", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)C(c1ccccc1)c1ccccc1.C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@@H](N)Cc2cccc(I)c2)C(N)=O)c1.O=C(O)C(F)(F)F", "products": "C=CCOC(=O)c1cccc(COC[C@H](NC(=O)[C@H](Cc2cccc(I)c2)NC(=O)C(c2ccccc2)c2ccccc2)C(N)=O)c1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40676296", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma", "By: Bollu, Lakshmi R.; et al", "Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.", "10.1021/acs.jmedchem.2c00771"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 138227-63-1 + 1923836-34-3 | PRO: 2872618-08-9 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676296\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"202. Scheme 202 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma\", \"By: Bollu, Lakshmi R.; et al\", \"Journal of Medicinal Chemistry (2022), 65(23), 15642-15662.\", \"10.1021/acs.jmedchem.2c00771\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"138227-63-1\", \"1923836-34-3\"], \"pro_cas\": [\"2872618-08-9\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["138227-63-1", "1923836-34-3"], "products": ["2872618-08-9"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676310", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 83.0}, "smiles": {"reactants": "Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.COC(=O)c1cn(CCC[C@H](N)C(N)=O)nn1.O=C(O)C(F)(F)F", "products": "COC(=O)c1cn(CCC[C@H](NC(=O)[C@H](Cc2cccc(C)c2)NC(=O)OC(C)(C)C)C(N)=O)nn1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-40676310", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction", "By: Christie, Louisa A.; et al", "Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.", "10.1021/acs.jmedchem.3c00630"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 1368644-06-7 + 902152-76-5 | PRO: 2919851-73-1 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676310\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"120. Scheme 120 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction\", \"By: Christie, Louisa A.; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 11718-11731.\", \"10.1021/acs.jmedchem.3c00630\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1368644-06-7\", \"902152-76-5\"], \"pro_cas\": [\"2919851-73-1\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["1368644-06-7", "902152-76-5"], "products": ["2919851-73-1"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676316", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 89.0}, "smiles": {"reactants": "Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.COC(=O)Cn1cc(COC[C@H](N)C(N)=O)nn1.O=C(O)C(F)(F)F", "products": "COC(=O)Cn1cc(COC[C@H](NC(=O)[C@H](Cc2cccc(C)c2)NC(=O)OC(C)(C)C)C(N)=O)nn1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-40676316", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 117-34-0 + 3026371-20-7 | PRO: 3026370-34-0 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676316\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"139. Scheme 139 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"117-34-0\", \"3026371-20-7\"], \"pro_cas\": [\"3026370-34-0\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["117-34-0", "3026371-20-7"], "products": ["3026370-34-0"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676331", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 82.0}, "smiles": {"reactants": "Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.C#C[C@@H](N)COCc1cccc(C(=O)OCC=C)c1.O=C(O)C(F)(F)F", "products": "C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)OC(C)(C)C.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-40676331", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 89-86-1 + 251105-80-3 | PRO: 2892016-13-4 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676331\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"75. Scheme 75 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"89-86-1\", \"251105-80-3\"], \"pro_cas\": [\"2892016-13-4\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["89-86-1", "251105-80-3"], "products": ["2892016-13-4"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676332", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Isobutyl chloroformate", "cas": "543-27-1", "role": "BASE"}, {"name": "NaOH", "cas": "1310-73-2", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "Sodium hydroxide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": -25.0, "time_h": 1.333, "yield_pct": 91.0}, "smiles": {"reactants": "Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.N#CCN.O=S(=O)(O)O", "products": "Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)NCC#N)c1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-40676332", "1.1|Reagents: 4-Methylmorpholine, Isobutyl chloroformate", "Solvents: Tetrahydrofuran; -25 °C; 10 min, -25 °C; 30 min, rt", "1.2|Reagents: Sodium hydroxide", "Solvents: Water; 10 min, -25 °C; 30 min, rt", "Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells", "By: Takashima, Katsuki; et al", "Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.", "10.1016/j.bmcl.2022.129034"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+Isobutyl chloroformate|543-27-1+N-Methylmorpholine|109-02-4+NaOH|1310-73-2+Sodium hydroxide|/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "8202d752", "fam_sig": "f026cbb6"}, "raw_data": {"raw_cas": "RCT: 64-04-0 + 126802-52-6 | PRO: 154078-50-9 | RGT: 109-02-4 + 543-27-1 + 1310-73-2 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"4-Methylmorpholine\", \"Isobutyl chloroformate\", \"Sodium hydroxide\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676332\", \"1.1\", \"Reagents: 4-Methylmorpholine, Isobutyl chloroformate\", \"Solvents: Tetrahydrofuran; -25 °C; 10 min, -25 °C; 30 min, rt\", \"1.2\", \"Reagents: Sodium hydroxide\", \"Solvents: Water; 10 min, -25 °C; 30 min, rt\", \"116. Scheme 116 (1 Reaction)\", \"Structure-activity relationship study of 4,5-didehydroguadiscine, an aporphine alkaloid showing potent melanogenesis-inhibitory activity in B16 melanoma cells\", \"By: Takashima, Katsuki; et al\", \"Bioorganic & Medicinal Chemistry Letters (2022), 78, 129034.\", \"10.1016/j.bmcl.2022.129034\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"64-04-0\", \"126802-52-6\"], \"pro_cas\": [\"154078-50-9\"], \"rgt_cas\": [\"109-02-4\", \"543-27-1\", \"1310-73-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": [\"inverse addition (stage 2)\"]}}", "enriched_names": {"reactants": ["64-04-0", "126802-52-6"], "products": ["154078-50-9"], "reagents": ["N-Methylmorpholine", "543-27-1", "NaOH"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676337", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Isobutyl chloroformate", "cas": "543-27-1", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": -25.0, "time_h": 0.667, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O.C#CCN", "products": "C#CCNC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-40676337", "1.1|Reagents: 4-Methylmorpholine, Isobutyl chloroformate", "Solvents: Tetrahydrofuran; -25 °C", "1.2|10 min, -25 °C; 30 min, rt", "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "By: Morozova, Alisa; et al", "European Journal of Medicinal Chemistry (2024), 266, 116101.", "10.1016/j.ejmech.2023.116101"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+Isobutyl chloroformate|543-27-1+N-Methylmorpholine|109-02-4/Tetrahydrofuran|109-99-9", "cond_sig": "4d99427a", "fam_sig": "c490e3d0"}, "raw_data": {"raw_cas": "RCT: 753-90-2 + 66572-56-3 | PRO: 1691123-87-1 | RGT: 109-02-4 + 543-27-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"4-Methylmorpholine\", \"Isobutyl chloroformate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676337\", \"1.1\", \"Reagents: 4-Methylmorpholine, Isobutyl chloroformate\", \"Solvents: Tetrahydrofuran; -25 °C\", \"1.2\", \"10 min, -25 °C; 30 min, rt\", \"33. Scheme 33 (1 Reaction)\", \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"By: Morozova, Alisa; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"10.1016/j.ejmech.2023.116101\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"753-90-2\", \"66572-56-3\"], \"pro_cas\": [\"1691123-87-1\"], \"rgt_cas\": [\"109-02-4\", \"543-27-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["753-90-2", "66572-56-3"], "products": ["1691123-87-1"], "reagents": ["N-Methylmorpholine", "543-27-1"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676339", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "Isobutyl chloroformate", "cas": "543-27-1", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": -25.0, "time_h": 0.667, "yield_pct": 88.0}, "smiles": {"reactants": "Cc1cccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c1.C#CCN", "products": "C#CCNC(=O)[C@H](Cc1cccc(C)c1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-40676339", "1.1|Reagents: 4-Methylmorpholine, Isobutyl chloroformate", "Solvents: Tetrahydrofuran; -25 °C", "1.2|10 min, -25 °C; 30 min, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA)", "By: Conlon, Patrick R.; et al", "Organic Process Research & Development (2022), 26(8), 2124-2137.", "10.1021/acs.oprd.1c00449"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+Isobutyl chloroformate|543-27-1+N-Methylmorpholine|109-02-4/Tetrahydrofuran|109-99-9", "cond_sig": "4d99427a", "fam_sig": "c490e3d0"}, "raw_data": {"raw_cas": "RCT: 156-87-6 + 13734-34-4 | PRO: 120125-31-7 | RGT: 109-02-4 + 543-27-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"4-Methylmorpholine\", \"Isobutyl chloroformate\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676339\", \"1.1\", \"Reagents: 4-Methylmorpholine, Isobutyl chloroformate\", \"Solvents: Tetrahydrofuran; -25 °C\", \"1.2\", \"10 min, -25 °C; 30 min, rt\", \"118. Scheme 118 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Process Development and GMP Production of a Conjugate Warhead: Auristatin F-HPA-Ala/TFA (XMT-1864/TFA)\", \"By: Conlon, Patrick R.; et al\", \"Organic Process Research & Development (2022), 26(8), 2124-2137.\", \"10.1021/acs.oprd.1c00449\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"156-87-6\", \"13734-34-4\"], \"pro_cas\": [\"120125-31-7\"], \"rgt_cas\": [\"109-02-4\", \"543-27-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["156-87-6", "13734-34-4"], "products": ["120125-31-7"], "reagents": ["N-Methylmorpholine", "543-27-1"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676380", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 90.0}, "smiles": {"reactants": "O=C(O)C(c1ccccc1)c1ccccc1.C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F", "products": "C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)C(c1ccccc1)c1ccccc1.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)C(c1ccccc1)c1ccccc1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-40676380", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity", "By: Chen, Chen; et al", "Journal of Medicinal Chemistry (2022), 65(4), 3667-3683.", "10.1021/acs.jmedchem.1c02225"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 95-54-5 + 2766688-22-4 | PRO: 2766688-34-8 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676380\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"123. Scheme 123 (1 Reaction)\", \"Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity\", \"By: Chen, Chen; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 3667-3683.\", \"10.1021/acs.jmedchem.1c02225\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"95-54-5\", \"2766688-22-4\"], \"pro_cas\": [\"2766688-34-8\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["95-54-5", "2766688-22-4"], "products": ["2766688-34-8"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40676385", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1ccc(I)cc1.C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@@H](N)Cc1cccc(C)c1.O=C(O)C(F)(F)F", "products": "C#C[C@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)c1ccc(I)cc1.C#C[C@@H](COCc1cccc(C(=O)OCC=C)c1)NC(=O)[C@H](Cc1cccc(C)c1)NC(=O)c1ccc(I)cc1"}, "reference": {"title": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "authors": "Behring, Lydia; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "doi": "10.1021/acs.jmedchem.2c01360", "raw": "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins | Behring, Lydia; et al | Journal of Medicinal Chemistry (2023), 66(6), 3818-3851. | 10.1021/acs.jmedchem.2c01360"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40676385", "1.1|Reagents: Diisopropylethylamine, PyBOP", "Solvents: Tetrahydrofuran; 3 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency", "By: Guzelj, Samo; et al", "ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.", "10.1021/acsmedchemlett.2c00121"], "signatures": {"cond_key": "none/none/Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "563cac48", "fam_sig": "e8cd760b"}, "raw_data": {"raw_cas": "RCT: 3032888-56-2 + 4530-20-5 | PRO: 3032888-68-6 | RGT: 7087-68-5 + 128625-52-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"authors\": \"Behring, Lydia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"reagents\": [\"Diisopropylethylamine\", \"PyBOP\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40676385\", \"1.1\", \"Reagents: Diisopropylethylamine, PyBOP\", \"Solvents: Tetrahydrofuran; 3 h, rt\", \"157. Scheme 157 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency\", \"By: Guzelj, Samo; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.\", \"10.1021/acsmedchemlett.2c00121\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3032888-56-2\", \"4530-20-5\"], \"pro_cas\": [\"3032888-68-6\"], \"rgt_cas\": [\"7087-68-5\", \"128625-52-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["3032888-56-2", "4530-20-5"], "products": ["3032888-68-6"], "reagents": ["N,N-Diisopropylethylamine", "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40678189", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 55.5, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)[C@@H](N)Cc1ccccc1.Cl", "products": "COC(=O)C(Cc1ccccc1)NC(=O)c1cccc2c1-c1ccccc1C2=O"}, "reference": {"title": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "authors": "Narayanan, Dilip; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "doi": "10.1021/acs.jmedchem.2c00830", "raw": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery | Narayanan, Dilip; et al | Journal of Medicinal Chemistry (2022), 65(21), 14481-14526. | 10.1021/acs.jmedchem.2c00830"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40678189", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, 0 °C", "1.2|5 - 55 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen", "By: Hekking, Koen F. W.; et al", "Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.", "10.1021/acs.jmedchem.3c02206"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 18942-49-9 + 51179-05-6 | PRO: 3076055-71-2 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"authors\": \"Narayanan, Dilip; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40678189\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, 0 °C\", \"1.2\", \"5 - 55 h, rt\", \"337. Scheme 337 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen\", \"By: Hekking, Koen F. W.; et al\", \"Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.\", \"10.1021/acs.jmedchem.3c02206\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"18942-49-9\", \"51179-05-6\"], \"pro_cas\": [\"3076055-71-2\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["tert-Butyldimethylsilyl chloride", "51179-05-6"], "products": ["3076055-71-2"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40678191", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 55.5, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)C(N)c1ccccc1.Cl", "products": "COC(=O)C(NC(=O)c1cccc2c1-c1ccccc1C2=O)c1ccccc1"}, "reference": {"title": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "authors": "Narayanan, Dilip; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "doi": "10.1021/acs.jmedchem.2c00830", "raw": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery | Narayanan, Dilip; et al | Journal of Medicinal Chemistry (2022), 65(21), 14481-14526. | 10.1021/acs.jmedchem.2c00830"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40678191", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, 0 °C", "1.2|5 - 55 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "By: Narayanan, Dilip; et al", "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "10.1021/acs.jmedchem.2c00830"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 6223-83-2 + 7524-50-7 | PRO: 3031559-90-4 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"authors\": \"Narayanan, Dilip; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40678191\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, 0 °C\", \"1.2\", \"5 - 55 h, rt\", \"336. Scheme 336 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"By: Narayanan, Dilip; et al\", \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"10.1021/acs.jmedchem.2c00830\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6223-83-2\", \"7524-50-7\"], \"pro_cas\": [\"3031559-90-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["6223-83-2", "7524-50-7"], "products": ["3031559-90-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.168044", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40678197", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 55.5, "yield_pct": 84.0}, "smiles": {"reactants": "O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)CC(N)Cc1ccccc1.Cl", "products": "COC(=O)CC(Cc1ccccc1)NC(=O)c1cccc2c1-c1ccccc1C2=O"}, "reference": {"title": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "authors": "Narayanan, Dilip; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "doi": "10.1021/acs.jmedchem.2c00830", "raw": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery | Narayanan, Dilip; et al | Journal of Medicinal Chemistry (2022), 65(21), 14481-14526. | 10.1021/acs.jmedchem.2c00830"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-40678197", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, 0 °C", "1.2|5 - 55 h, rt", "Identification of ss-Glucocerebrosidase Activators for Glucosylceramide hydrolysis", "By: Schulze, Monika-Sarah E. D.; et al", "ChemMedChem (2024), 19(7), e202300548.", "10.1002/cmdc.202300548"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 871124-99-1 + 3087166-25-1 | PRO: 3087166-26-2 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"authors\": \"Narayanan, Dilip; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40678197\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, 0 °C\", \"1.2\", \"5 - 55 h, rt\", \"324. Scheme 324 (1 Reaction)\", \"Identification of ss-Glucocerebrosidase Activators for Glucosylceramide hydrolysis\", \"By: Schulze, Monika-Sarah E. D.; et al\", \"ChemMedChem (2024), 19(7), e202300548.\", \"10.1002/cmdc.202300548\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"871124-99-1\", \"3087166-25-1\"], \"pro_cas\": [\"3087166-26-2\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["871124-99-1", "3087166-25-1"], "products": ["3087166-26-2"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.182486", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40678201", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 55.5, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)c1cccc2c1-c1ccccc1C2=O.COC(=O)CC(N)c1ccccc1.Cl", "products": "COC(=O)CC(NC(=O)c1cccc2c1-c1ccccc1C2=O)c1ccccc1"}, "reference": {"title": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery", "authors": "Narayanan, Dilip; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.", "doi": "10.1021/acs.jmedchem.2c00830", "raw": "Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery | Narayanan, Dilip; et al | Journal of Medicinal Chemistry (2022), 65(21), 14481-14526. | 10.1021/acs.jmedchem.2c00830"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40678201", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 30 min, 0 °C", "1.2|5 - 55 h, rt", "A new chemotype with promise against Trypanosoma cruzi", "By: Wang, Xiaofang; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.", "10.1016/j.bmcl.2019.126778"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 3430-33-9 + 438575-58-7 | PRO: 2581109-86-4 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery\", \"authors\": \"Narayanan, Dilip; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(21), 14481-14526.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40678201\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 30 min, 0 °C\", \"1.2\", \"5 - 55 h, rt\", \"327. Scheme 327 (1 Reaction)\", \"A new chemotype with promise against Trypanosoma cruzi\", \"By: Wang, Xiaofang; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(1), 126778.\", \"10.1016/j.bmcl.2019.126778\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3430-33-9\", \"438575-58-7\"], \"pro_cas\": [\"2581109-86-4\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3430-33-9", "438575-58-7"], "products": ["2581109-86-4"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40724155", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Trimethyl borate", "cas": "121-43-7", "role": "UNK"}, {"name": "Lithium diisopropylamide", "cas": "4111-54-0", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Water", "cas": "7732-18-5"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 30.0, "time_h": 18.25, "yield_pct": 99.0}, "smiles": {"reactants": "CN.Cl.COc1ccc2occ(C(=O)O)c2c1", "products": "CNC(=O)c1c(B(O)O)oc2ccc(OC)cc12"}, "reference": {"title": "Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target", "authors": "Wilson, Caroline; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(1), 409-423.", "doi": "10.1021/acs.jmedchem.1c01586", "raw": "Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target | Wilson, Caroline; et al | Journal of Medicinal Chemistry (2022), 65(1), 409-423. | 10.1021/acs.jmedchem.1c01586"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-40724155", "1.1|Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 16 h, 30 °C", "1.2|Solvents: Water; 15 min", "1.3|Reagents: Trimethyl borate, Lithium diisopropylamide", "Solvents: Tetrahydrofuran; -78 °C; 2 h, -78 °C", "1.4|Reagents: Hydrochloric acid", "Solvents: Water", "Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease", "By: Kilpelainen, Tommi P.; et al", "Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.", "10.1021/acs.jmedchem.3c00235"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Hydrochloric acid|7647-01-0+Lithium diisopropylamide|4111-54-0+Pyridine|110-86-1+Trimethyl borate|121-43-7/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "8f908fe9", "fam_sig": "bc53cafc"}, "raw_data": {"raw_cas": "RCT: 830-96-6 + 13515-97-4 | PRO: 3007690-42-5 | RGT: 110-86-1 + 25952-53-8 + 121-43-7 + 4111-54-0 + 7647-01-0 | SOL: 7732-18-5 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target\", \"authors\": \"Wilson, Caroline; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(1), 409-423.\", \"reagents\": [\"Pyridine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Trimethyl borate\", \"Lithium diisopropylamide\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Water\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40724155\", \"1.1\", \"Reagents: Pyridine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 16 h, 30 °C\", \"1.2\", \"Solvents: Water; 15 min\", \"1.3\", \"Reagents: Trimethyl borate, Lithium diisopropylamide\", \"Solvents: Tetrahydrofuran; -78 °C; 2 h, -78 °C\", \"1.4\", \"Reagents: Hydrochloric acid\", \"Solvents: Water\", \"228. Scheme 228 (1 Reaction)\", \"Nonpeptidic Oxazole Based Prolyl Oligopeptidase Ligands with Disease Modifying Effects on alpha Synuclein Mouse Models of Parkinson Disease\", \"By: Kilpelainen, Tommi P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(11), 7475-7496.\", \"10.1021/acs.jmedchem.3c00235\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"830-96-6\", \"13515-97-4\"], \"pro_cas\": [\"3007690-42-5\"], \"rgt_cas\": [\"110-86-1\", \"25952-53-8\", \"121-43-7\", \"4111-54-0\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"7732-18-5\", \"109-99-9\"], \"notes\": [\"pyridine also used as a solvent in stage 1\"]}}", "enriched_names": {"reactants": ["830-96-6", "13515-97-4"], "products": ["3007690-42-5"], "reagents": ["Pyridine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "121-43-7", "4111-54-0", "Hydrochloric acid"], "catalysts": [], "solvents": ["Water", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40724397", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "O=C(O)COP(=O)(OCc1ccccc1)OCc1ccccc1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(F)c([C@H]3CC[C@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)n(COC(=O)[C@@H](N)C(C)C)c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)cc2[nH]1)[C@@H](C)OC", "products": "COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(F)c([C@H]3CC[C@@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)n(COC(=O)[C@@H](NC(=O)COP(=O)(OCc6ccccc6)OCc6ccccc6)C(C)C)c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)cc2[nH]1)[C@@H](C)OC"}, "reference": {"title": "Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530)", "authors": "Randolph, John T.; et al", "citation": "Journal of Medicinal Chemistry (2020), 63(19), 11034-11044.", "doi": "10.1021/acs.jmedchem.0c00956", "raw": "Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530) | Randolph, John T.; et al | Journal of Medicinal Chemistry (2020), 63(19), 11034-11044. | 10.1021/acs.jmedchem.0c00956"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-40724397", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1626337-85-6 + 2896197-79-6 | PRO: 2896197-80-9 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530)\", \"authors\": \"Randolph, John T.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2020), 63(19), 11034-11044.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40724397\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"488. Scheme 488 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1626337-85-6\", \"2896197-79-6\"], \"pro_cas\": [\"2896197-80-9\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1626337-85-6", "2896197-79-6"], "products": ["2896197-80-9"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40728145", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 89.0}, "smiles": {"reactants": "COc1ccc(C(=O)O)cc1[N+](=O)[O-].CN(C)c1ccc(N)cc1", "products": "COc1ccc(C(=O)Nc2ccc(N(C)C)cc2)cc1[N+](=O)[O-]"}, "reference": {"title": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "authors": "Liu, Yonghua; et al", "citation": "European Journal of Medicinal Chemistry (2022), 228, 114033.", "doi": "10.1016/j.ejmech.2021.114033", "raw": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus | Liu, Yonghua; et al | European Journal of Medicinal Chemistry (2022), 228, 114033. | 10.1016/j.ejmech.2021.114033"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-40728145", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 16 h, rt", "Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis", "By: Sarkar, Dipayan; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.", "10.1021/acs.jmedchem.3c01431"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 616-79-5 + 27578-60-5 | PRO: 1455659-36-5 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"authors\": \"Liu, Yonghua; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40728145\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 16 h, rt\", \"196. Scheme 196 (1 Reaction)\", \"Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis\", \"By: Sarkar, Dipayan; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16728-16761.\", \"10.1021/acs.jmedchem.3c01431\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"616-79-5\", \"27578-60-5\"], \"pro_cas\": [\"1455659-36-5\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["616-79-5", "27578-60-5"], "products": ["1455659-36-5"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40728186", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 87.0}, "smiles": {"reactants": "CN(C)c1ccc(N)cc1.CC(C)Oc1ccc(C(=O)O)cc1[N+](=O)[O-]", "products": "CC(C)Oc1ccc(C(=O)Nc2ccc(N(C)C)cc2)cc1[N+](=O)[O-]"}, "reference": {"title": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "authors": "Liu, Yonghua; et al", "citation": "European Journal of Medicinal Chemistry (2022), 228, 114033.", "doi": "10.1016/j.ejmech.2021.114033", "raw": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus | Liu, Yonghua; et al | European Journal of Medicinal Chemistry (2022), 228, 114033. | 10.1016/j.ejmech.2021.114033"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-40728186", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 16 h, rt", "Double bond geometry shown", "NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer", "By: Xu, Zhongren; et al", "Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.", "10.1021/acs.jmedchem.3c00063"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 38194-50-2 + 2450-71-7 | PRO: 3033692-54-2 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"authors\": \"Liu, Yonghua; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40728186\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 16 h, rt\", \"261. Scheme 261 (1 Reaction)\", \"Double bond geometry shown\", \"NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer\", \"By: Xu, Zhongren; et al\", \"Journal of Medicinal Chemistry (2023), 66(12), 7813-7833.\", \"10.1021/acs.jmedchem.3c00063\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"38194-50-2\", \"2450-71-7\"], \"pro_cas\": [\"3033692-54-2\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["38194-50-2", "2450-71-7"], "products": ["3033692-54-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40728187", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 89.0}, "smiles": {"reactants": "CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1.O=C(O)c1ccc(OCCCCl)c(F)c1", "products": "CN1CCN(Cc2ccc(NC(=O)c3ccc(OCCCCl)c(F)c3)cc2C(F)(F)F)CC1"}, "reference": {"title": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "authors": "Liu, Yonghua; et al", "citation": "European Journal of Medicinal Chemistry (2022), 228, 114033.", "doi": "10.1016/j.ejmech.2021.114033", "raw": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus | Liu, Yonghua; et al | European Journal of Medicinal Chemistry (2022), 228, 114033. | 10.1016/j.ejmech.2021.114033"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-40728187", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 16 h, rt", "Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine", "By: Jiang, Xueyang; et al", "European Journal of Medicinal Chemistry (2021), 223, 113663.", "10.1016/j.ejmech.2021.113663"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 157688-46-5 + 404827-77-6 | PRO: 2798054-37-0 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"authors\": \"Liu, Yonghua; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40728187\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 16 h, rt\", \"95. Scheme 95 (1 Reaction)\", \"Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer’s disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine\", \"By: Jiang, Xueyang; et al\", \"European Journal of Medicinal Chemistry (2021), 223, 113663.\", \"10.1016/j.ejmech.2021.113663\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"157688-46-5\", \"404827-77-6\"], \"pro_cas\": [\"2798054-37-0\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["157688-46-5", "404827-77-6"], "products": ["2798054-37-0"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40728204", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 93.0}, "smiles": {"reactants": "CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1.O=C(O)c1ccc(OCCCCl)c(Cl)c1", "products": "CN1CCN(Cc2ccc(NC(=O)c3ccc(OCCCCl)c(Cl)c3)cc2C(F)(F)F)CC1"}, "reference": {"title": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "authors": "Liu, Yonghua; et al", "citation": "European Journal of Medicinal Chemistry (2022), 228, 114033.", "doi": "10.1016/j.ejmech.2021.114033", "raw": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus | Liu, Yonghua; et al | European Journal of Medicinal Chemistry (2022), 228, 114033. | 10.1016/j.ejmech.2021.114033"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-40728204", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 16 h, rt", "Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors", "By: Reddy, Julakanti Satyanarayana; et al", "Organic Process Research & Development (2021), 25(4), 817-830.", "10.1021/acs.oprd.0c00515"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 446-32-2 + 3473-63-0 + 3179-63-3 | PRO: 557093-50-2 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"authors\": \"Liu, Yonghua; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40728204\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 16 h, rt\", \"102. Scheme 102 (1 Reaction)\", \"Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors\", \"By: Reddy, Julakanti Satyanarayana; et al\", \"Organic Process Research & Development (2021), 25(4), 817-830.\", \"10.1021/acs.oprd.0c00515\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"446-32-2\", \"3473-63-0\", \"3179-63-3\"], \"pro_cas\": [\"557093-50-2\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["446-32-2", "3473-63-0", "3179-63-3"], "products": ["557093-50-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40728206", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 87.0}, "smiles": {"reactants": "CN1CCN(Cc2ccc(N)cc2C(F)(F)F)CC1.O=C(O)c1ccc(OCCCl)c([N+](=O)[O-])c1", "products": "CN1CCN(Cc2ccc(NC(=O)c3ccc(OCCCl)c([N+](=O)[O-])c3)cc2C(F)(F)F)CC1"}, "reference": {"title": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus", "authors": "Liu, Yonghua; et al", "citation": "European Journal of Medicinal Chemistry (2022), 228, 114033.", "doi": "10.1016/j.ejmech.2021.114033", "raw": "Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus | Liu, Yonghua; et al | European Journal of Medicinal Chemistry (2022), 228, 114033. | 10.1016/j.ejmech.2021.114033"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-40728206", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 16 h, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 3075104-36-5 + 62965-35-9 | PRO: 3075104-47-8 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus\", \"authors\": \"Liu, Yonghua; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2022), 228, 114033.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40728206\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 16 h, rt\", \"148. Scheme 148 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-36-5\", \"62965-35-9\"], \"pro_cas\": [\"3075104-47-8\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3075104-36-5", "62965-35-9"], "products": ["3075104-47-8"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.183329", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40761032", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 94.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2o1.CC(C)(C)OC(=O)NCC1CCCN(CCCCN)C1", "products": "CC(C)(C)OC(=O)NCC1CCCN(CCCCNC(=O)c2cc3ccccc3o2)C1"}, "reference": {"title": "Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands", "authors": "Shaik, Anver Basha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.", "doi": "10.1021/acs.jmedchem.1c01353", "raw": "Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands | Shaik, Anver Basha; et al | Journal of Medicinal Chemistry (2021), 64(20), 15313-15333. | 10.1021/acs.jmedchem.1c01353"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40761032", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "By: Novotna, Katerina; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "10.1021/acs.jmedchem.3c01681"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Tetrahydrofuran|109-99-9", "cond_sig": "86e9832a", "fam_sig": "47dee7bd"}, "raw_data": {"raw_cas": "RCT: 139551-74-9 + 2851863-10-8 | PRO: 2861234-25-3 | RGT: 530-62-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands\", \"authors\": \"Shaik, Anver Basha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40761032\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt\", \"154. Scheme 154 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"By: Novotna, Katerina; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"10.1021/acs.jmedchem.3c01681\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"139551-74-9\", \"2851863-10-8\"], \"pro_cas\": [\"2861234-25-3\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["139551-74-9", "2851863-10-8"], "products": ["2861234-25-3"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185076", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40761033", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 99.0}, "smiles": {"reactants": "O=C(O)c1cc2ccccc2[nH]1.CC(C)(C)OC(=O)NCC1CCCN(CCCCN)C1", "products": "CC(C)(C)OC(=O)NCC1CCCN(CCCCNC(=O)c2cc3ccccc3[nH]2)C1"}, "reference": {"title": "Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands", "authors": "Shaik, Anver Basha; et al", "citation": "Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.", "doi": "10.1021/acs.jmedchem.1c01353", "raw": "Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands | Shaik, Anver Basha; et al | Journal of Medicinal Chemistry (2021), 64(20), 15313-15333. | 10.1021/acs.jmedchem.1c01353"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-40761033", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury", "By: Cui, Yingjun; et al", "Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.", "10.1021/acs.jmedchem.1c01583"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+N,N'-Carbonyldiimidazole|530-62-1/Tetrahydrofuran|109-99-9", "cond_sig": "86e9832a", "fam_sig": "47dee7bd"}, "raw_data": {"raw_cas": "RCT: 171814-05-4 + 2757278-37-6 | PRO: 2757278-20-7 | RGT: 530-62-1 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands\", \"authors\": \"Shaik, Anver Basha; et al\", \"citation\": \"Journal of Medicinal Chemistry (2021), 64(20), 15313-15333.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40761033\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Tetrahydrofuran; 0 °C; 0 °C → rt; overnight, rt\", \"67. Scheme 67 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Elastase inhibitor cyclotheonellazole A: Total synthesis and in vivo biological evaluation for acute lung injury\", \"By: Cui, Yingjun; et al\", \"Journal of Medicinal Chemistry (2022), 65(4), 2971-2987.\", \"10.1021/acs.jmedchem.1c01583\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"171814-05-4\", \"2757278-37-6\"], \"pro_cas\": [\"2757278-20-7\"], \"rgt_cas\": [\"530-62-1\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["171814-05-4", "2757278-37-6"], "products": ["2757278-20-7"], "reagents": ["N,N'-Carbonyldiimidazole"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185076", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40763299", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.0, "yield_pct": 83.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCCCC(=O)O.COC(=O)c1cc(OC(=O)OC(C)(C)C)c2cc(N)ccc2c1", "products": "COC(=O)c1cc(OC(=O)OC(C)(C)C)c2cc(NC(=O)CCCCNC(=O)OC(C)(C)C)ccc2c1"}, "reference": {"title": "Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach", "authors": "Iannelli, Giulia; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(17), 11574-11606.", "doi": "10.1021/acs.jmedchem.2c00252", "raw": "Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach | Iannelli, Giulia; et al | Journal of Medicinal Chemistry (2022), 65(17), 11574-11606. | 10.1021/acs.jmedchem.2c00252"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-40763299", "1.1|Reagents: Dicyclohexylcarbodiimide", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 8 - 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "By: Huang, Danling; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "10.1016/j.bmcl.2021.128006"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 1092569-57-7 + 2566496-79-3 | PRO: 2656367-52-9 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach\", \"authors\": \"Iannelli, Giulia; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(17), 11574-11606.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40763299\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 8 - 12 h, rt\", \"181. Scheme 181 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"By: Huang, Danling; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"10.1016/j.bmcl.2021.128006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1092569-57-7\", \"2566496-79-3\"], \"pro_cas\": [\"2656367-52-9\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": [\"Steglich esterification\"]}}", "enriched_names": {"reactants": ["1092569-57-7", "2566496-79-3"], "products": ["2656367-52-9"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40763496", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 86.0}, "smiles": {"reactants": "CN(C)C(=O)[C@@H](CSCc1cc(Br)ccc1C(=O)OCC(Cl)(Cl)Cl)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](CO)C(=O)O", "products": "CN(C)C(=O)[C@@H](CSCc1cc(Br)ccc1C(=O)OCC(Cl)(Cl)Cl)NC(=O)[C@@H](CO)NC(=O)OC(C)(C)C"}, "reference": {"title": "Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction", "authors": "Begnini, Fabio; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3473-3517.", "doi": "10.1021/acs.jmedchem.1c01975", "raw": "Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction | Begnini, Fabio; et al | Journal of Medicinal Chemistry (2022), 65(4), 3473-3517. | 10.1021/acs.jmedchem.1c01975"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-40763496", "1.1|Reagents: Hydrochloric acid", "Solvents: 1,4-Dioxane; 1 h, rt", "1.2|Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Acetonitrile; 2 h, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies", "By: Jung, Sascha; et al", "Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.", "10.1021/acs.jmedchem.1c01002"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5/1,4-Dioxane|123-91-1+Acetonitrile|75-05-8", "cond_sig": "d4d7a20a", "fam_sig": "e29585d8"}, "raw_data": {"raw_cas": "RCT: 455-40-3 + 2761157-88-2 | PRO: 2761157-40-6 | RGT: 7647-01-0 + 7087-68-5 + 25952-53-8 | SOL: 123-91-1 + 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction\", \"authors\": \"Begnini, Fabio; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3473-3517.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\", \"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40763496\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: 1,4-Dioxane; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Acetonitrile; 2 h, rt\", \"50. Scheme 50 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies\", \"By: Jung, Sascha; et al\", \"Journal of Medicinal Chemistry (2021), 64(16), 12322-12358.\", \"10.1021/acs.jmedchem.1c01002\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-40-3\", \"2761157-88-2\"], \"pro_cas\": [\"2761157-40-6\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\", \"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-40-3", "2761157-88-2"], "products": ["2761157-40-6"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["1,4-Dioxane", "Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40776767", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Sodium chloride", "cas": "7647-14-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 83.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CC(C)C.Cl.CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "COC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C"}, "reference": {"title": "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities", "authors": "Wang, Juan; et al", "citation": "European Journal of Medicinal Chemistry (2021), 215, 113267.", "doi": "10.1016/j.ejmech.2021.113267", "raw": "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities | Wang, Juan; et al | European Journal of Medicinal Chemistry (2021), 215, 113267. | 10.1016/j.ejmech.2021.113267"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-40776767", "1.1|Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; rt → 0 °C", "1.2|Reagents: Diisopropylethylamine; 0 °C → rt; 1 h, rt", "1.3|Reagents: Sodium chloride", "Solvents: Water; rt", "Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7", "By: Li, Cuixia; et al", "Journal of Medicinal Chemistry (2023), 66(17), 11855-11868.", "10.1021/acs.jmedchem.2c01795"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium chloride|7647-14-5/Tetrahydrofuran|109-99-9+Water|7732-18-5", "cond_sig": "ab8607fb", "fam_sig": "c19e7b20"}, "raw_data": {"raw_cas": "RCT: 456-22-4 + 24477-57-4 | PRO: 913248-18-7 | RGT: 2592-95-2 + 148893-10-1 + 7087-68-5 + 7647-14-5 | SOL: 109-99-9 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities\", \"authors\": \"Wang, Juan; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 215, 113267.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\", \"Sodium chloride\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40776767\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; rt → 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 0 °C → rt; 1 h, rt\", \"1.3\", \"Reagents: Sodium chloride\", \"Solvents: Water; rt\", \"95. Scheme 95 (1 Reaction)\", \"Structure-Based Ligand Discovery Targeting the Transmembrane Domain of Frizzled Receptor FZD7\", \"By: Li, Cuixia; et al\", \"Journal of Medicinal Chemistry (2023), 66(17), 11855-11868.\", \"10.1021/acs.jmedchem.2c01795\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"456-22-4\", \"24477-57-4\"], \"pro_cas\": [\"913248-18-7\"], \"rgt_cas\": [\"2592-95-2\", \"148893-10-1\", \"7087-68-5\", \"7647-14-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["456-22-4", "24477-57-4"], "products": ["913248-18-7"], "reagents": ["1-Hydroxybenzotriazole", "HATU", "N,N-Diisopropylethylamine", "7647-14-5"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40804341", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 94.0}, "smiles": {"reactants": "Nc1ccccc1N.CN1c2ccc(F)cc2C(=O)N2CCc3c(n(C(=O)OC(C)(C)C)c4ccc(OCCCC(=O)O)cc34)C21", "products": "CN1c2ccc(F)cc2C(=O)N2CCc3c(n(C(=O)OC(C)(C)C)c4ccc(OCCCC(=O)Nc5ccccc5N)cc34)C21"}, "reference": {"title": "Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy", "authors": "Wu, Shanchao; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(6), 4818-4831.", "doi": "10.1021/acs.jmedchem.1c02026", "raw": "Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy | Wu, Shanchao; et al | Journal of Medicinal Chemistry (2022), 65(6), 4818-4831. | 10.1021/acs.jmedchem.1c02026"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40804341", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold", "By: Gillis, Eric P.; et al", "Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.", "10.1021/acs.jmedchem.2c01732"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 1626337-85-6 + 2417093-05-9 | PRO: 2250415-70-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy\", \"authors\": \"Wu, Shanchao; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(6), 4818-4831.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40804341\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 2 h, rt\", \"482. Scheme 482 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold\", \"By: Gillis, Eric P.; et al\", \"Journal of Medicinal Chemistry (2023), 66(3), 1941-1954.\", \"10.1021/acs.jmedchem.2c01732\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1626337-85-6\", \"2417093-05-9\"], \"pro_cas\": [\"2250415-70-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1626337-85-6", "2417093-05-9"], "products": ["2250415-70-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40804554", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.017, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CCOC(OCC)[C@H](N)C(C)C", "products": "CCOC(OCC)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21)C(C)C"}, "reference": {"title": "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models", "authors": "Winter-Holt, Jon J.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.", "doi": "10.1021/acs.jmedchem.1c01871", "raw": "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models | Winter-Holt, Jon J.; et al | Journal of Medicinal Chemistry (2022), 65(4), 3306-3331. | 10.1021/acs.jmedchem.1c01871"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40804554", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; > 1 min, rt", "1.2|Solvents: Dichloromethane; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 5106-98-9 + 772318-79-3 | PRO: 2892016-33-8 | RGT: 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models\", \"authors\": \"Winter-Holt, Jon J.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40804554\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; > 1 min, rt\", \"1.2\", \"Solvents: Dichloromethane; 2 h, rt\", \"69. Scheme 69 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"5106-98-9\", \"772318-79-3\"], \"pro_cas\": [\"2892016-33-8\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["5106-98-9", "772318-79-3"], "products": ["2892016-33-8"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40804566", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 100.0}, "smiles": {"reactants": "COC(CN)OC.O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21", "products": "COC(CNC(=O)[C@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21)OC"}, "reference": {"title": "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models", "authors": "Winter-Holt, Jon J.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.", "doi": "10.1021/acs.jmedchem.1c01871", "raw": "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models | Winter-Holt, Jon J.; et al | Journal of Medicinal Chemistry (2022), 65(4), 3306-3331. | 10.1021/acs.jmedchem.1c01871"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40804566", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 1 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies", "By: Alford, Joshua S.; et al", "ACS Medicinal Chemistry Letters (2022), 13(7), 1137-1143.", "10.1021/acsmedchemlett.2c00167"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 721884-82-8 + 891724-25-7 | PRO: 2834724-50-2 | RGT: 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models\", \"authors\": \"Winter-Holt, Jon J.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40804566\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 1 h, rt\", \"422. Scheme 422 (2 Reactions)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies\", \"By: Alford, Joshua S.; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(7), 1137-1143.\", \"10.1021/acsmedchemlett.2c00167\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"721884-82-8\", \"891724-25-7\"], \"pro_cas\": [\"2834724-50-2\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["721884-82-8", "891724-25-7"], "products": ["2834724-50-2"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40804610", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 92.0}, "smiles": {"reactants": "C[C@@H](N)CO.O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21", "products": "C[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21"}, "reference": {"title": "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models", "authors": "Winter-Holt, Jon J.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.", "doi": "10.1021/acs.jmedchem.1c01871", "raw": "Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models | Winter-Holt, Jon J.; et al | Journal of Medicinal Chemistry (2022), 65(4), 3306-3331. | 10.1021/acs.jmedchem.1c01871"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-40804610", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 4 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening", "By: Tian, Xinrong; et al", "Journal of Medicinal Chemistry (2022), 65(21), 14391-14408.", "10.1021/acs.jmedchem.2c00670"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 104-94-9 + 37784-17-1 | PRO: 877594-22-4 | RGT: 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models\", \"authors\": \"Winter-Holt, Jon J.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3306-3331.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40804610\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 4 h, rt\", \"350. Scheme 350 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening\", \"By: Tian, Xinrong; et al\", \"Journal of Medicinal Chemistry (2022), 65(21), 14391-14408.\", \"10.1021/acs.jmedchem.2c00670\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"104-94-9\", \"37784-17-1\"], \"pro_cas\": [\"877594-22-4\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["104-94-9", "37784-17-1"], "products": ["877594-22-4"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40807666", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "6-Chloro-1-hydroxybenzotriazole", "cas": "26198-19-6", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.083, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](CCCNC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)CCCNC(=O)OCc1ccccc1.Cl", "products": "COC(=O)[C@H](CCCNC(=O)OCc1ccccc1)NC(=O)[C@H](CCCNC(=O)OCc1ccccc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-Diketopiperazines", "authors": "Grant, Thomas M.; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(4), 632-640.", "doi": "10.1021/acsmedchemlett.1c00683", "raw": "Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-Diketopiperazines | Grant, Thomas M.; et al | ACS Medicinal Chemistry Letters (2022), 13(4), 632-640. | 10.1021/acsmedchemlett.1c00683"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-40807666", "1.1|Reagents: Diisopropylethylamine, 6-Chloro-1-hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 5 min, rt", "1.2|5 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors", "By: Wei, Huiqiang; et al", "European Journal of Medicinal Chemistry (2022), 227, 113918.", "10.1016/j.ejmech.2021.113918"], "signatures": {"cond_key": "none/none/6-Chloro-1-hydroxybenzotriazole|26198-19-6+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "13d861ec", "fam_sig": "3ad4c340"}, "raw_data": {"raw_cas": "RCT: 7372-30-7 + 2576-47-8 | PRO: 2416910-54-6 | RGT: 7087-68-5 + 26198-19-6 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-Diketopiperazines\", \"authors\": \"Grant, Thomas M.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(4), 632-640.\", \"reagents\": [\"Diisopropylethylamine\", \"6-Chloro-1-hydroxybenzotriazole\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40807666\", \"1.1\", \"Reagents: Diisopropylethylamine, 6-Chloro-1-hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 5 min, rt\", \"1.2\", \"5 h, rt\", \"5. Scheme 5 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors\", \"By: Wei, Huiqiang; et al\", \"European Journal of Medicinal Chemistry (2022), 227, 113918.\", \"10.1016/j.ejmech.2021.113918\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"7372-30-7\", \"2576-47-8\"], \"pro_cas\": [\"2416910-54-6\"], \"rgt_cas\": [\"7087-68-5\", \"26198-19-6\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["7372-30-7", "2576-47-8"], "products": ["2416910-54-6"], "reagents": ["N,N-Diisopropylethylamine", "26198-19-6", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40816897", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}, {"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 80.0}, "smiles": {"reactants": "C=C(F)C(=O)O.CC1(C)OB(c2ccc(N)cc2)OC1(C)C", "products": "C=C(F)C(=O)Nc1ccc(B2OC(C)(C)C(C)(C)O2)cc1"}, "reference": {"title": "Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor", "authors": "Li, Huiqiong; et al", "citation": "European Journal of Medicinal Chemistry (2024), 272, 116473.", "doi": "10.1016/j.ejmech.2024.116473", "raw": "Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor | Li, Huiqiong; et al | European Journal of Medicinal Chemistry (2024), 272, 116473. | 10.1016/j.ejmech.2024.116473"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-40816897", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Tetrahydrofuran, Ethyl acetate; 4 h, rt", "From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase", "By: Juillet, Charlotte; et al", "Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.", "10.1021/acs.jmedchem.0c02064"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/Ethyl Acetate|141-78-6+Tetrahydrofuran|109-99-9", "cond_sig": "9d7ed0d4", "fam_sig": "9d13876a"}, "raw_data": {"raw_cas": "RCT: 2434-03-9 + 2450-71-7 | PRO: 2698371-56-9 | RGT: 7087-68-5 + 68957-94-8 | SOL: 109-99-9 + 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor\", \"authors\": \"Li, Huiqiong; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 272, 116473.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\", \"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40816897\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Tetrahydrofuran, Ethyl acetate; 4 h, rt\", \"72. Scheme 72 (1 Reaction)\", \"From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase\", \"By: Juillet, Charlotte; et al\", \"Journal of Medicinal Chemistry (2021), 64(2), 1197-1219.\", \"10.1021/acs.jmedchem.0c02064\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2434-03-9\", \"2450-71-7\"], \"pro_cas\": [\"2698371-56-9\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\", \"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["2434-03-9", "2450-71-7"], "products": ["2698371-56-9"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Tetrahydrofuran", "Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40818679", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 81.0}, "smiles": {"reactants": "COc1ccc(CCN)cc1OC.O=C(O)CCc1c[nH]c2ccccc12", "products": "COc1ccc(CCNC(=O)CCc2c[nH]c3ccccc23)cc1OC"}, "reference": {"title": "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease", "authors": "Zhou, Jianhui; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.", "doi": "10.1021/acs.jmedchem.4c00159", "raw": "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease | Zhou, Jianhui; et al | Journal of Medicinal Chemistry (2024), 67(11), 8836-8861. | 10.1021/acs.jmedchem.4c00159"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40818679", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 4 h, rt", "Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors", "By: Tormaehlen, Niklas M.; et al", "Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.", "10.1021/acs.jmedchem.0c01773"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 1417404-28-4 + 62-53-3 | PRO: 2614241-99-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease\", \"authors\": \"Zhou, Jianhui; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40818679\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 4 h, rt\", \"353. Scheme 353 (1 Reaction)\", \"Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors\", \"By: Tormaehlen, Niklas M.; et al\", \"Journal of Medicinal Chemistry (2022), 65(2), 1225-1242.\", \"10.1021/acs.jmedchem.0c01773\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1417404-28-4\", \"62-53-3\"], \"pro_cas\": [\"2614241-99-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1417404-28-4", "62-53-3"], "products": ["2614241-99-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40818683", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)CCc1c[nH]c2ccccc12.CCOc1ccc(CCN)cc1OC", "products": "CCOc1ccc(CCNC(=O)CCc2c[nH]c3ccccc23)cc1OC"}, "reference": {"title": "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease", "authors": "Zhou, Jianhui; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.", "doi": "10.1021/acs.jmedchem.4c00159", "raw": "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease | Zhou, Jianhui; et al | Journal of Medicinal Chemistry (2024), 67(11), 8836-8861. | 10.1021/acs.jmedchem.4c00159"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-40818683", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 4 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 50-79-3 + 2387522-87-2 | PRO: 2387522-88-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease\", \"authors\": \"Zhou, Jianhui; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40818683\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 4 h, rt\", \"395. Scheme 395 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"50-79-3\", \"2387522-87-2\"], \"pro_cas\": [\"2387522-88-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["50-79-3", "2387522-87-2"], "products": ["2387522-88-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40818685", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)CCc1c[nH]c2ccccc12.NCCc1ccc2c(c1)OCO2", "products": "O=C(CCc1c[nH]c2ccccc12)NCCc1ccc2c(c1)OCO2"}, "reference": {"title": "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease", "authors": "Zhou, Jianhui; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.", "doi": "10.1021/acs.jmedchem.4c00159", "raw": "Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease | Zhou, Jianhui; et al | Journal of Medicinal Chemistry (2024), 67(11), 8836-8861. | 10.1021/acs.jmedchem.4c00159"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40818685", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 4 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "2277bd3c", "fam_sig": "58da7331"}, "raw_data": {"raw_cas": "RCT: 1912-47-6 + 36377-59-0 | PRO: 2565618-12-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer’s Disease\", \"authors\": \"Zhou, Jianhui; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8836-8861.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40818685\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 4 h, rt\", \"435. Scheme 435 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1912-47-6\", \"36377-59-0\"], \"pro_cas\": [\"2565618-12-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1912-47-6", "36377-59-0"], "products": ["2565618-12-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40832861", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 5.0, "time_h": 5.0, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)Oc1cc(Oc2cnc(C(=O)N3CCC3)cn2)cc(C(=O)O)c1.CCOP(=O)(Cn1ccc(N)n1)OCC", "products": "CCOP(=O)(Cn1ccc(NC(=O)c2cc(Oc3cnc(C(=O)N4CCC4)cn3)cc(OC(C)C)c2)n1)OCC"}, "reference": {"title": "Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)", "authors": "Shi, Yan; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(5), 4291-4317.", "doi": "10.1021/acs.jmedchem.1c02110", "raw": "Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132) | Shi, Yan; et al | Journal of Medicinal Chemistry (2022), 65(5), 4291-4317. | 10.1021/acs.jmedchem.1c02110"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-40832861", "1.1|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 5 h, 0 - 5 °C", "AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2", "By: Narjes, Frank; et al", "Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.", "10.1021/acs.jmedchem.1c01197"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|/Dichloromethane|75-09-2", "cond_sig": "b6616d09", "fam_sig": "e02d9956"}, "raw_data": {"raw_cas": "RCT: 722-92-9 + 2101238-41-7 | PRO: 2101238-42-8 | RGT: 25952-53-8 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)\", \"authors\": \"Shi, Yan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(5), 4291-4317.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40832861\", \"1.1\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 5 h, 0 - 5 °C\", \"436. Scheme 436 (1 Reaction)\", \"AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2\", \"By: Narjes, Frank; et al\", \"Journal of Medicinal Chemistry (2021), 64(18), 13807-13829.\", \"10.1021/acs.jmedchem.1c01197\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"722-92-9\", \"2101238-41-7\"], \"pro_cas\": [\"2101238-42-8\"], \"rgt_cas\": [\"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["722-92-9", "2101238-41-7"], "products": ["2101238-42-8"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40871414", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N'-Carbonyldiimidazole", "cas": "530-62-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1,1′-Carbonyldiimidazole", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 100.0}, "smiles": {"reactants": "O=C(O)c1[nH]c(Cc2ccc(-c3ccccc3)cc2)nc(=O)c1OCc1ccccc1.CCOC(=O)CN.Cl", "products": "CCOC(=O)CNC(=O)c1[nH]c(Cc2ccc(-c3ccccc3)cc2)nc(=O)c1OCc1ccccc1"}, "reference": {"title": "Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia", "authors": "Fukuda, Takeshi; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2024), 108, 129799.", "doi": "10.1016/j.bmcl.2024.129799", "raw": "Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia | Fukuda, Takeshi; et al | Bioorganic & Medicinal Chemistry Letters (2024), 108, 129799. | 10.1016/j.bmcl.2024.129799"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-40871414", "1.1|Reagents: 1,1′-Carbonyldiimidazole", "Solvents: Dimethylformamide; 1 h, rt", "1.2|Reagents: Diisopropylethylamine; 15 h, rt", "Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors", "By: Xu, Shujing; et al", "Bioorganic & Medicinal Chemistry (2022), 53, 116531.", "10.1016/j.bmc.2021.116531"], "signatures": {"cond_key": "none/none/1,1′-Carbonyldiimidazole|+Diisopropylethylamine|+N,N'-Carbonyldiimidazole|530-62-1+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7259750f", "fam_sig": "cd0051f8"}, "raw_data": {"raw_cas": "RCT: 87120-72-7 + 473257-46-4 | PRO: 2055145-99-6 | RGT: 530-62-1 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia\", \"authors\": \"Fukuda, Takeshi; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2024), 108, 129799.\", \"reagents\": [\"1,1′-Carbonyldiimidazole\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40871414\", \"1.1\", \"Reagents: 1,1′-Carbonyldiimidazole\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; 15 h, rt\", \"350. Scheme 350 (1 Reaction)\", \"Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors\", \"By: Xu, Shujing; et al\", \"Bioorganic & Medicinal Chemistry (2022), 53, 116531.\", \"10.1016/j.bmc.2021.116531\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"87120-72-7\", \"473257-46-4\"], \"pro_cas\": [\"2055145-99-6\"], \"rgt_cas\": [\"530-62-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["87120-72-7", "473257-46-4"], "products": ["2055145-99-6"], "reagents": ["N,N'-Carbonyldiimidazole", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40877727", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Oxalyl chloride", "cas": "79-37-8", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 26.25, "yield_pct": 91.0}, "smiles": {"reactants": "COC(=O)C(CC(=O)O)c1ccc(C(F)(F)F)cc1.Nc1ccc(-c2ncco2)cc1", "products": "COC(=O)C(CC(=O)Nc1ccc(-c2ncco2)cc1)c1ccc(C(F)(F)F)cc1"}, "reference": {"title": "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer", "authors": "Sharma, Horrick; et al", "citation": "European Journal of Medicinal Chemistry (2024), 275, 116598.", "doi": "10.1016/j.ejmech.2024.116598", "raw": "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer | Sharma, Horrick; et al | European Journal of Medicinal Chemistry (2024), 275, 116598. | 10.1016/j.ejmech.2024.116598"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-40877727", "1.1|Reagents: Oxalyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 0 °C; 15 min, 0 °C; 2 h, 0 °C → rt", "1.2|Reagents: Triethylamine", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; 24 h, rt", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/Hydrochloric acid|7647-01-0+Oxalyl chloride|79-37-8+Triethylamine|121-44-8/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "f1c4c537", "fam_sig": "b40a84fd"}, "raw_data": {"raw_cas": "RCT: 69-72-7 + 772318-79-3 | PRO: 2892016-29-2 | RGT: 79-37-8 + 121-44-8 + 7647-01-0 | CAT: 68-12-2 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer\", \"authors\": \"Sharma, Horrick; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 275, 116598.\", \"reagents\": [\"Oxalyl chloride\", \"Triethylamine\", \"Hydrochloric acid\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40877727\", \"1.1\", \"Reagents: Oxalyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 0 °C; 15 min, 0 °C; 2 h, 0 °C → rt\", \"1.2\", \"Reagents: Triethylamine\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; 24 h, rt\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; rt\", \"478. Scheme 478 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"69-72-7\", \"772318-79-3\"], \"pro_cas\": [\"2892016-29-2\"], \"rgt_cas\": [\"79-37-8\", \"121-44-8\", \"7647-01-0\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["69-72-7", "772318-79-3"], "products": ["2892016-29-2"], "reagents": ["79-37-8", "Triethylamine", "Hydrochloric acid"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40877745", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 82.0}, "smiles": {"reactants": "O=C(O)CCc1ccccc1.CCOC(=O)CC(N)c1cccc(Cl)c1", "products": "CCOC(=O)CC(NC(=O)CCc1ccccc1)c1cccc(Cl)c1"}, "reference": {"title": "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer", "authors": "Sharma, Horrick; et al", "citation": "European Journal of Medicinal Chemistry (2024), 275, 116598.", "doi": "10.1016/j.ejmech.2024.116598", "raw": "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer | Sharma, Horrick; et al | European Journal of Medicinal Chemistry (2024), 275, 116598. | 10.1016/j.ejmech.2024.116598"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-40877745", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 24 h, rt", "Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway", "By: Rastelli, Ettore J.; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.", "10.1016/j.bmcl.2021.128167"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 4942-47-6 + 153086-78-3 | PRO: 1263772-35-5 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer\", \"authors\": \"Sharma, Horrick; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 275, 116598.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40877745\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 24 h, rt\", \"208. Scheme 208 (1 Reaction)\", \"Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway\", \"By: Rastelli, Ettore J.; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 46, 128167.\", \"10.1016/j.bmcl.2021.128167\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4942-47-6\", \"153086-78-3\"], \"pro_cas\": [\"1263772-35-5\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4942-47-6", "153086-78-3"], "products": ["1263772-35-5"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40877747", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 24.0, "yield_pct": 93.0}, "smiles": {"reactants": "O=C(O)Cc1ccccc1.CCOC(=O)CC(N)c1cccc(Cl)c1", "products": "CCOC(=O)CC(NC(=O)Cc1ccccc1)c1cccc(Cl)c1"}, "reference": {"title": "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer", "authors": "Sharma, Horrick; et al", "citation": "European Journal of Medicinal Chemistry (2024), 275, 116598.", "doi": "10.1016/j.ejmech.2024.116598", "raw": "Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer | Sharma, Horrick; et al | European Journal of Medicinal Chemistry (2024), 275, 116598. | 10.1016/j.ejmech.2024.116598"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-40877747", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 24 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 40004-69-1 + 2760538-76-7 | PRO: 2760538-93-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and biological characterization of an orally bioavailable lactate dehydrogenase-A inhibitor against pancreatic cancer\", \"authors\": \"Sharma, Horrick; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 275, 116598.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40877747\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 24 h, rt\", \"199. Scheme 199 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"40004-69-1\", \"2760538-76-7\"], \"pro_cas\": [\"2760538-93-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["40004-69-1", "2760538-76-7"], "products": ["2760538-93-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40881641", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 13.5, "yield_pct": 94.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1.C[C@H](N)c1ccc([N+](=O)[O-])cc1.Cl", "products": "C[C@H](NC(=O)c1cn(C2CC2)c2cc(N3CCN(C(=O)OC(C)(C)C)CC3)c(F)cc2c1=O)c1ccc([N+](=O)[O-])cc1"}, "reference": {"title": "Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug", "authors": "Ross, Catherine L.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 9599-9612.", "doi": "10.1021/acs.jmedchem.4c00724", "raw": "Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug | Ross, Catherine L.; et al | Journal of Medicinal Chemistry (2024), 67(11), 9599-9612. | 10.1021/acs.jmedchem.4c00724"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40881641", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 30 min, 25 °C", "1.2|12 h, 25 °C", "Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity", "By: Elsner, Jan; et al", "Journal of Medicinal Chemistry (2021), 64(17), 12670-12679.", "10.1021/acs.jmedchem.1c00635"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "71ba53e8", "fam_sig": "f5a9bca4"}, "raw_data": {"raw_cas": "RCT: 579-66-8 + 2820453-44-7 | PRO: 2820453-45-8 | RGT: 7087-68-5 + 94790-37-1 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug\", \"authors\": \"Ross, Catherine L.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 9599-9612.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40881641\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 30 min, 25 °C\", \"1.2\", \"12 h, 25 °C\", \"396. Scheme 396 (1 Reaction)\", \"Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity\", \"By: Elsner, Jan; et al\", \"Journal of Medicinal Chemistry (2021), 64(17), 12670-12679.\", \"10.1021/acs.jmedchem.1c00635\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"579-66-8\", \"2820453-44-7\"], \"pro_cas\": [\"2820453-45-8\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["579-66-8", "2820453-44-7"], "products": ["2820453-45-8"], "reagents": ["N,N-Diisopropylethylamine", "HBTU"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40890886", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "cas": "128625-52-5", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 12.333, "yield_pct": 81.0}, "smiles": {"reactants": "CCCC[C@@H](N)C(=O)OC.Cl.O=C(O)CC(O)/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1", "products": "CCCC[C@H](NC(=O)CC(O)/C=C/CCSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)OC"}, "reference": {"title": "Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice", "authors": "Belayet, Jawad B.; et al", "citation": "Journal of Medicinal Chemistry (2022), 65(4), 3388-3403.", "doi": "10.1021/acs.jmedchem.1c01928", "raw": "Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice | Belayet, Jawad B.; et al | Journal of Medicinal Chemistry (2022), 65(4), 3388-3403. | 10.1021/acs.jmedchem.1c01928"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40890886", "1.1|Reagents: PyBOP", "Solvents: Dichloromethane; 20 min, 0 °C", "1.2|Reagents: Diisopropylethylamine; 12 h, 0 °C → 25 °C", "1.3|Reagents: Ammonium chloride", "Solvents: Water", "Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors", "By: Ma, Shuchao; et al", "Bioorganic & Medicinal Chemistry (2020), 28(19), 115683.", "10.1016/j.bmc.2020.115683"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate|128625-52-5+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "89bb1cbe", "fam_sig": "8ab5b869"}, "raw_data": {"raw_cas": "RCT: 59-67-6 + 30235-28-0 | PRO: 1328467-31-7 | RGT: 128625-52-5 + 7087-68-5 + 12125-02-9 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice\", \"authors\": \"Belayet, Jawad B.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2022), 65(4), 3388-3403.\", \"reagents\": [\"PyBOP\", \"Diisopropylethylamine\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40890886\", \"1.1\", \"Reagents: PyBOP\", \"Solvents: Dichloromethane; 20 min, 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 12 h, 0 °C → 25 °C\", \"1.3\", \"Reagents: Ammonium chloride\", \"Solvents: Water\", \"274. Scheme 274 (1 Reaction)\", \"Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors\", \"By: Ma, Shuchao; et al\", \"Bioorganic & Medicinal Chemistry (2020), 28(19), 115683.\", \"10.1016/j.bmc.2020.115683\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"59-67-6\", \"30235-28-0\"], \"pro_cas\": [\"1328467-31-7\"], \"rgt_cas\": [\"128625-52-5\", \"7087-68-5\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["59-67-6", "30235-28-0"], "products": ["1328467-31-7"], "reagents": ["Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate", "N,N-Diisopropylethylamine", "12125-02-9"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40892466", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.5, "yield_pct": 86.0}, "smiles": {"reactants": "Cc1noc(C)c1COc1ccccc1C(=O)O.NCCc1ccc(S(N)(=O)=O)cc1", "products": "Cc1noc(C)c1COc1ccccc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1"}, "reference": {"title": "Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance", "authors": "He, Siyu; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294.", "doi": "10.1021/acsmedchemlett.2c00175", "raw": "Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance | He, Siyu; et al | ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294. | 10.1021/acsmedchemlett.2c00175"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-40892466", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, 25 °C", "1.2|12 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity", "By: Guzelj, Samo; et al", "Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.", "10.1021/acs.jmedchem.1c00644"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 3031625-39-2 | PRO: 3031089-24-1 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance\", \"authors\": \"He, Siyu; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(8), 1286-1294.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40892466\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, 25 °C\", \"1.2\", \"12 h, 25 °C\", \"58. Scheme 58 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity\", \"By: Guzelj, Samo; et al\", \"Journal of Medicinal Chemistry (2021), 64(11), 7809-7838.\", \"10.1021/acs.jmedchem.1c00644\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"3031625-39-2\"], \"pro_cas\": [\"3031089-24-1\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4530-20-5", "3031625-39-2"], "products": ["3031089-24-1"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40893413", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 20.25, "yield_pct": 85.0}, "smiles": {"reactants": "CCOC(=O)CC[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)OC(C)(C)C)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O", "products": "CCOC(=O)CC[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)CNC(=O)OC(C)(C)C)C(=O)OCC"}, "reference": {"title": "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency", "authors": "Guzelj, Samo; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.", "doi": "10.1021/acsmedchemlett.2c00121", "raw": "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency | Guzelj, Samo; et al | ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277. | 10.1021/acsmedchemlett.2c00121"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-40893413", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C → rt; 4 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-Diketopiperazines", "By: Grant, Thomas M.; et al", "ACS Medicinal Chemistry Letters (2022), 13(4), 632-640.", "10.1021/acsmedchemlett.1c00683"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "c68e4a5c", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 2480-93-5 + 5874-75-9 | PRO: 19792-09-7 | RGT: 76-05-1 + 7087-68-5 + 1892-57-5 + 2592-95-2 | CAT: 1122-58-3 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40893413\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C → rt; 4 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt\", \"4. Scheme 4 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-Diketopiperazines\", \"By: Grant, Thomas M.; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(4), 632-640.\", \"10.1021/acsmedchemlett.1c00683\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2480-93-5\", \"5874-75-9\"], \"pro_cas\": [\"19792-09-7\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2480-93-5", "5874-75-9"], "products": ["19792-09-7"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40893416", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 20.25, "yield_pct": 94.0}, "smiles": {"reactants": "CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C12CC3CC(CC(C3)C1)C2)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O", "products": "CCOC(=O)CC[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C12CC3CC(CC(C3)C1)C2)C(=O)OCC"}, "reference": {"title": "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency", "authors": "Guzelj, Samo; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.", "doi": "10.1021/acsmedchemlett.2c00121", "raw": "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency | Guzelj, Samo; et al | ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277. | 10.1021/acsmedchemlett.2c00121"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-40893416", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C → rt; 4 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "c68e4a5c", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 2387522-98-5 + 1148157-29-2 | PRO: 2387523-20-6 | RGT: 76-05-1 + 7087-68-5 + 1892-57-5 + 2592-95-2 | CAT: 1122-58-3 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40893416\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C → rt; 4 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt\", \"158. Scheme 158 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-98-5\", \"1148157-29-2\"], \"pro_cas\": [\"2387523-20-6\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2387522-98-5", "1148157-29-2"], "products": ["2387523-20-6"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40893417", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "cas": "1892-57-5", "role": "UNK"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 20.25, "yield_pct": 93.0}, "smiles": {"reactants": "CCOC(=O)CC[C@@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)OC(C)(C)C)C(=O)OCC.CC(C)(C)OC(=O)NCC(=O)O", "products": "CCOC(=O)CC[C@@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)CNC(=O)OC(C)(C)C)C(=O)OCC"}, "reference": {"title": "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency", "authors": "Guzelj, Samo; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.", "doi": "10.1021/acsmedchemlett.2c00121", "raw": "Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency | Guzelj, Samo; et al | ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277. | 10.1021/acsmedchemlett.2c00121"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-40893417", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C → rt; 4 h, rt", "1.2|Reagents: Diisopropylethylamine", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole", "Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide|1892-57-5+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "c68e4a5c", "fam_sig": "276c92b5"}, "raw_data": {"raw_cas": "RCT: 69-72-7 + 251105-80-3 | PRO: 2892016-09-8 | RGT: 76-05-1 + 7087-68-5 + 1892-57-5 + 2592-95-2 | CAT: 1122-58-3 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency\", \"authors\": \"Guzelj, Samo; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(8), 1270-1277.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide\", \"1-Hydroxybenzotriazole\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40893417\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C → rt; 4 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, 1-Hydroxybenzotriazole\", \"Catalysts: 4-(Dimethylamino)pyridine; 0 °C → rt; overnight, rt\", \"7. Scheme 7 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"69-72-7\", \"251105-80-3\"], \"pro_cas\": [\"2892016-09-8\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"1892-57-5\", \"2592-95-2\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["69-72-7", "251105-80-3"], "products": ["2892016-09-8"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide", "1-Hydroxybenzotriazole"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40893914", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 5.0, "yield_pct": 82.0}, "smiles": {"reactants": "COC(=O)CCCCCCC(=O)O.COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(N)cc3)CC1)C2", "products": "COC(=O)CCCCCCC(=O)Nc1ccc(CN2CCC(CC3Cc4cc(OC)c(OC)cc4C3=O)CC2)cc1"}, "reference": {"title": "Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects", "authors": "Nepali, Kunal; et al", "citation": "European Journal of Medicinal Chemistry (2023), 248, 115054.", "doi": "10.1016/j.ejmech.2022.115054", "raw": "Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects | Nepali, Kunal; et al | European Journal of Medicinal Chemistry (2023), 248, 115054. | 10.1016/j.ejmech.2022.115054"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-40893914", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 5 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "[18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging", "By: De Dominicis, Carlo; et al", "ACS Medicinal Chemistry Letters (2020), 11(5), 933-939.", "10.1021/acsmedchemlett.9b00677"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 15761-39-4 + 6373-46-2 | PRO: 2309071-94-9 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects\", \"authors\": \"Nepali, Kunal; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2023), 248, 115054.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40893914\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 5 h, rt\", \"40. Scheme 40 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"[18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging\", \"By: De Dominicis, Carlo; et al\", \"ACS Medicinal Chemistry Letters (2020), 11(5), 933-939.\", \"10.1021/acsmedchemlett.9b00677\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15761-39-4\", \"6373-46-2\"], \"pro_cas\": [\"2309071-94-9\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["15761-39-4", "6373-46-2"], "products": ["2309071-94-9"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40910307", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 21.0, "time_h": 2.0, "yield_pct": 96.0}, "smiles": {"reactants": "N[C@@H]1CCC[C@@H](O)C1.Cc1ccc(F)c2cc(C(=O)O)[nH]c12", "products": "Cc1ccc(F)c2cc(C(=O)N[C@@H]3CCC[C@@H](O)C3)[nH]c12"}, "reference": {"title": "Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies", "authors": "Alford, Joshua S.; et al", "citation": "ACS Medicinal Chemistry Letters (2022), 13(7), 1137-1143.", "doi": "10.1021/acsmedchemlett.2c00167", "raw": "Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies | Alford, Joshua S.; et al | ACS Medicinal Chemistry Letters (2022), 13(7), 1137-1143. | 10.1021/acsmedchemlett.2c00167"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-40910307", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 2 h, 21 °C", "Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies", "By: Lampe, John W.; et al", "ACS Medicinal Chemistry Letters (2021), 12(10), 1539-1545.", "10.1021/acsmedchemlett.1c00272"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 721884-82-8 + 891724-25-7 | PRO: 2834724-50-2 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies\", \"authors\": \"Alford, Joshua S.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2022), 13(7), 1137-1143.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40910307\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 2 h, 21 °C\", \"Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies\", \"By: Lampe, John W.; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(10), 1539-1545.\", \"10.1021/acsmedchemlett.1c00272\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"721884-82-8\", \"891724-25-7\"], \"pro_cas\": [\"2834724-50-2\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["721884-82-8", "891724-25-7"], "products": ["2834724-50-2"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40920475", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 20.0, "yield_pct": 86.0}, "smiles": {"reactants": "NC12CC3CC(CC(C3)C1)C2.Cc1cc(C)n(C(C(=O)O)n2nc(C)cc2C)n1", "products": "Cc1cc(C)n(C(C(=O)NC23CC4CC(CC(C4)C2)C3)n2nc(C)cc2C)n1"}, "reference": {"title": "Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma", "authors": "Morelli, Maria Beatrice; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 9662-9685.", "doi": "10.1021/acs.jmedchem.4c00821", "raw": "Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma | Morelli, Maria Beatrice; et al | Journal of Medicinal Chemistry (2024), 67(11), 9662-9685. | 10.1021/acs.jmedchem.4c00821"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-40920475", "1.1|Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; rt; 20 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain", "By: Hartz, Richard A.; et al", "Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.", "10.1021/acs.jmedchem.1c00472"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6/Dimethylformamide|68-12-2", "cond_sig": "7dec0139", "fam_sig": "3e568a1e"}, "raw_data": {"raw_cas": "RCT: 16937-99-8 + 19056-40-7 | PRO: 1644249-96-6 | RGT: 7087-68-5 + 125700-67-6 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma\", \"authors\": \"Morelli, Maria Beatrice; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 9662-9685.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40920475\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; rt; 20 h, rt\", \"355. Scheme 355 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain\", \"By: Hartz, Richard A.; et al\", \"Journal of Medicinal Chemistry (2021), 64(15), 11090-11128.\", \"10.1021/acs.jmedchem.1c00472\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"16937-99-8\", \"19056-40-7\"], \"pro_cas\": [\"1644249-96-6\"], \"rgt_cas\": [\"7087-68-5\", \"125700-67-6\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["16937-99-8", "19056-40-7"], "products": ["1644249-96-6"], "reagents": ["N,N-Diisopropylethylamine", "125700-67-6"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40922525", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.5, "yield_pct": 92.0}, "smiles": {"reactants": "COc1cccc(C(=O)O)c1F.CC(C)(C)OC(=O)N1CC[C@H](n2cc(-c3ccncc3)c(-c3cccc(N)c3)n2)C1", "products": "COc1cccc(C(=O)Nc2cccc(-c3nn([C@H]4CCN(C(=O)OC(C)(C)C)C4)cc3-c3ccncc3)c2)c1F"}, "reference": {"title": "Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations", "authors": "Thomson, Clare; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.", "doi": "10.1021/acs.jmedchem.4c00227", "raw": "Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations | Thomson, Clare; et al | Journal of Medicinal Chemistry (2024), 67(11), 8988-9027. | 10.1021/acs.jmedchem.4c00227"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-40922525", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1.5 h, rt", "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "By: Chen, Bei; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "10.1021/acs.jmedchem.3c01326"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 1307702-36-8 + 3002420-87-0 | PRO: 3002420-83-6 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations\", \"authors\": \"Thomson, Clare; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40922525\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1.5 h, rt\", \"391. Scheme 391 (1 Reaction)\", \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"By: Chen, Bei; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"10.1021/acs.jmedchem.3c01326\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1307702-36-8\", \"3002420-87-0\"], \"pro_cas\": [\"3002420-83-6\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1307702-36-8", "3002420-87-0"], "products": ["3002420-83-6"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40922535", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 81.0}, "smiles": {"reactants": "O=C(O)c1cn(C2CC2)cn1.CC(C)(C)OC(=O)N1CC[C@H](n2cc(-c3ccncc3)c(-c3cccc(N)c3)n2)C1", "products": "CC(C)(C)OC(=O)N1CC[C@H](n2cc(-c3ccncc3)c(-c3cccc(NC(=O)c4cn(C5CC5)cn4)c3)n2)C1"}, "reference": {"title": "Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations", "authors": "Thomson, Clare; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.", "doi": "10.1021/acs.jmedchem.4c00227", "raw": "Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations | Thomson, Clare; et al | Journal of Medicinal Chemistry (2024), 67(11), 8988-9027. | 10.1021/acs.jmedchem.4c00227"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-40922535", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents", "By: Pal, Kavita; et al", "European Journal of Medicinal Chemistry (2023), 248, 115055.", "10.1016/j.ejmech.2022.115055"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2892557-02-5 + 104-94-9 | PRO: 2892557-10-5 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations\", \"authors\": \"Thomson, Clare; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8988-9027.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40922535\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"377. Scheme 377 (1 Reaction)\", \"Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents\", \"By: Pal, Kavita; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115055.\", \"10.1016/j.ejmech.2022.115055\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2892557-02-5\", \"104-94-9\"], \"pro_cas\": [\"2892557-10-5\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2892557-02-5", "104-94-9"], "products": ["2892557-10-5"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-40947705", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.083, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)O.CCCCCCCCN", "products": "CCCCCCCCNC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C"}, "reference": {"title": "Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways", "authors": "Ma, Xiaoyu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8791-8816.", "doi": "10.1021/acs.jmedchem.4c00131", "raw": "Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways | Ma, Xiaoyu; et al | Journal of Medicinal Chemistry (2024), 67(11), 8791-8816. | 10.1021/acs.jmedchem.4c00131"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-40947705", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 5 min, 0 °C", "1.2|2 h, rt", "Double bond geometry shown", "Double bond geometry shown", "Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system", "By: Wei, Bin; et al", "Bioorganic & Medicinal Chemistry (2023), 84, 117257.", "10.1016/j.bmc.2023.117257"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 4530-20-5 + 161810-34-0 | PRO: 3082557-28-3 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways\", \"authors\": \"Ma, Xiaoyu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8791-8816.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-40947705\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 5 min, 0 °C\", \"1.2\", \"2 h, rt\", \"173. Scheme 173 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system\", \"By: Wei, Bin; et al\", \"Bioorganic & Medicinal Chemistry (2023), 84, 117257.\", \"10.1016/j.bmc.2023.117257\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4530-20-5\", \"161810-34-0\"], \"pro_cas\": [\"3082557-28-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"unspecified reagent used for quenching (stage 2)\"]}}", "enriched_names": {"reactants": ["4530-20-5", "161810-34-0"], "products": ["3082557-28-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41010411", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 18.0, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N(Cc1ccc(C(=O)O)cc1)C[C@H](O[Si](C)(C)C(C)(C)C)c1ccc(O)c2[nH]c(=O)ccc12.CN1CCC[C@@H](OC(=O)[C@](O)(c2ccccc2)c2cccc(OCCCN)c2)C1.Cl", "products": "CN1CCC[C@@H](OC(=O)[C@](O)(c2ccccc2)c2cccc(OCCCNC(=O)c3ccc(CN(C[C@H](O[Si](C)(C)C(C)(C)C)c4ccc(O)c5[nH]c(=O)ccc45)C(=O)OC(C)(C)C)cc3)c2)C1"}, "reference": {"title": "Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases", "authors": "Carzaniga, Laura; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 9816-9841.", "doi": "10.1021/acs.jmedchem.4c00298", "raw": "Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases | Carzaniga, Laura; et al | Journal of Medicinal Chemistry (2024), 67(12), 9816-9841. | 10.1021/acs.jmedchem.4c00298"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-41010411", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dimethylformamide; 18 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer", "By: Tang, Baolan; et al", "European Journal of Medicinal Chemistry (2020), 193, 112204.", "10.1016/j.ejmech.2020.112204"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 3034871-49-0 + 2920717-27-5 | PRO: 3034871-50-3 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | CAT: 1122-58-3 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases\", \"authors\": \"Carzaniga, Laura; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 9816-9841.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41010411\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dimethylformamide; 18 h, rt\", \"461. Scheme 461 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer\", \"By: Tang, Baolan; et al\", \"European Journal of Medicinal Chemistry (2020), 193, 112204.\", \"10.1016/j.ejmech.2020.112204\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3034871-49-0\", \"2920717-27-5\"], \"pro_cas\": [\"3034871-50-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3034871-49-0", "2920717-27-5"], "products": ["3034871-50-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41033862", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "2,4,6-Trimethylpyridine", "cas": "108-75-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 16.167, "yield_pct": 96.0}, "smiles": {"reactants": "O=C(O)C1CCOCC1.COC(=O)[C@@H](N)CC1CCCCC1.Cl", "products": "COC(=O)[C@H](CC1CCCCC1)NC(=O)C1CCOCC1"}, "reference": {"title": "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability", "authors": "Meta, Mergim; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.", "doi": "10.1021/acsmedchemlett.4c00050", "raw": "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability | Meta, Mergim; et al | ACS Medicinal Chemistry Letters (2024), 15(6), 837-844. | 10.1021/acsmedchemlett.4c00050"}, "original_text": ["Steps: 1, Yield: 96%", "CAS Reaction Number: 31-614-CAS-41033862", "1.1|Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C", "1.2|Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt", "1.3|Solvents: Water; rt", "Double bond geometry shown", "Double bond geometry shown", "Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment", "By: Li, Di; et al", "Journal of Medicinal Chemistry (2022), 65(7), 5334-5354.", "10.1021/acs.jmedchem.1c00710"], "signatures": {"cond_key": "none/none/2,4,6-Trimethylpyridine|108-75-8+HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "1831fa04", "fam_sig": "b08a79ed"}, "raw_data": {"raw_cas": "RCT: 3095-95-2 + 2131230-48-1 | PRO: 2364326-50-9 | RGT: 108-75-8 + 148893-10-1 | SOL: 68-12-2 + 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability\", \"authors\": \"Meta, Mergim; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.\", \"reagents\": [\"2,4,6-Trimethylpyridine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41033862\", \"1.1\", \"Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt\", \"1.3\", \"Solvents: Water; rt\", \"139. Scheme 139 (1 Reaction)\", \"Double bond geometry shown\", \"Double bond geometry shown\", \"Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment\", \"By: Li, Di; et al\", \"Journal of Medicinal Chemistry (2022), 65(7), 5334-5354.\", \"10.1021/acs.jmedchem.1c00710\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3095-95-2\", \"2131230-48-1\"], \"pro_cas\": [\"2364326-50-9\"], \"rgt_cas\": [\"108-75-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["3095-95-2", "2131230-48-1"], "products": ["2364326-50-9"], "reagents": ["108-75-8", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41033865", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "2,4,6-Trimethylpyridine", "cas": "108-75-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 16.167, "yield_pct": 98.0}, "smiles": {"reactants": "O=C(O)c1ccncc1.COC(=O)[C@@H](N)CC1CCCCC1.Cl", "products": "COC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccncc1"}, "reference": {"title": "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability", "authors": "Meta, Mergim; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.", "doi": "10.1021/acsmedchemlett.4c00050", "raw": "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability | Meta, Mergim; et al | ACS Medicinal Chemistry Letters (2024), 15(6), 837-844. | 10.1021/acsmedchemlett.4c00050"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-41033865", "1.1|Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C", "1.2|Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt", "1.3|Solvents: Water; rt", "Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis", "By: Betzemeier, Bodo; et al", "European Journal of Medicinal Chemistry (2024), 265, 116038.", "10.1016/j.ejmech.2023.116038"], "signatures": {"cond_key": "none/none/2,4,6-Trimethylpyridine|108-75-8+HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "1831fa04", "fam_sig": "b08a79ed"}, "raw_data": {"raw_cas": "RCT: 2727-13-1 + 623-33-6 | PRO: 3042822-46-5 | RGT: 108-75-8 + 148893-10-1 | SOL: 68-12-2 + 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability\", \"authors\": \"Meta, Mergim; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.\", \"reagents\": [\"2,4,6-Trimethylpyridine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41033865\", \"1.1\", \"Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt\", \"1.3\", \"Solvents: Water; rt\", \"133. Scheme 133 (1 Reaction)\", \"Discovery and development of BI 1265162, an ENaC inhibitor for the treatment of cystic fibrosis\", \"By: Betzemeier, Bodo; et al\", \"European Journal of Medicinal Chemistry (2024), 265, 116038.\", \"10.1016/j.ejmech.2023.116038\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2727-13-1\", \"623-33-6\"], \"pro_cas\": [\"3042822-46-5\"], \"rgt_cas\": [\"108-75-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2727-13-1", "623-33-6"], "products": ["3042822-46-5"], "reagents": ["108-75-8", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41033879", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "2,4,6-Trimethylpyridine", "cas": "108-75-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 16.167, "yield_pct": 82.0}, "smiles": {"reactants": "CS(=O)(=O)C[C@H](N[C@@H](c1ccc([N+](=O)[O-])cc1)C(F)(F)F)C(=O)O.N#C[C@@H](N)COCc1ccccc1", "products": "CS(=O)(=O)C[C@H](N[C@@H](c1ccc([N+](=O)[O-])cc1)C(F)(F)F)C(=O)N[C@H](C#N)COCc1ccccc1"}, "reference": {"title": "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability", "authors": "Meta, Mergim; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.", "doi": "10.1021/acsmedchemlett.4c00050", "raw": "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability | Meta, Mergim; et al | ACS Medicinal Chemistry Letters (2024), 15(6), 837-844. | 10.1021/acsmedchemlett.4c00050"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-41033879", "1.1|Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C", "1.2|Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt", "1.3|Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/2,4,6-Trimethylpyridine|108-75-8+HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "1831fa04", "fam_sig": "b08a79ed"}, "raw_data": {"raw_cas": "RCT: 2237-36-7 + 772318-79-3 | PRO: 2892016-34-9 | RGT: 108-75-8 + 148893-10-1 | SOL: 68-12-2 + 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability\", \"authors\": \"Meta, Mergim; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.\", \"reagents\": [\"2,4,6-Trimethylpyridine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41033879\", \"1.1\", \"Reagents: 2,4,6-Trimethylpyridine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Dichloromethane; 0 °C; 10 min, 0 °C\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 0 °C → rt; overnight, rt\", \"1.3\", \"Solvents: Water; rt\", \"114. Scheme 114 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2237-36-7\", \"772318-79-3\"], \"pro_cas\": [\"2892016-34-9\"], \"rgt_cas\": [\"108-75-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2237-36-7", "772318-79-3"], "products": ["2892016-34-9"], "reagents": ["108-75-8", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41034407", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 88.0}, "smiles": {"reactants": "COC(=O)c1ccc(C(=O)O)nc1.Cc1c(N)cccc1-c1cccc(NC(=O)OC(C)(C)C)c1C", "products": "COC(=O)c1ccc(C(=O)Nc2cccc(-c3cccc(NC(=O)OC(C)(C)C)c3C)c2C)nc1"}, "reference": {"title": "Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction", "authors": "Hec-Galazka, Aleksandra; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.", "doi": "10.1021/acsmedchemlett.4c00042", "raw": "Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction | Hec-Galazka, Aleksandra; et al | ACS Medicinal Chemistry Letters (2024), 15(6), 828-836. | 10.1021/acsmedchemlett.4c00042"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-41034407", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 0 °C; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents", "By: Mohy El Dine, Tharwat; et al", "Journal of Medicinal Chemistry (2021), 64(19), 14728-14744.", "10.1021/acs.jmedchem.1c01241"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Dimethylformamide|68-12-2", "cond_sig": "7e618d50", "fam_sig": "44d19c66"}, "raw_data": {"raw_cas": "RCT: 15252-45-6 + 2843601-89-6 | PRO: 2843601-86-3 | RGT: 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction\", \"authors\": \"Hec-Galazka, Aleksandra; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41034407\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 0 °C; overnight, rt\", \"73. Scheme 73 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents\", \"By: Mohy El Dine, Tharwat; et al\", \"Journal of Medicinal Chemistry (2021), 64(19), 14728-14744.\", \"10.1021/acs.jmedchem.1c01241\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"15252-45-6\", \"2843601-89-6\"], \"pro_cas\": [\"2843601-86-3\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["15252-45-6", "2843601-89-6"], "products": ["2843601-86-3"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41034446", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 99.0}, "smiles": {"reactants": "COC(=O)c1ccc(C(=O)O)nc1.Cc1c(N)cccc1-c1cccc(NC(=O)c2ccc(CN3CCC(O[Si](C)(C)C(C)(C)C)CC3)cn2)c1C", "products": "COC(=O)c1ccc(C(=O)Nc2cccc(-c3cccc(NC(=O)c4ccc(CN5CCC(O[Si](C)(C)C(C)(C)C)CC5)cn4)c3C)c2C)nc1"}, "reference": {"title": "Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction", "authors": "Hec-Galazka, Aleksandra; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.", "doi": "10.1021/acsmedchemlett.4c00042", "raw": "Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction | Hec-Galazka, Aleksandra; et al | ACS Medicinal Chemistry Letters (2024), 15(6), 828-836. | 10.1021/acsmedchemlett.4c00042"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-41034446", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 0 °C; overnight, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease", "By: Shen, Wen; et al", "Bioorganic & Medicinal Chemistry Letters (2024), 112, 129942.", "10.1016/j.bmcl.2024.129942"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 3094306-01-8 + 219754-02-6 | PRO: 2755813-10-4 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Nonsymmetrically Substituted 1,1’-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction\", \"authors\": \"Hec-Galazka, Aleksandra; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(6), 828-836.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41034446\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 0 °C; overnight, rt\", \"259. Scheme 259 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease\", \"By: Shen, Wen; et al\", \"Bioorganic & Medicinal Chemistry Letters (2024), 112, 129942.\", \"10.1016/j.bmcl.2024.129942\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3094306-01-8\", \"219754-02-6\"], \"pro_cas\": [\"2755813-10-4\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["3094306-01-8", "219754-02-6"], "products": ["2755813-10-4"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41034619", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 3.333, "yield_pct": 90.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)[C@H](CN)NC(=O)OCc1ccccc1.O=C(O)Cn1c(=O)[nH]c2ncccc21", "products": "CC(C)(C)OC(=O)[C@H](CNC(=O)Cn1c(=O)[nH]c2ncccc21)NC(=O)OCc1ccccc1"}, "reference": {"title": "Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1", "authors": "Sabat, Mark; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 10306-10320.", "doi": "10.1021/acs.jmedchem.4c00743", "raw": "Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1 | Sabat, Mark; et al | Journal of Medicinal Chemistry (2024), 67(12), 10306-10320. | 10.1021/acs.jmedchem.4c00743"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-41034619", "1.1|Reagents: Diisopropylethylamine, Propylphosphonic anhydride", "Solvents: Dimethylformamide, Water; 20 min, < 10 °C; 3 h, 10 °C → 25 °C", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Propylphosphonic anhydride|68957-94-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "b4cdd190", "fam_sig": "e8da6822"}, "raw_data": {"raw_cas": "RCT: 586-76-5 + 2919713-61-2 | PRO: 2919713-70-3 | RGT: 7087-68-5 + 68957-94-8 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1\", \"authors\": \"Sabat, Mark; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 10306-10320.\", \"reagents\": [\"Diisopropylethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41034619\", \"1.1\", \"Reagents: Diisopropylethylamine, Propylphosphonic anhydride\", \"Solvents: Dimethylformamide, Water; 20 min, < 10 °C; 3 h, 10 °C → 25 °C\", \"274. Scheme 274 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"586-76-5\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-70-3\"], \"rgt_cas\": [\"7087-68-5\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["586-76-5", "2919713-61-2"], "products": ["2919713-70-3"], "reagents": ["N,N-Diisopropylethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41035940", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 13.0, "yield_pct": 82.0}, "smiles": {"reactants": "COC(=O)[C@@H](N)CC(C)C.Cl.CC(C)(C)OC(=O)N[C@@H](Cc1cccc(Cl)c1)C(=O)O", "products": "COC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cccc(Cl)c1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Identification of highly potent and selective HTRA1 inhibitors", "authors": "Dennis, David G.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2024), 109, 129814.", "doi": "10.1016/j.bmcl.2024.129814", "raw": "Identification of highly potent and selective HTRA1 inhibitors | Dennis, David G.; et al | Bioorganic & Medicinal Chemistry Letters (2024), 109, 129814. | 10.1016/j.bmcl.2024.129814"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-41035940", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 12 h, 0 °C → rt", "Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21", "By: Goericke, Fabian; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.", "10.1021/acs.jmedchem.2c01933"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5/Dichloromethane|75-09-2", "cond_sig": "71ba53e8", "fam_sig": "f5a9bca4"}, "raw_data": {"raw_cas": "RCT: 856417-65-7 + 247225-84-9 | PRO: 3042818-51-6 | RGT: 7087-68-5 + 94790-37-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Identification of highly potent and selective HTRA1 inhibitors\", \"authors\": \"Dennis, David G.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2024), 109, 129814.\", \"reagents\": [\"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41035940\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 12 h, 0 °C → rt\", \"343. Scheme 343 (1 Reaction)\", \"Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21\", \"By: Goericke, Fabian; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3431-3447.\", \"10.1021/acs.jmedchem.2c01933\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"856417-65-7\", \"247225-84-9\"], \"pro_cas\": [\"3042818-51-6\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["856417-65-7", "247225-84-9"], "products": ["3042818-51-6"], "reagents": ["N,N-Diisopropylethylamine", "HBTU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41060792", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "7647-14-5", "cas": "7647-14-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium chloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 17.5, "yield_pct": 91.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCc1ccc(C(=O)O)cc1.COc1ccccc1CN", "products": "COc1ccccc1CNC(=O)c1ccc(CNC(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis", "authors": "Zimmermann, Thomas; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.", "doi": "10.1021/acs.jmedchem.4c00230", "raw": "Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis | Zimmermann, Thomas; et al | Journal of Medicinal Chemistry (2024), 67(13), 10710-10742. | 10.1021/acs.jmedchem.4c00230"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-41060792", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|0 °C; overnight, rt", "1.3|Reagents: Sodium chloride", "Solvents: Water; rt", "Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27", "By: Pillaiyar, Thanigaimalai; et al", "European Journal of Medicinal Chemistry (2021), 225, 113777.", "10.1016/j.ejmech.2021.113777"], "signatures": {"cond_key": "none/none/7647-14-5|7647-14-5+Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5+Sodium chloride|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "92f059b9", "fam_sig": "e82fe33b"}, "raw_data": {"raw_cas": "RCT: 554-00-7 + 6314-72-3 | PRO: 2832987-89-8 | RGT: 7087-68-5 + 94790-37-1 + 7647-14-5 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis\", \"authors\": \"Zimmermann, Thomas; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.\", \"reagents\": [\"Diisopropylethylamine\", \"Sodium chloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41060792\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"0 °C; overnight, rt\", \"1.3\", \"Reagents: Sodium chloride\", \"Solvents: Water; rt\", \"214. Scheme 214 (1 Reaction)\", \"Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27\", \"By: Pillaiyar, Thanigaimalai; et al\", \"European Journal of Medicinal Chemistry (2021), 225, 113777.\", \"10.1016/j.ejmech.2021.113777\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"554-00-7\", \"6314-72-3\"], \"pro_cas\": [\"2832987-89-8\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\", \"7647-14-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["554-00-7", "6314-72-3"], "products": ["2832987-89-8"], "reagents": ["N,N-Diisopropylethylamine", "HBTU", "7647-14-5"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41060811", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "7647-14-5", "cas": "7647-14-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Sodium chloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 17.5, "yield_pct": 94.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCc1ccc(C(=O)O)cc1.CCOc1ccccc1CN", "products": "CCOc1ccccc1CNC(=O)c1ccc(CNC(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis", "authors": "Zimmermann, Thomas; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.", "doi": "10.1021/acs.jmedchem.4c00230", "raw": "Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis | Zimmermann, Thomas; et al | Journal of Medicinal Chemistry (2024), 67(13), 10710-10742. | 10.1021/acs.jmedchem.4c00230"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-41060811", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dichloromethane; 30 min, 0 °C", "1.2|overnight, rt", "1.3|Reagents: Sodium chloride", "Solvents: Water; rt", "Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme", "By: Hamilton, Matthew M.; et al", "Journal of Medicinal Chemistry (2021), 64(15), 11302-11329.", "10.1021/acs.jmedchem.1c00679"], "signatures": {"cond_key": "none/none/7647-14-5|7647-14-5+Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5+Sodium chloride|/Dichloromethane|75-09-2+Water|7732-18-5", "cond_sig": "92f059b9", "fam_sig": "e82fe33b"}, "raw_data": {"raw_cas": "RCT: 74-11-3 + 2760687-93-0 | PRO: 2760687-94-1 | RGT: 7087-68-5 + 94790-37-1 + 7647-14-5 | SOL: 75-09-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis\", \"authors\": \"Zimmermann, Thomas; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(13), 10710-10742.\", \"reagents\": [\"Diisopropylethylamine\", \"Sodium chloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41060811\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dichloromethane; 30 min, 0 °C\", \"1.2\", \"overnight, rt\", \"1.3\", \"Reagents: Sodium chloride\", \"Solvents: Water; rt\", \"267. Scheme 267 (1 Reaction)\", \"Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme\", \"By: Hamilton, Matthew M.; et al\", \"Journal of Medicinal Chemistry (2021), 64(15), 11302-11329.\", \"10.1021/acs.jmedchem.1c00679\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"74-11-3\", \"2760687-93-0\"], \"pro_cas\": [\"2760687-94-1\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\", \"7647-14-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["74-11-3", "2760687-93-0"], "products": ["2760687-94-1"], "reagents": ["N,N-Diisopropylethylamine", "HBTU", "7647-14-5"], "catalysts": [], "solvents": ["Dichloromethane", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41063829", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 87.0}, "smiles": {"reactants": "C[C@H](NC(=O)OC(C)(C)C)C(=O)O.COC(=O)[C@@H](N)Cc1ccc(OC)cc1", "products": "COC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)[C@H](C)NC(=O)OC(C)(C)C"}, "reference": {"title": "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities", "authors": "Wang, Juan; et al", "citation": "European Journal of Medicinal Chemistry (2021), 215, 113267.", "doi": "10.1016/j.ejmech.2021.113267", "raw": "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities | Wang, Juan; et al | European Journal of Medicinal Chemistry (2021), 215, 113267. | 10.1016/j.ejmech.2021.113267"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-41063829", "1.1|Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Tetrahydrofuran; rt → 0 °C", "1.2|Reagents: Diisopropylethylamine; 1 h, 0 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2", "By: Chhabra, Mohit; et al", "Journal of Medicinal Chemistry (2024), 67(14), 11885-11916.", "10.1021/acs.jmedchem.4c00487"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Tetrahydrofuran|109-99-9", "cond_sig": "8d7cce52", "fam_sig": "967b17ec"}, "raw_data": {"raw_cas": "RCT: 2450-71-7 + 4057-84-5 | PRO: 1801369-46-9 | RGT: 2592-95-2 + 148893-10-1 + 7087-68-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities\", \"authors\": \"Wang, Juan; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 215, 113267.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41063829\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Tetrahydrofuran; rt → 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 1 h, 0 °C\", \"296. Scheme 296 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2\", \"By: Chhabra, Mohit; et al\", \"Journal of Medicinal Chemistry (2024), 67(14), 11885-11916.\", \"10.1021/acs.jmedchem.4c00487\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2450-71-7\", \"4057-84-5\"], \"pro_cas\": [\"1801369-46-9\"], \"rgt_cas\": [\"2592-95-2\", \"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": [\"alternate reaction conditions also shown\"]}}", "enriched_names": {"reactants": ["2450-71-7", "4057-84-5"], "products": ["1801369-46-9"], "reagents": ["1-Hydroxybenzotriazole", "HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41063830", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "Sodium chloride", "cas": "7647-14-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)O.COC(=O)[C@@H](N)Cc1c[nH]c2ccccc12.Cl", "products": "COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1"}, "reference": {"title": "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities", "authors": "Wang, Juan; et al", "citation": "European Journal of Medicinal Chemistry (2021), 215, 113267.", "doi": "10.1016/j.ejmech.2021.113267", "raw": "A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities | Wang, Juan; et al | European Journal of Medicinal Chemistry (2021), 215, 113267. | 10.1016/j.ejmech.2021.113267"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-41063830", "1.1|Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; rt → 0 °C", "1.2|Reagents: Diisopropylethylamine; 0 °C → rt; 1 h, rt", "1.3|Reagents: Sodium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease", "By: Liu, Longbin; et al", "Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.", "10.1021/acs.jmedchem.3c01173"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium chloride|7647-14-5/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "501fa1f4", "fam_sig": "2defe63a"}, "raw_data": {"raw_cas": "RCT: 1643412-36-5 + 2743340-80-7 | PRO: 3033861-51-4 | RGT: 2592-95-2 + 148893-10-1 + 7087-68-5 + 7647-14-5 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities\", \"authors\": \"Wang, Juan; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2021), 215, 113267.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\", \"Sodium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41063830\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; rt → 0 °C\", \"1.2\", \"Reagents: Diisopropylethylamine; 0 °C → rt; 1 h, rt\", \"1.3\", \"Reagents: Sodium chloride\", \"Solvents: Water; rt\", \"212. Scheme 212 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease\", \"By: Liu, Longbin; et al\", \"Journal of Medicinal Chemistry (2023), 66(18), 13205-13246.\", \"10.1021/acs.jmedchem.3c01173\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1643412-36-5\", \"2743340-80-7\"], \"pro_cas\": [\"3033861-51-4\"], \"rgt_cas\": [\"2592-95-2\", \"148893-10-1\", \"7087-68-5\", \"7647-14-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["1643412-36-5", "2743340-80-7"], "products": ["3033861-51-4"], "reagents": ["1-Hydroxybenzotriazole", "HATU", "N,N-Diisopropylethylamine", "7647-14-5"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41112180", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.5, "yield_pct": 85.0}, "smiles": {"reactants": "C=CCOC(=O)Nc1ccc(C[C@@H](CO)NC(=O)OC(C)(C)C)cc1.CCOP(=O)(CC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)O)OCC", "products": "C=CCOC(=O)Nc1ccc(C[C@@H](CO)NC(=O)[C@H](CCCCNC(=O)CP(=O)(OCC)OCC)NC(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells", "authors": "Obara, Takahiro; et al", "citation": "Bioorganic & Medicinal Chemistry (2024), 108, 117773.", "doi": "10.1016/j.bmc.2024.117773", "raw": "Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells | Obara, Takahiro; et al | Bioorganic & Medicinal Chemistry (2024), 108, 117773. | 10.1016/j.bmc.2024.117773"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-41112180", "1.1|Reagents: Hydrochloric acid", "Solvents: 1,4-Dioxane; 30 min, rt", "1.2|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 2 h, rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5/1,4-Dioxane|123-91-1+Dimethylformamide|68-12-2", "cond_sig": "8a93b852", "fam_sig": "d90461b0"}, "raw_data": {"raw_cas": "RCT: 120-20-7 + 1912-44-3 | PRO: 1990296-36-0 | RGT: 7647-01-0 + 2592-95-2 + 7087-68-5 + 25952-53-8 | SOL: 123-91-1 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells\", \"authors\": \"Obara, Takahiro; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2024), 108, 117773.\", \"reagents\": [\"Hydrochloric acid\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41112180\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: 1,4-Dioxane; 30 min, rt\", \"1.2\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 2 h, rt\", \"15. Scheme 15 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"120-20-7\", \"1912-44-3\"], \"pro_cas\": [\"1990296-36-0\"], \"rgt_cas\": [\"7647-01-0\", \"2592-95-2\", \"7087-68-5\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\", \"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["120-20-7", "1912-44-3"], "products": ["1990296-36-0"], "reagents": ["Hydrochloric acid", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["1,4-Dioxane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41293635", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCC[C@H](N)C1.Cc1ccc([C@@H](Oc2ccc(C(=O)O)nc2)[C@H](C)NC(=O)C(F)(F)F)cc1", "products": "Cc1ccc([C@@H](Oc2ccc(C(=O)N[C@H]3CCCN(C(=O)OC(C)(C)C)C3)nc2)[C@H](C)NC(=O)C(F)(F)F)cc1"}, "reference": {"title": "Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology", "authors": "Dack, Kevin N.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402.", "doi": "10.1016/j.bmcl.2020.127402", "raw": "Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology | Dack, Kevin N.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402. | 10.1016/j.bmcl.2020.127402"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-41293635", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "10.1021/acs.jmedchem.3c02184"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 78-81-9 + 2787516-58-7 | PRO: 2787520-00-5 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology\", \"authors\": \"Dack, Kevin N.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(17), 127402.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41293635\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; overnight, rt\", \"393. Scheme 393 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"10.1021/acs.jmedchem.3c02184\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"78-81-9\", \"2787516-58-7\"], \"pro_cas\": [\"2787520-00-5\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["78-81-9", "2787516-58-7"], "products": ["2787520-00-5"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41302566", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.167, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.COc1cc(/C=C/c2ccc(N)cc2)cc(OC)c1", "products": "COc1cc(/C=C/c2ccc(NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)OC(C)(C)C)cc2)cc(OC)c1"}, "reference": {"title": "A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer", "authors": "Cordella, Fabiana; et al", "citation": "ChemMedChem (2024), 19(14), e202300727.", "doi": "10.1002/cmdc.202300727", "raw": "A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer | Cordella, Fabiana; et al | ChemMedChem (2024), 19(14), e202300727. | 10.1002/cmdc.202300727"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-41302566", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 10 min, rt", "1.2|Reagents: Triethylamine; rt; 2 h, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors", "By: Martinez-Gualda, Belen; et al", "Journal of Medicinal Chemistry (2020), 63(1), 349-368.", "10.1021/acs.jmedchem.9b01737"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 4299-70-1 + 59085-15-3 | PRO: 2644023-48-1 | RGT: 148893-10-1 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer\", \"authors\": \"Cordella, Fabiana; et al\", \"citation\": \"ChemMedChem (2024), 19(14), e202300727.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41302566\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 10 min, rt\", \"1.2\", \"Reagents: Triethylamine; rt; 2 h, rt\", \"216. Scheme 216 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors\", \"By: Martinez-Gualda, Belen; et al\", \"Journal of Medicinal Chemistry (2020), 63(1), 349-368.\", \"10.1021/acs.jmedchem.9b01737\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4299-70-1\", \"59085-15-3\"], \"pro_cas\": [\"2644023-48-1\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["4299-70-1", "59085-15-3"], "products": ["2644023-48-1"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41302576", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.167, "yield_pct": 86.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@@H](Cc1cncn1C(=O)OC(C)(C)C)C(=O)O.COc1cc(/C=C/c2ccc(N)cc2)cc(OC)c1", "products": "COc1cc(/C=C/c2ccc(NC(=O)[C@H](Cc3cncn3C(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)cc2)cc(OC)c1"}, "reference": {"title": "A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer", "authors": "Cordella, Fabiana; et al", "citation": "ChemMedChem (2024), 19(14), e202300727.", "doi": "10.1002/cmdc.202300727", "raw": "A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer | Cordella, Fabiana; et al | ChemMedChem (2024), 19(14), e202300727. | 10.1002/cmdc.202300727"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-41302576", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 10 min, rt", "1.2|Reagents: Triethylamine; rt; 4 h, rt", "Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders", "By: Si, Ru; et al", "Bioorganic & Medicinal Chemistry (2023), 77, 117115.", "10.1016/j.bmc.2022.117115"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 57294-38-9 + 191732-72-6 | PRO: 2353563-39-8 | RGT: 148893-10-1 + 121-44-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer\", \"authors\": \"Cordella, Fabiana; et al\", \"citation\": \"ChemMedChem (2024), 19(14), e202300727.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Triethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41302576\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 10 min, rt\", \"1.2\", \"Reagents: Triethylamine; rt; 4 h, rt\", \"339. Scheme 339 (1 Reaction)\", \"Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders\", \"By: Si, Ru; et al\", \"Bioorganic & Medicinal Chemistry (2023), 77, 117115.\", \"10.1016/j.bmc.2022.117115\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"57294-38-9\", \"191732-72-6\"], \"pro_cas\": [\"2353563-39-8\"], \"rgt_cas\": [\"148893-10-1\", \"121-44-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["57294-38-9", "191732-72-6"], "products": ["2353563-39-8"], "reagents": ["HATU", "Triethylamine"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41322613", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Water", "cas": "7732-18-5"}, {"name": "Methanol", "cas": "67-56-1"}], "conditions": {"temperature_c": 25.0, "time_h": 20.167, "yield_pct": 97.0}, "smiles": {"reactants": "Nc1ccccc1.O=C(O)C#Cc1ccccc1", "products": "O=C(C#Cc1ccccc1)Nc1ccccc1"}, "reference": {"title": "Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator", "authors": "Yin, Jianpeng; et al", "citation": "Organic Process Research & Development (2021), 25(10), 2260-2269.", "doi": "10.1021/acs.oprd.1c00150", "raw": "Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator | Yin, Jianpeng; et al | Organic Process Research & Development (2021), 25(10), 2260-2269. | 10.1021/acs.oprd.1c00150"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-41322613", "1.1|Solvents: Dichloromethane; 30 min, rt", "1.2|Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 30 min, 10 - 20 °C; 16 h, 25 °C", "1.3|Reagents: Hydrochloric acid", "Solvents: Water; 10 min", "1.4|Solvents: Methanol, Water; 1 h, 15 - 20 °C; 2 h, 15 °C", "Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents", "By: Cao, Longcai; et al", "Bioorganic & Medicinal Chemistry (2023), 85, 117241.", "10.1016/j.bmc.2023.117241"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+Hydrochloric acid|7647-01-0/Dichloromethane|75-09-2+Methanol|67-56-1+Water|7732-18-5", "cond_sig": "e7514bb5", "fam_sig": "932a1f62"}, "raw_data": {"raw_cas": "RCT: 552-16-9 + 593-51-1 | PRO: 3400-29-1 | RGT: 25952-53-8 + 7647-01-0 | SOL: 75-09-2 + 7732-18-5 + 67-56-1", "raw_data_json": "{\"txt\": {\"title\": \"Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator\", \"authors\": \"Yin, Jianpeng; et al\", \"citation\": \"Organic Process Research & Development (2021), 25(10), 2260-2269.\", \"reagents\": [\"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Water\", \"Methanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41322613\", \"1.1\", \"Solvents: Dichloromethane; 30 min, rt\", \"1.2\", \"Reagents: 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride; 30 min, 10 - 20 °C; 16 h, 25 °C\", \"1.3\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; 10 min\", \"1.4\", \"Solvents: Methanol, Water; 1 h, 15 - 20 °C; 2 h, 15 °C\", \"9. Scheme 9 (1 Reaction)\", \"Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents\", \"By: Cao, Longcai; et al\", \"Bioorganic & Medicinal Chemistry (2023), 85, 117241.\", \"10.1016/j.bmc.2023.117241\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"552-16-9\", \"593-51-1\"], \"pro_cas\": [\"3400-29-1\"], \"rgt_cas\": [\"25952-53-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"7732-18-5\", \"67-56-1\"], \"notes\": [\"alternate reaction conditions gave lower yield,alternative preparation shown\"]}}", "enriched_names": {"reactants": ["552-16-9", "593-51-1"], "products": ["3400-29-1"], "reagents": ["1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dichloromethane", "Water", "Methanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41431404", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 5.167, "yield_pct": 91.0}, "smiles": {"reactants": "Cn1nc(C(=O)O)c2cc([N+](=O)[O-])ccc21.CN", "products": "CNC(=O)c1nn(C)c2ccc([N+](=O)[O-])cc12"}, "reference": {"title": "Optimization of a series of potent, selective and orally bioavailable SYK inhibitors", "authors": "Grimster, Neil P.; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433.", "doi": "10.1016/j.bmcl.2020.127433", "raw": "Optimization of a series of potent, selective and orally bioavailable SYK inhibitors | Grimster, Neil P.; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433. | 10.1016/j.bmcl.2020.127433"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-41431404", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 10 min, rt", "1.2|Reagents: Hydrochloric acid", "Solvents: Water; 5 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+Hydrochloric acid|7647-01-0+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "f5bfcf6b", "fam_sig": "640133b7"}, "raw_data": {"raw_cas": "RCT: 117-34-0 + 3026372-58-4 | PRO: 225120-29-6 | RGT: 148893-10-1 + 7647-01-0 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Optimization of a series of potent, selective and orally bioavailable SYK inhibitors\", \"authors\": \"Grimster, Neil P.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127433.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41431404\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 10 min, rt\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: Water; 5 h, rt\", \"184. Scheme 184 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"117-34-0\", \"3026372-58-4\"], \"pro_cas\": [\"225120-29-6\"], \"rgt_cas\": [\"148893-10-1\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["117-34-0", "3026372-58-4"], "products": ["225120-29-6"], "reagents": ["HATU", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41433749", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Acetonitrile", "cas": "75-05-8"}], "conditions": {"temperature_c": 35.0, "time_h": 3.0, "yield_pct": 92.0}, "smiles": {"reactants": "O=C(O)Cn1nc(C(F)(F)F)c2c1C(F)(F)[C@@H]1C[C@H]21.CC(C)(C#Cc1ccc(Br)c([C@@H](N)Cc2cc(F)cc(F)c2)n1)S(C)(=O)=O", "products": "CC(C)(C#Cc1ccc(Br)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O"}, "reference": {"title": "Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process Development and Scale-up", "authors": "Wagner, Anna M.; et al", "citation": "Organic Process Research & Development (2024), 28(8), 3382-3395.", "doi": "10.1021/acs.oprd.4c00242", "raw": "Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process Development and Scale-up | Wagner, Anna M.; et al | Organic Process Research & Development (2024), 28(8), 3382-3395. | 10.1021/acs.oprd.4c00242"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-41433749", "1.1|Reagents: Triethylamine, Propylphosphonic anhydride", "Solvents: Dimethylformamide, Acetonitrile; < 35 °C; 3 h, 20 °C", "Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC", "By: Tang, Sheng; et al", "European Journal of Medicinal Chemistry (2024), 263, 115939.", "10.1016/j.ejmech.2023.115939"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Triethylamine|121-44-8/Acetonitrile|75-05-8+Dimethylformamide|68-12-2", "cond_sig": "cee3a498", "fam_sig": "83ba97ae"}, "raw_data": {"raw_cas": "RCT: 4521-28-2 + 2761180-24-7 + 638-29-9 | PRO: 3020728-49-5 | RGT: 121-44-8 + 68957-94-8 | SOL: 68-12-2 + 75-05-8", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis of Lenacapavir Sodium: Active Pharmaceutical Ingredient Process Development and Scale-up\", \"authors\": \"Wagner, Anna M.; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(8), 3382-3395.\", \"reagents\": [\"Triethylamine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Acetonitrile\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41433749\", \"1.1\", \"Reagents: Triethylamine, Propylphosphonic anhydride\", \"Solvents: Dimethylformamide, Acetonitrile; < 35 °C; 3 h, 20 °C\", \"414. Scheme 414 (1 Reaction)\", \"Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC\", \"By: Tang, Sheng; et al\", \"European Journal of Medicinal Chemistry (2024), 263, 115939.\", \"10.1016/j.ejmech.2023.115939\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"4521-28-2\", \"2761180-24-7\", \"638-29-9\"], \"pro_cas\": [\"3020728-49-5\"], \"rgt_cas\": [\"121-44-8\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-05-8\"], \"notes\": []}}", "enriched_names": {"reactants": ["4521-28-2", "2761180-24-7", "638-29-9"], "products": ["3020728-49-5"], "reagents": ["Triethylamine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Dimethylformamide", "Acetonitrile"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41446153", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 95.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1C[C@@H](O)C[C@H]1C(=O)O.Cc1ncsc1-c1ccc(CN)cc1", "products": "Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)OC(C)(C)C)cc1"}, "reference": {"title": "Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs", "authors": "Shah, Rishi R.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(6), 4641-4654.", "doi": "10.1021/acs.jmedchem.3c02123", "raw": "Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs | Shah, Rishi R.; et al | Journal of Medicinal Chemistry (2024), 67(6), 4641-4654. | 10.1021/acs.jmedchem.3c02123"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-41446153", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants", "By: Hu, Shangjiu; et al", "Bioorganic & Medicinal Chemistry (2022), 64, 116760.", "10.1016/j.bmc.2022.116760"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 2237-36-7 + 2415386-52-4 | PRO: 2892016-25-8 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs\", \"authors\": \"Shah, Rishi R.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(6), 4641-4654.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41446153\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"134. Scheme 134 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants\", \"By: Hu, Shangjiu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 64, 116760.\", \"10.1016/j.bmc.2022.116760\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2237-36-7\", \"2415386-52-4\"], \"pro_cas\": [\"2892016-25-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2237-36-7", "2415386-52-4"], "products": ["2892016-25-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41746955", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "1,4-Dioxane", "cas": "123-91-1"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 40.0, "time_h": 11.5, "yield_pct": 83.0}, "smiles": {"reactants": "CC(=O)/C(C)=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C)C2(C)C.CC(C)(C)OC(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)O)C2(C)C", "products": "CC(C)(C)OC(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(N)=O)C2(C)C"}, "reference": {"title": "Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease", "authors": "Shen, Wen; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2024), 112, 129942.", "doi": "10.1016/j.bmcl.2024.129942", "raw": "Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease | Shen, Wen; et al | Bioorganic & Medicinal Chemistry Letters (2024), 112, 129942. | 10.1016/j.bmcl.2024.129942"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-41746955", "1.1|Reagents: Hydrochloric acid", "Solvents: 1,4-Dioxane; rt → 40 °C; 1 h, 40 °C", "1.2|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 30 min, 25 °C", "1.3|Reagents: Diisopropylethylamine; 10 h, 25 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists", "By: Cooper, Martin; et al", "Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.", "10.1021/acs.jmedchem.0c00828"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/1,4-Dioxane|123-91-1+Dichloromethane|75-09-2", "cond_sig": "289ddb53", "fam_sig": "fd542d0b"}, "raw_data": {"raw_cas": "RCT: 10241-97-1 + 2602442-14-6 | PRO: 2602442-15-7 | RGT: 7647-01-0 + 148893-10-1 + 7087-68-5 | SOL: 123-91-1 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease\", \"authors\": \"Shen, Wen; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2024), 112, 129942.\", \"reagents\": [\"Hydrochloric acid\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"1,4-Dioxane\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41746955\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: 1,4-Dioxane; rt → 40 °C; 1 h, 40 °C\", \"1.2\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 30 min, 25 °C\", \"1.3\", \"Reagents: Diisopropylethylamine; 10 h, 25 °C\", \"260. Scheme 260 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists\", \"By: Cooper, Martin; et al\", \"Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.\", \"10.1021/acs.jmedchem.0c00828\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"10241-97-1\", \"2602442-14-6\"], \"pro_cas\": [\"2602442-15-7\"], \"rgt_cas\": [\"7647-01-0\", \"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"123-91-1\", \"75-09-2\"], \"notes\": [\"intermediate from stage 1 added in stage 3 (stage 3)\"]}}", "enriched_names": {"reactants": ["10241-97-1", "2602442-14-6"], "products": ["2602442-15-7"], "reagents": ["Hydrochloric acid", "HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["1,4-Dioxane", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41763296", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [], "conditions": {"temperature_c": 162.0, "time_h": 40.0, "yield_pct": 99.0}, "smiles": {"reactants": "CC(O)CN.O=C(O)CCCS(=O)(=O)c1ccccc1", "products": "CC(O)CNC(=O)CCCS(=O)(=O)c1ccccc1"}, "reference": {"title": "Efficient Total Synthesis of Bilirubin IXα from Butyrolactone", "authors": "Chen, Fapu; et al", "citation": "Organic Process Research & Development (2024), 28(7), 2777-2788.", "doi": "10.1021/acs.oprd.4c00122", "raw": "Efficient Total Synthesis of Bilirubin IXα from Butyrolactone | Chen, Fapu; et al | Organic Process Research & Development (2024), 28(7), 2777-2788. | 10.1021/acs.oprd.4c00122"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-41763296", "1.1|40 h, 155 - 162 °C", "Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases", "By: Liu, Fei; et al", "ACS Medicinal Chemistry Letters (2022), 13(11), 1730-1738.", "10.1021/acsmedchemlett.2c00334"], "signatures": {"cond_key": "none/none/none/none", "cond_sig": "f6128e7e", "fam_sig": "f6128e7e"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 2245238-80-4 | PRO: 1609393-89-6", "raw_data_json": "{\"txt\": {\"title\": \"Efficient Total Synthesis of Bilirubin IXα from Butyrolactone\", \"authors\": \"Chen, Fapu; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(7), 2777-2788.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41763296\", \"1.1\", \"40 h, 155 - 162 °C\", \"25. Scheme 25 (1 Reaction)\", \"Novel TYK2 Inhibitors with an N-(Methyl-d3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases\", \"By: Liu, Fei; et al\", \"ACS Medicinal Chemistry Letters (2022), 13(11), 1730-1738.\", \"10.1021/acsmedchemlett.2c00334\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"2245238-80-4\"], \"pro_cas\": [\"1609393-89-6\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "2245238-80-4"], "products": ["1609393-89-6"], "reagents": [], "catalysts": [], "solvents": []}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41860736", "reaction_type": "Other", "catalyst": {"core": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "generic": [], "ligands": [], "full_system": [{"name": "Dimethylformamide", "cas": "68-12-2"}]}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "Triethylamine", "cas": "121-44-8", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 50.0, "time_h": 5.0, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)c1cc(-c2ccccc2)no1.CC(C)(C)OC(=O)N1CC2(CC(N)C2)C1", "products": "CC(C)(C)OC(=O)N1CC2(CC(NC(=O)c3cc(-c4ccccc4)no3)C2)C1"}, "reference": {"title": "Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers", "authors": "Katayama, Katsushi; et al", "citation": "Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127425.", "doi": "10.1016/j.bmcl.2020.127425", "raw": "Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers | Katayama, Katsushi; et al | Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127425. | 10.1016/j.bmcl.2020.127425"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-41860736", "1.1|Reagents: Thionyl chloride", "Catalysts: Dimethylformamide", "Solvents: Dichloromethane; rt; 4 h, 50 °C", "1.2|Reagents: Triethylamine", "Solvents: Dichloromethane; 0 °C; 1 h, rt", "Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers", "By: Vaidya, Sandeep; et al", "ChemMedChem (2023), 18(16), e202300097.", "10.1002/cmdc.202300097"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "7e24dde3", "fam_sig": "465abb34"}, "raw_data": {"raw_cas": "RCT: 53716-49-7 + 2128731-38-2 | PRO: 3055833-22-9 | RGT: 7719-09-7 + 121-44-8 | CAT: 68-12-2 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers\", \"authors\": \"Katayama, Katsushi; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry Letters (2020), 30(19), 127425.\", \"reagents\": [\"Thionyl chloride\", \"Triethylamine\"], \"catalysts\": [\"Dimethylformamide\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41860736\", \"1.1\", \"Reagents: Thionyl chloride\", \"Catalysts: Dimethylformamide\", \"Solvents: Dichloromethane; rt; 4 h, 50 °C\", \"1.2\", \"Reagents: Triethylamine\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"461. Scheme 461 (1 Reaction)\", \"Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers\", \"By: Vaidya, Sandeep; et al\", \"ChemMedChem (2023), 18(16), e202300097.\", \"10.1002/cmdc.202300097\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"53716-49-7\", \"2128731-38-2\"], \"pro_cas\": [\"3055833-22-9\"], \"rgt_cas\": [\"7719-09-7\", \"121-44-8\"], \"cat_cas\": [\"68-12-2\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["53716-49-7", "2128731-38-2"], "products": ["3055833-22-9"], "reagents": ["7719-09-7", "Triethylamine"], "catalysts": ["Dimethylformamide"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-41901045", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Pyridine", "cas": "110-86-1", "role": "BASE"}, {"name": "Propylphosphonic anhydride", "cas": "68957-94-8", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}], "conditions": {"temperature_c": 40.0, "time_h": 18.167, "yield_pct": 82.0}, "smiles": {"reactants": "Cn1ccc([C@H]2C[C@H](N(c3cc(F)c(N)cc3F)c3nccn4nccc34)C2)n1.O=C(O)c1ccnn(-c2ccc(F)cn2)c1=O", "products": "Cn1ccc([C@H]2C[C@H](N(c3cc(F)c(NC(=O)c4ccnn(-c5ccc(F)cn5)c4=O)cc3F)c3nccn4nccc34)C2)n1"}, "reference": {"title": "Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy", "authors": "Bumpers, Quinn A.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(16), 14466-14477.", "doi": "10.1021/acs.jmedchem.4c01232", "raw": "Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy | Bumpers, Quinn A.; et al | Journal of Medicinal Chemistry (2024), 67(16), 14466-14477. | 10.1021/acs.jmedchem.4c01232"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-41901045", "1.1|Reagents: Pyridine, Propylphosphonic anhydride", "Solvents: Ethyl acetate; 0 °C; 10 min, rt; 18 h, 40 °C", "Relative stereochemistry shown", "Relative stereochemistry shown", "Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360", "By: Rueeger, Heinrich; et al", "Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.", "10.1021/acs.jmedchem.0c02143"], "signatures": {"cond_key": "none/none/Propylphosphonic anhydride|68957-94-8+Pyridine|110-86-1/Ethyl Acetate|141-78-6", "cond_sig": "8c6e1da2", "fam_sig": "2425fcc8"}, "raw_data": {"raw_cas": "RCT: 30766-11-1 + 2641064-91-5 | PRO: 2641064-93-7 | RGT: 110-86-1 + 68957-94-8 | SOL: 141-78-6", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy\", \"authors\": \"Bumpers, Quinn A.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(16), 14466-14477.\", \"reagents\": [\"Pyridine\", \"Propylphosphonic anhydride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-41901045\", \"1.1\", \"Reagents: Pyridine, Propylphosphonic anhydride\", \"Solvents: Ethyl acetate; 0 °C; 10 min, rt; 18 h, 40 °C\", \"453. Scheme 453 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Synthesis of the Potent, Selective and Efficacious β-Secretase (BACE1) Inhibitor NB-360\", \"By: Rueeger, Heinrich; et al\", \"Journal of Medicinal Chemistry (2021), 64(8), 4677-4696.\", \"10.1021/acs.jmedchem.0c02143\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"30766-11-1\", \"2641064-91-5\"], \"pro_cas\": [\"2641064-93-7\"], \"rgt_cas\": [\"110-86-1\", \"68957-94-8\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\"], \"notes\": []}}", "enriched_names": {"reactants": ["30766-11-1", "2641064-91-5"], "products": ["2641064-93-7"], "reagents": ["Pyridine", "Propylphosphonic anhydride"], "catalysts": [], "solvents": ["Ethyl Acetate"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42074935", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1,1′-carbonylbis-", "cas": "37868-93-2", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 50.0, "time_h": 30.0, "yield_pct": 93.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.Nc1ccccc1", "products": "CC(C)(C)OC(=O)NCC(=O)Nc1ccccc1"}, "reference": {"title": "Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors", "authors": "Zhao, Zhixiang; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 80, 117172.", "doi": "10.1016/j.bmc.2023.117172", "raw": "Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors | Zhao, Zhixiang; et al | Bioorganic & Medicinal Chemistry (2023), 80, 117172. | 10.1016/j.bmc.2023.117172"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-42074935", "1.1|Reagents: 1H-Pyrazole, 1,1′-carbonylbis-", "Solvents: Tetrahydrofuran; 5 h, rt", "1.2|rt → 50 °C; 24 h, 50 °C", "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "By: Morozova, Alisa; et al", "European Journal of Medicinal Chemistry (2024), 266, 116101.", "10.1016/j.ejmech.2023.116101"], "signatures": {"cond_key": "none/none/1,1′-carbonylbis-|37868-93-2/Tetrahydrofuran|109-99-9", "cond_sig": "1266c183", "fam_sig": "beb34b1d"}, "raw_data": {"raw_cas": "RCT: 753-90-2 + 16694-18-1 | PRO: 2327050-90-6 | RGT: 37868-93-2 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors\", \"authors\": \"Zhao, Zhixiang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 80, 117172.\", \"reagents\": [\"1,1′-carbonylbis-\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42074935\", \"1.1\", \"Reagents: 1H-Pyrazole, 1,1′-carbonylbis-\", \"Solvents: Tetrahydrofuran; 5 h, rt\", \"1.2\", \"rt → 50 °C; 24 h, 50 °C\", \"38. Scheme 38 (1 Reaction)\", \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"By: Morozova, Alisa; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"10.1016/j.ejmech.2023.116101\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"753-90-2\", \"16694-18-1\"], \"pro_cas\": [\"2327050-90-6\"], \"rgt_cas\": [\"37868-93-2\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["753-90-2", "16694-18-1"], "products": ["2327050-90-6"], "reagents": ["37868-93-2"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42085179", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 85.0}, "smiles": {"reactants": "CN.Cl.C[C@@H](c1ccccc1)N(Cc1ccccc1)[C@@H](CCC(C)(F)F)[C@H](O)C(=O)O", "products": "CNC(=O)[C@@H](O)[C@H](CCC(C)(F)F)N(Cc1ccccc1)[C@@H](C)c1ccccc1"}, "reference": {"title": "Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic", "authors": "Shurtleff, Valerie W.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.", "doi": "10.1021/acs.jmedchem.3c02248", "raw": "Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic | Shurtleff, Valerie W.; et al | Journal of Medicinal Chemistry (2024), 67(5), 3935-3958. | 10.1021/acs.jmedchem.3c02248"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-42085179", "1.1|Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer", "By: Fuchs, Natalie; et al", "ChemMedChem (2023), 18(15), e202300160.", "10.1002/cmdc.202300160"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+HATU|148893-10-1+N-Methylmorpholine|109-02-4+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2", "cond_sig": "41053591", "fam_sig": "6d5830e8"}, "raw_data": {"raw_cas": "RCT: 55-22-1 + 3182-93-2 | PRO: 1957239-71-2 | RGT: 109-02-4 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic\", \"authors\": \"Shurtleff, Valerie W.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.\", \"reagents\": [\"4-Methylmorpholine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42085179\", \"1.1\", \"Reagents: 4-Methylmorpholine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; overnight, rt\", \"168. Scheme 168 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer\", \"By: Fuchs, Natalie; et al\", \"ChemMedChem (2023), 18(15), e202300160.\", \"10.1002/cmdc.202300160\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"55-22-1\", \"3182-93-2\"], \"pro_cas\": [\"1957239-71-2\"], \"rgt_cas\": [\"109-02-4\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["55-22-1", "3182-93-2"], "products": ["1957239-71-2"], "reagents": ["N-Methylmorpholine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42085218", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "156311-85-2", "cas": "156311-85-2", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "Phosphorus(1+)", "cas": "", "role": "UNK"}, {"name": "[3-(hydroxy-κO)-1,2,3-triazolo[4,5-b]pyridinato]tris(N-methylmethanaminato)-", "cas": "", "role": "UNK"}, {"name": "(T-4)-", "cas": "", "role": "UNK"}, {"name": "hexafluorophosphate(1-) (1:1)", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 0.167, "yield_pct": 91.0}, "smiles": {"reactants": "COC(OC)[C@@H](N)CCC(C)(F)F.O=C(O)[C@@H]1CC2(CCCCC2)CN1C(=O)OCc1ccccc1", "products": "COC(OC)[C@H](CCC(C)(F)F)NC(=O)[C@@H]1CC2(CCCCC2)CN1C(=O)OCc1ccccc1"}, "reference": {"title": "Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic", "authors": "Shurtleff, Valerie W.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.", "doi": "10.1021/acs.jmedchem.3c02248", "raw": "Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic | Shurtleff, Valerie W.; et al | Journal of Medicinal Chemistry (2024), 67(5), 3935-3958. | 10.1021/acs.jmedchem.3c02248"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-42085218", "1.1|Reagents: Diisopropylethylamine, Phosphorus(1+), [3-(hydroxy-κO)-1,2,3-triazolo[4,5-b]pyridinato]tris(N-methylmethanaminato)-, (T-4)-, hexafluorophosphate(1-) (1:1)", "Solvents: Dimethylformamide; 10 min, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/(T-4)-|+156311-85-2|156311-85-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Phosphorus(1+)|+[3-(hydroxy-κO)-1,2,3-triazolo[4,5-b]pyridinato]tris(N-methylmethanaminato)-|+hexafluorophosphate(1-) (1:1)|/Dimethylformamide|68-12-2", "cond_sig": "80b9e08d", "fam_sig": "1505dda8"}, "raw_data": {"raw_cas": "RCT: 619-86-3 + 2919713-61-2 | PRO: 2919713-78-1 | RGT: 7087-68-5 + 156311-85-2 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic\", \"authors\": \"Shurtleff, Valerie W.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.\", \"reagents\": [\"Diisopropylethylamine\", \"Phosphorus(1+)\", \"[3-(hydroxy-κO)-1,2,3-triazolo[4,5-b]pyridinato]tris(N-methylmethanaminato)-\", \"(T-4)-\", \"hexafluorophosphate(1-) (1:1)\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42085218\", \"1.1\", \"Reagents: Diisopropylethylamine, Phosphorus(1+), [3-(hydroxy-κO)-1,2,3-triazolo[4,5-b]pyridinato]tris(N-methylmethanaminato)-, (T-4)-, hexafluorophosphate(1-) (1:1)\", \"Solvents: Dimethylformamide; 10 min, rt\", \"266. Scheme 266 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"619-86-3\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-78-1\"], \"rgt_cas\": [\"7087-68-5\", \"156311-85-2\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["619-86-3", "2919713-61-2"], "products": ["2919713-78-1"], "reagents": ["N,N-Diisopropylethylamine", "156311-85-2"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42203010", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [], "solvents": [{"name": "Ethanol", "cas": "64-17-5"}], "conditions": {"temperature_c": 80.0, "time_h": 50.0, "yield_pct": 89.0}, "smiles": {"reactants": "Nc1cccc(Cl)c1C(=O)O.CC(=O)O.N=CN", "products": "O=c1nc[nH]c2cccc(Cl)c12"}, "reference": {"title": "Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases", "authors": "Yang, Leifu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(7), 5662-5682.", "doi": "10.1021/acs.jmedchem.3c02302", "raw": "Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases | Yang, Leifu; et al | Journal of Medicinal Chemistry (2024), 67(7), 5662-5682. | 10.1021/acs.jmedchem.3c02302"}, "original_text": ["Steps: 1, Yield: 85-89%", "CAS Reaction Number: 31-614-CAS-42203010", "1.1|Solvents: Ethanol; 48 h, 80 °C", "Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino[2,3-f]quinazoline derivatives as EGFR-TKIs", "By: Qin, Xuemei; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 80, 129104.", "10.1016/j.bmcl.2022.129104"], "signatures": {"cond_key": "none/none/none/Ethanol|64-17-5", "cond_sig": "9fc9dc04", "fam_sig": "9fc9dc04"}, "raw_data": {"raw_cas": "RCT: 2148-56-3 + 3473-63-0 | PRO: 60233-66-1 | SOL: 64-17-5", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases\", \"authors\": \"Yang, Leifu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(7), 5662-5682.\", \"reagents\": [], \"catalysts\": [], \"solvents\": [\"Ethanol\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42203010\", \"1.1\", \"Solvents: Ethanol; 48 h, 80 °C\", \"Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino[2,3-f]quinazoline derivatives as EGFR-TKIs\", \"By: Qin, Xuemei; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 80, 129104.\", \"10.1016/j.bmcl.2022.129104\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2148-56-3\", \"3473-63-0\"], \"pro_cas\": [\"60233-66-1\"], \"rgt_cas\": [], \"cat_cas\": [], \"sol_cas\": [\"64-17-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2148-56-3", "3473-63-0"], "products": ["60233-66-1"], "reagents": [], "catalysts": [], "solvents": ["Ethanol"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42356617", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "DBU", "cas": "6674-22-2", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "1,8-Diazabicyclo[5.4.0]undec-7-ene", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.333, "yield_pct": 81.0}, "smiles": {"reactants": "C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O.CC(=O)N[C@H]1[C@H](OCCN=[N+]=[N-])O[C@@H]2COC(c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)O", "products": "CC(=O)N[C@H]1[C@H](OCCN=[N+]=[N-])O[C@@H]2COC(c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O"}, "reference": {"title": "Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists", "authors": "Ding, Dong; et al", "citation": "European Journal of Medicinal Chemistry (2024), 278, 116792.", "doi": "10.1016/j.ejmech.2024.116792", "raw": "Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists | Ding, Dong; et al | European Journal of Medicinal Chemistry (2024), 278, 116792. | 10.1016/j.ejmech.2024.116792"}, "original_text": ["Steps: 1, Yield: 81%", "CAS Reaction Number: 31-614-CAS-42356617", "1.1|Reagents: 1,8-Diazabicyclo[5.4.0]undec-7-ene", "Solvents: Dimethylformamide; 20 min, rt", "1.2|Reagents: 1-Hydroxybenzotriazole", "1.3|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 12 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases", "By: Carzaniga, Laura; et al", "Journal of Medicinal Chemistry (2024), 67(12), 9816-9841.", "10.1021/acs.jmedchem.4c00298"], "signatures": {"cond_key": "none/none/1,8-Diazabicyclo[5.4.0]undec-7-ene|+1-Hydroxybenzotriazole|2592-95-2+DBU|6674-22-2+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "e206b1ab", "fam_sig": "8471f14b"}, "raw_data": {"raw_cas": "RCT: 1989656-07-6 + 3052116-26-1 | PRO: 3052116-61-4 | RGT: 6674-22-2 + 2592-95-2 + 7087-68-5 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists\", \"authors\": \"Ding, Dong; et al\", \"citation\": \"European Journal of Medicinal Chemistry (2024), 278, 116792.\", \"reagents\": [\"1,8-Diazabicyclo[5.4.0]undec-7-ene\", \"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42356617\", \"1.1\", \"Reagents: 1,8-Diazabicyclo[5.4.0]undec-7-ene\", \"Solvents: Dimethylformamide; 20 min, rt\", \"1.2\", \"Reagents: 1-Hydroxybenzotriazole\", \"1.3\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate; 12 h, rt\", \"460. Scheme 460 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases\", \"By: Carzaniga, Laura; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 9816-9841.\", \"10.1021/acs.jmedchem.4c00298\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1989656-07-6\", \"3052116-26-1\"], \"pro_cas\": [\"3052116-61-4\"], \"rgt_cas\": [\"6674-22-2\", \"2592-95-2\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1989656-07-6", "3052116-26-1"], "products": ["3052116-61-4"], "reagents": ["DBU", "1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42622979", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 91.0}, "smiles": {"reactants": "Cc1ccc(N)cc1Cl.Cc1nnsc1C(=O)O", "products": "Cc1ccc(NC(=O)c2snnc2C)cc1Cl"}, "reference": {"title": "On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System", "authors": "Fang, Zhengqi; et al", "citation": "Organic Process Research & Development (2024), 28(8), 3143-3151.", "doi": "10.1021/acs.oprd.4c00043", "raw": "On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System | Fang, Zhengqi; et al | Organic Process Research & Development (2024), 28(8), 3143-3151. | 10.1021/acs.oprd.4c00043"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-42622979", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|Reagents: Hydrochloric acid", "Solvents: Water", "Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase", "By: Hiesinger, Kerstin; et al", "Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.", "10.1021/acs.jmedchem.0c00561"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Hydrochloric acid|7647-01-0/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "6e841fc1", "fam_sig": "7f15c38e"}, "raw_data": {"raw_cas": "RCT: 618-51-9 + 1140-29-0 | PRO: 2709014-34-4 | RGT: 2592-95-2 + 25952-53-8 + 7647-01-0 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System\", \"authors\": \"Fang, Zhengqi; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(8), 3143-3151.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42622979\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: Water\", \"128. Scheme 128 (1 Reaction)\", \"Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase\", \"By: Hiesinger, Kerstin; et al\", \"Journal of Medicinal Chemistry (2020), 63(20), 11498-11521.\", \"10.1021/acs.jmedchem.0c00561\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"618-51-9\", \"1140-29-0\"], \"pro_cas\": [\"2709014-34-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["618-51-9", "1140-29-0"], "products": ["2709014-34-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42622982", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 0.25, "yield_pct": 88.0}, "smiles": {"reactants": "Cc1cnc(N)s1.Cc1nnsc1C(=O)O", "products": "Cc1cnc(NC(=O)c2snnc2C)s1"}, "reference": {"title": "On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System", "authors": "Fang, Zhengqi; et al", "citation": "Organic Process Research & Development (2024), 28(8), 3143-3151.", "doi": "10.1021/acs.oprd.4c00043", "raw": "On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System | Fang, Zhengqi; et al | Organic Process Research & Development (2024), 28(8), 3143-3151. | 10.1021/acs.oprd.4c00043"}, "original_text": ["Steps: 1, Yield: 88%", "CAS Reaction Number: 31-614-CAS-42622982", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dimethylformamide; 15 min, rt", "1.2|Reagents: Hydrochloric acid", "Solvents: Water", "Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors", "By: Wang, Xinyu; et al", "Bioorganic & Medicinal Chemistry (2022), 72, 116995.", "10.1016/j.bmc.2022.116995"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Hydrochloric acid|7647-01-0/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "6e841fc1", "fam_sig": "7f15c38e"}, "raw_data": {"raw_cas": "RCT: 455-40-3 + 99-03-6 | PRO: 923829-43-0 | RGT: 2592-95-2 + 25952-53-8 + 7647-01-0 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"On-Demand Production of Two Commercial Plant Activators, Tiadinil and Methiadinil, under an Integrated Continuous Flow System\", \"authors\": \"Fang, Zhengqi; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(8), 3143-3151.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Hydrochloric acid\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42622982\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"Reagents: Hydrochloric acid\", \"Solvents: Water\", \"83. Scheme 83 (1 Reaction)\", \"Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors\", \"By: Wang, Xinyu; et al\", \"Bioorganic & Medicinal Chemistry (2022), 72, 116995.\", \"10.1016/j.bmc.2022.116995\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"455-40-3\", \"99-03-6\"], \"pro_cas\": [\"923829-43-0\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7647-01-0\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["455-40-3", "99-03-6"], "products": ["923829-43-0"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "Hydrochloric acid"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42806224", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylmorpholine", "cas": "109-02-4", "role": "NUC"}, {"name": "HBTU", "cas": "94790-37-1", "role": "UNK"}, {"name": "4-Methylmorpholine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 99.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCC(=O)O.Nc1ccc(Cl)c(Cl)c1", "products": "CC(C)(C)OC(=O)NCCC(=O)Nc1ccc(Cl)c(Cl)c1"}, "reference": {"title": "Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT", "authors": "Wannowius, Marie; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(21), 19342-19364.", "doi": "10.1021/acs.jmedchem.4c01743", "raw": "Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT | Wannowius, Marie; et al | Journal of Medicinal Chemistry (2024), 67(21), 19342-19364. | 10.1021/acs.jmedchem.4c01743"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-42806224", "1.1|Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 0.5 h, rt", "1.2|16 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis", "By: Koralewski, Robert; et al", "Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.", "10.1021/acs.jmedchem.0c01179"], "signatures": {"cond_key": "none/none/4-Methylmorpholine|+HBTU|94790-37-1+N-Methylmorpholine|109-02-4/Dimethylformamide|68-12-2", "cond_sig": "39d1d9a0", "fam_sig": "cd89fdb0"}, "raw_data": {"raw_cas": "RCT: 191221-33-7 + 201864-00-8 | PRO: 2088454-18-4 | RGT: 109-02-4 + 94790-37-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT\", \"authors\": \"Wannowius, Marie; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(21), 19342-19364.\", \"reagents\": [\"4-Methylmorpholine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42806224\", \"1.1\", \"Reagents: 4-Methylmorpholine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 0.5 h, rt\", \"1.2\", \"16 h, rt\", \"153. Scheme 153 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis\", \"By: Koralewski, Robert; et al\", \"Journal of Medicinal Chemistry (2020), 63(24), 15527-15540.\", \"10.1021/acs.jmedchem.0c01179\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"191221-33-7\", \"201864-00-8\"], \"pro_cas\": [\"2088454-18-4\"], \"rgt_cas\": [\"109-02-4\", \"94790-37-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["191221-33-7", "201864-00-8"], "products": ["2088454-18-4"], "reagents": ["N-Methylmorpholine", "HBTU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42806422", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 4.5, "yield_pct": 85.0}, "smiles": {"reactants": "COc1cc(OCc2ccccc2)c(C)cc1-n1nnc(C(=O)O)c1C.CCCCOc1ccc(C(C)(C)C)cc1N", "products": "CCCCOc1ccc(C(C)(C)C)cc1NC(=O)c1nnn(-c2cc(C)c(OCc3ccccc3)cc2OC)c1C"}, "reference": {"title": "First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy", "authors": "Huber, Andrew D.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(20), 18549-18575.", "doi": "10.1021/acs.jmedchem.4c01926", "raw": "First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy | Huber, Andrew D.; et al | Journal of Medicinal Chemistry (2024), 67(20), 18549-18575. | 10.1021/acs.jmedchem.4c01926"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-42806422", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 30 min, 20 °C", "1.2|4 h, 25 °C", "1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis", "By: Chen, Bei; et al", "Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.", "10.1021/acs.jmedchem.3c01326"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 1007695-49-9 + 1307702-36-8 | PRO: 3002420-79-0 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy\", \"authors\": \"Huber, Andrew D.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(20), 18549-18575.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42806422\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 30 min, 20 °C\", \"1.2\", \"4 h, 25 °C\", \"348. Scheme 348 (1 Reaction)\", \"1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis\", \"By: Chen, Bei; et al\", \"Journal of Medicinal Chemistry (2023), 66(24), 16680-16693.\", \"10.1021/acs.jmedchem.3c01326\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1007695-49-9\", \"1307702-36-8\"], \"pro_cas\": [\"3002420-79-0\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1007695-49-9", "1307702-36-8"], "products": ["3002420-79-0"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42895413", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "cas": "125700-67-6", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 93.0}, "smiles": {"reactants": "CN.Cl.CC(C)(C)OC(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)O", "products": "CNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C"}, "reference": {"title": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "authors": "Wang, Xu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "doi": "10.1021/acs.jmedchem.4c02009", "raw": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants | Wang, Xu; et al | Journal of Medicinal Chemistry (2024), 67(21), 19623-19667. | 10.1021/acs.jmedchem.4c02009"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-42895413", "1.1|Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate", "Solvents: Dimethylformamide; 2 h, 0 °C", "1.2|Reagents: Water", "Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni", "By: Kanyanta, Masebe; et al", "Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.", "10.1016/j.bmcl.2023.129164"], "signatures": {"cond_key": "none/none/1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate|125700-67-6+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "66044816", "fam_sig": "8358f9af"}, "raw_data": {"raw_cas": "RCT: 65-85-0 + 6315-89-5 | PRO: 39078-05-2 | RGT: 2592-95-2 + 7087-68-5 + 125700-67-6 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"authors\": \"Wang, Xu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"Diisopropylethylamine\", \"O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42895413\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, Diisopropylethylamine, O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate\", \"Solvents: Dimethylformamide; 2 h, 0 °C\", \"1.2\", \"Reagents: Water\", \"105. Scheme 105 (1 Reaction)\", \"Activity of N-phenylbenzamide analogs against the neglected disease pathogen, Schistosoma mansoni\", \"By: Kanyanta, Masebe; et al\", \"Bioorganic & Medicinal Chemistry Letters (2023), 82, 129164.\", \"10.1016/j.bmcl.2023.129164\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"65-85-0\", \"6315-89-5\"], \"pro_cas\": [\"39078-05-2\"], \"rgt_cas\": [\"2592-95-2\", \"7087-68-5\", \"125700-67-6\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["65-85-0", "6315-89-5"], "products": ["39078-05-2"], "reagents": ["1-Hydroxybenzotriazole", "N,N-Diisopropylethylamine", "125700-67-6", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42895443", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.0, "yield_pct": 82.0}, "smiles": {"reactants": "C=CCCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O", "products": "C=CCCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C"}, "reference": {"title": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "authors": "Wang, Xu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "doi": "10.1021/acs.jmedchem.4c02009", "raw": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants | Wang, Xu; et al | Journal of Medicinal Chemistry (2024), 67(21), 19623-19667. | 10.1021/acs.jmedchem.4c02009"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-42895443", "1.1|Reagents: Hydrochloric acid", "Solvents: Ethyl acetate; 1 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 0 °C; 2 h, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold", "By: Huang, Danling; et al", "Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.", "10.1016/j.bmcl.2021.128006"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "370868f8", "fam_sig": "5ea96387"}, "raw_data": {"raw_cas": "RCT: 1092569-57-7 + 1187932-83-7 | PRO: 2656367-54-1 | RGT: 7647-01-0 + 7087-68-5 + 148893-10-1 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"authors\": \"Wang, Xu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42895443\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Ethyl acetate; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 0 °C; 2 h, rt\", \"225. Scheme 225 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis, fungicidal activities and structure-activity relationship studies of (-)-borneol derivatives containing 2-aryl-thiazole scaffold\", \"By: Huang, Danling; et al\", \"Bioorganic & Medicinal Chemistry Letters (2021), 45, 128006.\", \"10.1016/j.bmcl.2021.128006\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1092569-57-7\", \"1187932-83-7\"], \"pro_cas\": [\"2656367-54-1\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1092569-57-7", "1187932-83-7"], "products": ["2656367-54-1"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42895446", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 3.0, "yield_pct": 87.0}, "smiles": {"reactants": "C=CCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O", "products": "C=CCCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C"}, "reference": {"title": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "authors": "Wang, Xu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "doi": "10.1021/acs.jmedchem.4c02009", "raw": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants | Wang, Xu; et al | Journal of Medicinal Chemistry (2024), 67(21), 19623-19667. | 10.1021/acs.jmedchem.4c02009"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-42895446", "1.1|Reagents: Hydrochloric acid", "Solvents: Ethyl acetate; 1 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 0 °C; 2 h, rt", "Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity", "By: Yang, Zhikun; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.", "10.1021/acs.jmedchem.2c01999"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "370868f8", "fam_sig": "5ea96387"}, "raw_data": {"raw_cas": "RCT: 65-85-0 + 2919713-61-2 | PRO: 2919713-64-5 | RGT: 7647-01-0 + 7087-68-5 + 148893-10-1 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"authors\": \"Wang, Xu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42895446\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Ethyl acetate; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 0 °C; 2 h, rt\", \"221. Scheme 221 (1 Reaction)\", \"Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity\", \"By: Yang, Zhikun; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5550-5566.\", \"10.1021/acs.jmedchem.2c01999\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"65-85-0\", \"2919713-61-2\"], \"pro_cas\": [\"2919713-64-5\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["65-85-0", "2919713-61-2"], "products": ["2919713-64-5"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42895448", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 3.0, "yield_pct": 82.0}, "smiles": {"reactants": "C=CCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O", "products": "C=CCCCCOC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C"}, "reference": {"title": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "authors": "Wang, Xu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "doi": "10.1021/acs.jmedchem.4c02009", "raw": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants | Wang, Xu; et al | Journal of Medicinal Chemistry (2024), 67(21), 19623-19667. | 10.1021/acs.jmedchem.4c02009"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-42895448", "1.1|Reagents: Hydrochloric acid", "Solvents: Ethyl acetate; 1 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 2 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Double bond geometry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer", "By: Cordella, Fabiana; et al", "ChemMedChem (2024), 19(14), e202300727.", "10.1002/cmdc.202300727"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "370868f8", "fam_sig": "5ea96387"}, "raw_data": {"raw_cas": "RCT: 13139-14-5 + 586410-15-3 | PRO: 3081937-77-8 | RGT: 7647-01-0 + 7087-68-5 + 148893-10-1 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"authors\": \"Wang, Xu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42895448\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Ethyl acetate; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 2 h, rt\", \"215. Scheme 215 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"A Structure-Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer\", \"By: Cordella, Fabiana; et al\", \"ChemMedChem (2024), 19(14), e202300727.\", \"10.1002/cmdc.202300727\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"13139-14-5\", \"586410-15-3\"], \"pro_cas\": [\"3081937-77-8\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["13139-14-5", "586410-15-3"], "products": ["3081937-77-8"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42895457", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 12.5, "yield_pct": 86.0}, "smiles": {"reactants": "C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CCC[C@@H]1CC(=O)O", "products": "C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C[C@H]1CCCN1C(=O)OC(C)(C)C"}, "reference": {"title": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "authors": "Wang, Xu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "doi": "10.1021/acs.jmedchem.4c02009", "raw": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants | Wang, Xu; et al | Journal of Medicinal Chemistry (2024), 67(21), 19623-19667. | 10.1021/acs.jmedchem.4c02009"}, "original_text": ["Steps: 1, Yield: 86%", "CAS Reaction Number: 31-614-CAS-42895457", "1.1|Reagents: Hydrochloric acid", "Solvents: Ethyl acetate; 30 min, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 12 h, rt", "1.3|Reagents: Water; rt", "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "By: Amblard, Franck; et al", "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "10.1016/j.bmc.2020.115952"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "a054a894", "fam_sig": "0e3e74ab"}, "raw_data": {"raw_cas": "RCT: 100-46-9 + 1644485-79-9 | PRO: 2133017-48-6 | RGT: 7647-01-0 + 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"authors\": \"Wang, Xu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42895457\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Ethyl acetate; 30 min, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 12 h, rt\", \"1.3\", \"Reagents: Water; rt\", \"164. Scheme 164 (1 Reaction)\", \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"By: Amblard, Franck; et al\", \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"10.1016/j.bmc.2020.115952\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"100-46-9\", \"1644485-79-9\"], \"pro_cas\": [\"2133017-48-6\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["100-46-9", "1644485-79-9"], "products": ["2133017-48-6"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-42895499", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Hydrochloric acid", "cas": "7647-01-0", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 2.0, "yield_pct": 91.0}, "smiles": {"reactants": "C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1Cl)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N1CC2(CC2)C[C@@H]1CC(=O)O", "products": "C=CCCCCCNC(=O)[C@@H](Cc1ccc(Cl)cc1Cl)NC(=O)C[C@H]1CC2(CC2)CN1C(=O)OC(C)(C)C"}, "reference": {"title": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants", "authors": "Wang, Xu; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.", "doi": "10.1021/acs.jmedchem.4c02009", "raw": "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants | Wang, Xu; et al | Journal of Medicinal Chemistry (2024), 67(21), 19623-19667. | 10.1021/acs.jmedchem.4c02009"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-42895499", "1.1|Reagents: Hydrochloric acid", "Solvents: Ethyl acetate; 1 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 1 h, rt", "1.3|Reagents: Water; rt", "Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell", "By: Yang, Zhikun; et al", "European Journal of Medicinal Chemistry (2023), 248, 115092.", "10.1016/j.ejmech.2023.115092"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+Hydrochloric acid|7647-01-0+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Water|7732-18-5/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "a054a894", "fam_sig": "0e3e74ab"}, "raw_data": {"raw_cas": "RCT: 1070-83-3 + 2632874-83-8 | PRO: 2897680-76-9 | RGT: 7647-01-0 + 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants\", \"authors\": \"Wang, Xu; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(21), 19623-19667.\", \"reagents\": [\"Hydrochloric acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-42895499\", \"1.1\", \"Reagents: Hydrochloric acid\", \"Solvents: Ethyl acetate; 1 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 1 h, rt\", \"1.3\", \"Reagents: Water; rt\", \"292. Scheme 292 (1 Reaction)\", \"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell\", \"By: Yang, Zhikun; et al\", \"European Journal of Medicinal Chemistry (2023), 248, 115092.\", \"10.1016/j.ejmech.2023.115092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"1070-83-3\", \"2632874-83-8\"], \"pro_cas\": [\"2897680-76-9\"], \"rgt_cas\": [\"7647-01-0\", \"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["1070-83-3", "2632874-83-8"], "products": ["2897680-76-9"], "reagents": ["Hydrochloric acid", "N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43022053", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 30.0, "time_h": 5.0, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N1CCc2c(cc(Cl)c(C(=O)O)c2Cl)C1.CS(=O)(=O)c1cccc(C[C@H](N)C(=O)OCc2ccccc2)c1.Cl", "products": "CC(C)(C)OC(=O)N1CCc2c(cc(Cl)c(C(=O)N[C@@H](Cc3cccc(S(C)(=O)=O)c3)C(=O)OCc3ccccc3)c2Cl)C1"}, "reference": {"title": "An improved commercial process for the preparation of Lifitegrast", "authors": "Girkar, Arvind; et al", "citation": "Organic Process Research & Development (2024), 28(12), 4374-4379.", "doi": "10.1021/acs.oprd.4c00356", "raw": "An improved commercial process for the preparation of Lifitegrast | Girkar, Arvind; et al | Organic Process Research & Development (2024), 28(12), 4374-4379. | 10.1021/acs.oprd.4c00356"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-43022053", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 4 - 5 h, 25 - 30 °C", "1.2|Solvents: Water; 20 - 25 °C", "Relative stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure", "By: Granberg, Kenneth L.; et al", "Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.", "10.1021/acs.jmedchem.3c02184"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "22191a61", "fam_sig": "11abe75c"}, "raw_data": {"raw_cas": "RCT: 2445749-73-3 + 2787515-84-6 | PRO: 2787515-86-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"An improved commercial process for the preparation of Lifitegrast\", \"authors\": \"Girkar, Arvind; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(12), 4374-4379.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43022053\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 4 - 5 h, 25 - 30 °C\", \"1.2\", \"Solvents: Water; 20 - 25 °C\", \"388. Scheme 388 (1 Reaction)\", \"Relative stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure\", \"By: Granberg, Kenneth L.; et al\", \"Journal of Medicinal Chemistry (2024), 67(6), 4419-4441.\", \"10.1021/acs.jmedchem.3c02184\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2445749-73-3\", \"2787515-84-6\"], \"pro_cas\": [\"2787515-86-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": [\"stereoselective\"]}}", "enriched_names": {"reactants": ["2445749-73-3", "2787515-84-6"], "products": ["2787515-86-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43597120", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 16.0, "yield_pct": 98.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCCC(=O)O.Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O", "products": "CC(C)(C)OC(=O)NCCCC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O"}, "reference": {"title": "Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders", "authors": "Si, Ru; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 77, 117115.", "doi": "10.1016/j.bmc.2022.117115", "raw": "Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders | Si, Ru; et al | Bioorganic & Medicinal Chemistry (2023), 77, 117115. | 10.1016/j.bmc.2022.117115"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-43597120", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dichloromethane; 0 °C; overnight, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "ff3cc7e6", "fam_sig": "795fcf91"}, "raw_data": {"raw_cas": "RCT: 783350-37-8 + 2765293-24-9 | PRO: 2765293-57-8 | RGT: 121-44-8 + 148893-10-1 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders\", \"authors\": \"Si, Ru; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 77, 117115.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43597120\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dichloromethane; 0 °C; overnight, rt\", \"340. Scheme 340 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"783350-37-8\", \"2765293-24-9\"], \"pro_cas\": [\"2765293-57-8\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["783350-37-8", "2765293-24-9"], "products": ["2765293-57-8"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43646483", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "HATU", "cas": "148893-10-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 16.25, "yield_pct": 90.0}, "smiles": {"reactants": "COc1cc(N)cc(OC)c1.Nc1ncc(Br)nc1C(=O)O", "products": "COc1cc(NC(=O)c2nc(Br)cnc2N)cc(OC)c1"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors", "authors": "Zheng, Jia; et al", "citation": "ACS Medicinal Chemistry Letters (2024), 15(11), 2019-2031.", "doi": "10.1021/acsmedchemlett.4c00431", "raw": "Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors | Zheng, Jia; et al | ACS Medicinal Chemistry Letters (2024), 15(11), 2019-2031. | 10.1021/acsmedchemlett.4c00431"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-43646483", "1.1|Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, rt", "1.2|Reagents: Diisopropylethylamine; overnight, rt", "HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies", "By: Pasqua, A. Elisa; et al", "Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.", "10.1021/acs.jmedchem.3c00156"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2", "cond_sig": "356c35eb", "fam_sig": "a7c7440d"}, "raw_data": {"raw_cas": "RCT: 635-80-3 + 6283-25-6 | PRO: 1693735-05-5 | RGT: 148893-10-1 + 7087-68-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors\", \"authors\": \"Zheng, Jia; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2024), 15(11), 2019-2031.\", \"reagents\": [\"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43646483\", \"1.1\", \"Reagents: O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; overnight, rt\", \"333. Scheme 333 (1 Reaction)\", \"HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies\", \"By: Pasqua, A. Elisa; et al\", \"Journal of Medicinal Chemistry (2023), 66(8), 5907-5936.\", \"10.1021/acs.jmedchem.3c00156\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"635-80-3\", \"6283-25-6\"], \"pro_cas\": [\"1693735-05-5\"], \"rgt_cas\": [\"148893-10-1\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["635-80-3", "6283-25-6"], "products": ["1693735-05-5"], "reagents": ["HATU", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43877333", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N-Methylimidazole", "cas": "616-47-7", "role": "BASE"}, {"name": "Tetramethylchloroformamidinium hexafluorophosphate", "cas": "94790-35-9", "role": "UNK"}, {"name": "1-Methylimidazole", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylacetamide", "cas": "127-19-5"}, {"name": "Isopropanol", "cas": "67-63-0"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 20.0, "time_h": 11.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1cnc(C(F)(F)F)nc1.C[C@@H](OC(=O)Nc1c(-c2ccc(N)cn2)nnn1C)c1cc(F)cnc1F.Cc1ccc(S(=O)(=O)O)cc1", "products": "C[C@@H](OC(=O)Nc1c(-c2ccc(NC(=O)c3cnc(C(F)(F)F)nc3)cn2)nnn1C)c1cc(F)cnc1F"}, "reference": {"title": "Early Process Development of an LPAR1 Antagonist, GS-2278", "authors": "Kadunce, Nathaniel; et al", "citation": "Organic Process Research & Development (2024), 28(11), 4099-4113.", "doi": "10.1021/acs.oprd.4c00369", "raw": "Early Process Development of an LPAR1 Antagonist, GS-2278 | Kadunce, Nathaniel; et al | Organic Process Research & Development (2024), 28(11), 4099-4113. | 10.1021/acs.oprd.4c00369"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-43877333", "1.1|Reagents: 1-Methylimidazole, Tetramethylchloroformamidinium hexafluorophosphate", "Solvents: Dimethylacetamide; 15 min, 0 °C; 15 min, 0 °C", "1.2|30 min, 0 °C", "1.3|Solvents: Isopropanol, Water; 0 °C → 20 °C; 8 h, 20 °C; 2 h, 20 °C → 0 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase", "By: Lv, Lijuan; et al", "Journal of Medicinal Chemistry (2024), 67(9), 7385-7405.", "10.1021/acs.jmedchem.4c00222"], "signatures": {"cond_key": "none/none/1-Methylimidazole|+N-Methylimidazole|616-47-7+Tetramethylchloroformamidinium hexafluorophosphate|94790-35-9/Dimethylacetamide|127-19-5+Isopropanol|67-63-0+Water|7732-18-5", "cond_sig": "d1d9dcb6", "fam_sig": "c176f433"}, "raw_data": {"raw_cas": "RCT: 129724-84-1 + 1926-80-3 | PRO: 2919975-48-5 | RGT: 616-47-7 + 94790-35-9 | SOL: 127-19-5 + 67-63-0 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Early Process Development of an LPAR1 Antagonist, GS-2278\", \"authors\": \"Kadunce, Nathaniel; et al\", \"citation\": \"Organic Process Research & Development (2024), 28(11), 4099-4113.\", \"reagents\": [\"1-Methylimidazole\", \"Tetramethylchloroformamidinium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylacetamide\", \"Isopropanol\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43877333\", \"1.1\", \"Reagents: 1-Methylimidazole, Tetramethylchloroformamidinium hexafluorophosphate\", \"Solvents: Dimethylacetamide; 15 min, 0 °C; 15 min, 0 °C\", \"1.2\", \"30 min, 0 °C\", \"1.3\", \"Solvents: Isopropanol, Water; 0 °C → 20 °C; 8 h, 20 °C; 2 h, 20 °C → 0 °C\", \"416. Scheme 416 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase\", \"By: Lv, Lijuan; et al\", \"Journal of Medicinal Chemistry (2024), 67(9), 7385-7405.\", \"10.1021/acs.jmedchem.4c00222\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"129724-84-1\", \"1926-80-3\"], \"pro_cas\": [\"2919975-48-5\"], \"rgt_cas\": [\"616-47-7\", \"94790-35-9\"], \"cat_cas\": [], \"sol_cas\": [\"127-19-5\", \"67-63-0\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["129724-84-1", "1926-80-3"], "products": ["2919975-48-5"], "reagents": ["N-Methylimidazole", "94790-35-9"], "catalysts": [], "solvents": ["Dimethylacetamide", "Isopropanol", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43930961", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.0, "yield_pct": 92.0}, "smiles": {"reactants": "CN.Cl.COc1cc(Br)cc(C(=O)O)c1", "products": "CNC(=O)c1cc(Br)cc(OC)c1"}, "reference": {"title": "Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B", "authors": "Lv, Gang; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 80, 117173.", "doi": "10.1016/j.bmc.2023.117173", "raw": "Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B | Lv, Gang; et al | Bioorganic & Medicinal Chemistry (2023), 80, 117173. | 10.1016/j.bmc.2023.117173"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-43930961", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 8 h, rt", "Efficient Total Synthesis of Bilirubin IXα from Butyrolactone", "By: Chen, Fapu; et al", "Organic Process Research & Development (2024), 28(7), 2777-2788.", "10.1021/acs.oprd.4c00122"], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RCT: 78-96-6 + 6178-52-5 | PRO: 2334110-56-2 | RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B\", \"authors\": \"Lv, Gang; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 80, 117173.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43930961\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 8 h, rt\", \"24. Scheme 24 (1 Reaction)\", \"Efficient Total Synthesis of Bilirubin IXα from Butyrolactone\", \"By: Chen, Fapu; et al\", \"Organic Process Research & Development (2024), 28(7), 2777-2788.\", \"10.1021/acs.oprd.4c00122\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"78-96-6\", \"6178-52-5\"], \"pro_cas\": [\"2334110-56-2\"], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": [\"combinatorial\"]}}", "enriched_names": {"reactants": ["78-96-6", "6178-52-5"], "products": ["2334110-56-2"], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43967946", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "Piperidine", "cas": "110-89-4", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "1,1,1,3,3,3-Hexafluoro-2-propanol", "cas": "920-66-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 8.25, "yield_pct": 80.0}, "smiles": {"reactants": "O=C(O)[C@@H]1CCCCN1C(=O)OCC1c2ccccc2-c2ccccc21.O=C(NC[C@@H](NC(=O)OCc1ccccc1)C(=O)O)OCC1c2ccccc2-c2ccccc21.CC(C)[C@@H](C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21.CN(CC(=O)O)C(=O)OCC1c2ccccc2-c2ccccc21.O=C(O)CNC(=O)OCC1c2ccccc2-c2ccccc21.CC(C)(C)OC(=O)N[C@H](CNC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O", "products": "CC(C)[C@@H](C(=O)NC[C@@H](NC(=O)OC(C)(C)C)C(=O)N1CCCC[C@H]1C(=O)NCC(=O)N(C)CC(=O)N(C)[C@H](C(=O)NC[C@@H](NC(=O)OCc1ccccc1)C(=O)N1CCCC[C@H]1C(=O)O)C(C)C)N(C)C(=O)CN(C)C(=O)CN"}, "reference": {"title": "Structure-activity relationships of bis-intercalating peptides and their application as antibody-drug conjugate payloads", "authors": "Petersen, Mark E.; et al", "citation": "Journal of Medicinal Chemistry (2023), 66(12), 8288-8309.", "doi": "10.1021/acs.jmedchem.3c00760", "raw": "Structure-activity relationships of bis-intercalating peptides and their application as antibody-drug conjugate payloads | Petersen, Mark E.; et al | Journal of Medicinal Chemistry (2023), 66(12), 8288-8309. | 10.1021/acs.jmedchem.3c00760"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-43967946", "1.1|Reagents: Diisopropylethylamine", "Solvents: Dichloromethane; 3 h, rt", "1.2|Reagents: Piperidine", "Solvents: Dimethylformamide; rt", "1.3|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.4|Reagents: Piperidine", "Solvents: Dimethylformamide; rt", "1.5|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.6|Reagents: Piperidine", "Solvents: Dimethylformamide; rt", "1.7|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.8|Reagents: Piperidine", "Solvents: Dimethylformamide; rt", "1.9|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.10|Reagents: Piperidine", "Solvents: Dimethylformamide; rt", "1.11|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "1.12|Reagents: Piperidine", "Solvents: Dimethylformamide; rt", "1.13|Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol", "Solvents: Dichloromethane; 15 min, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery", "By: Novotna, Katerina; et al", "Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.", "10.1021/acs.jmedchem.3c01681"], "signatures": {"cond_key": "none/none/1,1,1,3,3,3-Hexafluoro-2-propanol|920-66-1+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Piperidine|110-89-4/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "d9455c46", "fam_sig": "c12fcae9"}, "raw_data": {"raw_cas": "RCT: 198560-68-8 + 2851863-10-8 | PRO: 2861234-23-1 | RGT: 7087-68-5 + 110-89-4 + 148893-10-1 + 920-66-1 | SOL: 75-09-2 + 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Structure-activity relationships of bis-intercalating peptides and their application as antibody-drug conjugate payloads\", \"authors\": \"Petersen, Mark E.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2023), 66(12), 8288-8309.\", \"reagents\": [\"Diisopropylethylamine\", \"Piperidine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"1,1,1,3,3,3-Hexafluoro-2-propanol\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43967946\", \"1.1\", \"Reagents: Diisopropylethylamine\", \"Solvents: Dichloromethane; 3 h, rt\", \"1.2\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; rt\", \"1.3\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.4\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; rt\", \"1.5\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.6\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; rt\", \"1.7\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.8\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; rt\", \"1.9\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.10\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; rt\", \"1.11\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"1.12\", \"Reagents: Piperidine\", \"Solvents: Dimethylformamide; rt\", \"1.13\", \"Reagents: 1,1,1,3,3,3-Hexafluoro-2-propanol\", \"Solvents: Dichloromethane; 15 min, rt\", \"321. Scheme 321 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of tert-butyl ester-based DON prodrugs for enhanced metabolic stability and tumor delivery\", \"By: Novotna, Katerina; et al\", \"Journal of Medicinal Chemistry (2023), 66(22), 15493-15510.\", \"10.1021/acs.jmedchem.3c01681\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"198560-68-8\", \"2851863-10-8\"], \"pro_cas\": [\"2861234-23-1\"], \"rgt_cas\": [\"7087-68-5\", \"110-89-4\", \"148893-10-1\", \"920-66-1\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\"], \"notes\": [\"solid-supported reaction, attachment to 2-chlorotrityl resin in stage 1,solid phase peptide synthesis\"]}}", "enriched_names": {"reactants": ["198560-68-8", "2851863-10-8"], "products": ["2861234-23-1"], "reagents": ["N,N-Diisopropylethylamine", "Piperidine", "HATU", "1,1,1,3,3,3-Hexafluoro-2-propanol"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43968811", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 91.0}, "smiles": {"reactants": "NCc1cccnc1.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1", "products": "O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)NCc4cccnc4)cc3)c3cccc(F)c3)nn2)N1"}, "reference": {"title": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "authors": "Stachura, Damian L.; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "doi": "10.1021/acsmedchemlett.2c00505", "raw": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase | Stachura, Damian L.; et al | ACS Medicinal Chemistry Letters (2023), 14(3), 285-290. | 10.1021/acsmedchemlett.2c00505"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-43968811", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic", "By: Shurtleff, Valerie W.; et al", "Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.", "10.1021/acs.jmedchem.3c02248"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "eb9a32e6", "fam_sig": "5f51edc3"}, "raw_data": {"raw_cas": "RCT: 2952553-12-5 + 3056237-98-7 | PRO: 3056237-99-8 | RGT: 7087-68-5 + 148893-10-1 + 12125-02-9 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"authors\": \"Stachura, Damian L.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43968811\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"265. Scheme 265 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Invention of MK-7845, a SARS-CoV-2 3CL protease inhibitor employing a novel difluorinated glutamine mimic\", \"By: Shurtleff, Valerie W.; et al\", \"Journal of Medicinal Chemistry (2024), 67(5), 3935-3958.\", \"10.1021/acs.jmedchem.3c02248\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2952553-12-5\", \"3056237-98-7\"], \"pro_cas\": [\"3056237-99-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": [\"alternate reaction conditions also shown,product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["2952553-12-5", "3056237-98-7"], "products": ["3056237-99-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43968812", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 91.0}, "smiles": {"reactants": "NCc1ccccn1.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1", "products": "O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)NCc4ccccn4)cc3)c3cccc(F)c3)nn2)N1"}, "reference": {"title": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "authors": "Stachura, Damian L.; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "doi": "10.1021/acsmedchemlett.2c00505", "raw": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase | Stachura, Damian L.; et al | ACS Medicinal Chemistry Letters (2023), 14(3), 285-290. | 10.1021/acsmedchemlett.2c00505"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-43968812", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists", "By: Cooper, Martin; et al", "Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.", "10.1021/acs.jmedchem.0c00828"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "eb9a32e6", "fam_sig": "5f51edc3"}, "raw_data": {"raw_cas": "RCT: 10241-97-1 + 2602442-39-5 | PRO: 2602442-40-8 | RGT: 7087-68-5 + 148893-10-1 + 12125-02-9 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"authors\": \"Stachura, Damian L.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43968812\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"247. Scheme 247 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists\", \"By: Cooper, Martin; et al\", \"Journal of Medicinal Chemistry (2020), 63(17), 9705-9730.\", \"10.1021/acs.jmedchem.0c00828\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"10241-97-1\", \"2602442-39-5\"], \"pro_cas\": [\"2602442-40-8\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": [\"alternate reaction conditions also shown,product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["10241-97-1", "2602442-39-5"], "products": ["2602442-40-8"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43968813", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 93.0}, "smiles": {"reactants": "Cl.NCc1ccc(N)cc1.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1", "products": "Nc1ccc(CNC(=O)c2ccc(C(c3cccc(F)c3)n3cc(CCCCC[C@@H]4SC[C@@H]5NC(=O)N[C@@H]54)nn3)cc2)cc1"}, "reference": {"title": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "authors": "Stachura, Damian L.; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "doi": "10.1021/acsmedchemlett.2c00505", "raw": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase | Stachura, Damian L.; et al | ACS Medicinal Chemistry Letters (2023), 14(3), 285-290. | 10.1021/acsmedchemlett.2c00505"}, "original_text": ["Steps: 1, Yield: 93%", "CAS Reaction Number: 31-614-CAS-43968813", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "eb9a32e6", "fam_sig": "5f51edc3"}, "raw_data": {"raw_cas": "RCT: 2387522-94-1 + 1148157-29-2 | PRO: 2387523-13-7 | RGT: 7087-68-5 + 148893-10-1 + 12125-02-9 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"authors\": \"Stachura, Damian L.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43968813\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"208. Scheme 208 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2387522-94-1\", \"1148157-29-2\"], \"pro_cas\": [\"2387523-13-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": [\"alternate reaction conditions also shown,product obtained as mixture of diastereomers\"]}}", "enriched_names": {"reactants": ["2387522-94-1", "1148157-29-2"], "products": ["2387523-13-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-43968824", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "WORKUP"}, {"name": "Ammonium chloride", "cas": "12125-02-9", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 25.0, "time_h": 16.0, "yield_pct": 95.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCCCN.O=C1N[C@H]2[C@H](CS[C@H]2CCCCCc2cn(C(c3ccc(C(=O)O)cc3)c3cccc(F)c3)nn2)N1", "products": "CC(C)(C)OC(=O)NCCCNC(=O)c1ccc(C(c2cccc(F)c2)n2cc(CCCCC[C@@H]3SC[C@@H]4NC(=O)N[C@@H]43)nn2)cc1"}, "reference": {"title": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase", "authors": "Stachura, Damian L.; et al", "citation": "ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.", "doi": "10.1021/acsmedchemlett.2c00505", "raw": "Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase | Stachura, Damian L.; et al | ACS Medicinal Chemistry Letters (2023), 14(3), 285-290. | 10.1021/acsmedchemlett.2c00505"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-43968824", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 16 h, rt", "1.2|Reagents: Ammonium chloride", "Solvents: Water; rt", "Relative stereochemistry shown", "Relative stereochemistry shown", "Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras", "By: Takwale, Akshay D.; et al", "European Journal of Medicinal Chemistry (2020), 208, 112769.", "10.1016/j.ejmech.2020.112769"], "signatures": {"cond_key": "none/none/Ammonium chloride|12125-02-9+Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "eb9a32e6", "fam_sig": "5f51edc3"}, "raw_data": {"raw_cas": "RCT: 162046-66-4 + 1818885-55-0 | PRO: 2760704-84-3 | RGT: 7087-68-5 + 148893-10-1 + 12125-02-9 | SOL: 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Structural study of potent triazole-based inhibitors of Staphylococcus aureus biotin protein ligase\", \"authors\": \"Stachura, Damian L.; et al\", \"citation\": \"ACS Medicinal Chemistry Letters (2023), 14(3), 285-290.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Ammonium chloride\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-43968824\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 16 h, rt\", \"1.2\", \"Reagents: Ammonium chloride\", \"Solvents: Water; rt\", \"326. Scheme 326 (1 Reaction)\", \"Relative stereochemistry shown\", \"Relative stereochemistry shown\", \"Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras\", \"By: Takwale, Akshay D.; et al\", \"European Journal of Medicinal Chemistry (2020), 208, 112769.\", \"10.1016/j.ejmech.2020.112769\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"162046-66-4\", \"1818885-55-0\"], \"pro_cas\": [\"2760704-84-3\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\", \"12125-02-9\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["162046-66-4", "1818885-55-0"], "products": ["2760704-84-3"], "reagents": ["N,N-Diisopropylethylamine", "HATU", "12125-02-9"], "catalysts": [], "solvents": ["Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44298691", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 80.0, "time_h": 5.0, "yield_pct": 92.0}, "smiles": {"reactants": "O=C(O)c1ccc(CBr)cc1.COCCCN", "products": "COCCCNC(=O)c1ccc(CBr)cc1"}, "reference": {"title": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "authors": "Li, Bing-yan; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "doi": "10.1021/acs.jmedchem.3c02407", "raw": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis | Li, Bing-yan; et al | Journal of Medicinal Chemistry (2024), 67(12), 9869-9895. | 10.1021/acs.jmedchem.3c02407"}, "original_text": ["Steps: 1, Yield: 92%", "CAS Reaction Number: 31-614-CAS-44298691", "1.1|Reagents: Thionyl chloride", "Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt", "1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt", "Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties", "By: Morozova, Alisa; et al", "European Journal of Medicinal Chemistry (2024), 266, 116101.", "10.1016/j.ejmech.2023.116101"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "11a3f850", "fam_sig": "7db74d31"}, "raw_data": {"raw_cas": "RCT: 753-90-2 + 54045-76-0 | PRO: 2922532-52-1 | RGT: 7719-09-7 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"authors\": \"Li, Bing-yan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44298691\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"28. Scheme 28 (1 Reaction)\", \"Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties\", \"By: Morozova, Alisa; et al\", \"European Journal of Medicinal Chemistry (2024), 266, 116101.\", \"10.1016/j.ejmech.2023.116101\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"753-90-2\", \"54045-76-0\"], \"pro_cas\": [\"2922532-52-1\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["753-90-2", "54045-76-0"], "products": ["2922532-52-1"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44298735", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 80.0, "time_h": 5.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1ccc(CBr)cc1.CCCCCN", "products": "CCCCCNC(=O)c1ccc(CBr)cc1"}, "reference": {"title": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "authors": "Li, Bing-yan; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "doi": "10.1021/acs.jmedchem.3c02407", "raw": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis | Li, Bing-yan; et al | Journal of Medicinal Chemistry (2024), 67(12), 9869-9895. | 10.1021/acs.jmedchem.3c02407"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-44298735", "1.1|Reagents: Thionyl chloride", "Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt", "1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt", "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "By: Ashton, Trent D.; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "10.1021/acs.jmedchem.2c02092"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "11a3f850", "fam_sig": "7db74d31"}, "raw_data": {"raw_cas": "RCT: 20776-50-5 + 74-89-5 | PRO: 864866-77-3 | RGT: 7719-09-7 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"authors\": \"Li, Bing-yan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44298735\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"14. Scheme 14 (1 Reaction)\", \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"By: Ashton, Trent D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"10.1021/acs.jmedchem.2c02092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"20776-50-5\", \"74-89-5\"], \"pro_cas\": [\"864866-77-3\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["20776-50-5", "74-89-5"], "products": ["864866-77-3"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44298736", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 80.0, "time_h": 5.0, "yield_pct": 83.0}, "smiles": {"reactants": "O=C(O)c1ccc(CBr)cc1.COCCN", "products": "COCCNC(=O)c1ccc(CBr)cc1"}, "reference": {"title": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "authors": "Li, Bing-yan; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "doi": "10.1021/acs.jmedchem.3c02407", "raw": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis | Li, Bing-yan; et al | Journal of Medicinal Chemistry (2024), 67(12), 9869-9895. | 10.1021/acs.jmedchem.3c02407"}, "original_text": ["Steps: 1, Yield: 83%", "CAS Reaction Number: 31-614-CAS-44298736", "1.1|Reagents: Thionyl chloride", "Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt", "1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt", "Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4", "By: Ashton, Trent D.; et al", "Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.", "10.1021/acs.jmedchem.2c02092"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "11a3f850", "fam_sig": "7db74d31"}, "raw_data": {"raw_cas": "RCT: 593-51-1 + 635-21-2 | PRO: 19178-37-1 | RGT: 7719-09-7 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"authors\": \"Li, Bing-yan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44298736\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"20. Scheme 20 (1 Reaction)\", \"Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4\", \"By: Ashton, Trent D.; et al\", \"Journal of Medicinal Chemistry (2023), 66(5), 3540-3565.\", \"10.1021/acs.jmedchem.2c02092\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"593-51-1\", \"635-21-2\"], \"pro_cas\": [\"19178-37-1\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["593-51-1", "635-21-2"], "products": ["19178-37-1"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44298740", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 80.0, "time_h": 5.0, "yield_pct": 89.0}, "smiles": {"reactants": "O=C(O)c1ccc(CBr)cc1.CCCCN", "products": "CCCCNC(=O)c1ccc(CBr)cc1"}, "reference": {"title": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "authors": "Li, Bing-yan; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "doi": "10.1021/acs.jmedchem.3c02407", "raw": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis | Li, Bing-yan; et al | Journal of Medicinal Chemistry (2024), 67(12), 9869-9895. | 10.1021/acs.jmedchem.3c02407"}, "original_text": ["Steps: 1, Yield: 89%", "CAS Reaction Number: 31-614-CAS-44298740", "1.1|Reagents: Thionyl chloride", "Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt", "1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt", "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "By: Li, Bing-yan; et al", "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "10.1021/acs.jmedchem.3c02407"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "11a3f850", "fam_sig": "7db74d31"}, "raw_data": {"raw_cas": "RCT: 6232-88-8 + 110-58-7 | PRO: 1225982-52-4 | RGT: 7719-09-7 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"authors\": \"Li, Bing-yan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44298740\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"13. Scheme 13 (1 Reaction)\", \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"By: Li, Bing-yan; et al\", \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"10.1021/acs.jmedchem.3c02407\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"6232-88-8\", \"110-58-7\"], \"pro_cas\": [\"1225982-52-4\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["6232-88-8", "110-58-7"], "products": ["1225982-52-4"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44298741", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 80.0, "time_h": 11189.0, "yield_pct": 91.0}, "smiles": {"reactants": "O=C(O)c1ccc(CBr)cc1.CCCN", "products": "CCCNC(=O)c1ccc(CBr)cc1"}, "reference": {"title": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "authors": "Li, Bing-yan; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "doi": "10.1021/acs.jmedchem.3c02407", "raw": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis | Li, Bing-yan; et al | Journal of Medicinal Chemistry (2024), 67(12), 9869-9895. | 10.1021/acs.jmedchem.3c02407"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-44298741", "1.1|Reagents: Thionyl chloride", "Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt", "1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt", "Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator", "By: Yin, Jianpeng; et al", "Organic Process Research & Development (2021), 25(10), 2260-2269.", "10.1021/acs.oprd.1c00150"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "11a3f850", "fam_sig": "7db74d31"}, "raw_data": {"raw_cas": "RCT: 62-53-3 + 637-44-5 | PRO: 7342-02-1 | RGT: 7719-09-7 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"authors\": \"Li, Bing-yan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44298741\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"8. Scheme 8 (1 Reaction)\", \"Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator\", \"By: Yin, Jianpeng; et al\", \"Organic Process Research & Development (2021), 25(10), 2260-2269.\", \"10.1021/acs.oprd.1c00150\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"62-53-3\", \"637-44-5\"], \"pro_cas\": [\"7342-02-1\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["62-53-3", "637-44-5"], "products": ["7342-02-1"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44298742", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "UNK"}], "solvents": [{"name": "Ethyl Acetate", "cas": "141-78-6"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 80.0, "time_h": 5.0, "yield_pct": 87.0}, "smiles": {"reactants": "O=C(O)c1ccc(CBr)cc1.CCN", "products": "CCNC(=O)c1ccc(CBr)cc1"}, "reference": {"title": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis", "authors": "Li, Bing-yan; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.", "doi": "10.1021/acs.jmedchem.3c02407", "raw": "Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis | Li, Bing-yan; et al | Journal of Medicinal Chemistry (2024), 67(12), 9869-9895. | 10.1021/acs.jmedchem.3c02407"}, "original_text": ["Steps: 1, Yield: 87%", "CAS Reaction Number: 31-614-CAS-44298742", "1.1|Reagents: Thionyl chloride", "Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt", "1.2|Solvents: Dichloromethane; 0 °C; 1 h, rt", "The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles", "By: Reddyrajula, Rajkumar; et al", "Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.", "10.1016/j.bmcl.2019.126846"], "signatures": {"cond_key": "none/none/Thionyl chloride|7719-09-7/Dichloromethane|75-09-2+Ethyl Acetate|141-78-6", "cond_sig": "11a3f850", "fam_sig": "7db74d31"}, "raw_data": {"raw_cas": "RCT: 59-67-6 + 2450-71-7 | PRO: 18327-30-5 | RGT: 7719-09-7 | SOL: 141-78-6 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis\", \"authors\": \"Li, Bing-yan; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(12), 9869-9895.\", \"reagents\": [\"Thionyl chloride\"], \"catalysts\": [], \"solvents\": [\"Ethyl acetate\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44298742\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Ethyl acetate; 4 h, 80 °C; 80 °C → rt\", \"1.2\", \"Solvents: Dichloromethane; 0 °C; 1 h, rt\", \"5. Scheme 5 (1 Reaction)\", \"The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles\", \"By: Reddyrajula, Rajkumar; et al\", \"Bioorganic & Medicinal Chemistry Letters (2020), 30(2), 126846.\", \"10.1016/j.bmcl.2019.126846\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"59-67-6\", \"2450-71-7\"], \"pro_cas\": [\"18327-30-5\"], \"rgt_cas\": [\"7719-09-7\"], \"cat_cas\": [], \"sol_cas\": [\"141-78-6\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["59-67-6", "2450-71-7"], "products": ["18327-30-5"], "reagents": ["7719-09-7"], "catalysts": [], "solvents": ["Ethyl Acetate", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.185580", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44299839", "reaction_type": "Other", "catalyst": {"core": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}], "generic": [], "ligands": [], "full_system": [{"name": "4-Dimethylaminopyridine", "cas": "1122-58-3"}]}, "reagents": [{"name": "N,N-Dicyclohexylcarbodiimide", "cas": "538-75-0", "role": "UNK"}, {"name": "Dicyclohexylcarbodiimide", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 80.0}, "smiles": {"reactants": "C#CCN.CC(=O)O[C@@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]32)C1", "products": "C#CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(C)=O)CC[C@]4(C)[C@H]3CC[C@]12C"}, "reference": {"title": "Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2", "authors": "Chhabra, Mohit; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(14), 11885-11916.", "doi": "10.1021/acs.jmedchem.4c00487", "raw": "Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2 | Chhabra, Mohit; et al | Journal of Medicinal Chemistry (2024), 67(14), 11885-11916. | 10.1021/acs.jmedchem.4c00487"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-44299839", "1.1|Reagents: Dicyclohexylcarbodiimide", "Catalysts: 4-(Dimethylamino)pyridine", "Solvents: Dichloromethane; 1 h, rt", "Double bond geometry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown", "Double bond geometry shown", "An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity", "By: Lemke, Carina; et al", "Journal of Medicinal Chemistry (2021), 64(18), 13793-13806.", "10.1021/acs.jmedchem.1c01178"], "signatures": {"cond_key": "none/none/Dicyclohexylcarbodiimide|+N,N-Dicyclohexylcarbodiimide|538-75-0/Dichloromethane|75-09-2", "cond_sig": "51e34883", "fam_sig": "962d4cca"}, "raw_data": {"raw_cas": "RCT: 2965359-39-9 + 13139-15-6 | PRO: 2965359-40-2 | RGT: 538-75-0 | CAT: 1122-58-3 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2\", \"authors\": \"Chhabra, Mohit; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(14), 11885-11916.\", \"reagents\": [\"Dicyclohexylcarbodiimide\"], \"catalysts\": [\"4-(Dimethylamino)pyridine\"], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44299839\", \"1.1\", \"Reagents: Dicyclohexylcarbodiimide\", \"Catalysts: 4-(Dimethylamino)pyridine\", \"Solvents: Dichloromethane; 1 h, rt\", \"297. Scheme 297 (1 Reaction)\", \"Double bond geometry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity\", \"By: Lemke, Carina; et al\", \"Journal of Medicinal Chemistry (2021), 64(18), 13793-13806.\", \"10.1021/acs.jmedchem.1c01178\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2965359-39-9\", \"13139-15-6\"], \"pro_cas\": [\"2965359-40-2\"], \"rgt_cas\": [\"538-75-0\"], \"cat_cas\": [\"1122-58-3\"], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2965359-39-9", "13139-15-6"], "products": ["2965359-40-2"], "reagents": ["N,N-Dicyclohexylcarbodiimide"], "catalysts": ["4-Dimethylaminopyridine"], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.198226", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44479951", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "BASE"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 16.25, "yield_pct": 85.0}, "smiles": {"reactants": "CC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@@H]2CO[C@@H](c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)O.C[C@H](N)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O", "products": "CC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@@H]2CO[C@@H](c3ccccc3)O[C@H]2[C@@H]1O[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O"}, "reference": {"title": "Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists", "authors": "Mhamane, Tukaram B.; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.", "doi": "10.1016/j.bmc.2023.117296", "raw": "Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists | Mhamane, Tukaram B.; et al | Bioorganic & Medicinal Chemistry (2023), 88-89, 117296. | 10.1016/j.bmc.2023.117296"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-44479951", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Tetrahydrofuran; 15 min, rt", "1.2|Reagents: Diisopropylethylamine; 0 °C; 16 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites", "By: Belouin, Audrey; et al", "Bioorganic & Medicinal Chemistry (2024), 98, 117553.", "10.1016/j.bmc.2023.117553"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5/Tetrahydrofuran|109-99-9", "cond_sig": "2001d9e7", "fam_sig": "a3e71454"}, "raw_data": {"raw_cas": "RCT: 58480-39-0 + 3036050-18-4 | PRO: 3036050-26-4 | RGT: 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists\", \"authors\": \"Mhamane, Tukaram B.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44479951\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Tetrahydrofuran; 15 min, rt\", \"1.2\", \"Reagents: Diisopropylethylamine; 0 °C; 16 h, rt\", \"467. Scheme 467 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites\", \"By: Belouin, Audrey; et al\", \"Bioorganic & Medicinal Chemistry (2024), 98, 117553.\", \"10.1016/j.bmc.2023.117553\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"58480-39-0\", \"3036050-18-4\"], \"pro_cas\": [\"3036050-26-4\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"109-99-9\"], \"notes\": []}}", "enriched_names": {"reactants": ["58480-39-0", "3036050-18-4"], "products": ["3036050-26-4"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.198226", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44479962", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Tetrahydrofuran", "cas": "109-99-9"}], "conditions": {"temperature_c": 0.0, "time_h": 17.0, "yield_pct": 85.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O.C[C@H](NC(=O)OC(C)(C)C)C(=O)O", "products": "C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](CCC(=O)OCc1ccccc1)C(N)=O"}, "reference": {"title": "Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists", "authors": "Mhamane, Tukaram B.; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.", "doi": "10.1016/j.bmc.2023.117296", "raw": "Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists | Mhamane, Tukaram B.; et al | Bioorganic & Medicinal Chemistry (2023), 88-89, 117296. | 10.1016/j.bmc.2023.117296"}, "original_text": ["Steps: 1, Yield: 85%", "CAS Reaction Number: 31-614-CAS-44479962", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 0 °C; 1.5 h, rt", "1.2|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Tetrahydrofuran; 30 min, rt", "1.3|Reagents: Diisopropylethylamine", "Solvents: Tetrahydrofuran; 15 h, rt", "Absolute stereochemistry shown,", "Rotation (-)", "Absolute stereochemistry shown,", "Rotation (-)", "Insights into Fast Amide Couplings in Aqueous Nanomicelles", "By: Sharma, Sudripet; et al", "Organic Process Research & Development (2021), 25(8), 1960-1965.", "10.1021/acs.oprd.1c00203"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Diisopropylethylamine|+N,N-Diisopropylethylamine|7087-68-5+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Tetrahydrofuran|109-99-9", "cond_sig": "eefce332", "fam_sig": "1364c895"}, "raw_data": {"raw_cas": "RCT: 108-69-0 + 15761-39-4 | PRO: 137496-70-9 | RGT: 76-05-1 + 2592-95-2 + 25952-53-8 + 7087-68-5 | SOL: 75-09-2 + 109-99-9", "raw_data_json": "{\"txt\": {\"title\": \"Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists\", \"authors\": \"Mhamane, Tukaram B.; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.\", \"reagents\": [\"Trifluoroacetic acid\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Diisopropylethylamine\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Tetrahydrofuran\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44479962\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 0 °C; 1.5 h, rt\", \"1.2\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Tetrahydrofuran; 30 min, rt\", \"1.3\", \"Reagents: Diisopropylethylamine\", \"Solvents: Tetrahydrofuran; 15 h, rt\", \"299. Scheme 299 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Insights into Fast Amide Couplings in Aqueous Nanomicelles\", \"By: Sharma, Sudripet; et al\", \"Organic Process Research & Development (2021), 25(8), 1960-1965.\", \"10.1021/acs.oprd.1c00203\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"108-69-0\", \"15761-39-4\"], \"pro_cas\": [\"137496-70-9\"], \"rgt_cas\": [\"76-05-1\", \"2592-95-2\", \"25952-53-8\", \"7087-68-5\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"109-99-9\"], \"notes\": [\"intermediate from stage 1 added in stage 3 (stage 3)\"]}}", "enriched_names": {"reactants": ["108-69-0", "15761-39-4"], "products": ["137496-70-9"], "reagents": ["Trifluoroacetic acid", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "N,N-Diisopropylethylamine"], "catalysts": [], "solvents": ["Dichloromethane", "Tetrahydrofuran"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.198226", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44725294", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 1.0, "yield_pct": 95.0}, "smiles": {"reactants": "CCOc1cc(I)cc(COc2ccc(CCNC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)C[C@H]3CC[C@@H](N)CC3)c3ccccc3)cc2)c1OCC(=O)O.Cl", "products": "CCOc1cc(I)cc2c1OCC(=O)NC1CCC(CC1)CC(=O)NC(c1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCCc1ccc(cc1)OC2"}, "reference": {"title": "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen", "authors": "Hekking, Koen F. W.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.", "doi": "10.1021/acs.jmedchem.3c02206", "raw": "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen | Hekking, Koen F. W.; et al | Journal of Medicinal Chemistry (2024), 67(4), 3039-3065. | 10.1021/acs.jmedchem.3c02206"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-44725294", "1.1|Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 1 h, rt", "Copyright © 2025 American Chemical Society (ACS). All Rights Reserved."], "signatures": {"cond_key": "none/none/HATU|148893-10-1+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Triethylamine|121-44-8/Dimethylformamide|68-12-2", "cond_sig": "7506d0ed", "fam_sig": "61fdd8c8"}, "raw_data": {"raw_cas": "RGT: 121-44-8 + 148893-10-1 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen\", \"authors\": \"Hekking, Koen F. W.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.\", \"reagents\": [\"Triethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44725294\", \"1.1\", \"Reagents: Triethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 1 h, rt\", \"Copyright © 2025 American Chemical Society (ACS). All Rights Reserved.\"]}, \"rdf\": {\"rct_cas\": [], \"pro_cas\": [], \"rgt_cas\": [\"121-44-8\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": [], "products": [], "reagents": ["Triethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44725301", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 100.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O.NCCc1ccc(OCc2ccccc2)cc1", "products": "CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)NCCc1ccc(OCc2ccccc2)cc1"}, "reference": {"title": "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen", "authors": "Hekking, Koen F. W.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.", "doi": "10.1021/acs.jmedchem.3c02206", "raw": "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen | Hekking, Koen F. W.; et al | Journal of Medicinal Chemistry (2024), 67(4), 3039-3065. | 10.1021/acs.jmedchem.3c02206"}, "original_text": ["Steps: 1, Yield: 100%", "CAS Reaction Number: 31-614-CAS-44725301", "1.1|Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 1 h, 0 °C", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils", "By: Zhu, Di; et al", "European Journal of Medicinal Chemistry (2023), 258, 115619.", "10.1016/j.ejmech.2023.115619"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2/Dichloromethane|75-09-2", "cond_sig": "8b668ff3", "fam_sig": "ace9a72b"}, "raw_data": {"raw_cas": "RCT: 2480-93-5 + 100-46-9 | PRO: 1374311-23-5 | RGT: 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen\", \"authors\": \"Hekking, Koen F. W.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.\", \"reagents\": [\"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44725301\", \"1.1\", \"Reagents: 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 1 h, 0 °C\", \"338. Scheme 338 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils\", \"By: Zhu, Di; et al\", \"European Journal of Medicinal Chemistry (2023), 258, 115619.\", \"10.1016/j.ejmech.2023.115619\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2480-93-5\", \"100-46-9\"], \"pro_cas\": [\"1374311-23-5\"], \"rgt_cas\": [\"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["2480-93-5", "100-46-9"], "products": ["1374311-23-5"], "reagents": ["1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44725302", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Triethylamine", "cas": "121-44-8", "role": "BASE"}, {"name": "1-Hydroxybenzotriazole", "cas": "2592-95-2", "role": "UNK"}, {"name": "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "25952-53-8", "role": "UNK"}, {"name": "1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 2.0, "yield_pct": 97.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CC(=O)O)CC1.Cl.N[C@H](C(=O)N[C@H](Cc1ccccc1)C(=O)NCCc1ccc(OCc2ccccc2)cc1)c1ccccc1", "products": "CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CC(=O)N[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)NCCc2ccc(OCc3ccccc3)cc2)c2ccccc2)CC1"}, "reference": {"title": "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen", "authors": "Hekking, Koen F. W.; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.", "doi": "10.1021/acs.jmedchem.3c02206", "raw": "Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen | Hekking, Koen F. W.; et al | Journal of Medicinal Chemistry (2024), 67(4), 3039-3065. | 10.1021/acs.jmedchem.3c02206"}, "original_text": ["Steps: 1, Yield: 97%", "CAS Reaction Number: 31-614-CAS-44725302", "1.1|Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride", "Solvents: Dichloromethane; 2 h, 0 °C → rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride|25952-53-8+1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride|+1-Hydroxybenzotriazole|2592-95-2+Triethylamine|121-44-8/Dichloromethane|75-09-2", "cond_sig": "4da6172b", "fam_sig": "2c09422f"}, "raw_data": {"raw_cas": "RCT: 619-58-9 + 3026372-08-4 + 3026373-07-6 | PRO: 3026372-27-7 + 3026372-29-9 | RGT: 121-44-8 + 2592-95-2 + 25952-53-8 | SOL: 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen\", \"authors\": \"Hekking, Koen F. W.; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(4), 3039-3065.\", \"reagents\": [\"Triethylamine\", \"1-Hydroxybenzotriazole\", \"1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44725302\", \"1.1\", \"Reagents: Triethylamine, 1-Hydroxybenzotriazole, 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride\", \"Solvents: Dichloromethane; 2 h, 0 °C → rt\", \"156. Scheme 156 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"619-58-9\", \"3026372-08-4\", \"3026373-07-6\"], \"pro_cas\": [\"3026372-27-7\", \"3026372-29-9\"], \"rgt_cas\": [\"121-44-8\", \"2592-95-2\", \"25952-53-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["619-58-9", "3026372-08-4", "3026373-07-6"], "products": ["3026372-27-7", "3026372-29-9"], "reagents": ["Triethylamine", "1-Hydroxybenzotriazole", "1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride"], "catalysts": [], "solvents": ["Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44938486", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Thionyl chloride", "cas": "7719-09-7", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "WORKUP"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Methanol", "cas": "67-56-1"}, {"name": "Dimethyl Sulfoxide", "cas": "67-68-5"}], "conditions": {"temperature_c": 60.0, "time_h": 4.0, "yield_pct": 80.0}, "smiles": {"reactants": "CO.COC(=O)[C@@H](N)Cc1ccc(O)c(I)c1.CC(C)(C)OC(=O)NCCC(=O)O", "products": "COC(=O)[C@H](Cc1ccc(O)c(I)c1)NC(=O)CCNC(=O)OC(C)(C)C"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria", "authors": "Zhang, Yinyong; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.", "doi": "10.1021/acs.jmedchem.4c00018", "raw": "Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria | Zhang, Yinyong; et al | Journal of Medicinal Chemistry (2024), 67(8), 6585-6609. | 10.1021/acs.jmedchem.4c00018"}, "original_text": ["Steps: 1, Yield: 80%", "CAS Reaction Number: 31-614-CAS-44938486", "1.1|Reagents: Thionyl chloride", "Solvents: Methanol; 0 °C; 2 h, 0 °C → 60 °C", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethyl sulfoxide; 2 h, rt", "1.3|Reagents: Water; rt", "Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment", "By: Zhang, Rui; et al", "European Journal of Medicinal Chemistry (2021), 211, 113004.", "10.1016/j.ejmech.2020.113004"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Thionyl chloride|7719-09-7+Water|7732-18-5/Dimethyl Sulfoxide|67-68-5+Methanol|67-56-1", "cond_sig": "eeaad183", "fam_sig": "f48ff557"}, "raw_data": {"raw_cas": "RCT: 87-51-4 + 120-20-7 | PRO: 13433-48-2 | RGT: 7719-09-7 + 7087-68-5 + 148893-10-1 + 7732-18-5 | SOL: 67-56-1 + 67-68-5", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria\", \"authors\": \"Zhang, Yinyong; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.\", \"reagents\": [\"Thionyl chloride\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Methanol\", \"Dimethyl sulfoxide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44938486\", \"1.1\", \"Reagents: Thionyl chloride\", \"Solvents: Methanol; 0 °C; 2 h, 0 °C → 60 °C\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethyl sulfoxide; 2 h, rt\", \"1.3\", \"Reagents: Water; rt\", \"371. Scheme 371 (1 Reaction)\", \"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment\", \"By: Zhang, Rui; et al\", \"European Journal of Medicinal Chemistry (2021), 211, 113004.\", \"10.1016/j.ejmech.2020.113004\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"87-51-4\", \"120-20-7\"], \"pro_cas\": [\"13433-48-2\"], \"rgt_cas\": [\"7719-09-7\", \"7087-68-5\", \"148893-10-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"67-56-1\", \"67-68-5\"], \"notes\": [\"alternate reaction conditions also shown\"]}}", "enriched_names": {"reactants": ["87-51-4", "120-20-7"], "products": ["13433-48-2"], "reagents": ["7719-09-7", "N,N-Diisopropylethylamine", "HATU", "Water"], "catalysts": [], "solvents": ["Methanol", "Dimethyl Sulfoxide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-44938560", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Dichloromethane", "cas": "75-09-2"}], "conditions": {"temperature_c": 0.0, "time_h": 1.0, "yield_pct": 99.0}, "smiles": {"reactants": "Cl.N#CCN.C[C@@H]1NC(=O)[C@@H](N(C)C(=O)[C@H](CCNC(=O)OC(C)(C)C)NC(=O)OCc2ccccc2)c2ccc(OCCNC(=O)OC(C)(C)C)c(c2)-c2cc(ccc2OCCNC(=O)OC(C)(C)C)C[C@@H](C(=O)O)NC1=O", "products": "C[C@@H]1NC(=O)[C@@H](N(C)C(=O)[C@H](CCNC(=O)OC(C)(C)C)NC(=O)OCc2ccccc2)c2ccc(OCCNC(=O)OC(C)(C)C)c(c2)-c2cc(ccc2OCCNC(=O)OC(C)(C)C)C[C@@H](C(=O)NCC#N)NC1=O"}, "reference": {"title": "Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria", "authors": "Zhang, Yinyong; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.", "doi": "10.1021/acs.jmedchem.4c00018", "raw": "Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria | Zhang, Yinyong; et al | Journal of Medicinal Chemistry (2024), 67(8), 6585-6609. | 10.1021/acs.jmedchem.4c00018"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-44938560", "1.1|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide, Dichloromethane; 1 h, 0 °C", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists", "By: Mhamane, Tukaram B.; et al", "Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.", "10.1016/j.bmc.2023.117296"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|/Dichloromethane|75-09-2+Dimethylformamide|68-12-2", "cond_sig": "87124669", "fam_sig": "748b7b68"}, "raw_data": {"raw_cas": "RCT: 73089-68-6 + 62853-36-5 | PRO: 170210-30-7 | RGT: 7087-68-5 + 148893-10-1 | SOL: 68-12-2 + 75-09-2", "raw_data_json": "{\"txt\": {\"title\": \"Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria\", \"authors\": \"Zhang, Yinyong; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(8), 6585-6609.\", \"reagents\": [\"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\", \"Dichloromethane\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-44938560\", \"1.1\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide, Dichloromethane; 1 h, 0 °C\", \"466. Scheme 466 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists\", \"By: Mhamane, Tukaram B.; et al\", \"Bioorganic & Medicinal Chemistry (2023), 88-89, 117296.\", \"10.1016/j.bmc.2023.117296\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"73089-68-6\", \"62853-36-5\"], \"pro_cas\": [\"170210-30-7\"], \"rgt_cas\": [\"7087-68-5\", \"148893-10-1\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\", \"75-09-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["73089-68-6", "62853-36-5"], "products": ["170210-30-7"], "reagents": ["N,N-Diisopropylethylamine", "HATU"], "catalysts": [], "solvents": ["Dimethylformamide", "Dichloromethane"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45117379", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "BASE"}, {"name": "HBTU", "cas": "94790-37-1", "role": "WORKUP"}, {"name": "Water", "cas": "7732-18-5", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dimethylformamide", "cas": "68-12-2"}], "conditions": {"temperature_c": 25.0, "time_h": 17.5, "yield_pct": 84.0}, "smiles": {"reactants": "CC(C)(C)OC(=O)NCC(=O)O.CN(C)c1ccc(/C=C/c2ccc(N)cc2)cc1", "products": "CN(C)c1ccc(/C=C/c2ccc(NC(=O)CNC(=O)OC(C)(C)C)cc2)cc1"}, "reference": {"title": "Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system", "authors": "Wei, Bin; et al", "citation": "Bioorganic & Medicinal Chemistry (2023), 84, 117257.", "doi": "10.1016/j.bmc.2023.117257", "raw": "Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system | Wei, Bin; et al | Bioorganic & Medicinal Chemistry (2023), 84, 117257. | 10.1016/j.bmc.2023.117257"}, "original_text": ["Steps: 1, Yield: 84%", "CAS Reaction Number: 31-614-CAS-45117379", "1.1|Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide", "Solvents: Dimethylformamide; 0.5 h, rt", "1.2|overnight, rt", "1.3|Reagents: Water", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma", "By: Zhang, Wen; et al", "Bioorganic & Medicinal Chemistry (2021), 40, 116182.", "10.1016/j.bmc.2021.116182"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HBTU|94790-37-1+N,N-Diisopropylethylamine|7087-68-5+Water|7732-18-5/Dimethylformamide|68-12-2", "cond_sig": "556adacb", "fam_sig": "d670dab7"}, "raw_data": {"raw_cas": "RCT: 98-97-5 + 2387522-87-2 | PRO: 2760538-84-7 | RGT: 7087-68-5 + 94790-37-1 + 7732-18-5 | SOL: 68-12-2", "raw_data_json": "{\"txt\": {\"title\": \"Synthesis and bioactivity evaluation of a myelin-specific contrast agent for magnetic resonance imaging of myelination in central nervous system\", \"authors\": \"Wei, Bin; et al\", \"citation\": \"Bioorganic & Medicinal Chemistry (2023), 84, 117257.\", \"reagents\": [\"Diisopropylethylamine\", \"Water\"], \"catalysts\": [], \"solvents\": [\"Dimethylformamide\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45117379\", \"1.1\", \"Reagents: Diisopropylethylamine, 1-[Bis(dimethylamino)methylene]-1H-benzotriazolium hexafluorophosphate(1-) 3-oxide\", \"Solvents: Dimethylformamide; 0.5 h, rt\", \"1.2\", \"overnight, rt\", \"1.3\", \"Reagents: Water\", \"174. Scheme 174 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma\", \"By: Zhang, Wen; et al\", \"Bioorganic & Medicinal Chemistry (2021), 40, 116182.\", \"10.1016/j.bmc.2021.116182\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"98-97-5\", \"2387522-87-2\"], \"pro_cas\": [\"2760538-84-7\"], \"rgt_cas\": [\"7087-68-5\", \"94790-37-1\", \"7732-18-5\"], \"cat_cas\": [], \"sol_cas\": [\"68-12-2\"], \"notes\": []}}", "enriched_names": {"reactants": ["98-97-5", "2387522-87-2"], "products": ["2760538-84-7"], "reagents": ["N,N-Diisopropylethylamine", "HBTU", "Water"], "catalysts": [], "solvents": ["Dimethylformamide"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941654", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 90.0}, "smiles": {"reactants": "CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C.O=C(O)COc1ccc(Cl)cc1Cl", "products": "CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)COc1ccc(Cl)cc1Cl"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-45941654", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown,", "Rotation (+)", "Absolute stereochemistry shown", "Absolute stereochemistry shown,", "Rotation (-)", "Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability", "By: Meta, Mergim; et al", "ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.", "10.1021/acsmedchemlett.4c00050"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 3085792-03-3 + 645394-47-4 | PRO: 3085792-16-8 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941654\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"113. Scheme 113 (1 Reaction)\", \"Absolute stereochemistry shown,\", \"Rotation (+)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown,\", \"Rotation (-)\", \"Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability\", \"By: Meta, Mergim; et al\", \"ACS Medicinal Chemistry Letters (2024), 15(6), 837-844.\", \"10.1021/acsmedchemlett.4c00050\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3085792-03-3\", \"645394-47-4\"], \"pro_cas\": [\"3085792-16-8\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["3085792-03-3", "645394-47-4"], "products": ["3085792-16-8"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941714", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 94.0}, "smiles": {"reactants": "CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1ccc(Cl)cc1)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-45941714", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 155480-08-3 + 157567-13-0 | PRO: 2765293-50-1 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941714\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"2. Scheme 2 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"155480-08-3\", \"157567-13-0\"], \"pro_cas\": [\"2765293-50-1\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["155480-08-3", "157567-13-0"], "products": ["2765293-50-1"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941790", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Potassium bisulfate", "cas": "7646-93-7", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 98.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-45941790", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Potassium bisulfate", "Solvents: Water; pH 1 - 2, rt", "Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands", "By: Andreasson, Maans; et al", "Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.", "10.1021/acs.jmedchem.3c02127"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Potassium bisulfate|7646-93-7+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "82ea884a", "fam_sig": "60c2ec33"}, "raw_data": {"raw_cas": "RCT: 113-24-6 + 5348-42-5 | PRO: 73148-15-9 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 7646-93-7 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Potassium bisulfate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941790\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Potassium bisulfate\", \"Solvents: Water; pH 1 - 2, rt\", \"97. Scheme 97 (1 Reaction)\", \"Exploring the Dispersion and Electrostatic Components in Arene-Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands\", \"By: Andreasson, Maans; et al\", \"Journal of Medicinal Chemistry (2024), 67(3), 2202-2219.\", \"10.1021/acs.jmedchem.3c02127\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"113-24-6\", \"5348-42-5\"], \"pro_cas\": [\"73148-15-9\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"7646-93-7\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["113-24-6", "5348-42-5"], "products": ["73148-15-9"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "7646-93-7"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941791", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 91.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1F)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1F)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 91%", "CAS Reaction Number: 31-614-CAS-45941791", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C", "By: Zhu, Mei; et al", "European Journal of Medicinal Chemistry (2022), 233, 114251.", "10.1016/j.ejmech.2022.114251"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 157567-13-0 + 1315051-74-1 | PRO: 2765293-27-2 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941791\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"152. Scheme 152 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Design, synthesis and biological evaluation of protease inhibitors containing morpholine cores with remarkable potency against both HIV-1 subtypes B and C\", \"By: Zhu, Mei; et al\", \"European Journal of Medicinal Chemistry (2022), 233, 114251.\", \"10.1016/j.ejmech.2022.114251\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"157567-13-0\", \"1315051-74-1\"], \"pro_cas\": [\"2765293-27-2\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["157567-13-0", "1315051-74-1"], "products": ["2765293-27-2"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.199192", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941792", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 99.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(Cl)c1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(Cl)c1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-45941792", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins", "By: Behring, Lydia; et al", "Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.", "10.1021/acs.jmedchem.2c01360"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 114873-06-2 + 3026371-88-7 | PRO: 3026370-92-0 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941792\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"138. Scheme 138 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Dipeptide-derived alkynes as potent and selective irreversible inhibitors of cysteine cathepsins\", \"By: Behring, Lydia; et al\", \"Journal of Medicinal Chemistry (2023), 66(6), 3818-3851.\", \"10.1021/acs.jmedchem.2c01360\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"114873-06-2\", \"3026371-88-7\"], \"pro_cas\": [\"3026370-92-0\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["114873-06-2", "3026371-88-7"], "products": ["3026370-92-0"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.201429", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941797", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 95.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(F)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 95%", "CAS Reaction Number: 31-614-CAS-45941797", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 3075104-40-1 + 62965-35-9 | PRO: 3075104-51-4 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941797\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"145. Scheme 145 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-40-1\", \"62965-35-9\"], \"pro_cas\": [\"3075104-51-4\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["3075104-40-1", "62965-35-9"], "products": ["3075104-51-4"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.201429", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941798", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 98.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1Cl)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccccc1Cl)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 98%", "CAS Reaction Number: 31-614-CAS-45941798", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections", "By: Fei, Yue; et al", "Journal of Medicinal Chemistry (2020), 63(17), 9127-9135.", "10.1021/acs.jmedchem.9b01832"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 53293-00-8 + 1446557-76-1 | PRO: 2982239-51-8 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941798\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"149. Scheme 149 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections\", \"By: Fei, Yue; et al\", \"Journal of Medicinal Chemistry (2020), 63(17), 9127-9135.\", \"10.1021/acs.jmedchem.9b01832\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"53293-00-8\", \"1446557-76-1\"], \"pro_cas\": [\"2982239-51-8\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["53293-00-8", "1446557-76-1"], "products": ["2982239-51-8"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.201429", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941800", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 94.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 94%", "CAS Reaction Number: 31-614-CAS-45941800", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum", "By: Teno, Naoki; et al", "ACS Medicinal Chemistry Letters (2021), 12(3), 420-425.", "10.1021/acsmedchemlett.0c00640"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 118482-03-4 + 368866-15-3 | PRO: 2762438-73-1 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941800\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"146. Scheme 146 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum\", \"By: Teno, Naoki; et al\", \"ACS Medicinal Chemistry Letters (2021), 12(3), 420-425.\", \"10.1021/acsmedchemlett.0c00640\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"118482-03-4\", \"368866-15-3\"], \"pro_cas\": [\"2762438-73-1\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["118482-03-4", "368866-15-3"], "products": ["2762438-73-1"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.201429", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941801", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 90.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(F)c1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccc(F)c1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 90%", "CAS Reaction Number: 31-614-CAS-45941801", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 3075104-39-8 + 62965-35-9 | PRO: 3075104-50-3 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941801\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"144. Scheme 144 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-39-8\", \"62965-35-9\"], \"pro_cas\": [\"3075104-50-3\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["3075104-39-8", "62965-35-9"], "products": ["3075104-50-3"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.201429", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941810", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "NaHCO3", "cas": "144-55-8", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}, {"name": "Sodium bicarbonate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 82.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccs1)NC(=O)OC(C)(C)C.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@H](Cc1cccs1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 82%", "CAS Reaction Number: 31-614-CAS-45941810", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Sodium bicarbonate", "Solvents: Dichloromethane, Water; pH 12, rt", "Absolute stereochemistry shown", "Double bond geometry shown", "Absolute stereochemistry shown", "Absolute stereochemistry shown", "Double bond geometry shown", "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "By: Breidenbach, Julian; et al", "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "10.1021/acs.jmedchem.4c00053"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+NaHCO3|144-55-8+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Sodium bicarbonate|+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "7b469fd8", "fam_sig": "51813427"}, "raw_data": {"raw_cas": "RCT: 3075104-35-4 + 62965-35-9 | PRO: 3075104-46-7 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 144-55-8 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Sodium bicarbonate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941810\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Sodium bicarbonate\", \"Solvents: Dichloromethane, Water; pH 12, rt\", \"151. Scheme 151 (1 Reaction)\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Absolute stereochemistry shown\", \"Absolute stereochemistry shown\", \"Double bond geometry shown\", \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"By: Breidenbach, Julian; et al\", \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"10.1021/acs.jmedchem.4c00053\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"3075104-35-4\", \"62965-35-9\"], \"pro_cas\": [\"3075104-46-7\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"144-55-8\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": [\"intermediate from stage 1 added in stage 3,see experimental details\"]}}", "enriched_names": {"reactants": ["3075104-35-4", "62965-35-9"], "products": ["3075104-46-7"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "NaHCO3"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.201429", "export_version": "1.0"}}
{"reaction_id": "31-614-CAS-45941817", "reaction_type": "Other", "catalyst": {"core": [], "generic": [], "ligands": [], "full_system": []}, "reagents": [{"name": "Trifluoroacetic acid", "cas": "76-05-1", "role": "BASE"}, {"name": "N,N-Diisopropylethylamine", "cas": "7087-68-5", "role": "UNK"}, {"name": "HATU", "cas": "148893-10-1", "role": "UNK"}, {"name": "Potassium bisulfate", "cas": "7646-93-7", "role": "UNK"}, {"name": "Diisopropylethylamine", "cas": "", "role": "UNK"}, {"name": "O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "cas": "", "role": "UNK"}], "solvents": [{"name": "Dichloromethane", "cas": "75-09-2"}, {"name": "Dimethylformamide", "cas": "68-12-2"}, {"name": "Water", "cas": "7732-18-5"}], "conditions": {"temperature_c": 0.0, "time_h": 18.25, "yield_pct": 99.0}, "smiles": {"reactants": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@@H](NC(=O)OC(C)(C)C)C1CCCCC1.CC(C)(C)OC(=O)N[C@H](C(=O)O)C(C)(C)C", "products": "CN(/N=C/c1cccc(Cl)c1F)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C1CCCCC1"}, "reference": {"title": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs", "authors": "Breidenbach, Julian; et al", "citation": "Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.", "doi": "10.1021/acs.jmedchem.4c00053", "raw": "Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs | Breidenbach, Julian; et al | Journal of Medicinal Chemistry (2024), 67(11), 8757-8790. | 10.1021/acs.jmedchem.4c00053"}, "original_text": ["Steps: 1, Yield: 99%", "CAS Reaction Number: 31-614-CAS-45941817", "1.1|Reagents: Trifluoroacetic acid", "Solvents: Dichloromethane; 2 h, rt", "1.2|Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate", "Solvents: Dimethylformamide; 15 min, 0 °C", "1.3|Solvents: Dimethylformamide; 0 °C; 16 h, rt", "1.4|Reagents: Potassium bisulfate", "Solvents: Water; pH 1 - 2, rt", "Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents", "By: Amblard, Franck; et al", "Bioorganic & Medicinal Chemistry (2021), 31, 115952.", "10.1016/j.bmc.2020.115952"], "signatures": {"cond_key": "none/none/Diisopropylethylamine|+HATU|148893-10-1+N,N-Diisopropylethylamine|7087-68-5+O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate|+Potassium bisulfate|7646-93-7+Trifluoroacetic acid|76-05-1/Dichloromethane|75-09-2+Dimethylformamide|68-12-2+Water|7732-18-5", "cond_sig": "82ea884a", "fam_sig": "60c2ec33"}, "raw_data": {"raw_cas": "RCT: 2450-71-7 + 1644485-79-9 | PRO: 2736516-78-0 | RGT: 76-05-1 + 7087-68-5 + 148893-10-1 + 7646-93-7 | SOL: 75-09-2 + 68-12-2 + 7732-18-5", "raw_data_json": "{\"txt\": {\"title\": \"Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs\", \"authors\": \"Breidenbach, Julian; et al\", \"citation\": \"Journal of Medicinal Chemistry (2024), 67(11), 8757-8790.\", \"reagents\": [\"Trifluoroacetic acid\", \"Diisopropylethylamine\", \"O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Potassium bisulfate\"], \"catalysts\": [], \"solvents\": [\"Dichloromethane\", \"Dimethylformamide\", \"Water\"], \"base_from_txt\": null, \"all_condition_lines\": [\"CAS Reaction Number: 31-614-CAS-45941817\", \"1.1\", \"Reagents: Trifluoroacetic acid\", \"Solvents: Dichloromethane; 2 h, rt\", \"1.2\", \"Reagents: Diisopropylethylamine, O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate\", \"Solvents: Dimethylformamide; 15 min, 0 °C\", \"1.3\", \"Solvents: Dimethylformamide; 0 °C; 16 h, rt\", \"1.4\", \"Reagents: Potassium bisulfate\", \"Solvents: Water; pH 1 - 2, rt\", \"104. Scheme 104 (1 Reaction)\", \"Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents\", \"By: Amblard, Franck; et al\", \"Bioorganic & Medicinal Chemistry (2021), 31, 115952.\", \"10.1016/j.bmc.2020.115952\", \"View All Sources in CAS SciFinder\"]}, \"rdf\": {\"rct_cas\": [\"2450-71-7\", \"1644485-79-9\"], \"pro_cas\": [\"2736516-78-0\"], \"rgt_cas\": [\"76-05-1\", \"7087-68-5\", \"148893-10-1\", \"7646-93-7\"], \"cat_cas\": [], \"sol_cas\": [\"75-09-2\", \"68-12-2\", \"7732-18-5\"], \"notes\": []}}", "enriched_names": {"reactants": ["2450-71-7", "1644485-79-9"], "products": ["2736516-78-0"], "reagents": ["Trifluoroacetic acid", "N,N-Diisopropylethylamine", "HATU", "7646-93-7"], "catalysts": [], "solvents": ["Dichloromethane", "Dimethylformamide", "Water"]}}, "metadata": {"export_timestamp": "2025-08-30T15:13:36.201429", "export_version": "1.0"}}
